data_2khw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2khw _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.1 164.84 0.23 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.227 1.951 . . . . 0.0 112.75 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -2.12 6.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.735 -0.603 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -122.46 11.65 9.97 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.171 -0.956 . . . . 0.0 110.591 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.6 mm -114.36 130.32 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.232 -0.917 . . . . 0.0 110.774 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.26 138.16 20.5 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.75 -33.65 9.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.142 1.895 . . . . 0.0 113.072 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -43.0 99.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.863 . . . . 0.0 110.679 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.32 -23.81 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.704 -1.247 . . . . 0.0 109.878 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -68.29 -54.83 14.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.852 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -60.82 -15.25 28.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.42 -6.47 59.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.68 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.03 151.98 45.7 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.189 -0.945 . . . . 0.0 109.559 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.74 154.79 24.54 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.267 1.978 . . . . 0.0 111.961 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -62.73 -52.17 64.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 110.584 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.02 -44.09 30.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.968 -1.082 . . . . 0.0 110.036 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.2 t -74.93 -32.19 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.937 -1.102 . . . . 0.0 108.489 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.414 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.3 tt0 -60.51 -50.03 75.17 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -57.56 -48.7 78.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.59 -0.694 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -56.68 -41.64 77.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.024 -1.047 . . . . 0.0 110.064 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.93 -38.46 69.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.074 -1.016 . . . . 0.0 109.786 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.53 -39.59 77.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.69 -1.256 . . . . 0.0 109.024 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.119 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -74.61 -38.11 62.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.4 m0 . . . . . 0 C--N 1.303 -1.43 0 O-C-N 121.013 -1.054 . . . . 0.0 108.865 179.039 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -97.57 163.06 13.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.465 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.36 143.53 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.31 141.68 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.54 108.53 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.54 131.04 39.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 108.822 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 24.1 p -90.57 -175.82 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.102 -0.999 . . . . 0.0 110.676 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 35.4 mt -70.71 -20.71 62.64 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.463 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.1 p -94.25 -4.08 49.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.725 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.28 5.89 56.91 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.367 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -69.8 118.89 13.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.966 -1.314 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 134.39 44.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 35.4 mt -131.07 136.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.866 . . . . 0.0 109.635 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -105.69 114.58 28.83 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.411 ' HB3' ' HZ3' ' B' ' 229' ' ' LYS . 21.2 mt -118.54 123.64 45.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 110.4 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.59 132.17 46.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.7 m -139.79 -170.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.919 -1.113 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.13 152.84 76.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.033 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.74 -20.03 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.381 2.054 . . . . 0.0 111.943 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 17.7 m -105.2 7.57 33.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -70.29 141.86 52.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.045 -1.034 . . . . 0.0 109.408 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.9 p -86.29 148.8 25.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.958 . . . . 0.0 110.099 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 41.3 mm -54.23 -35.46 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -60.14 -30.22 69.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.723 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -74.29 -51.33 15.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.084 -1.01 . . . . 0.0 109.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.98 -47.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 108.809 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -54.2 -42.22 69.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 0.0 109.442 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.85 76.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' B' ' 215' ' ' LEU . 5.2 mtpm? -57.66 -53.92 52.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.074 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' B' ' 234' ' ' GLU . 3.5 mp -58.52 -32.12 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.911 . . . . 0.0 108.781 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . 0.417 HE21 ' HA ' ' B' ' 237' ' ' PRO . 39.5 tt0 -63.27 -49.57 73.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.059 -1.025 . . . . 0.0 109.734 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -23.6 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.056 -1.028 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -98.72 -53.15 3.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 230' ' ' ILE . 25.0 mm-40 -88.69 -8.22 54.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 0.0 111.317 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 22.58 76.1 Favored Glycine 0 N--CA 1.493 2.493 0 O-C-N 120.567 -1.333 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . 0.401 HG22 HD13 ' B' ' 236' ' ' ILE . 22.5 mt -100.86 131.13 23.85 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.992 -1.299 . . . . 0.0 109.087 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.601 ' C ' HE21 ' B' ' 241' ' ' GLN . 59.0 Cg_endo -75.11 160.27 39.98 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.045 1.83 . . . . 0.0 112.549 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . 0.51 ' N ' HE21 ' B' ' 241' ' ' GLN . 38.2 Cg_endo -69.5 -34.43 15.45 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.288 2.658 . . . . 0.0 113.486 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' B' ' 239' ' ' ASP . 4.0 p30 -69.89 -5.44 25.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.998 . . . . 0.0 111.501 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -25.83 3.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 111.315 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . 0.601 HE21 ' C ' ' B' ' 237' ' ' PRO . 16.9 pt20 -88.55 144.7 26.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.235 -1.541 . . . . 0.0 109.418 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -129.32 134.05 47.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 109.663 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.65 126.14 51.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.508 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.35 135.75 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -130.59 114.12 15.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.313 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.25 39.05 7.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 109.434 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.54 12.52 66.96 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.846 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -111.68 136.78 50.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -1.155 . . . . 0.0 109.674 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -83.57 122.74 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 109.218 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 38.9 mt -69.86 144.31 52.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.4 ' N ' ' OH ' ' B' ' 259' ' ' TYR . 37.3 tt0 -100.89 147.0 26.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.997 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -73.4 3.71 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.431 -0.793 . . . . 0.0 109.649 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -121.93 41.68 1.81 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -150.18 172.07 15.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.293 . . . . 0.0 109.539 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 68.2 p -111.9 162.13 15.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -0.79 . . . . 0.0 109.883 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.8 mt -58.12 -43.91 87.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.811 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 73.1 p -59.9 -27.69 66.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -25.74 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.687 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . 0.4 ' OH ' ' N ' ' B' ' 251' ' ' GLU . 38.6 m-85 -96.73 5.55 50.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.217 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.9 38.18 2.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.53 136.7 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.146 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . 0.426 ' O ' ' OG ' ' B' ' 265' ' ' SER . 1.6 mt-30 -124.47 175.28 7.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.916 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.631 ' HZ1' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.81 160.24 1.45 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.739 0.781 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 56.4 9.9 0.59 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.406 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 16.1 p -73.61 146.86 44.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.008 -1.058 . . . . 0.0 108.367 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.4 m -114.06 139.38 49.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.539 -0.726 . . . . 0.0 109.913 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.2 mp -121.14 165.92 14.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -113.1 139.27 48.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.466 -0.771 . . . . 0.0 109.191 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.03 125.15 51.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 109.513 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.52 129.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 39.2 mt -83.23 142.44 31.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.167 -0.958 . . . . 0.0 109.992 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.781 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.22 164.3 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.287 1.992 . . . . 0.0 113.0 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.9 m -67.66 -1.91 6.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 110.296 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.01 7.87 9.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.26 -0.9 . . . . 0.0 110.782 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.3 mm -108.65 128.74 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.06 . . . . 0.0 110.81 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.77 109.67 58.44 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -47.32 -45.07 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.252 1.968 . . . . 0.0 112.539 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -49.69 -48.21 49.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 110.313 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.16 -24.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.796 -1.19 . . . . 0.0 108.902 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.1 t80 -67.99 -52.86 30.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 110.922 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -18.85 62.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -83.15 -5.41 59.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.75 151.99 46.26 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.945 . . . . 0.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.51 153.02 24.59 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.536 2.157 . . . . 0.0 112.099 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.98 -50.9 68.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 110.635 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.69 -43.9 37.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.942 -1.099 . . . . 0.0 109.838 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.6 t -75.01 -33.59 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 108.763 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.41 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -58.96 -49.97 75.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -58.9 -49.71 76.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 110.237 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -56.18 -42.3 76.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.076 -1.015 . . . . 0.0 110.412 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.41 -36.99 74.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.148 . . . . 0.0 109.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.5 -38.27 74.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.716 -1.24 . . . . 0.0 109.102 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.23 73.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 108.862 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -72.82 -37.74 67.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.4 m0 . . . . . 0 C--N 1.301 -1.517 0 O-C-N 120.999 -1.063 . . . . 0.0 108.933 179.213 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.85 162.73 13.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 110.39 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.2 145.81 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.618 -0.677 . . . . 0.0 109.36 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -99.34 144.07 28.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.51 112.18 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.483 ' NZ ' ' CG2' ' B' ' 266' ' ' THR . 0.1 OUTLIER -96.71 131.64 43.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 108.846 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.8 p -92.0 177.12 6.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 110.65 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 29.9 mt -64.03 -11.16 26.65 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.497 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 11.1 p -102.53 -3.37 26.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.09 -0.2 64.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -65.74 118.93 10.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.249 . . . . 0.0 108.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.4 m -100.17 137.93 37.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.937 . . . . 0.0 109.159 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 26.6 mt -134.09 136.26 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.19 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 44.1 m -105.04 119.56 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 108.948 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.98 121.88 38.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -0.766 . . . . 0.0 110.058 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.82 132.37 47.27 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.8 m -139.8 -172.11 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.907 -1.121 . . . . 0.0 109.979 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -135.99 155.02 77.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.32 -19.08 26.75 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.528 2.152 . . . . 0.0 112.165 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.58 8.99 29.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.158 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.0 141.53 50.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.875 -1.141 . . . . 0.0 109.379 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 22.5 p -85.99 144.55 27.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.56 -33.66 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 108.899 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -62.42 -30.94 71.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.205 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 86.4 m-20 -73.96 -52.4 12.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 108.905 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 31.6 t -52.3 -47.76 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -51.48 -43.05 62.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.477 0.656 . . . . 0.0 109.292 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.54 80.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -56.51 -53.85 52.67 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.03 -1.044 . . . . 0.0 109.351 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.7 mp -58.16 -34.43 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 108.908 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -62.75 -49.66 74.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 0.0 109.748 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -22.9 66.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.42 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -100.11 -59.92 1.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.004 -1.06 . . . . 0.0 110.17 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' B' ' 230' ' ' ILE . 77.9 mm-40 -79.78 -6.6 57.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.977 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.82 25.7 71.92 Favored Glycine 0 N--CA 1.492 2.432 0 O-C-N 120.544 -1.348 . . . . 0.0 110.358 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.61 133.87 20.05 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.155 -1.203 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.404 ' HD2' HE21 ' B' ' 240' ' ' GLN . 56.6 Cg_endo -73.05 153.14 52.04 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.45 2.1 . . . . 0.0 112.024 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.19 -34.06 10.6 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.676 2.251 . . . . 0.0 113.272 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.1 -7.95 27.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.498 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.404 HE21 ' HD2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -127.25 -14.24 5.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.78 136.18 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.755 -1.215 . . . . 0.0 108.362 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -125.22 134.97 52.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.172 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.28 124.89 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.88 135.41 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.516 -0.74 . . . . 0.0 109.48 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -130.06 118.72 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 61.06 37.56 17.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.645 -1.284 . . . . 0.0 109.57 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.88 -10.12 9.91 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.124 -0.985 . . . . 0.0 111.486 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.96 136.23 33.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.542 -1.564 . . . . 0.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -82.17 126.42 32.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.8 mt -74.25 146.92 42.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.449 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -103.34 146.12 28.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.887 . . . . 0.0 109.752 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 p30 -71.0 3.86 3.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.8 37.34 3.15 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.725 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -145.87 173.65 11.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.019 -1.283 . . . . 0.0 109.638 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 71.7 p -113.15 161.58 16.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.129 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.9 mt -59.7 -43.03 94.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.873 . . . . 0.0 110.035 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 97.6 p -60.72 -29.22 69.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 109.796 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.78 -15.23 63.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.033 . . . . 0.0 109.272 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -107.26 3.73 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.17 38.79 3.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.399 -0.813 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.0 135.26 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.892 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -123.58 172.58 8.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.099 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.486 ' N ' ' CD ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -50.97 157.99 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.568 0.699 . . . . 0.0 110.382 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 59.18 10.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 17.1 m -75.17 150.14 38.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.932 -1.105 . . . . 0.0 108.38 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' THR . . . . . 0.483 ' CG2' ' NZ ' ' B' ' 206' ' ' LYS . 7.7 m -116.23 139.12 50.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -124.43 140.47 52.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.543 -0.723 . . . . 0.0 109.56 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . 0.46 ' NE2' ' CE ' ' B' ' 206' ' ' LYS . 64.6 m80 -89.36 142.23 27.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.142 -0.974 . . . . 0.0 110.015 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.02 127.93 55.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 0.0 109.097 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.22 130.83 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.396 -0.815 . . . . 0.0 110.154 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 36.2 mt -79.64 141.59 36.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.232 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.348 -0.845 . . . . 0.0 108.778 -179.002 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.421 0.153 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -47.89 165.36 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 112.875 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -2.67 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.729 -0.607 . . . . 0.0 110.738 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -121.88 6.82 9.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.083 -1.011 . . . . 0.0 110.125 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 mm -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 111.223 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.97 138.12 20.26 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.52 -38.76 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.58 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -55.37 -44.72 76.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.569 -0.707 . . . . 0.0 110.516 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.8 t -80.76 -23.66 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.852 -1.155 . . . . 0.0 110.283 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.3 t80 -69.1 -53.5 19.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 110.822 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -62.39 -15.71 50.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.088 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.19 -6.6 59.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.6 mt -90.39 151.85 44.86 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.228 -0.92 . . . . 0.0 109.776 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.71 154.14 27.2 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.453 2.102 . . . . 0.0 112.092 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.92 -50.93 68.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -45.06 38.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.945 -1.097 . . . . 0.0 110.262 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.88 -31.93 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 108.509 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.401 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.19 -50.76 72.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -56.68 -47.3 80.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.434 -0.792 . . . . 0.0 110.01 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -58.87 -37.72 77.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 0.0 110.482 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.37 -40.34 62.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.812 -1.18 . . . . 0.0 110.145 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -69.88 -38.8 76.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.763 -1.21 . . . . 0.0 108.874 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.16 77.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 108.906 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 4.8 tm-20 -69.0 -38.55 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 108.877 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.461 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.0 m0 . . . . . 0 C--N 1.303 -1.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.041 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.68 164.99 12.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.231 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 pp -144.26 147.9 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -102.04 144.17 30.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.222 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.98 112.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.984 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 133.98 41.31 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 29.5 p -93.98 -174.39 3.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.781 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 26.9 mt -72.26 -11.72 60.84 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.9 p -102.61 -2.44 28.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.36 -0.838 . . . . 0.0 109.574 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 94.99 2.73 62.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -67.22 118.37 10.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -1.225 . . . . 0.0 108.823 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.1 m -99.62 138.12 37.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.033 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 40.0 mt -135.01 136.21 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.334 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 72.5 m -105.34 120.21 41.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.609 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 13.1 mt -125.68 121.84 34.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.963 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . 0.656 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 4.8 mt-10 -67.18 130.3 42.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.496 -0.753 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.551 ' CG1' ' HZ2' ' B' ' 229' ' ' LYS . 27.5 m -136.16 -174.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.08 -1.012 . . . . 0.0 110.131 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -133.86 155.3 80.42 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.43 -20.39 56.2 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.402 2.068 . . . . 0.0 112.195 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -105.24 7.95 33.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.24 143.47 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.839 -1.163 . . . . 0.0 109.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 52.3 p -86.37 145.94 26.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -51.68 -26.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -36.22 83.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.205 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.0 -52.75 21.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.109 -0.994 . . . . 0.0 109.021 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 35.7 t -52.28 -37.54 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 108.926 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -65.41 -32.48 74.13 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.441 -0.787 . . . . 0.0 108.959 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.89 69.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.656 ' NZ ' ' O ' ' B' ' 216' ' ' GLU . 12.6 mtpt -57.37 -52.65 64.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 108.781 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.71 -36.52 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 108.808 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -59.98 -42.81 94.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.063 -1.023 . . . . 0.0 110.07 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.49 -31.31 68.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.116 -0.99 . . . . 0.0 110.831 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -92.76 -50.43 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.43 -6.44 57.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.972 . . . . 0.0 111.331 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.48 26.95 72.05 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.51 -1.369 . . . . 0.0 110.456 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.07 131.6 21.79 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.128 -1.219 . . . . 0.0 109.569 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.62 156.67 44.69 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.212 1.941 . . . . 0.0 112.261 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.6 -34.67 8.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.922 2.414 . . . . 0.0 113.393 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -65.34 -6.8 10.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.228 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.89 -21.06 3.4 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.748 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.5 136.52 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.606 -1.309 . . . . 0.0 109.252 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -125.98 135.73 52.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.95 126.61 52.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 79.7 mt -120.21 136.52 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -129.65 112.82 14.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.32 -0.863 . . . . 0.0 109.435 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' B' ' 248' ' ' LYS . . . 64.95 44.56 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.865 -1.147 . . . . 0.0 109.485 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 -6.07 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' B' ' 246' ' ' ALA . 1.1 ptmm? -94.19 137.77 32.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.817 -1.402 . . . . 0.0 109.504 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -84.4 132.59 34.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.875 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.56 146.33 28.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 109.09 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 2.6 tt0 -105.49 148.0 27.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.69 3.82 3.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.921 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -120.63 45.54 1.22 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.874 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.54 172.39 18.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.987 -1.302 . . . . 0.0 109.261 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 65.1 p -109.84 161.07 15.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.4 mt -58.01 -40.44 80.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.815 . . . . 0.0 109.938 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 98.3 p -62.51 -28.04 69.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.08 -15.8 62.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.255 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -105.03 1.72 28.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 109.067 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.8 39.73 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.88 133.99 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.038 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.34 174.59 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.15 158.09 1.64 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.895 0.855 . . . . 0.0 110.698 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 57.99 14.26 2.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.044 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 70.4 p -78.03 150.44 33.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.955 -1.091 . . . . 0.0 108.79 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 6.7 m -115.03 138.58 50.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -0.796 . . . . 0.0 110.233 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -124.82 140.97 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.527 -0.733 . . . . 0.0 109.641 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -90.19 141.71 28.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 109.783 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 13.5 tp -108.94 126.06 52.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.376 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 42.8 t -112.69 128.09 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.8 . . . . 0.0 109.546 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 47.1 mt -82.82 143.9 30.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.018 -1.052 . . . . 0.0 109.552 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.256 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.04 164.75 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.215 1.944 . . . . 0.0 112.762 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -2.75 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.739 -0.6 . . . . 0.0 110.722 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 4.1 m-20 -122.24 8.34 9.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.046 -1.034 . . . . 0.0 110.348 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 mm -111.05 129.34 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.272 -0.892 . . . . 0.0 111.001 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.7 t70 -99.85 139.56 20.89 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.48 -47.38 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.269 1.979 . . . . 0.0 112.242 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.478 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 6.8 tt0 -47.88 -44.68 29.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.696 -0.627 . . . . 0.0 110.33 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.85 -32.26 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.957 -1.09 . . . . 0.0 110.318 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -61.05 -54.13 48.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 110.742 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -61.25 -15.86 39.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.907 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -83.55 -6.12 59.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.053 . . . . 0.0 109.808 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.33 151.93 45.08 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.51 154.17 20.74 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.37 2.047 . . . . 0.0 112.098 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.82 -49.26 75.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.18 -44.74 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.064 . . . . 0.0 110.196 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.3 t -74.84 -32.46 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.874 -1.141 . . . . 0.0 108.478 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.2 tt0 -59.22 -51.83 68.29 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -57.25 -48.96 77.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -56.41 -42.76 78.53 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 110.56 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -69.97 -37.87 75.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.863 -1.148 . . . . 0.0 109.776 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.0 mt -70.03 -40.11 75.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.739 -1.226 . . . . 0.0 109.024 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.49 70.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 108.785 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.56 -40.19 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.9 m0 . . . . . 0 C--N 1.302 -1.491 0 O-C-N 121.005 -1.06 . . . . 0.0 109.535 179.687 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.34 164.76 12.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.55 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.7 142.72 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.462 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.33 141.7 28.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.443 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.6 t -120.82 108.23 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 109.608 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -94.61 135.32 36.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 46.4 p -97.14 -173.94 2.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.025 -1.047 . . . . 0.0 110.998 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 20.1 mt -71.4 -14.67 62.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.466 0.651 . . . . 0.0 109.284 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -99.93 -4.6 29.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.6 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.51 3.01 59.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -67.82 118.45 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.081 -1.247 . . . . 0.0 109.199 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 10.2 m -99.8 137.8 37.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 48.3 mt -133.49 135.34 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.8 m -104.22 117.03 33.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.724 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 20.8 mt -122.18 121.92 37.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.448 -0.783 . . . . 0.0 110.084 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -67.78 132.69 47.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.57 -174.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.797 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.72 152.55 77.79 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.975 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.15 -24.12 48.31 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.587 2.191 . . . . 0.0 112.191 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 49.2 m -100.4 6.1 44.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.879 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -71.44 143.55 50.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.966 -1.084 . . . . 0.0 109.375 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.586 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 45.0 p -86.26 151.49 23.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 0.0 109.932 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 35.2 mm -54.53 -43.32 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.404 ' CG ' ' HG1' ' B' ' 222' ' ' THR . 9.0 pt-20 -52.61 -35.65 54.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.586 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 84.1 m-20 -67.28 -52.77 36.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.337 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 25.1 t -52.05 -47.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 108.549 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -52.41 -43.49 64.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.507 -0.746 . . . . 0.0 109.182 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.79 -36.11 78.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.814 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -57.78 -53.46 57.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 0.0 109.41 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mp -58.3 -34.23 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.205 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . 0.408 HE21 ' HD3' ' B' ' 238' ' ' PRO . 15.3 tt0 -60.75 -47.39 86.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.921 -1.112 . . . . 0.0 109.826 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -68.69 -24.33 64.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.249 -0.907 . . . . 0.0 110.634 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -97.53 -53.24 3.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 110.457 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.17 -7.55 53.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.289 -0.882 . . . . 0.0 111.578 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.47 24.67 75.09 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.215 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 36.7 mt -104.41 124.94 35.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.498 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 154.73 31.35 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.164 1.91 . . . . 0.0 111.986 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . 0.408 ' HD3' HE21 ' B' ' 231' ' ' GLN . 29.7 Cg_endo -64.95 -28.57 58.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.733 2.289 . . . . 0.0 112.881 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 44.2 p30 -62.6 -14.73 46.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.952 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.51 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.0 OUTLIER -128.52 -21.41 3.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.57 136.54 33.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.897 -1.127 . . . . 0.0 109.243 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -129.46 132.11 46.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.421 -0.799 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.42 127.42 53.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.38 134.23 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.629 -0.669 . . . . 0.0 109.348 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -127.2 112.84 15.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.14 37.53 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.868 -1.145 . . . . 0.0 109.458 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.6 -7.66 18.26 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.144 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -94.06 134.78 36.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.74 -1.447 . . . . 0.0 109.692 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -80.97 125.0 29.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 29.0 mt -69.91 142.37 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -97.19 144.36 27.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.19 3.69 2.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.92 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.0 47.21 1.03 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.795 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -152.68 172.53 16.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.384 . . . . 0.0 109.078 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 37.9 p -111.5 159.24 18.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.948 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.3 -41.71 80.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 69.4 p -61.17 -29.12 69.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.845 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.24 -16.5 63.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 109.333 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -105.58 3.31 29.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.48 39.35 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.848 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.6 mt -91.71 135.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.25 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.31 173.11 7.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.04 162.66 0.44 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.548 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.37 10.46 0.47 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 62.7 p -73.67 148.32 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.823 -1.173 . . . . 0.0 108.657 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 22.1 m -113.77 137.89 51.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 0.0 110.038 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -121.03 160.14 24.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.011 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -107.58 139.62 41.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.333 -0.854 . . . . 0.0 109.741 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 24.8 tp -110.21 126.03 53.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.6 t -114.62 130.06 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 47.1 mt -82.42 144.4 30.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.652 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -47.66 165.56 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.454 2.102 . . . . 0.0 112.916 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.445 ' H ' ' HG ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -68.09 -6.18 21.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.697 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 1.8 m-20 -117.01 2.56 12.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.099 -1.001 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.77 128.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 4.7 t70 -98.91 138.35 20.64 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.62 -40.31 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.355 2.037 . . . . 0.0 112.467 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 37.4 tt0 -56.21 -43.49 78.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.617 -0.677 . . . . 0.0 110.581 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -80.09 -23.79 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.784 -1.198 . . . . 0.0 110.35 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.9 t80 -70.41 -52.38 22.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 110.832 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -64.32 -18.12 64.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.174 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -79.87 -7.94 59.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.861 -1.149 . . . . 0.0 109.49 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.8 mt -89.92 151.63 45.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 154.96 22.29 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.41 2.074 . . . . 0.0 111.95 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -63.05 -51.84 65.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.72 -44.33 38.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 110.09 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.3 t -74.77 -31.56 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.02 -1.05 . . . . 0.0 108.448 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.8 -50.05 75.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -58.36 -49.68 76.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.665 . . . . 0.0 110.38 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.72 -36.87 67.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.037 -1.039 . . . . 0.0 110.043 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.3 mt -75.44 -36.58 60.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.852 -1.155 . . . . 0.0 109.687 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.12 -40.34 71.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.77 -1.206 . . . . 0.0 109.147 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.73 79.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.965 . . . . 0.0 109.046 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.95 -38.48 82.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.0 m0 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.101 -1.0 . . . . 0.0 109.205 179.338 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.8 ptt? . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.08 166.51 11.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -145.29 145.11 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.628 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . 0.419 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.4 m-85 -95.75 142.4 28.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.01 108.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -93.33 134.11 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 108.767 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 20.8 p -94.33 -174.34 3.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.702 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 35.6 mt -72.36 -10.73 60.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 11.2 p -104.33 -3.1 24.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.782 . . . . 0.0 109.655 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.36 2.89 60.2 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -66.65 117.0 8.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -1.199 . . . . 0.0 108.854 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -99.19 136.73 38.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.102 -0.999 . . . . 0.0 109.086 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 23.2 mt -132.79 133.86 58.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.278 -0.889 . . . . 0.0 109.462 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.9 m -103.32 120.13 40.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.9 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 18.8 mt -123.85 120.5 32.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.846 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.62 133.05 49.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.69 -171.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 109.831 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -138.14 152.36 71.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.16 -28.2 78.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.422 2.081 . . . . 0.0 112.264 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.2 m -96.01 5.0 52.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 110.061 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.58 145.21 49.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.639 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.455 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 36.3 p -87.07 150.57 23.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.095 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.408 HG21 HD11 ' B' ' 223' ' ' ILE . 31.8 mm -56.81 -40.54 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.0 109.497 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.72 -31.38 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.087 -1.008 . . . . 0.0 109.604 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.455 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 64.1 m-20 -73.85 -51.13 17.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.99 -50.35 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 108.509 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -52.05 -39.46 59.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 0.0 109.198 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.16 86.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.43 -0.794 . . . . 0.0 109.591 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -57.81 -53.73 54.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.5 mp -57.88 -37.25 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.086 -1.009 . . . . 0.0 109.107 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -58.52 -43.14 89.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.43 -22.41 60.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 110.344 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -98.83 -56.45 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.026 -1.047 . . . . 0.0 110.484 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -83.35 -7.02 59.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 111.088 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.55 24.62 73.9 Favored Glycine 0 N--CA 1.49 2.274 0 O-C-N 120.575 -1.328 . . . . 0.0 109.974 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.72 125.21 33.86 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 109.467 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.62 154.67 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.996 1.797 . . . . 0.0 111.658 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.92 -29.82 67.25 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.7 2.267 . . . . 0.0 113.049 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.97 -17.27 36.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 110.475 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -127.99 -15.54 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.78 133.62 33.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 109.488 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -127.97 132.37 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.503 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.9 mt -105.85 127.34 53.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.93 136.03 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.683 -0.636 . . . . 0.0 109.413 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -131.25 119.06 21.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 108.983 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 59.73 42.45 16.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.87 -1.144 . . . . 0.0 109.455 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.26 23.87 70.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.112 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 140.51 52.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.117 -1.225 . . . . 0.0 109.615 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -87.97 125.14 34.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 109.603 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.2 mt -71.42 146.56 48.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -0.82 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' B' ' 253' ' ' GLY . 3.4 tp10 -99.68 142.59 30.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -68.6 3.2 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -122.99 40.41 2.01 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -144.55 168.63 19.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 109.258 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 15.0 p -108.79 155.48 20.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.814 . . . . 0.0 109.98 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.2 mt -54.16 -42.95 70.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.637 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 83.6 p -61.2 -27.14 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -15.85 62.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.515 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -106.54 3.42 27.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 109.242 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.59 40.53 1.86 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.53 -0.731 . . . . 0.0 109.285 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.57 133.43 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.364 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -124.79 176.28 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.54 159.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.277 -0.889 . . . . 0.0 111.07 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 57.85 13.14 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.092 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -75.23 148.19 39.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 108.676 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 8.0 m -114.06 137.05 52.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.405 -0.81 . . . . 0.0 110.647 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -124.66 144.42 50.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.772 . . . . 0.0 109.328 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -94.39 143.3 26.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.132 -0.98 . . . . 0.0 110.349 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.2 tp -109.56 125.88 52.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.352 -0.842 . . . . 0.0 109.415 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 34.8 t -115.25 131.25 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.91 . . . . 0.0 110.135 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.76 143.95 30.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -0.824 . . . . 0.0 109.626 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.478 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.19 165.18 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.191 1.927 . . . . 0.0 112.74 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -65.8 -14.71 61.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.754 -0.591 . . . . 0.0 110.469 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -108.65 8.45 27.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.08 -1.012 . . . . 0.0 110.45 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.12 129.54 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 111.071 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 5.0 t70 -99.74 138.65 20.43 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.69 -46.66 0.79 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.251 1.967 . . . . 0.0 112.315 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.7 tt0 -51.07 -44.64 61.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.695 -0.628 . . . . 0.0 110.656 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.06 -24.04 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.812 -1.18 . . . . 0.0 110.203 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -70.47 -51.44 29.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 110.699 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -63.09 -16.96 61.67 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.142 -0.974 . . . . 0.0 110.055 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -82.97 -7.06 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.1 mt -89.03 151.31 46.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.842 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.23 154.02 19.91 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.356 2.037 . . . . 0.0 111.913 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.04 -51.45 66.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.671 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.42 -44.81 45.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.982 -1.074 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.04 -30.66 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.992 -1.068 . . . . 0.0 108.716 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -61.7 -49.36 76.77 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -58.9 -49.7 76.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.552 -0.718 . . . . 0.0 110.359 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.92 -40.66 70.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.004 -1.06 . . . . 0.0 110.121 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.42 -36.2 71.23 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.987 -1.07 . . . . 0.0 109.837 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.92 -39.98 69.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.804 -1.185 . . . . 0.0 109.172 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.59 -32.95 72.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.87 -34.35 60.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 108.752 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.4 m0 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 120.962 -1.086 . . . . 0.0 108.491 178.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.92 164.04 12.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 110.585 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.8 141.95 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.32 141.96 27.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.969 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -121.35 110.03 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -96.41 135.65 37.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 108.735 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 34.4 p -96.35 -173.46 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.771 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 21.2 mt -72.55 -13.26 61.36 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.348 0.594 . . . . 0.0 109.671 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 9.6 p -100.8 -3.26 30.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.62 61.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.39 118.68 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 108.812 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 2.2 m -100.6 138.88 37.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.2 mt -135.22 136.72 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.3 m -104.06 121.43 43.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 108.818 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 16.1 mt -124.57 120.97 33.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.882 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.1 133.32 48.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.651 -0.656 . . . . 0.0 109.382 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 -173.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.935 -1.103 . . . . 0.0 110.126 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -135.93 153.68 77.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 108.959 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.26 -25.48 65.1 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.528 2.152 . . . . 0.0 112.171 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 m -100.24 5.94 44.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.936 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -71.87 144.93 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.022 -1.049 . . . . 0.0 109.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.3 p -86.71 146.19 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.84 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.2 mm -51.65 -34.3 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.431 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.2 OUTLIER -56.8 -38.39 72.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.384 -0.822 . . . . 0.0 109.037 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -66.57 -52.48 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 109.244 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 15.6 t -52.6 -48.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.758 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -53.44 -38.7 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.53 83.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.356 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -57.16 -52.84 63.68 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 109.111 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' B' ' 234' ' ' GLU . 3.9 mp -59.04 -36.46 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.178 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -58.81 -49.56 77.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.943 -1.098 . . . . 0.0 109.741 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.56 -27.6 68.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.422 -0.799 . . . . 0.0 110.649 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -95.4 -57.01 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.895 -1.128 . . . . 0.0 110.55 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' B' ' 230' ' ' ILE . 59.9 mm-40 -83.04 -6.18 59.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 111.311 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.08 24.76 71.94 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.244 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 63.1 mt -105.95 128.45 26.38 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.132 -1.217 . . . . 0.0 109.641 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.95 158.69 38.36 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.113 1.875 . . . . 0.0 111.933 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.11 -30.18 32.12 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.942 2.428 . . . . 0.0 113.196 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -69.14 -6.14 26.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.1 -20.68 3.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.39 139.03 31.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 109.341 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.94 132.31 47.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.404 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.01 123.42 47.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 109.439 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.51 135.81 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.662 -0.649 . . . . 0.0 109.357 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -129.84 113.64 14.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.761 . . . . 0.0 109.217 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.34 42.25 5.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.931 -1.106 . . . . 0.0 109.203 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.97 39.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.93 137.9 43.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -1.188 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.41 126.08 33.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.223 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.538 ' H ' ' HH ' ' B' ' 259' ' ' TYR . 0.4 OUTLIER -102.4 144.28 31.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.176 -0.953 . . . . 0.0 109.927 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.03 3.35 3.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 109.827 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.39 37.03 3.29 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -145.16 173.35 12.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.284 . . . . 0.0 109.542 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 81.6 p -113.17 161.22 17.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.498 -0.751 . . . . 0.0 109.943 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mt -60.42 -42.23 95.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.6 p -60.63 -28.26 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.089 -1.007 . . . . 0.0 109.201 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.26 -13.86 61.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 108.959 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . 0.611 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 25.7 m-85 -107.1 0.36 23.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.465 -0.772 . . . . 0.0 109.572 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' B' ' 260' ' ' ASN . 0.0 OUTLIER 68.25 33.42 4.3 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.132 0.968 . . . . 0.0 109.725 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -85.63 133.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.551 -1.343 . . . . 0.0 109.523 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . 0.484 ' O ' ' OG ' ' B' ' 265' ' ' SER . 26.1 mt-30 -120.66 170.51 9.36 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.696 0.76 . . . . 0.0 109.75 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.76 160.42 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.779 0.799 . . . . 0.0 110.698 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 56.58 13.58 1.41 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 3.0 p -76.7 150.02 36.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 108.525 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 11.4 m -114.59 137.01 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.383 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.25 140.18 53.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.264 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -89.46 141.84 28.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 0.0 109.796 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 17.2 tp -110.55 128.44 55.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 10.7 t -114.19 128.77 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 43.4 mt -82.4 145.43 29.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.035 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 108.754 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.72 164.61 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.485 2.123 . . . . 0.0 113.006 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.47 -1.94 9.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.825 -0.547 . . . . 0.0 110.284 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -120.67 7.23 10.51 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.178 -0.951 . . . . 0.0 110.214 -179.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.3 mm -109.3 127.67 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.84 . . . . 0.0 111.258 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.434 ' OD1' ' C ' ' A' ' 69' ' ' ASP . 9.6 t0 -102.24 110.71 63.27 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.96 -43.83 23.8 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.94 . . . . 0.0 112.625 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -47.86 -47.62 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 110.389 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.32 -23.5 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.693 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 21.0 t80 -70.66 -53.85 14.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.867 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -61.62 -17.49 55.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.876 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -81.98 -6.53 59.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.897 -1.127 . . . . 0.0 109.731 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.1 mt -90.56 151.48 44.12 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.169 -0.957 . . . . 0.0 109.546 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.66 154.63 19.83 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.301 2.0 . . . . 0.0 111.898 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -49.97 71.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.733 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.65 -44.33 47.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.101 . . . . 0.0 110.087 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.68 -32.07 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.954 -1.091 . . . . 0.0 108.38 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.1 tt0 -59.61 -52.16 66.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.11 -49.05 74.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.196 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.5 -40.79 75.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.021 . . . . 0.0 110.125 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.5 -37.83 68.3 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.49 -39.14 77.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.927 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.86 -32.9 72.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 108.925 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.28 -35.61 66.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.42 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 44.9 m0 . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 109.088 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.58 166.15 11.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 pp -145.79 142.11 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -95.18 143.07 26.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 29.2 t -123.43 111.58 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 109.685 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -97.04 140.43 31.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 108.68 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 43.9 p -100.56 -173.52 2.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.715 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.94 -13.58 62.06 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.527 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 11.3 p -102.16 -3.77 26.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.78 2.89 61.08 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -66.65 117.67 9.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.236 . . . . 0.0 108.571 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.0 m -99.91 139.2 35.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.47 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 23.2 mt -134.94 135.77 52.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.485 -0.759 . . . . 0.0 109.289 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -103.67 122.59 45.35 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.614 ' C ' ' HZ2' ' B' ' 229' ' ' LYS . 17.1 mt -126.04 119.66 28.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.44 -0.788 . . . . 0.0 109.935 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . 0.664 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 11.5 mt-10 -66.07 129.92 41.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.546 ' CG1' ' HZ1' ' B' ' 229' ' ' LYS . 14.1 m -137.38 -172.72 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.0 110.012 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.11 153.77 71.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 108.755 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.55 -25.87 42.94 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.577 2.184 . . . . 0.0 112.489 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -99.6 6.83 45.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.873 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 141.11 52.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.605 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.4 p -86.07 148.69 25.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.998 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -54.93 -42.5 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.311 -0.868 . . . . 0.0 109.257 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -52.44 -37.34 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 109.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -67.92 -49.25 62.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 108.971 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 52.8 t -52.1 -49.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 108.463 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 -37.79 49.21 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.99 87.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.664 ' NZ ' ' O ' ' B' ' 216' ' ' GLU . 15.1 mtpt -55.84 -53.49 56.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 109.056 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.9 mp -60.89 -32.81 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -62.41 -51.0 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.254 -0.904 . . . . 0.0 110.014 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -63.33 -29.33 70.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.522 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -94.22 -58.48 2.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.973 -1.08 . . . . 0.0 110.504 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' B' ' 230' ' ' ILE . 34.8 mm-40 -82.08 -6.55 59.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.955 . . . . 0.0 111.596 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.69 25.28 70.28 Favored Glycine 0 N--CA 1.492 2.416 0 O-C-N 120.338 -1.476 . . . . 0.0 110.541 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.63 129.06 26.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.063 -1.257 . . . . 0.0 109.325 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.02 155.2 42.8 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.985 1.79 . . . . 0.0 111.903 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.1 -29.82 26.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.772 2.314 . . . . 0.0 113.361 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.36 -8.34 45.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.55 -20.7 4.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.39 -0.819 . . . . 0.0 109.608 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 137.63 32.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 108.985 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -127.87 132.37 49.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.872 . . . . 0.0 109.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.19 124.52 49.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.435 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.8 mt -119.68 134.03 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -128.28 111.6 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.46 38.29 4.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.772 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.58 4.62 53.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . 0.594 ' CB ' ' HZ2' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -101.48 137.71 39.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 109.765 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -86.2 125.96 33.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.019 . . . . 0.0 109.492 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.1 mt -77.95 142.97 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' B' ' 253' ' ' GLY . 12.7 tt0 -99.8 143.56 29.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.405 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 3.83 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -123.7 49.24 0.91 Allowed Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.786 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -153.44 169.76 22.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -1.228 . . . . 0.0 109.211 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -110.94 158.08 19.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.434 -0.792 . . . . 0.0 110.097 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 8.0 mt -55.24 -42.53 73.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.72 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 24.6 p -61.9 -28.1 69.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.92 -13.97 61.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.297 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -105.9 1.94 27.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.7 37.97 3.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.07 135.14 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.35 175.26 6.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.237 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.49 162.09 0.59 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.986 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 56.42 13.38 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.216 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.3 m -75.37 148.17 39.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.794 -1.191 . . . . 0.0 108.585 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 4.1 m -114.04 137.43 51.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.458 -0.776 . . . . 0.0 110.177 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.93 141.97 51.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 109.286 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -90.85 143.06 27.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.874 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 tp -108.44 125.58 51.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.529 -0.732 . . . . 0.0 109.322 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.52 125.62 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 109.525 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 43.0 mt -82.31 144.78 30.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.034 -179.266 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.47 164.72 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.302 2.001 . . . . 0.0 112.881 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p -67.66 -1.81 5.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.757 -0.59 . . . . 0.0 110.789 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 66' ' ' SER . 6.7 m-20 -123.77 9.1 8.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.014 -1.054 . . . . 0.0 110.549 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.3 mm -110.12 129.07 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.08 -1.013 . . . . 0.0 111.463 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 7.7 t70 -93.34 136.91 23.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' O ' ' CD2' ' A' ' 74' ' ' TYR . 51.8 Cg_endo -72.12 -33.35 9.6 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.457 2.105 . . . . 0.0 113.233 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.43 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 39.3 tt0 -71.65 -37.06 70.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.0 110.577 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.23 -23.66 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.591 -1.318 . . . . 0.0 109.169 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.406 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -71.98 -53.33 13.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.409 -0.807 . . . . 0.0 110.698 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 70' ' ' PRO . 46.3 m-85 -61.36 -17.27 53.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.951 . . . . 0.0 109.949 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -83.42 -5.47 59.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.526 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.42 152.19 47.16 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.169 -0.957 . . . . 0.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.72 153.92 28.16 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.321 2.014 . . . . 0.0 111.938 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -50.68 69.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.572 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.45 -42.57 43.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.013 -1.054 . . . . 0.0 110.262 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.0 t -74.92 -32.89 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 108.325 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.406 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.7 tt0 -59.2 -51.95 67.79 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -56.7 -48.45 77.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.3 -40.71 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.61 -38.54 67.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.842 -1.161 . . . . 0.0 109.63 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.57 -38.78 77.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.736 -1.228 . . . . 0.0 108.948 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.02 73.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.53 -34.43 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 108.748 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 49.4 m0 . . . . . 0 C--N 1.301 -1.536 0 O-C-N 121.016 -1.052 . . . . 0.0 108.729 178.876 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.09 164.84 12.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.128 -0.983 . . . . 0.0 110.362 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.84 143.58 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.197 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.8 142.16 28.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.04 114.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -99.84 139.36 35.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 108.993 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.9 p -98.09 -178.18 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 110.945 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 51.3 mt -71.69 -12.63 61.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 9.3 p -102.59 -3.99 25.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.05 57.27 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.882 -1.152 . . . . 0.0 110.527 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -69.28 119.07 12.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.002 -1.293 . . . . 0.0 108.999 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 19.3 m -102.83 140.95 36.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 37.6 mt -138.75 137.51 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 37.6 m -104.94 119.34 38.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.15 121.5 36.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.18 131.49 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.89 -175.07 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.02 -1.05 . . . . 0.0 109.628 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -134.8 152.77 78.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.389 -0.819 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.64 -23.03 46.74 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.555 2.17 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' B' ' 220' ' ' SER . 1.4 t -104.47 5.83 34.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.956 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.89 144.99 52.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.956 -1.09 . . . . 0.0 109.412 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 73.1 p -85.81 150.38 24.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.2 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 36.6 mm -54.51 -45.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.369 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.51 -35.89 54.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -67.77 -52.58 35.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.072 -1.017 . . . . 0.0 109.129 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.7 t -51.9 -48.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.93 -1.106 . . . . 0.0 108.107 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.96 -46.64 61.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.55 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.03 -36.86 70.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.585 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -56.92 -54.24 48.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.983 -1.073 . . . . 0.0 109.259 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.9 mp -57.31 -33.68 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 108.975 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -30.95 71.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.634 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -96.27 -51.97 4.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.026 -1.046 . . . . 0.0 110.683 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' B' ' 230' ' ' ILE . 60.4 mm-40 -85.77 -8.0 58.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 111.413 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.69 25.06 72.88 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.501 -1.374 . . . . 0.0 110.524 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.66 130.31 23.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.139 -1.212 . . . . 0.0 109.733 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.92 155.01 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.214 1.942 . . . . 0.0 111.748 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.48 -30.57 29.05 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.738 2.292 . . . . 0.0 113.219 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.05 -13.04 61.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.73 -19.86 6.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.418 -0.802 . . . . 0.0 110.13 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.09 139.79 30.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.696 -1.253 . . . . 0.0 108.928 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . 0.4 ' NH1' HE22 ' B' ' 249' ' ' GLN . 66.5 mtt180 -129.76 129.63 44.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.345 -0.847 . . . . 0.0 109.449 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.1 mt -105.04 124.23 49.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.83 . . . . 0.0 109.338 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.99 134.08 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -130.36 121.12 25.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.092 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.46 39.4 28.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.735 -1.228 . . . . 0.0 109.871 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.3 7.31 60.05 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.057 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.66 132.86 52.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.242 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.4 HE22 ' NH1' ' B' ' 242' ' ' ARG . 30.3 tt0 -82.65 125.95 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 21.3 mt -76.54 141.83 41.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.49 147.16 26.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -68.91 3.91 1.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 110.131 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -121.57 48.29 0.96 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.916 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -156.08 171.7 19.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.989 -1.301 . . . . 0.0 109.245 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' B' ' 258' ' ' ASP . 7.0 p -112.69 161.32 16.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.478 -0.764 . . . . 0.0 110.058 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.8 mt -60.0 -42.56 94.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.956 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 78.2 p -60.55 -29.05 68.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.081 -1.012 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' B' ' 255' ' ' THR . 1.3 m-20 -70.96 -14.64 62.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.127 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.27 2.81 27.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.05 38.25 4.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.525 -0.734 . . . . 0.0 109.605 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.9 mt -91.19 135.25 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -122.46 172.96 7.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.649 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.93 160.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.709 0.766 . . . . 0.0 110.506 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 58.08 11.68 1.58 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 2.5 m -73.68 145.35 45.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.776 -1.202 . . . . 0.0 108.875 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 17.2 m -113.12 136.97 52.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.584 -0.698 . . . . 0.0 109.953 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . 0.401 ' CD1' ' N ' ' B' ' 267' ' ' LEU . 7.4 mp -124.69 141.7 51.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -88.57 141.06 28.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.092 -1.005 . . . . 0.0 110.059 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.5 tp -108.93 126.38 53.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.289 -0.882 . . . . 0.0 108.985 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 130.03 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.21 144.23 33.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 108.985 -179.13 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.32 164.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.323 2.016 . . . . 0.0 112.742 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.63 -1.88 5.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 110.762 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -122.9 8.29 9.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.066 -1.021 . . . . 0.0 110.367 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.8 mm -109.37 128.2 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.4 t70 -101.42 139.79 20.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.76 -46.99 1.45 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.502 2.135 . . . . 0.0 112.663 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 tt0 -47.44 -47.0 27.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 110.608 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.99 -42.82 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.4 t80 -51.43 -53.41 37.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.998 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -63.42 -18.82 64.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.0 110.281 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.81 -6.1 56.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.55 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.8 mt -91.07 152.35 44.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.147 -0.97 . . . . 0.0 109.836 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.62 154.51 30.56 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.416 2.077 . . . . 0.0 111.864 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -62.93 -50.16 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.698 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -44.61 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.971 -1.081 . . . . 0.0 110.092 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.3 -31.73 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 108.323 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.7 tt0 -60.02 -51.96 67.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.35 -49.57 74.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.589 -0.694 . . . . 0.0 110.307 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -56.5 -40.06 74.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.096 -1.003 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.96 -36.94 67.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.812 -1.18 . . . . 0.0 109.97 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -70.96 -38.71 72.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.716 -1.24 . . . . 0.0 108.884 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.72 -33.7 73.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.954 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.95 -35.06 66.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m0 . . . . . 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 108.749 179.053 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.13 165.03 12.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.467 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.42 142.56 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 109.581 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.06 140.84 29.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.2 108.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.513 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -96.54 135.37 38.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 70.4 p -96.27 -174.66 3.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 110.557 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 18.0 mt -72.45 -10.54 59.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.32 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -102.48 -3.43 26.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.88 . . . . 0.0 109.615 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.65 0.27 62.65 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.102 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -66.93 119.67 12.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 108.887 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.1 m -101.44 140.03 36.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.352 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 41.2 mt -135.4 136.19 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 109.212 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.0 m -105.26 121.05 43.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.4 120.73 31.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.437 -0.789 . . . . 0.0 109.868 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.39 133.85 51.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.4 m -140.88 -174.31 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 110.08 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -135.32 152.05 76.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.847 . . . . 0.0 109.068 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.04 -26.36 49.52 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.569 2.179 . . . . 0.0 112.516 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -98.1 7.22 46.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.55 142.08 50.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.104 -0.997 . . . . 0.0 110.009 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 62.4 p -86.02 144.59 27.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 26.2 mm -51.98 -31.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.129 -0.982 . . . . 0.0 108.699 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.431 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -61.58 -32.95 73.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 109.392 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -72.66 -52.55 14.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.127 -0.983 . . . . 0.0 108.778 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 66.5 t -52.61 -47.43 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.077 -1.015 . . . . 0.0 108.388 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -52.8 -40.56 63.36 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.77 80.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.522 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -59.04 -53.81 54.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.819 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.9 mp -58.98 -34.24 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.867 -1.145 . . . . 0.0 109.213 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -60.98 -47.0 88.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -21.73 61.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.034 -1.041 . . . . 0.0 110.281 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -97.56 -59.32 1.8 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' B' ' 230' ' ' ILE . 56.7 mm-40 -82.94 -5.05 58.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.905 . . . . 0.0 111.341 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.61 73.68 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.558 -1.339 . . . . 0.0 110.357 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.33 125.32 35.37 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.102 -1.234 . . . . 0.0 109.439 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.402 ' HG2' HE21 ' B' ' 240' ' ' GLN . 54.4 Cg_endo -73.63 154.12 49.41 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.956 1.77 . . . . 0.0 111.928 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.27 -31.23 53.59 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.673 2.249 . . . . 0.0 112.945 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -63.83 -13.0 40.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.296 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.402 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -126.54 -16.54 5.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.792 . . . . 0.0 110.357 -179.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.9 132.05 34.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 109.166 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.72 132.5 53.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.447 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.5 mt -107.16 126.56 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.498 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.44 134.54 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -128.71 114.44 16.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.158 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.05 42.47 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.008 -1.057 . . . . 0.0 109.193 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.69 16.81 61.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -114.78 138.94 50.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -1.157 . . . . 0.0 109.479 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -86.65 125.98 34.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.722 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.4 157.78 28.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' B' ' 253' ' ' GLY . 1.1 tt0 -117.48 144.48 45.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.483 -0.761 . . . . 0.0 109.842 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.18 3.77 1.98 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.698 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -118.02 33.71 4.77 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 -145.41 172.02 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.085 -1.244 . . . . 0.0 109.403 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.1 p -112.56 160.63 17.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.405 -0.809 . . . . 0.0 110.071 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.94 -42.38 79.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -0.891 . . . . 0.0 109.388 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.4 p -60.26 -29.11 68.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.534 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.95 -18.59 64.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.241 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.69 3.05 31.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.338 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.34 38.97 3.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.4 mt -91.02 135.87 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -121.77 172.91 7.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 109.545 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.73 ' HZ1' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.86 161.76 0.72 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.346 -0.847 . . . . 0.0 110.466 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 57.31 11.28 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 69.9 p -76.02 151.91 37.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.931 -1.105 . . . . 0.0 108.632 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 16.1 m -116.27 136.94 52.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 110.12 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.0 mp -122.06 140.95 51.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -89.92 139.8 30.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 20.8 tp -109.22 126.47 53.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.041 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.83 130.77 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.12 142.08 36.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -0.888 . . . . 0.0 109.136 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.184 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.2 165.25 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.388 2.058 . . . . 0.0 113.03 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -67.47 -2.35 6.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.818 -0.551 . . . . 0.0 110.692 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.95 9.02 9.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.028 -1.045 . . . . 0.0 110.321 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -111.55 129.35 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 0.0 110.956 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -96.08 137.01 21.77 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.86 -38.47 2.99 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.457 2.105 . . . . 0.0 112.643 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.37 -42.84 92.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 110.356 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.21 -23.76 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 0.0 109.783 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.408 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.6 t80 -68.04 -53.39 26.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.714 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -62.21 -17.29 57.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.969 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -81.78 -6.07 58.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.4 mt -90.23 151.44 44.7 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.532 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.79 155.06 18.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.436 2.091 . . . . 0.0 111.914 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.0 -50.52 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 110.769 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.27 54.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.057 . . . . 0.0 110.266 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.89 -31.1 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 108.234 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -60.51 -49.8 76.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -58.34 -48.27 81.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.553 -0.717 . . . . 0.0 110.163 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.1 -40.09 80.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.011 -1.056 . . . . 0.0 110.336 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.56 -39.05 70.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.884 -1.135 . . . . 0.0 109.874 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.22 -36.72 74.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.726 -1.234 . . . . 0.0 109.062 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.51 -34.16 76.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.233 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 5.3 tm-20 -72.0 -41.18 67.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.848 . . . . 0.0 109.082 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.521 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.1 m0 . . . . . 0 C--N 1.303 -1.416 0 O-C-N 120.95 -1.094 . . . . 0.0 109.045 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.26 163.44 13.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 110.233 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.62 140.97 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.537 -0.727 . . . . 0.0 109.139 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -93.77 142.23 27.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -122.69 110.94 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.412 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -98.46 138.31 35.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 43.0 p -97.27 -175.04 3.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 111.08 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 31.8 mt -71.54 -14.9 62.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.0 p -99.05 -4.06 33.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.616 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.31 2.42 60.47 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -67.63 119.19 11.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.045 -1.267 . . . . 0.0 109.062 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 135.71 41.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 47.4 mt -134.22 135.42 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.434 -0.791 . . . . 0.0 109.088 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 59.5 m -104.56 124.21 48.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.019 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.73 120.68 29.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.11 133.67 51.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.574 -0.704 . . . . 0.0 109.295 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.83 -174.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.969 -1.082 . . . . 0.0 109.788 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -133.92 153.36 79.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.115 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.16 -18.37 23.33 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.423 2.082 . . . . 0.0 111.876 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 31.4 t -108.67 7.66 26.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 110.071 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.68 145.86 46.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.39 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.481 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 58.3 p -87.84 145.3 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 28.3 mm -51.73 -34.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 0.0 109.163 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -62.3 -32.16 72.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.479 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.481 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 46.9 m-20 -70.21 -51.66 29.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.031 -1.043 . . . . 0.0 108.251 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 15.9 t -52.21 -44.14 40.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -48.31 63.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.622 -0.674 . . . . 0.0 109.431 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.46 70.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.729 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -58.76 -54.25 49.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.12 -0.988 . . . . 0.0 109.761 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.5 -34.36 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.097 . . . . 0.0 109.033 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.2 -50.38 72.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.955 -1.091 . . . . 0.0 109.821 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.72 -27.5 69.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.684 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -97.41 -54.41 3.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.967 -1.083 . . . . 0.0 110.518 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -86.1 -6.44 59.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 111.329 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.23 24.18 73.37 Favored Glycine 0 N--CA 1.492 2.379 0 O-C-N 120.467 -1.396 . . . . 0.0 110.281 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 59.6 mt -107.34 130.65 22.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -1.159 . . . . 0.0 109.675 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -69.66 166.59 26.95 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.029 1.819 . . . . 0.0 111.271 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -83.12 -27.75 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.464 2.109 . . . . 0.0 112.711 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.79 -10.16 58.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.937 . . . . 0.0 110.31 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.52 -25.63 5.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.485 -0.759 . . . . 0.0 109.78 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.02 137.8 31.98 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.621 -1.299 . . . . 0.0 108.55 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -124.07 134.39 53.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 110.156 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 16.9 mt -103.18 120.37 40.59 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 53.9 mt -115.24 133.94 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.598 -0.689 . . . . 0.0 109.399 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -128.23 123.79 35.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.55 41.58 30.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.629 -1.294 . . . . 0.0 108.935 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.29 1.07 6.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -93.02 134.19 35.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.035 -1.273 . . . . 0.0 109.458 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -84.2 120.83 26.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.919 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 24.2 mt -73.5 142.55 46.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.645 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 144.52 25.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.661 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -72.98 4.2 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.84 42.28 1.6 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -147.37 172.9 13.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.012 -1.287 . . . . 0.0 109.365 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' THR . . . . . 0.433 ' OG1' ' OD1' ' B' ' 258' ' ' ASP . 6.5 p -110.03 158.16 18.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.067 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 109.849 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.2 p -61.32 -28.99 69.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.807 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . 0.433 ' OD1' ' OG1' ' B' ' 255' ' ' THR . 0.7 OUTLIER -70.12 -15.97 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.129 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.69 3.03 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.82 39.05 3.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.748 . . . . 0.0 109.468 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.7 mt -92.78 136.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.124 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.64 175.11 7.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.386 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.81 162.94 0.53 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.345 -0.847 . . . . 0.0 110.686 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 57.36 13.36 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.098 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -77.01 148.84 36.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.94 -1.1 . . . . 0.0 108.595 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 6.7 m -115.09 137.8 51.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.977 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 9.5 mp -125.54 140.86 52.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.22 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -89.05 143.05 27.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.234 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.95 126.35 52.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.56 131.4 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.353 -0.842 . . . . 0.0 109.749 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 45.2 mt -81.58 143.97 31.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.324 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.285 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -47.64 164.75 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.364 2.042 . . . . 0.0 112.874 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.412 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -67.2 -1.72 4.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.757 -0.589 . . . . 0.0 110.682 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 4.0 m-20 -123.95 9.91 8.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.388 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.2 mm -112.63 129.99 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 0.0 111.268 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t70 -100.19 139.93 21.09 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -71.24 -48.88 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.221 1.947 . . . . 0.0 112.297 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 31.8 tt0 -47.98 -44.02 30.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.691 -0.631 . . . . 0.0 110.271 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.0 t -80.2 -23.63 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.79 -1.194 . . . . 0.0 110.035 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 27.7 t80 -70.55 -53.08 17.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.071 . . . . 0.0 111.074 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -61.63 -16.32 47.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.75 -5.32 58.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.731 -1.231 . . . . 0.0 110.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.2 mt -90.72 151.94 44.31 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.04 155.95 17.32 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.476 2.118 . . . . 0.0 112.08 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.29 -50.06 71.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.685 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.87 -43.05 59.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.92 -1.113 . . . . 0.0 110.115 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -75.85 -31.85 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 108.616 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.5 tt0 -60.84 -50.4 73.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -57.16 -49.04 77.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.661 -0.65 . . . . 0.0 110.277 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -57.7 -40.51 79.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.095 -1.003 . . . . 0.0 110.808 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.3 mt -70.53 -38.63 74.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.851 -1.156 . . . . 0.0 109.943 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.9 mt -71.49 -37.42 71.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.744 -1.222 . . . . 0.0 108.908 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.81 70.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 108.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.19 -37.7 57.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 108.793 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 34.1 m0 . . . . . 0 C--N 1.301 -1.503 0 O-C-N 120.925 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.5 167.62 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.54 143.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.37 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -95.62 144.03 26.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -0.856 . . . . 0.0 110.032 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.28 115.29 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 130.0 46.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 32.6 p -87.21 -177.1 5.91 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.011 0.91 . . . . 0.0 110.774 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 46.9 mt -72.74 -14.98 61.67 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.424 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -98.11 -3.88 36.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.529 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.04 5.05 57.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.311 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -71.37 118.08 13.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.364 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 20.0 m -99.59 135.56 40.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.278 -0.888 . . . . 0.0 109.012 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . 0.429 ' CD1' ' CG ' ' B' ' 234' ' ' GLU . 37.6 mt -134.11 137.35 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.521 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 86.5 m -104.77 125.23 50.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.5 mt -127.47 119.95 27.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 110.049 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.58 131.9 47.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.83 -173.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.573 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.19 153.06 76.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 108.869 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.75 -24.26 45.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.382 2.054 . . . . 0.0 111.906 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' SER . . . . . 0.455 ' H ' ' HG ' ' B' ' 220' ' ' SER . 0.0 OUTLIER -100.29 5.98 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.921 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -70.45 142.51 51.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.997 -1.064 . . . . 0.0 109.363 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 60.5 p -86.2 146.0 26.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.141 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.7 mm -51.41 -35.31 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.066 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -34.62 72.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.813 . . . . 0.0 109.546 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -70.99 -52.6 18.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.365 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 38.0 t -52.32 -43.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 108.824 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.31 -41.29 79.6 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.277 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -56.94 -53.72 54.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.095 -1.003 . . . . 0.0 108.744 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' B' ' 234' ' ' GLU . 3.5 mp -56.59 -35.49 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.934 . . . . 0.0 108.925 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.77 -49.58 74.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 0.0 109.921 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -31.45 70.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 110.763 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -98.1 -53.96 3.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.966 -1.083 . . . . 0.0 110.846 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 230' ' ' ILE . 14.7 mm-40 -81.22 -8.65 59.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.165 -0.959 . . . . 0.0 111.132 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.84 68.97 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 120.625 -1.297 . . . . 0.0 110.396 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 53.5 mt -100.72 129.51 27.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.238 . . . . 0.0 109.345 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.414 ' HG2' HE21 ' B' ' 240' ' ' GLN . 48.4 Cg_endo -73.23 158.67 48.49 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.069 1.846 . . . . 0.0 111.88 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.18 -31.25 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.692 2.261 . . . . 0.0 112.899 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.59 -6.24 29.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 110.443 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.414 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.99 -16.86 4.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 110.26 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.7 140.2 31.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 0.0 109.184 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -129.74 134.49 47.65 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.1 mt -106.85 126.67 52.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.269 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.9 mt -119.81 135.18 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.628 -0.67 . . . . 0.0 109.626 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . 0.4 ' O ' ' CB ' ' B' ' 246' ' ' ALA . 50.7 t80 -127.11 109.21 11.63 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' B' ' 245' ' ' PHE . . . 67.41 41.21 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.868 -1.145 . . . . 0.0 109.267 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.18 1.99 23.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -98.57 135.85 39.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.26 . . . . 0.0 109.585 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -82.75 123.62 29.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 109.272 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 39.7 mt -71.45 142.72 50.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.0 146.51 28.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.5 OUTLIER -72.81 3.43 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.684 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.23 44.09 1.46 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -155.86 172.44 18.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.905 -1.35 . . . . 0.0 109.461 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 76.2 p -113.54 162.5 16.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.624 -0.672 . . . . 0.0 110.149 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.34 -44.5 80.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.4 p -60.22 -27.99 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.88 . . . . 0.0 109.737 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -20.85 62.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.9 5.45 43.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 66.91 39.69 3.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.01 137.0 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -126.26 178.39 5.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.445 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.05 158.98 1.3 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.971 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 58.11 24.02 10.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.304 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.35 148.72 25.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.479 -1.388 . . . . 0.0 108.675 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.8 m -110.87 134.48 52.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.649 -0.657 . . . . 0.0 109.685 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.8 mp -124.04 139.06 54.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.541 -0.724 . . . . 0.0 109.226 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -89.05 143.56 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.08 -1.012 . . . . 0.0 110.001 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.86 127.41 54.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.023 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.76 128.17 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.9 mt -81.3 143.6 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.242 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 . . . . . 0 C--N 1.301 -1.527 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.312 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -48.12 164.81 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.457 2.104 . . . . 0.0 112.917 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -2.14 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.573 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -123.63 9.17 8.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.141 -0.975 . . . . 0.0 110.423 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.4 mm -110.84 129.37 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.167 -0.958 . . . . 0.0 111.267 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t0 -100.24 140.19 21.28 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.24 -47.04 0.57 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.407 2.071 . . . . 0.0 112.219 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.531 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -47.25 -45.32 23.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.738 -0.601 . . . . 0.0 110.336 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.71 -33.03 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.82 -1.175 . . . . 0.0 110.526 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.405 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 18.1 t80 -60.76 -54.39 45.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.909 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.66 -18.13 58.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -81.35 -5.88 58.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.86 -1.15 . . . . 0.0 109.712 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.63 151.56 44.09 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.619 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 155.28 16.34 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.342 2.028 . . . . 0.0 111.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -63.53 -49.03 75.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.02 -42.97 60.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.898 -1.126 . . . . 0.0 110.156 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.77 -32.19 27.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.373 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.403 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.61 -49.5 77.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -58.09 -49.47 76.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.206 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -58.29 -39.52 79.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.0 110.366 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.922 -1.111 . . . . 0.0 109.817 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.8 mt -71.04 -37.14 72.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 109.089 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -33.23 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.68 -38.22 64.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.267 -0.895 . . . . 0.0 109.0 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 38.0 m0 . . . . . 0 C--N 1.3 -1.582 0 O-C-N 120.949 -1.095 . . . . 0.0 108.485 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.86 163.92 12.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 110.482 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.52 145.93 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.226 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.13 141.98 31.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 113.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.714 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.548 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -100.81 129.31 46.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 108.79 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 31.1 p -90.19 -171.79 3.24 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.036 0.922 . . . . 0.0 111.36 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 40.8 mt -71.74 -17.79 62.17 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.716 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.8 p -97.56 -2.64 41.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.675 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.07 2.42 62.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.61 118.63 9.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -1.214 . . . . 0.0 108.856 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 23.0 m -101.35 133.07 46.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.5 mt -128.27 137.88 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.468 -0.77 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 49.6 m -105.96 120.76 42.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 108.768 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 23.6 mt -125.53 121.02 32.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.393 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.29 132.2 47.25 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.86 -172.56 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.888 -1.132 . . . . 0.0 109.854 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -134.73 153.56 78.93 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -58.15 -24.03 64.54 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.478 2.118 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.76 6.91 41.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.825 . . . . 0.0 109.783 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.63 143.93 49.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.954 -1.091 . . . . 0.0 109.571 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.493 ' HG1' HD21 ' B' ' 225' ' ' ASN . 16.2 p -87.63 145.92 25.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.0 109.824 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 33.2 mm -51.79 -39.82 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.178 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -34.4 57.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.565 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.493 HD21 ' HG1' ' B' ' 222' ' ' THR . 63.4 m-20 -72.24 -50.22 29.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.178 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 51.2 t -51.99 -49.72 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 108.557 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -42.87 62.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.571 -0.705 . . . . 0.0 109.477 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.88 75.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.517 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -57.41 -53.71 55.08 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.246 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.52 -33.16 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.013 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -61.04 -47.63 85.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.99 -1.069 . . . . 0.0 110.118 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.56 -26.71 63.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.008 -1.058 . . . . 0.0 110.906 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -94.52 -50.06 5.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.886 -1.134 . . . . 0.0 110.529 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -92.64 -7.69 46.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 0.0 111.396 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.27 21.18 77.19 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 120.44 -1.413 . . . . 0.0 110.726 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . 0.409 HG22 HD13 ' B' ' 236' ' ' ILE . 24.9 mt -103.98 128.11 27.88 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.909 -1.347 . . . . 0.0 109.587 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.87 164.79 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.183 1.922 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.9 -31.95 7.7 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.011 2.474 . . . . 0.0 113.383 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.63 -5.91 43.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.243 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.9 -25.97 4.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -90.19 147.95 23.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.385 -1.447 . . . . 0.0 108.816 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -131.37 133.37 45.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -0.995 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.5 mt -103.84 123.24 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.439 -0.788 . . . . 0.0 109.016 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 97.8 mt -117.55 133.97 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.65 -0.657 . . . . 0.0 109.378 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -129.05 117.24 20.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 60.3 37.23 20.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.654 -1.279 . . . . 0.0 109.21 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.29 28.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -94.96 132.56 39.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.828 -1.395 . . . . 0.0 109.501 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.58 125.07 30.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.11 140.75 41.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.568 ' H ' ' HH ' ' B' ' 259' ' ' TYR . 9.0 tp10 -101.62 148.92 24.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.58 4.16 2.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.337 -0.852 . . . . 0.0 110.832 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . 0.427 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -119.15 46.02 1.18 Allowed Glycine 0 N--CA 1.497 2.721 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.937 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.92 174.41 15.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.905 -1.35 . . . . 0.0 109.515 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 255' ' ' THR . . . . . 0.409 ' HG1' ' CG ' ' B' ' 258' ' ' ASP . 17.0 p -112.65 160.67 17.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 110.257 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.48 -41.11 84.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 109.749 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 257' ' ' SER . . . . . 0.467 ' HG ' ' N ' ' B' ' 258' ' ' ASP . 30.0 p -61.72 -28.04 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 0.0 109.418 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . 0.467 ' N ' ' HG ' ' B' ' 257' ' ' SER . 76.6 m-20 -70.55 -19.68 62.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.38 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . 0.568 ' HH ' ' H ' ' B' ' 251' ' ' GLU . 54.0 m-85 -103.17 3.58 35.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.062 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 66.54 38.93 3.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.551 -0.718 . . . . 0.0 109.99 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 49.6 mt -92.81 137.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.155 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -126.16 176.23 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.073 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.69 160.35 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.914 0.864 . . . . 0.0 110.834 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 56.04 12.67 0.97 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.123 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 16.1 m -78.22 152.03 32.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.882 -1.136 . . . . 0.0 108.644 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 15.4 m -116.34 137.97 51.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -0.764 . . . . 0.0 110.388 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.97 140.88 52.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.359 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . 0.421 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 68.2 m80 -88.95 141.12 28.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.115 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.3 tp -110.08 127.85 55.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 132.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 109.776 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 45.4 mt -80.84 141.39 34.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.115 -0.991 . . . . 0.0 109.289 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.361 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -48.25 164.84 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.309 2.006 . . . . 0.0 113.12 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.88 -2.16 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.754 -0.591 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' B' ' 209' ' ' THR . 2.2 m-20 -122.66 7.31 9.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.098 -1.001 . . . . 0.0 110.387 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.96 128.66 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -0.993 . . . . 0.0 110.967 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.3 t0 -101.09 140.45 21.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.11 -48.75 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.495 2.13 . . . . 0.0 112.432 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.3 tt0 -47.07 -46.86 22.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.733 -0.604 . . . . 0.0 110.46 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.42 -23.67 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.234 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.9 t80 -72.17 -54.89 8.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 111.03 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.9 -19.13 59.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -80.26 -4.18 52.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.877 -1.14 . . . . 0.0 109.302 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 152.65 43.41 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.257 -0.902 . . . . 0.0 109.847 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.5 154.36 30.62 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.415 2.077 . . . . 0.0 111.852 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -63.31 -48.06 79.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -0.854 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.16 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.92 -1.113 . . . . 0.0 110.44 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.06 -31.97 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 0.0 108.361 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.6 tt0 -59.88 -50.51 73.51 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -58.39 -48.14 81.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.86 -41.98 88.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 110.789 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.4 mt -71.15 -37.31 72.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.689 -1.257 . . . . 0.0 109.723 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.26 -37.54 74.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.855 -1.153 . . . . 0.0 109.036 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.78 73.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.055 -1.028 . . . . 0.0 109.003 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -71.36 -40.31 70.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 108.819 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 23.8 m0 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.057 -1.027 . . . . 0.0 109.192 179.225 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 164.28 12.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 110.599 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.0 143.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.83 140.78 29.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.712 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.04 110.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 109.304 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -97.1 132.4 42.93 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 34.8 p -94.45 -174.61 3.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.101 -1.0 . . . . 0.0 111.066 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.17 -14.27 61.77 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.343 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 11.1 p -99.71 -4.33 30.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.455 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.63 1.8 60.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -66.8 117.85 9.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -1.21 . . . . 0.0 108.848 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 8.6 m -101.0 133.07 46.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 108.978 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 26.6 mt -127.63 135.6 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 109.503 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 19.0 m -102.63 121.38 42.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 33.2 mt -127.39 119.45 26.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.369 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.5 130.97 45.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.27 -177.01 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -130.18 153.54 81.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 109.034 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.26 -17.95 42.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.401 2.068 . . . . 0.0 111.946 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.33 8.47 29.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.0 144.54 47.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.847 -1.158 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 64.6 p -87.04 145.86 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.129 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.88 -28.51 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 108.916 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.425 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -64.3 -37.39 87.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.388 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -69.06 -50.38 48.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.174 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.91 -48.81 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.096 -1.003 . . . . 0.0 108.685 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -52.5 -40.48 62.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.688 . . . . 0.0 109.359 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.41 -35.61 80.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.639 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -58.21 -53.64 55.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.915 -1.116 . . . . 0.0 109.145 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.8 mp -59.46 -35.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.111 -0.993 . . . . 0.0 109.204 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -59.36 -44.25 92.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.095 -1.003 . . . . 0.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.91 -29.28 63.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 0.0 110.764 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -91.99 -48.87 6.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.928 -1.108 . . . . 0.0 110.605 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -92.26 -6.71 49.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 111.58 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.68 22.98 73.85 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.482 -1.386 . . . . 0.0 110.389 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 56.5 mt -101.31 129.49 26.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.312 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.411 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.6 Cg_endo -75.4 155.46 41.08 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.029 1.819 . . . . 0.0 111.643 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.6 -32.39 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.698 2.265 . . . . 0.0 113.015 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -64.42 -8.97 15.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.411 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.64 -21.58 3.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.753 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.48 135.38 34.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.749 -1.219 . . . . 0.0 109.299 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.95 131.54 51.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.04 126.76 52.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.333 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.93 134.69 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -128.31 121.51 29.4 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.84 42.79 28.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.571 -1.331 . . . . 0.0 109.275 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.72 0.03 7.89 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -95.52 132.37 40.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.872 -1.37 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.7 123.61 29.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.084 -1.01 . . . . 0.0 108.83 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 19.4 mt -68.81 150.73 47.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 0.0 109.744 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.687 ' N ' ' HH ' ' B' ' 259' ' ' TYR . 4.1 mt-10 -104.3 141.57 36.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.51 3.49 3.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.322 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.18 35.77 3.4 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -142.34 170.95 14.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.295 . . . . 0.0 109.813 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.3 p -111.79 159.96 17.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.001 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.5 -42.85 79.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 257' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' B' ' 258' ' ' ASP . 79.5 p -62.74 -29.13 70.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . 0.434 ' N ' ' HG ' ' B' ' 257' ' ' SER . 3.7 m-20 -69.8 -18.61 63.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.158 -0.964 . . . . 0.0 109.101 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . 0.687 ' HH ' ' N ' ' B' ' 251' ' ' GLU . 18.4 m-85 -103.55 3.45 34.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.151 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.84 39.15 2.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.501 -0.749 . . . . 0.0 109.837 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.7 mt -93.86 136.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . 0.478 ' O ' ' OG ' ' B' ' 265' ' ' SER . 55.6 mt-30 -125.81 177.17 6.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.26 162.24 0.76 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.245 -0.909 . . . . 0.0 110.927 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 56.33 12.42 1.01 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.053 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 265' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 72.7 m -76.5 149.05 36.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.891 -1.131 . . . . 0.0 108.75 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 20.5 m -115.83 138.95 50.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 110.352 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.3 mp -124.88 142.81 51.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.432 -0.793 . . . . 0.0 109.406 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -90.67 141.75 28.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.034 -1.041 . . . . 0.0 109.858 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 23.0 tp -111.28 128.89 56.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.412 -0.805 . . . . 0.0 109.578 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 3.1 t -116.76 130.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 109.576 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 48.3 mt -82.57 145.66 29.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.369 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.566 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -48.09 164.13 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.287 1.991 . . . . 0.0 112.757 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -2.19 5.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.653 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.405 ' O ' ' CG2' ' B' ' 209' ' ' THR . 2.6 m-20 -123.22 9.66 9.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.081 -1.012 . . . . 0.0 110.698 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.29 127.61 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.101 -0.999 . . . . 0.0 111.119 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.0 t70 -98.33 138.73 20.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.36 -41.69 4.53 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.338 2.025 . . . . 0.0 112.567 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 61.2 tt0 -56.61 -43.34 80.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 110.466 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.0 t -81.11 -24.24 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.748 -1.22 . . . . 0.0 110.402 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -72.24 -55.07 7.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -59.09 -16.76 20.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -83.93 -5.76 59.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.996 -1.065 . . . . 0.0 109.877 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.4 151.38 48.39 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.006 -1.059 . . . . 0.0 109.786 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 153.81 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.28 1.987 . . . . 0.0 111.792 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -63.03 -51.57 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.583 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.5 39.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.928 -1.108 . . . . 0.0 110.239 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.27 -31.45 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.712 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.49 -50.03 75.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -58.1 -49.04 78.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.753 . . . . 0.0 110.145 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -57.11 -41.99 80.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.63 -38.61 73.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.852 -1.155 . . . . 0.0 110.023 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.56 -38.33 74.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.68 -1.262 . . . . 0.0 109.327 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.48 -31.44 70.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.161 -0.962 . . . . 0.0 108.708 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -72.21 -42.64 65.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.0 m0 . . . . . 0 C--N 1.302 -1.476 0 O-C-N 120.983 -1.073 . . . . 0.0 109.391 179.672 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.19 166.84 11.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 110.334 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.34 146.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.427 -0.796 . . . . 0.0 109.781 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -97.89 141.06 31.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.87 109.12 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.17 133.31 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 34.6 p -94.78 -176.38 3.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 110.914 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 25.7 mt -71.22 -12.8 61.67 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.489 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 10.7 p -101.79 -3.96 27.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.709 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.63 2.94 58.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -68.41 118.41 11.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.272 . . . . 0.0 109.021 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -101.01 135.86 41.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 40.9 mt -133.43 136.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.384 -0.823 . . . . 0.0 109.349 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.1 m -105.91 122.49 46.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 18.4 mt -126.11 121.7 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.391 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.54 132.24 47.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.2 m -140.2 -173.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.968 -1.082 . . . . 0.0 109.58 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -134.95 154.2 79.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.97 -20.62 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.545 2.163 . . . . 0.0 112.223 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 67.4 m -106.3 7.66 31.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 110.219 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 142.2 54.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.77 -1.206 . . . . 0.0 109.404 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.443 ' HG1' ' ND2' ' B' ' 225' ' ' ASN . 14.5 p -85.43 146.85 26.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 40.5 mm -51.7 -40.26 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.389 -0.82 . . . . 0.0 109.384 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.17 -35.67 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.568 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.443 ' ND2' ' HG1' ' B' ' 222' ' ' THR . 98.7 m-20 -69.13 -52.3 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 99.0 t -52.51 -45.58 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.377 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.06 -43.69 70.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.7 73.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.444 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.439 ' CB ' ' HZ2' ' B' ' 229' ' ' LYS . 4.4 mtpm? -58.55 -54.53 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.3 mp -57.86 -34.18 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.848 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.1 -46.14 88.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.236 -0.915 . . . . 0.0 109.997 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -30.81 71.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.184 -0.947 . . . . 0.0 110.902 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -95.87 -50.67 4.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.008 -1.058 . . . . 0.0 110.556 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -87.39 -7.69 57.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.032 -1.043 . . . . 0.0 111.412 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.75 23.27 70.67 Favored Glycine 0 N--CA 1.493 2.446 0 O-C-N 120.535 -1.353 . . . . 0.0 110.305 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 45.9 mt -100.48 126.7 34.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.086 -1.244 . . . . 0.0 109.271 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.15 152.78 40.48 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.064 1.843 . . . . 0.0 111.767 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.04 -30.1 47.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.668 2.245 . . . . 0.0 112.694 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.24 -16.1 41.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.521 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.08 -12.36 5.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.422 -0.798 . . . . 0.0 110.696 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.86 137.0 32.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.917 -1.115 . . . . 0.0 109.523 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.18 132.09 45.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.654 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.92 128.78 54.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 109.297 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.56 136.22 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.563 -0.711 . . . . 0.0 109.85 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -132.36 117.02 17.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.233 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.35 36.96 8.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.895 -1.128 . . . . 0.0 109.436 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.8 13.0 68.51 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.295 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -115.45 137.8 51.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.263 . . . . 0.0 109.524 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.56 126.17 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.013 . . . . 0.0 109.435 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.0 mt -70.69 139.78 51.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.622 ' H ' ' HH ' ' B' ' 259' ' ' TYR . 3.2 tp10 -92.6 142.2 27.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.192 -0.942 . . . . 0.0 109.486 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.5 m-20 -69.26 3.45 2.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 109.712 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -123.44 41.68 1.73 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.543 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -144.78 171.25 14.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 109.332 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 25.8 p -111.73 158.32 19.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.962 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 6.4 mt -54.88 -40.7 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 89.0 p -64.2 -28.35 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.547 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.61 -17.17 62.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . 0.622 ' HH ' ' H ' ' B' ' 251' ' ' GLU . 21.4 m-85 -105.17 3.16 29.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 109.084 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 37.85 3.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 0.0 109.999 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.48 135.92 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -125.74 177.78 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 109.925 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.53 157.13 3.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.021 0.915 . . . . 0.0 111.008 -178.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 57.87 12.43 1.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.671 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 22.0 m -75.9 148.3 38.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 30.8 m -115.58 138.97 50.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.772 . . . . 0.0 110.048 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.2 mp -120.72 166.46 13.68 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -112.13 137.47 50.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.795 . . . . 0.0 109.426 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 18.6 tp -108.86 126.05 52.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.478 -0.763 . . . . 0.0 109.285 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.07 130.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.435 -0.791 . . . . 0.0 109.624 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.4 mt -80.79 143.22 33.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.092 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 108.85 -178.876 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.84 164.79 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.642 2.228 . . . . 0.0 112.962 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.0 p -69.13 -2.47 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.768 -0.582 . . . . 0.0 110.509 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -121.56 6.62 10.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.017 -1.052 . . . . 0.0 110.204 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -108.78 129.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.905 . . . . 0.0 111.275 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.8 t0 -100.49 138.33 20.13 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.7 -47.12 1.45 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.149 1.899 . . . . 0.0 112.009 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 7.1 tt0 -50.47 -43.04 55.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.889 -0.507 . . . . 0.0 110.1 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.55 -23.97 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.699 -1.251 . . . . 0.0 110.022 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -73.59 -52.79 12.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.093 -1.005 . . . . 0.0 110.655 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -62.56 -17.4 59.88 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.916 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -81.07 -6.37 58.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.9 -1.125 . . . . 0.0 109.779 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.6 mt -90.65 151.74 44.24 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.13 155.99 17.61 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.005 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -50.03 71.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.96 -43.28 50.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.92 -1.113 . . . . 0.0 110.352 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.7 t -75.13 -32.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.889 -1.132 . . . . 0.0 108.642 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.1 tt0 -59.26 -51.44 69.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -57.62 -49.06 77.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.562 -0.711 . . . . 0.0 110.352 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.79 -41.28 81.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.045 . . . . 0.0 110.861 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.7 mt -71.22 -36.33 71.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.7 -1.25 . . . . 0.0 109.632 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 mt -71.45 -37.85 71.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.71 -1.244 . . . . 0.0 108.854 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.22 72.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.101 -0.999 . . . . 0.0 109.435 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -74.39 -37.02 63.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 108.888 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.1 m0 . . . . . 0 C--N 1.301 -1.536 0 O-C-N 120.882 -1.136 . . . . 0.0 108.612 178.809 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.45 165.63 12.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -146.66 141.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.0 109.235 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -94.52 141.98 27.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.974 . . . . 0.0 109.9 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.49 114.37 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.0 138.92 35.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.1 p -98.65 -175.5 3.09 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -0.936 . . . . 0.0 110.573 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.415 HD13 ' H ' ' B' ' 271' ' ' LEU . 48.7 mt -70.23 -15.91 62.98 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.188 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.9 p -100.3 -3.07 32.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.132 -0.98 . . . . 0.0 109.655 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.1 3.61 57.83 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.353 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.8 117.61 9.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.289 . . . . 0.0 108.962 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 4.7 m -99.92 132.97 44.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 20.5 mt -127.95 136.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.46 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 67.6 m -105.95 119.95 40.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.87 122.53 38.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 132.76 48.12 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.93 -174.04 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.93 -1.106 . . . . 0.0 109.77 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -135.93 154.51 77.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.89 . . . . 0.0 109.206 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.85 -29.03 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.69 2.26 . . . . 0.0 112.105 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 t -98.4 6.06 47.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.694 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.25 142.37 52.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.001 -1.062 . . . . 0.0 109.502 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.6 p -87.99 145.32 26.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.029 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 36.0 mm -51.5 -37.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.114 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -34.01 58.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -72.58 -50.48 25.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.193 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.9 -51.22 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 108.928 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -50.76 -42.31 57.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.336 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.0 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 0.0 109.735 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -57.03 -54.01 51.62 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.008 -1.057 . . . . 0.0 109.19 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.08 -32.36 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.612 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -62.1 -47.14 85.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -72.66 -26.51 61.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.806 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -92.48 -48.38 6.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.815 -1.178 . . . . 0.0 110.504 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.22 -6.66 47.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 111.261 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.46 72.54 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 120.571 -1.331 . . . . 0.0 110.328 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.82 126.68 31.95 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.086 -1.243 . . . . 0.0 109.232 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.415 ' HG2' HE21 ' B' ' 240' ' ' GLN . 38.6 Cg_endo -72.04 156.61 55.77 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.813 1.676 . . . . 0.0 111.58 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.93 -29.9 22.35 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.617 2.211 . . . . 0.0 112.851 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.3 -14.5 60.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.431 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.415 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.87 -20.97 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.37 -0.831 . . . . 0.0 110.288 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.67 136.27 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.857 -1.152 . . . . 0.0 108.894 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -127.47 132.8 49.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.53 123.53 48.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.099 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 93.9 mt -118.19 135.75 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -131.92 115.89 16.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.852 . . . . 0.0 108.956 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.9 35.87 8.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.97 10.49 68.34 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.173 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -111.28 136.86 49.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.686 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.94 122.21 27.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 109.483 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 29.5 mt -68.39 146.6 53.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 109.25 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -101.24 143.86 30.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.74 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.589 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.2 OUTLIER -71.26 3.91 3.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.949 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.6 36.31 3.17 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 19.8 mtt85 -142.54 174.34 10.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.903 -1.351 . . . . 0.0 109.692 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 14.1 p -113.09 158.79 19.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 110.104 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.5 mt -56.9 -43.45 81.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.78 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 59.1 p -59.63 -27.17 66.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -19.21 61.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.637 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -103.84 3.89 34.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.329 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.54 38.31 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.0 109.792 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -93.02 135.98 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.003 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.67 176.76 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.111 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.44 155.4 2.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.885 0.85 . . . . 0.0 111.196 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 59.93 14.21 4.14 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.19 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 88.9 p -76.87 149.91 36.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.801 -1.187 . . . . 0.0 108.551 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 3.1 m -114.57 135.68 53.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.737 . . . . 0.0 110.276 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 9.1 mp -122.98 140.11 53.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.504 -0.747 . . . . 0.0 109.253 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -88.5 141.55 28.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.144 -0.973 . . . . 0.0 110.203 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.05 126.96 53.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.452 -0.78 . . . . 0.0 108.951 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.75 128.99 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.884 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . 0.415 ' H ' HD13 ' B' ' 208' ' ' LEU . 48.9 mt -80.77 143.57 32.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.032 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -178.761 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -48.46 163.96 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.229 1.953 . . . . 0.0 112.749 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.45 -1.78 5.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -123.46 9.64 9.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.131 -0.981 . . . . 0.0 110.553 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 mm -111.28 129.17 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.218 -0.926 . . . . 0.0 111.327 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.7 t0 -98.44 138.93 20.86 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.81 -44.89 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.286 1.99 . . . . 0.0 112.066 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 14.2 tt0 -47.67 -47.01 29.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.878 -0.514 . . . . 0.0 110.409 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.7 t -79.87 -39.88 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.433 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -52.57 -54.59 30.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.838 -1.164 . . . . 0.0 111.007 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -61.3 -18.49 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 110.016 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -82.76 -5.36 58.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.822 -1.174 . . . . 0.0 109.638 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.1 mt -89.38 152.06 47.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.032 -1.043 . . . . 0.0 109.527 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.4 154.19 25.15 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.326 2.018 . . . . 0.0 112.004 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -48.57 77.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.835 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.59 -42.82 62.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.977 -1.077 . . . . 0.0 110.168 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.08 -31.64 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.9 -1.125 . . . . 0.0 108.475 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.3 tt0 -60.18 -53.17 60.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -54.95 -49.31 71.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -57.38 -39.25 75.64 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.006 -1.059 . . . . 0.0 110.609 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.87 -37.34 64.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.644 -1.285 . . . . 0.0 109.917 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.0 mt -71.44 -38.33 71.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.761 -1.212 . . . . 0.0 108.889 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.94 -34.15 75.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 109.442 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -74.31 -33.55 63.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.9 m0 . . . . . 0 C--N 1.3 -1.557 0 O-C-N 120.898 -1.126 . . . . 0.0 107.995 178.286 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.73 163.68 12.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.356 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.42 142.56 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.527 -0.733 . . . . 0.0 109.346 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.06 142.46 27.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.62 113.91 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.19 -0.944 . . . . 0.0 109.701 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.552 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.5 135.14 43.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.077 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 29.0 p -93.38 -175.61 3.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.014 0.912 . . . . 0.0 111.099 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.32 -19.8 63.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.6 p -96.56 -3.31 43.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.974 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.99 58.06 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.545 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -68.45 118.62 11.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.895 -1.356 . . . . 0.0 108.973 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.0 m -102.43 139.43 38.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.262 -0.899 . . . . 0.0 109.808 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 54.5 mt -137.94 137.67 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 0.0 109.339 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 36.1 m -105.45 122.55 46.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 108.741 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.414 ' HB3' ' HZ2' ' B' ' 229' ' ' LYS . 19.4 mt -125.29 121.55 34.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 110.567 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -65.79 131.38 46.16 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.95 -173.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.013 -1.054 . . . . 0.0 109.902 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -134.36 156.04 79.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.0 108.923 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.09 -20.42 67.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.433 2.088 . . . . 0.0 111.899 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 4.3 m -103.54 6.94 37.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.837 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 144.78 48.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.996 -1.065 . . . . 0.0 109.544 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 80.4 p -86.43 148.83 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.3 -25.16 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.912 . . . . 0.0 108.92 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -35.43 77.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.801 . . . . 0.0 109.35 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.09 -51.09 34.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.62 -48.18 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 108.385 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -51.05 -44.9 61.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.05 76.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.337 -0.852 . . . . 0.0 109.583 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . 0.414 ' HZ2' ' HB3' ' B' ' 215' ' ' LEU . 4.2 mtpm? -56.96 -54.69 43.83 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.544 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.414 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.5 mp -59.95 -31.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.037 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.94 -48.46 78.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.72 -27.9 67.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -94.67 -52.57 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.929 -1.107 . . . . 0.0 110.374 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 230' ' ' ILE . 69.8 mm-40 -87.93 -7.99 56.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 111.561 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.31 24.34 73.52 Favored Glycine 0 N--CA 1.494 2.503 0 O-C-N 120.44 -1.413 . . . . 0.0 110.458 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.5 mt -100.69 130.89 24.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.325 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.53 152.83 43.75 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.077 1.852 . . . . 0.0 111.676 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.07 -32.74 16.74 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.573 2.182 . . . . 0.0 113.107 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.408 ' C ' ' OD1' ' B' ' 239' ' ' ASP . 15.1 p30 -64.06 -8.84 13.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 -21.66 3.39 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.451 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.49 136.82 33.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.71 -1.244 . . . . 0.0 108.776 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -128.04 133.2 49.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.32 -0.863 . . . . 0.0 109.685 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.5 mt -105.24 125.8 51.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.0 mt -116.93 156.0 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -151.81 116.57 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.271 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 59.96 43.02 15.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.843 -1.161 . . . . 0.0 109.507 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 23.82 67.19 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -121.59 136.91 54.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 0.0 109.479 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.85 123.81 31.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.265 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.51 141.68 44.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.37 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.45 147.53 24.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.95 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -73.02 3.4 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.519 -0.738 . . . . 0.0 109.755 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.49 33.64 4.58 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -143.11 172.21 13.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.95 -1.323 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 255' ' ' THR . . . . . 0.403 ' HG1' ' HG ' ' B' ' 257' ' ' SER . 82.2 p -111.51 159.61 17.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 110.075 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.0 mt -55.51 -40.98 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.468 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 257' ' ' SER . . . . . 0.403 ' HG ' ' HG1' ' B' ' 255' ' ' THR . 85.7 p -63.28 -28.21 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.102 -0.999 . . . . 0.0 109.535 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -18.75 62.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.982 . . . . 0.0 109.53 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -103.06 4.09 36.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.097 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 69.81 40.91 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.687 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 52.0 mt -98.52 136.81 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 -178.87 4.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 108.96 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.41 163.31 0.63 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.37 1.081 . . . . 0.0 111.525 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 55.71 11.32 0.64 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.145 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 147.12 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.82 -1.175 . . . . 0.0 108.924 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 5.7 m -113.89 138.39 50.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.597 -0.689 . . . . 0.0 110.083 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.2 mp -127.17 144.27 51.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.34 -0.85 . . . . 0.0 110.18 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . 0.418 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 62.1 m80 -91.9 142.45 27.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.188 -0.945 . . . . 0.0 110.382 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.35 127.02 54.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.365 -0.835 . . . . 0.0 108.924 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.75 131.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.383 -0.823 . . . . 0.0 109.729 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 39.4 mt -81.76 143.87 31.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 108.706 -179.24 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.552 0.215 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.77 165.06 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.641 2.227 . . . . 0.0 113.176 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -2.75 10.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 110.691 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -120.85 5.61 10.45 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.031 -1.043 . . . . 0.0 109.894 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -109.62 130.44 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 111.001 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.85 134.57 20.4 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.01 -45.55 5.82 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.965 1.777 . . . . 0.0 112.024 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -50.23 -44.71 53.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.849 -0.532 . . . . 0.0 110.485 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.8 t -80.2 -26.44 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.834 -1.166 . . . . 0.0 110.147 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.0 t80 -68.99 -51.67 36.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.536 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -62.59 -17.48 60.22 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.803 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.94 -6.74 59.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.865 -1.147 . . . . 0.0 109.641 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.0 mt -89.15 151.75 47.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.144 -0.972 . . . . 0.0 109.753 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.38 155.64 19.81 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.41 2.074 . . . . 0.0 111.91 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.39 -50.81 68.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 110.679 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.22 -42.99 52.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.297 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.16 -30.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 108.423 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.0 tt0 -60.6 -51.59 68.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -56.9 -47.83 79.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.525 -0.735 . . . . 0.0 110.202 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.24 -40.31 85.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.044 -1.035 . . . . 0.0 110.775 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.0 mt -72.31 -35.7 68.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.796 -1.19 . . . . 0.0 109.561 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.44 -37.49 71.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 108.853 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.77 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.025 -1.047 . . . . 0.0 109.197 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -72.71 -37.89 67.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.401 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 42.5 m0 . . . . . 0 C--N 1.302 -1.487 0 O-C-N 120.95 -1.094 . . . . 0.0 108.77 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.12 165.59 12.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.86 151.97 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.392 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -104.29 142.61 34.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.878 . . . . 0.0 109.782 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.38 114.02 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.599 ' HZ2' ' CB ' ' B' ' 206' ' ' LYS . 0.4 OUTLIER -101.31 130.46 47.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 108.818 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 38.1 p -89.11 -175.53 4.84 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.999 0.904 . . . . 0.0 111.019 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 25.1 mt -71.41 -11.33 60.83 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.585 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 9.9 p -103.48 -2.88 26.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.836 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.35 60.51 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.243 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -67.77 117.84 10.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.265 . . . . 0.0 108.845 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -99.96 139.33 35.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.176 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . 0.401 ' CD1' ' CG ' ' B' ' 234' ' ' GLU . 29.1 mt -135.54 137.81 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.2 m -105.14 122.59 46.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 108.837 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 21.5 mt -127.01 119.29 26.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.945 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.71 132.36 49.44 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.3 -175.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.947 -1.095 . . . . 0.0 109.764 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.36 154.43 78.59 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 108.978 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.39 -24.74 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.62 2.214 . . . . 0.0 112.005 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 6.54 42.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.24 142.88 52.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.505 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' THR . . . . . 0.452 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 11.9 p -85.66 145.7 27.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.34 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 34.8 mm -51.81 -35.76 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.251 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' B' ' 225' ' ' ASN . 5.8 pt-20 -61.38 -36.21 79.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.452 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 63.4 m-20 -68.16 -52.45 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.25 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.84 -48.29 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.919 -1.113 . . . . 0.0 108.045 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.99 -43.65 60.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.709 -0.619 . . . . 0.0 109.492 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 109.27 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -57.48 -53.98 52.05 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.085 -1.009 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.22 -33.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.122 -0.986 . . . . 0.0 109.083 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.78 -48.46 79.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.212 -0.93 . . . . 0.0 110.031 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.76 -25.43 66.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.635 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -98.95 -57.62 2.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.043 . . . . 0.0 110.522 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' B' ' 230' ' ' ILE . 34.9 mm-40 -81.43 -8.48 59.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.25 -0.906 . . . . 0.0 111.187 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.77 22.24 73.55 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 120.502 -1.374 . . . . 0.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . 0.402 HG22 HD11 ' B' ' 236' ' ' ILE . 64.7 mt -101.73 131.13 23.24 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.977 -1.307 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.409 ' HG2' HE21 ' B' ' 240' ' ' GLN . 58.6 Cg_endo -75.2 153.65 41.01 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.029 1.819 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.43 -30.86 43.6 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.558 2.172 . . . . 0.0 112.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.27 -16.62 63.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.638 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.409 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.78 -18.22 7.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.25 137.57 32.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.75 -1.219 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -129.0 134.12 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.9 mt -105.71 124.8 50.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 78.4 mt -118.33 135.46 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.71 -0.619 . . . . 0.0 109.533 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -129.91 113.49 14.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.47 -0.769 . . . . 0.0 109.004 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.34 38.7 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.65 7.78 55.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.75 135.84 46.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.242 . . . . 0.0 109.489 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -83.61 119.76 25.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 0.0 109.338 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.6 140.47 56.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 2.0 tm-20 -92.5 143.1 26.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -71.54 3.5 3.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 109.636 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 251' ' ' GLU . . . -121.35 39.66 2.32 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -146.21 173.7 11.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.968 -1.313 . . . . 0.0 109.383 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 5.7 p -112.32 161.56 16.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 109.864 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mt -58.54 -41.16 84.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.787 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 93.7 p -62.24 -29.04 70.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.742 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.57 -19.98 62.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -101.93 3.97 39.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.267 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.6 38.18 3.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 32.7 mt -93.27 136.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -125.19 176.74 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.539 -0.726 . . . . 0.0 109.757 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.78 159.58 1.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.935 0.874 . . . . 0.0 110.719 -179.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 55.76 27.55 10.94 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.162 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.17 149.09 21.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.164 . . . . 0.0 108.525 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 9.5 m -112.65 136.36 52.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 110.268 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -124.56 139.47 53.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.129 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -87.79 141.51 28.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.9 tp -108.86 126.62 53.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.53 129.21 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.639 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 48.5 mt -81.31 143.89 31.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.0 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.91 . . . . 0.0 109.061 -179.222 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.37 164.12 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.451 2.1 . . . . 0.0 113.172 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -68.6 -2.09 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.761 -0.587 . . . . 0.0 110.468 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 0.7 OUTLIER -122.12 8.41 9.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.074 -1.016 . . . . 0.0 110.436 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 68' ' ' ILE . 25.6 mm -108.71 126.5 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.924 . . . . 0.0 111.295 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 69' ' ' ASP . 5.3 t0 -98.25 113.38 63.94 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -46.49 -47.24 15.85 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.161 1.907 . . . . 0.0 112.271 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -48.53 -45.18 37.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.469 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.47 -24.25 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.646 -1.284 . . . . 0.0 110.423 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.2 t80 -69.68 -52.6 24.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.77 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -62.52 -17.07 58.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.925 . . . . 0.0 110.021 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -81.66 -6.36 58.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.787 -1.196 . . . . 0.0 109.95 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.61 152.64 43.59 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 109.63 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.09 155.22 19.68 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.534 2.156 . . . . 0.0 112.135 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -50.25 70.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.12 -43.2 51.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.889 -1.132 . . . . 0.0 110.387 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.35 -30.99 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.982 -1.074 . . . . 0.0 108.324 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.2 tt0 -59.96 -51.45 69.64 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -57.56 -48.06 80.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.613 -0.679 . . . . 0.0 110.244 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.15 -39.81 79.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.696 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.75 -36.81 67.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.714 -1.241 . . . . 0.0 109.745 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.93 -37.77 69.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.785 -1.197 . . . . 0.0 108.789 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.76 -34.23 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 109.515 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.92 -33.69 59.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 108.644 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 50.4 m0 . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.261 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.39 163.9 13.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.917 . . . . 0.0 109.999 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.87 142.3 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.221 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -94.48 142.82 26.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.092 -1.005 . . . . 0.0 109.691 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.48 114.7 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -101.42 132.98 46.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.898 . . . . 0.0 109.159 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 18.6 p -91.01 -175.62 4.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.32 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.69 -15.54 62.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -101.93 -1.68 31.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.688 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.77 4.8 58.91 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.392 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -68.3 117.75 10.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.323 . . . . 0.0 108.807 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.9 m -99.74 140.41 33.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.421 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 22.2 mt -137.56 137.86 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 22.7 m -104.26 124.35 49.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 23.5 mt -129.2 119.3 23.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.87 . . . . 0.0 110.06 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.88 133.94 51.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.65 -0.656 . . . . 0.0 109.439 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.26 -173.38 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 0.0 109.616 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -135.81 153.38 77.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 108.862 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.68 -21.47 25.22 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.569 2.18 . . . . 0.0 112.03 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.0 7.58 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.955 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.29 142.34 52.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.901 -1.125 . . . . 0.0 109.507 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.6 p -86.55 145.8 26.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.188 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.2 mm -50.97 -43.17 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.418 ' CD ' ' OD1' ' B' ' 225' ' ' ASN . 0.2 OUTLIER -52.62 -34.76 52.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.475 -0.766 . . . . 0.0 109.699 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . 0.418 ' OD1' ' CD ' ' B' ' 224' ' ' GLU . 63.5 m-20 -71.22 -52.21 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.23 -45.47 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.037 -1.04 . . . . 0.0 108.529 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -43.12 70.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.98 78.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.413 -0.804 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -57.78 -53.75 54.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.084 -1.01 . . . . 0.0 109.363 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -57.22 -35.61 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.007 -1.058 . . . . 0.0 109.246 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.895 -1.128 . . . . 0.0 109.967 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.98 -29.2 70.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.843 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -95.51 -52.28 4.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.381 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -87.76 -6.58 58.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.31 24.02 71.93 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.45 -1.406 . . . . 0.0 110.289 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 44.6 mt -103.03 128.79 26.92 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.25 . . . . 0.0 109.774 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.57 155.95 31.85 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.159 1.906 . . . . 0.0 111.828 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.77 -30.62 33.69 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.944 2.429 . . . . 0.0 112.939 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -61.95 -13.3 23.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 -17.2 4.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -0.77 . . . . 0.0 110.746 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.23 137.04 32.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.701 -1.25 . . . . 0.0 109.417 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -129.54 130.78 46.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 109.567 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.74 125.13 50.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 109.32 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 39.9 mt -118.78 136.22 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.672 -0.642 . . . . 0.0 109.428 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -131.06 119.23 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.758 . . . . 0.0 109.459 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.0 47.29 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.923 -1.111 . . . . 0.0 109.464 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.53 26.28 64.29 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.7 OUTLIER -123.91 135.3 53.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.315 -1.109 . . . . 0.0 109.622 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -84.09 122.11 28.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 109.258 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 38.1 mt -72.38 144.02 48.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -96.89 143.5 27.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 3.68 3.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.442 -0.786 . . . . 0.0 109.843 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.11 44.74 1.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.49 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -148.26 174.1 12.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.141 -1.211 . . . . 0.0 109.079 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.7 p -111.91 160.15 17.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.354 -0.841 . . . . 0.0 110.185 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.21 -40.72 91.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.842 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.4 p -61.68 -28.77 69.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.957 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.58 -15.86 62.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -104.28 2.38 31.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 108.933 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.07 38.54 3.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.89 137.45 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.102 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . 0.482 HE21 ' HZ3' ' B' ' 263' ' ' LYS . 4.1 mt-30 -126.7 179.49 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 108.987 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.482 ' HZ3' HE21 ' B' ' 262' ' ' GLN . 0.0 OUTLIER -53.17 163.73 0.51 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.45 1.119 . . . . 0.0 111.492 -178.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 55.54 12.04 0.72 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.093 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 89.2 p -76.09 148.31 38.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 108.714 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 17.7 m -114.19 136.8 52.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.459 -0.776 . . . . 0.0 110.268 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -123.74 139.43 53.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.533 -0.73 . . . . 0.0 109.361 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -88.77 142.13 27.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 110.287 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.58 125.61 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.39 130.05 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.746 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 36.7 mt -80.76 143.34 32.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.082 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 108.694 -179.199 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.61 165.2 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.055 1.837 . . . . 0.0 112.22 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 t -66.01 -12.53 55.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.701 -0.624 . . . . 0.0 110.88 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.49 8.65 19.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.4 mm -111.41 129.71 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.111 -0.993 . . . . 0.0 110.707 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.4 t70 -97.96 139.13 21.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.27 -36.58 3.99 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.228 1.952 . . . . 0.0 112.537 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 8.5 tp60 -59.13 -44.5 92.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.536 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -79.02 -23.9 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.809 -1.182 . . . . 0.0 110.047 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 19.8 t80 -66.4 -52.38 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.087 -1.008 . . . . 0.0 110.729 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -63.41 -16.31 60.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.52 -6.87 59.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 109.767 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.5 mt -90.18 152.26 45.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.13 154.86 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.409 2.073 . . . . 0.0 112.03 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.1 -50.47 70.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.4 -44.37 34.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.936 -1.103 . . . . 0.0 110.013 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.61 -31.82 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.911 -1.118 . . . . 0.0 108.603 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -59.57 -50.06 75.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -57.85 -48.56 79.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.804 . . . . 0.0 109.944 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.18 -35.12 71.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.95 . . . . 0.0 110.113 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.66 -41.74 37.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.962 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.78 -38.23 88.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.647 -1.283 . . . . 0.0 108.671 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.74 82.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 108.981 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.13 -33.19 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 108.639 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.43 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 48.0 m0 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.51 166.92 10.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 110.387 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.43 142.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 0.0 109.376 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -95.14 146.96 23.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.571 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.47 110.93 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.202 -0.937 . . . . 0.0 110.161 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.537 ' HZ1' ' CG2' ' B' ' 266' ' ' THR . 0.0 OUTLIER -96.99 138.7 34.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 43.8 p -102.7 -173.03 2.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 111.3 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 21.4 mt -70.81 -17.86 62.75 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.298 0.57 . . . . 0.0 109.597 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -96.84 -5.15 38.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 109.299 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.64 60.63 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -69.67 119.44 13.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 0.0 108.948 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 47.7 m -101.04 133.15 45.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 109.335 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.0 mt -128.2 136.87 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 58.5 m -105.34 124.34 49.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.381 -0.824 . . . . 0.0 109.029 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.7 mt -129.8 120.01 24.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.842 . . . . 0.0 110.234 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.78 132.65 48.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.709 . . . . 0.0 109.17 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.97 -175.7 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.014 -1.054 . . . . 0.0 109.972 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -132.49 154.89 81.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.532 -0.73 . . . . 0.0 109.074 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.02 -19.35 47.94 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.505 2.137 . . . . 0.0 112.123 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.19 8.2 31.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.22 143.17 48.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.939 -1.101 . . . . 0.0 109.784 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 13.6 p -85.7 148.53 25.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.799 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.432 HG23 HD13 ' B' ' 223' ' ' ILE . 39.0 mm -52.2 -39.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.79 67.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.775 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -70.06 -53.3 18.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 0.0 109.302 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.52 -44.15 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.179 -0.951 . . . . 0.0 108.638 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -57.56 -38.71 75.25 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.75 -36.87 84.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -57.59 -53.31 59.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.24 -34.57 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -61.67 -43.47 98.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -28.78 63.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.977 -1.077 . . . . 0.0 110.721 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -92.99 -49.86 5.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 110.489 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -91.39 -6.86 52.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.195 -0.941 . . . . 0.0 111.357 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.97 74.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.104 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 61.2 mt -102.06 123.19 44.38 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.046 -1.267 . . . . 0.0 109.135 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.71 152.13 41.94 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.83 1.687 . . . . 0.0 111.802 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.99 -29.47 75.63 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.597 2.198 . . . . 0.0 112.802 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 49.9 p-10 -64.15 -13.74 50.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.085 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.0 OUTLIER -126.89 -20.79 4.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.464 -0.772 . . . . 0.0 109.945 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.91 133.39 33.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 109.043 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -126.98 132.42 50.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.88 123.38 47.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.372 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.4 132.82 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.53 123.73 34.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 54.13 41.63 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.786 -1.197 . . . . 0.0 109.312 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 67.68 3.97 30.19 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 135.4 42.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.82 125.63 33.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.154 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.8 mt -74.89 139.67 43.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 109.794 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.07 146.95 23.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -72.12 3.82 4.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.122 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.62 46.32 1.11 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.685 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -151.38 172.46 15.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -1.23 . . . . 0.0 109.485 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 63.9 p -111.57 160.89 16.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 110.106 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt -60.63 -43.68 97.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.232 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 56.9 p -59.35 -28.35 66.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.38 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.23 -13.1 61.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 109.065 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . 0.584 ' C ' HD21 ' B' ' 260' ' ' ASN . 33.2 m-85 -107.35 5.32 27.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -0.829 . . . . 0.0 109.116 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . 0.584 HD21 ' C ' ' B' ' 259' ' ' TYR . 1.0 OUTLIER 63.03 39.31 10.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 -179.481 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 57.9 mt -92.74 136.36 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 108.987 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . 0.43 ' O ' ' OG ' ' B' ' 265' ' ' SER . 34.6 mt-30 -125.54 175.71 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.765 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.405 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.91 160.65 0.67 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.776 0.798 . . . . 0.0 110.71 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 56.77 13.97 1.63 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.291 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 265' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 55.2 m -75.84 146.1 40.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.752 -1.217 . . . . 0.0 108.607 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 266' ' ' THR . . . . . 0.537 ' CG2' ' HZ1' ' B' ' 206' ' ' LYS . 5.5 m -112.31 138.01 49.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 0.0 110.018 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -124.7 138.79 54.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -86.86 140.73 29.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 18.9 tp -110.31 127.71 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.452 -0.78 . . . . 0.0 109.693 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 14.9 t -114.62 129.39 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 47.3 mt -82.27 143.97 30.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.168 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.3 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.9 164.58 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.224 1.949 . . . . 0.0 113.05 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 -2.07 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.568 . . . . 0.0 110.517 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.05 10.57 9.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.148 -0.97 . . . . 0.0 110.373 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -113.21 129.85 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.244 -0.91 . . . . 0.0 111.361 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.6 t70 -99.33 140.24 21.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.07 -37.51 3.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.41 2.073 . . . . 0.0 112.723 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.7 tt0 -61.26 -41.01 96.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.861 . . . . 0.0 110.184 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.98 -24.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.0 110.036 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -72.6 -53.58 11.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.993 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -61.29 -15.81 39.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.47 -5.23 59.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.911 -1.118 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.6 151.66 48.29 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 109.819 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.12 152.73 29.28 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.006 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.03 -50.39 70.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.777 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.15 -43.28 51.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.987 -1.071 . . . . 0.0 109.96 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 63.7 t -74.76 -32.12 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.009 -1.057 . . . . 0.0 108.348 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -60.41 -51.74 68.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -55.15 -49.16 72.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.715 . . . . 0.0 109.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -58.45 -36.85 74.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 0.0 110.49 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.74 -39.9 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.749 -1.22 . . . . 0.0 109.831 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.41 -37.86 74.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 108.986 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.1 79.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 108.973 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.84 -36.78 75.84 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.5 m0 . . . . . 0 C--N 1.301 -1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.758 179.059 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.14 165.13 12.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 0.0 110.67 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.95 143.07 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.557 -0.714 . . . . 0.0 109.269 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -95.13 142.48 27.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.56 112.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.548 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.25 131.8 47.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 108.948 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 32.8 p -91.55 -173.75 3.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 110.968 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.5 mt -70.58 -16.21 62.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.229 0.538 . . . . 0.0 109.954 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 9.7 p -99.39 -2.64 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.957 . . . . 0.0 109.614 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.16 1.38 61.14 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.217 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -64.42 116.9 6.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.332 . . . . 0.0 108.675 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.1 m -99.42 136.63 39.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.98 137.04 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.8 m -105.98 118.91 37.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 108.81 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 20.7 mt -124.6 122.18 36.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.388 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -68.29 133.56 48.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.0 m -139.73 -174.24 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.822 -1.173 . . . . 0.0 110.004 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.15 154.56 81.7 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 0.0 109.053 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.81 -21.79 58.7 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.573 2.182 . . . . 0.0 112.013 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 28.0 p -103.31 8.17 38.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.653 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -71.73 142.03 49.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.017 . . . . 0.0 109.497 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.9 p -85.93 145.63 27.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.415 HG21 HD13 ' B' ' 223' ' ' ILE . 36.5 mm -51.62 -21.54 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -37.07 70.06 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.998 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.11 -52.52 34.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.24 -46.32 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 108.548 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -43.12 72.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.292 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.13 72.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 109.561 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -60.29 -53.29 59.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.023 -1.048 . . . . 0.0 109.122 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.71 -32.01 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.106 -0.996 . . . . 0.0 108.928 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -63.51 -44.76 93.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.37 -23.54 61.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.444 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -97.66 -51.39 4.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 110.672 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -89.4 -7.97 54.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.03 24.34 76.56 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.497 -1.377 . . . . 0.0 110.577 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 34.0 mt -106.65 131.76 21.45 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.059 -1.259 . . . . 0.0 109.594 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.41 ' HG2' HE21 ' B' ' 240' ' ' GLN . 37.9 Cg_endo -71.15 162.26 43.16 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.204 1.936 . . . . 0.0 112.678 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.94 -34.05 7.0 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.155 2.57 . . . . 0.0 113.131 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.62 -5.98 33.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.28 -0.888 . . . . 0.0 111.152 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.41 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -124.22 -26.18 4.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.252 -0.905 . . . . 0.0 111.356 -179.278 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -88.61 127.74 35.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.283 -1.511 . . . . 0.0 109.23 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -111.96 134.93 53.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.35 126.02 51.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 108.91 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.28 134.92 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.567 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -128.11 110.52 12.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.181 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 67.34 39.4 2.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.328 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.5 2.94 45.85 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.886 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -100.86 137.34 39.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.299 . . . . 0.0 109.689 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.23 122.33 28.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.963 -1.086 . . . . 0.0 109.292 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.95 145.74 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 109.315 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -100.59 144.93 28.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.1 3.69 4.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.413 -0.804 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.58 43.79 1.41 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -150.06 172.08 15.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.145 -1.209 . . . . 0.0 109.325 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.4 p -110.9 159.41 17.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.8 mt -56.61 -42.16 78.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.692 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.1 p -61.21 -27.96 68.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.005 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -20.15 63.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -102.78 3.85 37.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.166 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.44 39.34 2.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.582 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.8 mt -92.94 135.53 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.308 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -124.02 176.56 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.12 159.69 1.19 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.978 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.04 28.49 12.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.097 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 12.5 p -91.28 149.65 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.588 -1.32 . . . . 0.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 4.3 m -111.4 135.39 52.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.533 -0.729 . . . . 0.0 109.966 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.7 mp -124.29 140.21 53.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.539 -0.726 . . . . 0.0 109.315 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -88.77 142.01 28.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 13.5 tp -110.74 129.59 55.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.433 -0.792 . . . . 0.0 109.249 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.06 133.09 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.408 -0.808 . . . . 0.0 109.891 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 47.2 mt -80.68 143.19 33.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 108.733 -179.196 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.13 164.65 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.34 2.027 . . . . 0.0 112.956 178.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.8 t -67.13 -2.45 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -123.18 9.39 9.23 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.72 128.78 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.14 -0.975 . . . . 0.0 110.951 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.37 139.3 21.36 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.21 -36.42 4.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.404 2.069 . . . . 0.0 112.97 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.82 -40.74 97.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.511 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.1 -23.67 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.68 -1.263 . . . . 0.0 109.559 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.2 t80 -71.7 -54.0 11.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.718 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -61.1 -18.19 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.06 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -82.39 -4.88 58.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.142 . . . . 0.0 109.343 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.6 mt -89.99 151.96 45.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.842 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.98 153.34 32.27 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.318 2.012 . . . . 0.0 111.985 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.13 -49.53 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.698 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.64 -44.38 57.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 -178.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.79 -31.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 108.377 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -61.58 -49.1 77.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -58.8 -48.55 80.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.623 -0.673 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.9 -40.27 75.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 110.051 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.58 -38.1 67.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.882 -1.136 . . . . 0.0 109.741 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.61 -39.18 73.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.713 -1.242 . . . . 0.0 108.996 178.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.135 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -73.14 -35.52 66.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.835 . . . . 0.0 108.944 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 44.1 m0 . . . . . 0 C--N 1.302 -1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.846 179.102 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.4 ptt? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.42 166.37 10.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.748 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.65 142.92 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.589 -0.694 . . . . 0.0 109.33 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -95.74 143.6 26.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 31.8 t -123.85 109.05 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -0.879 . . . . 0.0 109.808 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . 0.4 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.1 OUTLIER -93.09 135.45 34.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 108.57 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 29.5 p -96.26 -174.9 3.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.243 -0.91 . . . . 0.0 110.867 -178.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.17 -13.86 61.66 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.8 p -99.56 -4.11 31.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.451 -0.781 . . . . 0.0 109.558 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.08 1.12 61.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -67.03 119.05 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -1.148 . . . . 0.0 109.118 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.7 m -100.09 135.78 41.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.043 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 43.7 mt -131.25 135.18 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.571 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 33.4 m -104.55 120.28 40.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.416 -0.802 . . . . 0.0 108.886 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 26.1 mt -123.85 119.59 30.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.772 . . . . 0.0 110.017 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -66.83 131.16 45.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.43 -175.57 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 110.065 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.48 154.4 81.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.044 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -58.79 -20.16 50.3 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.599 2.199 . . . . 0.0 112.386 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.4 t -105.24 9.3 34.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.9 142.99 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.98 -1.075 . . . . 0.0 109.433 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 69.6 p -86.46 147.62 25.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 110.144 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mm -51.64 -33.8 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -33.95 73.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -71.44 -51.32 24.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 108.954 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.6 -50.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -50.41 -38.12 41.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.484 0.659 . . . . 0.0 109.265 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.72 84.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -57.9 -53.15 61.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.2 -0.938 . . . . 0.0 109.223 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.7 mp -58.43 -35.23 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.062 -1.024 . . . . 0.0 108.566 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.53 -45.94 90.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 109.743 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -24.12 64.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -100.26 -54.52 2.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.051 -1.031 . . . . 0.0 110.465 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' B' ' 230' ' ' ILE . 27.7 mm-40 -85.89 -5.83 59.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 111.243 -178.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.28 27.01 70.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.594 -1.317 . . . . 0.0 110.321 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.99 128.56 26.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -1.205 . . . . 0.0 109.283 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.407 ' HG2' HE21 ' B' ' 240' ' ' GLN . 47.6 Cg_endo -73.77 157.01 48.37 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.892 1.728 . . . . 0.0 111.932 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.54 -30.84 22.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.683 2.256 . . . . 0.0 112.385 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.4 -9.13 22.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.399 -0.813 . . . . 0.0 110.248 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.407 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.9 -20.33 3.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 110.431 -179.669 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.39 133.88 34.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.848 -1.158 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.46 134.95 50.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 109.457 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.38 126.95 52.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 109.638 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.03 133.43 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -128.49 114.54 16.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.124 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 63.06 46.6 4.62 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.781 -1.199 . . . . 0.0 109.075 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.97 6.4 6.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . 0.46 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -103.22 137.55 41.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -1.143 . . . . 0.0 109.537 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -85.81 128.58 34.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.493 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 28.8 mt -80.25 140.38 36.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' B' ' 253' ' ' GLY . 11.3 tp10 -90.87 142.62 27.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.588 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.0 OUTLIER -68.75 3.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.474 -0.766 . . . . 0.0 109.791 179.883 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -127.85 40.94 1.66 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.661 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.51 168.38 19.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.279 . . . . 0.0 108.977 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 21.0 p -106.59 157.45 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.1 mt -58.46 -42.36 87.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.012 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 40.2 p -61.73 -29.04 69.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.54 -16.93 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.131 -0.981 . . . . 0.0 109.277 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -104.56 2.91 31.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.092 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.55 38.93 2.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.408 -0.807 . . . . 0.0 109.773 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 37.7 mt -91.62 136.41 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.308 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . 0.469 ' O ' ' OG ' ' B' ' 265' ' ' SER . 10.4 mt-30 -122.9 172.78 8.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.581 ' H ' ' HZ3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.89 162.61 0.42 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.963 0.887 . . . . 0.0 110.844 -178.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 54.46 11.08 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.81 177.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 265' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 39.0 m -72.08 144.82 48.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.893 -1.129 . . . . 0.0 108.631 178.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.8 m -111.16 137.08 49.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 110.296 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.3 mp -120.9 162.85 19.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . 0.4 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 79.4 m80 -108.22 137.44 46.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.318 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.0 tp -106.87 123.07 47.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.009 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.6 127.11 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.454 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.5 mt -81.46 142.95 32.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.224 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.245 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.02 164.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.257 1.971 . . . . 0.0 112.804 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 t -67.85 -2.68 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.67 -0.644 . . . . 0.0 110.508 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -121.37 6.58 10.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.001 . . . . 0.0 110.296 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.66 128.21 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.834 -179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.6 t70 -99.56 140.04 21.31 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.73 -48.73 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.425 2.084 . . . . 0.0 112.196 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.1 tt0 -48.2 -44.19 32.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.698 -0.626 . . . . 0.0 110.228 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.27 -23.5 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.006 -1.059 . . . . 0.0 110.439 -179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 25.4 t80 -72.11 -53.01 14.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 110.918 -178.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -62.71 -17.36 60.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.24 -7.32 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.863 -1.148 . . . . 0.0 109.749 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.84 152.39 46.57 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.41 154.58 29.1 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.455 2.103 . . . . 0.0 111.922 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -62.99 -49.03 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -44.75 54.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.951 -1.093 . . . . 0.0 110.24 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -74.73 -29.94 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.023 -1.048 . . . . 0.0 108.426 178.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.5 tt0 -61.53 -51.65 67.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -56.88 -49.29 75.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -56.69 -37.62 71.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.107 -0.995 . . . . 0.0 110.451 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.2 mt -74.8 -36.98 62.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.865 -1.147 . . . . 0.0 109.886 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -71.01 -39.77 72.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.844 -1.16 . . . . 0.0 109.049 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.71 75.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.932 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -70.42 -38.21 74.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 30.7 m0 . . . . . 0 C--N 1.301 -1.531 0 O-C-N 120.947 -1.096 . . . . 0.0 108.886 179.113 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.19 165.83 11.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.094 -1.004 . . . . 0.0 110.572 -178.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 145.33 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.593 -0.692 . . . . 0.0 109.681 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.0 m-30 -94.02 139.97 30.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 109.035 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.91 106.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -92.63 134.89 34.57 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 44.4 p -94.58 -177.4 4.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 110.541 -178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 53.5 mt -72.51 -12.12 60.95 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.7 p -100.95 -3.03 30.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.63 -1.44 63.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -66.07 119.73 11.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.986 -1.302 . . . . 0.0 108.843 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 27.7 m -100.82 137.81 38.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 57.2 mt -133.58 136.82 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 109.329 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 18.2 m -104.86 119.37 38.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 108.681 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.2 mt -123.16 120.08 32.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -66.36 132.87 49.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.513 -0.742 . . . . 0.0 109.065 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.75 -176.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.87 -1.144 . . . . 0.0 110.01 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -134.09 154.06 79.96 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.5 -26.85 65.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.598 2.199 . . . . 0.0 112.328 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 t -97.65 7.18 46.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.3 140.67 48.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.079 -1.013 . . . . 0.0 109.34 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 38.5 p -85.92 146.72 26.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 29.2 mm -51.8 -27.25 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 109.206 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.22 -29.24 67.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.729 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -75.44 -51.15 13.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.72 -47.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -51.99 -46.55 64.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.43 70.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.621 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -55.95 -53.65 54.3 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.2 -34.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.035 . . . . 0.0 109.257 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.08 -53.4 55.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.933 -1.104 . . . . 0.0 109.852 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.25 -29.54 67.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.558 -178.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -95.92 -57.86 2.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.021 -1.049 . . . . 0.0 110.666 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 230' ' ' ILE . 68.4 mm-40 -84.09 -5.36 59.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 111.509 -178.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.14 24.83 70.66 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 120.524 -1.36 . . . . 0.0 110.462 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.7 mt -104.21 128.48 27.0 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.026 -1.279 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . 0.401 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.5 Cg_endo -75.71 156.48 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.124 1.883 . . . . 0.0 111.914 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.51 -29.19 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.724 2.283 . . . . 0.0 112.951 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -65.21 -15.51 62.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . 0.401 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.8 -22.47 5.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.481 -179.536 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.585 -1.322 . . . . 0.0 108.964 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -125.51 132.52 52.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -0.842 . . . . 0.0 109.807 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.36 125.45 51.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.303 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 60.5 mt -120.29 136.17 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -131.6 114.3 14.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.4 -0.813 . . . . 0.0 109.327 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.21 39.26 5.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.01 -1.057 . . . . 0.0 109.323 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.79 15.97 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -97.65 138.29 35.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.318 . . . . 0.0 109.702 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -83.47 128.3 34.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.985 . . . . 0.0 109.244 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.2 mt -78.32 137.29 37.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.029 -1.045 . . . . 0.0 109.326 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.53 146.46 23.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.027 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.18 3.95 3.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.074 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.19 40.04 2.09 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.624 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -147.41 151.35 36.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.113 -1.228 . . . . 0.0 109.272 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.8 p -91.16 161.61 15.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.13 -42.38 80.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.718 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 77.4 p -60.98 -28.35 68.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 109.75 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -70.73 -13.23 61.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.164 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -109.9 2.39 19.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.444 -0.785 . . . . 0.0 109.268 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.39 39.61 5.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.471 -0.768 . . . . 0.0 109.253 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.0 mt -92.79 98.45 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . 0.419 ' O ' ' OG ' ' B' ' 265' ' ' SER . 17.3 mt-30 -87.37 174.81 8.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.052 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.484 ' H ' ' HZ3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.1 165.39 0.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.0 0.905 . . . . 0.0 111.262 -178.879 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 55.57 11.58 0.65 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.913 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 265' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 43.0 m -74.97 148.38 40.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.631 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 22.2 m -115.14 138.19 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.502 -0.748 . . . . 0.0 109.8 -179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.3 166.41 14.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.2 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -113.04 138.96 49.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.637 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 9.4 tp -107.99 124.47 50.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.444 -0.785 . . . . 0.0 109.242 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.43 130.26 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.7 mt -79.0 142.67 36.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.237 -0.914 . . . . 0.0 108.937 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 -179.115 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.95 164.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.404 2.07 . . . . 0.0 112.967 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -2.48 7.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.851 -0.53 . . . . 0.0 110.652 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 7.12 10.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.0 110.114 -179.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 68' ' ' ILE . 28.2 mm -109.97 128.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 111.178 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.69 138.73 20.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 -31.18 14.97 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.303 2.002 . . . . 0.0 113.112 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.72 -38.91 77.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.6 t -79.77 -23.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.3 t80 -73.4 -54.75 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 111.105 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -61.87 -14.93 38.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.989 -1.069 . . . . 0.0 109.842 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -84.35 -7.65 59.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.995 -1.065 . . . . 0.0 109.876 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.77 151.43 49.99 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' GLU . 10.8 Cg_endo -56.66 128.38 29.77 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.299 1.999 . . . . 0.0 112.172 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' PRO . 28.9 tt0 -40.24 -47.96 2.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.451 -0.78 . . . . 0.0 110.688 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.97 -45.36 51.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.8 -1.187 . . . . 0.0 109.829 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -74.6 -30.27 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 108.594 178.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.76 -50.95 71.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -58.29 -47.82 82.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.574 -0.704 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -57.81 -39.66 78.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 110.044 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.4 -36.18 65.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.95 -1.094 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.61 -38.94 74.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.76 -1.213 . . . . 0.0 108.883 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.95 74.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.06 -36.21 66.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 108.863 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.4 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 45.1 m0 . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.117 -0.989 . . . . 0.0 108.702 178.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -98.9 167.01 11.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.02 144.13 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.5 m-30 -94.07 138.99 31.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.98 108.82 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.471 -0.768 . . . . 0.0 109.081 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -95.84 137.77 34.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 43.7 p -99.22 -175.1 2.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.997 . . . . 0.0 110.662 -178.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.96 -9.47 58.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.608 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 16.2 p -102.83 -4.12 25.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.89 . . . . 0.0 109.397 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.0 1.45 63.06 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -66.86 118.88 10.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -1.173 . . . . 0.0 108.831 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.6 m -101.42 139.54 36.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 50.2 mt -135.02 136.85 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.382 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 8.7 m -105.02 118.94 37.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 0.0 108.928 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.51 120.56 34.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.943 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.99 132.08 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.6 -175.32 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.08 . . . . 0.0 109.864 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -134.27 154.98 80.26 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.451 -0.781 . . . . 0.0 109.046 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.65 -21.38 46.84 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.51 2.14 . . . . 0.0 112.207 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.4 7.51 38.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.238 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.84 142.12 49.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.865 -1.147 . . . . 0.0 109.389 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.3 p -87.12 145.36 26.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 109.814 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . 0.413 HD13 HG22 ' B' ' 223' ' ' ILE . 34.3 mm -51.57 -22.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 109.054 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . 0.434 ' O ' ' CD ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -70.06 -35.47 74.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.408 -0.808 . . . . 0.0 109.011 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -72.38 -49.88 30.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 45.5 t -52.21 -51.85 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.043 -1.036 . . . . 0.0 108.775 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -50.68 -41.01 55.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.547 -0.72 . . . . 0.0 109.482 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.07 83.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.222 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -55.91 -53.6 54.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.332 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.03 -35.0 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 0.0 109.2 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.18 -39.21 91.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.993 . . . . 0.0 109.773 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.07 -28.25 62.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -98.02 -54.15 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.049 . . . . 0.0 110.668 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' B' ' 230' ' ' ILE . 75.7 mm-40 -83.84 -8.73 59.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.12 -0.988 . . . . 0.0 111.254 -178.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.65 73.64 Favored Glycine 0 N--CA 1.493 2.451 0 O-C-N 120.526 -1.359 . . . . 0.0 110.513 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.9 mt -105.22 132.17 21.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.116 -1.226 . . . . 0.0 109.266 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -71.25 161.64 45.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.216 1.944 . . . . 0.0 112.617 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.61 -34.66 8.91 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.158 2.572 . . . . 0.0 113.467 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -71.14 -5.92 35.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.998 -1.064 . . . . 0.0 111.534 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.26 -26.74 4.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.227 -0.921 . . . . 0.0 110.718 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -88.96 132.63 34.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.431 -1.418 . . . . 0.0 109.156 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -117.95 135.31 54.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 109.682 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.06 124.51 49.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.078 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 92.4 mt -118.81 135.14 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.608 -0.682 . . . . 0.0 109.392 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -131.36 114.6 15.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.023 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.26 39.04 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.006 -1.059 . . . . 0.0 109.355 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.23 17.67 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.853 178.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -100.34 138.58 37.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.285 . . . . 0.0 109.68 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -84.04 125.93 32.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 109.527 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 39.8 mt -73.26 145.09 46.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.21 -0.931 . . . . 0.0 109.094 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . 0.447 ' H ' ' HH ' ' B' ' 259' ' ' TYR . 12.9 tt0 -101.09 146.89 26.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.931 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.64 3.78 4.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.335 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -120.18 32.85 4.76 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.648 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -142.42 170.3 15.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.989 -1.301 . . . . 0.0 109.628 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.3 p -110.27 160.97 16.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 0.0 110.135 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.8 mt -58.15 -44.08 87.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.7 p -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.427 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.31 -12.02 60.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . 0.656 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 28.1 m-85 -108.12 4.81 25.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' B' ' 259' ' ' TYR . 0.2 OUTLIER 64.21 36.49 9.41 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.092 0.948 . . . . 0.0 109.911 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 90.7 mt -89.73 134.42 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.263 . . . . 0.0 109.075 178.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -123.19 174.33 7.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 158.58 1.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.42 -0.8 . . . . 0.0 110.724 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER 57.21 11.37 1.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.427 179.242 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 4.2 m -72.42 144.88 47.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.947 -1.095 . . . . 0.0 108.352 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 26.4 m -111.71 136.9 50.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 -179.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.66 166.29 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -112.78 137.94 50.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.678 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 16.5 tp -108.1 125.19 51.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.236 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.22 130.41 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.713 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.39 140.47 37.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.264 -0.897 . . . . 0.0 109.226 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 . . . . . 0 C--N 1.302 -1.489 0 O-C-N 121.339 -0.851 . . . . 0.0 108.731 -179.261 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.32 165.37 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.268 1.979 . . . . 0.0 113.026 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.7 t -67.98 -2.72 8.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.728 -0.608 . . . . 0.0 110.78 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.426 ' O ' ' CG2' ' B' ' 209' ' ' THR . 76.3 m-20 -121.54 3.36 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.984 -1.073 . . . . 0.0 110.408 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mm -105.89 129.57 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.157 -0.964 . . . . 0.0 110.432 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.5 t70 -98.18 139.05 20.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 -36.97 7.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.497 2.131 . . . . 0.0 112.693 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 24.1 tt0 -60.75 -42.48 97.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.476 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.7 t -80.9 -24.17 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 110.566 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.3 t80 -69.83 -54.1 15.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.992 -1.067 . . . . 0.0 110.706 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -62.36 -16.65 55.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.748 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.47 -7.11 58.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.603 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.35 152.08 43.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.51 156.45 17.82 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.304 2.003 . . . . 0.0 111.932 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.53 -51.49 67.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 110.648 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -43.79 36.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -178.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -31.77 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 108.807 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.0 tt0 -60.25 -49.35 77.96 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -58.93 -48.43 81.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.52 -0.737 . . . . 0.0 110.158 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -57.7 -41.48 81.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.049 -1.032 . . . . 0.0 110.496 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.27 -38.82 75.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.827 -1.17 . . . . 0.0 109.817 -179.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.7 mt -68.79 -37.52 79.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.769 -1.207 . . . . 0.0 108.922 178.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.84 76.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 108.954 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -68.69 -39.43 80.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 108.9 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.8 m0 . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.062 -1.023 . . . . 0.0 109.099 179.211 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.92 11.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.955 . . . . 0.0 110.588 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.45 144.07 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.464 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 3.0 m-30 -94.38 142.44 27.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 109.357 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.29 112.04 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.315 -0.866 . . . . 0.0 109.684 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 131.27 43.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 108.725 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 28.0 p -91.29 -175.64 4.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -178.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 24.7 mt -71.85 -11.47 60.81 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.218 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 209' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 11.2 p -101.49 -2.55 30.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.802 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.47 0.06 63.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -66.02 118.91 10.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -1.181 . . . . 0.0 109.066 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.96 131.01 47.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.341 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.08 134.24 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.488 -0.757 . . . . 0.0 109.501 -179.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 24.9 m -103.3 122.97 45.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 24.7 mt -125.95 121.71 33.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.377 -0.827 . . . . 0.0 110.319 -179.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.9 130.15 42.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.49 -174.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.059 -1.025 . . . . 0.0 109.881 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -137.35 154.61 75.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.67 -23.56 41.38 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.491 2.127 . . . . 0.0 112.307 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 95.3 p -101.2 7.26 43.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.015 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.01 141.48 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.954 -1.092 . . . . 0.0 109.354 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 59.8 p -85.43 149.05 25.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.178 -0.951 . . . . 0.0 109.969 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.7 -40.7 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 109.513 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -56.86 -33.85 67.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.584 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.19 -52.92 28.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 108.897 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.6 t -52.6 -49.15 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.82 -42.35 58.3 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.526 0.679 . . . . 0.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.32 83.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -56.42 -53.19 60.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.086 -1.008 . . . . 0.0 109.378 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.97 -32.92 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 109.22 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -62.71 -44.11 97.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.88 -27.13 61.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.979 -1.075 . . . . 0.0 110.439 -179.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -93.52 -50.38 5.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.026 -1.046 . . . . 0.0 110.375 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.33 -7.29 51.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.196 -0.94 . . . . 0.0 111.441 -178.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.47 23.27 76.59 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.382 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . 0.423 HG22 HD13 ' B' ' 236' ' ' ILE . 67.7 mt -102.83 124.07 40.1 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.144 -1.209 . . . . 0.0 109.348 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.4 155.41 41.09 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.027 1.818 . . . . 0.0 112.04 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.79 -30.36 49.86 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.729 2.286 . . . . 0.0 112.961 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.24 -8.92 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -18.15 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.222 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.64 139.31 30.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.97 -1.081 . . . . 0.0 109.57 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -130.64 133.45 46.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.785 . . . . 0.0 109.093 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.3 mt -106.01 125.97 51.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 58.9 mt -120.84 135.63 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.61 -0.681 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -129.65 122.81 29.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 108.806 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.93 45.83 23.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.27 0.77 4.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -98.07 134.75 40.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.318 . . . . 0.0 109.44 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -85.02 123.17 30.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.41 144.2 49.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -96.93 144.58 26.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.99 3.42 3.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 109.729 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.44 44.03 1.33 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.481 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . 0.615 HH11 ' HH ' ' B' ' 259' ' ' TYR . 4.2 mtt180 -148.08 172.57 14.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -1.218 . . . . 0.0 109.56 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.6 p -110.84 159.52 17.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.195 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 mt -59.23 -43.09 92.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.0 p -60.57 -29.33 69.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.669 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.03 -14.24 62.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.15 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . 0.615 ' HH ' HH11 ' B' ' 254' ' ' ARG . 26.1 m-85 -107.65 2.25 23.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.0 109.278 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.68 39.5 2.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -0.823 . . . . 0.0 109.877 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.16 135.7 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -124.44 175.98 6.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.481 -0.762 . . . . 0.0 109.569 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.417 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.62 162.33 0.4 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.852 0.835 . . . . 0.0 110.908 -178.877 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 55.35 11.23 0.55 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.891 177.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.6 m -72.26 144.13 48.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.862 -1.149 . . . . 0.0 108.538 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -110.73 134.92 52.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.019 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -120.92 158.07 28.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.773 . . . . 0.0 109.182 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -105.72 138.22 42.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.9 tp -106.88 124.15 49.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 108.941 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.36 127.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 36.8 mt -80.99 142.14 33.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.273 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' B' ' 272' ' ' ARG . 19.3 ttt-85 . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -47.57 165.27 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.497 2.131 . . . . 0.0 112.859 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.496 ' H ' ' HG ' ' A' ' 66' ' ' SER . 0.3 OUTLIER -68.4 -1.93 7.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.648 . . . . 0.0 110.719 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.43 ' O ' ' CG2' ' B' ' 209' ' ' THR . 39.3 m-20 -122.37 6.9 9.59 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.2 mm -110.54 130.49 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.381 -0.824 . . . . 0.0 110.756 -179.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.5 139.35 20.56 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.54 -45.83 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.441 2.094 . . . . 0.0 112.295 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -47.35 -48.56 25.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.701 -0.625 . . . . 0.0 110.814 -179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.27 -26.82 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.856 -1.152 . . . . 0.0 110.71 -179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -65.73 -52.85 47.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.031 -1.043 . . . . 0.0 110.912 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -62.33 -18.46 61.48 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -81.34 -5.72 58.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.863 -1.148 . . . . 0.0 109.558 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.0 mt -89.96 151.86 45.7 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.24 156.26 21.61 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.342 2.028 . . . . 0.0 111.887 179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.38 -52.45 61.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.48 -43.87 24.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -178.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.1 t -74.82 -31.52 26.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 108.639 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.8 tt0 -60.2 -50.83 72.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -57.27 -48.71 78.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -58.12 -43.57 87.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.076 -1.015 . . . . 0.0 110.612 -178.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.24 -37.34 77.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.914 -1.116 . . . . 0.0 109.739 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 mt -70.62 -37.21 73.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 108.829 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.21 71.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.01 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -75.97 -38.95 56.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 109.121 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.2 m0 . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.015 -1.053 . . . . 0.0 108.95 179.286 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.9 ptt? . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.63 164.72 12.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 -179.276 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -144.63 142.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.311 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -94.41 143.08 26.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.892 . . . . 0.0 109.731 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.5 t -122.02 109.85 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.46 127.49 42.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 23.9 p -87.91 -175.56 5.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 111.065 -178.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 23.7 mt -71.68 -16.3 62.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.414 0.626 . . . . 0.0 109.347 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 209' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 9.5 p -98.15 -4.41 35.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.48 2.4 57.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -66.55 117.1 8.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.245 . . . . 0.0 109.106 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.57 132.85 45.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -130.55 136.79 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.427 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 60.8 m -105.5 121.07 43.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 17.5 mt -125.4 121.88 35.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 110.268 -179.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.15 133.22 48.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.645 . . . . 0.0 109.417 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 m -140.19 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.911 -1.118 . . . . 0.0 109.753 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -136.53 152.84 75.47 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.209 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.26 -26.96 54.63 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.565 2.177 . . . . 0.0 112.271 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.5 p -99.38 5.99 46.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.03 143.38 50.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 70.4 p -87.09 147.13 25.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.729 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.8 mm -52.78 -42.47 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -52.09 -32.04 33.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -73.38 -53.11 11.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.011 -1.055 . . . . 0.0 109.223 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 39.1 t -52.49 -42.18 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.959 . . . . 0.0 108.599 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . 0.518 ' NZ ' ' OD1' ' B' ' 252' ' ' ASP . 6.1 ttmt -58.48 -42.47 87.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.19 -33.47 73.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.721 . . . . 0.0 109.264 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -58.63 -53.16 61.5 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 108.94 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.9 mp -59.99 -32.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.41 -45.11 94.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.03 . . . . 0.0 110.025 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -73.32 -23.86 60.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -179.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -95.36 -50.59 4.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 110.039 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -91.86 -5.74 52.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 111.44 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.11 22.86 71.04 Favored Glycine 0 N--CA 1.492 2.4 0 O-C-N 120.53 -1.356 . . . . 0.0 110.371 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 62.3 mt -101.66 130.45 24.59 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 0.0 109.403 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.04 156.7 47.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.051 1.834 . . . . 0.0 111.949 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.47 -31.94 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.734 2.289 . . . . 0.0 112.785 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -66.95 -7.16 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 110.061 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -22.33 3.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.83 138.15 31.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.687 -1.258 . . . . 0.0 108.93 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -128.54 132.99 48.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.859 . . . . 0.0 109.654 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -105.5 125.85 51.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 109.174 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.17 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.597 -0.69 . . . . 0.0 109.505 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -127.84 112.62 14.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 0.0 109.149 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.56 40.68 5.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.041 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.74 17.06 66.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -112.18 135.52 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -1.153 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.32 125.75 33.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.037 -1.039 . . . . 0.0 109.53 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.28 143.99 33.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.624 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.33 147.2 28.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . 0.518 ' OD1' ' NZ ' ' B' ' 227' ' ' LYS . 18.0 m-20 -69.72 3.37 2.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.929 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.83 42.2 1.84 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.855 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -150.51 172.89 14.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.078 -1.248 . . . . 0.0 109.475 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.0 p -113.28 157.39 21.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 110.198 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.12 -43.63 78.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.271 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 67.9 p -60.49 -28.97 68.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -16.75 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 108.819 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -106.52 0.99 25.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.482 -0.761 . . . . 0.0 108.983 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' B' ' 260' ' ' ASN . 0.9 OUTLIER 66.33 39.42 4.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -0.78 . . . . 0.0 109.879 179.843 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.04 138.34 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.69 175.37 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.63 161.14 1.13 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.862 0.839 . . . . 0.0 110.913 -179.073 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 58.17 10.54 1.27 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.328 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.1 m -75.35 149.69 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.891 -1.131 . . . . 0.0 108.682 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.3 m -114.32 137.41 51.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.468 -0.77 . . . . 0.0 110.071 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.8 mp -124.44 139.62 53.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -0.81 . . . . 0.0 109.423 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -88.89 142.6 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.91 -179.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.42 126.96 54.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.152 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.96 128.61 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 50.1 mt -82.03 143.91 31.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.649 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.437 HG23 HD11 ' A' ' 62' ' ' ILE . 35.6 mt -113.7 132.06 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 110.452 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.4 m -113.83 127.91 56.19 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.426 ' CZ ' ' CG2' ' A' ' 62' ' ' ILE . 89.7 m-85 -112.9 135.9 21.66 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.1 164.84 0.23 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.227 1.951 . . . . 0.0 112.75 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -2.12 6.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.735 -0.603 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -122.46 11.65 9.97 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.171 -0.956 . . . . 0.0 110.591 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 31.6 mm -114.36 130.32 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.232 -0.917 . . . . 0.0 110.774 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.26 138.16 20.5 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.75 -33.65 9.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.142 1.895 . . . . 0.0 113.072 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -43.0 99.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.863 . . . . 0.0 110.679 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.32 -23.81 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.704 -1.247 . . . . 0.0 109.878 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -68.29 -54.83 14.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.852 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -60.82 -15.25 28.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.42 -6.47 59.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.68 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.03 151.98 45.7 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.189 -0.945 . . . . 0.0 109.559 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.74 154.79 24.54 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.267 1.978 . . . . 0.0 111.961 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -62.73 -52.17 64.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 110.584 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.02 -44.09 30.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.968 -1.082 . . . . 0.0 110.036 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 67.2 t -74.93 -32.19 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.937 -1.102 . . . . 0.0 108.489 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.414 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.3 tt0 -60.51 -50.03 75.17 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -57.56 -48.7 78.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.59 -0.694 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -56.68 -41.64 77.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.024 -1.047 . . . . 0.0 110.064 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.93 -38.46 69.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.074 -1.016 . . . . 0.0 109.786 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.53 -39.59 77.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.69 -1.256 . . . . 0.0 109.024 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.119 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -74.61 -38.11 62.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.4 m0 -73.37 -21.17 60.58 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.013 -1.054 . . . . 0.0 108.865 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -87.06 -45.5 10.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.294 -0.879 . . . . 0.0 109.808 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -40.96 74.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.715 -1.241 . . . . 0.0 108.732 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.402 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 11.0 t -89.75 -37.28 14.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.055 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -97.57 163.06 13.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.465 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.36 143.53 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.31 141.68 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.54 108.53 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.54 131.04 39.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 108.822 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 24.1 p -90.57 -175.82 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.102 -0.999 . . . . 0.0 110.676 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 35.4 mt -70.71 -20.71 62.64 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.463 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.1 p -94.25 -4.08 49.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.725 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.28 5.89 56.91 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.367 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -69.8 118.89 13.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.966 -1.314 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 134.39 44.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 35.4 mt -131.07 136.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.866 . . . . 0.0 109.635 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -105.69 114.58 28.83 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.411 ' HB3' ' HZ3' ' B' ' 229' ' ' LYS . 21.2 mt -118.54 123.64 45.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 110.4 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.59 132.17 46.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.7 m -139.79 -170.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.919 -1.113 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.13 152.84 76.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.033 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.74 -20.03 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.381 2.054 . . . . 0.0 111.943 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 17.7 m -105.2 7.57 33.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -70.29 141.86 52.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.045 -1.034 . . . . 0.0 109.408 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.9 p -86.29 148.8 25.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.958 . . . . 0.0 110.099 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 41.3 mm -54.23 -35.46 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -60.14 -30.22 69.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.723 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -74.29 -51.33 15.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.084 -1.01 . . . . 0.0 109.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.98 -47.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 108.809 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -54.2 -42.22 69.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 0.0 109.442 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.85 76.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.411 ' HZ3' ' HB3' ' B' ' 215' ' ' LEU . 5.2 mtpm? -57.66 -53.92 52.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.074 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' B' ' 234' ' ' GLU . 3.5 mp -58.52 -32.12 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.911 . . . . 0.0 108.781 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.417 HE21 ' HA ' ' B' ' 237' ' ' PRO . 39.5 tt0 -63.27 -49.57 73.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.059 -1.025 . . . . 0.0 109.734 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -23.6 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.056 -1.028 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -98.72 -53.15 3.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' B' ' 230' ' ' ILE . 25.0 mm-40 -88.69 -8.22 54.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 0.0 111.317 -179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 22.58 76.1 Favored Glycine 0 N--CA 1.493 2.493 0 O-C-N 120.567 -1.333 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . 0.401 HG22 HD13 ' B' ' 236' ' ' ILE . 22.5 mt -100.86 131.13 23.85 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.992 -1.299 . . . . 0.0 109.087 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.601 ' C ' HE21 ' B' ' 241' ' ' GLN . 59.0 Cg_endo -75.11 160.27 39.98 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.045 1.83 . . . . 0.0 112.549 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . 0.51 ' N ' HE21 ' B' ' 241' ' ' GLN . 38.2 Cg_endo -69.5 -34.43 15.45 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.288 2.658 . . . . 0.0 113.486 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' B' ' 239' ' ' ASP . 4.0 p30 -69.89 -5.44 25.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.998 . . . . 0.0 111.501 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -25.83 3.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 111.315 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . 0.601 HE21 ' C ' ' B' ' 237' ' ' PRO . 16.9 pt20 -88.55 144.7 26.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.235 -1.541 . . . . 0.0 109.418 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -129.32 134.05 47.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 109.663 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.65 126.14 51.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.508 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.35 135.75 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -130.59 114.12 15.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.313 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.25 39.05 7.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 109.434 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.54 12.52 66.96 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.846 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -111.68 136.78 50.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -1.155 . . . . 0.0 109.674 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -83.57 122.74 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 109.218 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 38.9 mt -69.86 144.31 52.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.4 ' N ' ' OH ' ' B' ' 259' ' ' TYR . 37.3 tt0 -100.89 147.0 26.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.997 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -73.4 3.71 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.431 -0.793 . . . . 0.0 109.649 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -121.93 41.68 1.81 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -150.18 172.07 15.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.293 . . . . 0.0 109.539 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 68.2 p -111.9 162.13 15.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -0.79 . . . . 0.0 109.883 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.8 mt -58.12 -43.91 87.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.811 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 73.1 p -59.9 -27.69 66.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -25.74 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.687 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . 0.4 ' OH ' ' N ' ' B' ' 251' ' ' GLU . 38.6 m-85 -96.73 5.55 50.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.217 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.9 38.18 2.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.53 136.7 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.146 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . 0.426 ' O ' ' OG ' ' B' ' 265' ' ' SER . 1.6 mt-30 -124.47 175.28 7.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.916 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.631 ' H ' ' HZ1' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.81 160.24 1.45 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.739 0.781 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 56.4 9.9 0.59 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.406 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 16.1 p -73.61 146.86 44.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.008 -1.058 . . . . 0.0 108.367 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.4 m -114.06 139.38 49.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.539 -0.726 . . . . 0.0 109.913 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.2 mp -121.14 165.92 14.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -113.1 139.27 48.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.466 -0.771 . . . . 0.0 109.191 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.03 125.15 51.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 109.513 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.5 t -113.52 129.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 39.2 mt -83.23 142.44 31.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.167 -0.958 . . . . 0.0 109.992 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.0 ttt180 -91.06 -139.05 0.16 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.526 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 52.6 mt -123.42 -45.56 2.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.046 -1.033 . . . . 0.0 109.187 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.508 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mttp . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.408 ' CG2' ' CZ ' ' A' ' 64' ' ' PHE . 40.0 mt -108.13 132.38 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -0.87 . . . . 0.0 109.779 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.9 m -113.22 124.3 52.2 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.408 ' CZ ' ' CG2' ' A' ' 62' ' ' ILE . 98.1 m-85 -111.35 136.73 20.94 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.584 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.22 164.3 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.287 1.992 . . . . 0.0 113.0 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.9 m -67.66 -1.91 6.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 110.296 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -123.01 7.87 9.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.26 -0.9 . . . . 0.0 110.782 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.3 mm -108.65 128.74 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.06 . . . . 0.0 110.81 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.77 109.67 58.44 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -47.32 -45.07 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.252 1.968 . . . . 0.0 112.539 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -49.69 -48.21 49.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 110.313 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.16 -24.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.796 -1.19 . . . . 0.0 108.902 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.1 t80 -67.99 -52.86 30.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 110.922 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -18.85 62.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -83.15 -5.41 59.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.75 151.99 46.26 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.945 . . . . 0.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.51 153.02 24.59 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.536 2.157 . . . . 0.0 112.099 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.98 -50.9 68.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 110.635 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.69 -43.9 37.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.942 -1.099 . . . . 0.0 109.838 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.6 t -75.01 -33.59 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 108.763 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.41 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -58.96 -49.97 75.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -58.9 -49.71 76.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 110.237 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -56.18 -42.3 76.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.076 -1.015 . . . . 0.0 110.412 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.41 -36.99 74.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.148 . . . . 0.0 109.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.5 -38.27 74.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.716 -1.24 . . . . 0.0 109.102 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.23 73.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 108.862 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -72.82 -37.74 67.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -78.06 -13.63 59.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.999 -1.063 . . . . 0.0 108.933 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -92.63 -47.24 7.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -0.839 . . . . 0.0 109.029 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.41 ' CG ' ' N ' ' A' ' 91' ' ' THR . 17.2 ptp180 -55.12 -40.64 70.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.008 -1.057 . . . . 0.0 108.582 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.444 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 2.1 t -88.76 -36.71 15.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 108.861 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.468 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.85 162.73 13.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 110.39 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.2 145.81 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.618 -0.677 . . . . 0.0 109.36 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -99.34 144.07 28.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.51 112.18 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.483 ' NZ ' ' CG2' ' B' ' 266' ' ' THR . 0.1 OUTLIER -96.71 131.64 43.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 108.846 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.8 p -92.0 177.12 6.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 110.65 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 29.9 mt -64.03 -11.16 26.65 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.497 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 11.1 p -102.53 -3.37 26.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.09 -0.2 64.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -65.74 118.93 10.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.249 . . . . 0.0 108.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.4 m -100.17 137.93 37.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.937 . . . . 0.0 109.159 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 26.6 mt -134.09 136.26 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.19 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 44.1 m -105.04 119.56 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 108.948 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 20.1 mt -121.98 121.88 38.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -0.766 . . . . 0.0 110.058 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.82 132.37 47.27 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.8 m -139.8 -172.11 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.907 -1.121 . . . . 0.0 109.979 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -135.99 155.02 77.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.32 -19.08 26.75 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.528 2.152 . . . . 0.0 112.165 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.58 8.99 29.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.158 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.0 141.53 50.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.875 -1.141 . . . . 0.0 109.379 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 22.5 p -85.99 144.55 27.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.56 -33.66 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 108.899 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -62.42 -30.94 71.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.205 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 86.4 m-20 -73.96 -52.4 12.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 108.905 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 31.6 t -52.3 -47.76 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -51.48 -43.05 62.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.477 0.656 . . . . 0.0 109.292 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.54 80.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -56.51 -53.85 52.67 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.03 -1.044 . . . . 0.0 109.351 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.7 mp -58.16 -34.43 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 108.908 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -62.75 -49.66 74.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 0.0 109.748 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -22.9 66.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.42 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -100.11 -59.92 1.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.004 -1.06 . . . . 0.0 110.17 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' B' ' 230' ' ' ILE . 77.9 mm-40 -79.78 -6.6 57.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.977 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.82 25.7 71.92 Favored Glycine 0 N--CA 1.492 2.432 0 O-C-N 120.544 -1.348 . . . . 0.0 110.358 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.61 133.87 20.05 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.155 -1.203 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.404 ' HD2' HE21 ' B' ' 240' ' ' GLN . 56.6 Cg_endo -73.05 153.14 52.04 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.45 2.1 . . . . 0.0 112.024 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.19 -34.06 10.6 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.676 2.251 . . . . 0.0 113.272 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.1 -7.95 27.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.498 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.404 HE21 ' HD2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -127.25 -14.24 5.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.78 136.18 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.755 -1.215 . . . . 0.0 108.362 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 78.0 mtt180 -125.22 134.97 52.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.172 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.28 124.89 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.88 135.41 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.516 -0.74 . . . . 0.0 109.48 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -130.06 118.72 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 61.06 37.56 17.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.645 -1.284 . . . . 0.0 109.57 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.88 -10.12 9.91 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.124 -0.985 . . . . 0.0 111.486 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.96 136.23 33.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.542 -1.564 . . . . 0.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -82.17 126.42 32.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.8 mt -74.25 146.92 42.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.449 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -103.34 146.12 28.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.887 . . . . 0.0 109.752 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 p30 -71.0 3.86 3.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.8 37.34 3.15 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.725 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -145.87 173.65 11.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.019 -1.283 . . . . 0.0 109.638 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 71.7 p -113.15 161.58 16.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.129 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.9 mt -59.7 -43.03 94.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.873 . . . . 0.0 110.035 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 97.6 p -60.72 -29.22 69.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 109.796 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.78 -15.23 63.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.033 . . . . 0.0 109.272 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -107.26 3.73 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.17 38.79 3.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.399 -0.813 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.0 135.26 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.892 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -123.58 172.58 8.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.099 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.486 ' N ' ' CD ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -50.97 157.99 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.568 0.699 . . . . 0.0 110.382 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 59.18 10.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 17.1 m -75.17 150.14 38.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.932 -1.105 . . . . 0.0 108.38 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' THR . . . . . 0.483 ' CG2' ' NZ ' ' B' ' 206' ' ' LYS . 7.7 m -116.23 139.12 50.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -124.43 140.47 52.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.543 -0.723 . . . . 0.0 109.56 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . 0.46 ' NE2' ' CE ' ' B' ' 206' ' ' LYS . 64.6 m80 -89.36 142.23 27.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.142 -0.974 . . . . 0.0 110.015 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 22.4 tp -110.02 127.93 55.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 0.0 109.097 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.22 130.83 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.396 -0.815 . . . . 0.0 110.154 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 36.2 mt -79.64 141.59 36.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.232 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.561 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 22.4 ttt180 -95.04 -140.0 0.24 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -0.845 . . . . 0.0 108.778 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.561 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 63.5 mt -124.84 -52.03 1.68 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.326 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.409 -0.807 . . . . 0.0 109.63 -179.81 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.8 tttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.422 HD12 HG23 ' A' ' 62' ' ' ILE . 35.6 mt -115.58 133.76 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.429 -0.794 . . . . 0.0 111.229 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.8 m -116.95 129.16 55.87 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -113.72 135.65 21.99 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.355 -0.841 . . . . 0.0 110.692 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -47.89 165.36 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 112.875 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -2.67 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.729 -0.607 . . . . 0.0 110.738 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 0.6 OUTLIER -121.88 6.82 9.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.083 -1.011 . . . . 0.0 110.125 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 mm -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 111.223 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.97 138.12 20.26 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.52 -38.76 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.58 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -55.37 -44.72 76.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.569 -0.707 . . . . 0.0 110.516 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.8 t -80.76 -23.66 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.852 -1.155 . . . . 0.0 110.283 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.401 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.3 t80 -69.1 -53.5 19.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 110.822 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -62.39 -15.71 50.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.088 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.19 -6.6 59.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.6 mt -90.39 151.85 44.86 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.228 -0.92 . . . . 0.0 109.776 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.71 154.14 27.2 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.453 2.102 . . . . 0.0 112.092 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.92 -50.93 68.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -45.06 38.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.945 -1.097 . . . . 0.0 110.262 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.88 -31.93 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 108.509 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.401 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.19 -50.76 72.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -56.68 -47.3 80.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.434 -0.792 . . . . 0.0 110.01 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -58.87 -37.72 77.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 0.0 110.482 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.37 -40.34 62.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.812 -1.18 . . . . 0.0 110.145 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -69.88 -38.8 76.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.763 -1.21 . . . . 0.0 108.874 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.16 77.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 108.906 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 4.8 tm-20 -69.0 -38.55 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 108.877 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.461 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.0 m0 -76.16 -11.68 59.97 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.041 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -91.44 -46.67 7.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.298 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -57.48 -42.43 82.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.971 -1.081 . . . . 0.0 108.429 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 14.5 t -84.12 -37.68 21.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 108.482 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.68 164.99 12.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.231 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 pp -144.26 147.9 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -102.04 144.17 30.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.222 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.98 112.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.984 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.46 133.98 41.31 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 29.5 p -93.98 -174.39 3.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.781 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 26.9 mt -72.26 -11.72 60.84 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.9 p -102.61 -2.44 28.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.36 -0.838 . . . . 0.0 109.574 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 94.99 2.73 62.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -67.22 118.37 10.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -1.225 . . . . 0.0 108.823 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.1 m -99.62 138.12 37.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.033 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 40.0 mt -135.01 136.21 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.334 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 72.5 m -105.34 120.21 41.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.609 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 13.1 mt -125.68 121.84 34.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.963 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . 0.656 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 4.8 mt-10 -67.18 130.3 42.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.496 -0.753 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.551 ' CG1' ' HZ2' ' B' ' 229' ' ' LYS . 27.5 m -136.16 -174.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.08 -1.012 . . . . 0.0 110.131 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -133.86 155.3 80.42 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.43 -20.39 56.2 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.402 2.068 . . . . 0.0 112.195 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -105.24 7.95 33.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.24 143.47 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.839 -1.163 . . . . 0.0 109.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 52.3 p -86.37 145.94 26.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -51.68 -26.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -36.22 83.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.205 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.0 -52.75 21.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.109 -0.994 . . . . 0.0 109.021 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 35.7 t -52.28 -37.54 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 108.926 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -65.41 -32.48 74.13 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.441 -0.787 . . . . 0.0 108.959 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.89 69.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.656 ' NZ ' ' O ' ' B' ' 216' ' ' GLU . 12.6 mtpt -57.37 -52.65 64.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 108.781 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mp -59.71 -36.52 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 108.808 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -59.98 -42.81 94.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.063 -1.023 . . . . 0.0 110.07 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.49 -31.31 68.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.116 -0.99 . . . . 0.0 110.831 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -92.76 -50.43 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.43 -6.44 57.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.972 . . . . 0.0 111.331 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.48 26.95 72.05 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.51 -1.369 . . . . 0.0 110.456 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.07 131.6 21.79 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.128 -1.219 . . . . 0.0 109.569 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.62 156.67 44.69 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.212 1.941 . . . . 0.0 112.261 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.6 -34.67 8.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.922 2.414 . . . . 0.0 113.393 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -65.34 -6.8 10.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.228 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.89 -21.06 3.4 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.748 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.5 136.52 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.606 -1.309 . . . . 0.0 109.252 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -125.98 135.73 52.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.95 126.61 52.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 79.7 mt -120.21 136.52 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -129.65 112.82 14.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.32 -0.863 . . . . 0.0 109.435 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' B' ' 248' ' ' LYS . . . 64.95 44.56 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.865 -1.147 . . . . 0.0 109.485 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 -6.07 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . 0.423 ' H ' ' C ' ' B' ' 246' ' ' ALA . 1.1 ptmm? -94.19 137.77 32.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.817 -1.402 . . . . 0.0 109.504 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -84.4 132.59 34.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.875 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.56 146.33 28.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 109.09 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 2.6 tt0 -105.49 148.0 27.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.69 3.82 3.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.921 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -120.63 45.54 1.22 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.874 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.54 172.39 18.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.987 -1.302 . . . . 0.0 109.261 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 65.1 p -109.84 161.07 15.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.4 mt -58.01 -40.44 80.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.815 . . . . 0.0 109.938 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 98.3 p -62.51 -28.04 69.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.08 -15.8 62.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.255 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -105.03 1.72 28.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 109.067 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.8 39.73 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.88 133.99 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.038 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.34 174.59 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.15 158.09 1.64 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.895 0.855 . . . . 0.0 110.698 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 57.99 14.26 2.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.044 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 70.4 p -78.03 150.44 33.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.955 -1.091 . . . . 0.0 108.79 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 6.7 m -115.03 138.58 50.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -0.796 . . . . 0.0 110.233 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -124.82 140.97 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.527 -0.733 . . . . 0.0 109.641 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 58.4 m80 -90.19 141.71 28.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 109.783 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 13.5 tp -108.94 126.06 52.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.376 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 42.8 t -112.69 128.09 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.8 . . . . 0.0 109.546 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 47.1 mt -82.82 143.9 30.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.018 -1.052 . . . . 0.0 109.552 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.533 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.1 ttt180 -95.25 -137.57 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.533 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 56.4 mt -124.02 -29.19 3.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.275 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.843 . . . . 0.0 109.492 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 pttt . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.0 mt -112.74 132.22 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.034 -1.041 . . . . 0.0 110.834 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.9 m -116.48 126.64 53.67 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -111.54 135.14 21.08 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.34 -0.85 . . . . 0.0 110.233 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.04 164.75 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.215 1.944 . . . . 0.0 112.762 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -2.75 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.739 -0.6 . . . . 0.0 110.722 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 4.1 m-20 -122.24 8.34 9.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.046 -1.034 . . . . 0.0 110.348 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 mm -111.05 129.34 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.272 -0.892 . . . . 0.0 111.001 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.7 t70 -99.85 139.56 20.89 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.48 -47.38 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.269 1.979 . . . . 0.0 112.242 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.478 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 6.8 tt0 -47.88 -44.68 29.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.696 -0.627 . . . . 0.0 110.33 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 41.4 t -80.85 -32.26 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.957 -1.09 . . . . 0.0 110.318 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -61.05 -54.13 48.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 110.742 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -61.25 -15.86 39.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.907 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -83.55 -6.12 59.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.053 . . . . 0.0 109.808 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.6 mt -90.33 151.93 45.08 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.51 154.17 20.74 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.37 2.047 . . . . 0.0 112.098 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.82 -49.26 75.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.18 -44.74 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.064 . . . . 0.0 110.196 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.3 t -74.84 -32.46 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.874 -1.141 . . . . 0.0 108.478 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.2 tt0 -59.22 -51.83 68.29 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -57.25 -48.96 77.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -56.41 -42.76 78.53 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 110.56 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -69.97 -37.87 75.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.863 -1.148 . . . . 0.0 109.776 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.0 mt -70.03 -40.11 75.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.739 -1.226 . . . . 0.0 109.024 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.49 70.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 108.785 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.56 -40.19 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -75.63 -12.36 60.19 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.005 -1.06 . . . . 0.0 109.535 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -93.04 -46.75 7.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.033 . . . . 0.0 109.188 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -55.67 -40.46 72.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.818 -1.176 . . . . 0.0 108.421 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.9 t -88.98 -36.88 15.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 108.662 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.778 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.34 164.76 12.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.55 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.7 142.72 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.462 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.33 141.7 28.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.443 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.6 t -120.82 108.23 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 109.608 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -94.61 135.32 36.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 46.4 p -97.14 -173.94 2.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.025 -1.047 . . . . 0.0 110.998 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 20.1 mt -71.4 -14.67 62.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.466 0.651 . . . . 0.0 109.284 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -99.93 -4.6 29.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.6 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.51 3.01 59.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -67.82 118.45 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.081 -1.247 . . . . 0.0 109.199 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 10.2 m -99.8 137.8 37.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 48.3 mt -133.49 135.34 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.8 m -104.22 117.03 33.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.724 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 20.8 mt -122.18 121.92 37.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.448 -0.783 . . . . 0.0 110.084 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -67.78 132.69 47.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.57 -174.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.797 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.72 152.55 77.79 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.975 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.15 -24.12 48.31 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.587 2.191 . . . . 0.0 112.191 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 49.2 m -100.4 6.1 44.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.879 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -71.44 143.55 50.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.966 -1.084 . . . . 0.0 109.375 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.586 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 45.0 p -86.26 151.49 23.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 0.0 109.932 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 35.2 mm -54.53 -43.32 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.404 ' CG ' ' HG1' ' B' ' 222' ' ' THR . 9.0 pt-20 -52.61 -35.65 54.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.586 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 84.1 m-20 -67.28 -52.77 36.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.337 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 25.1 t -52.05 -47.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 108.549 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -52.41 -43.49 64.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.507 -0.746 . . . . 0.0 109.182 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.79 -36.11 78.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.814 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -57.78 -53.46 57.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 0.0 109.41 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.6 mp -58.3 -34.23 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.205 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . 0.408 HE21 ' HD3' ' B' ' 238' ' ' PRO . 15.3 tt0 -60.75 -47.39 86.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.921 -1.112 . . . . 0.0 109.826 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -68.69 -24.33 64.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.249 -0.907 . . . . 0.0 110.634 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -97.53 -53.24 3.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 110.457 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.17 -7.55 53.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.289 -0.882 . . . . 0.0 111.578 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.47 24.67 75.09 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.215 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 36.7 mt -104.41 124.94 35.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.498 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 154.73 31.35 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.164 1.91 . . . . 0.0 111.986 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . 0.408 ' HD3' HE21 ' B' ' 231' ' ' GLN . 29.7 Cg_endo -64.95 -28.57 58.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.733 2.289 . . . . 0.0 112.881 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 44.2 p30 -62.6 -14.73 46.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.952 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.51 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.0 OUTLIER -128.52 -21.41 3.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.57 136.54 33.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.897 -1.127 . . . . 0.0 109.243 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -129.46 132.11 46.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.421 -0.799 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.42 127.42 53.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.38 134.23 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.629 -0.669 . . . . 0.0 109.348 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -127.2 112.84 15.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.14 37.53 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.868 -1.145 . . . . 0.0 109.458 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.6 -7.66 18.26 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.144 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -94.06 134.78 36.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.74 -1.447 . . . . 0.0 109.692 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -80.97 125.0 29.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 29.0 mt -69.91 142.37 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -97.19 144.36 27.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.19 3.69 2.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.92 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.0 47.21 1.03 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.795 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -152.68 172.53 16.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.384 . . . . 0.0 109.078 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 37.9 p -111.5 159.24 18.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.948 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.2 mt -57.3 -41.71 80.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 69.4 p -61.17 -29.12 69.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.845 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.24 -16.5 63.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 109.333 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -105.58 3.31 29.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.48 39.35 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.848 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.6 mt -91.71 135.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.25 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.31 173.11 7.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.04 162.66 0.44 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.548 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.37 10.46 0.47 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 62.7 p -73.67 148.32 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.823 -1.173 . . . . 0.0 108.657 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 22.1 m -113.77 137.89 51.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 0.0 110.038 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -121.03 160.14 24.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.011 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -107.58 139.62 41.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.333 -0.854 . . . . 0.0 109.741 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 24.8 tp -110.21 126.03 53.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.6 t -114.62 130.06 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.454 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 47.1 mt -82.42 144.4 30.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.511 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 27.2 ttt180 -93.21 -138.62 0.2 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.511 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.2 mt -122.36 -26.56 4.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 109.548 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 63.3 mtt-85 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 109.422 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.4 mt -112.53 131.73 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.471 -0.768 . . . . 0.0 110.293 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -115.53 128.96 56.36 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -114.13 135.61 22.15 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.156 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -47.66 165.56 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.454 2.102 . . . . 0.0 112.916 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.445 ' H ' ' HG ' ' A' ' 66' ' ' SER . 0.1 OUTLIER -68.09 -6.18 21.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.697 179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 1.8 m-20 -117.01 2.56 12.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.099 -1.001 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.77 128.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 4.7 t70 -98.91 138.35 20.64 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.62 -40.31 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.355 2.037 . . . . 0.0 112.467 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 37.4 tt0 -56.21 -43.49 78.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.617 -0.677 . . . . 0.0 110.581 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.4 t -80.09 -23.79 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.784 -1.198 . . . . 0.0 110.35 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.9 t80 -70.41 -52.38 22.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 110.832 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -64.32 -18.12 64.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.174 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -79.87 -7.94 59.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.861 -1.149 . . . . 0.0 109.49 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.8 mt -89.92 151.63 45.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 154.96 22.29 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.41 2.074 . . . . 0.0 111.95 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -63.05 -51.84 65.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.72 -44.33 38.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 110.09 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.3 t -74.77 -31.56 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.02 -1.05 . . . . 0.0 108.448 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.8 -50.05 75.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -58.36 -49.68 76.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.665 . . . . 0.0 110.38 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.72 -36.87 67.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.037 -1.039 . . . . 0.0 110.043 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.3 mt -75.44 -36.58 60.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.852 -1.155 . . . . 0.0 109.687 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.12 -40.34 71.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.77 -1.206 . . . . 0.0 109.147 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.73 79.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.965 . . . . 0.0 109.046 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.95 -38.48 82.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -76.85 -12.76 60.01 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.101 -1.0 . . . . 0.0 109.205 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.97 -45.75 9.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 109.055 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -39.62 80.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.137 -0.977 . . . . 0.0 109.234 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.465 ' O ' ' C ' ' A' ' 92' ' ' GLY . 11.8 t -94.77 -37.01 11.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.044 -1.035 . . . . 0.0 109.695 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.8 ptt? . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.08 166.51 11.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -145.29 145.11 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.628 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . 0.419 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.4 m-85 -95.75 142.4 28.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.01 108.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -93.33 134.11 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 108.767 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 20.8 p -94.33 -174.34 3.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.702 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 35.6 mt -72.36 -10.73 60.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 11.2 p -104.33 -3.1 24.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.782 . . . . 0.0 109.655 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.36 2.89 60.2 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -66.65 117.0 8.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -1.199 . . . . 0.0 108.854 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -99.19 136.73 38.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.102 -0.999 . . . . 0.0 109.086 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 23.2 mt -132.79 133.86 58.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.278 -0.889 . . . . 0.0 109.462 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.9 m -103.32 120.13 40.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.9 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 18.8 mt -123.85 120.5 32.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.846 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.62 133.05 49.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.69 -171.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 109.831 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -138.14 152.36 71.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.16 -28.2 78.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.422 2.081 . . . . 0.0 112.264 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.2 m -96.01 5.0 52.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 110.061 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.58 145.21 49.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.639 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.455 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 36.3 p -87.07 150.57 23.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.095 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.408 HG21 HD11 ' B' ' 223' ' ' ILE . 31.8 mm -56.81 -40.54 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.0 109.497 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.72 -31.38 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.087 -1.008 . . . . 0.0 109.604 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.455 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 64.1 m-20 -73.85 -51.13 17.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.99 -50.35 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 108.509 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -52.05 -39.46 59.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 0.0 109.198 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.16 86.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.43 -0.794 . . . . 0.0 109.591 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -57.81 -53.73 54.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.5 mp -57.88 -37.25 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.086 -1.009 . . . . 0.0 109.107 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -58.52 -43.14 89.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.43 -22.41 60.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 110.344 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -98.83 -56.45 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.026 -1.047 . . . . 0.0 110.484 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -83.35 -7.02 59.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 111.088 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.55 24.62 73.9 Favored Glycine 0 N--CA 1.49 2.274 0 O-C-N 120.575 -1.328 . . . . 0.0 109.974 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.72 125.21 33.86 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 109.467 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.62 154.67 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.996 1.797 . . . . 0.0 111.658 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.92 -29.82 67.25 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.7 2.267 . . . . 0.0 113.049 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.97 -17.27 36.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 110.475 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -127.99 -15.54 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.78 133.62 33.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 109.488 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -127.97 132.37 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.503 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.9 mt -105.85 127.34 53.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.93 136.03 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.683 -0.636 . . . . 0.0 109.413 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -131.25 119.06 21.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 108.983 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 59.73 42.45 16.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.87 -1.144 . . . . 0.0 109.455 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.26 23.87 70.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.112 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 140.51 52.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.117 -1.225 . . . . 0.0 109.615 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -87.97 125.14 34.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 109.603 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.2 mt -71.42 146.56 48.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -0.82 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.43 ' C ' ' H ' ' B' ' 253' ' ' GLY . 3.4 tp10 -99.68 142.59 30.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -68.6 3.2 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -122.99 40.41 2.01 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -144.55 168.63 19.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 109.258 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 15.0 p -108.79 155.48 20.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.814 . . . . 0.0 109.98 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.2 mt -54.16 -42.95 70.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.637 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 83.6 p -61.2 -27.14 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -15.85 62.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.515 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -106.54 3.42 27.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 109.242 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.59 40.53 1.86 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.53 -0.731 . . . . 0.0 109.285 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.57 133.43 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.364 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -124.79 176.28 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.54 159.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.277 -0.889 . . . . 0.0 111.07 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 57.85 13.14 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.092 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -75.23 148.19 39.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 108.676 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 8.0 m -114.06 137.05 52.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.405 -0.81 . . . . 0.0 110.647 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -124.66 144.42 50.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.772 . . . . 0.0 109.328 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -94.39 143.3 26.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.132 -0.98 . . . . 0.0 110.349 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.2 tp -109.56 125.88 52.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.352 -0.842 . . . . 0.0 109.415 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 34.8 t -115.25 131.25 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.91 . . . . 0.0 110.135 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.76 143.95 30.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -0.824 . . . . 0.0 109.626 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.516 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 23.2 ttt180 -98.46 -137.15 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.516 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 67.4 mt -124.23 -34.75 2.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 109.098 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' B' ' 273' ' ' LEU . 11.5 ttt85 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.338 -0.852 . . . . 0.0 109.545 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.2 mt -107.68 134.61 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 109.942 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.7 m -117.17 126.34 52.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -113.35 135.1 21.82 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.388 -0.82 . . . . 0.0 109.544 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.19 165.18 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.191 1.927 . . . . 0.0 112.74 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -65.8 -14.71 61.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.754 -0.591 . . . . 0.0 110.469 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -108.65 8.45 27.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.08 -1.012 . . . . 0.0 110.45 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.12 129.54 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 111.071 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 5.0 t70 -99.74 138.65 20.43 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.69 -46.66 0.79 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.251 1.967 . . . . 0.0 112.315 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.7 tt0 -51.07 -44.64 61.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.695 -0.628 . . . . 0.0 110.656 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.0 t -79.06 -24.04 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.812 -1.18 . . . . 0.0 110.203 -179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -70.47 -51.44 29.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 110.699 -179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -63.09 -16.96 61.67 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.142 -0.974 . . . . 0.0 110.055 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -82.97 -7.06 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.1 mt -89.03 151.31 46.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.842 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.23 154.02 19.91 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.356 2.037 . . . . 0.0 111.913 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.04 -51.45 66.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.671 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.42 -44.81 45.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.982 -1.074 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.04 -30.66 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.992 -1.068 . . . . 0.0 108.716 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -61.7 -49.36 76.77 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -58.9 -49.7 76.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.552 -0.718 . . . . 0.0 110.359 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.92 -40.66 70.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.004 -1.06 . . . . 0.0 110.121 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.42 -36.2 71.23 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.987 -1.07 . . . . 0.0 109.837 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.92 -39.98 69.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.804 -1.185 . . . . 0.0 109.172 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.59 -32.95 72.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.87 -34.35 60.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 108.752 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -76.88 -17.45 58.95 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.962 -1.086 . . . . 0.0 108.491 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -89.19 -47.23 8.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.828 . . . . 0.0 109.279 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -54.62 -39.34 67.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.797 -1.19 . . . . 0.0 108.731 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.459 ' O ' ' C ' ' A' ' 92' ' ' GLY . 14.6 t -93.52 -36.53 12.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.148 -0.97 . . . . 0.0 109.178 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.494 2.555 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.92 164.04 12.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 110.585 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.8 141.95 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.32 141.96 27.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.969 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -121.35 110.03 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -96.41 135.65 37.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 108.735 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 34.4 p -96.35 -173.46 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.771 -178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 21.2 mt -72.55 -13.26 61.36 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.348 0.594 . . . . 0.0 109.671 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 9.6 p -100.8 -3.26 30.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.62 61.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.39 118.68 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 108.812 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 2.2 m -100.6 138.88 37.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.2 mt -135.22 136.72 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.3 m -104.06 121.43 43.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 108.818 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 16.1 mt -124.57 120.97 33.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.882 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.1 133.32 48.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.651 -0.656 . . . . 0.0 109.382 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 -173.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.935 -1.103 . . . . 0.0 110.126 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -135.93 153.68 77.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 108.959 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.26 -25.48 65.1 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.528 2.152 . . . . 0.0 112.171 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 m -100.24 5.94 44.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.936 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -71.87 144.93 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.022 -1.049 . . . . 0.0 109.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.3 p -86.71 146.19 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.84 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.2 mm -51.65 -34.3 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.431 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.2 OUTLIER -56.8 -38.39 72.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.384 -0.822 . . . . 0.0 109.037 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -66.57 -52.48 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 109.244 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 15.6 t -52.6 -48.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.758 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -53.44 -38.7 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.53 83.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.356 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -57.16 -52.84 63.68 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 109.111 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.427 ' O ' ' N ' ' B' ' 234' ' ' GLU . 3.9 mp -59.04 -36.46 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.178 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -58.81 -49.56 77.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.943 -1.098 . . . . 0.0 109.741 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.56 -27.6 68.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.422 -0.799 . . . . 0.0 110.649 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -95.4 -57.01 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.895 -1.128 . . . . 0.0 110.55 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' B' ' 230' ' ' ILE . 59.9 mm-40 -83.04 -6.18 59.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 111.311 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.08 24.76 71.94 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.244 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 63.1 mt -105.95 128.45 26.38 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.132 -1.217 . . . . 0.0 109.641 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.95 158.69 38.36 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.113 1.875 . . . . 0.0 111.933 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.11 -30.18 32.12 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.942 2.428 . . . . 0.0 113.196 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -69.14 -6.14 26.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.1 -20.68 3.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.39 139.03 31.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 109.341 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.94 132.31 47.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.404 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.01 123.42 47.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 109.439 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.51 135.81 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.662 -0.649 . . . . 0.0 109.357 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -129.84 113.64 14.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.761 . . . . 0.0 109.217 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.34 42.25 5.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.931 -1.106 . . . . 0.0 109.203 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.97 39.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.93 137.9 43.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -1.188 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.41 126.08 33.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 22.2 mt -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.223 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.538 ' H ' ' HH ' ' B' ' 259' ' ' TYR . 0.4 OUTLIER -102.4 144.28 31.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.176 -0.953 . . . . 0.0 109.927 -179.656 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.03 3.35 3.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 109.827 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.39 37.03 3.29 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -145.16 173.35 12.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.284 . . . . 0.0 109.542 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 81.6 p -113.17 161.22 17.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.498 -0.751 . . . . 0.0 109.943 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mt -60.42 -42.23 95.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.6 p -60.63 -28.26 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.089 -1.007 . . . . 0.0 109.201 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.26 -13.86 61.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 108.959 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . 0.611 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 25.7 m-85 -107.1 0.36 23.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.465 -0.772 . . . . 0.0 109.572 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' B' ' 260' ' ' ASN . 0.0 OUTLIER 68.25 33.42 4.3 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.132 0.968 . . . . 0.0 109.725 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -85.63 133.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.551 -1.343 . . . . 0.0 109.523 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . 0.484 ' O ' ' OG ' ' B' ' 265' ' ' SER . 26.1 mt-30 -120.66 170.51 9.36 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.696 0.76 . . . . 0.0 109.75 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.474 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.76 160.42 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.779 0.799 . . . . 0.0 110.698 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 56.58 13.58 1.41 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 3.0 p -76.7 150.02 36.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 108.525 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 11.4 m -114.59 137.01 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.383 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.25 140.18 53.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.264 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -89.46 141.84 28.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 0.0 109.796 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 17.2 tp -110.55 128.44 55.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 10.7 t -114.19 128.77 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 43.4 mt -82.4 145.43 29.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.035 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.516 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 28.1 ttt-85 -96.33 -137.12 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 108.754 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.516 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 59.3 mt -123.1 -12.72 7.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.228 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.415 ' CG2' ' CZ ' ' A' ' 64' ' ' PHE . 39.2 mt -109.98 133.72 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.9 m -115.03 126.51 54.81 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.415 ' CZ ' ' CG2' ' A' ' 62' ' ' ILE . 89.0 m-85 -113.04 137.18 21.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.025 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.72 164.61 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.485 2.123 . . . . 0.0 113.006 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.47 -1.94 9.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.825 -0.547 . . . . 0.0 110.284 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.445 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 0.2 OUTLIER -120.67 7.23 10.51 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.178 -0.951 . . . . 0.0 110.214 -179.46 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.3 mm -109.3 127.67 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.84 . . . . 0.0 111.258 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 9.6 t0 -102.24 110.71 63.27 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.96 -43.83 23.8 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.94 . . . . 0.0 112.625 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -47.86 -47.62 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 110.389 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.8 t -78.32 -23.5 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.693 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 21.0 t80 -70.66 -53.85 14.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.867 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -61.62 -17.49 55.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.876 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -81.98 -6.53 59.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.897 -1.127 . . . . 0.0 109.731 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.1 mt -90.56 151.48 44.12 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.169 -0.957 . . . . 0.0 109.546 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.66 154.63 19.83 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.301 2.0 . . . . 0.0 111.898 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -49.97 71.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.733 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.65 -44.33 47.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.101 . . . . 0.0 110.087 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.7 t -74.68 -32.07 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.954 -1.091 . . . . 0.0 108.38 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.1 tt0 -59.61 -52.16 66.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.11 -49.05 74.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.196 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.5 -40.79 75.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.021 . . . . 0.0 110.125 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.5 -37.83 68.3 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.49 -39.14 77.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.927 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.86 -32.9 72.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 108.925 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.28 -35.61 66.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.42 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 44.9 m0 -78.56 -19.24 53.26 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 109.088 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -88.71 -46.91 8.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 0.0 109.143 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.421 ' CG ' ' N ' ' A' ' 91' ' ' THR . 9.7 ptm180 -54.05 -41.49 68.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.849 -1.157 . . . . 0.0 108.367 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.421 ' N ' ' CG ' ' A' ' 90' ' ' ARG . 8.9 t -86.69 -35.52 19.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.073 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -179.48 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.58 166.15 11.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 pp -145.79 142.11 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -95.18 143.07 26.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 29.2 t -123.43 111.58 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 109.685 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -97.04 140.43 31.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 108.68 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 43.9 p -100.56 -173.52 2.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.715 -178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.94 -13.58 62.06 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.527 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 11.3 p -102.16 -3.77 26.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.78 2.89 61.08 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -66.65 117.67 9.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.236 . . . . 0.0 108.571 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.0 m -99.91 139.2 35.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.47 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 23.2 mt -134.94 135.77 52.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.485 -0.759 . . . . 0.0 109.289 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -103.67 122.59 45.35 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.614 ' C ' ' HZ2' ' B' ' 229' ' ' LYS . 17.1 mt -126.04 119.66 28.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.44 -0.788 . . . . 0.0 109.935 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . 0.664 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 11.5 mt-10 -66.07 129.92 41.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.546 ' CG1' ' HZ1' ' B' ' 229' ' ' LYS . 14.1 m -137.38 -172.72 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.0 110.012 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.11 153.77 71.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 108.755 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.55 -25.87 42.94 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.577 2.184 . . . . 0.0 112.489 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -99.6 6.83 45.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.873 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 141.11 52.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.605 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.4 p -86.07 148.69 25.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.998 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -54.93 -42.5 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.311 -0.868 . . . . 0.0 109.257 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -52.44 -37.34 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 109.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -67.92 -49.25 62.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 108.971 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 52.8 t -52.1 -49.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 108.463 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 -37.79 49.21 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.99 87.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.664 ' NZ ' ' O ' ' B' ' 216' ' ' GLU . 15.1 mtpt -55.84 -53.49 56.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 109.056 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.422 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.9 mp -60.89 -32.81 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -62.41 -51.0 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.254 -0.904 . . . . 0.0 110.014 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -63.33 -29.33 70.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.522 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -94.22 -58.48 2.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.973 -1.08 . . . . 0.0 110.504 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' B' ' 230' ' ' ILE . 34.8 mm-40 -82.08 -6.55 59.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.955 . . . . 0.0 111.596 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.69 25.28 70.28 Favored Glycine 0 N--CA 1.492 2.416 0 O-C-N 120.338 -1.476 . . . . 0.0 110.541 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.63 129.06 26.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.063 -1.257 . . . . 0.0 109.325 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.02 155.2 42.8 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.985 1.79 . . . . 0.0 111.903 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.1 -29.82 26.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.772 2.314 . . . . 0.0 113.361 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.36 -8.34 45.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.55 -20.7 4.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.39 -0.819 . . . . 0.0 109.608 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 137.63 32.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 108.985 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -127.87 132.37 49.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.872 . . . . 0.0 109.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.19 124.52 49.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.435 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.8 mt -119.68 134.03 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -128.28 111.6 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.46 38.29 4.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.772 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.58 4.62 53.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . 0.594 ' HZ2' ' CB ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -101.48 137.71 39.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 109.765 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -86.2 125.96 33.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.019 . . . . 0.0 109.492 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.1 mt -77.95 142.97 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' B' ' 253' ' ' GLY . 12.7 tt0 -99.8 143.56 29.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.405 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 3.83 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -123.7 49.24 0.91 Allowed Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.786 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -153.44 169.76 22.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -1.228 . . . . 0.0 109.211 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -110.94 158.08 19.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.434 -0.792 . . . . 0.0 110.097 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 8.0 mt -55.24 -42.53 73.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.72 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 24.6 p -61.9 -28.1 69.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.92 -13.97 61.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.297 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -105.9 1.94 27.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.7 37.97 3.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.07 135.14 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.35 175.26 6.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.237 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.49 162.09 0.59 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.986 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 56.42 13.38 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.216 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.3 m -75.37 148.17 39.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.794 -1.191 . . . . 0.0 108.585 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 4.1 m -114.04 137.43 51.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.458 -0.776 . . . . 0.0 110.177 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.93 141.97 51.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 109.286 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -90.85 143.06 27.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.874 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 tp -108.44 125.58 51.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.529 -0.732 . . . . 0.0 109.322 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.52 125.62 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 109.525 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 43.0 mt -82.31 144.78 30.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.443 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 22.8 ttt180 -95.76 -137.8 0.24 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.034 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.443 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 62.9 mt -123.06 -8.78 8.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.239 -0.913 . . . . 0.0 109.677 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.2 tttp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.4 mt -113.24 132.99 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 110.657 -179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.7 m -116.9 129.77 56.27 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -114.1 135.92 22.16 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.469 -0.77 . . . . 0.0 110.251 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.47 164.72 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.302 2.001 . . . . 0.0 112.881 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p -67.66 -1.81 5.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.757 -0.59 . . . . 0.0 110.789 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 66' ' ' SER . 6.7 m-20 -123.77 9.1 8.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.014 -1.054 . . . . 0.0 110.549 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.3 mm -110.12 129.07 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.08 -1.013 . . . . 0.0 111.463 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 7.7 t70 -93.34 136.91 23.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' O ' ' CD2' ' A' ' 74' ' ' TYR . 51.8 Cg_endo -72.12 -33.35 9.6 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.457 2.105 . . . . 0.0 113.233 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.43 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 39.3 tt0 -71.65 -37.06 70.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.0 110.577 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -78.23 -23.66 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.591 -1.318 . . . . 0.0 109.169 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.406 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -71.98 -53.33 13.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.409 -0.807 . . . . 0.0 110.698 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 70' ' ' PRO . 46.3 m-85 -61.36 -17.27 53.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.951 . . . . 0.0 109.949 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -83.42 -5.47 59.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.526 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.3 mt -89.42 152.19 47.16 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.169 -0.957 . . . . 0.0 109.598 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.72 153.92 28.16 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.321 2.014 . . . . 0.0 111.938 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -50.68 69.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.572 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.45 -42.57 43.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.013 -1.054 . . . . 0.0 110.262 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.0 t -74.92 -32.89 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 108.325 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.406 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.7 tt0 -59.2 -51.95 67.79 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -56.7 -48.45 77.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.3 -40.71 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.61 -38.54 67.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.842 -1.161 . . . . 0.0 109.63 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.57 -38.78 77.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.736 -1.228 . . . . 0.0 108.948 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.02 73.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.53 -34.43 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 108.748 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 49.4 m0 -74.34 -17.98 60.76 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.016 -1.052 . . . . 0.0 108.729 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -90.71 -44.31 9.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.525 -0.734 . . . . 0.0 110.017 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' CG ' ' N ' ' A' ' 91' ' ' THR . 9.9 ptm180 -56.32 -41.24 75.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.632 -1.292 . . . . 0.0 108.004 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 92' ' ' GLY . 7.1 t -89.41 -36.26 15.57 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.494 2.549 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.09 164.84 12.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.128 -0.983 . . . . 0.0 110.362 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.84 143.58 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.197 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.8 142.16 28.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.04 114.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -99.84 139.36 35.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 108.993 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.9 p -98.09 -178.18 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 110.945 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 51.3 mt -71.69 -12.63 61.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 9.3 p -102.59 -3.99 25.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.05 57.27 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.882 -1.152 . . . . 0.0 110.527 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -69.28 119.07 12.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.002 -1.293 . . . . 0.0 108.999 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 19.3 m -102.83 140.95 36.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 37.6 mt -138.75 137.51 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 37.6 m -104.94 119.34 38.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.15 121.5 36.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.18 131.49 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.89 -175.07 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.02 -1.05 . . . . 0.0 109.628 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -134.8 152.77 78.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.389 -0.819 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.64 -23.03 46.74 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.555 2.17 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' B' ' 220' ' ' SER . 1.4 t -104.47 5.83 34.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.956 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.89 144.99 52.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.956 -1.09 . . . . 0.0 109.412 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 73.1 p -85.81 150.38 24.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.2 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 36.6 mm -54.51 -45.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.369 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.51 -35.89 54.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -67.77 -52.58 35.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.072 -1.017 . . . . 0.0 109.129 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.7 t -51.9 -48.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.93 -1.106 . . . . 0.0 108.107 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.96 -46.64 61.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.55 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.03 -36.86 70.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.585 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp -56.92 -54.24 48.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.983 -1.073 . . . . 0.0 109.259 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.9 mp -57.31 -33.68 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 108.975 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -30.95 71.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.634 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -96.27 -51.97 4.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.026 -1.046 . . . . 0.0 110.683 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' B' ' 230' ' ' ILE . 60.4 mm-40 -85.77 -8.0 58.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 111.413 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.69 25.06 72.88 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.501 -1.374 . . . . 0.0 110.524 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.66 130.31 23.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.139 -1.212 . . . . 0.0 109.733 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.92 155.01 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.214 1.942 . . . . 0.0 111.748 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.48 -30.57 29.05 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.738 2.292 . . . . 0.0 113.219 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.05 -13.04 61.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.73 -19.86 6.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.418 -0.802 . . . . 0.0 110.13 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.09 139.79 30.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.696 -1.253 . . . . 0.0 108.928 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . 0.4 ' NH1' HE22 ' B' ' 249' ' ' GLN . 66.5 mtt180 -129.76 129.63 44.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.345 -0.847 . . . . 0.0 109.449 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.1 mt -105.04 124.23 49.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.83 . . . . 0.0 109.338 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.99 134.08 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -130.36 121.12 25.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.092 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.46 39.4 28.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.735 -1.228 . . . . 0.0 109.871 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.3 7.31 60.05 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.057 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.66 132.86 52.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.242 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.4 HE22 ' NH1' ' B' ' 242' ' ' ARG . 30.3 tt0 -82.65 125.95 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 21.3 mt -76.54 141.83 41.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.49 147.16 26.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -68.91 3.91 1.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 110.131 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -121.57 48.29 0.96 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.916 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -156.08 171.7 19.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.989 -1.301 . . . . 0.0 109.245 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' B' ' 258' ' ' ASP . 7.0 p -112.69 161.32 16.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.478 -0.764 . . . . 0.0 110.058 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.8 mt -60.0 -42.56 94.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.956 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 78.2 p -60.55 -29.05 68.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.081 -1.012 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' B' ' 255' ' ' THR . 1.3 m-20 -70.96 -14.64 62.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.127 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.27 2.81 27.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.05 38.25 4.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.525 -0.734 . . . . 0.0 109.605 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.9 mt -91.19 135.25 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -122.46 172.96 7.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.649 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.93 160.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.709 0.766 . . . . 0.0 110.506 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 58.08 11.68 1.58 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 2.5 m -73.68 145.35 45.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.776 -1.202 . . . . 0.0 108.875 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 17.2 m -113.12 136.97 52.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.584 -0.698 . . . . 0.0 109.953 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . 0.401 ' CD1' ' N ' ' B' ' 267' ' ' LEU . 7.4 mp -124.69 141.7 51.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -88.57 141.06 28.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.092 -1.005 . . . . 0.0 110.059 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.5 tp -108.93 126.38 53.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.289 -0.882 . . . . 0.0 108.985 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 130.03 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.21 144.23 33.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.464 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 17.5 ttt180 -92.13 -140.76 0.19 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 108.985 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.464 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.8 mt -123.17 -21.85 5.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 109.496 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.38 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 122.044 0.926 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.0 mt -111.38 141.38 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.477 0.655 . . . . 0.0 109.694 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.3 m -115.94 122.13 44.36 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -111.54 135.57 21.07 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.122 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.32 164.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.323 2.016 . . . . 0.0 112.742 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.63 -1.88 5.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 110.762 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -122.9 8.29 9.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.066 -1.021 . . . . 0.0 110.367 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.8 mm -109.37 128.2 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.4 t70 -101.42 139.79 20.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.76 -46.99 1.45 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.502 2.135 . . . . 0.0 112.663 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 tt0 -47.44 -47.0 27.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 110.608 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 50.3 t -78.99 -42.82 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.4 t80 -51.43 -53.41 37.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.998 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -63.42 -18.82 64.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.0 110.281 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.81 -6.1 56.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.55 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 92.8 mt -91.07 152.35 44.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.147 -0.97 . . . . 0.0 109.836 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.62 154.51 30.56 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.416 2.077 . . . . 0.0 111.864 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -62.93 -50.16 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.698 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -44.61 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.971 -1.081 . . . . 0.0 110.092 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.3 -31.73 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 108.323 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.7 tt0 -60.02 -51.96 67.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.35 -49.57 74.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.589 -0.694 . . . . 0.0 110.307 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -56.5 -40.06 74.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.096 -1.003 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.96 -36.94 67.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.812 -1.18 . . . . 0.0 109.97 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -70.96 -38.71 72.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.716 -1.24 . . . . 0.0 108.884 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.72 -33.7 73.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.954 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.95 -35.06 66.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -79.0 -11.29 60.0 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 108.749 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -92.88 -47.7 6.9 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.328 -0.858 . . . . 0.0 108.893 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -54.4 -39.7 67.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.857 -1.152 . . . . 0.0 108.241 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 t -89.21 -36.89 15.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 108.966 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.5 ptt? . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.13 165.03 12.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.467 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.42 142.56 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 109.581 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.06 140.84 29.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.2 108.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.513 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -96.54 135.37 38.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 70.4 p -96.27 -174.66 3.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 110.557 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 18.0 mt -72.45 -10.54 59.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.32 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -102.48 -3.43 26.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.88 . . . . 0.0 109.615 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.65 0.27 62.65 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.102 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -66.93 119.67 12.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 108.887 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.1 m -101.44 140.03 36.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.352 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 41.2 mt -135.4 136.19 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 109.212 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.0 m -105.26 121.05 43.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 18.8 mt -125.4 120.73 31.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.437 -0.789 . . . . 0.0 109.868 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.39 133.85 51.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.4 m -140.88 -174.31 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 110.08 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -135.32 152.05 76.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.847 . . . . 0.0 109.068 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.04 -26.36 49.52 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.569 2.179 . . . . 0.0 112.516 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -98.1 7.22 46.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.55 142.08 50.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.104 -0.997 . . . . 0.0 110.009 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 62.4 p -86.02 144.59 27.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 26.2 mm -51.98 -31.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.129 -0.982 . . . . 0.0 108.699 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.431 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -61.58 -32.95 73.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 109.392 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -72.66 -52.55 14.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.127 -0.983 . . . . 0.0 108.778 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 66.5 t -52.61 -47.43 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.077 -1.015 . . . . 0.0 108.388 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -52.8 -40.56 63.36 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.77 80.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.522 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -59.04 -53.81 54.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.819 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.9 mp -58.98 -34.24 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.867 -1.145 . . . . 0.0 109.213 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -60.98 -47.0 88.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -21.73 61.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.034 -1.041 . . . . 0.0 110.281 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -97.56 -59.32 1.8 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' B' ' 230' ' ' ILE . 56.7 mm-40 -82.94 -5.05 58.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.905 . . . . 0.0 111.341 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.61 73.68 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.558 -1.339 . . . . 0.0 110.357 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.33 125.32 35.37 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.102 -1.234 . . . . 0.0 109.439 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.402 ' HG2' HE21 ' B' ' 240' ' ' GLN . 54.4 Cg_endo -73.63 154.12 49.41 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.956 1.77 . . . . 0.0 111.928 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.27 -31.23 53.59 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.673 2.249 . . . . 0.0 112.945 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -63.83 -13.0 40.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.296 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.402 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -126.54 -16.54 5.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.792 . . . . 0.0 110.357 -179.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.9 132.05 34.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 109.166 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.72 132.5 53.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.447 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.5 mt -107.16 126.56 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.498 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.44 134.54 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -128.71 114.44 16.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.158 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.05 42.47 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.008 -1.057 . . . . 0.0 109.193 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.69 16.81 61.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -114.78 138.94 50.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -1.157 . . . . 0.0 109.479 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -86.65 125.98 34.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.722 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.4 157.78 28.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.405 ' C ' ' H ' ' B' ' 253' ' ' GLY . 1.1 tt0 -117.48 144.48 45.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.483 -0.761 . . . . 0.0 109.842 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.18 3.77 1.98 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.698 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -118.02 33.71 4.77 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 -145.41 172.02 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.085 -1.244 . . . . 0.0 109.403 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.1 p -112.56 160.63 17.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.405 -0.809 . . . . 0.0 110.071 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.94 -42.38 79.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -0.891 . . . . 0.0 109.388 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.4 p -60.26 -29.11 68.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.534 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.95 -18.59 64.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.241 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.69 3.05 31.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.338 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.34 38.97 3.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.4 mt -91.02 135.87 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -121.77 172.91 7.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 109.545 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.73 ' HZ1' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.86 161.76 0.72 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.346 -0.847 . . . . 0.0 110.466 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 57.31 11.28 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 69.9 p -76.02 151.91 37.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.931 -1.105 . . . . 0.0 108.632 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 16.1 m -116.27 136.94 52.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 110.12 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.0 mp -122.06 140.95 51.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -89.92 139.8 30.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 20.8 tp -109.22 126.47 53.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.041 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.83 130.77 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.12 142.08 36.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -0.888 . . . . 0.0 109.136 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.546 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.6 ttt180 -92.38 -141.73 0.2 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.546 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 69.9 mt -124.62 -54.36 1.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.458 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.786 . . . . 0.0 109.343 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 mttm . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 62' ' ' ILE . 36.2 mt -111.8 131.37 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.927 . . . . 0.0 110.314 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.1 m -114.36 128.21 56.23 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -113.51 135.08 21.87 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.927 -179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.2 165.25 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.388 2.058 . . . . 0.0 113.03 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -67.47 -2.35 6.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.818 -0.551 . . . . 0.0 110.692 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -122.95 9.02 9.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.028 -1.045 . . . . 0.0 110.321 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -111.55 129.35 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 0.0 110.956 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -96.08 137.01 21.77 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.86 -38.47 2.99 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.457 2.105 . . . . 0.0 112.643 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.37 -42.84 92.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 110.356 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.1 t -79.21 -23.76 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 0.0 109.783 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.408 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.6 t80 -68.04 -53.39 26.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.714 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -62.21 -17.29 57.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.969 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -81.78 -6.07 58.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.4 mt -90.23 151.44 44.7 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.532 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.79 155.06 18.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.436 2.091 . . . . 0.0 111.914 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.0 -50.52 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 110.769 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.27 54.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.057 . . . . 0.0 110.266 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.89 -31.1 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 108.234 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -60.51 -49.8 76.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -58.34 -48.27 81.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.553 -0.717 . . . . 0.0 110.163 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.1 -40.09 80.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.011 -1.056 . . . . 0.0 110.336 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.56 -39.05 70.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.884 -1.135 . . . . 0.0 109.874 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.22 -36.72 74.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.726 -1.234 . . . . 0.0 109.062 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.51 -34.16 76.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.233 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 5.3 tm-20 -72.0 -41.18 67.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.848 . . . . 0.0 109.082 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.521 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.1 m0 -74.8 -13.13 60.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.95 -1.094 . . . . 0.0 109.045 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -92.79 -47.35 7.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.779 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -53.85 -38.83 65.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.745 -1.222 . . . . 0.0 108.508 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.423 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 5.8 t -93.25 -36.86 12.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.268 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.26 163.44 13.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 110.233 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.62 140.97 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.537 -0.727 . . . . 0.0 109.139 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -93.77 142.23 27.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -122.69 110.94 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.412 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -98.46 138.31 35.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 43.0 p -97.27 -175.04 3.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 111.08 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 31.8 mt -71.54 -14.9 62.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.0 p -99.05 -4.06 33.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.616 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.31 2.42 60.47 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -67.63 119.19 11.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.045 -1.267 . . . . 0.0 109.062 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 135.71 41.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 47.4 mt -134.22 135.42 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.434 -0.791 . . . . 0.0 109.088 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 59.5 m -104.56 124.21 48.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.019 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 22.0 mt -126.73 120.68 29.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.11 133.67 51.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.574 -0.704 . . . . 0.0 109.295 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.83 -174.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.969 -1.082 . . . . 0.0 109.788 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -133.92 153.36 79.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.115 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.16 -18.37 23.33 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.423 2.082 . . . . 0.0 111.876 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 31.4 t -108.67 7.66 26.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 110.071 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.68 145.86 46.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.39 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.481 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 58.3 p -87.84 145.3 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 28.3 mm -51.73 -34.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 0.0 109.163 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -62.3 -32.16 72.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.479 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.481 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 46.9 m-20 -70.21 -51.66 29.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.031 -1.043 . . . . 0.0 108.251 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 15.9 t -52.21 -44.14 40.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.63 -48.31 63.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.622 -0.674 . . . . 0.0 109.431 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.46 70.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.729 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -58.76 -54.25 49.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.12 -0.988 . . . . 0.0 109.761 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.5 -34.36 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.097 . . . . 0.0 109.033 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -62.2 -50.38 72.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.955 -1.091 . . . . 0.0 109.821 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.72 -27.5 69.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.684 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -97.41 -54.41 3.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.967 -1.083 . . . . 0.0 110.518 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -86.1 -6.44 59.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 111.329 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.23 24.18 73.37 Favored Glycine 0 N--CA 1.492 2.379 0 O-C-N 120.467 -1.396 . . . . 0.0 110.281 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 59.6 mt -107.34 130.65 22.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -1.159 . . . . 0.0 109.675 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -69.66 166.59 26.95 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.029 1.819 . . . . 0.0 111.271 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -83.12 -27.75 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.464 2.109 . . . . 0.0 112.711 -179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.79 -10.16 58.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.937 . . . . 0.0 110.31 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.52 -25.63 5.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.485 -0.759 . . . . 0.0 109.78 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.02 137.8 31.98 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.621 -1.299 . . . . 0.0 108.55 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -124.07 134.39 53.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 110.156 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 16.9 mt -103.18 120.37 40.59 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 53.9 mt -115.24 133.94 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.598 -0.689 . . . . 0.0 109.399 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -128.23 123.79 35.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.55 41.58 30.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.629 -1.294 . . . . 0.0 108.935 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.29 1.07 6.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -93.02 134.19 35.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.035 -1.273 . . . . 0.0 109.458 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -84.2 120.83 26.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.919 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 24.2 mt -73.5 142.55 46.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.645 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 144.52 25.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.661 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -72.98 4.2 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.84 42.28 1.6 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -147.37 172.9 13.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.012 -1.287 . . . . 0.0 109.365 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' THR . . . . . 0.433 ' OG1' ' OD1' ' B' ' 258' ' ' ASP . 6.5 p -110.03 158.16 18.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.067 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 6.7 mt -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 109.849 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.2 p -61.32 -28.99 69.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.807 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.433 ' OD1' ' OG1' ' B' ' 255' ' ' THR . 0.7 OUTLIER -70.12 -15.97 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.129 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.69 3.03 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.82 39.05 3.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.748 . . . . 0.0 109.468 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.7 mt -92.78 136.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.124 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.64 175.11 7.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.386 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.81 162.94 0.53 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.345 -0.847 . . . . 0.0 110.686 -178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 57.36 13.36 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.098 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -77.01 148.84 36.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.94 -1.1 . . . . 0.0 108.595 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 6.7 m -115.09 137.8 51.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.977 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 9.5 mp -125.54 140.86 52.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.22 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -89.05 143.05 27.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.234 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.95 126.35 52.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.56 131.4 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.353 -0.842 . . . . 0.0 109.749 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 45.2 mt -81.58 143.97 31.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.324 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.9 ttt180 -98.69 -136.16 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.538 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.4 mt -124.09 -35.04 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 108.694 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.46 -0.775 . . . . 0.0 109.252 179.884 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.1 mt -109.36 131.81 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 110.14 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 m -115.61 126.11 53.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -110.33 135.44 20.61 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.464 -0.772 . . . . 0.0 109.83 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -47.64 164.75 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.364 2.042 . . . . 0.0 112.874 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.412 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -67.2 -1.72 4.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.757 -0.589 . . . . 0.0 110.682 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 4.0 m-20 -123.95 9.91 8.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.388 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.2 mm -112.63 129.99 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 0.0 111.268 -179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t70 -100.19 139.93 21.09 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -71.24 -48.88 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.221 1.947 . . . . 0.0 112.297 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 31.8 tt0 -47.98 -44.02 30.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.691 -0.631 . . . . 0.0 110.271 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.0 t -80.2 -23.63 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.79 -1.194 . . . . 0.0 110.035 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 27.7 t80 -70.55 -53.08 17.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.071 . . . . 0.0 111.074 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -61.63 -16.32 47.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.75 -5.32 58.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.731 -1.231 . . . . 0.0 110.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.2 mt -90.72 151.94 44.31 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.04 155.95 17.32 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.476 2.118 . . . . 0.0 112.08 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.29 -50.06 71.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.685 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.87 -43.05 59.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.92 -1.113 . . . . 0.0 110.115 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -75.85 -31.85 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 108.616 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.5 tt0 -60.84 -50.4 73.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -57.16 -49.04 77.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.661 -0.65 . . . . 0.0 110.277 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -57.7 -40.51 79.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.095 -1.003 . . . . 0.0 110.808 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.3 mt -70.53 -38.63 74.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.851 -1.156 . . . . 0.0 109.943 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.9 mt -71.49 -37.42 71.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.744 -1.222 . . . . 0.0 108.908 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.81 70.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 108.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.19 -37.7 57.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 108.793 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 34.1 m0 -77.52 -18.21 57.22 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.925 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -92.25 -45.3 8.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' CG ' ' N ' ' A' ' 91' ' ' THR . 1.1 ptm85 -53.27 -39.0 63.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.864 -1.147 . . . . 0.0 107.992 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.424 ' N ' ' CG ' ' A' ' 90' ' ' ARG . 6.5 t -94.26 -36.2 12.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 0.0 109.152 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.727 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.5 167.62 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.54 143.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.37 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -95.62 144.03 26.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -0.856 . . . . 0.0 110.032 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.28 115.29 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 130.0 46.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 32.6 p -87.21 -177.1 5.91 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.011 0.91 . . . . 0.0 110.774 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 46.9 mt -72.74 -14.98 61.67 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.424 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -98.11 -3.88 36.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.529 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.04 5.05 57.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.311 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -71.37 118.08 13.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.364 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 20.0 m -99.59 135.56 40.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.278 -0.888 . . . . 0.0 109.012 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . 0.429 ' CD1' ' CG ' ' B' ' 234' ' ' GLU . 37.6 mt -134.11 137.35 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.521 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 86.5 m -104.77 125.23 50.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.5 mt -127.47 119.95 27.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 110.049 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.58 131.9 47.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.83 -173.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.573 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.19 153.06 76.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 108.869 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.75 -24.26 45.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.382 2.054 . . . . 0.0 111.906 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' SER . . . . . 0.455 ' H ' ' HG ' ' B' ' 220' ' ' SER . 0.0 OUTLIER -100.29 5.98 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.921 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -70.45 142.51 51.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.997 -1.064 . . . . 0.0 109.363 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 60.5 p -86.2 146.0 26.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.141 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.7 mm -51.41 -35.31 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.066 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -34.62 72.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.813 . . . . 0.0 109.546 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -70.99 -52.6 18.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.365 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 38.0 t -52.32 -43.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 108.824 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.31 -41.29 79.6 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.277 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -56.94 -53.72 54.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.095 -1.003 . . . . 0.0 108.744 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' B' ' 234' ' ' GLU . 3.5 mp -56.59 -35.49 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.934 . . . . 0.0 108.925 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.77 -49.58 74.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 0.0 109.921 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -31.45 70.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 110.763 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -98.1 -53.96 3.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.966 -1.083 . . . . 0.0 110.846 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 230' ' ' ILE . 14.7 mm-40 -81.22 -8.65 59.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.165 -0.959 . . . . 0.0 111.132 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.84 68.97 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 120.625 -1.297 . . . . 0.0 110.396 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 53.5 mt -100.72 129.51 27.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.238 . . . . 0.0 109.345 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.414 ' HG2' HE21 ' B' ' 240' ' ' GLN . 48.4 Cg_endo -73.23 158.67 48.49 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.069 1.846 . . . . 0.0 111.88 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.18 -31.25 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.692 2.261 . . . . 0.0 112.899 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.59 -6.24 29.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 110.443 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.414 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.99 -16.86 4.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 110.26 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.7 140.2 31.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 0.0 109.184 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -129.74 134.49 47.65 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.1 mt -106.85 126.67 52.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.269 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.9 mt -119.81 135.18 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.628 -0.67 . . . . 0.0 109.626 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . 0.4 ' O ' ' CB ' ' B' ' 246' ' ' ALA . 50.7 t80 -127.11 109.21 11.63 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' B' ' 245' ' ' PHE . . . 67.41 41.21 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.868 -1.145 . . . . 0.0 109.267 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.18 1.99 23.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -98.57 135.85 39.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.26 . . . . 0.0 109.585 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -82.75 123.62 29.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 109.272 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 39.7 mt -71.45 142.72 50.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.0 146.51 28.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.5 OUTLIER -72.81 3.43 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.684 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.23 44.09 1.46 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -155.86 172.44 18.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.905 -1.35 . . . . 0.0 109.461 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 76.2 p -113.54 162.5 16.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.624 -0.672 . . . . 0.0 110.149 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.34 -44.5 80.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.4 p -60.22 -27.99 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.88 . . . . 0.0 109.737 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -20.85 62.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.9 5.45 43.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 66.91 39.69 3.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.01 137.0 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -126.26 178.39 5.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.445 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.05 158.98 1.3 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.971 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 58.11 24.02 10.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.304 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.35 148.72 25.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.479 -1.388 . . . . 0.0 108.675 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.8 m -110.87 134.48 52.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.649 -0.657 . . . . 0.0 109.685 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.8 mp -124.04 139.06 54.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.541 -0.724 . . . . 0.0 109.226 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -89.05 143.56 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.08 -1.012 . . . . 0.0 110.001 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.86 127.41 54.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.023 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.76 128.17 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.9 mt -81.3 143.6 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.242 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.52 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 31.9 ttt180 -96.94 -136.26 0.25 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.52 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 46.5 mt -123.75 -24.63 4.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.955 . . . . 0.0 109.073 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.825 . . . . 0.0 109.389 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mttm . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.431 HD13 HG22 ' A' ' 62' ' ' ILE . 49.2 mt -109.44 131.99 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.882 . . . . 0.0 110.391 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.2 m -113.76 125.41 54.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.429 ' CZ ' ' CG2' ' A' ' 62' ' ' ILE . 80.0 m-85 -111.58 136.37 21.06 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.351 -0.843 . . . . 0.0 110.079 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -48.12 164.81 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.457 2.104 . . . . 0.0 112.917 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -2.14 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.573 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 0.5 OUTLIER -123.63 9.17 8.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.141 -0.975 . . . . 0.0 110.423 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.4 mm -110.84 129.37 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.167 -0.958 . . . . 0.0 111.267 -179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t0 -100.24 140.19 21.28 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.24 -47.04 0.57 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.407 2.071 . . . . 0.0 112.219 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.531 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -47.25 -45.32 23.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.738 -0.601 . . . . 0.0 110.336 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.71 -33.03 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.82 -1.175 . . . . 0.0 110.526 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.405 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 18.1 t80 -60.76 -54.39 45.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.909 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.66 -18.13 58.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -81.35 -5.88 58.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.86 -1.15 . . . . 0.0 109.712 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.2 mt -90.63 151.56 44.09 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.619 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 155.28 16.34 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.342 2.028 . . . . 0.0 111.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -63.53 -49.03 75.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.02 -42.97 60.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.898 -1.126 . . . . 0.0 110.156 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.77 -32.19 27.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.373 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.403 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.61 -49.5 77.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -58.09 -49.47 76.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.206 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -58.29 -39.52 79.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.0 110.366 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.922 -1.111 . . . . 0.0 109.817 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.8 mt -71.04 -37.14 72.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 109.089 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -33.23 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.68 -38.22 64.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.267 -0.895 . . . . 0.0 109.0 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 38.0 m0 -75.97 -14.71 60.24 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.949 -1.095 . . . . 0.0 108.485 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -92.96 -46.28 7.56 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.388 -0.82 . . . . 0.0 109.439 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -53.97 -40.5 66.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.73 -1.231 . . . . 0.0 108.028 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.7 t -87.05 -36.89 17.93 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.625 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.86 163.92 12.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 110.482 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.52 145.93 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.226 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.13 141.98 31.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 113.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.714 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.548 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -100.81 129.31 46.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 108.79 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 31.1 p -90.19 -171.79 3.24 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.036 0.922 . . . . 0.0 111.36 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 40.8 mt -71.74 -17.79 62.17 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.716 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.8 p -97.56 -2.64 41.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.675 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.07 2.42 62.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.61 118.63 9.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -1.214 . . . . 0.0 108.856 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 23.0 m -101.35 133.07 46.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.5 mt -128.27 137.88 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.468 -0.77 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 49.6 m -105.96 120.76 42.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 108.768 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 23.6 mt -125.53 121.02 32.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.393 -179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.29 132.2 47.25 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.86 -172.56 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.888 -1.132 . . . . 0.0 109.854 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -134.73 153.56 78.93 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -58.15 -24.03 64.54 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.478 2.118 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.76 6.91 41.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.825 . . . . 0.0 109.783 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.63 143.93 49.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.954 -1.091 . . . . 0.0 109.571 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.493 ' HG1' HD21 ' B' ' 225' ' ' ASN . 16.2 p -87.63 145.92 25.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.0 109.824 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 33.2 mm -51.79 -39.82 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.178 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -34.4 57.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.565 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.493 HD21 ' HG1' ' B' ' 222' ' ' THR . 63.4 m-20 -72.24 -50.22 29.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.178 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 51.2 t -51.99 -49.72 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 108.557 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -42.87 62.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.571 -0.705 . . . . 0.0 109.477 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.88 75.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.517 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 19.5 mtpp -57.41 -53.71 55.08 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.246 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.52 -33.16 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.013 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -61.04 -47.63 85.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.99 -1.069 . . . . 0.0 110.118 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.56 -26.71 63.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.008 -1.058 . . . . 0.0 110.906 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -94.52 -50.06 5.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.886 -1.134 . . . . 0.0 110.529 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -92.64 -7.69 46.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 0.0 111.396 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.27 21.18 77.19 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 120.44 -1.413 . . . . 0.0 110.726 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . 0.409 HG22 HD13 ' B' ' 236' ' ' ILE . 24.9 mt -103.98 128.11 27.88 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.909 -1.347 . . . . 0.0 109.587 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.87 164.79 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.183 1.922 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.9 -31.95 7.7 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.011 2.474 . . . . 0.0 113.383 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.63 -5.91 43.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.243 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.9 -25.97 4.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -90.19 147.95 23.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.385 -1.447 . . . . 0.0 108.816 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -131.37 133.37 45.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -0.995 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.5 mt -103.84 123.24 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.439 -0.788 . . . . 0.0 109.016 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 97.8 mt -117.55 133.97 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.65 -0.657 . . . . 0.0 109.378 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -129.05 117.24 20.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 60.3 37.23 20.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.654 -1.279 . . . . 0.0 109.21 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.29 28.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -94.96 132.56 39.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.828 -1.395 . . . . 0.0 109.501 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.58 125.07 30.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.11 140.75 41.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.568 ' H ' ' HH ' ' B' ' 259' ' ' TYR . 9.0 tp10 -101.62 148.92 24.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.58 4.16 2.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.337 -0.852 . . . . 0.0 110.832 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.427 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -119.15 46.02 1.18 Allowed Glycine 0 N--CA 1.497 2.721 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.937 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.92 174.41 15.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.905 -1.35 . . . . 0.0 109.515 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' THR . . . . . 0.409 ' HG1' ' CG ' ' B' ' 258' ' ' ASP . 17.0 p -112.65 160.67 17.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 110.257 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.6 mt -58.48 -41.11 84.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 109.749 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' SER . . . . . 0.467 ' HG ' ' N ' ' B' ' 258' ' ' ASP . 30.0 p -61.72 -28.04 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 0.0 109.418 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.467 ' N ' ' HG ' ' B' ' 257' ' ' SER . 76.6 m-20 -70.55 -19.68 62.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.38 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . 0.568 ' HH ' ' H ' ' B' ' 251' ' ' GLU . 54.0 m-85 -103.17 3.58 35.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.062 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 66.54 38.93 3.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.551 -0.718 . . . . 0.0 109.99 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 49.6 mt -92.81 137.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.155 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -126.16 176.23 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.073 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.69 160.35 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.914 0.864 . . . . 0.0 110.834 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 56.04 12.67 0.97 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.123 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 16.1 m -78.22 152.03 32.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.882 -1.136 . . . . 0.0 108.644 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 15.4 m -116.34 137.97 51.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -0.764 . . . . 0.0 110.388 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -123.97 140.88 52.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.359 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . 0.421 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 68.2 m80 -88.95 141.12 28.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.115 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.3 tp -110.08 127.85 55.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 132.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 109.776 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 45.4 mt -80.84 141.39 34.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.115 -0.991 . . . . 0.0 109.289 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.566 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 24.9 ttt180 -96.46 -137.31 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.566 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 82.3 mt -124.73 -45.47 1.9 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.466 -0.771 . . . . 0.0 109.511 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.419 ' CG2' ' CZ ' ' A' ' 64' ' ' PHE . 37.3 mt -110.43 131.61 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.266 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -113.58 127.93 56.25 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.419 ' CZ ' ' CG2' ' A' ' 62' ' ' ILE . 77.4 m-85 -113.98 136.13 22.12 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 110.285 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -48.25 164.84 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.309 2.006 . . . . 0.0 113.12 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.88 -2.16 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.754 -0.591 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.408 ' O ' ' CG2' ' B' ' 209' ' ' THR . 2.2 m-20 -122.66 7.31 9.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.098 -1.001 . . . . 0.0 110.387 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.96 128.66 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -0.993 . . . . 0.0 110.967 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.3 t0 -101.09 140.45 21.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.11 -48.75 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.495 2.13 . . . . 0.0 112.432 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.3 tt0 -47.07 -46.86 22.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.733 -0.604 . . . . 0.0 110.46 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.42 -23.67 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.234 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.9 t80 -72.17 -54.89 8.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 111.03 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.9 -19.13 59.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -80.26 -4.18 52.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.877 -1.14 . . . . 0.0 109.302 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 152.65 43.41 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.257 -0.902 . . . . 0.0 109.847 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.5 154.36 30.62 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.415 2.077 . . . . 0.0 111.852 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -63.31 -48.06 79.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -0.854 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.16 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.92 -1.113 . . . . 0.0 110.44 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.06 -31.97 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 0.0 108.361 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.6 tt0 -59.88 -50.51 73.51 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -58.39 -48.14 81.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.86 -41.98 88.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 110.789 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.4 mt -71.15 -37.31 72.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.689 -1.257 . . . . 0.0 109.723 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.26 -37.54 74.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.855 -1.153 . . . . 0.0 109.036 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.78 73.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.055 -1.028 . . . . 0.0 109.003 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -71.36 -40.31 70.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 108.819 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -74.86 -12.15 60.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.057 -1.027 . . . . 0.0 109.192 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -92.36 -47.87 6.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.0 109.506 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -53.63 -38.86 64.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.752 -1.217 . . . . 0.0 108.136 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 12.5 t -91.96 -36.76 13.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 108.97 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.707 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 164.28 12.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 110.599 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.0 143.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.83 140.78 29.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.712 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.04 110.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 109.304 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -97.1 132.4 42.93 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 34.8 p -94.45 -174.61 3.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.101 -1.0 . . . . 0.0 111.066 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.17 -14.27 61.77 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.343 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' THR . . . . . 0.408 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 11.1 p -99.71 -4.33 30.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.455 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.63 1.8 60.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -66.8 117.85 9.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -1.21 . . . . 0.0 108.848 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 8.6 m -101.0 133.07 46.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 108.978 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 26.6 mt -127.63 135.6 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 109.503 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 19.0 m -102.63 121.38 42.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 33.2 mt -127.39 119.45 26.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.369 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.5 130.97 45.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.27 -177.01 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -130.18 153.54 81.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 109.034 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.26 -17.95 42.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.401 2.068 . . . . 0.0 111.946 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.33 8.47 29.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.0 144.54 47.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.847 -1.158 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 64.6 p -87.04 145.86 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.129 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.88 -28.51 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 108.916 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.425 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -64.3 -37.39 87.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.388 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -69.06 -50.38 48.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.174 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.91 -48.81 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.096 -1.003 . . . . 0.0 108.685 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -52.5 -40.48 62.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.688 . . . . 0.0 109.359 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.41 -35.61 80.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.639 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 17.2 mtpp -58.21 -53.64 55.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.915 -1.116 . . . . 0.0 109.145 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.8 mp -59.46 -35.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.111 -0.993 . . . . 0.0 109.204 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -59.36 -44.25 92.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.095 -1.003 . . . . 0.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.91 -29.28 63.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 0.0 110.764 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -91.99 -48.87 6.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.928 -1.108 . . . . 0.0 110.605 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -92.26 -6.71 49.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 111.58 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.68 22.98 73.85 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.482 -1.386 . . . . 0.0 110.389 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 56.5 mt -101.31 129.49 26.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.312 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.411 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.6 Cg_endo -75.4 155.46 41.08 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.029 1.819 . . . . 0.0 111.643 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.6 -32.39 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.698 2.265 . . . . 0.0 113.015 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -64.42 -8.97 15.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.411 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.64 -21.58 3.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.753 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.48 135.38 34.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.749 -1.219 . . . . 0.0 109.299 -179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.95 131.54 51.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.04 126.76 52.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.333 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.93 134.69 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -128.31 121.51 29.4 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.84 42.79 28.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.571 -1.331 . . . . 0.0 109.275 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.72 0.03 7.89 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -95.52 132.37 40.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.872 -1.37 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.7 123.61 29.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.084 -1.01 . . . . 0.0 108.83 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 19.4 mt -68.81 150.73 47.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 0.0 109.744 -179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.687 ' N ' ' HH ' ' B' ' 259' ' ' TYR . 4.1 mt-10 -104.3 141.57 36.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.51 3.49 3.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.322 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.18 35.77 3.4 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -142.34 170.95 14.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.295 . . . . 0.0 109.813 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.3 p -111.79 159.96 17.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.001 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt -56.5 -42.85 79.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' B' ' 258' ' ' ASP . 79.5 p -62.74 -29.13 70.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . 0.434 ' N ' ' HG ' ' B' ' 257' ' ' SER . 3.7 m-20 -69.8 -18.61 63.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.158 -0.964 . . . . 0.0 109.101 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . 0.687 ' HH ' ' N ' ' B' ' 251' ' ' GLU . 18.4 m-85 -103.55 3.45 34.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.151 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.84 39.15 2.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.501 -0.749 . . . . 0.0 109.837 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.7 mt -93.86 136.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . 0.478 ' O ' ' OG ' ' B' ' 265' ' ' SER . 55.6 mt-30 -125.81 177.17 6.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.26 162.24 0.76 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.245 -0.909 . . . . 0.0 110.927 -178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 56.33 12.42 1.01 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.053 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 72.7 m -76.5 149.05 36.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.891 -1.131 . . . . 0.0 108.75 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 20.5 m -115.83 138.95 50.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 110.352 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.3 mp -124.88 142.81 51.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.432 -0.793 . . . . 0.0 109.406 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -90.67 141.75 28.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.034 -1.041 . . . . 0.0 109.858 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 23.0 tp -111.28 128.89 56.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.412 -0.805 . . . . 0.0 109.578 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 3.1 t -116.76 130.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 109.576 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 48.3 mt -82.57 145.66 29.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.369 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 32.0 ttt180 -97.69 -136.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.526 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.9 mt -124.25 -33.07 3.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 109.429 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 tptp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 122.052 0.929 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 30.1 mt -114.45 136.86 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.419 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.9 m -113.94 122.96 48.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -109.21 135.92 20.19 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.793 . . . . 0.0 109.94 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -48.09 164.13 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.287 1.991 . . . . 0.0 112.757 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -2.19 5.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.653 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.405 ' O ' ' CG2' ' B' ' 209' ' ' THR . 2.6 m-20 -123.22 9.66 9.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.081 -1.012 . . . . 0.0 110.698 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.29 127.61 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.101 -0.999 . . . . 0.0 111.119 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.0 t70 -98.33 138.73 20.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.36 -41.69 4.53 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.338 2.025 . . . . 0.0 112.567 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 61.2 tt0 -56.61 -43.34 80.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 110.466 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.0 t -81.11 -24.24 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.748 -1.22 . . . . 0.0 110.402 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -72.24 -55.07 7.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -59.09 -16.76 20.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -83.93 -5.76 59.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.996 -1.065 . . . . 0.0 109.877 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.4 151.38 48.39 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.006 -1.059 . . . . 0.0 109.786 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 153.81 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.28 1.987 . . . . 0.0 111.792 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -63.03 -51.57 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.583 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.5 39.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.928 -1.108 . . . . 0.0 110.239 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.27 -31.45 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.712 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -60.49 -50.03 75.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -58.1 -49.04 78.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.753 . . . . 0.0 110.145 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -57.11 -41.99 80.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.63 -38.61 73.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.852 -1.155 . . . . 0.0 110.023 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.56 -38.33 74.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.68 -1.262 . . . . 0.0 109.327 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.48 -31.44 70.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.161 -0.962 . . . . 0.0 108.708 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.547 ' OE2' ' CD2' ' B' ' 273' ' ' LEU . 5.9 tt0 -72.21 -42.64 65.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -73.02 -13.95 61.32 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.983 -1.073 . . . . 0.0 109.391 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -92.73 -46.28 7.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.191 -0.943 . . . . 0.0 109.504 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.426 ' HE ' ' HA ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -53.35 -38.75 63.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.765 -1.209 . . . . 0.0 108.15 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 6.3 t -91.32 -36.56 13.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 108.923 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.19 166.84 11.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 110.334 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.34 146.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.427 -0.796 . . . . 0.0 109.781 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -97.89 141.06 31.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.87 109.12 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.17 133.31 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 34.6 p -94.78 -176.38 3.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 110.914 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 25.7 mt -71.22 -12.8 61.67 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.489 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' THR . . . . . 0.405 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 10.7 p -101.79 -3.96 27.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.709 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.63 2.94 58.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -68.41 118.41 11.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.272 . . . . 0.0 109.021 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -101.01 135.86 41.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 40.9 mt -133.43 136.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.384 -0.823 . . . . 0.0 109.349 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.1 m -105.91 122.49 46.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 18.4 mt -126.11 121.7 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.391 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.54 132.24 47.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 8.2 m -140.2 -173.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.968 -1.082 . . . . 0.0 109.58 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -134.95 154.2 79.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.97 -20.62 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.545 2.163 . . . . 0.0 112.223 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 67.4 m -106.3 7.66 31.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 110.219 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 142.2 54.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.77 -1.206 . . . . 0.0 109.404 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.443 ' HG1' ' ND2' ' B' ' 225' ' ' ASN . 14.5 p -85.43 146.85 26.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 40.5 mm -51.7 -40.26 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.389 -0.82 . . . . 0.0 109.384 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.17 -35.67 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.568 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.443 ' ND2' ' HG1' ' B' ' 222' ' ' THR . 98.7 m-20 -69.13 -52.3 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 99.0 t -52.51 -45.58 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.377 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.06 -43.69 70.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.7 73.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.444 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.439 ' CB ' ' HZ2' ' B' ' 229' ' ' LYS . 4.4 mtpm? -58.55 -54.53 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.3 mp -57.86 -34.18 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.848 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.1 -46.14 88.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.236 -0.915 . . . . 0.0 109.997 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -30.81 71.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.184 -0.947 . . . . 0.0 110.902 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -95.87 -50.67 4.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.008 -1.058 . . . . 0.0 110.556 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -87.39 -7.69 57.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.032 -1.043 . . . . 0.0 111.412 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.75 23.27 70.67 Favored Glycine 0 N--CA 1.493 2.446 0 O-C-N 120.535 -1.353 . . . . 0.0 110.305 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 45.9 mt -100.48 126.7 34.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.086 -1.244 . . . . 0.0 109.271 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.15 152.78 40.48 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.064 1.843 . . . . 0.0 111.767 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.04 -30.1 47.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.668 2.245 . . . . 0.0 112.694 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.24 -16.1 41.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.521 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.08 -12.36 5.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.422 -0.798 . . . . 0.0 110.696 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.86 137.0 32.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.917 -1.115 . . . . 0.0 109.523 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.18 132.09 45.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.654 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.92 128.78 54.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 109.297 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.56 136.22 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.563 -0.711 . . . . 0.0 109.85 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -132.36 117.02 17.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.233 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.35 36.96 8.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.895 -1.128 . . . . 0.0 109.436 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.8 13.0 68.51 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.295 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -115.45 137.8 51.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.263 . . . . 0.0 109.524 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.56 126.17 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.013 . . . . 0.0 109.435 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.0 mt -70.69 139.78 51.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.622 ' H ' ' HH ' ' B' ' 259' ' ' TYR . 3.2 tp10 -92.6 142.2 27.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.192 -0.942 . . . . 0.0 109.486 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.5 m-20 -69.26 3.45 2.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 109.712 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -123.44 41.68 1.73 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.543 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -144.78 171.25 14.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 109.332 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 25.8 p -111.73 158.32 19.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.962 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 6.4 mt -54.88 -40.7 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 89.0 p -64.2 -28.35 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.547 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.61 -17.17 62.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . 0.622 ' HH ' ' H ' ' B' ' 251' ' ' GLU . 21.4 m-85 -105.17 3.16 29.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 109.084 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 37.85 3.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 0.0 109.999 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.48 135.92 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -125.74 177.78 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 109.925 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.433 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.53 157.13 3.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.021 0.915 . . . . 0.0 111.008 -178.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 57.87 12.43 1.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.671 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 22.0 m -75.9 148.3 38.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 30.8 m -115.58 138.97 50.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.772 . . . . 0.0 110.048 -179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.2 mp -120.72 166.46 13.68 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -112.13 137.47 50.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.795 . . . . 0.0 109.426 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 18.6 tp -108.86 126.05 52.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.478 -0.763 . . . . 0.0 109.285 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.07 130.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.435 -0.791 . . . . 0.0 109.624 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.4 mt -80.79 143.22 33.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.092 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.1 ttt180 -93.38 -140.3 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 108.85 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.547 ' CD2' ' OE2' ' A' ' 87' ' ' GLU . 56.3 mt -123.68 -16.95 6.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 109.602 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.122 -0.986 . . . . 0.0 109.455 -179.853 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 mttp . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.174 0.988 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.5 mt -117.15 138.06 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.112 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 m -114.5 125.26 53.61 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -113.7 137.28 22.17 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 110.489 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.84 164.79 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.642 2.228 . . . . 0.0 112.962 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.0 p -69.13 -2.47 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.768 -0.582 . . . . 0.0 110.509 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -121.56 6.62 10.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.017 -1.052 . . . . 0.0 110.204 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -108.78 129.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.905 . . . . 0.0 111.275 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.8 t0 -100.49 138.33 20.13 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.7 -47.12 1.45 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.149 1.899 . . . . 0.0 112.009 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 7.1 tt0 -50.47 -43.04 55.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.889 -0.507 . . . . 0.0 110.1 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.1 t -80.55 -23.97 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.699 -1.251 . . . . 0.0 110.022 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -73.59 -52.79 12.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.093 -1.005 . . . . 0.0 110.655 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -62.56 -17.4 59.88 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.916 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -81.07 -6.37 58.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.9 -1.125 . . . . 0.0 109.779 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.6 mt -90.65 151.74 44.24 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.13 155.99 17.61 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.005 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -50.03 71.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.96 -43.28 50.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.92 -1.113 . . . . 0.0 110.352 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 89.7 t -75.13 -32.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.889 -1.132 . . . . 0.0 108.642 178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.1 tt0 -59.26 -51.44 69.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -57.62 -49.06 77.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.562 -0.711 . . . . 0.0 110.352 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.79 -41.28 81.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.045 . . . . 0.0 110.861 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.7 mt -71.22 -36.33 71.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.7 -1.25 . . . . 0.0 109.632 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 mt -71.45 -37.85 71.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.71 -1.244 . . . . 0.0 108.854 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.22 72.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.101 -0.999 . . . . 0.0 109.435 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -74.39 -37.02 63.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 108.888 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -74.57 -12.35 60.44 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.882 -1.136 . . . . 0.0 108.612 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -92.81 -47.45 7.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.427 -0.796 . . . . 0.0 109.574 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -53.53 -39.36 64.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.678 -1.264 . . . . 0.0 107.766 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.3 t -84.51 -36.63 22.08 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.605 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.45 165.63 12.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -146.66 141.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.0 109.235 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -94.52 141.98 27.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.974 . . . . 0.0 109.9 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.49 114.37 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -99.0 138.92 35.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.1 p -98.65 -175.5 3.09 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -0.936 . . . . 0.0 110.573 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.415 HD13 ' H ' ' B' ' 271' ' ' LEU . 48.7 mt -70.23 -15.91 62.98 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.188 -179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.9 p -100.3 -3.07 32.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.132 -0.98 . . . . 0.0 109.655 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.1 3.61 57.83 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.353 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.8 117.61 9.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.289 . . . . 0.0 108.962 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 4.7 m -99.92 132.97 44.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 20.5 mt -127.95 136.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.46 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 67.6 m -105.95 119.95 40.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.8 mt -123.87 122.53 38.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 132.76 48.12 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.93 -174.04 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.93 -1.106 . . . . 0.0 109.77 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -135.93 154.51 77.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.89 . . . . 0.0 109.206 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.85 -29.03 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.69 2.26 . . . . 0.0 112.105 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 t -98.4 6.06 47.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.694 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.25 142.37 52.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.001 -1.062 . . . . 0.0 109.502 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.6 p -87.99 145.32 26.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.029 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 36.0 mm -51.5 -37.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.114 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -34.01 58.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -72.58 -50.48 25.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.193 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.9 -51.22 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 108.928 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -50.76 -42.31 57.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.336 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.0 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 0.0 109.735 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 19.8 mtpp -57.03 -54.01 51.62 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.008 -1.057 . . . . 0.0 109.19 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.9 mp -60.08 -32.36 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.612 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -62.1 -47.14 85.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -72.66 -26.51 61.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.806 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -92.48 -48.38 6.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.815 -1.178 . . . . 0.0 110.504 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.22 -6.66 47.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 111.261 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.46 72.54 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 120.571 -1.331 . . . . 0.0 110.328 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.82 126.68 31.95 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.086 -1.243 . . . . 0.0 109.232 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.415 ' HG2' HE21 ' B' ' 240' ' ' GLN . 38.6 Cg_endo -72.04 156.61 55.77 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.813 1.676 . . . . 0.0 111.58 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.93 -29.9 22.35 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.617 2.211 . . . . 0.0 112.851 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.3 -14.5 60.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.431 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.415 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.87 -20.97 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.37 -0.831 . . . . 0.0 110.288 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.67 136.27 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.857 -1.152 . . . . 0.0 108.894 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -127.47 132.8 49.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.53 123.53 48.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.099 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 93.9 mt -118.19 135.75 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -131.92 115.89 16.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.852 . . . . 0.0 108.956 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.9 35.87 8.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.97 10.49 68.34 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.173 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -111.28 136.86 49.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.686 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.94 122.21 27.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 109.483 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 29.5 mt -68.39 146.6 53.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 109.25 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -101.24 143.86 30.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.74 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.589 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.2 OUTLIER -71.26 3.91 3.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.949 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.6 36.31 3.17 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 19.8 mtt85 -142.54 174.34 10.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.903 -1.351 . . . . 0.0 109.692 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 14.1 p -113.09 158.79 19.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 110.104 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.5 mt -56.9 -43.45 81.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.78 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 59.1 p -59.63 -27.17 66.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -19.21 61.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.637 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -103.84 3.89 34.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.329 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.54 38.31 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.0 109.792 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -93.02 135.98 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.003 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.67 176.76 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.111 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.44 155.4 2.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.885 0.85 . . . . 0.0 111.196 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 59.93 14.21 4.14 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.19 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 88.9 p -76.87 149.91 36.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.801 -1.187 . . . . 0.0 108.551 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 3.1 m -114.57 135.68 53.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.737 . . . . 0.0 110.276 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 9.1 mp -122.98 140.11 53.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.504 -0.747 . . . . 0.0 109.253 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -88.5 141.55 28.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.144 -0.973 . . . . 0.0 110.203 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.05 126.96 53.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.452 -0.78 . . . . 0.0 108.951 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.5 t -114.75 128.99 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.884 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . 0.415 ' H ' HD13 ' B' ' 208' ' ' LEU . 48.9 mt -80.77 143.57 32.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.032 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.666 ' NH1' ' NH2' ' B' ' 274' ' ' ARG . 16.6 ttt180 -96.25 -139.19 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.447 ' H ' ' CG ' ' B' ' 272' ' ' ARG . 61.5 mt -123.72 -27.9 3.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.403 -0.811 . . . . 0.0 109.26 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.666 ' NH2' ' NH1' ' B' ' 272' ' ' ARG . 21.6 mtm105 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 51.4 mt -106.74 132.73 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 0.0 109.97 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 m -115.86 124.43 50.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -110.24 137.13 20.51 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.439 -0.788 . . . . 0.0 109.902 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -48.46 163.96 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.229 1.953 . . . . 0.0 112.749 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.45 -1.78 5.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -123.46 9.64 9.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.131 -0.981 . . . . 0.0 110.553 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.7 mm -111.28 129.17 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.218 -0.926 . . . . 0.0 111.327 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.7 t0 -98.44 138.93 20.86 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.81 -44.89 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.286 1.99 . . . . 0.0 112.066 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 14.2 tt0 -47.67 -47.01 29.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.878 -0.514 . . . . 0.0 110.409 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.7 t -79.87 -39.88 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.433 -179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -52.57 -54.59 30.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.838 -1.164 . . . . 0.0 111.007 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -61.3 -18.49 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 110.016 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -82.76 -5.36 58.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.822 -1.174 . . . . 0.0 109.638 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.1 mt -89.38 152.06 47.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.032 -1.043 . . . . 0.0 109.527 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.4 154.19 25.15 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.326 2.018 . . . . 0.0 112.004 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -48.57 77.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.835 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.59 -42.82 62.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.977 -1.077 . . . . 0.0 110.168 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.08 -31.64 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.9 -1.125 . . . . 0.0 108.475 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.3 tt0 -60.18 -53.17 60.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -54.95 -49.31 71.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -57.38 -39.25 75.64 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.006 -1.059 . . . . 0.0 110.609 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.87 -37.34 64.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.644 -1.285 . . . . 0.0 109.917 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.0 mt -71.44 -38.33 71.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.761 -1.212 . . . . 0.0 108.889 178.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.94 -34.15 75.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 109.442 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -74.31 -33.55 63.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.9 m0 -75.92 -15.26 60.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.898 -1.126 . . . . 0.0 107.995 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -92.61 -46.73 7.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.492 -0.755 . . . . 0.0 109.452 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' A' ' 91' ' ' THR . 11.5 ptm180 -54.03 -40.63 67.22 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.452 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 6.2 t -87.13 -36.78 17.89 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.73 163.68 12.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.356 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.42 142.56 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.527 -0.733 . . . . 0.0 109.346 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.06 142.46 27.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.62 113.91 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.19 -0.944 . . . . 0.0 109.701 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.552 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.5 135.14 43.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.077 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 29.0 p -93.38 -175.61 3.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.014 0.912 . . . . 0.0 111.099 -178.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 43.2 mt -70.32 -19.8 63.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.6 p -96.56 -3.31 43.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.974 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.99 58.06 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.545 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -68.45 118.62 11.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.895 -1.356 . . . . 0.0 108.973 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.0 m -102.43 139.43 38.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.262 -0.899 . . . . 0.0 109.808 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 54.5 mt -137.94 137.67 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 0.0 109.339 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 36.1 m -105.45 122.55 46.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 108.741 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.414 ' HB3' ' HZ2' ' B' ' 229' ' ' LYS . 19.4 mt -125.29 121.55 34.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 110.567 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -65.79 131.38 46.16 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.95 -173.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.013 -1.054 . . . . 0.0 109.902 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -134.36 156.04 79.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.0 108.923 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.09 -20.42 67.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.433 2.088 . . . . 0.0 111.899 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 4.3 m -103.54 6.94 37.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.837 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 144.78 48.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.996 -1.065 . . . . 0.0 109.544 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 80.4 p -86.43 148.83 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.3 -25.16 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.912 . . . . 0.0 108.92 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -35.43 77.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.801 . . . . 0.0 109.35 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.09 -51.09 34.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.62 -48.18 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 108.385 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -51.05 -44.9 61.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.05 76.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.337 -0.852 . . . . 0.0 109.583 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . 0.414 ' HZ2' ' HB3' ' B' ' 215' ' ' LEU . 4.2 mtpm? -56.96 -54.69 43.83 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.544 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.414 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.5 mp -59.95 -31.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.037 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.94 -48.46 78.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.72 -27.9 67.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -94.67 -52.57 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.929 -1.107 . . . . 0.0 110.374 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 230' ' ' ILE . 69.8 mm-40 -87.93 -7.99 56.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 111.561 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.31 24.34 73.52 Favored Glycine 0 N--CA 1.494 2.503 0 O-C-N 120.44 -1.413 . . . . 0.0 110.458 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.5 mt -100.69 130.89 24.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.325 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.53 152.83 43.75 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.077 1.852 . . . . 0.0 111.676 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.07 -32.74 16.74 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.573 2.182 . . . . 0.0 113.107 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.408 ' C ' ' OD1' ' B' ' 239' ' ' ASP . 15.1 p30 -64.06 -8.84 13.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 -21.66 3.39 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.451 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.49 136.82 33.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.71 -1.244 . . . . 0.0 108.776 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -128.04 133.2 49.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.32 -0.863 . . . . 0.0 109.685 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.5 mt -105.24 125.8 51.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.0 mt -116.93 156.0 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -151.81 116.57 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.271 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 59.96 43.02 15.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.843 -1.161 . . . . 0.0 109.507 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 23.82 67.19 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.2 ptmm? -121.59 136.91 54.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 0.0 109.479 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.85 123.81 31.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.265 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.7 mt -74.51 141.68 44.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.37 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.45 147.53 24.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.95 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -73.02 3.4 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.519 -0.738 . . . . 0.0 109.755 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.49 33.64 4.58 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -143.11 172.21 13.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.95 -1.323 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' THR . . . . . 0.403 ' HG1' ' HG ' ' B' ' 257' ' ' SER . 82.2 p -111.51 159.61 17.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 110.075 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.0 mt -55.51 -40.98 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.468 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' SER . . . . . 0.403 ' HG ' ' HG1' ' B' ' 255' ' ' THR . 85.7 p -63.28 -28.21 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.102 -0.999 . . . . 0.0 109.535 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -18.75 62.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.982 . . . . 0.0 109.53 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -103.06 4.09 36.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.097 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 69.81 40.91 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.687 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 52.0 mt -98.52 136.81 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 -178.87 4.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 108.96 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.456 ' H ' ' HD3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.41 163.31 0.63 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.37 1.081 . . . . 0.0 111.525 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 55.71 11.32 0.64 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.145 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 147.12 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.82 -1.175 . . . . 0.0 108.924 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 5.7 m -113.89 138.39 50.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.597 -0.689 . . . . 0.0 110.083 -179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.2 mp -127.17 144.27 51.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.34 -0.85 . . . . 0.0 110.18 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . 0.418 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 62.1 m80 -91.9 142.45 27.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.188 -0.945 . . . . 0.0 110.382 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.0 tp -109.35 127.02 54.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.365 -0.835 . . . . 0.0 108.924 179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.75 131.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.383 -0.823 . . . . 0.0 109.729 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 39.4 mt -81.76 143.87 31.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.545 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.1 ttt180 -94.93 -139.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 108.706 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.545 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 58.6 mt -123.93 -20.51 5.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 109.501 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.392 -0.818 . . . . 0.0 109.472 -179.928 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' CD ' ' H ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 122.093 0.949 . . . . 0.0 110.978 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.423 HD11 HG23 ' A' ' 62' ' ' ILE . 33.8 mt -118.44 137.41 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.485 0.659 . . . . 0.0 110.27 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -115.91 127.44 54.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -114.32 137.13 22.41 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.594 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.77 165.06 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.641 2.227 . . . . 0.0 113.176 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -2.75 10.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 110.691 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -120.85 5.61 10.45 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.031 -1.043 . . . . 0.0 109.894 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -109.62 130.44 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 111.001 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.85 134.57 20.4 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.01 -45.55 5.82 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.965 1.777 . . . . 0.0 112.024 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -50.23 -44.71 53.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.849 -0.532 . . . . 0.0 110.485 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 38.8 t -80.2 -26.44 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.834 -1.166 . . . . 0.0 110.147 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.0 t80 -68.99 -51.67 36.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.536 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -62.59 -17.48 60.22 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.803 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.94 -6.74 59.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.865 -1.147 . . . . 0.0 109.641 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.0 mt -89.15 151.75 47.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.144 -0.972 . . . . 0.0 109.753 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.38 155.64 19.81 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.41 2.074 . . . . 0.0 111.91 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.39 -50.81 68.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 110.679 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.22 -42.99 52.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.297 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.16 -30.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 108.423 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.419 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.0 tt0 -60.6 -51.59 68.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -56.9 -47.83 79.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.525 -0.735 . . . . 0.0 110.202 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.24 -40.31 85.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.044 -1.035 . . . . 0.0 110.775 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.0 mt -72.31 -35.7 68.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.796 -1.19 . . . . 0.0 109.561 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.44 -37.49 71.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 108.853 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.77 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.025 -1.047 . . . . 0.0 109.197 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -72.71 -37.89 67.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.401 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 42.5 m0 -75.17 -13.49 60.46 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.95 -1.094 . . . . 0.0 108.77 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -92.49 -46.83 7.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.408 -0.807 . . . . 0.0 109.604 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -39.41 67.82 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.668 -1.27 . . . . 0.0 107.949 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 3.7 t -87.73 -36.98 17.04 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.12 165.59 12.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.86 151.97 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.392 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -104.29 142.61 34.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.878 . . . . 0.0 109.782 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.38 114.02 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.599 ' HZ2' ' CB ' ' B' ' 206' ' ' LYS . 0.4 OUTLIER -101.31 130.46 47.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 108.818 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 38.1 p -89.11 -175.53 4.84 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.999 0.904 . . . . 0.0 111.019 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 25.1 mt -71.41 -11.33 60.83 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.585 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 9.9 p -103.48 -2.88 26.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.836 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.35 60.51 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.243 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -67.77 117.84 10.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.265 . . . . 0.0 108.845 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -99.96 139.33 35.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.176 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . 0.401 ' CD1' ' CG ' ' B' ' 234' ' ' GLU . 29.1 mt -135.54 137.81 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.2 m -105.14 122.59 46.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 108.837 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 21.5 mt -127.01 119.29 26.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.945 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.71 132.36 49.44 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.3 -175.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.947 -1.095 . . . . 0.0 109.764 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.36 154.43 78.59 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 108.978 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.39 -24.74 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.62 2.214 . . . . 0.0 112.005 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 6.54 42.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.24 142.88 52.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.505 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' THR . . . . . 0.452 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 11.9 p -85.66 145.7 27.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.34 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 34.8 mm -51.81 -35.76 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.251 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' B' ' 225' ' ' ASN . 5.8 pt-20 -61.38 -36.21 79.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.452 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 63.4 m-20 -68.16 -52.45 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.25 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.84 -48.29 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.919 -1.113 . . . . 0.0 108.045 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.99 -43.65 60.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.709 -0.619 . . . . 0.0 109.492 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 109.27 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -57.48 -53.98 52.05 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.085 -1.009 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.22 -33.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.122 -0.986 . . . . 0.0 109.083 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.78 -48.46 79.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.212 -0.93 . . . . 0.0 110.031 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.76 -25.43 66.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.635 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -98.95 -57.62 2.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.043 . . . . 0.0 110.522 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' B' ' 230' ' ' ILE . 34.9 mm-40 -81.43 -8.48 59.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.25 -0.906 . . . . 0.0 111.187 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.77 22.24 73.55 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 120.502 -1.374 . . . . 0.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . 0.402 HG22 HD11 ' B' ' 236' ' ' ILE . 64.7 mt -101.73 131.13 23.24 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.977 -1.307 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.409 ' HG2' HE21 ' B' ' 240' ' ' GLN . 58.6 Cg_endo -75.2 153.65 41.01 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.029 1.819 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.43 -30.86 43.6 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.558 2.172 . . . . 0.0 112.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.27 -16.62 63.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.638 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.409 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.78 -18.22 7.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.25 137.57 32.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.75 -1.219 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -129.0 134.12 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.9 mt -105.71 124.8 50.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 78.4 mt -118.33 135.46 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.71 -0.619 . . . . 0.0 109.533 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -129.91 113.49 14.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.47 -0.769 . . . . 0.0 109.004 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.34 38.7 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.65 7.78 55.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -105.75 135.84 46.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.242 . . . . 0.0 109.489 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -83.61 119.76 25.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 0.0 109.338 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 39.2 mt -67.6 140.47 56.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 2.0 tm-20 -92.5 143.1 26.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -71.54 3.5 3.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 109.636 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 251' ' ' GLU . . . -121.35 39.66 2.32 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -146.21 173.7 11.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.968 -1.313 . . . . 0.0 109.383 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 5.7 p -112.32 161.56 16.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 109.864 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mt -58.54 -41.16 84.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.787 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 93.7 p -62.24 -29.04 70.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.742 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.57 -19.98 62.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -101.93 3.97 39.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.267 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.6 38.18 3.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 32.7 mt -93.27 136.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -125.19 176.74 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.539 -0.726 . . . . 0.0 109.757 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.429 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.78 159.58 1.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.935 0.874 . . . . 0.0 110.719 -179.184 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 55.76 27.55 10.94 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.162 177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.17 149.09 21.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.164 . . . . 0.0 108.525 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 9.5 m -112.65 136.36 52.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 110.268 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -124.56 139.47 53.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.129 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -87.79 141.51 28.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.9 tp -108.86 126.62 53.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.53 129.21 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.639 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 48.5 mt -81.31 143.89 31.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.0 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.455 ' CG ' ' H ' ' B' ' 273' ' ' LEU . 17.6 ttt180 -95.53 -138.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.91 . . . . 0.0 109.061 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.455 ' H ' ' CG ' ' B' ' 272' ' ' ARG . 56.6 mt -123.52 -41.99 2.24 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.495 ' CD ' ' C ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.376 -0.828 . . . . 0.0 109.309 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.0 mt -110.85 132.73 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.392 -0.818 . . . . 0.0 110.374 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.4 m -113.95 124.96 53.43 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -110.18 136.98 20.46 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 110.212 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.37 164.12 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.451 2.1 . . . . 0.0 113.172 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -68.6 -2.09 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.761 -0.587 . . . . 0.0 110.468 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 0.7 OUTLIER -122.12 8.41 9.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.074 -1.016 . . . . 0.0 110.436 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 68' ' ' ILE . 25.6 mm -108.71 126.5 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.924 . . . . 0.0 111.295 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' OD1' ' C ' ' A' ' 69' ' ' ASP . 5.3 t0 -98.25 113.38 63.94 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -46.49 -47.24 15.85 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.161 1.907 . . . . 0.0 112.271 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -48.53 -45.18 37.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.469 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.47 -24.25 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.646 -1.284 . . . . 0.0 110.423 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.2 t80 -69.68 -52.6 24.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.77 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -62.52 -17.07 58.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.925 . . . . 0.0 110.021 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -81.66 -6.36 58.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.787 -1.196 . . . . 0.0 109.95 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.61 152.64 43.59 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 109.63 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.09 155.22 19.68 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.534 2.156 . . . . 0.0 112.135 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -50.25 70.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.12 -43.2 51.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.889 -1.132 . . . . 0.0 110.387 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.35 -30.99 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.982 -1.074 . . . . 0.0 108.324 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.418 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.2 tt0 -59.96 -51.45 69.64 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -57.56 -48.06 80.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.613 -0.679 . . . . 0.0 110.244 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.15 -39.81 79.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.696 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.75 -36.81 67.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.714 -1.241 . . . . 0.0 109.745 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.93 -37.77 69.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.785 -1.197 . . . . 0.0 108.789 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.76 -34.23 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 109.515 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.92 -33.69 59.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 108.644 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -74.04 -16.68 61.04 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -92.83 -44.8 8.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.592 -0.693 . . . . 0.0 109.81 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -53.98 -40.54 66.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.51 -1.369 . . . . 0.0 107.804 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 12.3 t -86.26 -36.64 19.25 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.39 163.9 13.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.917 . . . . 0.0 109.999 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.87 142.3 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.221 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -94.48 142.82 26.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.092 -1.005 . . . . 0.0 109.691 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.48 114.7 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -101.42 132.98 46.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.898 . . . . 0.0 109.159 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 18.6 p -91.01 -175.62 4.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.32 -178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.69 -15.54 62.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -101.93 -1.68 31.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.688 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.77 4.8 58.91 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.392 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -68.3 117.75 10.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.323 . . . . 0.0 108.807 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.9 m -99.74 140.41 33.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.421 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 22.2 mt -137.56 137.86 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 22.7 m -104.26 124.35 49.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 23.5 mt -129.2 119.3 23.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.87 . . . . 0.0 110.06 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.88 133.94 51.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.65 -0.656 . . . . 0.0 109.439 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.26 -173.38 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 0.0 109.616 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -135.81 153.38 77.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 108.862 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.68 -21.47 25.22 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.569 2.18 . . . . 0.0 112.03 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.0 7.58 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.955 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.29 142.34 52.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.901 -1.125 . . . . 0.0 109.507 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.6 p -86.55 145.8 26.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.188 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.2 mm -50.97 -43.17 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.418 ' CD ' ' OD1' ' B' ' 225' ' ' ASN . 0.2 OUTLIER -52.62 -34.76 52.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.475 -0.766 . . . . 0.0 109.699 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . 0.418 ' OD1' ' CD ' ' B' ' 224' ' ' GLU . 63.5 m-20 -71.22 -52.21 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.23 -45.47 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.037 -1.04 . . . . 0.0 108.529 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -43.12 70.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.98 78.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.413 -0.804 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -57.78 -53.75 54.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.084 -1.01 . . . . 0.0 109.363 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.7 mp -57.22 -35.61 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.007 -1.058 . . . . 0.0 109.246 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.895 -1.128 . . . . 0.0 109.967 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.98 -29.2 70.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.843 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -95.51 -52.28 4.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.381 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -87.76 -6.58 58.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.31 24.02 71.93 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.45 -1.406 . . . . 0.0 110.289 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 44.6 mt -103.03 128.79 26.92 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.25 . . . . 0.0 109.774 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.57 155.95 31.85 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.159 1.906 . . . . 0.0 111.828 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.77 -30.62 33.69 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.944 2.429 . . . . 0.0 112.939 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -61.95 -13.3 23.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 -17.2 4.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -0.77 . . . . 0.0 110.746 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.23 137.04 32.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.701 -1.25 . . . . 0.0 109.417 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -129.54 130.78 46.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 109.567 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.74 125.13 50.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 109.32 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 39.9 mt -118.78 136.22 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.672 -0.642 . . . . 0.0 109.428 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -131.06 119.23 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.758 . . . . 0.0 109.459 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.0 47.29 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.923 -1.111 . . . . 0.0 109.464 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.53 26.28 64.29 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.7 OUTLIER -123.91 135.3 53.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.315 -1.109 . . . . 0.0 109.622 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -84.09 122.11 28.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 109.258 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 38.1 mt -72.38 144.02 48.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -96.89 143.5 27.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 3.68 3.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.442 -0.786 . . . . 0.0 109.843 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.11 44.74 1.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.49 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -148.26 174.1 12.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.141 -1.211 . . . . 0.0 109.079 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.7 p -111.91 160.15 17.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.354 -0.841 . . . . 0.0 110.185 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.6 mt -60.21 -40.72 91.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.842 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.4 p -61.68 -28.77 69.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.957 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.58 -15.86 62.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -104.28 2.38 31.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 108.933 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.07 38.54 3.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.89 137.45 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.102 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . 0.482 HE21 ' HZ3' ' B' ' 263' ' ' LYS . 4.1 mt-30 -126.7 179.49 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 108.987 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.482 ' HZ3' HE21 ' B' ' 262' ' ' GLN . 0.0 OUTLIER -53.17 163.73 0.51 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.45 1.119 . . . . 0.0 111.492 -178.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 55.54 12.04 0.72 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.093 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 89.2 p -76.09 148.31 38.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 108.714 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 17.7 m -114.19 136.8 52.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.459 -0.776 . . . . 0.0 110.268 -179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.0 mp -123.74 139.43 53.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.533 -0.73 . . . . 0.0 109.361 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 60.9 m80 -88.77 142.13 27.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 110.287 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.58 125.61 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.39 130.05 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.746 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 36.7 mt -80.76 143.34 32.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.082 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.548 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 28.5 ttt180 -94.9 -139.26 0.23 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 108.694 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.548 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 50.5 mt -123.77 -47.7 1.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 109.331 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.508 ' CD ' ' C ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.161 -0.962 . . . . 0.0 109.466 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.425 ' CG2' ' CZ ' ' A' ' 64' ' ' PHE . 40.1 mt -108.79 133.88 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.427 -0.796 . . . . 0.0 110.102 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.6 m -116.08 126.7 54.11 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' CZ ' ' CG2' ' A' ' 62' ' ' ILE . 95.5 m-85 -112.68 134.41 21.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.2 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.61 165.2 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.055 1.837 . . . . 0.0 112.22 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 t -66.01 -12.53 55.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.701 -0.624 . . . . 0.0 110.88 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -112.49 8.65 19.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.4 mm -111.41 129.71 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.111 -0.993 . . . . 0.0 110.707 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.4 t70 -97.96 139.13 21.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.27 -36.58 3.99 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.228 1.952 . . . . 0.0 112.537 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 8.5 tp60 -59.13 -44.5 92.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.536 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -79.02 -23.9 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.809 -1.182 . . . . 0.0 110.047 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 19.8 t80 -66.4 -52.38 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.087 -1.008 . . . . 0.0 110.729 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -63.41 -16.31 60.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.52 -6.87 59.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 109.767 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 91.5 mt -90.18 152.26 45.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.13 154.86 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.409 2.073 . . . . 0.0 112.03 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.1 -50.47 70.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.4 -44.37 34.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.936 -1.103 . . . . 0.0 110.013 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.61 -31.82 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.911 -1.118 . . . . 0.0 108.603 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -59.57 -50.06 75.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -57.85 -48.56 79.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.804 . . . . 0.0 109.944 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.18 -35.12 71.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.95 . . . . 0.0 110.113 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.66 -41.74 37.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.962 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.78 -38.23 88.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.647 -1.283 . . . . 0.0 108.671 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.74 82.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 108.981 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.13 -33.19 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 108.639 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.43 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 48.0 m0 -78.28 -20.78 50.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -86.89 -38.8 16.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.15 -0.969 . . . . 0.0 109.643 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' CG ' ' N ' ' A' ' 91' ' ' THR . 11.9 ptm180 -65.34 -46.73 79.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.73 -1.231 . . . . 0.0 108.304 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.49 ' N ' ' CG ' ' A' ' 90' ' ' ARG . 11.9 t -71.23 -37.79 72.02 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.414 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.51 166.92 10.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 110.387 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.43 142.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 0.0 109.376 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -95.14 146.96 23.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.571 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.47 110.93 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.202 -0.937 . . . . 0.0 110.161 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.537 ' HZ1' ' CG2' ' B' ' 266' ' ' THR . 0.0 OUTLIER -96.99 138.7 34.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 43.8 p -102.7 -173.03 2.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 111.3 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 21.4 mt -70.81 -17.86 62.75 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.298 0.57 . . . . 0.0 109.597 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.5 p -96.84 -5.15 38.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 109.299 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.64 60.63 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -69.67 119.44 13.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 0.0 108.948 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 47.7 m -101.04 133.15 45.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 109.335 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.0 mt -128.2 136.87 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 58.5 m -105.34 124.34 49.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.381 -0.824 . . . . 0.0 109.029 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.7 mt -129.8 120.01 24.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.842 . . . . 0.0 110.234 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.78 132.65 48.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.709 . . . . 0.0 109.17 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.97 -175.7 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.014 -1.054 . . . . 0.0 109.972 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -132.49 154.89 81.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.532 -0.73 . . . . 0.0 109.074 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.02 -19.35 47.94 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.505 2.137 . . . . 0.0 112.123 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.19 8.2 31.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.22 143.17 48.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.939 -1.101 . . . . 0.0 109.784 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 13.6 p -85.7 148.53 25.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.799 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.432 HG23 HD13 ' B' ' 223' ' ' ILE . 39.0 mm -52.2 -39.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.79 67.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.775 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -70.06 -53.3 18.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 0.0 109.302 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.52 -44.15 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.179 -0.951 . . . . 0.0 108.638 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -57.56 -38.71 75.25 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.75 -36.87 84.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -57.59 -53.31 59.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.24 -34.57 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -61.67 -43.47 98.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -28.78 63.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.977 -1.077 . . . . 0.0 110.721 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -92.99 -49.86 5.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 110.489 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -91.39 -6.86 52.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.195 -0.941 . . . . 0.0 111.357 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.97 74.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.104 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 61.2 mt -102.06 123.19 44.38 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.046 -1.267 . . . . 0.0 109.135 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.71 152.13 41.94 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.83 1.687 . . . . 0.0 111.802 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.99 -29.47 75.63 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.597 2.198 . . . . 0.0 112.802 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 49.9 p-10 -64.15 -13.74 50.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.085 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.0 OUTLIER -126.89 -20.79 4.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.464 -0.772 . . . . 0.0 109.945 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.91 133.39 33.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 109.043 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -126.98 132.42 50.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.88 123.38 47.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.372 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.4 132.82 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.53 123.73 34.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 54.13 41.63 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.786 -1.197 . . . . 0.0 109.312 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 67.68 3.97 30.19 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 135.4 42.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.82 125.63 33.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.154 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.8 mt -74.89 139.67 43.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 109.794 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.07 146.95 23.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -72.12 3.82 4.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.122 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.62 46.32 1.11 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.685 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -151.38 172.46 15.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -1.23 . . . . 0.0 109.485 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 63.9 p -111.57 160.89 16.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 110.106 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 mt -60.63 -43.68 97.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.232 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 56.9 p -59.35 -28.35 66.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.38 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.23 -13.1 61.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 109.065 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . 0.584 ' C ' HD21 ' B' ' 260' ' ' ASN . 33.2 m-85 -107.35 5.32 27.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -0.829 . . . . 0.0 109.116 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . 0.584 HD21 ' C ' ' B' ' 259' ' ' TYR . 1.0 OUTLIER 63.03 39.31 10.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 -179.481 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 57.9 mt -92.74 136.36 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 108.987 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . 0.43 ' O ' ' OG ' ' B' ' 265' ' ' SER . 34.6 mt-30 -125.54 175.71 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.765 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.405 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.91 160.65 0.67 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.776 0.798 . . . . 0.0 110.71 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 56.77 13.97 1.63 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.291 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 55.2 m -75.84 146.1 40.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.752 -1.217 . . . . 0.0 108.607 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' THR . . . . . 0.537 ' CG2' ' HZ1' ' B' ' 206' ' ' LYS . 5.5 m -112.31 138.01 49.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 0.0 110.018 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -124.7 138.79 54.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -86.86 140.73 29.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 18.9 tp -110.31 127.71 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.452 -0.78 . . . . 0.0 109.693 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 14.9 t -114.62 129.39 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 47.3 mt -82.27 143.97 30.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.168 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.508 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 31.0 ttt180 -93.63 -138.85 0.21 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.508 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 64.4 mt -123.36 -33.33 3.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.143 -0.973 . . . . 0.0 109.374 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.444 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 31.5 mt -109.03 135.8 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -116.2 125.56 52.43 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -110.99 135.71 20.82 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 109.758 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.9 164.58 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.224 1.949 . . . . 0.0 113.05 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 -2.07 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.568 . . . . 0.0 110.517 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -123.05 10.57 9.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.148 -0.97 . . . . 0.0 110.373 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -113.21 129.85 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.244 -0.91 . . . . 0.0 111.361 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.6 t70 -99.33 140.24 21.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.07 -37.51 3.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.41 2.073 . . . . 0.0 112.723 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.7 tt0 -61.26 -41.01 96.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.861 . . . . 0.0 110.184 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.4 t -80.98 -24.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.0 110.036 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -72.6 -53.58 11.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.993 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -61.29 -15.81 39.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.47 -5.23 59.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.911 -1.118 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.6 151.66 48.29 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 109.819 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.12 152.73 29.28 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.006 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.03 -50.39 70.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.777 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.15 -43.28 51.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.987 -1.071 . . . . 0.0 109.96 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 63.7 t -74.76 -32.12 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.009 -1.057 . . . . 0.0 108.348 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -60.41 -51.74 68.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -55.15 -49.16 72.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.715 . . . . 0.0 109.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -58.45 -36.85 74.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 0.0 110.49 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.74 -39.9 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.749 -1.22 . . . . 0.0 109.831 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.41 -37.86 74.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 108.986 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.1 79.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 108.973 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.84 -36.78 75.84 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -77.47 -12.51 59.97 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.758 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -91.68 -44.02 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.33 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 -60.24 -43.07 96.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.88 -1.138 . . . . 0.0 108.754 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.8 t -84.71 -37.36 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.092 -1.005 . . . . 0.0 108.697 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.755 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.14 165.13 12.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 0.0 110.67 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.95 143.07 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.557 -0.714 . . . . 0.0 109.269 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -95.13 142.48 27.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.56 112.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.548 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.25 131.8 47.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 108.948 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 32.8 p -91.55 -173.75 3.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 110.968 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.5 mt -70.58 -16.21 62.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.229 0.538 . . . . 0.0 109.954 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 9.7 p -99.39 -2.64 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.957 . . . . 0.0 109.614 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.16 1.38 61.14 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.217 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -64.42 116.9 6.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.332 . . . . 0.0 108.675 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.1 m -99.42 136.63 39.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.98 137.04 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.8 m -105.98 118.91 37.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 108.81 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 20.7 mt -124.6 122.18 36.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.388 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -68.29 133.56 48.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.0 m -139.73 -174.24 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.822 -1.173 . . . . 0.0 110.004 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.15 154.56 81.7 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 0.0 109.053 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.81 -21.79 58.7 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.573 2.182 . . . . 0.0 112.013 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 28.0 p -103.31 8.17 38.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.653 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -71.73 142.03 49.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.017 . . . . 0.0 109.497 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.9 p -85.93 145.63 27.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.415 HG21 HD13 ' B' ' 223' ' ' ILE . 36.5 mm -51.62 -21.54 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -37.07 70.06 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.998 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.11 -52.52 34.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.24 -46.32 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 108.548 179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -43.12 72.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.292 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.13 72.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 109.561 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -60.29 -53.29 59.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.023 -1.048 . . . . 0.0 109.122 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.4 mp -59.71 -32.01 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.106 -0.996 . . . . 0.0 108.928 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -63.51 -44.76 93.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.37 -23.54 61.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.444 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -97.66 -51.39 4.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 110.672 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -89.4 -7.97 54.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.03 24.34 76.56 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.497 -1.377 . . . . 0.0 110.577 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 34.0 mt -106.65 131.76 21.45 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.059 -1.259 . . . . 0.0 109.594 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.41 ' HG2' HE21 ' B' ' 240' ' ' GLN . 37.9 Cg_endo -71.15 162.26 43.16 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.204 1.936 . . . . 0.0 112.678 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.94 -34.05 7.0 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.155 2.57 . . . . 0.0 113.131 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.62 -5.98 33.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.28 -0.888 . . . . 0.0 111.152 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.41 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -124.22 -26.18 4.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.252 -0.905 . . . . 0.0 111.356 -179.278 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -88.61 127.74 35.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.283 -1.511 . . . . 0.0 109.23 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -111.96 134.93 53.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.35 126.02 51.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 108.91 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.28 134.92 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.567 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -128.11 110.52 12.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.181 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 67.34 39.4 2.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.328 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.5 2.94 45.85 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.886 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -100.86 137.34 39.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.299 . . . . 0.0 109.689 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.23 122.33 28.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.963 -1.086 . . . . 0.0 109.292 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 41.8 mt -71.95 145.74 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 109.315 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -100.59 144.93 28.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.1 3.69 4.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.413 -0.804 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.58 43.79 1.41 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -150.06 172.08 15.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.145 -1.209 . . . . 0.0 109.325 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.4 p -110.9 159.41 17.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 5.8 mt -56.61 -42.16 78.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.692 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.1 p -61.21 -27.96 68.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.005 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -20.15 63.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -102.78 3.85 37.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.166 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.44 39.34 2.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.582 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.8 mt -92.94 135.53 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.308 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -124.02 176.56 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.12 159.69 1.19 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.978 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.04 28.49 12.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.097 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 12.5 p -91.28 149.65 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.588 -1.32 . . . . 0.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 4.3 m -111.4 135.39 52.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.533 -0.729 . . . . 0.0 109.966 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.7 mp -124.29 140.21 53.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.539 -0.726 . . . . 0.0 109.315 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -88.77 142.01 28.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 13.5 tp -110.74 129.59 55.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.433 -0.792 . . . . 0.0 109.249 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.06 133.09 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.408 -0.808 . . . . 0.0 109.891 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 47.2 mt -80.68 143.19 33.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.558 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 27.4 ttt180 -93.77 -140.02 0.22 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 108.733 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.558 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 67.0 mt -124.65 -54.38 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.416 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.405 ' NE ' ' O ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 109.505 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 tttt . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.418 ' CG2' ' CZ ' ' A' ' 64' ' ' PHE . 35.4 mt -111.57 131.6 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.138 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.0 m -114.87 127.76 55.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.418 ' CZ ' ' CG2' ' A' ' 62' ' ' ILE . 87.4 m-85 -112.79 135.74 21.61 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.9 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.13 164.65 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.34 2.027 . . . . 0.0 112.956 178.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.8 t -67.13 -2.45 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -123.18 9.39 9.23 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.72 128.78 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.14 -0.975 . . . . 0.0 110.951 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.37 139.3 21.36 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.21 -36.42 4.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.404 2.069 . . . . 0.0 112.97 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.82 -40.74 97.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.511 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.1 -23.67 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.68 -1.263 . . . . 0.0 109.559 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.2 t80 -71.7 -54.0 11.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.718 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -61.1 -18.19 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.06 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -82.39 -4.88 58.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.142 . . . . 0.0 109.343 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.6 mt -89.99 151.96 45.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.842 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.98 153.34 32.27 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.318 2.012 . . . . 0.0 111.985 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.13 -49.53 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.698 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.64 -44.38 57.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 -178.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.79 -31.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 108.377 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -61.58 -49.1 77.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -58.8 -48.55 80.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.623 -0.673 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.9 -40.27 75.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 110.051 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.58 -38.1 67.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.882 -1.136 . . . . 0.0 109.741 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.61 -39.18 73.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.713 -1.242 . . . . 0.0 108.996 178.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.135 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' OE2' ' CZ ' ' A' ' 90' ' ' ARG . 18.0 tp10 -73.14 -35.52 66.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.835 . . . . 0.0 108.944 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.436 ' O ' ' CA ' ' A' ' 92' ' ' GLY . 44.1 m0 -74.9 -16.53 60.66 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.846 179.102 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -89.16 -45.37 9.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.582 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' CZ ' ' OE2' ' A' ' 87' ' ' GLU . 14.8 ptt180 -58.36 -41.83 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.865 -1.147 . . . . 0.0 108.821 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 5.4 t -92.3 -36.88 12.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.96 . . . . 0.0 108.599 178.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.446 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.4 ptt? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.42 166.37 10.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.748 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.65 142.92 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.589 -0.694 . . . . 0.0 109.33 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -95.74 143.6 26.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 31.8 t -123.85 109.05 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -0.879 . . . . 0.0 109.808 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . 0.4 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.1 OUTLIER -93.09 135.45 34.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 108.57 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 29.5 p -96.26 -174.9 3.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.243 -0.91 . . . . 0.0 110.867 -178.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 27.5 mt -72.17 -13.86 61.66 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.8 p -99.56 -4.11 31.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.451 -0.781 . . . . 0.0 109.558 -179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.08 1.12 61.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -67.03 119.05 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -1.148 . . . . 0.0 109.118 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.7 m -100.09 135.78 41.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.043 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 43.7 mt -131.25 135.18 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.571 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 33.4 m -104.55 120.28 40.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.416 -0.802 . . . . 0.0 108.886 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 26.1 mt -123.85 119.59 30.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.772 . . . . 0.0 110.017 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -66.83 131.16 45.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.43 -175.57 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 110.065 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.48 154.4 81.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.044 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -58.79 -20.16 50.3 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.599 2.199 . . . . 0.0 112.386 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.4 t -105.24 9.3 34.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.9 142.99 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.98 -1.075 . . . . 0.0 109.433 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 69.6 p -86.46 147.62 25.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 110.144 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mm -51.64 -33.8 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -33.95 73.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -71.44 -51.32 24.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 108.954 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.6 -50.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -50.41 -38.12 41.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.484 0.659 . . . . 0.0 109.265 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.72 84.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -57.9 -53.15 61.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.2 -0.938 . . . . 0.0 109.223 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.7 mp -58.43 -35.23 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.062 -1.024 . . . . 0.0 108.566 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.53 -45.94 90.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 109.743 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -24.12 64.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -100.26 -54.52 2.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.051 -1.031 . . . . 0.0 110.465 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' B' ' 230' ' ' ILE . 27.7 mm-40 -85.89 -5.83 59.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 111.243 -178.629 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.28 27.01 70.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.594 -1.317 . . . . 0.0 110.321 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.99 128.56 26.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -1.205 . . . . 0.0 109.283 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.407 ' HG2' HE21 ' B' ' 240' ' ' GLN . 47.6 Cg_endo -73.77 157.01 48.37 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.892 1.728 . . . . 0.0 111.932 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.54 -30.84 22.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.683 2.256 . . . . 0.0 112.385 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.4 -9.13 22.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.399 -0.813 . . . . 0.0 110.248 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.407 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.9 -20.33 3.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 110.431 -179.669 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.39 133.88 34.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.848 -1.158 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.46 134.95 50.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 109.457 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.38 126.95 52.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 109.638 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.03 133.43 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -128.49 114.54 16.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.124 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 63.06 46.6 4.62 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.781 -1.199 . . . . 0.0 109.075 -179.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.97 6.4 6.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . 0.46 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -103.22 137.55 41.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -1.143 . . . . 0.0 109.537 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -85.81 128.58 34.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.493 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 28.8 mt -80.25 140.38 36.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.417 ' C ' ' H ' ' B' ' 253' ' ' GLY . 11.3 tp10 -90.87 142.62 27.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.588 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.0 OUTLIER -68.75 3.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.474 -0.766 . . . . 0.0 109.791 179.883 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -127.85 40.94 1.66 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.661 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.51 168.38 19.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.279 . . . . 0.0 108.977 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 21.0 p -106.59 157.45 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.1 mt -58.46 -42.36 87.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.012 -179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 40.2 p -61.73 -29.04 69.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.54 -16.93 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.131 -0.981 . . . . 0.0 109.277 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -104.56 2.91 31.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.092 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.55 38.93 2.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.408 -0.807 . . . . 0.0 109.773 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 37.7 mt -91.62 136.41 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.308 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . 0.469 ' O ' ' OG ' ' B' ' 265' ' ' SER . 10.4 mt-30 -122.9 172.78 8.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.581 ' H ' ' HZ3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.89 162.61 0.42 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.963 0.887 . . . . 0.0 110.844 -178.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 54.46 11.08 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.81 177.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 265' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 39.0 m -72.08 144.82 48.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.893 -1.129 . . . . 0.0 108.631 178.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.8 m -111.16 137.08 49.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 110.296 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.3 mp -120.9 162.85 19.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . 0.4 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 79.4 m80 -108.22 137.44 46.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.318 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.0 tp -106.87 123.07 47.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.009 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.6 127.11 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.454 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.5 mt -81.46 142.95 32.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.224 179.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.512 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 24.5 ttt180 -96.94 -136.65 0.25 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.512 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 51.1 mt -124.24 -49.33 1.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.457 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.918 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.7 tttm . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.431 HD12 HG21 ' A' ' 62' ' ' ILE . 38.2 mt -113.45 130.2 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.401 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.0 m -114.7 127.52 55.8 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.416 ' CZ ' ' CG2' ' A' ' 62' ' ' ILE . 81.4 m-85 -111.1 135.21 20.89 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 110.134 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.02 164.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.257 1.971 . . . . 0.0 112.804 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 t -67.85 -2.68 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.67 -0.644 . . . . 0.0 110.508 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -121.37 6.58 10.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.001 . . . . 0.0 110.296 -179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.66 128.21 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.834 -179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.6 t70 -99.56 140.04 21.31 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.73 -48.73 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.425 2.084 . . . . 0.0 112.196 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.1 tt0 -48.2 -44.19 32.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.698 -0.626 . . . . 0.0 110.228 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.27 -23.5 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.006 -1.059 . . . . 0.0 110.439 -179.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.412 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 25.4 t80 -72.11 -53.01 14.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 110.918 -178.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -62.71 -17.36 60.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.24 -7.32 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.863 -1.148 . . . . 0.0 109.749 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.84 152.39 46.57 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.41 154.58 29.1 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.455 2.103 . . . . 0.0 111.922 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -62.99 -49.03 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -44.75 54.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.951 -1.093 . . . . 0.0 110.24 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -74.73 -29.94 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.023 -1.048 . . . . 0.0 108.426 178.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.5 tt0 -61.53 -51.65 67.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -56.88 -49.29 75.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -56.69 -37.62 71.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.107 -0.995 . . . . 0.0 110.451 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.2 mt -74.8 -36.98 62.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.865 -1.147 . . . . 0.0 109.886 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -71.01 -39.77 72.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.844 -1.16 . . . . 0.0 109.049 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.71 75.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.932 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -70.42 -38.21 74.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -76.8 -11.7 59.87 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.947 -1.096 . . . . 0.0 108.886 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -90.66 -46.19 8.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.2 -0.938 . . . . 0.0 109.142 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -56.68 -39.76 74.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.975 -1.078 . . . . 0.0 108.661 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 t -90.06 -37.62 14.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.142 179.023 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.46 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.96 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.19 165.83 11.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.094 -1.004 . . . . 0.0 110.572 -178.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 145.33 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.593 -0.692 . . . . 0.0 109.681 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.0 m-30 -94.02 139.97 30.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 109.035 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.91 106.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -92.63 134.89 34.57 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.322 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 44.4 p -94.58 -177.4 4.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 110.541 -178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 53.5 mt -72.51 -12.12 60.95 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.81 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.7 p -100.95 -3.03 30.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.63 -1.44 63.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -66.07 119.73 11.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.986 -1.302 . . . . 0.0 108.843 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 27.7 m -100.82 137.81 38.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 57.2 mt -133.58 136.82 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 109.329 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 18.2 m -104.86 119.37 38.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 108.681 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 19.2 mt -123.16 120.08 32.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -66.36 132.87 49.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.513 -0.742 . . . . 0.0 109.065 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.75 -176.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.87 -1.144 . . . . 0.0 110.01 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -134.09 154.06 79.96 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.5 -26.85 65.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.598 2.199 . . . . 0.0 112.328 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 t -97.65 7.18 46.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.3 140.67 48.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.079 -1.013 . . . . 0.0 109.34 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 38.5 p -85.92 146.72 26.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 29.2 mm -51.8 -27.25 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 109.206 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.22 -29.24 67.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.729 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -75.44 -51.15 13.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.72 -47.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -51.99 -46.55 64.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.43 70.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.621 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 21.5 mtpp -55.95 -53.65 54.3 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.2 -34.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.035 . . . . 0.0 109.257 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.08 -53.4 55.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.933 -1.104 . . . . 0.0 109.852 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.25 -29.54 67.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.558 -178.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -95.92 -57.86 2.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.021 -1.049 . . . . 0.0 110.666 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' B' ' 230' ' ' ILE . 68.4 mm-40 -84.09 -5.36 59.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 111.509 -178.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.14 24.83 70.66 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 120.524 -1.36 . . . . 0.0 110.462 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.7 mt -104.21 128.48 27.0 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.026 -1.279 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . 0.401 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.5 Cg_endo -75.71 156.48 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.124 1.883 . . . . 0.0 111.914 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.51 -29.19 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.724 2.283 . . . . 0.0 112.951 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -65.21 -15.51 62.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.401 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.8 -22.47 5.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.481 -179.536 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.585 -1.322 . . . . 0.0 108.964 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -125.51 132.52 52.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -0.842 . . . . 0.0 109.807 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.36 125.45 51.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.303 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 60.5 mt -120.29 136.17 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -131.6 114.3 14.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.4 -0.813 . . . . 0.0 109.327 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.21 39.26 5.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.01 -1.057 . . . . 0.0 109.323 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.79 15.97 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -97.65 138.29 35.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.318 . . . . 0.0 109.702 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -83.47 128.3 34.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.985 . . . . 0.0 109.244 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.2 mt -78.32 137.29 37.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.029 -1.045 . . . . 0.0 109.326 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.53 146.46 23.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.027 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.18 3.95 3.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.074 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.19 40.04 2.09 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.624 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -147.41 151.35 36.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.113 -1.228 . . . . 0.0 109.272 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.8 p -91.16 161.61 15.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.13 -42.38 80.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.718 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 77.4 p -60.98 -28.35 68.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 109.75 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -70.73 -13.23 61.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.164 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -109.9 2.39 19.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.444 -0.785 . . . . 0.0 109.268 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.39 39.61 5.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.471 -0.768 . . . . 0.0 109.253 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.0 mt -92.79 98.45 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . 0.419 ' O ' ' OG ' ' B' ' 265' ' ' SER . 17.3 mt-30 -87.37 174.81 8.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.052 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.484 ' H ' ' HZ3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.1 165.39 0.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.0 0.905 . . . . 0.0 111.262 -178.879 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 55.57 11.58 0.65 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.913 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 265' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 43.0 m -74.97 148.38 40.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.631 179.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 22.2 m -115.14 138.19 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.502 -0.748 . . . . 0.0 109.8 -179.471 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.2 mp -121.3 166.41 14.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.2 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -113.04 138.96 49.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.637 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 9.4 tp -107.99 124.47 50.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.444 -0.785 . . . . 0.0 109.242 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.43 130.26 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.7 mt -79.0 142.67 36.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.237 -0.914 . . . . 0.0 108.937 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.483 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 17.4 ttt180 -94.44 -141.27 0.24 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.483 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 82.2 mt -124.65 -51.74 1.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.514 -0.741 . . . . 0.0 109.52 179.754 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.5 mt -112.14 129.42 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 110.022 -179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.8 m -112.84 126.08 55.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -111.54 134.4 21.23 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.387 -0.82 . . . . 0.0 109.504 -179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.95 164.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.404 2.07 . . . . 0.0 112.967 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -2.48 7.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.851 -0.53 . . . . 0.0 110.652 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.19 7.12 10.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.0 110.114 -179.486 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 68' ' ' ILE . 28.2 mm -109.97 128.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 111.178 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.69 138.73 20.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 -31.18 14.97 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.303 2.002 . . . . 0.0 113.112 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.72 -38.91 77.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.6 t -79.77 -23.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.821 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.3 t80 -73.4 -54.75 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 111.105 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -61.87 -14.93 38.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.989 -1.069 . . . . 0.0 109.842 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -84.35 -7.65 59.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.995 -1.065 . . . . 0.0 109.876 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 95.4 mt -87.77 151.43 49.99 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 109.532 -179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' GLU . 10.8 Cg_endo -56.66 128.38 29.77 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.299 1.999 . . . . 0.0 112.172 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' PRO . 28.9 tt0 -40.24 -47.96 2.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.451 -0.78 . . . . 0.0 110.688 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.97 -45.36 51.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.8 -1.187 . . . . 0.0 109.829 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 86.9 t -74.6 -30.27 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 108.594 178.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.409 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.76 -50.95 71.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -58.29 -47.82 82.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.574 -0.704 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -57.81 -39.66 78.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 110.044 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.4 -36.18 65.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.95 -1.094 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.61 -38.94 74.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.76 -1.213 . . . . 0.0 108.883 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.95 74.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.06 -36.21 66.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 108.863 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.4 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 45.1 m0 -75.88 -18.63 59.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.117 -0.989 . . . . 0.0 108.702 178.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -92.55 -41.56 10.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -0.797 . . . . 0.0 109.527 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' CG ' ' N ' ' A' ' 91' ' ' THR . 10.5 ptm180 -59.13 -43.41 91.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.885 -1.134 . . . . 0.0 108.343 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.49 ' N ' ' CG ' ' A' ' 90' ' ' ARG . 6.1 t -88.16 -37.5 16.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.238 -0.914 . . . . 0.0 108.625 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -98.9 167.01 11.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.02 144.13 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.5 m-30 -94.07 138.99 31.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.98 108.82 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.471 -0.768 . . . . 0.0 109.081 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -95.84 137.77 34.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 43.7 p -99.22 -175.1 2.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.997 . . . . 0.0 110.662 -178.837 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.96 -9.47 58.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.608 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 16.2 p -102.83 -4.12 25.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.89 . . . . 0.0 109.397 179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.0 1.45 63.06 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -66.86 118.88 10.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -1.173 . . . . 0.0 108.831 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.6 m -101.42 139.54 36.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 50.2 mt -135.02 136.85 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.382 -179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 8.7 m -105.02 118.94 37.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 0.0 108.928 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.51 120.56 34.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.943 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.99 132.08 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 12.2 m -139.6 -175.32 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.08 . . . . 0.0 109.864 -179.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -134.27 154.98 80.26 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.451 -0.781 . . . . 0.0 109.046 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.65 -21.38 46.84 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.51 2.14 . . . . 0.0 112.207 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.4 7.51 38.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.238 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.84 142.12 49.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.865 -1.147 . . . . 0.0 109.389 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.3 p -87.12 145.36 26.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 109.814 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . 0.413 HD13 HG22 ' B' ' 223' ' ' ILE . 34.3 mm -51.57 -22.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 109.054 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . 0.434 ' O ' ' CD ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -70.06 -35.47 74.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.408 -0.808 . . . . 0.0 109.011 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -72.38 -49.88 30.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 45.5 t -52.21 -51.85 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.043 -1.036 . . . . 0.0 108.775 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -50.68 -41.01 55.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.547 -0.72 . . . . 0.0 109.482 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.07 83.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.222 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -55.91 -53.6 54.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.332 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . 0.403 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.03 -35.0 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 0.0 109.2 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.18 -39.21 91.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.993 . . . . 0.0 109.773 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.07 -28.25 62.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -98.02 -54.15 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.049 . . . . 0.0 110.668 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' B' ' 230' ' ' ILE . 75.7 mm-40 -83.84 -8.73 59.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.12 -0.988 . . . . 0.0 111.254 -178.508 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.65 73.64 Favored Glycine 0 N--CA 1.493 2.451 0 O-C-N 120.526 -1.359 . . . . 0.0 110.513 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.9 mt -105.22 132.17 21.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.116 -1.226 . . . . 0.0 109.266 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -71.25 161.64 45.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.216 1.944 . . . . 0.0 112.617 -179.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.61 -34.66 8.91 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.158 2.572 . . . . 0.0 113.467 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -71.14 -5.92 35.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.998 -1.064 . . . . 0.0 111.534 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.26 -26.74 4.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.227 -0.921 . . . . 0.0 110.718 -179.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -88.96 132.63 34.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.431 -1.418 . . . . 0.0 109.156 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -117.95 135.31 54.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 109.682 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.06 124.51 49.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.078 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 92.4 mt -118.81 135.14 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.608 -0.682 . . . . 0.0 109.392 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -131.36 114.6 15.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.023 -179.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.26 39.04 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.006 -1.059 . . . . 0.0 109.355 -179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.23 17.67 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.853 178.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -100.34 138.58 37.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.285 . . . . 0.0 109.68 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -84.04 125.93 32.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 109.527 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 39.8 mt -73.26 145.09 46.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.21 -0.931 . . . . 0.0 109.094 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . 0.447 ' H ' ' HH ' ' B' ' 259' ' ' TYR . 12.9 tt0 -101.09 146.89 26.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.931 -179.561 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.64 3.78 4.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.335 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -120.18 32.85 4.76 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.648 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -142.42 170.3 15.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.989 -1.301 . . . . 0.0 109.628 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.3 p -110.27 160.97 16.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 0.0 110.135 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.8 mt -58.15 -44.08 87.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.7 p -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.427 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.31 -12.02 60.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . 0.656 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 28.1 m-85 -108.12 4.81 25.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' B' ' 259' ' ' TYR . 0.2 OUTLIER 64.21 36.49 9.41 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.092 0.948 . . . . 0.0 109.911 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 90.7 mt -89.73 134.42 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.263 . . . . 0.0 109.075 178.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -123.19 174.33 7.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 158.58 1.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.42 -0.8 . . . . 0.0 110.724 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER 57.21 11.37 1.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.427 179.242 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 4.2 m -72.42 144.88 47.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.947 -1.095 . . . . 0.0 108.352 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 26.4 m -111.71 136.9 50.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 -179.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.66 166.29 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -112.78 137.94 50.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.678 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 16.5 tp -108.1 125.19 51.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.236 179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.22 130.41 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.713 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.39 140.47 37.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.264 -0.897 . . . . 0.0 109.226 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.489 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 21.0 ttt180 -92.09 -141.87 0.19 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.339 -0.851 . . . . 0.0 108.731 -179.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.489 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 78.4 mt -124.62 -41.36 2.15 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.51 -0.744 . . . . 0.0 109.13 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.338 0.59 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.433 HG21 HD13 ' A' ' 62' ' ' ILE . 30.8 mt -124.41 133.42 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.613 -0.679 . . . . 0.0 110.525 -179.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.1 m -117.56 128.28 54.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -113.82 134.43 22.09 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 109.977 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.32 165.37 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.268 1.979 . . . . 0.0 113.026 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.7 t -67.98 -2.72 8.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.728 -0.608 . . . . 0.0 110.78 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.426 ' O ' ' CG2' ' B' ' 209' ' ' THR . 76.3 m-20 -121.54 3.36 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.984 -1.073 . . . . 0.0 110.408 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mm -105.89 129.57 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.157 -0.964 . . . . 0.0 110.432 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.5 t70 -98.18 139.05 20.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 -36.97 7.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.497 2.131 . . . . 0.0 112.693 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 24.1 tt0 -60.75 -42.48 97.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.476 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 36.7 t -80.9 -24.17 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 110.566 -179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.3 t80 -69.83 -54.1 15.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.992 -1.067 . . . . 0.0 110.706 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -62.36 -16.65 55.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.748 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.47 -7.11 58.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.603 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.3 mt -91.35 152.08 43.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 -179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.51 156.45 17.82 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.304 2.003 . . . . 0.0 111.932 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.53 -51.49 67.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 110.648 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -43.79 36.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -178.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -31.77 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 108.807 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.0 tt0 -60.25 -49.35 77.96 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -58.93 -48.43 81.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.52 -0.737 . . . . 0.0 110.158 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -57.7 -41.48 81.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.049 -1.032 . . . . 0.0 110.496 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.27 -38.82 75.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.827 -1.17 . . . . 0.0 109.817 -179.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.7 mt -68.79 -37.52 79.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.769 -1.207 . . . . 0.0 108.922 178.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.84 76.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 108.954 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -68.69 -39.43 80.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 108.9 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -74.9 -12.71 60.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.062 -1.023 . . . . 0.0 109.099 179.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -92.0 -45.54 8.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.935 . . . . 0.0 109.406 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -57.24 -40.89 78.5 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.809 -1.182 . . . . 0.0 108.201 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 92' ' ' GLY . 13.7 t -89.16 -36.62 15.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 108.801 178.872 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.92 11.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.955 . . . . 0.0 110.588 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.45 144.07 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.464 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . 0.418 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 3.0 m-30 -94.38 142.44 27.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 109.357 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.29 112.04 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.315 -0.866 . . . . 0.0 109.684 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 131.27 43.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 108.725 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 28.0 p -91.29 -175.64 4.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -178.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 24.7 mt -71.85 -11.47 60.81 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.218 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 209' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 11.2 p -101.49 -2.55 30.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.802 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.47 0.06 63.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -66.02 118.91 10.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -1.181 . . . . 0.0 109.066 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.96 131.01 47.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.341 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.08 134.24 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.488 -0.757 . . . . 0.0 109.501 -179.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 24.9 m -103.3 122.97 45.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 24.7 mt -125.95 121.71 33.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.377 -0.827 . . . . 0.0 110.319 -179.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.9 130.15 42.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.49 -174.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.059 -1.025 . . . . 0.0 109.881 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -137.35 154.61 75.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.67 -23.56 41.38 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.491 2.127 . . . . 0.0 112.307 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 95.3 p -101.2 7.26 43.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.015 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.01 141.48 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.954 -1.092 . . . . 0.0 109.354 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 59.8 p -85.43 149.05 25.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.178 -0.951 . . . . 0.0 109.969 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.7 -40.7 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 109.513 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -56.86 -33.85 67.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.584 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.19 -52.92 28.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 108.897 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.6 t -52.6 -49.15 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.82 -42.35 58.3 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.526 0.679 . . . . 0.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.32 83.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -56.42 -53.19 60.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.086 -1.008 . . . . 0.0 109.378 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.97 -32.92 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 109.22 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -62.71 -44.11 97.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.88 -27.13 61.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.979 -1.075 . . . . 0.0 110.439 -179.151 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -93.52 -50.38 5.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.026 -1.046 . . . . 0.0 110.375 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.33 -7.29 51.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.196 -0.94 . . . . 0.0 111.441 -178.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.47 23.27 76.59 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.382 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . 0.423 HG22 HD13 ' B' ' 236' ' ' ILE . 67.7 mt -102.83 124.07 40.1 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.144 -1.209 . . . . 0.0 109.348 179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.4 155.41 41.09 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.027 1.818 . . . . 0.0 112.04 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.79 -30.36 49.86 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.729 2.286 . . . . 0.0 112.961 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.24 -8.92 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -18.15 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.222 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.64 139.31 30.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.97 -1.081 . . . . 0.0 109.57 -179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -130.64 133.45 46.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.785 . . . . 0.0 109.093 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.3 mt -106.01 125.97 51.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 58.9 mt -120.84 135.63 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.61 -0.681 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -129.65 122.81 29.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 108.806 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.93 45.83 23.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.27 0.77 4.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -98.07 134.75 40.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.318 . . . . 0.0 109.44 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -85.02 123.17 30.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.41 144.2 49.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -96.93 144.58 26.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.99 3.42 3.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 109.729 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.44 44.03 1.33 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.481 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . 0.615 HH11 ' HH ' ' B' ' 259' ' ' TYR . 4.2 mtt180 -148.08 172.57 14.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -1.218 . . . . 0.0 109.56 179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.6 p -110.84 159.52 17.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.195 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 mt -59.23 -43.09 92.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.654 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.0 p -60.57 -29.33 69.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.669 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.03 -14.24 62.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.15 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . 0.615 ' HH ' HH11 ' B' ' 254' ' ' ARG . 26.1 m-85 -107.65 2.25 23.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.0 109.278 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.68 39.5 2.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -0.823 . . . . 0.0 109.877 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.16 135.7 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -124.44 175.98 6.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.481 -0.762 . . . . 0.0 109.569 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.417 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.62 162.33 0.4 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.852 0.835 . . . . 0.0 110.908 -178.877 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 55.35 11.23 0.55 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.891 177.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.6 m -72.26 144.13 48.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.862 -1.149 . . . . 0.0 108.538 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -110.73 134.92 52.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.019 -179.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 11.1 mp -120.92 158.07 28.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.773 . . . . 0.0 109.182 179.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 64.6 m80 -105.72 138.22 42.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.9 tp -106.88 124.15 49.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 108.941 179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.36 127.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 36.8 mt -80.99 142.14 33.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.273 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.557 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 19.3 ttt-85 -91.06 -141.38 0.17 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.557 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 57.3 mt -123.66 -27.83 3.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.576 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.742 0.782 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.43 ' CG2' ' CZ ' ' A' ' 64' ' ' PHE . 35.2 mt -118.07 134.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.508 0.671 . . . . 0.0 110.364 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.2 m -114.75 127.4 55.72 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.43 ' CZ ' ' CG2' ' A' ' 62' ' ' ILE . 79.1 m-85 -113.58 135.97 21.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 110.423 -178.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -47.57 165.27 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.497 2.131 . . . . 0.0 112.859 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.496 ' H ' ' HG ' ' A' ' 66' ' ' SER . 0.3 OUTLIER -68.4 -1.93 7.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.648 . . . . 0.0 110.719 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.43 ' O ' ' CG2' ' B' ' 209' ' ' THR . 39.3 m-20 -122.37 6.9 9.59 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.2 mm -110.54 130.49 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.381 -0.824 . . . . 0.0 110.756 -179.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.5 139.35 20.56 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.54 -45.83 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.441 2.094 . . . . 0.0 112.295 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -47.35 -48.56 25.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.701 -0.625 . . . . 0.0 110.814 -179.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.27 -26.82 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.856 -1.152 . . . . 0.0 110.71 -179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -65.73 -52.85 47.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.031 -1.043 . . . . 0.0 110.912 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -62.33 -18.46 61.48 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -81.34 -5.72 58.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.863 -1.148 . . . . 0.0 109.558 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 94.0 mt -89.96 151.86 45.7 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.24 156.26 21.61 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.342 2.028 . . . . 0.0 111.887 179.44 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.38 -52.45 61.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.48 -43.87 24.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -178.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.1 t -74.82 -31.52 26.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 108.639 178.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.8 tt0 -60.2 -50.83 72.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -57.27 -48.71 78.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -58.12 -43.57 87.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.076 -1.015 . . . . 0.0 110.612 -178.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.24 -37.34 77.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.914 -1.116 . . . . 0.0 109.739 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 mt -70.62 -37.21 73.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 108.829 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.21 71.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.01 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -75.97 -38.95 56.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 109.121 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.2 m0 -76.57 -17.86 58.98 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.015 -1.053 . . . . 0.0 108.95 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -92.62 -46.04 7.79 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.324 -0.86 . . . . 0.0 109.094 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' CG ' ' N ' ' A' ' 91' ' ' THR . 7.7 ptm180 -53.78 -40.07 65.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.931 -1.105 . . . . 0.0 108.332 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 92' ' ' GLY . 3.0 t -93.46 -36.37 12.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 108.944 178.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.477 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.9 ptt? . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.63 164.72 12.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 -179.276 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -144.63 142.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.311 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -94.41 143.08 26.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.892 . . . . 0.0 109.731 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.5 t -122.02 109.85 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.46 127.49 42.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 23.9 p -87.91 -175.56 5.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 111.065 -178.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 23.7 mt -71.68 -16.3 62.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.414 0.626 . . . . 0.0 109.347 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 209' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 67' ' ' ASP . 9.5 p -98.15 -4.41 35.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.48 2.4 57.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -66.55 117.1 8.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.245 . . . . 0.0 109.106 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.57 132.85 45.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -130.55 136.79 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.427 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 60.8 m -105.5 121.07 43.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 17.5 mt -125.4 121.88 35.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 110.268 -179.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.15 133.22 48.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.645 . . . . 0.0 109.417 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.6 m -140.19 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.911 -1.118 . . . . 0.0 109.753 179.65 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -136.53 152.84 75.47 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.209 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.26 -26.96 54.63 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.565 2.177 . . . . 0.0 112.271 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.5 p -99.38 5.99 46.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.03 143.38 50.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 70.4 p -87.09 147.13 25.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.729 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.8 mm -52.78 -42.47 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -52.09 -32.04 33.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -73.38 -53.11 11.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.011 -1.055 . . . . 0.0 109.223 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 39.1 t -52.49 -42.18 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.959 . . . . 0.0 108.599 179.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . 0.518 ' NZ ' ' OD1' ' B' ' 252' ' ' ASP . 6.1 ttmt -58.48 -42.47 87.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.19 -33.47 73.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.721 . . . . 0.0 109.264 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -58.63 -53.16 61.5 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 108.94 179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.9 mp -59.99 -32.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.41 -45.11 94.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.03 . . . . 0.0 110.025 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -73.32 -23.86 60.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -179.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -95.36 -50.59 4.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 110.039 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -91.86 -5.74 52.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 111.44 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.11 22.86 71.04 Favored Glycine 0 N--CA 1.492 2.4 0 O-C-N 120.53 -1.356 . . . . 0.0 110.371 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 62.3 mt -101.66 130.45 24.59 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 0.0 109.403 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.04 156.7 47.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.051 1.834 . . . . 0.0 111.949 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.47 -31.94 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.734 2.289 . . . . 0.0 112.785 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -66.95 -7.16 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 110.061 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -22.33 3.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.83 138.15 31.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.687 -1.258 . . . . 0.0 108.93 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -128.54 132.99 48.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.859 . . . . 0.0 109.654 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -105.5 125.85 51.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 109.174 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.17 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.597 -0.69 . . . . 0.0 109.505 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -127.84 112.62 14.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 0.0 109.149 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.56 40.68 5.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.041 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.74 17.06 66.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.4 ptmm? -112.18 135.52 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -1.153 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.32 125.75 33.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.037 -1.039 . . . . 0.0 109.53 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.28 143.99 33.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.624 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.33 147.2 28.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . 0.518 ' OD1' ' NZ ' ' B' ' 227' ' ' LYS . 18.0 m-20 -69.72 3.37 2.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.929 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.83 42.2 1.84 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.855 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -150.51 172.89 14.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.078 -1.248 . . . . 0.0 109.475 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.0 p -113.28 157.39 21.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 110.198 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 6.8 mt -56.12 -43.63 78.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.271 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 67.9 p -60.49 -28.97 68.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -16.75 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 108.819 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -106.52 0.99 25.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.482 -0.761 . . . . 0.0 108.983 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' B' ' 260' ' ' ASN . 0.9 OUTLIER 66.33 39.42 4.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -0.78 . . . . 0.0 109.879 179.843 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.04 138.34 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.69 175.37 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.63 161.14 1.13 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.862 0.839 . . . . 0.0 110.913 -179.073 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 58.17 10.54 1.27 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.328 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.1 m -75.35 149.69 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.891 -1.131 . . . . 0.0 108.682 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 10.3 m -114.32 137.41 51.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.468 -0.77 . . . . 0.0 110.071 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 10.8 mp -124.44 139.62 53.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -0.81 . . . . 0.0 109.423 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -88.89 142.6 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.91 -179.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.42 126.96 54.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.152 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.4 t -113.96 128.61 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 50.1 mt -82.03 143.91 31.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.51 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 27.9 ttt180 -96.05 -135.78 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . 0.51 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 49.2 mt -122.86 -26.98 4.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 108.992 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.57 ' C ' ' NE ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.089 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.1 164.84 0.23 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.227 1.951 . . . . 0.0 112.75 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -2.12 6.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.735 -0.603 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.832 ' O ' HG22 ' B' ' 209' ' ' THR . 5.3 m-20 -122.46 11.65 9.97 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.171 -0.956 . . . . 0.0 110.591 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 68' ' ' ILE . 31.6 mm -114.36 130.32 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.232 -0.917 . . . . 0.0 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.26 138.16 20.5 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.75 -33.65 9.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.142 1.895 . . . . 0.0 113.072 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -43.0 99.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.863 . . . . 0.0 110.679 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.63 HG11 ' O ' ' B' ' 207' ' ' THR . 61.8 t -80.32 -23.81 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.704 -1.247 . . . . 0.0 109.878 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -68.29 -54.83 14.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.852 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -60.82 -15.25 28.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.42 -6.47 59.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.68 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' B' ' 268' ' ' HIS . 90.4 mt -90.03 151.98 45.7 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.189 -0.945 . . . . 0.0 109.559 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.74 154.79 24.54 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.267 1.978 . . . . 0.0 111.961 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -62.73 -52.17 64.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 110.584 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.02 -44.09 30.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.968 -1.082 . . . . 0.0 110.036 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.521 HG11 HG21 ' B' ' 270' ' ' VAL . 67.2 t -74.93 -32.19 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.937 -1.102 . . . . 0.0 108.489 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.3 tt0 -60.51 -50.03 75.17 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -57.56 -48.7 78.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.59 -0.694 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -56.68 -41.64 77.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.024 -1.047 . . . . 0.0 110.064 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.93 -38.46 69.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.074 -1.016 . . . . 0.0 109.786 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.53 -39.59 77.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.69 -1.256 . . . . 0.0 109.024 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.119 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -74.61 -38.11 62.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.407 ' CH2' HG21 ' A' ' 68' ' ' ILE . 42.4 m0 . . . . . 0 C--N 1.303 -1.43 0 O-C-N 121.013 -1.054 . . . . 0.0 108.865 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -97.57 163.06 13.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.465 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.523 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.1 pp -144.36 143.53 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.31 141.68 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.54 108.53 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.401 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.4 OUTLIER -93.54 131.04 39.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 108.822 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.63 ' O ' HG11 ' A' ' 72' ' ' VAL . 24.1 p -90.57 -175.82 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.102 -0.999 . . . . 0.0 110.676 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.579 HD11 ' H ' ' B' ' 271' ' ' LEU . 35.4 mt -70.71 -20.71 62.64 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.463 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.1 p -94.25 -4.08 49.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.725 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.28 5.89 56.91 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.367 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -69.8 118.89 13.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.966 -1.314 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 134.39 44.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 35.4 mt -131.07 136.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.866 . . . . 0.0 109.635 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -105.69 114.58 28.83 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.614 HD13 ' CB ' ' B' ' 229' ' ' LYS . 21.2 mt -118.54 123.64 45.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 110.4 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.59 132.17 46.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.7 m -139.79 -170.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.919 -1.113 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.13 152.84 76.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.033 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.74 -20.03 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.381 2.054 . . . . 0.0 111.943 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 17.7 m -105.2 7.57 33.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -70.29 141.86 52.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.045 -1.034 . . . . 0.0 109.408 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.9 p -86.29 148.8 25.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.958 . . . . 0.0 110.099 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.459 HD12 HD13 ' B' ' 250' ' ' LEU . 41.3 mm -54.23 -35.46 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -60.14 -30.22 69.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.723 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -74.29 -51.33 15.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.084 -1.01 . . . . 0.0 109.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.98 -47.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 108.809 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -54.2 -42.22 69.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 0.0 109.442 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.85 76.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.614 ' CB ' HD13 ' B' ' 215' ' ' LEU . 5.2 mtpm? -57.66 -53.92 52.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.074 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.512 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.5 mp -58.52 -32.12 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.911 . . . . 0.0 108.781 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -63.27 -49.57 73.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.059 -1.025 . . . . 0.0 109.734 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -23.6 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.056 -1.028 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -98.72 -53.15 3.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -88.69 -8.22 54.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 0.0 111.317 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 22.58 76.1 Favored Glycine 0 N--CA 1.493 2.493 0 O-C-N 120.567 -1.333 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 22.5 mt -100.86 131.13 23.85 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.992 -1.299 . . . . 0.0 109.087 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.11 160.27 39.98 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.045 1.83 . . . . 0.0 112.549 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.5 -34.43 15.45 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.288 2.658 . . . . 0.0 113.486 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' B' ' 239' ' ' ASP . 4.0 p30 -69.89 -5.44 25.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.998 . . . . 0.0 111.501 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -25.83 3.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 111.315 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -88.55 144.7 26.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.235 -1.541 . . . . 0.0 109.418 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -129.32 134.05 47.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 109.663 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.65 126.14 51.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.508 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.35 135.75 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 50.5 t80 -130.59 114.12 15.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.313 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.25 39.05 7.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.54 12.52 66.96 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.846 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.443 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.5 ptmm? -111.68 136.78 50.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -1.155 . . . . 0.0 109.674 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -83.57 122.74 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 109.218 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.459 HD13 HD12 ' B' ' 223' ' ' ILE . 38.9 mt -69.86 144.31 52.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 37.3 tt0 -100.89 147.0 26.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.997 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -73.4 3.71 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.431 -0.793 . . . . 0.0 109.649 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 253' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -121.93 41.68 1.81 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -150.18 172.07 15.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.293 . . . . 0.0 109.539 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 68.2 p -111.9 162.13 15.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -0.79 . . . . 0.0 109.883 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.473 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.8 mt -58.12 -43.91 87.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.811 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 73.1 p -59.9 -27.69 66.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -25.74 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.687 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -96.73 5.55 50.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.217 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.9 38.18 2.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.53 136.7 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.146 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.47 175.28 7.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.916 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.604 ' H ' ' NZ ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.81 160.24 1.45 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.739 0.781 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 56.4 9.9 0.59 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.406 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.523 ' OG ' HG22 ' B' ' 203' ' ' ILE . 16.1 p -73.61 146.86 44.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.008 -1.058 . . . . 0.0 108.367 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.742 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.4 m -114.06 139.38 49.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.539 -0.726 . . . . 0.0 109.913 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.742 HD12 ' C ' ' B' ' 266' ' ' THR . 11.2 mp -121.14 165.92 14.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.409 ' HB3' HD21 ' A' ' 76' ' ' LEU . 79.8 m80 -113.1 139.27 48.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.466 -0.771 . . . . 0.0 109.191 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.03 125.15 51.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 109.513 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.521 HG21 HG11 ' A' ' 80' ' ' VAL . 2.5 t -113.52 129.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.579 ' H ' HD11 ' B' ' 208' ' ' LEU . 39.2 mt -83.23 142.44 31.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.167 -0.958 . . . . 0.0 109.992 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.781 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.22 164.3 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.287 1.992 . . . . 0.0 113.0 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.9 m -67.66 -1.91 6.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 110.296 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.924 ' O ' HG22 ' B' ' 209' ' ' THR . 2.3 m-20 -123.01 7.87 9.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.26 -0.9 . . . . 0.0 110.782 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.3 mm -108.65 128.74 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.06 . . . . 0.0 110.81 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.77 109.67 58.44 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -47.32 -45.07 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.252 1.968 . . . . 0.0 112.539 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -49.69 -48.21 49.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 110.313 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.16 -24.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.796 -1.19 . . . . 0.0 108.902 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.1 t80 -67.99 -52.86 30.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 110.922 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -18.85 62.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -83.15 -5.41 59.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.75 151.99 46.26 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.945 . . . . 0.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.51 153.02 24.59 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.536 2.157 . . . . 0.0 112.099 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.98 -50.9 68.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 110.635 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.69 -43.9 37.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.942 -1.099 . . . . 0.0 109.838 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.6 t -75.01 -33.59 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 108.763 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -58.96 -49.97 75.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -58.9 -49.71 76.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 110.237 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -56.18 -42.3 76.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.076 -1.015 . . . . 0.0 110.412 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.41 -36.99 74.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.148 . . . . 0.0 109.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.5 -38.27 74.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.716 -1.24 . . . . 0.0 109.102 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.23 73.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 108.862 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -72.82 -37.74 67.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.4 m0 . . . . . 0 C--N 1.301 -1.517 0 O-C-N 120.999 -1.063 . . . . 0.0 108.933 179.213 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -95.85 162.73 13.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 110.39 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.2 145.81 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.618 -0.677 . . . . 0.0 109.36 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -99.34 144.07 28.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.51 112.18 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.851 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.1 OUTLIER -96.71 131.64 43.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 108.846 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.8 p -92.0 177.12 6.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 110.65 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.627 HD11 ' H ' ' B' ' 271' ' ' LEU . 29.9 mt -64.03 -11.16 26.65 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.497 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.924 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.1 p -102.53 -3.37 26.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.09 -0.2 64.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -65.74 118.93 10.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.249 . . . . 0.0 108.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.4 m -100.17 137.93 37.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.937 . . . . 0.0 109.159 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' B' ' 234' ' ' GLU . 26.6 mt -134.09 136.26 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.19 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 44.1 m -105.04 119.56 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 108.948 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.1 mt -121.98 121.88 38.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -0.766 . . . . 0.0 110.058 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.82 132.37 47.27 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.8 m -139.8 -172.11 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.907 -1.121 . . . . 0.0 109.979 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -135.99 155.02 77.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.32 -19.08 26.75 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.528 2.152 . . . . 0.0 112.165 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.58 8.99 29.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.158 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.0 141.53 50.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.875 -1.141 . . . . 0.0 109.379 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 22.5 p -85.99 144.55 27.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.81 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.56 -33.66 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 108.899 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -62.42 -30.94 71.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.205 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -73.96 -52.4 12.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 108.905 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 31.6 t -52.3 -47.76 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -51.48 -43.05 62.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.477 0.656 . . . . 0.0 109.292 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.54 80.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.556 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.3 mtpp -56.51 -53.85 52.67 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.03 -1.044 . . . . 0.0 109.351 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.7 mp -58.16 -34.43 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 108.908 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -62.75 -49.66 74.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 0.0 109.748 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -22.9 66.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.42 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -100.11 -59.92 1.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.004 -1.06 . . . . 0.0 110.17 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' B' ' 213' ' ' ILE . 77.9 mm-40 -79.78 -6.6 57.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.977 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.82 25.7 71.92 Favored Glycine 0 N--CA 1.492 2.432 0 O-C-N 120.544 -1.348 . . . . 0.0 110.358 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.61 133.87 20.05 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.155 -1.203 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.05 153.14 52.04 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.45 2.1 . . . . 0.0 112.024 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.19 -34.06 10.6 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.676 2.251 . . . . 0.0 113.272 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.1 -7.95 27.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.498 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.25 -14.24 5.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.465 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -95.78 136.18 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.755 -1.215 . . . . 0.0 108.362 178.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.426 ' HE ' ' HD2' ' B' ' 272' ' ' ARG . 78.0 mtt180 -125.22 134.97 52.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.172 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.28 124.89 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.88 135.41 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.516 -0.74 . . . . 0.0 109.48 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -130.06 118.72 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 61.06 37.56 17.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.645 -1.284 . . . . 0.0 109.57 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.88 -10.12 9.91 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.124 -0.985 . . . . 0.0 111.486 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.96 136.23 33.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.542 -1.564 . . . . 0.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -82.17 126.42 32.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.8 mt -74.25 146.92 42.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.449 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -103.34 146.12 28.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.887 . . . . 0.0 109.752 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 p30 -71.0 3.86 3.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.8 37.34 3.15 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.725 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -145.87 173.65 11.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.019 -1.283 . . . . 0.0 109.638 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 71.7 p -113.15 161.58 16.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.129 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.541 HD23 ' N ' ' B' ' 256' ' ' LEU . 2.9 mt -59.7 -43.03 94.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.873 . . . . 0.0 110.035 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 97.6 p -60.72 -29.22 69.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 109.796 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.78 -15.23 63.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.033 . . . . 0.0 109.272 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -107.26 3.73 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.17 38.79 3.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.399 -0.813 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.0 135.26 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.892 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -123.58 172.58 8.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.099 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -50.97 157.99 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.568 0.699 . . . . 0.0 110.382 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 59.18 10.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 17.1 m -75.17 150.14 38.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.932 -1.105 . . . . 0.0 108.38 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.851 HG21 ' NZ ' ' B' ' 206' ' ' LYS . 7.7 m -116.23 139.12 50.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.43 140.47 52.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.543 -0.723 . . . . 0.0 109.56 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.46 ' NE2' ' CE ' ' B' ' 206' ' ' LYS . 64.6 m80 -89.36 142.23 27.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.142 -0.974 . . . . 0.0 110.015 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.465 HD11 ' HG3' ' B' ' 241' ' ' GLN . 22.4 tp -110.02 127.93 55.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 0.0 109.097 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.22 130.83 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.396 -0.815 . . . . 0.0 110.154 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.627 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.2 mt -79.64 141.59 36.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.232 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.426 ' HD2' ' HE ' ' B' ' 242' ' ' ARG . 22.4 ttt180 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.348 -0.845 . . . . 0.0 108.778 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.421 0.153 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -47.89 165.36 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 112.875 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -2.67 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.729 -0.607 . . . . 0.0 110.738 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.877 ' O ' HG22 ' B' ' 209' ' ' THR . 0.6 OUTLIER -121.88 6.82 9.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.083 -1.011 . . . . 0.0 110.125 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 mm -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 111.223 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.97 138.12 20.26 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.52 -38.76 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.58 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -55.37 -44.72 76.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.569 -0.707 . . . . 0.0 110.516 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.683 HG11 ' O ' ' B' ' 207' ' ' THR . 56.8 t -80.76 -23.66 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.852 -1.155 . . . . 0.0 110.283 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.3 t80 -69.1 -53.5 19.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 110.822 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -62.39 -15.71 50.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.088 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.19 -6.6 59.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.6 mt -90.39 151.85 44.86 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.228 -0.92 . . . . 0.0 109.776 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.71 154.14 27.2 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.453 2.102 . . . . 0.0 112.092 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.92 -50.93 68.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -45.06 38.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.945 -1.097 . . . . 0.0 110.262 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.88 -31.93 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 108.509 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.19 -50.76 72.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -56.68 -47.3 80.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.434 -0.792 . . . . 0.0 110.01 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -58.87 -37.72 77.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 0.0 110.482 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.37 -40.34 62.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.812 -1.18 . . . . 0.0 110.145 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -69.88 -38.8 76.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.763 -1.21 . . . . 0.0 108.874 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.16 77.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 108.906 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 4.8 tm-20 -69.0 -38.55 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 108.877 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.461 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.0 m0 . . . . . 0 C--N 1.303 -1.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.041 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -95.68 164.99 12.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.231 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.437 HG22 ' OG ' ' B' ' 265' ' ' SER . 1.8 pp -144.26 147.9 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' B' ' 264' ' ' GLU . 9.8 m-85 -102.04 144.17 30.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.222 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.98 112.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.984 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.575 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.2 OUTLIER -97.46 133.98 41.31 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.034 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.683 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.5 p -93.98 -174.39 3.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.781 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.522 HD11 ' H ' ' B' ' 271' ' ' LEU . 26.9 mt -72.26 -11.72 60.84 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.877 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.9 p -102.61 -2.44 28.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.36 -0.838 . . . . 0.0 109.574 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 94.99 2.73 62.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -67.22 118.37 10.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -1.225 . . . . 0.0 108.823 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.1 m -99.62 138.12 37.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.033 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.421 HG22 HD21 ' B' ' 215' ' ' LEU . 40.0 mt -135.01 136.21 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.334 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 72.5 m -105.34 120.21 41.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.663 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 13.1 mt -125.68 121.84 34.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.963 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.654 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 4.8 mt-10 -67.18 130.3 42.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.496 -0.753 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.522 HG13 ' NZ ' ' B' ' 229' ' ' LYS . 27.5 m -136.16 -174.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.08 -1.012 . . . . 0.0 110.131 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -133.86 155.3 80.42 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.43 -20.39 56.2 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.402 2.068 . . . . 0.0 112.195 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -105.24 7.95 33.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.24 143.47 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.839 -1.163 . . . . 0.0 109.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 52.3 p -86.37 145.94 26.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -51.68 -26.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -36.22 83.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.205 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.0 -52.75 21.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.109 -0.994 . . . . 0.0 109.021 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.42 ' O ' HD12 ' B' ' 230' ' ' ILE . 35.7 t -52.28 -37.54 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 108.926 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -65.41 -32.48 74.13 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.441 -0.787 . . . . 0.0 108.959 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.89 69.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.663 ' HZ3' ' C ' ' B' ' 215' ' ' LEU . 12.6 mtpt -57.37 -52.65 64.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 108.781 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.569 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.6 mp -59.71 -36.52 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 108.808 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -59.98 -42.81 94.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.063 -1.023 . . . . 0.0 110.07 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.49 -31.31 68.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.116 -0.99 . . . . 0.0 110.831 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -92.76 -50.43 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.43 -6.44 57.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.972 . . . . 0.0 111.331 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.48 26.95 72.05 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.51 -1.369 . . . . 0.0 110.456 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.07 131.6 21.79 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.128 -1.219 . . . . 0.0 109.569 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.62 156.67 44.69 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.212 1.941 . . . . 0.0 112.261 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.6 -34.67 8.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.922 2.414 . . . . 0.0 113.393 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -65.34 -6.8 10.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.228 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.89 -21.06 3.4 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.748 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.5 136.52 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.606 -1.309 . . . . 0.0 109.252 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -125.98 135.73 52.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.95 126.61 52.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 79.7 mt -120.21 136.52 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.9 t80 -129.65 112.82 14.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.32 -0.863 . . . . 0.0 109.435 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.95 44.56 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.865 -1.147 . . . . 0.0 109.485 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 -6.07 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -94.19 137.77 32.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.817 -1.402 . . . . 0.0 109.504 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -84.4 132.59 34.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.875 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.56 146.33 28.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 109.09 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 2.6 tt0 -105.49 148.0 27.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.69 3.82 3.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.921 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 253' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -120.63 45.54 1.22 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.874 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.54 172.39 18.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.987 -1.302 . . . . 0.0 109.261 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 65.1 p -109.84 161.07 15.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.482 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.4 mt -58.01 -40.44 80.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.815 . . . . 0.0 109.938 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 98.3 p -62.51 -28.04 69.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.08 -15.8 62.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.255 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -105.03 1.72 28.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 109.067 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.8 39.73 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.88 133.99 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.038 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.34 174.59 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.471 ' H ' ' HE3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.15 158.09 1.64 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.895 0.855 . . . . 0.0 110.698 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' CE2' ' B' ' 204' ' ' PHE . 91.5 mt-10 57.99 14.26 2.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.044 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.437 ' OG ' HG22 ' B' ' 203' ' ' ILE . 70.4 p -78.03 150.44 33.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.955 -1.091 . . . . 0.0 108.79 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.765 ' C ' HD12 ' B' ' 267' ' ' LEU . 6.7 m -115.03 138.58 50.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -0.796 . . . . 0.0 110.233 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.765 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.82 140.97 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.527 -0.733 . . . . 0.0 109.641 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.404 ' HB3' HD21 ' A' ' 76' ' ' LEU . 58.4 m80 -90.19 141.71 28.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 109.783 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 13.5 tp -108.94 126.06 52.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.376 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 42.8 t -112.69 128.09 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.8 . . . . 0.0 109.546 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.522 ' H ' HD11 ' B' ' 208' ' ' LEU . 47.1 mt -82.82 143.9 30.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.018 -1.052 . . . . 0.0 109.552 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.256 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.04 164.75 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.215 1.944 . . . . 0.0 112.762 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -2.75 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.739 -0.6 . . . . 0.0 110.722 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.899 ' O ' HG22 ' B' ' 209' ' ' THR . 4.1 m-20 -122.24 8.34 9.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.046 -1.034 . . . . 0.0 110.348 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 mm -111.05 129.34 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.272 -0.892 . . . . 0.0 111.001 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.7 t70 -99.85 139.56 20.89 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.48 -47.38 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.269 1.979 . . . . 0.0 112.242 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.478 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 6.8 tt0 -47.88 -44.68 29.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.696 -0.627 . . . . 0.0 110.33 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.658 HG11 ' O ' ' B' ' 207' ' ' THR . 41.4 t -80.85 -32.26 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.957 -1.09 . . . . 0.0 110.318 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -61.05 -54.13 48.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 110.742 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -61.25 -15.86 39.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.907 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -83.55 -6.12 59.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.053 . . . . 0.0 109.808 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' B' ' 268' ' ' HIS . 92.6 mt -90.33 151.93 45.08 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.51 154.17 20.74 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.37 2.047 . . . . 0.0 112.098 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.82 -49.26 75.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.18 -44.74 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.064 . . . . 0.0 110.196 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.3 t -74.84 -32.46 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.874 -1.141 . . . . 0.0 108.478 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.2 tt0 -59.22 -51.83 68.29 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -57.25 -48.96 77.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -56.41 -42.76 78.53 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 110.56 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -69.97 -37.87 75.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.863 -1.148 . . . . 0.0 109.776 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.0 mt -70.03 -40.11 75.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.739 -1.226 . . . . 0.0 109.024 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.49 70.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 108.785 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.56 -40.19 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.9 m0 . . . . . 0 C--N 1.302 -1.491 0 O-C-N 121.005 -1.06 . . . . 0.0 109.535 179.687 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.34 164.76 12.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.55 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.555 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.7 142.72 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.462 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.33 141.7 28.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.443 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.6 t -120.82 108.23 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 109.608 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 13.6 ptpt -94.61 135.32 36.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.658 ' O ' HG11 ' A' ' 72' ' ' VAL . 46.4 p -97.14 -173.94 2.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.025 -1.047 . . . . 0.0 110.998 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.681 HD11 ' H ' ' B' ' 271' ' ' LEU . 20.1 mt -71.4 -14.67 62.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.466 0.651 . . . . 0.0 109.284 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.899 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -99.93 -4.6 29.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.6 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.51 3.01 59.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -67.82 118.45 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.081 -1.247 . . . . 0.0 109.199 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 10.2 m -99.8 137.8 37.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 48.3 mt -133.49 135.34 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.8 m -104.22 117.03 33.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.724 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.8 mt -122.18 121.92 37.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.448 -0.783 . . . . 0.0 110.084 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -67.78 132.69 47.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.57 -174.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.797 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.72 152.55 77.79 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.975 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.15 -24.12 48.31 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.587 2.191 . . . . 0.0 112.191 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 49.2 m -100.4 6.1 44.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.879 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -71.44 143.55 50.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.966 -1.084 . . . . 0.0 109.375 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' B' ' 225' ' ' ASN . 45.0 p -86.26 151.49 23.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 0.0 109.932 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 35.2 mm -54.53 -43.32 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -52.61 -35.65 54.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.425 ' OD1' ' OG1' ' B' ' 222' ' ' THR . 20.6 m120 -67.28 -52.77 36.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.337 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 25.1 t -52.05 -47.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 108.549 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -52.41 -43.49 64.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.507 -0.746 . . . . 0.0 109.182 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.79 -36.11 78.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.814 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.54 ' HB2' HD13 ' B' ' 215' ' ' LEU . 15.3 mtpp -57.78 -53.46 57.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 0.0 109.41 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.529 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.6 mp -58.3 -34.23 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.205 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -60.75 -47.39 86.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.921 -1.112 . . . . 0.0 109.826 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -68.69 -24.33 64.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.249 -0.907 . . . . 0.0 110.634 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -97.53 -53.24 3.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 110.457 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.17 -7.55 53.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.289 -0.882 . . . . 0.0 111.578 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.47 24.67 75.09 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.215 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 36.7 mt -104.41 124.94 35.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.498 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 154.73 31.35 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.164 1.91 . . . . 0.0 111.986 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.95 -28.57 58.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.733 2.289 . . . . 0.0 112.881 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 44.2 p30 -62.6 -14.73 46.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.952 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.51 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.6 OUTLIER -128.52 -21.41 3.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.508 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -84.57 136.54 33.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.897 -1.127 . . . . 0.0 109.243 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -129.46 132.11 46.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.421 -0.799 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.42 127.42 53.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.38 134.23 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.629 -0.669 . . . . 0.0 109.348 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.6 t80 -127.2 112.84 15.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 65.14 37.53 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.868 -1.145 . . . . 0.0 109.458 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.6 -7.66 18.26 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.144 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -94.06 134.78 36.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.74 -1.447 . . . . 0.0 109.692 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -80.97 125.0 29.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.452 HD11 HD23 ' B' ' 267' ' ' LEU . 29.0 mt -69.91 142.37 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -97.19 144.36 27.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.19 3.69 2.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.92 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.0 47.21 1.03 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.795 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -152.68 172.53 16.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.384 . . . . 0.0 109.078 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 37.9 p -111.5 159.24 18.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.948 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.2 mt -57.3 -41.71 80.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 69.4 p -61.17 -29.12 69.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.845 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.24 -16.5 63.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 109.333 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -105.58 3.31 29.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 67.48 39.35 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.848 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.6 mt -91.71 135.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.25 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.31 173.11 7.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.04 162.66 0.44 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.548 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.37 10.46 0.47 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.555 ' OG ' HG22 ' B' ' 203' ' ' ILE . 62.7 p -73.67 148.32 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.823 -1.173 . . . . 0.0 108.657 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.721 ' C ' HD12 ' B' ' 267' ' ' LEU . 22.1 m -113.77 137.89 51.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 0.0 110.038 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.721 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -121.03 160.14 24.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.011 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.411 ' HB3' HD21 ' A' ' 76' ' ' LEU . 79.5 m80 -107.58 139.62 41.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.333 -0.854 . . . . 0.0 109.741 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' B' ' 241' ' ' GLN . 24.8 tp -110.21 126.03 53.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.401 ' HA ' HD21 ' B' ' 208' ' ' LEU . 11.6 t -114.62 130.06 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.454 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.681 ' H ' HD11 ' B' ' 208' ' ' LEU . 47.1 mt -82.42 144.4 30.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.652 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -47.66 165.56 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.454 2.102 . . . . 0.0 112.916 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -6.18 21.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.942 ' O ' HG22 ' B' ' 209' ' ' THR . 1.8 m-20 -117.01 2.56 12.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.099 -1.001 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.77 128.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 4.7 t70 -98.91 138.35 20.64 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.62 -40.31 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.355 2.037 . . . . 0.0 112.467 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 37.4 tt0 -56.21 -43.49 78.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.617 -0.677 . . . . 0.0 110.581 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.653 HG11 ' O ' ' B' ' 207' ' ' THR . 61.4 t -80.09 -23.79 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.784 -1.198 . . . . 0.0 110.35 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.9 t80 -70.41 -52.38 22.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 110.832 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -64.32 -18.12 64.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.174 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -79.87 -7.94 59.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.861 -1.149 . . . . 0.0 109.49 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.8 mt -89.92 151.63 45.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 154.96 22.29 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.41 2.074 . . . . 0.0 111.95 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -63.05 -51.84 65.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.72 -44.33 38.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 110.09 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.408 HG11 HG21 ' B' ' 270' ' ' VAL . 60.3 t -74.77 -31.56 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.02 -1.05 . . . . 0.0 108.448 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.8 -50.05 75.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -58.36 -49.68 76.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.665 . . . . 0.0 110.38 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.72 -36.87 67.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.037 -1.039 . . . . 0.0 110.043 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.3 mt -75.44 -36.58 60.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.852 -1.155 . . . . 0.0 109.687 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.12 -40.34 71.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.77 -1.206 . . . . 0.0 109.147 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.73 79.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.965 . . . . 0.0 109.046 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.95 -38.48 82.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.0 m0 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.101 -1.0 . . . . 0.0 109.205 179.338 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.429 ' O ' HG23 ' B' ' 217' ' ' VAL . 5.8 ptt? . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.08 166.51 11.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -145.29 145.11 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.628 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' B' ' 204' ' ' PHE . 2.4 m-85 -95.75 142.4 28.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.01 108.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -93.33 134.11 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 108.767 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.653 ' O ' HG11 ' A' ' 72' ' ' VAL . 20.8 p -94.33 -174.34 3.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.702 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 35.6 mt -72.36 -10.73 60.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.942 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.2 p -104.33 -3.1 24.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.782 . . . . 0.0 109.655 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.36 2.89 60.2 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -66.65 117.0 8.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -1.199 . . . . 0.0 108.854 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -99.19 136.73 38.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.102 -0.999 . . . . 0.0 109.086 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.568 HD11 ' OE2' ' B' ' 234' ' ' GLU . 23.2 mt -132.79 133.86 58.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.278 -0.889 . . . . 0.0 109.462 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.9 m -103.32 120.13 40.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.9 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' B' ' 229' ' ' LYS . 18.8 mt -123.85 120.5 32.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.846 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.62 133.05 49.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 201' ' ' MET . 11.5 m -140.69 -171.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 109.831 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -138.14 152.36 71.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.16 -28.2 78.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.422 2.081 . . . . 0.0 112.264 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.2 m -96.01 5.0 52.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 110.061 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.58 145.21 49.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.639 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 36.3 p -87.07 150.57 23.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 31.8 mm -56.81 -40.54 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.72 -31.38 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.087 -1.008 . . . . 0.0 109.604 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -73.85 -51.13 17.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.99 -50.35 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 108.509 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -52.05 -39.46 59.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 0.0 109.198 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.16 86.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.43 -0.794 . . . . 0.0 109.591 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' B' ' 215' ' ' LEU . 15.6 mtpp -57.81 -53.73 54.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.51 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.5 mp -57.88 -37.25 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.086 -1.009 . . . . 0.0 109.107 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -58.52 -43.14 89.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.43 -22.41 60.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 110.344 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -98.83 -56.45 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.026 -1.047 . . . . 0.0 110.484 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.568 ' OE2' HD11 ' B' ' 213' ' ' ILE . 58.6 mm-40 -83.35 -7.02 59.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 111.088 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.55 24.62 73.9 Favored Glycine 0 N--CA 1.49 2.274 0 O-C-N 120.575 -1.328 . . . . 0.0 109.974 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.72 125.21 33.86 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 109.467 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.62 154.67 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.996 1.797 . . . . 0.0 111.658 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.92 -29.82 67.25 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.7 2.267 . . . . 0.0 113.049 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.97 -17.27 36.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 110.475 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.448 HE21 HD22 ' B' ' 271' ' ' LEU . 6.6 pt20 -127.99 -15.54 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.78 133.62 33.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 109.488 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -127.97 132.37 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.503 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.9 mt -105.85 127.34 53.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.93 136.03 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.683 -0.636 . . . . 0.0 109.413 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -131.25 119.06 21.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 108.983 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 59.73 42.45 16.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.87 -1.144 . . . . 0.0 109.455 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.26 23.87 70.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.112 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 140.51 52.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.117 -1.225 . . . . 0.0 109.615 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -87.97 125.14 34.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 109.603 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.2 mt -71.42 146.56 48.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -0.82 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -99.68 142.59 30.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -68.6 3.2 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.99 40.41 2.01 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -144.55 168.63 19.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 109.258 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 15.0 p -108.79 155.48 20.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.814 . . . . 0.0 109.98 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.51 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.2 mt -54.16 -42.95 70.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 83.6 p -61.2 -27.14 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -15.85 62.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.515 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -106.54 3.42 27.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 109.242 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.59 40.53 1.86 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.53 -0.731 . . . . 0.0 109.285 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.57 133.43 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.364 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -124.79 176.28 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.54 159.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.277 -0.889 . . . . 0.0 111.07 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 57.85 13.14 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.092 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -75.23 148.19 39.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 108.676 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 8.0 m -114.06 137.05 52.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.405 -0.81 . . . . 0.0 110.647 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.66 144.42 50.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.772 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.42 ' HB3' HD21 ' A' ' 76' ' ' LEU . 32.5 m80 -94.39 143.3 26.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.132 -0.98 . . . . 0.0 110.349 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.2 tp -109.56 125.88 52.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.352 -0.842 . . . . 0.0 109.415 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.408 HG21 HG11 ' A' ' 80' ' ' VAL . 34.8 t -115.25 131.25 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.91 . . . . 0.0 110.135 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.448 HD22 HE21 ' B' ' 240' ' ' GLN . 46.5 mt -82.76 143.95 30.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -0.824 . . . . 0.0 109.626 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.478 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.19 165.18 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.191 1.927 . . . . 0.0 112.74 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -65.8 -14.71 61.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.754 -0.591 . . . . 0.0 110.469 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.876 ' O ' HG22 ' B' ' 209' ' ' THR . 0.5 OUTLIER -108.65 8.45 27.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.08 -1.012 . . . . 0.0 110.45 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.12 129.54 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 111.071 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 5.0 t70 -99.74 138.65 20.43 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.69 -46.66 0.79 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.251 1.967 . . . . 0.0 112.315 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.7 tt0 -51.07 -44.64 61.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.695 -0.628 . . . . 0.0 110.656 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.739 HG11 ' O ' ' B' ' 207' ' ' THR . 40.0 t -79.06 -24.04 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.812 -1.18 . . . . 0.0 110.203 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.428 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.9 t80 -70.47 -51.44 29.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 110.699 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -63.09 -16.96 61.67 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.142 -0.974 . . . . 0.0 110.055 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -82.97 -7.06 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 76' ' ' LEU . 95.1 mt -89.03 151.31 46.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.842 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.23 154.02 19.91 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.356 2.037 . . . . 0.0 111.913 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.04 -51.45 66.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.671 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.42 -44.81 45.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.982 -1.074 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.04 -30.66 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.992 -1.068 . . . . 0.0 108.716 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.428 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 39.7 tt0 -61.7 -49.36 76.77 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -58.9 -49.7 76.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.552 -0.718 . . . . 0.0 110.359 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.92 -40.66 70.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.004 -1.06 . . . . 0.0 110.121 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.42 -36.2 71.23 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.987 -1.07 . . . . 0.0 109.837 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.92 -39.98 69.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.804 -1.185 . . . . 0.0 109.172 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.59 -32.95 72.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.87 -34.35 60.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 108.752 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.4 m0 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 120.962 -1.086 . . . . 0.0 108.491 178.947 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.92 164.04 12.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 110.585 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.513 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.8 141.95 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.32 141.96 27.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.969 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -121.35 110.03 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -96.41 135.65 37.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 108.735 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.739 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.4 p -96.35 -173.46 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.771 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.442 HD11 ' H ' ' B' ' 271' ' ' LEU . 21.2 mt -72.55 -13.26 61.36 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.348 0.594 . . . . 0.0 109.671 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.876 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.6 p -100.8 -3.26 30.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.62 61.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.39 118.68 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 108.812 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 2.2 m -100.6 138.88 37.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.2 mt -135.22 136.72 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.3 m -104.06 121.43 43.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 108.818 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' B' ' 229' ' ' LYS . 16.1 mt -124.57 120.97 33.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.882 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.1 133.32 48.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.651 -0.656 . . . . 0.0 109.382 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 -173.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.935 -1.103 . . . . 0.0 110.126 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -135.93 153.68 77.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 108.959 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.26 -25.48 65.1 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.528 2.152 . . . . 0.0 112.171 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 m -100.24 5.94 44.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.936 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -71.87 144.93 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.022 -1.049 . . . . 0.0 109.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.3 p -86.71 146.19 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.84 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.411 HD12 HD13 ' B' ' 250' ' ' LEU . 32.2 mm -51.65 -34.3 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.431 ' C ' ' CD ' ' B' ' 224' ' ' GLU . 0.2 OUTLIER -56.8 -38.39 72.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.384 -0.822 . . . . 0.0 109.037 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -66.57 -52.48 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 109.244 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.412 ' H ' HG23 ' B' ' 226' ' ' VAL . 15.6 t -52.6 -48.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.758 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -53.44 -38.7 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.53 83.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.356 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.434 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.8 mtpp -57.16 -52.84 63.68 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 109.111 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.604 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.9 mp -59.04 -36.46 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.178 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -58.81 -49.56 77.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.943 -1.098 . . . . 0.0 109.741 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.56 -27.6 68.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.422 -0.799 . . . . 0.0 110.649 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -95.4 -57.01 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.895 -1.128 . . . . 0.0 110.55 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -83.04 -6.18 59.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 111.311 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.08 24.76 71.94 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.244 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.495 HD13 HD21 ' B' ' 271' ' ' LEU . 63.1 mt -105.95 128.45 26.38 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.132 -1.217 . . . . 0.0 109.641 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.95 158.69 38.36 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.113 1.875 . . . . 0.0 111.933 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.11 -30.18 32.12 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.942 2.428 . . . . 0.0 113.196 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -69.14 -6.14 26.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.1 -20.68 3.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.39 139.03 31.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 109.341 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.94 132.31 47.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.404 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.01 123.42 47.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 109.439 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.51 135.81 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.662 -0.649 . . . . 0.0 109.357 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.486 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.4 t80 -129.84 113.64 14.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.761 . . . . 0.0 109.217 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.34 42.25 5.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.931 -1.106 . . . . 0.0 109.203 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.97 39.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.93 137.9 43.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -1.188 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.41 126.08 33.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.411 HD13 HD12 ' B' ' 223' ' ' ILE . 22.2 mt -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.223 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.4 144.28 31.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.176 -0.953 . . . . 0.0 109.927 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.03 3.35 3.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 109.827 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.39 37.03 3.29 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -145.16 173.35 12.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.284 . . . . 0.0 109.542 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 81.6 p -113.17 161.22 17.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.498 -0.751 . . . . 0.0 109.943 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.494 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.1 mt -60.42 -42.23 95.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.6 p -60.63 -28.26 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.089 -1.007 . . . . 0.0 109.201 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.26 -13.86 61.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 108.959 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.611 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 25.7 m-85 -107.1 0.36 23.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.465 -0.772 . . . . 0.0 109.572 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 260' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' B' ' 260' ' ' ASN . 0.0 OUTLIER 68.25 33.42 4.3 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.132 0.968 . . . . 0.0 109.725 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -85.63 133.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.551 -1.343 . . . . 0.0 109.523 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 262' ' ' GLN . . . . . 0.432 ' O ' ' OG ' ' B' ' 265' ' ' SER . 26.1 mt-30 -120.66 170.51 9.36 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.696 0.76 . . . . 0.0 109.75 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.76 160.42 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.779 0.799 . . . . 0.0 110.698 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 56.58 13.58 1.41 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.513 ' OG ' HG22 ' B' ' 203' ' ' ILE . 3.0 p -76.7 150.02 36.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 108.525 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.745 ' C ' HD12 ' B' ' 267' ' ' LEU . 11.4 m -114.59 137.01 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.383 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.745 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -123.25 140.18 53.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.264 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.412 ' HB3' HD21 ' A' ' 76' ' ' LEU . 60.7 m80 -89.46 141.84 28.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 0.0 109.796 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 17.2 tp -110.55 128.44 55.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 10.7 t -114.19 128.77 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.495 HD21 HD13 ' B' ' 236' ' ' ILE . 43.4 mt -82.4 145.43 29.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.035 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 108.754 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.72 164.61 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.485 2.123 . . . . 0.0 113.006 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.47 -1.94 9.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.825 -0.547 . . . . 0.0 110.284 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.878 ' O ' HG22 ' B' ' 209' ' ' THR . 0.2 OUTLIER -120.67 7.23 10.51 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.178 -0.951 . . . . 0.0 110.214 -179.46 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 68' ' ' ILE . 27.3 mm -109.3 127.67 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.84 . . . . 0.0 111.258 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 9.6 t0 -102.24 110.71 63.27 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.96 -43.83 23.8 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.94 . . . . 0.0 112.625 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -47.86 -47.62 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 110.389 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.707 HG11 ' O ' ' B' ' 207' ' ' THR . 43.8 t -78.32 -23.5 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -70.66 -53.85 14.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.867 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -61.62 -17.49 55.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.876 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -81.98 -6.53 59.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.897 -1.127 . . . . 0.0 109.731 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 76' ' ' LEU . 93.1 mt -90.56 151.48 44.12 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.169 -0.957 . . . . 0.0 109.546 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.66 154.63 19.83 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.301 2.0 . . . . 0.0 111.898 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -49.97 71.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.733 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.65 -44.33 47.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.101 . . . . 0.0 110.087 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.484 HG11 HG21 ' B' ' 270' ' ' VAL . 45.7 t -74.68 -32.07 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.954 -1.091 . . . . 0.0 108.38 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.1 tt0 -59.61 -52.16 66.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.11 -49.05 74.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.196 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.5 -40.79 75.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.021 . . . . 0.0 110.125 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.5 -37.83 68.3 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.49 -39.14 77.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.927 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.86 -32.9 72.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 108.925 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.28 -35.61 66.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.42 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 44.9 m0 . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 109.088 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 202' ' ' GLN . . . . . 0.413 HE21 ' HE1' ' B' ' 204' ' ' PHE . 5.6 pt20 -97.58 166.15 11.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 pp -145.79 142.11 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.413 ' HE1' HE21 ' B' ' 202' ' ' GLN . 7.0 m-85 -95.18 143.07 26.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 29.2 t -123.43 111.58 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 109.685 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -97.04 140.43 31.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 108.68 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.707 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.9 p -100.56 -173.52 2.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.715 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.449 HD11 ' H ' ' B' ' 271' ' ' LEU . 30.6 mt -70.94 -13.58 62.06 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.527 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.878 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.3 p -102.16 -3.77 26.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.78 2.89 61.08 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -66.65 117.67 9.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.236 . . . . 0.0 108.571 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.0 m -99.91 139.2 35.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.47 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.477 HG22 HD21 ' B' ' 215' ' ' LEU . 23.2 mt -134.94 135.77 52.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.485 -0.759 . . . . 0.0 109.289 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -103.67 122.59 45.35 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.675 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 17.1 mt -126.04 119.66 28.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.44 -0.788 . . . . 0.0 109.935 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' GLU . . . . . 0.663 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 11.5 mt-10 -66.07 129.92 41.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.626 HG13 ' NZ ' ' B' ' 229' ' ' LYS . 14.1 m -137.38 -172.72 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.0 110.012 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.11 153.77 71.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 108.755 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.55 -25.87 42.94 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.577 2.184 . . . . 0.0 112.489 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -99.6 6.83 45.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.873 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 141.11 52.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.605 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.4 p -86.07 148.69 25.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.998 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -54.93 -42.5 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.311 -0.868 . . . . 0.0 109.257 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -52.44 -37.34 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 109.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -67.92 -49.25 62.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 108.971 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 52.8 t -52.1 -49.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 108.463 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 -37.79 49.21 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.99 87.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.675 ' HZ3' ' C ' ' B' ' 215' ' ' LEU . 15.1 mtpt -55.84 -53.49 56.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 109.056 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.446 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -60.89 -32.81 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -62.41 -51.0 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.254 -0.904 . . . . 0.0 110.014 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -63.33 -29.33 70.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.522 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -94.22 -58.48 2.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.973 -1.08 . . . . 0.0 110.504 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.08 -6.55 59.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.955 . . . . 0.0 111.596 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.69 25.28 70.28 Favored Glycine 0 N--CA 1.492 2.416 0 O-C-N 120.338 -1.476 . . . . 0.0 110.541 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.63 129.06 26.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.063 -1.257 . . . . 0.0 109.325 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.02 155.2 42.8 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.985 1.79 . . . . 0.0 111.903 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.1 -29.82 26.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.772 2.314 . . . . 0.0 113.361 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.36 -8.34 45.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.55 -20.7 4.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.39 -0.819 . . . . 0.0 109.608 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 137.63 32.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 108.985 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -127.87 132.37 49.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.872 . . . . 0.0 109.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.19 124.52 49.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.435 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.8 mt -119.68 134.03 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.549 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 45.6 t80 -128.28 111.6 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.46 38.29 4.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.772 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.58 4.62 53.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -101.48 137.71 39.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 109.765 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -86.2 125.96 33.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.019 . . . . 0.0 109.492 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.464 HD11 HD23 ' B' ' 267' ' ' LEU . 20.1 mt -77.95 142.97 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' B' ' 253' ' ' GLY . 12.7 tt0 -99.8 143.56 29.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.405 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 3.83 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 253' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -123.7 49.24 0.91 Allowed Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.786 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -153.44 169.76 22.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -1.228 . . . . 0.0 109.211 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -110.94 158.08 19.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.434 -0.792 . . . . 0.0 110.097 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.429 HD23 ' N ' ' B' ' 256' ' ' LEU . 8.0 mt -55.24 -42.53 73.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.72 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 24.6 p -61.9 -28.1 69.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.92 -13.97 61.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.297 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -105.9 1.94 27.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.7 37.97 3.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.07 135.14 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.35 175.26 6.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.237 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.49 162.09 0.59 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.986 -178.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 56.42 13.38 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.216 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.3 m -75.37 148.17 39.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.794 -1.191 . . . . 0.0 108.585 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.775 ' C ' HD12 ' B' ' 267' ' ' LEU . 4.1 m -114.04 137.43 51.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.458 -0.776 . . . . 0.0 110.177 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.775 HD12 ' C ' ' B' ' 266' ' ' THR . 8.2 mp -124.93 141.97 51.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -90.85 143.06 27.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.874 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 tp -108.44 125.58 51.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.529 -0.732 . . . . 0.0 109.322 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 80' ' ' VAL . 3.0 t -110.52 125.62 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 109.525 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.449 ' H ' HD11 ' B' ' 208' ' ' LEU . 43.0 mt -82.31 144.78 30.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.034 -179.266 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.47 164.72 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.302 2.001 . . . . 0.0 112.881 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p -67.66 -1.81 5.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.757 -0.59 . . . . 0.0 110.789 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.857 ' O ' HG22 ' B' ' 209' ' ' THR . 6.7 m-20 -123.77 9.1 8.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.014 -1.054 . . . . 0.0 110.549 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 68' ' ' ILE . 28.3 mm -110.12 129.07 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.08 -1.013 . . . . 0.0 111.463 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 7.7 t70 -93.34 136.91 23.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' O ' ' CD2' ' A' ' 74' ' ' TYR . 51.8 Cg_endo -72.12 -33.35 9.6 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.457 2.105 . . . . 0.0 113.233 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.43 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 39.3 tt0 -71.65 -37.06 70.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.0 110.577 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.631 HG11 ' O ' ' B' ' 207' ' ' THR . 61.8 t -78.23 -23.66 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.591 -1.318 . . . . 0.0 109.169 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -71.98 -53.33 13.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.409 -0.807 . . . . 0.0 110.698 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 70' ' ' PRO . 46.3 m-85 -61.36 -17.27 53.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.951 . . . . 0.0 109.949 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -83.42 -5.47 59.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.526 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 76' ' ' LEU . 91.3 mt -89.42 152.19 47.16 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.169 -0.957 . . . . 0.0 109.598 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.72 153.92 28.16 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.321 2.014 . . . . 0.0 111.938 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -50.68 69.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.572 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.45 -42.57 43.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.013 -1.054 . . . . 0.0 110.262 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.0 t -74.92 -32.89 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 108.325 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.7 tt0 -59.2 -51.95 67.79 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -56.7 -48.45 77.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.3 -40.71 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.61 -38.54 67.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.842 -1.161 . . . . 0.0 109.63 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.57 -38.78 77.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.736 -1.228 . . . . 0.0 108.948 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.02 73.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.53 -34.43 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 108.748 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 49.4 m0 . . . . . 0 C--N 1.301 -1.536 0 O-C-N 121.016 -1.052 . . . . 0.0 108.729 178.876 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.09 164.84 12.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.128 -0.983 . . . . 0.0 110.362 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.84 143.58 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.197 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.8 142.16 28.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.04 114.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.409 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.1 ptpt -99.84 139.36 35.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 108.993 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.631 ' O ' HG11 ' A' ' 72' ' ' VAL . 30.9 p -98.09 -178.18 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 110.945 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 51.3 mt -71.69 -12.63 61.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.3 p -102.59 -3.99 25.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.05 57.27 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.882 -1.152 . . . . 0.0 110.527 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -69.28 119.07 12.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.002 -1.293 . . . . 0.0 108.999 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 19.3 m -102.83 140.95 36.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.479 HD11 ' CD ' ' B' ' 234' ' ' GLU . 37.6 mt -138.75 137.51 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 37.6 m -104.94 119.34 38.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.6 mt -123.15 121.5 36.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.18 131.49 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.89 -175.07 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.02 -1.05 . . . . 0.0 109.628 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -134.8 152.77 78.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.389 -0.819 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.64 -23.03 46.74 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.555 2.17 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' B' ' 220' ' ' SER . 1.4 t -104.47 5.83 34.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.956 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.89 144.99 52.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.956 -1.09 . . . . 0.0 109.412 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 73.1 p -85.81 150.38 24.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.2 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 36.6 mm -54.51 -45.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.369 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.51 -35.89 54.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -67.77 -52.58 35.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.072 -1.017 . . . . 0.0 109.129 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.7 t -51.9 -48.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.93 -1.106 . . . . 0.0 108.107 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.96 -46.64 61.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.55 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.03 -36.86 70.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.585 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.7 mtpp -56.92 -54.24 48.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.983 -1.073 . . . . 0.0 109.259 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.406 HD13 ' OE1' ' B' ' 241' ' ' GLN . 2.9 mp -57.31 -33.68 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 108.975 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -30.95 71.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.634 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -96.27 -51.97 4.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.026 -1.046 . . . . 0.0 110.683 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.479 ' CD ' HD11 ' B' ' 213' ' ' ILE . 60.4 mm-40 -85.77 -8.0 58.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 111.413 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.69 25.06 72.88 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.501 -1.374 . . . . 0.0 110.524 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.66 130.31 23.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.139 -1.212 . . . . 0.0 109.733 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' PRO . . . . . 0.445 ' HG2' HE21 ' B' ' 240' ' ' GLN . 57.6 Cg_endo -74.92 155.01 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.214 1.942 . . . . 0.0 111.748 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.48 -30.57 29.05 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.738 2.292 . . . . 0.0 113.219 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.05 -13.04 61.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.445 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.73 -19.86 6.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.418 -0.802 . . . . 0.0 110.13 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.467 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -86.09 139.79 30.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.696 -1.253 . . . . 0.0 108.928 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -129.76 129.63 44.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.345 -0.847 . . . . 0.0 109.449 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.1 mt -105.04 124.23 49.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.83 . . . . 0.0 109.338 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.99 134.08 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -130.36 121.12 25.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.092 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.46 39.4 28.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.735 -1.228 . . . . 0.0 109.871 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.3 7.31 60.05 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.057 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.66 132.86 52.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.242 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -82.65 125.95 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.198 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.614 HD11 HD23 ' B' ' 267' ' ' LEU . 21.3 mt -76.54 141.83 41.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.49 147.16 26.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -68.91 3.91 1.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 110.131 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -121.57 48.29 0.96 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.916 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -156.08 171.7 19.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.989 -1.301 . . . . 0.0 109.245 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' B' ' 258' ' ' ASP . 7.0 p -112.69 161.32 16.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.478 -0.764 . . . . 0.0 110.058 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.519 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.8 mt -60.0 -42.56 94.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.956 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 78.2 p -60.55 -29.05 68.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.081 -1.012 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 258' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' B' ' 255' ' ' THR . 1.3 m-20 -70.96 -14.64 62.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.127 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.27 2.81 27.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 66.05 38.25 4.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.525 -0.734 . . . . 0.0 109.605 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.9 mt -91.19 135.25 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -122.46 172.96 7.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.649 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.606 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.93 160.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.709 0.766 . . . . 0.0 110.506 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 58.08 11.68 1.58 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 2.5 m -73.68 145.35 45.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.776 -1.202 . . . . 0.0 108.875 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.761 ' C ' HD12 ' B' ' 267' ' ' LEU . 17.2 m -113.12 136.97 52.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.584 -0.698 . . . . 0.0 109.953 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.761 HD12 ' C ' ' B' ' 266' ' ' THR . 7.4 mp -124.69 141.7 51.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.409 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 66.5 m80 -88.57 141.06 28.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.092 -1.005 . . . . 0.0 110.059 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' B' ' 241' ' ' GLN . 11.5 tp -108.93 126.38 53.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.289 -0.882 . . . . 0.0 108.985 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 130.03 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.21 144.23 33.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 108.985 -179.13 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.32 164.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.323 2.016 . . . . 0.0 112.742 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.63 -1.88 5.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 110.762 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.864 ' O ' HG22 ' B' ' 209' ' ' THR . 6.9 m-20 -122.9 8.29 9.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.066 -1.021 . . . . 0.0 110.367 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.8 mm -109.37 128.2 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.4 t70 -101.42 139.79 20.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.76 -46.99 1.45 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.502 2.135 . . . . 0.0 112.663 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 tt0 -47.44 -47.0 27.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 110.608 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.5 HG11 ' O ' ' B' ' 207' ' ' THR . 50.3 t -78.99 -42.82 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.4 t80 -51.43 -53.41 37.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.998 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -63.42 -18.82 64.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.0 110.281 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.81 -6.1 56.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.55 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' B' ' 268' ' ' HIS . 92.8 mt -91.07 152.35 44.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.147 -0.97 . . . . 0.0 109.836 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.62 154.51 30.56 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.416 2.077 . . . . 0.0 111.864 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -62.93 -50.16 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.698 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -44.61 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.971 -1.081 . . . . 0.0 110.092 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.3 -31.73 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 108.323 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.7 tt0 -60.02 -51.96 67.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.35 -49.57 74.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.589 -0.694 . . . . 0.0 110.307 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -56.5 -40.06 74.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.096 -1.003 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.96 -36.94 67.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.812 -1.18 . . . . 0.0 109.97 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -70.96 -38.71 72.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.716 -1.24 . . . . 0.0 108.884 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.72 -33.7 73.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.954 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.95 -35.06 66.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m0 . . . . . 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 108.749 179.053 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.431 ' HE2' HD12 ' B' ' 256' ' ' LEU . 2.5 ptt? . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.13 165.03 12.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.467 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.484 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -145.42 142.56 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.06 140.84 29.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.2 108.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.513 ' NZ ' ' CB ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -96.54 135.37 38.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.5 ' O ' HG11 ' A' ' 72' ' ' VAL . 70.4 p -96.27 -174.66 3.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 110.557 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 18.0 mt -72.45 -10.54 59.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.32 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -102.48 -3.43 26.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.88 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.65 0.27 62.65 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.102 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -66.93 119.67 12.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 108.887 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.1 m -101.44 140.03 36.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.352 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 41.2 mt -135.4 136.19 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 109.212 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.0 m -105.26 121.05 43.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' B' ' 229' ' ' LYS . 18.8 mt -125.4 120.73 31.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.437 -0.789 . . . . 0.0 109.868 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.39 133.85 51.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.457 HG11 HG22 ' B' ' 226' ' ' VAL . 11.4 m -140.88 -174.31 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 110.08 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -135.32 152.05 76.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.847 . . . . 0.0 109.068 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.04 -26.36 49.52 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.569 2.179 . . . . 0.0 112.516 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -98.1 7.22 46.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.55 142.08 50.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.104 -0.997 . . . . 0.0 110.009 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 62.4 p -86.02 144.59 27.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.409 ' H ' HG12 ' B' ' 223' ' ' ILE . 26.2 mm -51.98 -31.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.129 -0.982 . . . . 0.0 108.699 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.431 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -61.58 -32.95 73.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 109.392 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -72.66 -52.55 14.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.127 -0.983 . . . . 0.0 108.778 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.457 HG22 HG11 ' B' ' 217' ' ' VAL . 66.5 t -52.61 -47.43 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.077 -1.015 . . . . 0.0 108.388 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -52.8 -40.56 63.36 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.77 80.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.522 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.0 mtpp -59.04 -53.81 54.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.819 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.433 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -58.98 -34.24 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.867 -1.145 . . . . 0.0 109.213 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -60.98 -47.0 88.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -21.73 61.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.034 -1.041 . . . . 0.0 110.281 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -97.56 -59.32 1.8 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -82.94 -5.05 58.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.905 . . . . 0.0 111.341 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.61 73.68 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.558 -1.339 . . . . 0.0 110.357 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.33 125.32 35.37 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.102 -1.234 . . . . 0.0 109.439 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.63 154.12 49.41 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.956 1.77 . . . . 0.0 111.928 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.27 -31.23 53.59 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.673 2.249 . . . . 0.0 112.945 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -63.83 -13.0 40.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.296 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.502 HE21 HD22 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -126.54 -16.54 5.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.792 . . . . 0.0 110.357 -179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.499 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -88.9 132.05 34.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 109.166 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.72 132.5 53.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.447 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.5 mt -107.16 126.56 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.498 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.44 134.54 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 49.4 t80 -128.71 114.44 16.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.158 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.05 42.47 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.008 -1.057 . . . . 0.0 109.193 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.69 16.81 61.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.524 ' NZ ' ' CB ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -114.78 138.94 50.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -1.157 . . . . 0.0 109.479 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -86.65 125.98 34.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.722 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.4 157.78 28.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -117.48 144.48 45.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.483 -0.761 . . . . 0.0 109.842 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.18 3.77 1.98 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.698 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.02 33.71 4.77 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 -145.41 172.02 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.085 -1.244 . . . . 0.0 109.403 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.1 p -112.56 160.63 17.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.405 -0.809 . . . . 0.0 110.071 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.431 HD12 ' HE2' ' B' ' 201' ' ' MET . 3.1 mt -56.94 -42.38 79.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -0.891 . . . . 0.0 109.388 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.4 p -60.26 -29.11 68.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.534 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.95 -18.59 64.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.241 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.69 3.05 31.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.338 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.34 38.97 3.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.4 mt -91.02 135.87 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -121.77 172.91 7.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 109.545 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.837 ' HZ3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.86 161.76 0.72 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.346 -0.847 . . . . 0.0 110.466 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 57.31 11.28 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.484 ' OG ' HG22 ' B' ' 203' ' ' ILE . 69.9 p -76.02 151.91 37.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.931 -1.105 . . . . 0.0 108.632 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.749 ' C ' HD12 ' B' ' 267' ' ' LEU . 16.1 m -116.27 136.94 52.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 110.12 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.749 HD12 ' C ' ' B' ' 266' ' ' THR . 10.0 mp -122.06 140.95 51.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.402 ' HB3' HD21 ' A' ' 76' ' ' LEU . 52.7 m80 -89.92 139.8 30.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' B' ' 241' ' ' GLN . 20.8 tp -109.22 126.47 53.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.041 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.83 130.77 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.502 HD22 HE21 ' B' ' 240' ' ' GLN . 44.0 mt -79.12 142.08 36.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -0.888 . . . . 0.0 109.136 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.184 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.2 165.25 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.388 2.058 . . . . 0.0 113.03 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -67.47 -2.35 6.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.818 -0.551 . . . . 0.0 110.692 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.905 ' O ' HG22 ' B' ' 209' ' ' THR . 1.6 m-20 -122.95 9.02 9.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.028 -1.045 . . . . 0.0 110.321 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -111.55 129.35 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 0.0 110.956 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -96.08 137.01 21.77 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.86 -38.47 2.99 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.457 2.105 . . . . 0.0 112.643 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.37 -42.84 92.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 110.356 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.56 HG11 ' O ' ' B' ' 207' ' ' THR . 84.1 t -79.21 -23.76 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 0.0 109.783 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.6 t80 -68.04 -53.39 26.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.714 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -62.21 -17.29 57.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.969 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -81.78 -6.07 58.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 76' ' ' LEU . 91.4 mt -90.23 151.44 44.7 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.532 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.79 155.06 18.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.436 2.091 . . . . 0.0 111.914 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.0 -50.52 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 110.769 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.27 54.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.057 . . . . 0.0 110.266 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.89 -31.1 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 108.234 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -60.51 -49.8 76.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -58.34 -48.27 81.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.553 -0.717 . . . . 0.0 110.163 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.1 -40.09 80.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.011 -1.056 . . . . 0.0 110.336 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.56 -39.05 70.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.884 -1.135 . . . . 0.0 109.874 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.22 -36.72 74.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.726 -1.234 . . . . 0.0 109.062 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.51 -34.16 76.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.233 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 5.3 tm-20 -72.0 -41.18 67.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.848 . . . . 0.0 109.082 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.521 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.1 m0 . . . . . 0 C--N 1.303 -1.416 0 O-C-N 120.95 -1.094 . . . . 0.0 109.045 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -95.26 163.44 13.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 110.233 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.62 140.97 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.537 -0.727 . . . . 0.0 109.139 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -93.77 142.23 27.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -122.69 110.94 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.412 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -98.46 138.31 35.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.56 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.0 p -97.27 -175.04 3.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 111.08 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.501 HD11 ' H ' ' B' ' 271' ' ' LEU . 31.8 mt -71.54 -14.9 62.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.0 p -99.05 -4.06 33.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.616 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.31 2.42 60.47 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -67.63 119.19 11.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.045 -1.267 . . . . 0.0 109.062 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 135.71 41.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 47.4 mt -134.22 135.42 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.434 -0.791 . . . . 0.0 109.088 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 59.5 m -104.56 124.21 48.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.019 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' B' ' 229' ' ' LYS . 22.0 mt -126.73 120.68 29.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.11 133.67 51.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.574 -0.704 . . . . 0.0 109.295 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.83 -174.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.969 -1.082 . . . . 0.0 109.788 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -133.92 153.36 79.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.115 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.16 -18.37 23.33 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.423 2.082 . . . . 0.0 111.876 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 31.4 t -108.67 7.66 26.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 110.071 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.68 145.86 46.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.39 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 58.3 p -87.84 145.3 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.433 HD12 HD13 ' B' ' 250' ' ' LEU . 28.3 mm -51.73 -34.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 0.0 109.163 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -62.3 -32.16 72.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.479 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -70.21 -51.66 29.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.031 -1.043 . . . . 0.0 108.251 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.416 ' H ' HG23 ' B' ' 226' ' ' VAL . 15.9 t -52.21 -44.14 40.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.464 ' HD3' HD12 ' B' ' 243' ' ' LEU . 0.0 OUTLIER -51.63 -48.31 63.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.622 -0.674 . . . . 0.0 109.431 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.46 70.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.729 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.586 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.8 mtpp -58.76 -54.25 49.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.12 -0.988 . . . . 0.0 109.761 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.5 -34.36 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.097 . . . . 0.0 109.033 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -62.2 -50.38 72.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.955 -1.091 . . . . 0.0 109.821 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.72 -27.5 69.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.684 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -97.41 -54.41 3.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.967 -1.083 . . . . 0.0 110.518 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -86.1 -6.44 59.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 111.329 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.23 24.18 73.37 Favored Glycine 0 N--CA 1.492 2.379 0 O-C-N 120.467 -1.396 . . . . 0.0 110.281 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 59.6 mt -107.34 130.65 22.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -1.159 . . . . 0.0 109.675 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -69.66 166.59 26.95 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.029 1.819 . . . . 0.0 111.271 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' PRO . . . . . 0.402 ' CB ' ' HG2' ' B' ' 227' ' ' LYS . 64.8 Cg_endo -83.12 -27.75 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.464 2.109 . . . . 0.0 112.711 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.79 -10.16 58.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.937 . . . . 0.0 110.31 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.52 -25.63 5.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.485 -0.759 . . . . 0.0 109.78 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.02 137.8 31.98 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.621 -1.299 . . . . 0.0 108.55 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -124.07 134.39 53.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 110.156 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.464 HD12 ' HD3' ' B' ' 227' ' ' LYS . 16.9 mt -103.18 120.37 40.59 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 53.9 mt -115.24 133.94 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.598 -0.689 . . . . 0.0 109.399 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -128.23 123.79 35.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.55 41.58 30.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.629 -1.294 . . . . 0.0 108.935 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.29 1.07 6.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -93.02 134.19 35.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.035 -1.273 . . . . 0.0 109.458 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -84.2 120.83 26.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.919 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.535 HD11 HD23 ' B' ' 267' ' ' LEU . 24.2 mt -73.5 142.55 46.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.645 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 144.52 25.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.661 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -72.98 4.2 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.84 42.28 1.6 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -147.37 172.9 13.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.012 -1.287 . . . . 0.0 109.365 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.433 ' OG1' ' OD1' ' B' ' 258' ' ' ASP . 6.5 p -110.03 158.16 18.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.067 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.451 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.7 mt -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 109.849 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.2 p -61.32 -28.99 69.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.807 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 258' ' ' ASP . . . . . 0.433 ' OD1' ' OG1' ' B' ' 255' ' ' THR . 0.7 OUTLIER -70.12 -15.97 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.129 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.69 3.03 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.82 39.05 3.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.748 . . . . 0.0 109.468 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.7 mt -92.78 136.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.124 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.64 175.11 7.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.386 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.81 162.94 0.53 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.345 -0.847 . . . . 0.0 110.686 -178.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 57.36 13.36 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.098 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -77.01 148.84 36.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.94 -1.1 . . . . 0.0 108.595 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.809 ' C ' HD12 ' B' ' 267' ' ' LEU . 6.7 m -115.09 137.8 51.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.977 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.809 HD12 ' C ' ' B' ' 266' ' ' THR . 9.5 mp -125.54 140.86 52.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.22 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -89.05 143.05 27.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.234 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.95 126.35 52.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.56 131.4 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.353 -0.842 . . . . 0.0 109.749 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.501 ' H ' HD11 ' B' ' 208' ' ' LEU . 45.2 mt -81.58 143.97 31.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.324 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.285 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -47.64 164.75 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.364 2.042 . . . . 0.0 112.874 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.412 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -67.2 -1.72 4.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.757 -0.589 . . . . 0.0 110.682 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.851 ' O ' HG22 ' B' ' 209' ' ' THR . 4.0 m-20 -123.95 9.91 8.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.388 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.2 mm -112.63 129.99 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 0.0 111.268 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t70 -100.19 139.93 21.09 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -71.24 -48.88 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.221 1.947 . . . . 0.0 112.297 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 31.8 tt0 -47.98 -44.02 30.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.691 -0.631 . . . . 0.0 110.271 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.593 HG11 ' O ' ' B' ' 207' ' ' THR . 49.0 t -80.2 -23.63 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.79 -1.194 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 27.7 t80 -70.55 -53.08 17.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.071 . . . . 0.0 111.074 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -61.63 -16.32 47.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.75 -5.32 58.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.731 -1.231 . . . . 0.0 110.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.2 mt -90.72 151.94 44.31 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.04 155.95 17.32 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.476 2.118 . . . . 0.0 112.08 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.29 -50.06 71.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.685 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.87 -43.05 59.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.92 -1.113 . . . . 0.0 110.115 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.418 HG11 HG21 ' B' ' 270' ' ' VAL . 61.7 t -75.85 -31.85 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 108.616 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.5 tt0 -60.84 -50.4 73.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -57.16 -49.04 77.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.661 -0.65 . . . . 0.0 110.277 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -57.7 -40.51 79.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.095 -1.003 . . . . 0.0 110.808 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.3 mt -70.53 -38.63 74.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.851 -1.156 . . . . 0.0 109.943 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.9 mt -71.49 -37.42 71.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.744 -1.222 . . . . 0.0 108.908 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.81 70.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 108.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.19 -37.7 57.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 108.793 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 34.1 m0 . . . . . 0 C--N 1.301 -1.503 0 O-C-N 120.925 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -97.5 167.62 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.54 143.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.37 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -95.62 144.03 26.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -0.856 . . . . 0.0 110.032 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.28 115.29 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 130.0 46.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.593 ' O ' HG11 ' A' ' 72' ' ' VAL . 32.6 p -87.21 -177.1 5.91 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.011 0.91 . . . . 0.0 110.774 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.603 HD11 ' H ' ' B' ' 271' ' ' LEU . 46.9 mt -72.74 -14.98 61.67 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.424 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.851 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -98.11 -3.88 36.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.529 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.04 5.05 57.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.311 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -71.37 118.08 13.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.364 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 20.0 m -99.59 135.56 40.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.278 -0.888 . . . . 0.0 109.012 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.667 HD11 ' CD ' ' B' ' 234' ' ' GLU . 37.6 mt -134.11 137.35 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.521 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 86.5 m -104.77 125.23 50.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.5 mt -127.47 119.95 27.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.58 131.9 47.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.83 -173.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.573 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.19 153.06 76.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 108.869 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.75 -24.26 45.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.382 2.054 . . . . 0.0 111.906 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.29 5.98 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.921 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -70.45 142.51 51.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.997 -1.064 . . . . 0.0 109.363 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 60.5 p -86.2 146.0 26.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.141 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.7 mm -51.41 -35.31 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.066 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -34.62 72.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.813 . . . . 0.0 109.546 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -70.99 -52.6 18.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.365 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.407 ' O ' HD12 ' B' ' 230' ' ' ILE . 38.0 t -52.32 -43.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 108.824 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.31 -41.29 79.6 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.277 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' B' ' 215' ' ' LEU . 16.7 mtpp -56.94 -53.72 54.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.095 -1.003 . . . . 0.0 108.744 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.604 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.5 mp -56.59 -35.49 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.934 . . . . 0.0 108.925 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -62.77 -49.58 74.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 0.0 109.921 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -31.45 70.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 110.763 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -98.1 -53.96 3.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.966 -1.083 . . . . 0.0 110.846 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.667 ' CD ' HD11 ' B' ' 213' ' ' ILE . 14.7 mm-40 -81.22 -8.65 59.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.165 -0.959 . . . . 0.0 111.132 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.84 68.97 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 120.625 -1.297 . . . . 0.0 110.396 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 53.5 mt -100.72 129.51 27.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.238 . . . . 0.0 109.345 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.23 158.67 48.49 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.069 1.846 . . . . 0.0 111.88 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.18 -31.25 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.692 2.261 . . . . 0.0 112.899 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.59 -6.24 29.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 110.443 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -16.86 4.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 110.26 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.7 140.2 31.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 0.0 109.184 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -129.74 134.49 47.65 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.431 ' CB ' HD12 ' B' ' 250' ' ' LEU . 12.1 mt -106.85 126.67 52.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.269 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.9 mt -119.81 135.18 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.628 -0.67 . . . . 0.0 109.626 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.557 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 50.7 t80 -127.11 109.21 11.63 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 67.41 41.21 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.868 -1.145 . . . . 0.0 109.267 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.18 1.99 23.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -98.57 135.85 39.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.26 . . . . 0.0 109.585 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -82.75 123.62 29.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 109.272 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.524 HD11 HD23 ' B' ' 267' ' ' LEU . 39.7 mt -71.45 142.72 50.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.0 146.51 28.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.5 OUTLIER -72.81 3.43 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.684 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.23 44.09 1.46 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -155.86 172.44 18.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.905 -1.35 . . . . 0.0 109.461 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 76.2 p -113.54 162.5 16.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.624 -0.672 . . . . 0.0 110.149 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.472 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.8 mt -56.34 -44.5 80.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.4 p -60.22 -27.99 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.88 . . . . 0.0 109.737 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -20.85 62.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.9 5.45 43.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 66.91 39.69 3.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.01 137.0 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -126.26 178.39 5.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.05 158.98 1.3 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.971 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 58.11 24.02 10.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.304 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.35 148.72 25.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.479 -1.388 . . . . 0.0 108.675 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.786 ' C ' HD12 ' B' ' 267' ' ' LEU . 1.8 m -110.87 134.48 52.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.649 -0.657 . . . . 0.0 109.685 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.786 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -124.04 139.06 54.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.541 -0.724 . . . . 0.0 109.226 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -89.05 143.56 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.08 -1.012 . . . . 0.0 110.001 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.86 127.41 54.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.023 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 80' ' ' VAL . 42.5 t -112.76 128.17 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.576 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.603 ' H ' HD11 ' B' ' 208' ' ' LEU . 44.9 mt -81.3 143.6 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.242 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 . . . . . 0 C--N 1.301 -1.527 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.312 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -48.12 164.81 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.457 2.104 . . . . 0.0 112.917 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -2.14 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.573 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.877 ' O ' HG22 ' B' ' 209' ' ' THR . 0.5 OUTLIER -123.63 9.17 8.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.141 -0.975 . . . . 0.0 110.423 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.4 mm -110.84 129.37 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.167 -0.958 . . . . 0.0 111.267 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t0 -100.24 140.19 21.28 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.24 -47.04 0.57 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.407 2.071 . . . . 0.0 112.219 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.531 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -47.25 -45.32 23.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.738 -0.601 . . . . 0.0 110.336 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.595 HG11 ' O ' ' B' ' 207' ' ' THR . 21.6 t -80.71 -33.03 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.82 -1.175 . . . . 0.0 110.526 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 18.1 t80 -60.76 -54.39 45.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.909 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.66 -18.13 58.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -81.35 -5.88 58.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.86 -1.15 . . . . 0.0 109.712 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 76' ' ' LEU . 95.2 mt -90.63 151.56 44.09 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.619 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 155.28 16.34 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.342 2.028 . . . . 0.0 111.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -63.53 -49.03 75.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.02 -42.97 60.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.898 -1.126 . . . . 0.0 110.156 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.77 -32.19 27.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.373 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.61 -49.5 77.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -58.09 -49.47 76.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.206 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -58.29 -39.52 79.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.0 110.366 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.922 -1.111 . . . . 0.0 109.817 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.8 mt -71.04 -37.14 72.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 109.089 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -33.23 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.68 -38.22 64.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.267 -0.895 . . . . 0.0 109.0 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 38.0 m0 . . . . . 0 C--N 1.3 -1.582 0 O-C-N 120.949 -1.095 . . . . 0.0 108.485 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.86 163.92 12.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 110.482 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.52 145.93 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.226 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.13 141.98 31.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 113.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.714 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.548 ' NZ ' ' CB ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -100.81 129.31 46.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 108.79 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.595 ' O ' HG11 ' A' ' 72' ' ' VAL . 31.1 p -90.19 -171.79 3.24 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.036 0.922 . . . . 0.0 111.36 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.617 HD11 ' H ' ' B' ' 271' ' ' LEU . 40.8 mt -71.74 -17.79 62.17 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.716 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.877 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.8 p -97.56 -2.64 41.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.675 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.07 2.42 62.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.61 118.63 9.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -1.214 . . . . 0.0 108.856 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 23.0 m -101.35 133.07 46.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.5 mt -128.27 137.88 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.468 -0.77 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 49.6 m -105.96 120.76 42.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 108.768 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' B' ' 229' ' ' LYS . 23.6 mt -125.53 121.02 32.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.393 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.29 132.2 47.25 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.86 -172.56 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.888 -1.132 . . . . 0.0 109.854 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -134.73 153.56 78.93 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -58.15 -24.03 64.54 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.478 2.118 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.76 6.91 41.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.825 . . . . 0.0 109.783 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.63 143.93 49.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.954 -1.091 . . . . 0.0 109.571 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.2 p -87.63 145.92 25.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.0 109.824 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 33.2 mm -51.79 -39.82 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.178 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -34.4 57.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.565 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -72.24 -50.22 29.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.178 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 51.2 t -51.99 -49.72 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 108.557 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -42.87 62.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.571 -0.705 . . . . 0.0 109.477 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.88 75.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.517 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.5 mtpp -57.41 -53.71 55.08 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.246 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.52 -33.16 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.013 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.04 -47.63 85.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.99 -1.069 . . . . 0.0 110.118 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.56 -26.71 63.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.008 -1.058 . . . . 0.0 110.906 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -94.52 -50.06 5.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.886 -1.134 . . . . 0.0 110.529 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -92.64 -7.69 46.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 0.0 111.396 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.27 21.18 77.19 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 120.44 -1.413 . . . . 0.0 110.726 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 24.9 mt -103.98 128.11 27.88 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.909 -1.347 . . . . 0.0 109.587 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.87 164.79 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.183 1.922 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.9 -31.95 7.7 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.011 2.474 . . . . 0.0 113.383 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.63 -5.91 43.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.243 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.499 HE21 HD22 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -121.9 -25.97 4.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.476 ' HB2' HD11 ' B' ' 269' ' ' LEU . 1.6 pt20 -90.19 147.95 23.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.385 -1.447 . . . . 0.0 108.816 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -131.37 133.37 45.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -0.995 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.5 mt -103.84 123.24 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.439 -0.788 . . . . 0.0 109.016 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 97.8 mt -117.55 133.97 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.65 -0.657 . . . . 0.0 109.378 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 44.5 t80 -129.05 117.24 20.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 60.3 37.23 20.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.654 -1.279 . . . . 0.0 109.21 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.29 28.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -94.96 132.56 39.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.828 -1.395 . . . . 0.0 109.501 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -82.58 125.07 30.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.11 140.75 41.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' B' ' 253' ' ' GLY . 9.0 tp10 -101.62 148.92 24.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.58 4.16 2.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.337 -0.852 . . . . 0.0 110.832 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 253' ' ' GLY . . . . . 0.453 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -119.15 46.02 1.18 Allowed Glycine 0 N--CA 1.497 2.721 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.937 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.92 174.41 15.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.905 -1.35 . . . . 0.0 109.515 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 17.0 p -112.65 160.67 17.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 110.257 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.6 mt -58.48 -41.11 84.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 109.749 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 30.0 p -61.72 -28.04 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 0.0 109.418 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -70.55 -19.68 62.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.38 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -103.17 3.58 35.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.062 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 66.54 38.93 3.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.551 -0.718 . . . . 0.0 109.99 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 49.6 mt -92.81 137.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.155 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -126.16 176.23 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.073 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.509 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.69 160.35 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.914 0.864 . . . . 0.0 110.834 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 56.04 12.67 0.97 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.123 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 16.1 m -78.22 152.03 32.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.882 -1.136 . . . . 0.0 108.644 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.781 ' C ' HD12 ' B' ' 267' ' ' LEU . 15.4 m -116.34 137.97 51.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -0.764 . . . . 0.0 110.388 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.781 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -123.97 140.88 52.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.359 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.433 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 68.2 m80 -88.95 141.12 28.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.115 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' B' ' 241' ' ' GLN . 14.3 tp -110.08 127.85 55.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 132.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 109.776 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.617 ' H ' HD11 ' B' ' 208' ' ' LEU . 45.4 mt -80.84 141.39 34.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.115 -0.991 . . . . 0.0 109.289 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.361 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -48.25 164.84 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.309 2.006 . . . . 0.0 113.12 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.88 -2.16 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.754 -0.591 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.952 ' O ' HG22 ' B' ' 209' ' ' THR . 2.2 m-20 -122.66 7.31 9.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.098 -1.001 . . . . 0.0 110.387 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.96 128.66 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -0.993 . . . . 0.0 110.967 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.3 t0 -101.09 140.45 21.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.11 -48.75 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.495 2.13 . . . . 0.0 112.432 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.3 tt0 -47.07 -46.86 22.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.733 -0.604 . . . . 0.0 110.46 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.674 HG11 ' O ' ' B' ' 207' ' ' THR . 57.8 t -80.42 -23.67 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.234 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.9 t80 -72.17 -54.89 8.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 111.03 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.9 -19.13 59.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -80.26 -4.18 52.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.877 -1.14 . . . . 0.0 109.302 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 152.65 43.41 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.257 -0.902 . . . . 0.0 109.847 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.5 154.36 30.62 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.415 2.077 . . . . 0.0 111.852 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -63.31 -48.06 79.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -0.854 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.16 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.92 -1.113 . . . . 0.0 110.44 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.49 HG11 HG21 ' B' ' 270' ' ' VAL . 57.9 t -75.06 -31.97 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 0.0 108.361 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.6 tt0 -59.88 -50.51 73.51 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -58.39 -48.14 81.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.86 -41.98 88.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 110.789 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.4 mt -71.15 -37.31 72.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.689 -1.257 . . . . 0.0 109.723 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.26 -37.54 74.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.855 -1.153 . . . . 0.0 109.036 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.78 73.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.055 -1.028 . . . . 0.0 109.003 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -71.36 -40.31 70.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 108.819 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 23.8 m0 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.057 -1.027 . . . . 0.0 109.192 179.225 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -97.58 164.28 12.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 110.599 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.0 143.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.83 140.78 29.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.712 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.04 110.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 109.304 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.7 ptpt -97.1 132.4 42.93 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.674 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.8 p -94.45 -174.61 3.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.101 -1.0 . . . . 0.0 111.066 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.17 -14.27 61.77 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.343 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.952 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.1 p -99.71 -4.33 30.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.455 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.63 1.8 60.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -66.8 117.85 9.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -1.21 . . . . 0.0 108.848 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 8.6 m -101.0 133.07 46.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 108.978 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 26.6 mt -127.63 135.6 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 109.503 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 19.0 m -102.63 121.38 42.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.591 HD13 ' CB ' ' B' ' 229' ' ' LYS . 33.2 mt -127.39 119.45 26.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.369 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.5 130.97 45.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.27 -177.01 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -130.18 153.54 81.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 109.034 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.26 -17.95 42.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.401 2.068 . . . . 0.0 111.946 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.33 8.47 29.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.0 144.54 47.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.847 -1.158 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 64.6 p -87.04 145.86 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.129 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.455 HD12 HD13 ' B' ' 250' ' ' LEU . 42.9 mm -50.88 -28.51 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 108.916 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -64.3 -37.39 87.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.388 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -69.06 -50.38 48.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.174 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.91 -48.81 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.096 -1.003 . . . . 0.0 108.685 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -52.5 -40.48 62.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.688 . . . . 0.0 109.359 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.41 -35.61 80.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.639 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.591 ' CB ' HD13 ' B' ' 215' ' ' LEU . 17.2 mtpp -58.21 -53.64 55.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.915 -1.116 . . . . 0.0 109.145 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.8 mp -59.46 -35.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.111 -0.993 . . . . 0.0 109.204 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -59.36 -44.25 92.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.095 -1.003 . . . . 0.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.91 -29.28 63.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 0.0 110.764 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -91.99 -48.87 6.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.928 -1.108 . . . . 0.0 110.605 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -92.26 -6.71 49.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 111.58 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.68 22.98 73.85 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.482 -1.386 . . . . 0.0 110.389 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 56.5 mt -101.31 129.49 26.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.312 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.4 155.46 41.08 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.029 1.819 . . . . 0.0 111.643 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.6 -32.39 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.698 2.265 . . . . 0.0 113.015 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -64.42 -8.97 15.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.55 HE21 HD22 ' B' ' 271' ' ' LEU . 0.1 OUTLIER -128.64 -21.58 3.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.753 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.532 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -84.48 135.38 34.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.749 -1.219 . . . . 0.0 109.299 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.95 131.54 51.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.04 126.76 52.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.333 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.93 134.69 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -128.31 121.51 29.4 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.84 42.79 28.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.571 -1.331 . . . . 0.0 109.275 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.72 0.03 7.89 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -95.52 132.37 40.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.872 -1.37 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.7 123.61 29.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.084 -1.01 . . . . 0.0 108.83 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.548 HD11 HD23 ' B' ' 267' ' ' LEU . 19.4 mt -68.81 150.73 47.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 0.0 109.744 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.3 141.57 36.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.51 3.49 3.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.322 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.18 35.77 3.4 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -142.34 170.95 14.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.295 . . . . 0.0 109.813 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.3 p -111.79 159.96 17.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.001 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.505 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.0 mt -56.5 -42.85 79.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 79.5 p -62.74 -29.13 70.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.8 -18.61 63.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.158 -0.964 . . . . 0.0 109.101 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.55 3.45 34.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.151 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.84 39.15 2.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.501 -0.749 . . . . 0.0 109.837 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.7 mt -93.86 136.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 262' ' ' GLN . . . . . 0.467 ' O ' ' OG ' ' B' ' 265' ' ' SER . 55.6 mt-30 -125.81 177.17 6.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.26 162.24 0.76 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.245 -0.909 . . . . 0.0 110.927 -178.832 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 56.33 12.42 1.01 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.053 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 72.7 m -76.5 149.05 36.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.891 -1.131 . . . . 0.0 108.75 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.799 ' C ' HD12 ' B' ' 267' ' ' LEU . 20.5 m -115.83 138.95 50.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 110.352 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.799 HD12 ' C ' ' B' ' 266' ' ' THR . 10.3 mp -124.88 142.81 51.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.432 -0.793 . . . . 0.0 109.406 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.407 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 69.2 m80 -90.67 141.75 28.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.034 -1.041 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' B' ' 241' ' ' GLN . 23.0 tp -111.28 128.89 56.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.412 -0.805 . . . . 0.0 109.578 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 80' ' ' VAL . 3.1 t -116.76 130.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.55 HD22 HE21 ' B' ' 240' ' ' GLN . 48.3 mt -82.57 145.66 29.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.566 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -48.09 164.13 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.287 1.991 . . . . 0.0 112.757 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -2.19 5.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.653 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.932 ' O ' HG22 ' B' ' 209' ' ' THR . 2.6 m-20 -123.22 9.66 9.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.081 -1.012 . . . . 0.0 110.698 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.8 mm -110.29 127.61 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.101 -0.999 . . . . 0.0 111.119 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.0 t70 -98.33 138.73 20.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.36 -41.69 4.53 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.338 2.025 . . . . 0.0 112.567 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 61.2 tt0 -56.61 -43.34 80.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 110.466 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.599 HG11 ' O ' ' B' ' 207' ' ' THR . 66.0 t -81.11 -24.24 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.748 -1.22 . . . . 0.0 110.402 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -72.24 -55.07 7.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -59.09 -16.76 20.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -83.93 -5.76 59.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.996 -1.065 . . . . 0.0 109.877 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.4 151.38 48.39 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.006 -1.059 . . . . 0.0 109.786 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 153.81 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.28 1.987 . . . . 0.0 111.792 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -63.03 -51.57 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.583 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.5 39.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.928 -1.108 . . . . 0.0 110.239 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.27 -31.45 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.712 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -60.49 -50.03 75.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -58.1 -49.04 78.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.753 . . . . 0.0 110.145 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -57.11 -41.99 80.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.63 -38.61 73.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.852 -1.155 . . . . 0.0 110.023 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.56 -38.33 74.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.68 -1.262 . . . . 0.0 109.327 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.48 -31.44 70.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.161 -0.962 . . . . 0.0 108.708 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -72.21 -42.64 65.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.0 m0 . . . . . 0 C--N 1.302 -1.476 0 O-C-N 120.983 -1.073 . . . . 0.0 109.391 179.672 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.441 ' O ' HG23 ' B' ' 217' ' ' VAL . 3.2 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 202' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' B' ' 202' ' ' GLN . 0.7 OUTLIER -98.19 166.84 11.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 110.334 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.34 146.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.427 -0.796 . . . . 0.0 109.781 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -97.89 141.06 31.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.87 109.12 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.463 ' HE2' HG21 ' B' ' 266' ' ' THR . 0.5 OUTLIER -95.17 133.31 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.599 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.6 p -94.78 -176.38 3.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 110.914 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.592 HD11 ' H ' ' B' ' 271' ' ' LEU . 25.7 mt -71.22 -12.8 61.67 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.489 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.932 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.7 p -101.79 -3.96 27.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.709 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.63 2.94 58.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -68.41 118.41 11.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.272 . . . . 0.0 109.021 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -101.01 135.86 41.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 40.9 mt -133.43 136.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.384 -0.823 . . . . 0.0 109.349 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.1 m -105.91 122.49 46.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.534 HD13 ' CB ' ' B' ' 229' ' ' LYS . 18.4 mt -126.11 121.7 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.391 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.54 132.24 47.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 201' ' ' MET . 8.2 m -140.2 -173.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.968 -1.082 . . . . 0.0 109.58 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -134.95 154.2 79.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.97 -20.62 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.545 2.163 . . . . 0.0 112.223 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 67.4 m -106.3 7.66 31.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 110.219 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 142.2 54.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.77 -1.206 . . . . 0.0 109.404 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.5 p -85.43 146.85 26.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.414 HD12 HD13 ' B' ' 250' ' ' LEU . 40.5 mm -51.7 -40.26 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.389 -0.82 . . . . 0.0 109.384 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.17 -35.67 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.568 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.408 ' HA ' HD21 ' B' ' 225' ' ' ASN . 9.9 m120 -69.13 -52.3 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 99.0 t -52.51 -45.58 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.377 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.06 -43.69 70.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.7 73.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.444 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.534 ' CB ' HD13 ' B' ' 215' ' ' LEU . 4.4 mtpm? -58.55 -54.53 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.495 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.3 mp -57.86 -34.18 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.848 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -63.1 -46.14 88.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.236 -0.915 . . . . 0.0 109.997 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -30.81 71.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.184 -0.947 . . . . 0.0 110.902 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -95.87 -50.67 4.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.008 -1.058 . . . . 0.0 110.556 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -87.39 -7.69 57.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.032 -1.043 . . . . 0.0 111.412 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.75 23.27 70.67 Favored Glycine 0 N--CA 1.493 2.446 0 O-C-N 120.535 -1.353 . . . . 0.0 110.305 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 45.9 mt -100.48 126.7 34.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.086 -1.244 . . . . 0.0 109.271 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.15 152.78 40.48 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.064 1.843 . . . . 0.0 111.767 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.04 -30.1 47.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.668 2.245 . . . . 0.0 112.694 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.24 -16.1 41.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.521 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.08 -12.36 5.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.422 -0.798 . . . . 0.0 110.696 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.575 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -90.86 137.0 32.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.917 -1.115 . . . . 0.0 109.523 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.18 132.09 45.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.654 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.92 128.78 54.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 109.297 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.56 136.22 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.563 -0.711 . . . . 0.0 109.85 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 40.9 t80 -132.36 117.02 17.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.233 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.35 36.96 8.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.895 -1.128 . . . . 0.0 109.436 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.8 13.0 68.51 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.295 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -115.45 137.8 51.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.263 . . . . 0.0 109.524 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.56 126.17 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.013 . . . . 0.0 109.435 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.414 HD13 HD12 ' B' ' 223' ' ' ILE . 23.0 mt -70.69 139.78 51.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -92.6 142.2 27.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.192 -0.942 . . . . 0.0 109.486 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.5 m-20 -69.26 3.45 2.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 109.712 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.44 41.68 1.73 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.543 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -144.78 171.25 14.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 109.332 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 25.8 p -111.73 158.32 19.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.962 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.481 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.4 mt -54.88 -40.7 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 89.0 p -64.2 -28.35 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.547 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.61 -17.17 62.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.17 3.16 29.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 109.084 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 37.85 3.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 0.0 109.999 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.48 135.92 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -125.74 177.78 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 109.925 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.489 ' H ' ' HE3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.53 157.13 3.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.021 0.915 . . . . 0.0 111.008 -178.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 57.87 12.43 1.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.671 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 22.0 m -75.9 148.3 38.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.729 ' C ' HD12 ' B' ' 267' ' ' LEU . 30.8 m -115.58 138.97 50.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.772 . . . . 0.0 110.048 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 266' ' ' THR . 11.2 mp -120.72 166.46 13.68 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -112.13 137.47 50.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.795 . . . . 0.0 109.426 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.575 HD11 ' HG3' ' B' ' 241' ' ' GLN . 18.6 tp -108.86 126.05 52.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.478 -0.763 . . . . 0.0 109.285 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.07 130.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.435 -0.791 . . . . 0.0 109.624 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.592 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.4 mt -80.79 143.22 33.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.092 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 108.85 -178.876 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.84 164.79 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.642 2.228 . . . . 0.0 112.962 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.0 p -69.13 -2.47 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.768 -0.582 . . . . 0.0 110.509 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.847 ' O ' HG22 ' B' ' 209' ' ' THR . 32.2 m-20 -121.56 6.62 10.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.017 -1.052 . . . . 0.0 110.204 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -108.78 129.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.905 . . . . 0.0 111.275 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.8 t0 -100.49 138.33 20.13 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.7 -47.12 1.45 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.149 1.899 . . . . 0.0 112.009 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 7.1 tt0 -50.47 -43.04 55.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.889 -0.507 . . . . 0.0 110.1 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.629 HG11 ' O ' ' B' ' 207' ' ' THR . 62.1 t -80.55 -23.97 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.699 -1.251 . . . . 0.0 110.022 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -73.59 -52.79 12.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.093 -1.005 . . . . 0.0 110.655 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -62.56 -17.4 59.88 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.916 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -81.07 -6.37 58.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.9 -1.125 . . . . 0.0 109.779 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' B' ' 268' ' ' HIS . 95.6 mt -90.65 151.74 44.24 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.13 155.99 17.61 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.005 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -50.03 71.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.96 -43.28 50.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.92 -1.113 . . . . 0.0 110.352 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' B' ' 270' ' ' VAL . 89.7 t -75.13 -32.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.889 -1.132 . . . . 0.0 108.642 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.1 tt0 -59.26 -51.44 69.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -57.62 -49.06 77.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.562 -0.711 . . . . 0.0 110.352 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.79 -41.28 81.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.045 . . . . 0.0 110.861 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.7 mt -71.22 -36.33 71.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.7 -1.25 . . . . 0.0 109.632 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 mt -71.45 -37.85 71.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.71 -1.244 . . . . 0.0 108.854 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.22 72.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.101 -0.999 . . . . 0.0 109.435 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -74.39 -37.02 63.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 108.888 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.1 m0 . . . . . 0 C--N 1.301 -1.536 0 O-C-N 120.882 -1.136 . . . . 0.0 108.612 178.809 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -95.45 165.63 12.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.437 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.0 pp -146.66 141.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' B' ' 266' ' ' THR . 8.6 m-85 -94.52 141.98 27.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.974 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.49 114.37 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.479 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.3 OUTLIER -99.0 138.92 35.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.629 ' O ' HG11 ' A' ' 72' ' ' VAL . 30.1 p -98.65 -175.5 3.09 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -0.936 . . . . 0.0 110.573 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.23 -15.91 62.98 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.188 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.847 HG22 ' O ' ' A' ' 67' ' ' ASP . 7.9 p -100.3 -3.07 32.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.132 -0.98 . . . . 0.0 109.655 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.1 3.61 57.83 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.353 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.8 117.61 9.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.289 . . . . 0.0 108.962 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 4.7 m -99.92 132.97 44.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 20.5 mt -127.95 136.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.46 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 67.6 m -105.95 119.95 40.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.8 mt -123.87 122.53 38.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 132.76 48.12 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.93 -174.04 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.93 -1.106 . . . . 0.0 109.77 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -135.93 154.51 77.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.89 . . . . 0.0 109.206 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.85 -29.03 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.69 2.26 . . . . 0.0 112.105 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 t -98.4 6.06 47.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.694 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.25 142.37 52.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.001 -1.062 . . . . 0.0 109.502 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.6 p -87.99 145.32 26.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.029 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.412 HD12 HD13 ' B' ' 250' ' ' LEU . 36.0 mm -51.5 -37.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.114 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -34.01 58.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -72.58 -50.48 25.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.193 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.9 -51.22 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 108.928 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -50.76 -42.31 57.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.336 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.0 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 0.0 109.735 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.511 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.8 mtpp -57.03 -54.01 51.62 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.008 -1.057 . . . . 0.0 109.19 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.431 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -60.08 -32.36 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -62.1 -47.14 85.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -72.66 -26.51 61.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.806 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -92.48 -48.38 6.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.815 -1.178 . . . . 0.0 110.504 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.22 -6.66 47.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 111.261 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.46 72.54 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 120.571 -1.331 . . . . 0.0 110.328 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.82 126.68 31.95 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.086 -1.243 . . . . 0.0 109.232 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -72.04 156.61 55.77 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.813 1.676 . . . . 0.0 111.58 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.93 -29.9 22.35 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.617 2.211 . . . . 0.0 112.851 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.3 -14.5 60.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.431 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.462 HE21 HD22 ' B' ' 271' ' ' LEU . 0.3 OUTLIER -122.87 -20.97 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.37 -0.831 . . . . 0.0 110.288 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.67 136.27 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.857 -1.152 . . . . 0.0 108.894 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -127.47 132.8 49.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.53 123.53 48.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.099 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 93.9 mt -118.19 135.75 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.7 t80 -131.92 115.89 16.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.852 . . . . 0.0 108.956 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.9 35.87 8.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.97 10.49 68.34 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.173 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -111.28 136.86 49.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.686 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.94 122.21 27.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 109.483 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.576 HD11 HD23 ' B' ' 267' ' ' LEU . 29.5 mt -68.39 146.6 53.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 109.25 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -101.24 143.86 30.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.74 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.589 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.2 OUTLIER -71.26 3.91 3.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.949 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.6 36.31 3.17 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 19.8 mtt85 -142.54 174.34 10.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.903 -1.351 . . . . 0.0 109.692 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 14.1 p -113.09 158.79 19.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 110.104 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.5 mt -56.9 -43.45 81.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.78 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 59.1 p -59.63 -27.17 66.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -19.21 61.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.637 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -103.84 3.89 34.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.329 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.54 38.31 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.0 109.792 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -93.02 135.98 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.003 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.67 176.76 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.111 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.588 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.44 155.4 2.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.885 0.85 . . . . 0.0 111.196 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 59.93 14.21 4.14 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.19 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.437 ' OG ' HG22 ' B' ' 203' ' ' ILE . 88.9 p -76.87 149.91 36.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.801 -1.187 . . . . 0.0 108.551 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.767 ' C ' HD12 ' B' ' 267' ' ' LEU . 3.1 m -114.57 135.68 53.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.737 . . . . 0.0 110.276 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.767 HD12 ' C ' ' B' ' 266' ' ' THR . 9.1 mp -122.98 140.11 53.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.504 -0.747 . . . . 0.0 109.253 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.408 ' HB3' HD21 ' A' ' 76' ' ' LEU . 66.1 m80 -88.5 141.55 28.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.144 -0.973 . . . . 0.0 110.203 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.05 126.96 53.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.452 -0.78 . . . . 0.0 108.951 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 2.5 t -114.75 128.99 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.884 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.462 HD22 HE21 ' B' ' 240' ' ' GLN . 48.9 mt -80.77 143.57 32.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.032 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -178.761 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -48.46 163.96 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.229 1.953 . . . . 0.0 112.749 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.45 -1.78 5.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.862 ' O ' HG22 ' B' ' 209' ' ' THR . 8.5 m-20 -123.46 9.64 9.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.131 -0.981 . . . . 0.0 110.553 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 68' ' ' ILE . 25.7 mm -111.28 129.17 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.218 -0.926 . . . . 0.0 111.327 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.7 t0 -98.44 138.93 20.86 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.81 -44.89 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.286 1.99 . . . . 0.0 112.066 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 14.2 tt0 -47.67 -47.01 29.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.878 -0.514 . . . . 0.0 110.409 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG11 ' O ' ' B' ' 207' ' ' THR . 24.7 t -79.87 -39.88 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -52.57 -54.59 30.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.838 -1.164 . . . . 0.0 111.007 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -61.3 -18.49 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 110.016 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -82.76 -5.36 58.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.822 -1.174 . . . . 0.0 109.638 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD11 ' CD2' ' B' ' 208' ' ' LEU . 95.1 mt -89.38 152.06 47.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.032 -1.043 . . . . 0.0 109.527 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.4 154.19 25.15 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.326 2.018 . . . . 0.0 112.004 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -48.57 77.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.835 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.59 -42.82 62.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.977 -1.077 . . . . 0.0 110.168 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.08 -31.64 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.9 -1.125 . . . . 0.0 108.475 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.446 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.3 tt0 -60.18 -53.17 60.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -54.95 -49.31 71.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -57.38 -39.25 75.64 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.006 -1.059 . . . . 0.0 110.609 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.87 -37.34 64.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.644 -1.285 . . . . 0.0 109.917 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.406 HD23 ' HE3' ' A' ' 88' ' ' TRP . 28.0 mt -71.44 -38.33 71.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.761 -1.212 . . . . 0.0 108.889 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.94 -34.15 75.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 109.442 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -74.31 -33.55 63.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.406 ' HE3' HD23 ' A' ' 85' ' ' LEU . 42.9 m0 . . . . . 0 C--N 1.3 -1.557 0 O-C-N 120.898 -1.126 . . . . 0.0 107.995 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -96.73 163.68 12.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.356 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.42 142.56 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.527 -0.733 . . . . 0.0 109.346 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' B' ' 266' ' ' THR . 9.5 m-85 -94.06 142.46 27.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.62 113.91 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.19 -0.944 . . . . 0.0 109.701 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.552 ' NZ ' ' CB ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.5 135.14 43.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.077 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.501 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.0 p -93.38 -175.61 3.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.014 0.912 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.493 HD11 ' H ' ' B' ' 271' ' ' LEU . 43.2 mt -70.32 -19.8 63.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.6 p -96.56 -3.31 43.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.974 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.99 58.06 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.545 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -68.45 118.62 11.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.895 -1.356 . . . . 0.0 108.973 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.0 m -102.43 139.43 38.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.262 -0.899 . . . . 0.0 109.808 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.403 HG21 HD13 ' B' ' 213' ' ' ILE . 54.5 mt -137.94 137.67 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 0.0 109.339 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 36.1 m -105.45 122.55 46.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 108.741 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.545 HD13 ' CB ' ' B' ' 229' ' ' LYS . 19.4 mt -125.29 121.55 34.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 110.567 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -65.79 131.38 46.16 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.95 -173.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.013 -1.054 . . . . 0.0 109.902 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -134.36 156.04 79.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.0 108.923 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.09 -20.42 67.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.433 2.088 . . . . 0.0 111.899 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 4.3 m -103.54 6.94 37.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.837 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 144.78 48.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.996 -1.065 . . . . 0.0 109.544 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 80.4 p -86.43 148.83 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.3 -25.16 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.912 . . . . 0.0 108.92 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -35.43 77.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.801 . . . . 0.0 109.35 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.09 -51.09 34.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.62 -48.18 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 108.385 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -51.05 -44.9 61.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.05 76.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.337 -0.852 . . . . 0.0 109.583 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.545 ' CB ' HD13 ' B' ' 215' ' ' LEU . 4.2 mtpm? -56.96 -54.69 43.83 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.544 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.411 HG13 HD11 ' B' ' 215' ' ' LEU . 2.5 mp -59.95 -31.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.037 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.94 -48.46 78.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.72 -27.9 67.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -94.67 -52.57 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.929 -1.107 . . . . 0.0 110.374 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -87.93 -7.99 56.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.31 24.34 73.52 Favored Glycine 0 N--CA 1.494 2.503 0 O-C-N 120.44 -1.413 . . . . 0.0 110.458 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.5 mt -100.69 130.89 24.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.325 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.53 152.83 43.75 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.077 1.852 . . . . 0.0 111.676 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.07 -32.74 16.74 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.573 2.182 . . . . 0.0 113.107 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.408 ' C ' ' OD1' ' B' ' 239' ' ' ASP . 15.1 p30 -64.06 -8.84 13.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 -21.66 3.39 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.451 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.473 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -85.49 136.82 33.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.71 -1.244 . . . . 0.0 108.776 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -128.04 133.2 49.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.32 -0.863 . . . . 0.0 109.685 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.407 ' CB ' HD12 ' B' ' 250' ' ' LEU . 11.5 mt -105.24 125.8 51.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.0 mt -116.93 156.0 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.1 t80 -151.81 116.57 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.271 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 59.96 43.02 15.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.843 -1.161 . . . . 0.0 109.507 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 23.82 67.19 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.2 ptmm? -121.59 136.91 54.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 0.0 109.479 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.85 123.81 31.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.265 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.426 HD11 HD23 ' B' ' 267' ' ' LEU . 25.7 mt -74.51 141.68 44.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.37 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.45 147.53 24.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.95 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -73.02 3.4 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.519 -0.738 . . . . 0.0 109.755 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.49 33.64 4.58 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -143.11 172.21 13.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.95 -1.323 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 82.2 p -111.51 159.61 17.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 110.075 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.498 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.0 mt -55.51 -40.98 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.468 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.7 p -63.28 -28.21 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.102 -0.999 . . . . 0.0 109.535 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -18.75 62.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.982 . . . . 0.0 109.53 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -103.06 4.09 36.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.097 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 69.81 40.91 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.687 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 52.0 mt -98.52 136.81 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 -178.87 4.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 108.96 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.533 ' HD3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.41 163.31 0.63 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.37 1.081 . . . . 0.0 111.525 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 55.71 11.32 0.64 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.145 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 147.12 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.82 -1.175 . . . . 0.0 108.924 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.838 ' C ' HD12 ' B' ' 267' ' ' LEU . 5.7 m -113.89 138.39 50.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.597 -0.689 . . . . 0.0 110.083 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.838 HD12 ' C ' ' B' ' 266' ' ' THR . 10.2 mp -127.17 144.27 51.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.34 -0.85 . . . . 0.0 110.18 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.43 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 62.1 m80 -91.9 142.45 27.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.188 -0.945 . . . . 0.0 110.382 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.473 HD11 ' HG3' ' B' ' 241' ' ' GLN . 14.0 tp -109.35 127.02 54.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.365 -0.835 . . . . 0.0 108.924 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.75 131.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.383 -0.823 . . . . 0.0 109.729 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.493 ' H ' HD11 ' B' ' 208' ' ' LEU . 39.4 mt -81.76 143.87 31.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 108.706 -179.24 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.552 0.215 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.77 165.06 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.641 2.227 . . . . 0.0 113.176 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -2.75 10.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 110.691 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.839 ' O ' HG22 ' B' ' 209' ' ' THR . 45.4 m-20 -120.85 5.61 10.45 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.031 -1.043 . . . . 0.0 109.894 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.7 mm -109.62 130.44 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 111.001 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.85 134.57 20.4 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.01 -45.55 5.82 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.965 1.777 . . . . 0.0 112.024 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -50.23 -44.71 53.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.849 -0.532 . . . . 0.0 110.485 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.62 HG11 ' O ' ' B' ' 207' ' ' THR . 38.8 t -80.2 -26.44 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.834 -1.166 . . . . 0.0 110.147 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.0 t80 -68.99 -51.67 36.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.536 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -62.59 -17.48 60.22 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.803 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.94 -6.74 59.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.865 -1.147 . . . . 0.0 109.641 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 76' ' ' LEU . 97.0 mt -89.15 151.75 47.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.144 -0.972 . . . . 0.0 109.753 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.38 155.64 19.81 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.41 2.074 . . . . 0.0 111.91 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.39 -50.81 68.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 110.679 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.22 -42.99 52.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.297 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.16 -30.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 108.423 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.0 tt0 -60.6 -51.59 68.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -56.9 -47.83 79.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.525 -0.735 . . . . 0.0 110.202 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.24 -40.31 85.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.044 -1.035 . . . . 0.0 110.775 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.0 mt -72.31 -35.7 68.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.796 -1.19 . . . . 0.0 109.561 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.44 -37.49 71.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 108.853 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.77 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.025 -1.047 . . . . 0.0 109.197 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -72.71 -37.89 67.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.401 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 42.5 m0 . . . . . 0 C--N 1.302 -1.487 0 O-C-N 120.95 -1.094 . . . . 0.0 108.77 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -95.12 165.59 12.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.86 151.97 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.392 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' B' ' 264' ' ' GLU . 8.8 m-85 -104.29 142.61 34.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.878 . . . . 0.0 109.782 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.38 114.02 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.528 ' HE3' HG22 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -101.31 130.46 47.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 108.818 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.62 ' O ' HG11 ' A' ' 72' ' ' VAL . 38.1 p -89.11 -175.53 4.84 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.999 0.904 . . . . 0.0 111.019 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.517 HD11 ' H ' ' B' ' 271' ' ' LEU . 25.1 mt -71.41 -11.33 60.83 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.585 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.9 p -103.48 -2.88 26.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.836 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.35 60.51 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.243 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -67.77 117.84 10.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.265 . . . . 0.0 108.845 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -99.96 139.33 35.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.176 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.549 HD11 ' CD ' ' B' ' 234' ' ' GLU . 29.1 mt -135.54 137.81 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.2 m -105.14 122.59 46.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 108.837 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' B' ' 229' ' ' LYS . 21.5 mt -127.01 119.29 26.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.945 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.71 132.36 49.44 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.3 -175.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.947 -1.095 . . . . 0.0 109.764 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.36 154.43 78.59 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 108.978 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.39 -24.74 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.62 2.214 . . . . 0.0 112.005 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 6.54 42.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.24 142.88 52.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.505 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 11.9 p -85.66 145.7 27.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.34 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 34.8 mm -51.81 -35.76 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.251 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' B' ' 225' ' ' ASN . 5.8 pt-20 -61.38 -36.21 79.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.417 ' N ' ' CG ' ' B' ' 224' ' ' GLU . 7.2 m120 -68.16 -52.45 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.25 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.84 -48.29 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.919 -1.113 . . . . 0.0 108.045 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.99 -43.65 60.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.709 -0.619 . . . . 0.0 109.492 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 109.27 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.511 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.7 mtpp -57.48 -53.98 52.05 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.085 -1.009 . . . . 0.0 109.433 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.22 -33.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.122 -0.986 . . . . 0.0 109.083 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -62.78 -48.46 79.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.212 -0.93 . . . . 0.0 110.031 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.76 -25.43 66.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.635 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -98.95 -57.62 2.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.043 . . . . 0.0 110.522 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.549 ' CD ' HD11 ' B' ' 213' ' ' ILE . 34.9 mm-40 -81.43 -8.48 59.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.25 -0.906 . . . . 0.0 111.187 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.77 22.24 73.55 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 120.502 -1.374 . . . . 0.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.422 HD13 HD21 ' B' ' 271' ' ' LEU . 64.7 mt -101.73 131.13 23.24 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.977 -1.307 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.2 153.65 41.01 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.029 1.819 . . . . 0.0 111.798 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.43 -30.86 43.6 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.558 2.172 . . . . 0.0 112.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.27 -16.62 63.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.638 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.472 HE21 HD22 ' B' ' 271' ' ' LEU . 0.4 OUTLIER -121.78 -18.22 7.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.25 137.57 32.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.75 -1.219 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -129.0 134.12 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.403 ' HB3' HD12 ' B' ' 250' ' ' LEU . 11.9 mt -105.71 124.8 50.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 78.4 mt -118.33 135.46 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.71 -0.619 . . . . 0.0 109.533 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.539 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 41.2 t80 -129.91 113.49 14.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.47 -0.769 . . . . 0.0 109.004 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.34 38.7 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.65 7.78 55.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.441 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.6 OUTLIER -105.75 135.84 46.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.242 . . . . 0.0 109.489 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -83.61 119.76 25.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 0.0 109.338 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' B' ' 243' ' ' LEU . 39.2 mt -67.6 140.47 56.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 2.0 tm-20 -92.5 143.1 26.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -71.54 3.5 3.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 109.636 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 253' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 251' ' ' GLU . . . -121.35 39.66 2.32 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -146.21 173.7 11.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.968 -1.313 . . . . 0.0 109.383 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 5.7 p -112.32 161.56 16.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 109.864 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.509 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.1 mt -58.54 -41.16 84.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.787 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 93.7 p -62.24 -29.04 70.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.742 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.57 -19.98 62.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -101.93 3.97 39.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.267 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.6 38.18 3.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 32.7 mt -93.27 136.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -125.19 176.74 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.539 -0.726 . . . . 0.0 109.757 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.78 159.58 1.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.935 0.874 . . . . 0.0 110.719 -179.184 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' CE2' ' B' ' 204' ' ' PHE . 2.7 mm-40 55.76 27.55 10.94 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.162 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.17 149.09 21.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.164 . . . . 0.0 108.525 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 9.5 m -112.65 136.36 52.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 110.268 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.56 139.47 53.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.129 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -87.79 141.51 28.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.9 tp -108.86 126.62 53.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.53 129.21 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.639 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.517 ' H ' HD11 ' B' ' 208' ' ' LEU . 48.5 mt -81.31 143.89 31.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.0 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.91 . . . . 0.0 109.061 -179.222 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.37 164.12 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.451 2.1 . . . . 0.0 113.172 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -68.6 -2.09 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.761 -0.587 . . . . 0.0 110.468 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.891 ' O ' HG22 ' B' ' 209' ' ' THR . 0.7 OUTLIER -122.12 8.41 9.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.074 -1.016 . . . . 0.0 110.436 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HA ' HD13 ' A' ' 68' ' ' ILE . 25.6 mm -108.71 126.5 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.924 . . . . 0.0 111.295 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 5.3 t0 -98.25 113.38 63.94 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -46.49 -47.24 15.85 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.161 1.907 . . . . 0.0 112.271 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -48.53 -45.18 37.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.469 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG11 ' O ' ' B' ' 207' ' ' THR . 40.6 t -80.47 -24.25 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.646 -1.284 . . . . 0.0 110.423 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.2 t80 -69.68 -52.6 24.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.77 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -62.52 -17.07 58.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.925 . . . . 0.0 110.021 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -81.66 -6.36 58.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.787 -1.196 . . . . 0.0 109.95 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.61 152.64 43.59 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 109.63 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.09 155.22 19.68 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.534 2.156 . . . . 0.0 112.135 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -50.25 70.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.12 -43.2 51.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.889 -1.132 . . . . 0.0 110.387 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.35 -30.99 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.982 -1.074 . . . . 0.0 108.324 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.2 tt0 -59.96 -51.45 69.64 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -57.56 -48.06 80.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.613 -0.679 . . . . 0.0 110.244 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.15 -39.81 79.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.696 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.75 -36.81 67.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.714 -1.241 . . . . 0.0 109.745 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.93 -37.77 69.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.785 -1.197 . . . . 0.0 108.789 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.76 -34.23 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 109.515 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.92 -33.69 59.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 108.644 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 50.4 m0 . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.261 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -94.39 163.9 13.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.917 . . . . 0.0 109.999 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.533 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.87 142.3 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.221 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -94.48 142.82 26.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.092 -1.005 . . . . 0.0 109.691 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.48 114.7 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' B' ' 268' ' ' HIS . 14.0 ptmt -101.42 132.98 46.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.898 . . . . 0.0 109.159 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.67 ' O ' HG11 ' A' ' 72' ' ' VAL . 18.6 p -91.01 -175.62 4.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.32 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.469 HD11 ' H ' ' B' ' 271' ' ' LEU . 74.8 mt -70.69 -15.54 62.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -101.93 -1.68 31.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.688 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.77 4.8 58.91 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.392 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -68.3 117.75 10.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.323 . . . . 0.0 108.807 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.9 m -99.74 140.41 33.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.421 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 22.2 mt -137.56 137.86 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 22.7 m -104.26 124.35 49.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' B' ' 229' ' ' LYS . 23.5 mt -129.2 119.3 23.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.87 . . . . 0.0 110.06 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.88 133.94 51.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.65 -0.656 . . . . 0.0 109.439 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.26 -173.38 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 0.0 109.616 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' B' ' 221' ' ' ASP . 20.1 mt-10 -135.81 153.38 77.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 108.862 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.68 -21.47 25.22 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.569 2.18 . . . . 0.0 112.03 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.0 7.58 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.955 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' B' ' 218' ' ' GLU . 0.9 OUTLIER -70.29 142.34 52.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.901 -1.125 . . . . 0.0 109.507 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.6 p -86.55 145.8 26.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.188 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.432 HD12 HD13 ' B' ' 250' ' ' LEU . 39.2 mm -50.97 -43.17 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.418 ' CD ' ' OD1' ' B' ' 225' ' ' ASN . 0.2 OUTLIER -52.62 -34.76 52.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.475 -0.766 . . . . 0.0 109.699 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.418 ' OD1' ' CD ' ' B' ' 224' ' ' GLU . 63.5 m-20 -71.22 -52.21 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.23 -45.47 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.037 -1.04 . . . . 0.0 108.529 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -43.12 70.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.98 78.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.413 -0.804 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.558 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.1 mtpp -57.78 -53.75 54.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.084 -1.01 . . . . 0.0 109.363 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.564 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.7 mp -57.22 -35.61 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.007 -1.058 . . . . 0.0 109.246 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.895 -1.128 . . . . 0.0 109.967 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.98 -29.2 70.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.843 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -95.51 -52.28 4.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.381 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -87.76 -6.58 58.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.31 24.02 71.93 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.45 -1.406 . . . . 0.0 110.289 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 44.6 mt -103.03 128.79 26.92 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.25 . . . . 0.0 109.774 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.57 155.95 31.85 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.159 1.906 . . . . 0.0 111.828 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.77 -30.62 33.69 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.944 2.429 . . . . 0.0 112.939 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -61.95 -13.3 23.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.465 HE21 HD22 ' B' ' 271' ' ' LEU . 0.7 OUTLIER -128.77 -17.2 4.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -0.77 . . . . 0.0 110.746 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.23 137.04 32.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.701 -1.25 . . . . 0.0 109.417 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -129.54 130.78 46.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 109.567 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.74 125.13 50.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 109.32 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 39.9 mt -118.78 136.22 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.672 -0.642 . . . . 0.0 109.428 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -131.06 119.23 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.758 . . . . 0.0 109.459 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.0 47.29 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.923 -1.111 . . . . 0.0 109.464 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.53 26.28 64.29 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.7 OUTLIER -123.91 135.3 53.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.315 -1.109 . . . . 0.0 109.622 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -84.09 122.11 28.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 109.258 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.432 HD13 HD12 ' B' ' 223' ' ' ILE . 38.1 mt -72.38 144.02 48.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -96.89 143.5 27.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 3.68 3.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.442 -0.786 . . . . 0.0 109.843 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.11 44.74 1.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.49 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -148.26 174.1 12.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.141 -1.211 . . . . 0.0 109.079 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.7 p -111.91 160.15 17.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.354 -0.841 . . . . 0.0 110.185 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.493 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.6 mt -60.21 -40.72 91.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.842 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.4 p -61.68 -28.77 69.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.957 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.58 -15.86 62.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -104.28 2.38 31.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 108.933 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.07 38.54 3.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.89 137.45 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.102 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -126.7 179.49 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 108.987 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 163.73 0.51 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.45 1.119 . . . . 0.0 111.492 -178.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 55.54 12.04 0.72 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.093 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.533 ' OG ' HG22 ' B' ' 203' ' ' ILE . 89.2 p -76.09 148.31 38.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 108.714 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.75 ' C ' HD12 ' B' ' 267' ' ' LEU . 17.7 m -114.19 136.8 52.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.459 -0.776 . . . . 0.0 110.268 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.75 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -123.74 139.43 53.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.533 -0.73 . . . . 0.0 109.361 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 60.9 m80 -88.77 142.13 27.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 110.287 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.58 125.61 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.39 130.05 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.746 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.469 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.7 mt -80.76 143.34 32.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.082 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 108.694 -179.199 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.61 165.2 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.055 1.837 . . . . 0.0 112.22 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 t -66.01 -12.53 55.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.701 -0.624 . . . . 0.0 110.88 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.884 ' O ' HG22 ' B' ' 209' ' ' THR . 1.6 m-20 -112.49 8.65 19.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.479 HG21 ' CH2' ' A' ' 88' ' ' TRP . 30.4 mm -111.41 129.71 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.111 -0.993 . . . . 0.0 110.707 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.4 t70 -97.96 139.13 21.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.27 -36.58 3.99 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.228 1.952 . . . . 0.0 112.537 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 8.5 tp60 -59.13 -44.5 92.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.536 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.704 HG11 ' O ' ' B' ' 207' ' ' THR . 61.6 t -79.02 -23.9 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.809 -1.182 . . . . 0.0 110.047 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 19.8 t80 -66.4 -52.38 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.087 -1.008 . . . . 0.0 110.729 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -63.41 -16.31 60.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.52 -6.87 59.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 109.767 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.473 HD11 ' CD2' ' B' ' 208' ' ' LEU . 91.5 mt -90.18 152.26 45.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.13 154.86 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.409 2.073 . . . . 0.0 112.03 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.1 -50.47 70.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.4 -44.37 34.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.936 -1.103 . . . . 0.0 110.013 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' B' ' 270' ' ' VAL . 57.4 t -74.61 -31.82 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.911 -1.118 . . . . 0.0 108.603 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.3 tt0 -59.57 -50.06 75.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -57.85 -48.56 79.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.804 . . . . 0.0 109.944 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.18 -35.12 71.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.95 . . . . 0.0 110.113 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.66 -41.74 37.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.962 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.78 -38.23 88.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.647 -1.283 . . . . 0.0 108.671 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.74 82.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 108.981 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.13 -33.19 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 108.639 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.479 ' CH2' HG21 ' A' ' 68' ' ' ILE . 48.0 m0 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 217' ' ' VAL . 6.9 ptt? . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.51 166.92 10.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 110.387 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.43 142.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 0.0 109.376 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -95.14 146.96 23.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.571 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.47 110.93 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.202 -0.937 . . . . 0.0 110.161 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.855 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.0 OUTLIER -96.99 138.7 34.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.704 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.8 p -102.7 -173.03 2.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 111.3 -178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.473 ' CD2' HD11 ' A' ' 76' ' ' LEU . 21.4 mt -70.81 -17.86 62.75 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.298 0.57 . . . . 0.0 109.597 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -96.84 -5.15 38.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 109.299 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.64 60.63 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -69.67 119.44 13.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 0.0 108.948 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 47.7 m -101.04 133.15 45.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 109.335 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.0 mt -128.2 136.87 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 214' ' ' THR . . . . . 0.416 ' O ' HD23 ' B' ' 215' ' ' LEU . 58.5 m -105.34 124.34 49.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.381 -0.824 . . . . 0.0 109.029 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.7 mt -129.8 120.01 24.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.842 . . . . 0.0 110.234 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.78 132.65 48.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.709 . . . . 0.0 109.17 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 201' ' ' MET . 15.5 m -138.97 -175.7 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.014 -1.054 . . . . 0.0 109.972 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -132.49 154.89 81.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.532 -0.73 . . . . 0.0 109.074 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.02 -19.35 47.94 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.505 2.137 . . . . 0.0 112.123 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.19 8.2 31.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.22 143.17 48.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.939 -1.101 . . . . 0.0 109.784 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 13.6 p -85.7 148.53 25.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.799 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.0 mm -52.2 -39.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.79 67.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.775 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -70.06 -53.3 18.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 0.0 109.302 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.52 -44.15 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.179 -0.951 . . . . 0.0 108.638 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -57.56 -38.71 75.25 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.75 -36.87 84.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.537 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.3 mtpp -57.59 -53.31 59.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.564 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.8 mp -59.24 -34.57 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 109.131 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -61.67 -43.47 98.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -28.78 63.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.977 -1.077 . . . . 0.0 110.721 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -92.99 -49.86 5.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 110.489 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -91.39 -6.86 52.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.195 -0.941 . . . . 0.0 111.357 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.97 74.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.104 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 61.2 mt -102.06 123.19 44.38 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.046 -1.267 . . . . 0.0 109.135 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.71 152.13 41.94 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.83 1.687 . . . . 0.0 111.802 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.99 -29.47 75.63 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.597 2.198 . . . . 0.0 112.802 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 49.9 p-10 -64.15 -13.74 50.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.085 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.2 OUTLIER -126.89 -20.79 4.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.464 -0.772 . . . . 0.0 109.945 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.588 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -85.91 133.39 33.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 109.043 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -126.98 132.42 50.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.88 123.38 47.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.372 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.4 132.82 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.53 123.73 34.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 54.13 41.63 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.786 -1.197 . . . . 0.0 109.312 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 67.68 3.97 30.19 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 135.4 42.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.82 125.63 33.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.154 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.8 mt -74.89 139.67 43.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 109.794 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.07 146.95 23.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.12 3.82 4.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.122 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.62 46.32 1.11 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.685 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -151.38 172.46 15.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -1.23 . . . . 0.0 109.485 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 63.9 p -111.57 160.89 16.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 110.106 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.496 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.0 mt -60.63 -43.68 97.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.232 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 56.9 p -59.35 -28.35 66.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.38 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.23 -13.1 61.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 109.065 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -107.35 5.32 27.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -0.829 . . . . 0.0 109.116 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.03 39.31 10.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 57.9 mt -92.74 136.36 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 108.987 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -125.54 175.71 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.765 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.91 160.65 0.67 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.776 0.798 . . . . 0.0 110.71 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 56.77 13.97 1.63 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.291 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 55.2 m -75.84 146.1 40.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.752 -1.217 . . . . 0.0 108.607 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.855 HG21 ' NZ ' ' B' ' 206' ' ' LYS . 5.5 m -112.31 138.01 49.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 0.0 110.018 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.786 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -124.7 138.79 54.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -86.86 140.73 29.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' B' ' 241' ' ' GLN . 18.9 tp -110.31 127.71 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.452 -0.78 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 14.9 t -114.62 129.39 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.439 HD22 HE21 ' B' ' 240' ' ' GLN . 47.3 mt -82.27 143.97 30.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.168 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.3 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.9 164.58 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.224 1.949 . . . . 0.0 113.05 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 -2.07 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.568 . . . . 0.0 110.517 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.872 ' O ' HG22 ' B' ' 209' ' ' THR . 1.8 m-20 -123.05 10.57 9.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.148 -0.97 . . . . 0.0 110.373 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.7 mm -113.21 129.85 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.244 -0.91 . . . . 0.0 111.361 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.6 t70 -99.33 140.24 21.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.07 -37.51 3.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.41 2.073 . . . . 0.0 112.723 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.7 tt0 -61.26 -41.01 96.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.861 . . . . 0.0 110.184 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.69 HG11 ' O ' ' B' ' 207' ' ' THR . 25.4 t -80.98 -24.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.0 110.036 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 27.2 t80 -72.6 -53.58 11.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.993 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -61.29 -15.81 39.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.47 -5.23 59.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.911 -1.118 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.6 151.66 48.29 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 109.819 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.12 152.73 29.28 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.006 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.03 -50.39 70.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.777 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.15 -43.28 51.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.987 -1.071 . . . . 0.0 109.96 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 63.7 t -74.76 -32.12 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.009 -1.057 . . . . 0.0 108.348 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.8 tt0 -60.41 -51.74 68.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -55.15 -49.16 72.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.715 . . . . 0.0 109.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -58.45 -36.85 74.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 0.0 110.49 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.74 -39.9 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.749 -1.22 . . . . 0.0 109.831 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.41 -37.86 74.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 108.986 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.1 79.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 108.973 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.84 -36.78 75.84 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.5 m0 . . . . . 0 C--N 1.301 -1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.758 179.059 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.14 165.13 12.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 0.0 110.67 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.95 143.07 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.557 -0.714 . . . . 0.0 109.269 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -95.13 142.48 27.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.56 112.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.548 ' NZ ' ' CB ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.25 131.8 47.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 108.948 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.69 ' O ' HG11 ' A' ' 72' ' ' VAL . 32.8 p -91.55 -173.75 3.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 110.968 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.5 mt -70.58 -16.21 62.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.229 0.538 . . . . 0.0 109.954 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.872 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.7 p -99.39 -2.64 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.957 . . . . 0.0 109.614 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.16 1.38 61.14 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.217 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -64.42 116.9 6.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.332 . . . . 0.0 108.675 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.1 m -99.42 136.63 39.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.98 137.04 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.8 m -105.98 118.91 37.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 108.81 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' B' ' 229' ' ' LYS . 20.7 mt -124.6 122.18 36.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.388 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -68.29 133.56 48.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.429 HG11 HG22 ' B' ' 226' ' ' VAL . 11.0 m -139.73 -174.24 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.822 -1.173 . . . . 0.0 110.004 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.15 154.56 81.7 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 0.0 109.053 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.81 -21.79 58.7 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.573 2.182 . . . . 0.0 112.013 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 28.0 p -103.31 8.17 38.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.653 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -71.73 142.03 49.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.017 . . . . 0.0 109.497 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.9 p -85.93 145.63 27.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.479 HD12 HD13 ' B' ' 250' ' ' LEU . 36.5 mm -51.62 -21.54 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -37.07 70.06 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.998 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.11 -52.52 34.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.429 HG22 HG11 ' B' ' 217' ' ' VAL . 47.9 t -52.24 -46.32 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 108.548 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -43.12 72.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.292 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.13 72.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 109.561 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.525 ' CB ' HD13 ' B' ' 215' ' ' LEU . 22.3 mtpp -60.29 -53.29 59.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.023 -1.048 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.472 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.4 mp -59.71 -32.01 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.106 -0.996 . . . . 0.0 108.928 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -63.51 -44.76 93.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.37 -23.54 61.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.444 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -97.66 -51.39 4.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 110.672 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -89.4 -7.97 54.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.03 24.34 76.56 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.497 -1.377 . . . . 0.0 110.577 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 34.0 mt -106.65 131.76 21.45 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.059 -1.259 . . . . 0.0 109.594 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 237' ' ' PRO . . . . . 0.454 ' HG2' HE21 ' B' ' 240' ' ' GLN . 37.9 Cg_endo -71.15 162.26 43.16 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.204 1.936 . . . . 0.0 112.678 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.94 -34.05 7.0 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.155 2.57 . . . . 0.0 113.131 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.62 -5.98 33.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.28 -0.888 . . . . 0.0 111.152 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.454 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -124.22 -26.18 4.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.252 -0.905 . . . . 0.0 111.356 -179.278 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' B' ' 269' ' ' LEU . 2.0 pt20 -88.61 127.74 35.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.283 -1.511 . . . . 0.0 109.23 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.42 ' HE ' ' HD2' ' B' ' 272' ' ' ARG . 93.6 mtt180 -111.96 134.93 53.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.35 126.02 51.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 108.91 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.28 134.92 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.567 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.551 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 47.5 t80 -128.11 110.52 12.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.181 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 67.34 39.4 2.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.328 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.5 2.94 45.85 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.886 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -100.86 137.34 39.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.299 . . . . 0.0 109.689 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.23 122.33 28.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.963 -1.086 . . . . 0.0 109.292 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.479 HD13 HD12 ' B' ' 223' ' ' ILE . 41.8 mt -71.95 145.74 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 109.315 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -100.59 144.93 28.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.1 3.69 4.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.413 -0.804 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.58 43.79 1.41 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -150.06 172.08 15.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.145 -1.209 . . . . 0.0 109.325 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.4 p -110.9 159.41 17.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.472 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.8 mt -56.61 -42.16 78.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.692 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.1 p -61.21 -27.96 68.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.005 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -20.15 63.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -102.78 3.85 37.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.166 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.44 39.34 2.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.582 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.8 mt -92.94 135.53 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.308 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -124.02 176.56 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.12 159.69 1.19 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.978 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.04 28.49 12.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.097 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 12.5 p -91.28 149.65 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.588 -1.32 . . . . 0.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 4.3 m -111.4 135.39 52.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.533 -0.729 . . . . 0.0 109.966 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 10.7 mp -124.29 140.21 53.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.539 -0.726 . . . . 0.0 109.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -88.77 142.01 28.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' B' ' 241' ' ' GLN . 13.5 tp -110.74 129.59 55.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.433 -0.792 . . . . 0.0 109.249 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.06 133.09 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.408 -0.808 . . . . 0.0 109.891 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' B' ' 271' ' ' LEU . 47.2 mt -80.68 143.19 33.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.42 ' HD2' ' HE ' ' B' ' 242' ' ' ARG . 27.4 ttt180 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 108.733 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.13 164.65 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.34 2.027 . . . . 0.0 112.956 178.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.8 t -67.13 -2.45 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.908 ' O ' HG22 ' B' ' 209' ' ' THR . 7.6 m-20 -123.18 9.39 9.23 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.72 128.78 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.14 -0.975 . . . . 0.0 110.951 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.37 139.3 21.36 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.21 -36.42 4.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.404 2.069 . . . . 0.0 112.97 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.82 -40.74 97.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.511 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.724 HG11 ' O ' ' B' ' 207' ' ' THR . 21.8 t -80.1 -23.67 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.68 -1.263 . . . . 0.0 109.559 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.2 t80 -71.7 -54.0 11.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.718 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -61.1 -18.19 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.06 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -82.39 -4.88 58.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.142 . . . . 0.0 109.343 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.6 mt -89.99 151.96 45.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.842 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.98 153.34 32.27 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.318 2.012 . . . . 0.0 111.985 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.13 -49.53 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.698 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.64 -44.38 57.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 -178.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.79 -31.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 108.377 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -61.58 -49.1 77.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -58.8 -48.55 80.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.623 -0.673 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.9 -40.27 75.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 110.051 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.58 -38.1 67.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.882 -1.136 . . . . 0.0 109.741 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.61 -39.18 73.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.713 -1.242 . . . . 0.0 108.996 178.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.135 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -73.14 -35.52 66.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.835 . . . . 0.0 108.944 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 44.1 m0 . . . . . 0 C--N 1.302 -1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.846 179.102 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.4 ptt? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.42 166.37 10.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.748 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.65 142.92 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.589 -0.694 . . . . 0.0 109.33 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -95.74 143.6 26.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 31.8 t -123.85 109.05 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -0.879 . . . . 0.0 109.808 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.1 OUTLIER -93.09 135.45 34.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 108.57 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.724 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.5 p -96.26 -174.9 3.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.243 -0.91 . . . . 0.0 110.867 -178.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.573 HD11 ' H ' ' B' ' 271' ' ' LEU . 27.5 mt -72.17 -13.86 61.66 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.908 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.8 p -99.56 -4.11 31.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.451 -0.781 . . . . 0.0 109.558 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.08 1.12 61.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -67.03 119.05 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -1.148 . . . . 0.0 109.118 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.7 m -100.09 135.78 41.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.043 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 43.7 mt -131.25 135.18 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.571 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 33.4 m -104.55 120.28 40.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.416 -0.802 . . . . 0.0 108.886 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' B' ' 229' ' ' LYS . 26.1 mt -123.85 119.59 30.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.772 . . . . 0.0 110.017 -179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -66.83 131.16 45.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.43 -175.57 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 110.065 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.48 154.4 81.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.044 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -58.79 -20.16 50.3 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.599 2.199 . . . . 0.0 112.386 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.4 t -105.24 9.3 34.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.9 142.99 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.98 -1.075 . . . . 0.0 109.433 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 69.6 p -86.46 147.62 25.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 110.144 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mm -51.64 -33.8 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -33.95 73.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -71.44 -51.32 24.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 108.954 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.6 -50.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -50.41 -38.12 41.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.484 0.659 . . . . 0.0 109.265 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.72 84.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.585 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.4 mtpp -57.9 -53.15 61.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.2 -0.938 . . . . 0.0 109.223 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.43 -35.23 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.062 -1.024 . . . . 0.0 108.566 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.53 -45.94 90.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 109.743 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -24.12 64.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -100.26 -54.52 2.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.051 -1.031 . . . . 0.0 110.465 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -85.89 -5.83 59.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 111.243 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.28 27.01 70.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.594 -1.317 . . . . 0.0 110.321 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.99 128.56 26.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -1.205 . . . . 0.0 109.283 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.77 157.01 48.37 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.892 1.728 . . . . 0.0 111.932 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.54 -30.84 22.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.683 2.256 . . . . 0.0 112.385 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.4 -9.13 22.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.399 -0.813 . . . . 0.0 110.248 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.408 HE21 HD22 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -128.9 -20.33 3.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 110.431 -179.669 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.39 133.88 34.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.848 -1.158 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.46 134.95 50.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 109.457 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.38 126.95 52.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 109.638 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.03 133.43 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 41.6 t80 -128.49 114.54 16.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.124 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 63.06 46.6 4.62 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.781 -1.199 . . . . 0.0 109.075 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.97 6.4 6.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.46 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -103.22 137.55 41.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -1.143 . . . . 0.0 109.537 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -85.81 128.58 34.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.493 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 28.8 mt -80.25 140.38 36.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 251' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' B' ' 253' ' ' GLY . 11.3 tp10 -90.87 142.62 27.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.588 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.0 OUTLIER -68.75 3.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.474 -0.766 . . . . 0.0 109.791 179.883 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 253' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -127.85 40.94 1.66 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.661 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.51 168.38 19.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.279 . . . . 0.0 108.977 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 21.0 p -106.59 157.45 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.529 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.1 mt -58.46 -42.36 87.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.012 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 40.2 p -61.73 -29.04 69.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.54 -16.93 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.131 -0.981 . . . . 0.0 109.277 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -104.56 2.91 31.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.092 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 67.55 38.93 2.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.408 -0.807 . . . . 0.0 109.773 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 37.7 mt -91.62 136.41 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.308 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 262' ' ' GLN . . . . . 0.469 ' O ' ' OG ' ' B' ' 265' ' ' SER . 57.5 mt-30 -122.9 172.78 8.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.89 162.61 0.42 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.963 0.887 . . . . 0.0 110.844 -178.915 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 54.46 11.08 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.81 177.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 39.0 m -72.08 144.82 48.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.893 -1.129 . . . . 0.0 108.631 178.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.736 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.8 m -111.16 137.08 49.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 110.296 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.736 HD12 ' C ' ' B' ' 266' ' ' THR . 11.3 mp -120.9 162.85 19.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 79.4 m80 -108.22 137.44 46.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.318 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.0 tp -106.87 123.07 47.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.009 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.6 127.11 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.454 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.573 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.5 mt -81.46 142.95 32.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.224 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.245 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.02 164.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.257 1.971 . . . . 0.0 112.804 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 t -67.85 -2.68 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.67 -0.644 . . . . 0.0 110.508 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.904 ' O ' HG22 ' B' ' 209' ' ' THR . 9.3 m-20 -121.37 6.58 10.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.001 . . . . 0.0 110.296 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.66 128.21 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.834 -179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.6 t70 -99.56 140.04 21.31 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.73 -48.73 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.425 2.084 . . . . 0.0 112.196 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.1 tt0 -48.2 -44.19 32.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.698 -0.626 . . . . 0.0 110.228 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG11 ' O ' ' B' ' 207' ' ' THR . 58.1 t -80.27 -23.5 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.006 -1.059 . . . . 0.0 110.439 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 25.4 t80 -72.11 -53.01 14.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 110.918 -178.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -62.71 -17.36 60.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.24 -7.32 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.863 -1.148 . . . . 0.0 109.749 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.84 152.39 46.57 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.41 154.58 29.1 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.455 2.103 . . . . 0.0 111.922 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -62.99 -49.03 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -44.75 54.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.951 -1.093 . . . . 0.0 110.24 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -74.73 -29.94 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.023 -1.048 . . . . 0.0 108.426 178.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.5 tt0 -61.53 -51.65 67.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -56.88 -49.29 75.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -56.69 -37.62 71.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.107 -0.995 . . . . 0.0 110.451 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.2 mt -74.8 -36.98 62.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.865 -1.147 . . . . 0.0 109.886 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -71.01 -39.77 72.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.844 -1.16 . . . . 0.0 109.049 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.71 75.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.932 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -70.42 -38.21 74.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 30.7 m0 . . . . . 0 C--N 1.301 -1.531 0 O-C-N 120.947 -1.096 . . . . 0.0 108.886 179.113 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.19 165.83 11.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.094 -1.004 . . . . 0.0 110.572 -178.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 145.33 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.593 -0.692 . . . . 0.0 109.681 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.0 m-30 -94.02 139.97 30.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 109.035 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.91 106.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.5 ptpt -92.63 134.89 34.57 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.322 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.586 ' O ' HG11 ' A' ' 72' ' ' VAL . 44.4 p -94.58 -177.4 4.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 110.541 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' B' ' 270' ' ' VAL . 53.5 mt -72.51 -12.12 60.95 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.7 p -100.95 -3.03 30.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.63 -1.44 63.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -66.07 119.73 11.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.986 -1.302 . . . . 0.0 108.843 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 27.7 m -100.82 137.81 38.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 57.2 mt -133.58 136.82 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 109.329 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 18.2 m -104.86 119.37 38.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 108.681 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.2 mt -123.16 120.08 32.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -66.36 132.87 49.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.513 -0.742 . . . . 0.0 109.065 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.75 -176.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.87 -1.144 . . . . 0.0 110.01 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -134.09 154.06 79.96 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.5 -26.85 65.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.598 2.199 . . . . 0.0 112.328 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 t -97.65 7.18 46.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.3 140.67 48.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.079 -1.013 . . . . 0.0 109.34 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 38.5 p -85.92 146.72 26.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 29.2 mm -51.8 -27.25 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 109.206 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.22 -29.24 67.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.729 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -75.44 -51.15 13.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.72 -47.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -51.99 -46.55 64.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.43 70.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.621 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.569 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.5 mtpp -55.95 -53.65 54.3 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.404 HG13 HD11 ' B' ' 215' ' ' LEU . 2.6 mp -58.2 -34.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.035 . . . . 0.0 109.257 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -62.08 -53.4 55.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.933 -1.104 . . . . 0.0 109.852 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.25 -29.54 67.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.558 -178.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -95.92 -57.86 2.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.021 -1.049 . . . . 0.0 110.666 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -84.09 -5.36 59.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 111.509 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.14 24.83 70.66 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 120.524 -1.36 . . . . 0.0 110.462 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.7 mt -104.21 128.48 27.0 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.026 -1.279 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 237' ' ' PRO . . . . . 0.45 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.5 Cg_endo -75.71 156.48 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.124 1.883 . . . . 0.0 111.914 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.51 -29.19 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.724 2.283 . . . . 0.0 112.951 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -65.21 -15.51 62.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.45 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.8 -22.47 5.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.481 -179.536 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.585 -1.322 . . . . 0.0 108.964 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -125.51 132.52 52.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -0.842 . . . . 0.0 109.807 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.36 125.45 51.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.303 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 60.5 mt -120.29 136.17 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.3 t80 -131.6 114.3 14.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.4 -0.813 . . . . 0.0 109.327 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 65.21 39.26 5.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.01 -1.057 . . . . 0.0 109.323 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.79 15.97 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -97.65 138.29 35.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.318 . . . . 0.0 109.702 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -83.47 128.3 34.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.985 . . . . 0.0 109.244 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.2 mt -78.32 137.29 37.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.029 -1.045 . . . . 0.0 109.326 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.53 146.46 23.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.027 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.18 3.95 3.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.074 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.19 40.04 2.09 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.624 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -147.41 151.35 36.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.113 -1.228 . . . . 0.0 109.272 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.8 p -91.16 161.61 15.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.461 HD23 ' N ' ' B' ' 256' ' ' LEU . 7.5 mt -57.13 -42.38 80.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.718 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 77.4 p -60.98 -28.35 68.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 109.75 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -70.73 -13.23 61.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.164 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -109.9 2.39 19.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.444 -0.785 . . . . 0.0 109.268 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.39 39.61 5.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.471 -0.768 . . . . 0.0 109.253 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.0 mt -92.79 98.45 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -87.37 174.81 8.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.453 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.1 165.39 0.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.0 0.905 . . . . 0.0 111.262 -178.879 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 55.57 11.58 0.65 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.913 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 43.0 m -74.97 148.38 40.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.631 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.764 ' C ' HD12 ' B' ' 267' ' ' LEU . 22.2 m -115.14 138.19 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.502 -0.748 . . . . 0.0 109.8 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.764 HD12 ' C ' ' B' ' 266' ' ' THR . 10.2 mp -121.3 166.41 14.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.2 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 56.5 m80 -113.04 138.96 49.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.637 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 9.4 tp -107.99 124.47 50.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.444 -0.785 . . . . 0.0 109.242 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.459 ' HA ' HD11 ' B' ' 208' ' ' LEU . 2.3 t -115.43 130.26 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.4 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.7 mt -79.0 142.67 36.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.237 -0.914 . . . . 0.0 108.937 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 -179.115 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.95 164.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.404 2.07 . . . . 0.0 112.967 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -2.48 7.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.851 -0.53 . . . . 0.0 110.652 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.891 ' O ' HG22 ' B' ' 209' ' ' THR . 0.0 OUTLIER -121.19 7.12 10.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.0 110.114 -179.486 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 68' ' ' ILE . 28.2 mm -109.97 128.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 111.178 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.69 138.73 20.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 -31.18 14.97 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.303 2.002 . . . . 0.0 113.112 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.72 -38.91 77.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.615 HG11 ' O ' ' B' ' 207' ' ' THR . 98.6 t -79.77 -23.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.3 t80 -73.4 -54.75 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 111.105 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -61.87 -14.93 38.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.989 -1.069 . . . . 0.0 109.842 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -84.35 -7.65 59.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.995 -1.065 . . . . 0.0 109.876 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' B' ' 268' ' ' HIS . 95.4 mt -87.77 151.43 49.99 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 109.532 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' GLU . 10.8 Cg_endo -56.66 128.38 29.77 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.299 1.999 . . . . 0.0 112.172 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' PRO . 28.9 tt0 -40.24 -47.96 2.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.451 -0.78 . . . . 0.0 110.688 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.97 -45.36 51.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.8 -1.187 . . . . 0.0 109.829 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.536 HG11 HG21 ' B' ' 270' ' ' VAL . 86.9 t -74.6 -30.27 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 108.594 178.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 16.5 tt0 -60.76 -50.95 71.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -58.29 -47.82 82.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.574 -0.704 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -57.81 -39.66 78.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 110.044 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.4 -36.18 65.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.95 -1.094 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.61 -38.94 74.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.76 -1.213 . . . . 0.0 108.883 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.95 74.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.06 -36.21 66.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 108.863 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.4 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 45.1 m0 . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.117 -0.989 . . . . 0.0 108.702 178.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 217' ' ' VAL . 3.9 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -98.9 167.01 11.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.02 144.13 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' B' ' 204' ' ' PHE . 2.5 m-30 -94.07 138.99 31.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.98 108.82 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.471 -0.768 . . . . 0.0 109.081 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 13.6 ptpt -95.84 137.77 34.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.615 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.7 p -99.22 -175.1 2.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.997 . . . . 0.0 110.662 -178.837 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.96 -9.47 58.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.608 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 67' ' ' ASP . 16.2 p -102.83 -4.12 25.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.89 . . . . 0.0 109.397 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.0 1.45 63.06 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -66.86 118.88 10.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -1.173 . . . . 0.0 108.831 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.6 m -101.42 139.54 36.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.716 HD11 ' OE2' ' B' ' 234' ' ' GLU . 50.2 mt -135.02 136.85 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.382 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 8.7 m -105.02 118.94 37.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 0.0 108.928 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.4 mt -122.51 120.56 34.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.943 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.99 132.08 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 201' ' ' MET . 12.2 m -139.6 -175.32 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.08 . . . . 0.0 109.864 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -134.27 154.98 80.26 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.451 -0.781 . . . . 0.0 109.046 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.65 -21.38 46.84 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.51 2.14 . . . . 0.0 112.207 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.4 7.51 38.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.238 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.84 142.12 49.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.865 -1.147 . . . . 0.0 109.389 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.3 p -87.12 145.36 26.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 109.814 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.44 HD12 HD13 ' B' ' 250' ' ' LEU . 34.3 mm -51.57 -22.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 109.054 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 224' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -70.06 -35.47 74.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.408 -0.808 . . . . 0.0 109.011 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -72.38 -49.88 30.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 45.5 t -52.21 -51.85 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.043 -1.036 . . . . 0.0 108.775 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -50.68 -41.01 55.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.547 -0.72 . . . . 0.0 109.482 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.07 83.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.222 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.552 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.0 mtpp -55.91 -53.6 54.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.332 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.411 HG13 HD11 ' B' ' 215' ' ' LEU . 2.6 mp -58.03 -35.0 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 0.0 109.2 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -62.18 -39.21 91.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.993 . . . . 0.0 109.773 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.07 -28.25 62.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -98.02 -54.15 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.049 . . . . 0.0 110.668 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 234' ' ' GLU . . . . . 0.716 ' OE2' HD11 ' B' ' 213' ' ' ILE . 75.7 mm-40 -83.84 -8.73 59.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.12 -0.988 . . . . 0.0 111.254 -178.508 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.65 73.64 Favored Glycine 0 N--CA 1.493 2.451 0 O-C-N 120.526 -1.359 . . . . 0.0 110.513 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.9 mt -105.22 132.17 21.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.116 -1.226 . . . . 0.0 109.266 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 237' ' ' PRO . . . . . 0.429 ' HG2' HE21 ' B' ' 240' ' ' GLN . 38.4 Cg_endo -71.25 161.64 45.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.216 1.944 . . . . 0.0 112.617 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.61 -34.66 8.91 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.158 2.572 . . . . 0.0 113.467 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -71.14 -5.92 35.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.998 -1.064 . . . . 0.0 111.534 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.429 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.26 -26.74 4.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.227 -0.921 . . . . 0.0 110.718 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.686 ' HB2' HD11 ' B' ' 269' ' ' LEU . 1.7 pt20 -88.96 132.63 34.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.431 -1.418 . . . . 0.0 109.156 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -117.95 135.31 54.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 109.682 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.06 124.51 49.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.078 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 92.4 mt -118.81 135.14 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.608 -0.682 . . . . 0.0 109.392 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.544 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 44.6 t80 -131.36 114.6 15.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.023 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.26 39.04 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.006 -1.059 . . . . 0.0 109.355 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.23 17.67 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.853 178.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -100.34 138.58 37.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.285 . . . . 0.0 109.68 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -84.04 125.93 32.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 109.527 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.44 HD13 HD12 ' B' ' 223' ' ' ILE . 39.8 mt -73.26 145.09 46.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.21 -0.931 . . . . 0.0 109.094 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -101.09 146.89 26.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.931 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.64 3.78 4.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.335 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -120.18 32.85 4.76 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.648 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -142.42 170.3 15.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.989 -1.301 . . . . 0.0 109.628 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.3 p -110.27 160.97 16.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 0.0 110.135 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.501 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.8 mt -58.15 -44.08 87.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.7 p -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.427 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.31 -12.02 60.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.656 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 28.1 m-85 -108.12 4.81 25.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 260' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' B' ' 259' ' ' TYR . 0.2 OUTLIER 64.21 36.49 9.41 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.092 0.948 . . . . 0.0 109.911 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 90.7 mt -89.73 134.42 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.263 . . . . 0.0 109.075 178.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -123.19 174.33 7.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.433 ' H ' ' HE3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 158.58 1.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.42 -0.8 . . . . 0.0 110.724 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 264' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER 57.21 11.37 1.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.427 179.242 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 4.2 m -72.42 144.88 47.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.947 -1.095 . . . . 0.0 108.352 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.746 ' C ' HD12 ' B' ' 267' ' ' LEU . 26.4 m -111.71 136.9 50.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.746 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -120.66 166.29 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.409 ' HB3' HD21 ' A' ' 76' ' ' LEU . 73.2 m80 -112.78 137.94 50.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.678 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' B' ' 241' ' ' GLN . 16.5 tp -108.1 125.19 51.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.236 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 80' ' ' VAL . 2.3 t -115.22 130.41 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.713 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.39 140.47 37.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.264 -0.897 . . . . 0.0 109.226 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 . . . . . 0 C--N 1.302 -1.489 0 O-C-N 121.339 -0.851 . . . . 0.0 108.731 -179.261 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.32 165.37 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.268 1.979 . . . . 0.0 113.026 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.7 t -67.98 -2.72 8.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.728 -0.608 . . . . 0.0 110.78 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.941 ' O ' HG22 ' B' ' 209' ' ' THR . 76.3 m-20 -121.54 3.36 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.984 -1.073 . . . . 0.0 110.408 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mm -105.89 129.57 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.157 -0.964 . . . . 0.0 110.432 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.5 t70 -98.18 139.05 20.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 -36.97 7.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.497 2.131 . . . . 0.0 112.693 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 24.1 tt0 -60.75 -42.48 97.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.476 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.733 HG11 ' O ' ' B' ' 207' ' ' THR . 36.7 t -80.9 -24.17 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 110.566 -179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.3 t80 -69.83 -54.1 15.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.992 -1.067 . . . . 0.0 110.706 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -62.36 -16.65 55.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.748 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.47 -7.11 58.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.603 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' B' ' 268' ' ' HIS . 93.3 mt -91.35 152.08 43.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.51 156.45 17.82 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.304 2.003 . . . . 0.0 111.932 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.53 -51.49 67.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 110.648 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -43.79 36.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -178.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -31.77 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 108.807 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.0 tt0 -60.25 -49.35 77.96 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -58.93 -48.43 81.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.52 -0.737 . . . . 0.0 110.158 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -57.7 -41.48 81.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.049 -1.032 . . . . 0.0 110.496 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.27 -38.82 75.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.827 -1.17 . . . . 0.0 109.817 -179.31 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.7 mt -68.79 -37.52 79.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.769 -1.207 . . . . 0.0 108.922 178.49 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.84 76.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 108.954 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -68.69 -39.43 80.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 108.9 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.8 m0 . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.062 -1.023 . . . . 0.0 109.099 179.211 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -98.65 165.92 11.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.955 . . . . 0.0 110.588 -178.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.45 144.07 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.464 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.419 ' HB2' HG23 ' B' ' 266' ' ' THR . 3.0 m-30 -94.38 142.44 27.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 109.357 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.29 112.04 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.315 -0.866 . . . . 0.0 109.684 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 131.27 43.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 108.725 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.733 ' O ' HG11 ' A' ' 72' ' ' VAL . 28.0 p -91.29 -175.64 4.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.707 HD11 ' H ' ' B' ' 271' ' ' LEU . 24.7 mt -71.85 -11.47 60.81 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.218 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.941 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.2 p -101.49 -2.55 30.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.802 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.47 0.06 63.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -66.02 118.91 10.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -1.181 . . . . 0.0 109.066 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.96 131.01 47.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.341 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.08 134.24 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.488 -0.757 . . . . 0.0 109.501 -179.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 24.9 m -103.3 122.97 45.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' B' ' 229' ' ' LYS . 24.7 mt -125.95 121.71 33.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.377 -0.827 . . . . 0.0 110.319 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.9 130.15 42.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.49 -174.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.059 -1.025 . . . . 0.0 109.881 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -137.35 154.61 75.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.67 -23.56 41.38 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.491 2.127 . . . . 0.0 112.307 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 95.3 p -101.2 7.26 43.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.015 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.01 141.48 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.954 -1.092 . . . . 0.0 109.354 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 59.8 p -85.43 149.05 25.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.178 -0.951 . . . . 0.0 109.969 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.7 -40.7 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 109.513 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -56.86 -33.85 67.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.584 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.19 -52.92 28.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 108.897 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.6 t -52.6 -49.15 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.82 -42.35 58.3 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.526 0.679 . . . . 0.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.32 83.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.593 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.1 mtpp -56.42 -53.19 60.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.086 -1.008 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.97 -32.92 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 109.22 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -62.71 -44.11 97.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.88 -27.13 61.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.979 -1.075 . . . . 0.0 110.439 -179.151 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -93.52 -50.38 5.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.026 -1.046 . . . . 0.0 110.375 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.33 -7.29 51.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.196 -0.94 . . . . 0.0 111.441 -178.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.47 23.27 76.59 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.382 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 124.07 40.1 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.144 -1.209 . . . . 0.0 109.348 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.4 155.41 41.09 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.027 1.818 . . . . 0.0 112.04 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.79 -30.36 49.86 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.729 2.286 . . . . 0.0 112.961 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.24 -8.92 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.52 -18.15 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.222 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.457 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -92.64 139.31 30.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.97 -1.081 . . . . 0.0 109.57 -179.47 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -130.64 133.45 46.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.785 . . . . 0.0 109.093 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.3 mt -106.01 125.97 51.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 58.9 mt -120.84 135.63 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.61 -0.681 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -129.65 122.81 29.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 108.806 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.93 45.83 23.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.27 0.77 4.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -98.07 134.75 40.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.318 . . . . 0.0 109.44 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -85.02 123.17 30.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.41 144.2 49.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -96.93 144.58 26.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.99 3.42 3.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 109.729 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.44 44.03 1.33 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.481 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -148.08 172.57 14.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -1.218 . . . . 0.0 109.56 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.6 p -110.84 159.52 17.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.195 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.507 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.7 mt -59.23 -43.09 92.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.654 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.0 p -60.57 -29.33 69.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.669 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.03 -14.24 62.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.15 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -107.65 2.25 23.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.0 109.278 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.68 39.5 2.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -0.823 . . . . 0.0 109.877 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.16 135.7 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -124.44 175.98 6.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.481 -0.762 . . . . 0.0 109.569 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.62 162.33 0.4 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.852 0.835 . . . . 0.0 110.908 -178.877 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 55.35 11.23 0.55 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.891 177.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.6 m -72.26 144.13 48.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.862 -1.149 . . . . 0.0 108.538 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.718 ' C ' HD12 ' B' ' 267' ' ' LEU . 1.7 m -110.73 134.92 52.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.019 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.718 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -120.92 158.07 28.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.773 . . . . 0.0 109.182 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.417 ' HB3' HD21 ' A' ' 76' ' ' LEU . 64.6 m80 -105.72 138.22 42.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.457 HD11 ' HG3' ' B' ' 241' ' ' GLN . 11.9 tp -106.88 124.15 49.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 108.941 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.36 127.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.707 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.8 mt -80.99 142.14 33.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.273 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' B' ' 272' ' ' ARG . 19.3 ttt-85 . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -47.57 165.27 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.497 2.131 . . . . 0.0 112.859 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -1.93 7.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.648 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.938 ' O ' HG22 ' B' ' 209' ' ' THR . 39.3 m-20 -122.37 6.9 9.59 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 68' ' ' ILE . 27.2 mm -110.54 130.49 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.381 -0.824 . . . . 0.0 110.756 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.5 139.35 20.56 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.54 -45.83 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.441 2.094 . . . . 0.0 112.295 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -47.35 -48.56 25.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.701 -0.625 . . . . 0.0 110.814 -179.461 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.575 HG11 ' O ' ' B' ' 207' ' ' THR . 59.5 t -78.27 -26.82 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.856 -1.152 . . . . 0.0 110.71 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.455 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -65.73 -52.85 47.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.031 -1.043 . . . . 0.0 110.912 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -62.33 -18.46 61.48 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -81.34 -5.72 58.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.863 -1.148 . . . . 0.0 109.558 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.0 mt -89.96 151.86 45.7 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.24 156.26 21.61 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.342 2.028 . . . . 0.0 111.887 179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.38 -52.45 61.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.48 -43.87 24.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -178.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.487 HG11 HG21 ' B' ' 270' ' ' VAL . 87.1 t -74.82 -31.52 26.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 108.639 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.455 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.8 tt0 -60.2 -50.83 72.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -57.27 -48.71 78.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -58.12 -43.57 87.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.076 -1.015 . . . . 0.0 110.612 -178.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.24 -37.34 77.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.914 -1.116 . . . . 0.0 109.739 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 mt -70.62 -37.21 73.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 108.829 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.21 71.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.01 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -75.97 -38.95 56.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 109.121 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.2 m0 . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.015 -1.053 . . . . 0.0 108.95 179.286 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 201' ' ' MET . . . . . 0.403 ' O ' HG23 ' B' ' 217' ' ' VAL . 10.9 ptt? . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.63 164.72 12.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -144.63 142.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.311 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -94.41 143.08 26.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.892 . . . . 0.0 109.731 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.5 t -122.02 109.85 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.46 127.49 42.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.575 ' O ' HG11 ' A' ' 72' ' ' VAL . 23.9 p -87.91 -175.56 5.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 111.065 -178.412 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.468 HD11 ' H ' ' B' ' 271' ' ' LEU . 23.7 mt -71.68 -16.3 62.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.414 0.626 . . . . 0.0 109.347 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.938 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.5 p -98.15 -4.41 35.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.48 2.4 57.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -66.55 117.1 8.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.245 . . . . 0.0 109.106 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.57 132.85 45.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -130.55 136.79 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.427 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 60.8 m -105.5 121.07 43.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' B' ' 229' ' ' LYS . 17.5 mt -125.4 121.88 35.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 110.268 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.15 133.22 48.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.645 . . . . 0.0 109.417 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.475 HG11 HG22 ' B' ' 226' ' ' VAL . 7.6 m -140.19 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.911 -1.118 . . . . 0.0 109.753 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -136.53 152.84 75.47 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.209 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.26 -26.96 54.63 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.565 2.177 . . . . 0.0 112.271 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.5 p -99.38 5.99 46.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.03 143.38 50.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 70.4 p -87.09 147.13 25.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.729 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.422 HD12 HD13 ' B' ' 250' ' ' LEU . 32.8 mm -52.78 -42.47 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -52.09 -32.04 33.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -73.38 -53.11 11.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.011 -1.055 . . . . 0.0 109.223 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.475 HG22 HG11 ' B' ' 217' ' ' VAL . 39.1 t -52.49 -42.18 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.959 . . . . 0.0 108.599 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.511 ' NZ ' ' OD1' ' B' ' 252' ' ' ASP . 6.1 ttmt -58.48 -42.47 87.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.19 -33.47 73.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.721 . . . . 0.0 109.264 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.507 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.1 mtpp -58.63 -53.16 61.5 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 108.94 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.592 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.9 mp -59.99 -32.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.41 -45.11 94.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.03 . . . . 0.0 110.025 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -73.32 -23.86 60.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -179.12 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -95.36 -50.59 4.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 110.039 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -91.86 -5.74 52.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 111.44 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.11 22.86 71.04 Favored Glycine 0 N--CA 1.492 2.4 0 O-C-N 120.53 -1.356 . . . . 0.0 110.371 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 62.3 mt -101.66 130.45 24.59 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 0.0 109.403 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.04 156.7 47.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.051 1.834 . . . . 0.0 111.949 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.47 -31.94 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.734 2.289 . . . . 0.0 112.785 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -66.95 -7.16 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 110.061 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.461 HE21 HD22 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -128.52 -22.33 3.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 -179.592 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.83 138.15 31.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.687 -1.258 . . . . 0.0 108.93 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -128.54 132.99 48.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.859 . . . . 0.0 109.654 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -105.5 125.85 51.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 109.174 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.17 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.597 -0.69 . . . . 0.0 109.505 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.504 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 49.3 t80 -127.84 112.62 14.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 0.0 109.149 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.56 40.68 5.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.041 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.74 17.06 66.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.475 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.4 ptmm? -112.18 135.52 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -1.153 . . . . 0.0 109.437 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.32 125.75 33.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.037 -1.039 . . . . 0.0 109.53 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.422 HD13 HD12 ' B' ' 223' ' ' ILE . 25.8 mt -80.28 143.99 33.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.624 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.33 147.2 28.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 252' ' ' ASP . . . . . 0.511 ' OD1' ' NZ ' ' B' ' 227' ' ' LYS . 18.0 m-20 -69.72 3.37 2.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.929 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.83 42.2 1.84 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.855 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -150.51 172.89 14.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.078 -1.248 . . . . 0.0 109.475 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.0 p -113.28 157.39 21.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 110.198 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.8 mt -56.12 -43.63 78.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.271 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 67.9 p -60.49 -28.97 68.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -16.75 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 108.819 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -106.52 0.99 25.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.482 -0.761 . . . . 0.0 108.983 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 260' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' B' ' 260' ' ' ASN . 0.9 OUTLIER 66.33 39.42 4.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -0.78 . . . . 0.0 109.879 179.843 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.04 138.34 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.69 175.37 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 263' ' ' LYS . . . . . 0.57 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.63 161.14 1.13 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.862 0.839 . . . . 0.0 110.913 -179.073 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 58.17 10.54 1.27 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.328 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.1 m -75.35 149.69 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.891 -1.131 . . . . 0.0 108.682 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 266' ' ' THR . . . . . 0.781 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.3 m -114.32 137.41 51.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.468 -0.77 . . . . 0.0 110.071 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.781 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -124.44 139.62 53.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -0.81 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.405 ' HB3' HD21 ' A' ' 76' ' ' LEU . 42.5 m80 -88.89 142.6 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.42 126.96 54.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.152 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.487 HG21 HG11 ' A' ' 80' ' ' VAL . 4.4 t -113.96 128.61 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.468 ' H ' HD11 ' B' ' 208' ' ' LEU . 50.1 mt -82.03 143.91 31.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.649 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.471 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.6 mt -113.7 132.06 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 110.452 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.4 m -113.83 127.91 56.19 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 89.7 m-85 -112.9 135.9 21.66 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.1 164.84 0.23 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.227 1.951 . . . . 0.0 112.75 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -2.12 6.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.735 -0.603 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.832 ' O ' HG22 ' B' ' 209' ' ' THR . 5.3 m-20 -122.46 11.65 9.97 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.171 -0.956 . . . . 0.0 110.591 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 68' ' ' ILE . 31.6 mm -114.36 130.32 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.232 -0.917 . . . . 0.0 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.26 138.16 20.5 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.75 -33.65 9.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.142 1.895 . . . . 0.0 113.072 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -43.0 99.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.863 . . . . 0.0 110.679 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.63 HG11 ' O ' ' B' ' 207' ' ' THR . 61.8 t -80.32 -23.81 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.704 -1.247 . . . . 0.0 109.878 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -68.29 -54.83 14.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.852 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -60.82 -15.25 28.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.42 -6.47 59.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.68 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' B' ' 268' ' ' HIS . 90.4 mt -90.03 151.98 45.7 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.189 -0.945 . . . . 0.0 109.559 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.74 154.79 24.54 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.267 1.978 . . . . 0.0 111.961 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -62.73 -52.17 64.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 110.584 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.02 -44.09 30.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.968 -1.082 . . . . 0.0 110.036 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG11 HG21 ' B' ' 270' ' ' VAL . 67.2 t -74.93 -32.19 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.937 -1.102 . . . . 0.0 108.489 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.3 tt0 -60.51 -50.03 75.17 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -57.56 -48.7 78.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.59 -0.694 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -56.68 -41.64 77.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.024 -1.047 . . . . 0.0 110.064 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.93 -38.46 69.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.074 -1.016 . . . . 0.0 109.786 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.53 -39.59 77.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.69 -1.256 . . . . 0.0 109.024 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.119 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -74.61 -38.11 62.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.407 ' CH2' HG21 ' A' ' 68' ' ' ILE . 42.4 m0 -73.37 -21.17 60.58 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.013 -1.054 . . . . 0.0 108.865 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -87.06 -45.5 10.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.294 -0.879 . . . . 0.0 109.808 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -40.96 74.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.715 -1.241 . . . . 0.0 108.732 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 92' ' ' GLY . 11.0 t -89.75 -37.28 14.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.055 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -97.57 163.06 13.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.465 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.523 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.1 pp -144.36 143.53 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.31 141.68 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.54 108.53 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.401 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.4 OUTLIER -93.54 131.04 39.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 108.822 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.63 ' O ' HG11 ' A' ' 72' ' ' VAL . 24.1 p -90.57 -175.82 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.102 -0.999 . . . . 0.0 110.676 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.579 HD11 ' H ' ' B' ' 271' ' ' LEU . 35.4 mt -70.71 -20.71 62.64 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.463 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.1 p -94.25 -4.08 49.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.725 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.28 5.89 56.91 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.367 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -69.8 118.89 13.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.966 -1.314 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 134.39 44.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 35.4 mt -131.07 136.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.866 . . . . 0.0 109.635 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -105.69 114.58 28.83 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.614 HD13 ' CB ' ' B' ' 229' ' ' LYS . 21.2 mt -118.54 123.64 45.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 110.4 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.59 132.17 46.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.7 m -139.79 -170.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.919 -1.113 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.13 152.84 76.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.033 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.74 -20.03 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.381 2.054 . . . . 0.0 111.943 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 17.7 m -105.2 7.57 33.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -70.29 141.86 52.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.045 -1.034 . . . . 0.0 109.408 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.9 p -86.29 148.8 25.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.958 . . . . 0.0 110.099 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.459 HD12 HD13 ' B' ' 250' ' ' LEU . 41.3 mm -54.23 -35.46 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -60.14 -30.22 69.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.723 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -74.29 -51.33 15.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.084 -1.01 . . . . 0.0 109.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.98 -47.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 108.809 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -54.2 -42.22 69.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 0.0 109.442 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.85 76.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.614 ' CB ' HD13 ' B' ' 215' ' ' LEU . 5.2 mtpm? -57.66 -53.92 52.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.074 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.512 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.5 mp -58.52 -32.12 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.911 . . . . 0.0 108.781 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -63.27 -49.57 73.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.059 -1.025 . . . . 0.0 109.734 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -23.6 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.056 -1.028 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -98.72 -53.15 3.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -88.69 -8.22 54.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 0.0 111.317 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 22.58 76.1 Favored Glycine 0 N--CA 1.493 2.493 0 O-C-N 120.567 -1.333 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 22.5 mt -100.86 131.13 23.85 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.992 -1.299 . . . . 0.0 109.087 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.11 160.27 39.98 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.045 1.83 . . . . 0.0 112.549 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.5 -34.43 15.45 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.288 2.658 . . . . 0.0 113.486 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.428 ' OD1' ' C ' ' B' ' 239' ' ' ASP . 4.0 p30 -69.89 -5.44 25.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.998 . . . . 0.0 111.501 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -25.83 3.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 111.315 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -88.55 144.7 26.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.235 -1.541 . . . . 0.0 109.418 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -129.32 134.05 47.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 109.663 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.65 126.14 51.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.508 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.35 135.75 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 50.5 t80 -130.59 114.12 15.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.313 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.25 39.05 7.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.54 12.52 66.96 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.846 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.443 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.5 ptmm? -111.68 136.78 50.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -1.155 . . . . 0.0 109.674 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -83.57 122.74 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 109.218 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.459 HD13 HD12 ' B' ' 223' ' ' ILE . 38.9 mt -69.86 144.31 52.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 37.3 tt0 -100.89 147.0 26.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.997 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -73.4 3.71 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.431 -0.793 . . . . 0.0 109.649 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -121.93 41.68 1.81 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -150.18 172.07 15.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.293 . . . . 0.0 109.539 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 68.2 p -111.9 162.13 15.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -0.79 . . . . 0.0 109.883 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.473 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.8 mt -58.12 -43.91 87.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.811 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 73.1 p -59.9 -27.69 66.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -25.74 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.687 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -96.73 5.55 50.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.217 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.9 38.18 2.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.53 136.7 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.146 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.47 175.28 7.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.916 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.604 ' H ' ' NZ ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.81 160.24 1.45 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.739 0.781 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 56.4 9.9 0.59 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.406 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.523 ' OG ' HG22 ' B' ' 203' ' ' ILE . 16.1 p -73.61 146.86 44.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.008 -1.058 . . . . 0.0 108.367 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.742 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.4 m -114.06 139.38 49.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.539 -0.726 . . . . 0.0 109.913 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.742 HD12 ' C ' ' B' ' 266' ' ' THR . 11.2 mp -121.14 165.92 14.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.409 ' HB3' HD21 ' A' ' 76' ' ' LEU . 79.8 m80 -113.1 139.27 48.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.466 -0.771 . . . . 0.0 109.191 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.03 125.15 51.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 109.513 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.521 HG21 HG11 ' A' ' 80' ' ' VAL . 2.5 t -113.52 129.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.579 ' H ' HD11 ' B' ' 208' ' ' LEU . 39.2 mt -83.23 142.44 31.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.167 -0.958 . . . . 0.0 109.992 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.0 ttt180 -91.06 -139.05 0.16 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.538 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 52.6 mt -123.42 -45.56 2.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.046 -1.033 . . . . 0.0 109.187 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.508 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mttp . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.555 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 40.0 mt -108.13 132.38 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -0.87 . . . . 0.0 109.779 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.9 m -113.22 124.3 52.2 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 98.1 m-85 -111.35 136.73 20.94 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.584 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.22 164.3 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.287 1.992 . . . . 0.0 113.0 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.9 m -67.66 -1.91 6.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 110.296 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.924 ' O ' HG22 ' B' ' 209' ' ' THR . 2.3 m-20 -123.01 7.87 9.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.26 -0.9 . . . . 0.0 110.782 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.3 mm -108.65 128.74 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.06 . . . . 0.0 110.81 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.77 109.67 58.44 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -47.32 -45.07 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.252 1.968 . . . . 0.0 112.539 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -49.69 -48.21 49.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 110.313 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.16 -24.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.796 -1.19 . . . . 0.0 108.902 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.1 t80 -67.99 -52.86 30.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 110.922 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -18.85 62.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -83.15 -5.41 59.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.75 151.99 46.26 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.945 . . . . 0.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.51 153.02 24.59 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.536 2.157 . . . . 0.0 112.099 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.98 -50.9 68.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 110.635 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.69 -43.9 37.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.942 -1.099 . . . . 0.0 109.838 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.6 t -75.01 -33.59 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 108.763 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -58.96 -49.97 75.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -58.9 -49.71 76.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 110.237 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -56.18 -42.3 76.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.076 -1.015 . . . . 0.0 110.412 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.41 -36.99 74.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.148 . . . . 0.0 109.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.5 -38.27 74.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.716 -1.24 . . . . 0.0 109.102 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.23 73.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 108.862 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' OE1' HD21 ' B' ' 273' ' ' LEU . 37.0 tt0 -72.82 -37.74 67.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -78.06 -13.63 59.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.999 -1.063 . . . . 0.0 108.933 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -92.63 -47.24 7.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -0.839 . . . . 0.0 109.029 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.41 ' CG ' ' N ' ' A' ' 91' ' ' THR . 17.2 ptp180 -55.12 -40.64 70.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.008 -1.057 . . . . 0.0 108.582 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.444 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 2.1 t -88.76 -36.71 15.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 108.861 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.468 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -95.85 162.73 13.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 110.39 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.2 145.81 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.618 -0.677 . . . . 0.0 109.36 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -99.34 144.07 28.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.51 112.18 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.851 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.1 OUTLIER -96.71 131.64 43.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 108.846 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.8 p -92.0 177.12 6.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 110.65 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.627 HD11 ' H ' ' B' ' 271' ' ' LEU . 29.9 mt -64.03 -11.16 26.65 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.497 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.924 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.1 p -102.53 -3.37 26.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.09 -0.2 64.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -65.74 118.93 10.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.249 . . . . 0.0 108.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.4 m -100.17 137.93 37.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.937 . . . . 0.0 109.159 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' B' ' 234' ' ' GLU . 26.6 mt -134.09 136.26 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.19 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 44.1 m -105.04 119.56 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 108.948 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.1 mt -121.98 121.88 38.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -0.766 . . . . 0.0 110.058 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.82 132.37 47.27 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.8 m -139.8 -172.11 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.907 -1.121 . . . . 0.0 109.979 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -135.99 155.02 77.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.32 -19.08 26.75 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.528 2.152 . . . . 0.0 112.165 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.58 8.99 29.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.158 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.0 141.53 50.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.875 -1.141 . . . . 0.0 109.379 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 22.5 p -85.99 144.55 27.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.81 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.56 -33.66 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 108.899 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -62.42 -30.94 71.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.205 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -73.96 -52.4 12.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 108.905 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 31.6 t -52.3 -47.76 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -51.48 -43.05 62.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.477 0.656 . . . . 0.0 109.292 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.54 80.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.556 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.3 mtpp -56.51 -53.85 52.67 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.03 -1.044 . . . . 0.0 109.351 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.7 mp -58.16 -34.43 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 108.908 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -62.75 -49.66 74.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 0.0 109.748 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -22.9 66.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.42 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -100.11 -59.92 1.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.004 -1.06 . . . . 0.0 110.17 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' B' ' 213' ' ' ILE . 77.9 mm-40 -79.78 -6.6 57.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.977 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.82 25.7 71.92 Favored Glycine 0 N--CA 1.492 2.432 0 O-C-N 120.544 -1.348 . . . . 0.0 110.358 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.8 mt -103.61 133.87 20.05 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.155 -1.203 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.05 153.14 52.04 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.45 2.1 . . . . 0.0 112.024 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.19 -34.06 10.6 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.676 2.251 . . . . 0.0 113.272 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.1 -7.95 27.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.498 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.25 -14.24 5.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.465 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -95.78 136.18 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.755 -1.215 . . . . 0.0 108.362 178.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.426 ' HE ' ' HD2' ' B' ' 272' ' ' ARG . 78.0 mtt180 -125.22 134.97 52.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.172 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.28 124.89 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.88 135.41 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.516 -0.74 . . . . 0.0 109.48 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -130.06 118.72 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 61.06 37.56 17.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.645 -1.284 . . . . 0.0 109.57 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.88 -10.12 9.91 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.124 -0.985 . . . . 0.0 111.486 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.96 136.23 33.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.542 -1.564 . . . . 0.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -82.17 126.42 32.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.8 mt -74.25 146.92 42.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.449 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -103.34 146.12 28.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.887 . . . . 0.0 109.752 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 p30 -71.0 3.86 3.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.8 37.34 3.15 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.725 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -145.87 173.65 11.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.019 -1.283 . . . . 0.0 109.638 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 71.7 p -113.15 161.58 16.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.129 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.541 HD23 ' N ' ' B' ' 256' ' ' LEU . 2.9 mt -59.7 -43.03 94.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.873 . . . . 0.0 110.035 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 97.6 p -60.72 -29.22 69.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 109.796 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.78 -15.23 63.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.033 . . . . 0.0 109.272 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -107.26 3.73 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.17 38.79 3.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.399 -0.813 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.0 135.26 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.892 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -123.58 172.58 8.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.099 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -50.97 157.99 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.568 0.699 . . . . 0.0 110.382 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 59.18 10.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 17.1 m -75.17 150.14 38.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.932 -1.105 . . . . 0.0 108.38 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.851 HG21 ' NZ ' ' B' ' 206' ' ' LYS . 7.7 m -116.23 139.12 50.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.43 140.47 52.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.543 -0.723 . . . . 0.0 109.56 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.46 ' NE2' ' CE ' ' B' ' 206' ' ' LYS . 64.6 m80 -89.36 142.23 27.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.142 -0.974 . . . . 0.0 110.015 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.465 HD11 ' HG3' ' B' ' 241' ' ' GLN . 22.4 tp -110.02 127.93 55.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 0.0 109.097 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.22 130.83 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.396 -0.815 . . . . 0.0 110.154 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.627 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.2 mt -79.64 141.59 36.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.232 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 22.4 ttt180 -95.04 -140.0 0.24 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -0.845 . . . . 0.0 108.778 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.575 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 63.5 mt -124.84 -52.03 1.68 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.326 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.409 -0.807 . . . . 0.0 109.63 -179.81 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.8 tttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.6 mt -115.58 133.76 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.429 -0.794 . . . . 0.0 111.229 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.8 m -116.95 129.16 55.87 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 74.8 m-85 -113.72 135.65 21.99 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.355 -0.841 . . . . 0.0 110.692 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -47.89 165.36 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 112.875 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -2.67 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.729 -0.607 . . . . 0.0 110.738 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.877 ' O ' HG22 ' B' ' 209' ' ' THR . 0.6 OUTLIER -121.88 6.82 9.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.083 -1.011 . . . . 0.0 110.125 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 mm -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 111.223 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.97 138.12 20.26 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.52 -38.76 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.58 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -55.37 -44.72 76.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.569 -0.707 . . . . 0.0 110.516 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.683 HG11 ' O ' ' B' ' 207' ' ' THR . 56.8 t -80.76 -23.66 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.852 -1.155 . . . . 0.0 110.283 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.3 t80 -69.1 -53.5 19.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 110.822 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' OH ' HD12 ' A' ' 62' ' ' ILE . 56.1 m-85 -62.39 -15.71 50.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.088 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.19 -6.6 59.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.6 mt -90.39 151.85 44.86 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.228 -0.92 . . . . 0.0 109.776 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.71 154.14 27.2 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.453 2.102 . . . . 0.0 112.092 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.92 -50.93 68.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -45.06 38.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.945 -1.097 . . . . 0.0 110.262 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.88 -31.93 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 108.509 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.19 -50.76 72.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -56.68 -47.3 80.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.434 -0.792 . . . . 0.0 110.01 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -58.87 -37.72 77.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 0.0 110.482 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.37 -40.34 62.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.812 -1.18 . . . . 0.0 110.145 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -69.88 -38.8 76.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.763 -1.21 . . . . 0.0 108.874 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.16 77.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 108.906 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 4.8 tm-20 -69.0 -38.55 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 108.877 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.461 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.0 m0 -76.16 -11.68 59.97 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.041 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -91.44 -46.67 7.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.298 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -57.48 -42.43 82.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.971 -1.081 . . . . 0.0 108.429 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 92' ' ' GLY . 14.5 t -84.12 -37.68 21.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 108.482 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -95.68 164.99 12.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.231 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.437 HG22 ' OG ' ' B' ' 265' ' ' SER . 1.8 pp -144.26 147.9 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' B' ' 264' ' ' GLU . 9.8 m-85 -102.04 144.17 30.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.222 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.98 112.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.984 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.575 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.2 OUTLIER -97.46 133.98 41.31 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.034 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.683 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.5 p -93.98 -174.39 3.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.781 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.522 HD11 ' H ' ' B' ' 271' ' ' LEU . 26.9 mt -72.26 -11.72 60.84 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.877 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.9 p -102.61 -2.44 28.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.36 -0.838 . . . . 0.0 109.574 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 94.99 2.73 62.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -67.22 118.37 10.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -1.225 . . . . 0.0 108.823 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.1 m -99.62 138.12 37.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.033 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.421 HG22 HD21 ' B' ' 215' ' ' LEU . 40.0 mt -135.01 136.21 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.334 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 72.5 m -105.34 120.21 41.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.663 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 13.1 mt -125.68 121.84 34.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.963 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.654 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 4.8 mt-10 -67.18 130.3 42.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.496 -0.753 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.522 HG13 ' NZ ' ' B' ' 229' ' ' LYS . 27.5 m -136.16 -174.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.08 -1.012 . . . . 0.0 110.131 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -133.86 155.3 80.42 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.43 -20.39 56.2 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.402 2.068 . . . . 0.0 112.195 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -105.24 7.95 33.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.24 143.47 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.839 -1.163 . . . . 0.0 109.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 52.3 p -86.37 145.94 26.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -51.68 -26.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -36.22 83.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.205 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.0 -52.75 21.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.109 -0.994 . . . . 0.0 109.021 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.42 ' O ' HD12 ' B' ' 230' ' ' ILE . 35.7 t -52.28 -37.54 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 108.926 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -65.41 -32.48 74.13 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.441 -0.787 . . . . 0.0 108.959 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.89 69.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.663 ' HZ3' ' C ' ' B' ' 215' ' ' LEU . 12.6 mtpt -57.37 -52.65 64.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 108.781 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.569 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.6 mp -59.71 -36.52 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 108.808 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -59.98 -42.81 94.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.063 -1.023 . . . . 0.0 110.07 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.49 -31.31 68.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.116 -0.99 . . . . 0.0 110.831 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -92.76 -50.43 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.43 -6.44 57.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.972 . . . . 0.0 111.331 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.48 26.95 72.05 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.51 -1.369 . . . . 0.0 110.456 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.07 131.6 21.79 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.128 -1.219 . . . . 0.0 109.569 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.62 156.67 44.69 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.212 1.941 . . . . 0.0 112.261 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.6 -34.67 8.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.922 2.414 . . . . 0.0 113.393 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -65.34 -6.8 10.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.228 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.89 -21.06 3.4 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.748 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.5 136.52 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.606 -1.309 . . . . 0.0 109.252 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -125.98 135.73 52.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.95 126.61 52.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 79.7 mt -120.21 136.52 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.9 t80 -129.65 112.82 14.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.32 -0.863 . . . . 0.0 109.435 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.95 44.56 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.865 -1.147 . . . . 0.0 109.485 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 -6.07 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -94.19 137.77 32.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.817 -1.402 . . . . 0.0 109.504 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -84.4 132.59 34.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.875 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.56 146.33 28.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 109.09 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 2.6 tt0 -105.49 148.0 27.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.69 3.82 3.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.921 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -120.63 45.54 1.22 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.874 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.54 172.39 18.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.987 -1.302 . . . . 0.0 109.261 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 65.1 p -109.84 161.07 15.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.482 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.4 mt -58.01 -40.44 80.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.815 . . . . 0.0 109.938 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 98.3 p -62.51 -28.04 69.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.08 -15.8 62.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.255 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -105.03 1.72 28.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 109.067 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.8 39.73 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.88 133.99 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.038 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.34 174.59 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.471 ' H ' ' HE3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.15 158.09 1.64 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.895 0.855 . . . . 0.0 110.698 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' CE2' ' B' ' 204' ' ' PHE . 91.5 mt-10 57.99 14.26 2.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.044 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.437 ' OG ' HG22 ' B' ' 203' ' ' ILE . 70.4 p -78.03 150.44 33.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.955 -1.091 . . . . 0.0 108.79 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.765 ' C ' HD12 ' B' ' 267' ' ' LEU . 6.7 m -115.03 138.58 50.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -0.796 . . . . 0.0 110.233 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.765 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.82 140.97 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.527 -0.733 . . . . 0.0 109.641 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.404 ' HB3' HD21 ' A' ' 76' ' ' LEU . 58.4 m80 -90.19 141.71 28.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 109.783 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 13.5 tp -108.94 126.06 52.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.376 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 42.8 t -112.69 128.09 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.8 . . . . 0.0 109.546 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.522 ' H ' HD11 ' B' ' 208' ' ' LEU . 47.1 mt -82.82 143.9 30.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.018 -1.052 . . . . 0.0 109.552 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.546 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.1 ttt180 -95.25 -137.57 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.546 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 56.4 mt -124.02 -29.19 3.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.275 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.843 . . . . 0.0 109.492 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 pttt . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.509 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 42.0 mt -112.74 132.22 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.034 -1.041 . . . . 0.0 110.834 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.9 m -116.48 126.64 53.67 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.509 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 77.0 m-85 -111.54 135.14 21.08 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.34 -0.85 . . . . 0.0 110.233 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.04 164.75 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.215 1.944 . . . . 0.0 112.762 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -2.75 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.739 -0.6 . . . . 0.0 110.722 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.899 ' O ' HG22 ' B' ' 209' ' ' THR . 4.1 m-20 -122.24 8.34 9.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.046 -1.034 . . . . 0.0 110.348 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 mm -111.05 129.34 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.272 -0.892 . . . . 0.0 111.001 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.7 t70 -99.85 139.56 20.89 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.48 -47.38 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.269 1.979 . . . . 0.0 112.242 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.478 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 6.8 tt0 -47.88 -44.68 29.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.696 -0.627 . . . . 0.0 110.33 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.658 HG11 ' O ' ' B' ' 207' ' ' THR . 41.4 t -80.85 -32.26 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.957 -1.09 . . . . 0.0 110.318 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -61.05 -54.13 48.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 110.742 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -61.25 -15.86 39.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.907 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -83.55 -6.12 59.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.053 . . . . 0.0 109.808 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' B' ' 268' ' ' HIS . 92.6 mt -90.33 151.93 45.08 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.51 154.17 20.74 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.37 2.047 . . . . 0.0 112.098 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.82 -49.26 75.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.18 -44.74 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.064 . . . . 0.0 110.196 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.3 t -74.84 -32.46 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.874 -1.141 . . . . 0.0 108.478 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.2 tt0 -59.22 -51.83 68.29 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -57.25 -48.96 77.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -56.41 -42.76 78.53 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 110.56 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -69.97 -37.87 75.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.863 -1.148 . . . . 0.0 109.776 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.0 mt -70.03 -40.11 75.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.739 -1.226 . . . . 0.0 109.024 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.49 70.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 108.785 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.661 ' O ' HG22 ' A' ' 91' ' ' THR . 6.9 tt0 -70.56 -40.19 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -75.63 -12.36 60.19 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.005 -1.06 . . . . 0.0 109.535 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -93.04 -46.75 7.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.033 . . . . 0.0 109.188 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -55.67 -40.46 72.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.818 -1.176 . . . . 0.0 108.421 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 87' ' ' GLU . 8.9 t -88.98 -36.88 15.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 108.662 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.34 164.76 12.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.55 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.555 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.7 142.72 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.462 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.33 141.7 28.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.443 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.6 t -120.82 108.23 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 109.608 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 13.6 ptpt -94.61 135.32 36.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.658 ' O ' HG11 ' A' ' 72' ' ' VAL . 46.4 p -97.14 -173.94 2.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.025 -1.047 . . . . 0.0 110.998 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.681 HD11 ' H ' ' B' ' 271' ' ' LEU . 20.1 mt -71.4 -14.67 62.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.466 0.651 . . . . 0.0 109.284 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.899 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -99.93 -4.6 29.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.6 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.51 3.01 59.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -67.82 118.45 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.081 -1.247 . . . . 0.0 109.199 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 10.2 m -99.8 137.8 37.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 48.3 mt -133.49 135.34 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.8 m -104.22 117.03 33.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.724 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.8 mt -122.18 121.92 37.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.448 -0.783 . . . . 0.0 110.084 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -67.78 132.69 47.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.57 -174.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.797 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.72 152.55 77.79 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.975 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.15 -24.12 48.31 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.587 2.191 . . . . 0.0 112.191 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 49.2 m -100.4 6.1 44.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.879 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -71.44 143.55 50.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.966 -1.084 . . . . 0.0 109.375 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' B' ' 225' ' ' ASN . 45.0 p -86.26 151.49 23.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 0.0 109.932 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 35.2 mm -54.53 -43.32 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -52.61 -35.65 54.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.425 ' OD1' ' OG1' ' B' ' 222' ' ' THR . 20.6 m120 -67.28 -52.77 36.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.337 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 25.1 t -52.05 -47.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 108.549 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -52.41 -43.49 64.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.507 -0.746 . . . . 0.0 109.182 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.79 -36.11 78.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.814 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.54 ' HB2' HD13 ' B' ' 215' ' ' LEU . 15.3 mtpp -57.78 -53.46 57.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 0.0 109.41 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.529 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.6 mp -58.3 -34.23 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.205 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -60.75 -47.39 86.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.921 -1.112 . . . . 0.0 109.826 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -68.69 -24.33 64.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.249 -0.907 . . . . 0.0 110.634 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -97.53 -53.24 3.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 110.457 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.17 -7.55 53.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.289 -0.882 . . . . 0.0 111.578 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.47 24.67 75.09 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.215 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 36.7 mt -104.41 124.94 35.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.498 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.56 154.73 31.35 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.164 1.91 . . . . 0.0 111.986 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -64.95 -28.57 58.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.733 2.289 . . . . 0.0 112.881 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 44.2 p30 -62.6 -14.73 46.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.952 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.51 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.6 OUTLIER -128.52 -21.41 3.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.508 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -84.57 136.54 33.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.897 -1.127 . . . . 0.0 109.243 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -129.46 132.11 46.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.421 -0.799 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.42 127.42 53.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.38 134.23 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.629 -0.669 . . . . 0.0 109.348 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.6 t80 -127.2 112.84 15.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 65.14 37.53 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.868 -1.145 . . . . 0.0 109.458 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.6 -7.66 18.26 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.144 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -94.06 134.78 36.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.74 -1.447 . . . . 0.0 109.692 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -80.97 125.0 29.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.452 HD11 HD23 ' B' ' 267' ' ' LEU . 29.0 mt -69.91 142.37 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -97.19 144.36 27.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.19 3.69 2.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.92 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.0 47.21 1.03 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.795 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -152.68 172.53 16.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.384 . . . . 0.0 109.078 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 37.9 p -111.5 159.24 18.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.948 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.2 mt -57.3 -41.71 80.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 69.4 p -61.17 -29.12 69.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.845 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.24 -16.5 63.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 109.333 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -105.58 3.31 29.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 67.48 39.35 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.848 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.6 mt -91.71 135.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.25 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.31 173.11 7.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.04 162.66 0.44 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.548 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.37 10.46 0.47 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.555 ' OG ' HG22 ' B' ' 203' ' ' ILE . 62.7 p -73.67 148.32 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.823 -1.173 . . . . 0.0 108.657 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.721 ' C ' HD12 ' B' ' 267' ' ' LEU . 22.1 m -113.77 137.89 51.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 0.0 110.038 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.721 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -121.03 160.14 24.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.011 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.411 ' HB3' HD21 ' A' ' 76' ' ' LEU . 79.5 m80 -107.58 139.62 41.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.333 -0.854 . . . . 0.0 109.741 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' B' ' 241' ' ' GLN . 24.8 tp -110.21 126.03 53.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.401 ' HA ' HD21 ' B' ' 208' ' ' LEU . 11.6 t -114.62 130.06 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.454 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.681 ' H ' HD11 ' B' ' 208' ' ' LEU . 47.1 mt -82.42 144.4 30.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.524 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 27.2 ttt180 -93.21 -138.62 0.2 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.524 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.2 mt -122.36 -26.56 4.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 109.548 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 63.3 mtt-85 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 109.422 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.476 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.4 mt -112.53 131.73 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.471 -0.768 . . . . 0.0 110.293 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -115.53 128.96 56.36 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.476 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 77.3 m-85 -114.13 135.61 22.15 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.156 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -47.66 165.56 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.454 2.102 . . . . 0.0 112.916 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -6.18 21.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.942 ' O ' HG22 ' B' ' 209' ' ' THR . 1.8 m-20 -117.01 2.56 12.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.099 -1.001 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.77 128.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 4.7 t70 -98.91 138.35 20.64 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.62 -40.31 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.355 2.037 . . . . 0.0 112.467 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 37.4 tt0 -56.21 -43.49 78.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.617 -0.677 . . . . 0.0 110.581 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG11 ' O ' ' B' ' 207' ' ' THR . 61.4 t -80.09 -23.79 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.784 -1.198 . . . . 0.0 110.35 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.9 t80 -70.41 -52.38 22.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 110.832 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -64.32 -18.12 64.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.174 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -79.87 -7.94 59.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.861 -1.149 . . . . 0.0 109.49 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.8 mt -89.92 151.63 45.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 154.96 22.29 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.41 2.074 . . . . 0.0 111.95 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -63.05 -51.84 65.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.72 -44.33 38.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 110.09 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.408 HG11 HG21 ' B' ' 270' ' ' VAL . 60.3 t -74.77 -31.56 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.02 -1.05 . . . . 0.0 108.448 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.8 -50.05 75.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -58.36 -49.68 76.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.665 . . . . 0.0 110.38 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.72 -36.87 67.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.037 -1.039 . . . . 0.0 110.043 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.3 mt -75.44 -36.58 60.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.852 -1.155 . . . . 0.0 109.687 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.12 -40.34 71.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.77 -1.206 . . . . 0.0 109.147 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.73 79.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.965 . . . . 0.0 109.046 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.95 -38.48 82.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -76.85 -12.76 60.01 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.101 -1.0 . . . . 0.0 109.205 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.97 -45.75 9.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 109.055 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -58.54 -39.62 80.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.137 -0.977 . . . . 0.0 109.234 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.465 ' O ' ' C ' ' A' ' 92' ' ' GLY . 11.8 t -94.77 -37.01 11.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.044 -1.035 . . . . 0.0 109.695 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.429 ' O ' HG23 ' B' ' 217' ' ' VAL . 5.8 ptt? . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.08 166.51 11.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -145.29 145.11 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.628 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' B' ' 204' ' ' PHE . 2.4 m-85 -95.75 142.4 28.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.01 108.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -93.33 134.11 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 108.767 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.653 ' O ' HG11 ' A' ' 72' ' ' VAL . 20.8 p -94.33 -174.34 3.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.702 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 35.6 mt -72.36 -10.73 60.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.942 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.2 p -104.33 -3.1 24.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.782 . . . . 0.0 109.655 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.36 2.89 60.2 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -66.65 117.0 8.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -1.199 . . . . 0.0 108.854 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -99.19 136.73 38.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.102 -0.999 . . . . 0.0 109.086 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.568 HD11 ' OE2' ' B' ' 234' ' ' GLU . 23.2 mt -132.79 133.86 58.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.278 -0.889 . . . . 0.0 109.462 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.9 m -103.32 120.13 40.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.9 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' B' ' 229' ' ' LYS . 18.8 mt -123.85 120.5 32.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.846 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.62 133.05 49.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 201' ' ' MET . 11.5 m -140.69 -171.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 109.831 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -138.14 152.36 71.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.16 -28.2 78.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.422 2.081 . . . . 0.0 112.264 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.2 m -96.01 5.0 52.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 110.061 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.58 145.21 49.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.639 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 36.3 p -87.07 150.57 23.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 31.8 mm -56.81 -40.54 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.72 -31.38 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.087 -1.008 . . . . 0.0 109.604 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -73.85 -51.13 17.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.99 -50.35 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 108.509 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -52.05 -39.46 59.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 0.0 109.198 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.16 86.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.43 -0.794 . . . . 0.0 109.591 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' B' ' 215' ' ' LEU . 15.6 mtpp -57.81 -53.73 54.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.51 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.5 mp -57.88 -37.25 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.086 -1.009 . . . . 0.0 109.107 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -58.52 -43.14 89.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.43 -22.41 60.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 110.344 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -98.83 -56.45 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.026 -1.047 . . . . 0.0 110.484 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.568 ' OE2' HD11 ' B' ' 213' ' ' ILE . 58.6 mm-40 -83.35 -7.02 59.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 111.088 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.55 24.62 73.9 Favored Glycine 0 N--CA 1.49 2.274 0 O-C-N 120.575 -1.328 . . . . 0.0 109.974 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.72 125.21 33.86 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 109.467 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.62 154.67 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.996 1.797 . . . . 0.0 111.658 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.92 -29.82 67.25 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.7 2.267 . . . . 0.0 113.049 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.97 -17.27 36.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 110.475 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.448 HE21 HD22 ' B' ' 271' ' ' LEU . 6.6 pt20 -127.99 -15.54 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.78 133.62 33.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 109.488 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -127.97 132.37 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.503 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.9 mt -105.85 127.34 53.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.93 136.03 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.683 -0.636 . . . . 0.0 109.413 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -131.25 119.06 21.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 108.983 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 59.73 42.45 16.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.87 -1.144 . . . . 0.0 109.455 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.26 23.87 70.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.112 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 140.51 52.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.117 -1.225 . . . . 0.0 109.615 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -87.97 125.14 34.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 109.603 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.2 mt -71.42 146.56 48.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -0.82 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -99.68 142.59 30.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -68.6 3.2 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.99 40.41 2.01 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -144.55 168.63 19.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 109.258 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 15.0 p -108.79 155.48 20.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.814 . . . . 0.0 109.98 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.51 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.2 mt -54.16 -42.95 70.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 83.6 p -61.2 -27.14 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -15.85 62.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.515 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -106.54 3.42 27.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 109.242 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.59 40.53 1.86 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.53 -0.731 . . . . 0.0 109.285 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.57 133.43 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.364 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -124.79 176.28 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.54 159.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.277 -0.889 . . . . 0.0 111.07 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 57.85 13.14 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.092 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -75.23 148.19 39.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 108.676 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 8.0 m -114.06 137.05 52.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.405 -0.81 . . . . 0.0 110.647 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.66 144.42 50.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.772 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.42 ' HB3' HD21 ' A' ' 76' ' ' LEU . 32.5 m80 -94.39 143.3 26.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.132 -0.98 . . . . 0.0 110.349 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.2 tp -109.56 125.88 52.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.352 -0.842 . . . . 0.0 109.415 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.408 HG21 HG11 ' A' ' 80' ' ' VAL . 34.8 t -115.25 131.25 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.91 . . . . 0.0 110.135 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.448 HD22 HE21 ' B' ' 240' ' ' GLN . 46.5 mt -82.76 143.95 30.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -0.824 . . . . 0.0 109.626 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.528 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 23.2 ttt180 -98.46 -137.15 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.528 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 67.4 mt -124.23 -34.75 2.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 109.098 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' B' ' 273' ' ' LEU . 11.5 ttt85 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.338 -0.852 . . . . 0.0 109.545 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.459 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 39.2 mt -107.68 134.61 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 109.942 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.7 m -117.17 126.34 52.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 75.8 m-85 -113.35 135.1 21.82 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.388 -0.82 . . . . 0.0 109.544 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.19 165.18 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.191 1.927 . . . . 0.0 112.74 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -65.8 -14.71 61.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.754 -0.591 . . . . 0.0 110.469 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.876 ' O ' HG22 ' B' ' 209' ' ' THR . 0.5 OUTLIER -108.65 8.45 27.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.08 -1.012 . . . . 0.0 110.45 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.12 129.54 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 111.071 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 5.0 t70 -99.74 138.65 20.43 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.69 -46.66 0.79 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.251 1.967 . . . . 0.0 112.315 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.7 tt0 -51.07 -44.64 61.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.695 -0.628 . . . . 0.0 110.656 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.739 HG11 ' O ' ' B' ' 207' ' ' THR . 40.0 t -79.06 -24.04 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.812 -1.18 . . . . 0.0 110.203 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.428 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.9 t80 -70.47 -51.44 29.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 110.699 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -63.09 -16.96 61.67 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.142 -0.974 . . . . 0.0 110.055 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -82.97 -7.06 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 76' ' ' LEU . 95.1 mt -89.03 151.31 46.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.842 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.23 154.02 19.91 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.356 2.037 . . . . 0.0 111.913 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.04 -51.45 66.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.671 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.42 -44.81 45.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.982 -1.074 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.04 -30.66 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.992 -1.068 . . . . 0.0 108.716 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.428 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 39.7 tt0 -61.7 -49.36 76.77 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -58.9 -49.7 76.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.552 -0.718 . . . . 0.0 110.359 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.92 -40.66 70.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.004 -1.06 . . . . 0.0 110.121 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.42 -36.2 71.23 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.987 -1.07 . . . . 0.0 109.837 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.92 -39.98 69.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.804 -1.185 . . . . 0.0 109.172 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.59 -32.95 72.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.527 ' O ' HG22 ' A' ' 91' ' ' THR . 5.1 tp10 -75.87 -34.35 60.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 108.752 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -76.88 -17.45 58.95 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.962 -1.086 . . . . 0.0 108.491 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -89.19 -47.23 8.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.828 . . . . 0.0 109.279 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -54.62 -39.34 67.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.797 -1.19 . . . . 0.0 108.731 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 87' ' ' GLU . 14.6 t -93.52 -36.53 12.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.148 -0.97 . . . . 0.0 109.178 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.494 2.555 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -95.92 164.04 12.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 110.585 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.513 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.8 141.95 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.32 141.96 27.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.969 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -121.35 110.03 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -96.41 135.65 37.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 108.735 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.739 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.4 p -96.35 -173.46 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.771 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.442 HD11 ' H ' ' B' ' 271' ' ' LEU . 21.2 mt -72.55 -13.26 61.36 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.348 0.594 . . . . 0.0 109.671 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.876 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.6 p -100.8 -3.26 30.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.62 61.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.39 118.68 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 108.812 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 2.2 m -100.6 138.88 37.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.2 mt -135.22 136.72 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.3 m -104.06 121.43 43.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 108.818 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' B' ' 229' ' ' LYS . 16.1 mt -124.57 120.97 33.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.882 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.1 133.32 48.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.651 -0.656 . . . . 0.0 109.382 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 -173.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.935 -1.103 . . . . 0.0 110.126 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -135.93 153.68 77.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 108.959 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.26 -25.48 65.1 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.528 2.152 . . . . 0.0 112.171 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 m -100.24 5.94 44.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.936 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -71.87 144.93 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.022 -1.049 . . . . 0.0 109.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.3 p -86.71 146.19 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.84 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.411 HD12 HD13 ' B' ' 250' ' ' LEU . 32.2 mm -51.65 -34.3 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.431 ' C ' ' CD ' ' B' ' 224' ' ' GLU . 0.2 OUTLIER -56.8 -38.39 72.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.384 -0.822 . . . . 0.0 109.037 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -66.57 -52.48 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 109.244 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.412 ' H ' HG23 ' B' ' 226' ' ' VAL . 15.6 t -52.6 -48.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.758 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -53.44 -38.7 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.53 83.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.356 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.434 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.8 mtpp -57.16 -52.84 63.68 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 109.111 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.604 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.9 mp -59.04 -36.46 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.178 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -58.81 -49.56 77.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.943 -1.098 . . . . 0.0 109.741 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.56 -27.6 68.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.422 -0.799 . . . . 0.0 110.649 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -95.4 -57.01 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.895 -1.128 . . . . 0.0 110.55 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -83.04 -6.18 59.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 111.311 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.08 24.76 71.94 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.244 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.495 HD13 HD21 ' B' ' 271' ' ' LEU . 63.1 mt -105.95 128.45 26.38 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.132 -1.217 . . . . 0.0 109.641 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.95 158.69 38.36 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.113 1.875 . . . . 0.0 111.933 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.11 -30.18 32.12 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.942 2.428 . . . . 0.0 113.196 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -69.14 -6.14 26.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.1 -20.68 3.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.39 139.03 31.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 109.341 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.94 132.31 47.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.404 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.01 123.42 47.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 109.439 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.51 135.81 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.662 -0.649 . . . . 0.0 109.357 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.486 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.4 t80 -129.84 113.64 14.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.761 . . . . 0.0 109.217 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.34 42.25 5.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.931 -1.106 . . . . 0.0 109.203 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.97 39.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.93 137.9 43.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -1.188 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.41 126.08 33.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.411 HD13 HD12 ' B' ' 223' ' ' ILE . 22.2 mt -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.223 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.4 144.28 31.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.176 -0.953 . . . . 0.0 109.927 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.03 3.35 3.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 109.827 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.39 37.03 3.29 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -145.16 173.35 12.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.284 . . . . 0.0 109.542 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 81.6 p -113.17 161.22 17.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.498 -0.751 . . . . 0.0 109.943 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.494 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.1 mt -60.42 -42.23 95.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.6 p -60.63 -28.26 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.089 -1.007 . . . . 0.0 109.201 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.26 -13.86 61.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 108.959 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.611 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 25.7 m-85 -107.1 0.36 23.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.465 -0.772 . . . . 0.0 109.572 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 260' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' B' ' 260' ' ' ASN . 0.0 OUTLIER 68.25 33.42 4.3 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.132 0.968 . . . . 0.0 109.725 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -85.63 133.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.551 -1.343 . . . . 0.0 109.523 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 262' ' ' GLN . . . . . 0.432 ' O ' ' OG ' ' B' ' 265' ' ' SER . 26.1 mt-30 -120.66 170.51 9.36 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.696 0.76 . . . . 0.0 109.75 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.76 160.42 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.779 0.799 . . . . 0.0 110.698 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 56.58 13.58 1.41 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.513 ' OG ' HG22 ' B' ' 203' ' ' ILE . 3.0 p -76.7 150.02 36.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 108.525 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.745 ' C ' HD12 ' B' ' 267' ' ' LEU . 11.4 m -114.59 137.01 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.383 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.745 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -123.25 140.18 53.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.264 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.412 ' HB3' HD21 ' A' ' 76' ' ' LEU . 60.7 m80 -89.46 141.84 28.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 0.0 109.796 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 17.2 tp -110.55 128.44 55.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 10.7 t -114.19 128.77 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.495 HD21 HD13 ' B' ' 236' ' ' ILE . 43.4 mt -82.4 145.43 29.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.035 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.528 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 28.1 ttt-85 -96.33 -137.12 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 108.754 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.528 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 59.3 mt -123.1 -12.72 7.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.228 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.554 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 39.2 mt -109.98 133.72 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.9 m -115.03 126.51 54.81 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.554 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 89.0 m-85 -113.04 137.18 21.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.025 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.72 164.61 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.485 2.123 . . . . 0.0 113.006 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.47 -1.94 9.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.825 -0.547 . . . . 0.0 110.284 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.878 ' O ' HG22 ' B' ' 209' ' ' THR . 0.2 OUTLIER -120.67 7.23 10.51 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.178 -0.951 . . . . 0.0 110.214 -179.46 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 68' ' ' ILE . 27.3 mm -109.3 127.67 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.84 . . . . 0.0 111.258 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 9.6 t0 -102.24 110.71 63.27 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.96 -43.83 23.8 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.94 . . . . 0.0 112.625 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -47.86 -47.62 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 110.389 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.707 HG11 ' O ' ' B' ' 207' ' ' THR . 43.8 t -78.32 -23.5 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -70.66 -53.85 14.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.867 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -61.62 -17.49 55.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.876 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -81.98 -6.53 59.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.897 -1.127 . . . . 0.0 109.731 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 76' ' ' LEU . 93.1 mt -90.56 151.48 44.12 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.169 -0.957 . . . . 0.0 109.546 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.66 154.63 19.83 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.301 2.0 . . . . 0.0 111.898 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -49.97 71.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.733 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.65 -44.33 47.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.101 . . . . 0.0 110.087 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.484 HG11 HG21 ' B' ' 270' ' ' VAL . 45.7 t -74.68 -32.07 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.954 -1.091 . . . . 0.0 108.38 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.1 tt0 -59.61 -52.16 66.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.11 -49.05 74.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.196 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.5 -40.79 75.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.021 . . . . 0.0 110.125 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.5 -37.83 68.3 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.49 -39.14 77.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.927 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.86 -32.9 72.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 108.925 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.764 ' O ' HG22 ' A' ' 91' ' ' THR . 44.3 tt0 -73.28 -35.61 66.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.42 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 44.9 m0 -78.56 -19.24 53.26 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 109.088 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -88.71 -46.91 8.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 0.0 109.143 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.421 ' CG ' ' N ' ' A' ' 91' ' ' THR . 9.7 ptm180 -54.05 -41.49 68.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.849 -1.157 . . . . 0.0 108.367 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 87' ' ' GLU . 8.9 t -86.69 -35.52 19.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.487 2.073 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 202' ' ' GLN . . . . . 0.413 HE21 ' HE1' ' B' ' 204' ' ' PHE . 5.6 pt20 -97.58 166.15 11.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 pp -145.79 142.11 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.413 ' HE1' HE21 ' B' ' 202' ' ' GLN . 7.0 m-85 -95.18 143.07 26.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 29.2 t -123.43 111.58 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 109.685 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -97.04 140.43 31.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 108.68 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.707 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.9 p -100.56 -173.52 2.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.715 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.449 HD11 ' H ' ' B' ' 271' ' ' LEU . 30.6 mt -70.94 -13.58 62.06 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.527 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.878 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.3 p -102.16 -3.77 26.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.78 2.89 61.08 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -66.65 117.67 9.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.236 . . . . 0.0 108.571 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.0 m -99.91 139.2 35.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.47 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.477 HG22 HD21 ' B' ' 215' ' ' LEU . 23.2 mt -134.94 135.77 52.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.485 -0.759 . . . . 0.0 109.289 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -103.67 122.59 45.35 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.675 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 17.1 mt -126.04 119.66 28.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.44 -0.788 . . . . 0.0 109.935 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLU . . . . . 0.663 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 11.5 mt-10 -66.07 129.92 41.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.626 HG13 ' NZ ' ' B' ' 229' ' ' LYS . 14.1 m -137.38 -172.72 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.0 110.012 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.11 153.77 71.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 108.755 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.55 -25.87 42.94 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.577 2.184 . . . . 0.0 112.489 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -99.6 6.83 45.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.873 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 141.11 52.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.605 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.4 p -86.07 148.69 25.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.998 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -54.93 -42.5 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.311 -0.868 . . . . 0.0 109.257 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -52.44 -37.34 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 109.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -67.92 -49.25 62.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 108.971 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 52.8 t -52.1 -49.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 108.463 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 -37.79 49.21 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.99 87.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.675 ' HZ3' ' C ' ' B' ' 215' ' ' LEU . 15.1 mtpt -55.84 -53.49 56.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 109.056 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.446 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -60.89 -32.81 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -62.41 -51.0 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.254 -0.904 . . . . 0.0 110.014 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -63.33 -29.33 70.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.522 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -94.22 -58.48 2.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.973 -1.08 . . . . 0.0 110.504 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.08 -6.55 59.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.955 . . . . 0.0 111.596 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.69 25.28 70.28 Favored Glycine 0 N--CA 1.492 2.416 0 O-C-N 120.338 -1.476 . . . . 0.0 110.541 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.63 129.06 26.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.063 -1.257 . . . . 0.0 109.325 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.02 155.2 42.8 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.985 1.79 . . . . 0.0 111.903 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.1 -29.82 26.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.772 2.314 . . . . 0.0 113.361 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.36 -8.34 45.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.55 -20.7 4.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.39 -0.819 . . . . 0.0 109.608 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 137.63 32.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 108.985 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -127.87 132.37 49.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.872 . . . . 0.0 109.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.19 124.52 49.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.435 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.8 mt -119.68 134.03 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.549 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 45.6 t80 -128.28 111.6 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.46 38.29 4.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.772 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.58 4.62 53.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -101.48 137.71 39.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 109.765 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -86.2 125.96 33.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.019 . . . . 0.0 109.492 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.464 HD11 HD23 ' B' ' 267' ' ' LEU . 20.1 mt -77.95 142.97 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' B' ' 253' ' ' GLY . 12.7 tt0 -99.8 143.56 29.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.405 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 3.83 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -123.7 49.24 0.91 Allowed Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.786 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -153.44 169.76 22.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -1.228 . . . . 0.0 109.211 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -110.94 158.08 19.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.434 -0.792 . . . . 0.0 110.097 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.429 HD23 ' N ' ' B' ' 256' ' ' LEU . 8.0 mt -55.24 -42.53 73.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.72 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 24.6 p -61.9 -28.1 69.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.92 -13.97 61.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.297 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -105.9 1.94 27.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.7 37.97 3.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.07 135.14 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.35 175.26 6.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.237 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.49 162.09 0.59 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.986 -178.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 56.42 13.38 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.216 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.3 m -75.37 148.17 39.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.794 -1.191 . . . . 0.0 108.585 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.775 ' C ' HD12 ' B' ' 267' ' ' LEU . 4.1 m -114.04 137.43 51.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.458 -0.776 . . . . 0.0 110.177 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.775 HD12 ' C ' ' B' ' 266' ' ' THR . 8.2 mp -124.93 141.97 51.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -90.85 143.06 27.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.874 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 tp -108.44 125.58 51.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.529 -0.732 . . . . 0.0 109.322 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 80' ' ' VAL . 3.0 t -110.52 125.62 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 109.525 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.449 ' H ' HD11 ' B' ' 208' ' ' LEU . 43.0 mt -82.31 144.78 30.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -95.76 -137.8 0.24 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.034 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 62.9 mt -123.06 -8.78 8.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.239 -0.913 . . . . 0.0 109.677 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.2 tttp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 37.4 mt -113.24 132.99 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 110.657 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.7 m -116.9 129.77 56.27 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 90.2 m-85 -114.1 135.92 22.16 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.469 -0.77 . . . . 0.0 110.251 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.47 164.72 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.302 2.001 . . . . 0.0 112.881 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p -67.66 -1.81 5.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.757 -0.59 . . . . 0.0 110.789 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.857 ' O ' HG22 ' B' ' 209' ' ' THR . 6.7 m-20 -123.77 9.1 8.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.014 -1.054 . . . . 0.0 110.549 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 68' ' ' ILE . 28.3 mm -110.12 129.07 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.08 -1.013 . . . . 0.0 111.463 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 7.7 t70 -93.34 136.91 23.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' O ' ' CD2' ' A' ' 74' ' ' TYR . 51.8 Cg_endo -72.12 -33.35 9.6 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.457 2.105 . . . . 0.0 113.233 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.43 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 39.3 tt0 -71.65 -37.06 70.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.0 110.577 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.631 HG11 ' O ' ' B' ' 207' ' ' THR . 61.8 t -78.23 -23.66 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.591 -1.318 . . . . 0.0 109.169 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -71.98 -53.33 13.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.409 -0.807 . . . . 0.0 110.698 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 70' ' ' PRO . 46.3 m-85 -61.36 -17.27 53.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.951 . . . . 0.0 109.949 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -83.42 -5.47 59.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.526 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 76' ' ' LEU . 91.3 mt -89.42 152.19 47.16 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.169 -0.957 . . . . 0.0 109.598 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.72 153.92 28.16 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.321 2.014 . . . . 0.0 111.938 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -50.68 69.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.572 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.45 -42.57 43.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.013 -1.054 . . . . 0.0 110.262 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.0 t -74.92 -32.89 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 108.325 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.7 tt0 -59.2 -51.95 67.79 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -56.7 -48.45 77.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.3 -40.71 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.61 -38.54 67.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.842 -1.161 . . . . 0.0 109.63 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.57 -38.78 77.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.736 -1.228 . . . . 0.0 108.948 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.02 73.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.53 -34.43 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 108.748 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 49.4 m0 -74.34 -17.98 60.76 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.016 -1.052 . . . . 0.0 108.729 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -90.71 -44.31 9.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.525 -0.734 . . . . 0.0 110.017 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' CG ' ' N ' ' A' ' 91' ' ' THR . 9.9 ptm180 -56.32 -41.24 75.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.632 -1.292 . . . . 0.0 108.004 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 92' ' ' GLY . 7.1 t -89.41 -36.26 15.57 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.494 2.549 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.09 164.84 12.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.128 -0.983 . . . . 0.0 110.362 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.84 143.58 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.197 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.8 142.16 28.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.04 114.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.409 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.1 ptpt -99.84 139.36 35.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 108.993 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.631 ' O ' HG11 ' A' ' 72' ' ' VAL . 30.9 p -98.09 -178.18 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 110.945 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 51.3 mt -71.69 -12.63 61.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.3 p -102.59 -3.99 25.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.05 57.27 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.882 -1.152 . . . . 0.0 110.527 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -69.28 119.07 12.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.002 -1.293 . . . . 0.0 108.999 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 19.3 m -102.83 140.95 36.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.479 HD11 ' CD ' ' B' ' 234' ' ' GLU . 37.6 mt -138.75 137.51 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 37.6 m -104.94 119.34 38.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.6 mt -123.15 121.5 36.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.18 131.49 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.89 -175.07 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.02 -1.05 . . . . 0.0 109.628 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -134.8 152.77 78.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.389 -0.819 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.64 -23.03 46.74 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.555 2.17 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' B' ' 220' ' ' SER . 1.4 t -104.47 5.83 34.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.956 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.89 144.99 52.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.956 -1.09 . . . . 0.0 109.412 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 73.1 p -85.81 150.38 24.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.2 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 36.6 mm -54.51 -45.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.369 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.51 -35.89 54.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -67.77 -52.58 35.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.072 -1.017 . . . . 0.0 109.129 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.7 t -51.9 -48.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.93 -1.106 . . . . 0.0 108.107 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.96 -46.64 61.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.55 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.03 -36.86 70.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.585 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.7 mtpp -56.92 -54.24 48.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.983 -1.073 . . . . 0.0 109.259 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.406 HD13 ' OE1' ' B' ' 241' ' ' GLN . 2.9 mp -57.31 -33.68 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 108.975 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -30.95 71.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.634 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -96.27 -51.97 4.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.026 -1.046 . . . . 0.0 110.683 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.479 ' CD ' HD11 ' B' ' 213' ' ' ILE . 60.4 mm-40 -85.77 -8.0 58.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 111.413 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.69 25.06 72.88 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.501 -1.374 . . . . 0.0 110.524 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.66 130.31 23.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.139 -1.212 . . . . 0.0 109.733 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' PRO . . . . . 0.445 ' HG2' HE21 ' B' ' 240' ' ' GLN . 57.6 Cg_endo -74.92 155.01 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.214 1.942 . . . . 0.0 111.748 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.48 -30.57 29.05 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.738 2.292 . . . . 0.0 113.219 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.05 -13.04 61.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.445 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.73 -19.86 6.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.418 -0.802 . . . . 0.0 110.13 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.467 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -86.09 139.79 30.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.696 -1.253 . . . . 0.0 108.928 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -129.76 129.63 44.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.345 -0.847 . . . . 0.0 109.449 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.1 mt -105.04 124.23 49.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.83 . . . . 0.0 109.338 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.99 134.08 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -130.36 121.12 25.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.092 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.46 39.4 28.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.735 -1.228 . . . . 0.0 109.871 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.3 7.31 60.05 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.057 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.66 132.86 52.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.242 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -82.65 125.95 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.198 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.614 HD11 HD23 ' B' ' 267' ' ' LEU . 21.3 mt -76.54 141.83 41.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.49 147.16 26.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -68.91 3.91 1.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 110.131 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -121.57 48.29 0.96 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.916 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -156.08 171.7 19.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.989 -1.301 . . . . 0.0 109.245 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' B' ' 258' ' ' ASP . 7.0 p -112.69 161.32 16.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.478 -0.764 . . . . 0.0 110.058 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.519 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.8 mt -60.0 -42.56 94.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.956 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 78.2 p -60.55 -29.05 68.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.081 -1.012 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' B' ' 255' ' ' THR . 1.3 m-20 -70.96 -14.64 62.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.127 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.27 2.81 27.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 66.05 38.25 4.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.525 -0.734 . . . . 0.0 109.605 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.9 mt -91.19 135.25 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -122.46 172.96 7.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.649 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.606 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.93 160.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.709 0.766 . . . . 0.0 110.506 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 58.08 11.68 1.58 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 2.5 m -73.68 145.35 45.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.776 -1.202 . . . . 0.0 108.875 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.761 ' C ' HD12 ' B' ' 267' ' ' LEU . 17.2 m -113.12 136.97 52.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.584 -0.698 . . . . 0.0 109.953 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.761 HD12 ' C ' ' B' ' 266' ' ' THR . 7.4 mp -124.69 141.7 51.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.409 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 66.5 m80 -88.57 141.06 28.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.092 -1.005 . . . . 0.0 110.059 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' B' ' 241' ' ' GLN . 11.5 tp -108.93 126.38 53.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.289 -0.882 . . . . 0.0 108.985 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 130.03 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.21 144.23 33.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 17.5 ttt180 -92.13 -140.76 0.19 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 108.985 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.435 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.8 mt -123.17 -21.85 5.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 109.496 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.38 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 122.044 0.926 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.445 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 30.0 mt -111.38 141.38 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.477 0.655 . . . . 0.0 109.694 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.3 m -115.94 122.13 44.36 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 71.5 m-85 -111.54 135.57 21.07 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.122 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.32 164.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.323 2.016 . . . . 0.0 112.742 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.63 -1.88 5.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 110.762 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.864 ' O ' HG22 ' B' ' 209' ' ' THR . 6.9 m-20 -122.9 8.29 9.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.066 -1.021 . . . . 0.0 110.367 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.8 mm -109.37 128.2 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.4 t70 -101.42 139.79 20.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.76 -46.99 1.45 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.502 2.135 . . . . 0.0 112.663 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 tt0 -47.44 -47.0 27.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 110.608 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.5 HG11 ' O ' ' B' ' 207' ' ' THR . 50.3 t -78.99 -42.82 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.4 t80 -51.43 -53.41 37.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.998 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -63.42 -18.82 64.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.0 110.281 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.81 -6.1 56.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.55 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' B' ' 268' ' ' HIS . 92.8 mt -91.07 152.35 44.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.147 -0.97 . . . . 0.0 109.836 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.62 154.51 30.56 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.416 2.077 . . . . 0.0 111.864 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -62.93 -50.16 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.698 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -44.61 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.971 -1.081 . . . . 0.0 110.092 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.3 -31.73 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 108.323 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.7 tt0 -60.02 -51.96 67.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.35 -49.57 74.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.589 -0.694 . . . . 0.0 110.307 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -56.5 -40.06 74.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.096 -1.003 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.96 -36.94 67.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.812 -1.18 . . . . 0.0 109.97 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -70.96 -38.71 72.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.716 -1.24 . . . . 0.0 108.884 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.72 -33.7 73.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.954 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.759 ' O ' HG22 ' A' ' 91' ' ' THR . 1.7 tt0 -72.95 -35.06 66.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -79.0 -11.29 60.0 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 108.749 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -92.88 -47.7 6.9 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.328 -0.858 . . . . 0.0 108.893 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -54.4 -39.7 67.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.857 -1.152 . . . . 0.0 108.241 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 87' ' ' GLU . 7.0 t -89.21 -36.89 15.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 108.966 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.431 ' HE2' HD12 ' B' ' 256' ' ' LEU . 2.5 ptt? . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.13 165.03 12.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.467 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.484 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -145.42 142.56 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.06 140.84 29.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.2 108.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.513 ' NZ ' ' CB ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -96.54 135.37 38.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.5 ' O ' HG11 ' A' ' 72' ' ' VAL . 70.4 p -96.27 -174.66 3.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 110.557 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 18.0 mt -72.45 -10.54 59.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.32 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -102.48 -3.43 26.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.88 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.65 0.27 62.65 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.102 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -66.93 119.67 12.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 108.887 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.1 m -101.44 140.03 36.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.352 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 41.2 mt -135.4 136.19 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 109.212 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.0 m -105.26 121.05 43.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' B' ' 229' ' ' LYS . 18.8 mt -125.4 120.73 31.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.437 -0.789 . . . . 0.0 109.868 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.39 133.85 51.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.457 HG11 HG22 ' B' ' 226' ' ' VAL . 11.4 m -140.88 -174.31 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 110.08 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -135.32 152.05 76.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.847 . . . . 0.0 109.068 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.04 -26.36 49.52 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.569 2.179 . . . . 0.0 112.516 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -98.1 7.22 46.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.55 142.08 50.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.104 -0.997 . . . . 0.0 110.009 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 62.4 p -86.02 144.59 27.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.409 ' H ' HG12 ' B' ' 223' ' ' ILE . 26.2 mm -51.98 -31.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.129 -0.982 . . . . 0.0 108.699 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.431 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -61.58 -32.95 73.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 109.392 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -72.66 -52.55 14.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.127 -0.983 . . . . 0.0 108.778 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.457 HG22 HG11 ' B' ' 217' ' ' VAL . 66.5 t -52.61 -47.43 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.077 -1.015 . . . . 0.0 108.388 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -52.8 -40.56 63.36 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.77 80.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.522 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.0 mtpp -59.04 -53.81 54.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.819 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.433 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -58.98 -34.24 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.867 -1.145 . . . . 0.0 109.213 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -60.98 -47.0 88.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -21.73 61.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.034 -1.041 . . . . 0.0 110.281 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -97.56 -59.32 1.8 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -82.94 -5.05 58.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.905 . . . . 0.0 111.341 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.61 73.68 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.558 -1.339 . . . . 0.0 110.357 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.33 125.32 35.37 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.102 -1.234 . . . . 0.0 109.439 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -73.63 154.12 49.41 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.956 1.77 . . . . 0.0 111.928 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.27 -31.23 53.59 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.673 2.249 . . . . 0.0 112.945 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -63.83 -13.0 40.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.296 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.502 HE21 HD22 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -126.54 -16.54 5.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.792 . . . . 0.0 110.357 -179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.499 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -88.9 132.05 34.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 109.166 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.72 132.5 53.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.447 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.5 mt -107.16 126.56 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.498 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.44 134.54 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 49.4 t80 -128.71 114.44 16.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.158 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.05 42.47 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.008 -1.057 . . . . 0.0 109.193 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.69 16.81 61.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.524 ' NZ ' ' CB ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -114.78 138.94 50.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -1.157 . . . . 0.0 109.479 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -86.65 125.98 34.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.722 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.4 157.78 28.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -117.48 144.48 45.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.483 -0.761 . . . . 0.0 109.842 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.18 3.77 1.98 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.698 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.02 33.71 4.77 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 -145.41 172.02 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.085 -1.244 . . . . 0.0 109.403 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.1 p -112.56 160.63 17.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.405 -0.809 . . . . 0.0 110.071 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.431 HD12 ' HE2' ' B' ' 201' ' ' MET . 3.1 mt -56.94 -42.38 79.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -0.891 . . . . 0.0 109.388 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.4 p -60.26 -29.11 68.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.534 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.95 -18.59 64.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.241 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.69 3.05 31.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.338 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.34 38.97 3.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.4 mt -91.02 135.87 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -121.77 172.91 7.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 109.545 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.837 ' HZ3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.86 161.76 0.72 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.346 -0.847 . . . . 0.0 110.466 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 57.31 11.28 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.484 ' OG ' HG22 ' B' ' 203' ' ' ILE . 69.9 p -76.02 151.91 37.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.931 -1.105 . . . . 0.0 108.632 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.749 ' C ' HD12 ' B' ' 267' ' ' LEU . 16.1 m -116.27 136.94 52.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 110.12 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.749 HD12 ' C ' ' B' ' 266' ' ' THR . 10.0 mp -122.06 140.95 51.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.402 ' HB3' HD21 ' A' ' 76' ' ' LEU . 52.7 m80 -89.92 139.8 30.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' B' ' 241' ' ' GLN . 20.8 tp -109.22 126.47 53.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.041 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.83 130.77 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.502 HD22 HE21 ' B' ' 240' ' ' GLN . 44.0 mt -79.12 142.08 36.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -0.888 . . . . 0.0 109.136 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.6 ttt180 -92.38 -141.73 0.2 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.571 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 69.9 mt -124.62 -54.36 1.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.458 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.786 . . . . 0.0 109.343 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 mttm . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 36.2 mt -111.8 131.37 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.927 . . . . 0.0 110.314 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.1 m -114.36 128.21 56.23 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.516 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 75.7 m-85 -113.51 135.08 21.87 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.927 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.2 165.25 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.388 2.058 . . . . 0.0 113.03 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -67.47 -2.35 6.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.818 -0.551 . . . . 0.0 110.692 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.905 ' O ' HG22 ' B' ' 209' ' ' THR . 1.6 m-20 -122.95 9.02 9.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.028 -1.045 . . . . 0.0 110.321 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -111.55 129.35 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 0.0 110.956 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -96.08 137.01 21.77 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.86 -38.47 2.99 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.457 2.105 . . . . 0.0 112.643 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.37 -42.84 92.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 110.356 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.56 HG11 ' O ' ' B' ' 207' ' ' THR . 84.1 t -79.21 -23.76 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 0.0 109.783 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.6 t80 -68.04 -53.39 26.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.714 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -62.21 -17.29 57.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.969 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -81.78 -6.07 58.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 76' ' ' LEU . 91.4 mt -90.23 151.44 44.7 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.532 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.79 155.06 18.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.436 2.091 . . . . 0.0 111.914 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.0 -50.52 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 110.769 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.27 54.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.057 . . . . 0.0 110.266 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.89 -31.1 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 108.234 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -60.51 -49.8 76.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -58.34 -48.27 81.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.553 -0.717 . . . . 0.0 110.163 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.1 -40.09 80.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.011 -1.056 . . . . 0.0 110.336 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.56 -39.05 70.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.884 -1.135 . . . . 0.0 109.874 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.22 -36.72 74.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.726 -1.234 . . . . 0.0 109.062 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.51 -34.16 76.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.233 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 5.3 tm-20 -72.0 -41.18 67.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.848 . . . . 0.0 109.082 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.521 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.1 m0 -74.8 -13.13 60.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.95 -1.094 . . . . 0.0 109.045 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -92.79 -47.35 7.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.779 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 91' ' ' THR . 4.4 ptp180 -53.85 -38.83 65.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.745 -1.222 . . . . 0.0 108.508 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.423 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 5.8 t -93.25 -36.86 12.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.268 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -95.26 163.44 13.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 110.233 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.62 140.97 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.537 -0.727 . . . . 0.0 109.139 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -93.77 142.23 27.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -122.69 110.94 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.412 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -98.46 138.31 35.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.56 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.0 p -97.27 -175.04 3.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 111.08 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.501 HD11 ' H ' ' B' ' 271' ' ' LEU . 31.8 mt -71.54 -14.9 62.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.0 p -99.05 -4.06 33.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.616 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.31 2.42 60.47 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -67.63 119.19 11.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.045 -1.267 . . . . 0.0 109.062 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 135.71 41.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 47.4 mt -134.22 135.42 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.434 -0.791 . . . . 0.0 109.088 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 59.5 m -104.56 124.21 48.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.019 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' B' ' 229' ' ' LYS . 22.0 mt -126.73 120.68 29.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.11 133.67 51.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.574 -0.704 . . . . 0.0 109.295 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.83 -174.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.969 -1.082 . . . . 0.0 109.788 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -133.92 153.36 79.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.115 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.16 -18.37 23.33 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.423 2.082 . . . . 0.0 111.876 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 31.4 t -108.67 7.66 26.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 110.071 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.68 145.86 46.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.39 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 58.3 p -87.84 145.3 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.433 HD12 HD13 ' B' ' 250' ' ' LEU . 28.3 mm -51.73 -34.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 0.0 109.163 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -62.3 -32.16 72.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.479 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -70.21 -51.66 29.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.031 -1.043 . . . . 0.0 108.251 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.416 ' H ' HG23 ' B' ' 226' ' ' VAL . 15.9 t -52.21 -44.14 40.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.464 ' HD3' HD12 ' B' ' 243' ' ' LEU . 0.0 OUTLIER -51.63 -48.31 63.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.622 -0.674 . . . . 0.0 109.431 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.46 70.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.729 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.586 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.8 mtpp -58.76 -54.25 49.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.12 -0.988 . . . . 0.0 109.761 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.5 -34.36 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.097 . . . . 0.0 109.033 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -62.2 -50.38 72.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.955 -1.091 . . . . 0.0 109.821 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.72 -27.5 69.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.684 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -97.41 -54.41 3.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.967 -1.083 . . . . 0.0 110.518 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -86.1 -6.44 59.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 111.329 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.23 24.18 73.37 Favored Glycine 0 N--CA 1.492 2.379 0 O-C-N 120.467 -1.396 . . . . 0.0 110.281 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 59.6 mt -107.34 130.65 22.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -1.159 . . . . 0.0 109.675 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -69.66 166.59 26.95 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.029 1.819 . . . . 0.0 111.271 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' PRO . . . . . 0.402 ' CB ' ' HG2' ' B' ' 227' ' ' LYS . 64.8 Cg_endo -83.12 -27.75 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.464 2.109 . . . . 0.0 112.711 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.79 -10.16 58.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.937 . . . . 0.0 110.31 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.52 -25.63 5.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.485 -0.759 . . . . 0.0 109.78 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.02 137.8 31.98 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.621 -1.299 . . . . 0.0 108.55 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -124.07 134.39 53.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 110.156 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.464 HD12 ' HD3' ' B' ' 227' ' ' LYS . 16.9 mt -103.18 120.37 40.59 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 53.9 mt -115.24 133.94 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.598 -0.689 . . . . 0.0 109.399 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -128.23 123.79 35.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.55 41.58 30.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.629 -1.294 . . . . 0.0 108.935 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.29 1.07 6.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -93.02 134.19 35.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.035 -1.273 . . . . 0.0 109.458 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -84.2 120.83 26.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.919 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.535 HD11 HD23 ' B' ' 267' ' ' LEU . 24.2 mt -73.5 142.55 46.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.645 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 144.52 25.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.661 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -72.98 4.2 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.84 42.28 1.6 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -147.37 172.9 13.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.012 -1.287 . . . . 0.0 109.365 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.433 ' OG1' ' OD1' ' B' ' 258' ' ' ASP . 6.5 p -110.03 158.16 18.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.067 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.451 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.7 mt -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 109.849 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.2 p -61.32 -28.99 69.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.807 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ASP . . . . . 0.433 ' OD1' ' OG1' ' B' ' 255' ' ' THR . 0.7 OUTLIER -70.12 -15.97 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.129 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.69 3.03 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.82 39.05 3.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.748 . . . . 0.0 109.468 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.7 mt -92.78 136.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.124 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.64 175.11 7.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.386 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.81 162.94 0.53 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.345 -0.847 . . . . 0.0 110.686 -178.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 57.36 13.36 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.098 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -77.01 148.84 36.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.94 -1.1 . . . . 0.0 108.595 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.809 ' C ' HD12 ' B' ' 267' ' ' LEU . 6.7 m -115.09 137.8 51.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.977 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.809 HD12 ' C ' ' B' ' 266' ' ' THR . 9.5 mp -125.54 140.86 52.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.22 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -89.05 143.05 27.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.234 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.95 126.35 52.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.56 131.4 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.353 -0.842 . . . . 0.0 109.749 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.501 ' H ' HD11 ' B' ' 208' ' ' LEU . 45.2 mt -81.58 143.97 31.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.324 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.549 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.9 ttt180 -98.69 -136.16 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.549 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.4 mt -124.09 -35.04 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 108.694 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.46 -0.775 . . . . 0.0 109.252 179.884 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 37.1 mt -109.36 131.81 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 110.14 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 m -115.61 126.11 53.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 76.1 m-85 -110.33 135.44 20.61 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.464 -0.772 . . . . 0.0 109.83 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -47.64 164.75 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.364 2.042 . . . . 0.0 112.874 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.412 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -67.2 -1.72 4.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.757 -0.589 . . . . 0.0 110.682 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.851 ' O ' HG22 ' B' ' 209' ' ' THR . 4.0 m-20 -123.95 9.91 8.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.388 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.2 mm -112.63 129.99 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 0.0 111.268 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t70 -100.19 139.93 21.09 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -71.24 -48.88 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.221 1.947 . . . . 0.0 112.297 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 31.8 tt0 -47.98 -44.02 30.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.691 -0.631 . . . . 0.0 110.271 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.593 HG11 ' O ' ' B' ' 207' ' ' THR . 49.0 t -80.2 -23.63 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.79 -1.194 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 27.7 t80 -70.55 -53.08 17.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.071 . . . . 0.0 111.074 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -61.63 -16.32 47.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.75 -5.32 58.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.731 -1.231 . . . . 0.0 110.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.2 mt -90.72 151.94 44.31 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.04 155.95 17.32 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.476 2.118 . . . . 0.0 112.08 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.29 -50.06 71.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.685 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.87 -43.05 59.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.92 -1.113 . . . . 0.0 110.115 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.418 HG11 HG21 ' B' ' 270' ' ' VAL . 61.7 t -75.85 -31.85 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 108.616 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.5 tt0 -60.84 -50.4 73.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -57.16 -49.04 77.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.661 -0.65 . . . . 0.0 110.277 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -57.7 -40.51 79.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.095 -1.003 . . . . 0.0 110.808 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.3 mt -70.53 -38.63 74.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.851 -1.156 . . . . 0.0 109.943 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.9 mt -71.49 -37.42 71.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.744 -1.222 . . . . 0.0 108.908 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.81 70.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 108.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.19 -37.7 57.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 108.793 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 34.1 m0 -77.52 -18.21 57.22 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.925 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -92.25 -45.3 8.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' CG ' ' N ' ' A' ' 91' ' ' THR . 1.1 ptm85 -53.27 -39.0 63.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.864 -1.147 . . . . 0.0 107.992 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.424 ' N ' ' CG ' ' A' ' 90' ' ' ARG . 6.5 t -94.26 -36.2 12.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 0.0 109.152 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.727 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -97.5 167.62 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.54 143.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.37 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -95.62 144.03 26.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -0.856 . . . . 0.0 110.032 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.28 115.29 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 130.0 46.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.593 ' O ' HG11 ' A' ' 72' ' ' VAL . 32.6 p -87.21 -177.1 5.91 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.011 0.91 . . . . 0.0 110.774 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.603 HD11 ' H ' ' B' ' 271' ' ' LEU . 46.9 mt -72.74 -14.98 61.67 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.424 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.851 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -98.11 -3.88 36.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.529 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.04 5.05 57.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.311 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -71.37 118.08 13.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.364 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 20.0 m -99.59 135.56 40.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.278 -0.888 . . . . 0.0 109.012 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.667 HD11 ' CD ' ' B' ' 234' ' ' GLU . 37.6 mt -134.11 137.35 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.521 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 86.5 m -104.77 125.23 50.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.5 mt -127.47 119.95 27.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.58 131.9 47.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.83 -173.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.573 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.19 153.06 76.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 108.869 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.75 -24.26 45.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.382 2.054 . . . . 0.0 111.906 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.29 5.98 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.921 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -70.45 142.51 51.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.997 -1.064 . . . . 0.0 109.363 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 60.5 p -86.2 146.0 26.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.141 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.7 mm -51.41 -35.31 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.066 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -34.62 72.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.813 . . . . 0.0 109.546 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -70.99 -52.6 18.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.365 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.407 ' O ' HD12 ' B' ' 230' ' ' ILE . 38.0 t -52.32 -43.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 108.824 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.31 -41.29 79.6 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.277 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' B' ' 215' ' ' LEU . 16.7 mtpp -56.94 -53.72 54.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.095 -1.003 . . . . 0.0 108.744 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.604 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.5 mp -56.59 -35.49 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.934 . . . . 0.0 108.925 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -62.77 -49.58 74.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 0.0 109.921 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -31.45 70.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 110.763 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -98.1 -53.96 3.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.966 -1.083 . . . . 0.0 110.846 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.667 ' CD ' HD11 ' B' ' 213' ' ' ILE . 14.7 mm-40 -81.22 -8.65 59.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.165 -0.959 . . . . 0.0 111.132 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.84 68.97 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 120.625 -1.297 . . . . 0.0 110.396 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 53.5 mt -100.72 129.51 27.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.238 . . . . 0.0 109.345 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.23 158.67 48.49 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.069 1.846 . . . . 0.0 111.88 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.18 -31.25 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.692 2.261 . . . . 0.0 112.899 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.59 -6.24 29.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 110.443 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.99 -16.86 4.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 110.26 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.7 140.2 31.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 0.0 109.184 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -129.74 134.49 47.65 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.431 ' CB ' HD12 ' B' ' 250' ' ' LEU . 12.1 mt -106.85 126.67 52.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.269 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.9 mt -119.81 135.18 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.628 -0.67 . . . . 0.0 109.626 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.557 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 50.7 t80 -127.11 109.21 11.63 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 67.41 41.21 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.868 -1.145 . . . . 0.0 109.267 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.18 1.99 23.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -98.57 135.85 39.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.26 . . . . 0.0 109.585 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -82.75 123.62 29.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 109.272 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.524 HD11 HD23 ' B' ' 267' ' ' LEU . 39.7 mt -71.45 142.72 50.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.0 146.51 28.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.5 OUTLIER -72.81 3.43 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.684 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.23 44.09 1.46 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -155.86 172.44 18.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.905 -1.35 . . . . 0.0 109.461 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 76.2 p -113.54 162.5 16.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.624 -0.672 . . . . 0.0 110.149 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.472 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.8 mt -56.34 -44.5 80.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.4 p -60.22 -27.99 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.88 . . . . 0.0 109.737 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -20.85 62.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.9 5.45 43.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 66.91 39.69 3.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.01 137.0 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -126.26 178.39 5.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.05 158.98 1.3 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.971 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 58.11 24.02 10.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.304 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.35 148.72 25.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.479 -1.388 . . . . 0.0 108.675 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.786 ' C ' HD12 ' B' ' 267' ' ' LEU . 1.8 m -110.87 134.48 52.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.649 -0.657 . . . . 0.0 109.685 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.786 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -124.04 139.06 54.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.541 -0.724 . . . . 0.0 109.226 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -89.05 143.56 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.08 -1.012 . . . . 0.0 110.001 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.86 127.41 54.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.023 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 80' ' ' VAL . 42.5 t -112.76 128.17 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.576 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.603 ' H ' HD11 ' B' ' 208' ' ' LEU . 44.9 mt -81.3 143.6 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.242 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 31.9 ttt180 -96.94 -136.26 0.25 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.521 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 46.5 mt -123.75 -24.63 4.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.955 . . . . 0.0 109.073 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.825 . . . . 0.0 109.389 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mttm . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.587 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 49.2 mt -109.44 131.99 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.882 . . . . 0.0 110.391 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.2 m -113.76 125.41 54.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.587 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 80.0 m-85 -111.58 136.37 21.06 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.351 -0.843 . . . . 0.0 110.079 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -48.12 164.81 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.457 2.104 . . . . 0.0 112.917 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -2.14 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.573 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.877 ' O ' HG22 ' B' ' 209' ' ' THR . 0.5 OUTLIER -123.63 9.17 8.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.141 -0.975 . . . . 0.0 110.423 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.4 mm -110.84 129.37 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.167 -0.958 . . . . 0.0 111.267 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t0 -100.24 140.19 21.28 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.24 -47.04 0.57 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.407 2.071 . . . . 0.0 112.219 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.531 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -47.25 -45.32 23.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.738 -0.601 . . . . 0.0 110.336 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.595 HG11 ' O ' ' B' ' 207' ' ' THR . 21.6 t -80.71 -33.03 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.82 -1.175 . . . . 0.0 110.526 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 18.1 t80 -60.76 -54.39 45.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.909 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.66 -18.13 58.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -81.35 -5.88 58.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.86 -1.15 . . . . 0.0 109.712 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 76' ' ' LEU . 95.2 mt -90.63 151.56 44.09 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.619 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 155.28 16.34 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.342 2.028 . . . . 0.0 111.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -63.53 -49.03 75.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.02 -42.97 60.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.898 -1.126 . . . . 0.0 110.156 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.77 -32.19 27.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.373 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.61 -49.5 77.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -58.09 -49.47 76.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.206 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -58.29 -39.52 79.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.0 110.366 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.922 -1.111 . . . . 0.0 109.817 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.8 mt -71.04 -37.14 72.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 109.089 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -33.23 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 91' ' ' THR . 2.9 tm-20 -73.68 -38.22 64.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.267 -0.895 . . . . 0.0 109.0 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 38.0 m0 -75.97 -14.71 60.24 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.949 -1.095 . . . . 0.0 108.485 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -92.96 -46.28 7.56 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.388 -0.82 . . . . 0.0 109.439 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -53.97 -40.5 66.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.73 -1.231 . . . . 0.0 108.028 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 87' ' ' GLU . 14.7 t -87.05 -36.89 17.93 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.86 163.92 12.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 110.482 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.52 145.93 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.226 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.13 141.98 31.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 113.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.714 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.548 ' NZ ' ' CB ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -100.81 129.31 46.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 108.79 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.595 ' O ' HG11 ' A' ' 72' ' ' VAL . 31.1 p -90.19 -171.79 3.24 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.036 0.922 . . . . 0.0 111.36 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.617 HD11 ' H ' ' B' ' 271' ' ' LEU . 40.8 mt -71.74 -17.79 62.17 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.716 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.877 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.8 p -97.56 -2.64 41.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.675 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.07 2.42 62.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.61 118.63 9.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -1.214 . . . . 0.0 108.856 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 23.0 m -101.35 133.07 46.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.5 mt -128.27 137.88 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.468 -0.77 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 49.6 m -105.96 120.76 42.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 108.768 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' B' ' 229' ' ' LYS . 23.6 mt -125.53 121.02 32.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.393 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.29 132.2 47.25 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.86 -172.56 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.888 -1.132 . . . . 0.0 109.854 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -134.73 153.56 78.93 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -58.15 -24.03 64.54 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.478 2.118 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.76 6.91 41.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.825 . . . . 0.0 109.783 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.63 143.93 49.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.954 -1.091 . . . . 0.0 109.571 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.2 p -87.63 145.92 25.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.0 109.824 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 33.2 mm -51.79 -39.82 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.178 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -34.4 57.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.565 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -72.24 -50.22 29.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.178 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 51.2 t -51.99 -49.72 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 108.557 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -42.87 62.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.571 -0.705 . . . . 0.0 109.477 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.88 75.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.517 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.5 mtpp -57.41 -53.71 55.08 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.246 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.52 -33.16 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.013 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.04 -47.63 85.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.99 -1.069 . . . . 0.0 110.118 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.56 -26.71 63.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.008 -1.058 . . . . 0.0 110.906 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -94.52 -50.06 5.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.886 -1.134 . . . . 0.0 110.529 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -92.64 -7.69 46.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 0.0 111.396 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.27 21.18 77.19 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 120.44 -1.413 . . . . 0.0 110.726 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 24.9 mt -103.98 128.11 27.88 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.909 -1.347 . . . . 0.0 109.587 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -70.87 164.79 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.183 1.922 . . . . 0.0 112.497 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.9 -31.95 7.7 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.011 2.474 . . . . 0.0 113.383 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.63 -5.91 43.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.243 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.499 HE21 HD22 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -121.9 -25.97 4.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.476 ' HB2' HD11 ' B' ' 269' ' ' LEU . 1.6 pt20 -90.19 147.95 23.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.385 -1.447 . . . . 0.0 108.816 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -131.37 133.37 45.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -0.995 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.5 mt -103.84 123.24 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.439 -0.788 . . . . 0.0 109.016 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 97.8 mt -117.55 133.97 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.65 -0.657 . . . . 0.0 109.378 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 44.5 t80 -129.05 117.24 20.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 60.3 37.23 20.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.654 -1.279 . . . . 0.0 109.21 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.29 28.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -94.96 132.56 39.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.828 -1.395 . . . . 0.0 109.501 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -82.58 125.07 30.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.11 140.75 41.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' B' ' 253' ' ' GLY . 9.0 tp10 -101.62 148.92 24.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.58 4.16 2.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.337 -0.852 . . . . 0.0 110.832 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.453 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -119.15 46.02 1.18 Allowed Glycine 0 N--CA 1.497 2.721 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.937 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.92 174.41 15.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.905 -1.35 . . . . 0.0 109.515 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 17.0 p -112.65 160.67 17.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 110.257 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.6 mt -58.48 -41.11 84.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 109.749 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 30.0 p -61.72 -28.04 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 0.0 109.418 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -70.55 -19.68 62.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.38 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -103.17 3.58 35.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.062 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 66.54 38.93 3.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.551 -0.718 . . . . 0.0 109.99 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 49.6 mt -92.81 137.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.155 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -126.16 176.23 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.073 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.509 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.69 160.35 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.914 0.864 . . . . 0.0 110.834 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 56.04 12.67 0.97 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.123 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 16.1 m -78.22 152.03 32.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.882 -1.136 . . . . 0.0 108.644 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.781 ' C ' HD12 ' B' ' 267' ' ' LEU . 15.4 m -116.34 137.97 51.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -0.764 . . . . 0.0 110.388 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.781 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -123.97 140.88 52.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.359 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.433 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 68.2 m80 -88.95 141.12 28.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.115 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' B' ' 241' ' ' GLN . 14.3 tp -110.08 127.85 55.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 132.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 109.776 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.617 ' H ' HD11 ' B' ' 208' ' ' LEU . 45.4 mt -80.84 141.39 34.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.115 -0.991 . . . . 0.0 109.289 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.572 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 24.9 ttt180 -96.46 -137.31 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.572 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 82.3 mt -124.73 -45.47 1.9 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.466 -0.771 . . . . 0.0 109.511 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.524 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 37.3 mt -110.43 131.61 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.266 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -113.58 127.93 56.25 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.524 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 77.4 m-85 -113.98 136.13 22.12 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 110.285 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -48.25 164.84 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.309 2.006 . . . . 0.0 113.12 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.88 -2.16 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.754 -0.591 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.952 ' O ' HG22 ' B' ' 209' ' ' THR . 2.2 m-20 -122.66 7.31 9.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.098 -1.001 . . . . 0.0 110.387 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.96 128.66 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -0.993 . . . . 0.0 110.967 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.3 t0 -101.09 140.45 21.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.11 -48.75 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.495 2.13 . . . . 0.0 112.432 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.3 tt0 -47.07 -46.86 22.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.733 -0.604 . . . . 0.0 110.46 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.674 HG11 ' O ' ' B' ' 207' ' ' THR . 57.8 t -80.42 -23.67 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.234 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.9 t80 -72.17 -54.89 8.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 111.03 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.9 -19.13 59.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -80.26 -4.18 52.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.877 -1.14 . . . . 0.0 109.302 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 152.65 43.41 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.257 -0.902 . . . . 0.0 109.847 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.5 154.36 30.62 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.415 2.077 . . . . 0.0 111.852 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -63.31 -48.06 79.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -0.854 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.16 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.92 -1.113 . . . . 0.0 110.44 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.49 HG11 HG21 ' B' ' 270' ' ' VAL . 57.9 t -75.06 -31.97 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 0.0 108.361 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.6 tt0 -59.88 -50.51 73.51 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -58.39 -48.14 81.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.86 -41.98 88.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 110.789 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.4 mt -71.15 -37.31 72.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.689 -1.257 . . . . 0.0 109.723 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.26 -37.54 74.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.855 -1.153 . . . . 0.0 109.036 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.78 73.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.055 -1.028 . . . . 0.0 109.003 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' O ' HG22 ' A' ' 91' ' ' THR . 20.8 tt0 -71.36 -40.31 70.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 108.819 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -74.86 -12.15 60.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.057 -1.027 . . . . 0.0 109.192 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -92.36 -47.87 6.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.0 109.506 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -53.63 -38.86 64.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.752 -1.217 . . . . 0.0 108.136 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 87' ' ' GLU . 12.5 t -91.96 -36.76 13.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 108.97 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -97.58 164.28 12.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 110.599 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.0 143.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.83 140.78 29.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.712 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.04 110.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 109.304 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.7 ptpt -97.1 132.4 42.93 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.674 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.8 p -94.45 -174.61 3.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.101 -1.0 . . . . 0.0 111.066 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.17 -14.27 61.77 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.343 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.952 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.1 p -99.71 -4.33 30.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.455 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.63 1.8 60.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -66.8 117.85 9.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -1.21 . . . . 0.0 108.848 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 8.6 m -101.0 133.07 46.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 108.978 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 26.6 mt -127.63 135.6 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 109.503 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 19.0 m -102.63 121.38 42.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.591 HD13 ' CB ' ' B' ' 229' ' ' LYS . 33.2 mt -127.39 119.45 26.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.369 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.5 130.97 45.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.27 -177.01 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -130.18 153.54 81.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 109.034 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.26 -17.95 42.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.401 2.068 . . . . 0.0 111.946 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.33 8.47 29.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.0 144.54 47.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.847 -1.158 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 64.6 p -87.04 145.86 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.129 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.455 HD12 HD13 ' B' ' 250' ' ' LEU . 42.9 mm -50.88 -28.51 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 108.916 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -64.3 -37.39 87.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.388 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -69.06 -50.38 48.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.174 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.91 -48.81 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.096 -1.003 . . . . 0.0 108.685 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -52.5 -40.48 62.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.688 . . . . 0.0 109.359 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.41 -35.61 80.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.639 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.591 ' CB ' HD13 ' B' ' 215' ' ' LEU . 17.2 mtpp -58.21 -53.64 55.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.915 -1.116 . . . . 0.0 109.145 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.8 mp -59.46 -35.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.111 -0.993 . . . . 0.0 109.204 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -59.36 -44.25 92.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.095 -1.003 . . . . 0.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.91 -29.28 63.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 0.0 110.764 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -91.99 -48.87 6.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.928 -1.108 . . . . 0.0 110.605 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -92.26 -6.71 49.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 111.58 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.68 22.98 73.85 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.482 -1.386 . . . . 0.0 110.389 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 56.5 mt -101.31 129.49 26.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.312 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -75.4 155.46 41.08 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.029 1.819 . . . . 0.0 111.643 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.6 -32.39 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.698 2.265 . . . . 0.0 113.015 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -64.42 -8.97 15.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.55 HE21 HD22 ' B' ' 271' ' ' LEU . 0.1 OUTLIER -128.64 -21.58 3.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.753 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.532 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -84.48 135.38 34.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.749 -1.219 . . . . 0.0 109.299 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.95 131.54 51.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.04 126.76 52.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.333 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.93 134.69 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -128.31 121.51 29.4 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.84 42.79 28.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.571 -1.331 . . . . 0.0 109.275 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.72 0.03 7.89 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -95.52 132.37 40.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.872 -1.37 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.7 123.61 29.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.084 -1.01 . . . . 0.0 108.83 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.548 HD11 HD23 ' B' ' 267' ' ' LEU . 19.4 mt -68.81 150.73 47.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 0.0 109.744 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.3 141.57 36.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.51 3.49 3.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.322 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.18 35.77 3.4 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -142.34 170.95 14.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.295 . . . . 0.0 109.813 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.3 p -111.79 159.96 17.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.001 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.505 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.0 mt -56.5 -42.85 79.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 79.5 p -62.74 -29.13 70.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.8 -18.61 63.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.158 -0.964 . . . . 0.0 109.101 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.55 3.45 34.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.151 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.84 39.15 2.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.501 -0.749 . . . . 0.0 109.837 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.7 mt -93.86 136.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 262' ' ' GLN . . . . . 0.467 ' O ' ' OG ' ' B' ' 265' ' ' SER . 55.6 mt-30 -125.81 177.17 6.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.26 162.24 0.76 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.245 -0.909 . . . . 0.0 110.927 -178.832 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 56.33 12.42 1.01 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.053 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 72.7 m -76.5 149.05 36.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.891 -1.131 . . . . 0.0 108.75 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.799 ' C ' HD12 ' B' ' 267' ' ' LEU . 20.5 m -115.83 138.95 50.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 110.352 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.799 HD12 ' C ' ' B' ' 266' ' ' THR . 10.3 mp -124.88 142.81 51.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.432 -0.793 . . . . 0.0 109.406 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.407 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 69.2 m80 -90.67 141.75 28.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.034 -1.041 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' B' ' 241' ' ' GLN . 23.0 tp -111.28 128.89 56.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.412 -0.805 . . . . 0.0 109.578 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 80' ' ' VAL . 3.1 t -116.76 130.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.55 HD22 HE21 ' B' ' 240' ' ' GLN . 48.3 mt -82.57 145.66 29.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 32.0 ttt180 -97.69 -136.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.526 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.9 mt -124.25 -33.07 3.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 109.429 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 tptp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 122.052 0.929 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.407 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 30.1 mt -114.45 136.86 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.419 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.9 m -113.94 122.96 48.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 83.5 m-85 -109.21 135.92 20.19 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.793 . . . . 0.0 109.94 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -48.09 164.13 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.287 1.991 . . . . 0.0 112.757 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -2.19 5.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.653 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.932 ' O ' HG22 ' B' ' 209' ' ' THR . 2.6 m-20 -123.22 9.66 9.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.081 -1.012 . . . . 0.0 110.698 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.8 mm -110.29 127.61 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.101 -0.999 . . . . 0.0 111.119 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.0 t70 -98.33 138.73 20.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.36 -41.69 4.53 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.338 2.025 . . . . 0.0 112.567 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 61.2 tt0 -56.61 -43.34 80.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 110.466 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.599 HG11 ' O ' ' B' ' 207' ' ' THR . 66.0 t -81.11 -24.24 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.748 -1.22 . . . . 0.0 110.402 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -72.24 -55.07 7.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -59.09 -16.76 20.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -83.93 -5.76 59.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.996 -1.065 . . . . 0.0 109.877 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.4 151.38 48.39 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.006 -1.059 . . . . 0.0 109.786 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 153.81 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.28 1.987 . . . . 0.0 111.792 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -63.03 -51.57 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.583 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.5 39.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.928 -1.108 . . . . 0.0 110.239 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.27 -31.45 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.712 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -60.49 -50.03 75.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -58.1 -49.04 78.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.753 . . . . 0.0 110.145 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -57.11 -41.99 80.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.63 -38.61 73.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.852 -1.155 . . . . 0.0 110.023 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.56 -38.33 74.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.68 -1.262 . . . . 0.0 109.327 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.48 -31.44 70.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.161 -0.962 . . . . 0.0 108.708 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.547 ' OE2' ' CD2' ' B' ' 273' ' ' LEU . 5.9 tt0 -72.21 -42.64 65.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -73.02 -13.95 61.32 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.983 -1.073 . . . . 0.0 109.391 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -92.73 -46.28 7.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.191 -0.943 . . . . 0.0 109.504 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HE ' ' HA ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -53.35 -38.75 63.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.765 -1.209 . . . . 0.0 108.15 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 6.3 t -91.32 -36.56 13.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 108.923 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.441 ' O ' HG23 ' B' ' 217' ' ' VAL . 3.2 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 202' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' B' ' 202' ' ' GLN . 0.7 OUTLIER -98.19 166.84 11.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 110.334 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.34 146.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.427 -0.796 . . . . 0.0 109.781 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -97.89 141.06 31.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.87 109.12 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.463 ' HE2' HG21 ' B' ' 266' ' ' THR . 0.5 OUTLIER -95.17 133.31 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.599 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.6 p -94.78 -176.38 3.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 110.914 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.592 HD11 ' H ' ' B' ' 271' ' ' LEU . 25.7 mt -71.22 -12.8 61.67 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.489 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.932 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.7 p -101.79 -3.96 27.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.709 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.63 2.94 58.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -68.41 118.41 11.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.272 . . . . 0.0 109.021 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -101.01 135.86 41.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 40.9 mt -133.43 136.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.384 -0.823 . . . . 0.0 109.349 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.1 m -105.91 122.49 46.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.534 HD13 ' CB ' ' B' ' 229' ' ' LYS . 18.4 mt -126.11 121.7 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.391 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.54 132.24 47.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 201' ' ' MET . 8.2 m -140.2 -173.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.968 -1.082 . . . . 0.0 109.58 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -134.95 154.2 79.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.97 -20.62 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.545 2.163 . . . . 0.0 112.223 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 67.4 m -106.3 7.66 31.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 110.219 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 142.2 54.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.77 -1.206 . . . . 0.0 109.404 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.5 p -85.43 146.85 26.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.414 HD12 HD13 ' B' ' 250' ' ' LEU . 40.5 mm -51.7 -40.26 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.389 -0.82 . . . . 0.0 109.384 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.17 -35.67 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.568 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.408 ' HA ' HD21 ' B' ' 225' ' ' ASN . 9.9 m120 -69.13 -52.3 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.338 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 99.0 t -52.51 -45.58 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.377 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.06 -43.69 70.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.7 73.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.444 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.534 ' CB ' HD13 ' B' ' 215' ' ' LEU . 4.4 mtpm? -58.55 -54.53 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.495 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.3 mp -57.86 -34.18 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.848 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -63.1 -46.14 88.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.236 -0.915 . . . . 0.0 109.997 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -30.81 71.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.184 -0.947 . . . . 0.0 110.902 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -95.87 -50.67 4.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.008 -1.058 . . . . 0.0 110.556 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -87.39 -7.69 57.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.032 -1.043 . . . . 0.0 111.412 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.75 23.27 70.67 Favored Glycine 0 N--CA 1.493 2.446 0 O-C-N 120.535 -1.353 . . . . 0.0 110.305 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 45.9 mt -100.48 126.7 34.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.086 -1.244 . . . . 0.0 109.271 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -75.15 152.78 40.48 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.064 1.843 . . . . 0.0 111.767 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.04 -30.1 47.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.668 2.245 . . . . 0.0 112.694 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.24 -16.1 41.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.521 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.08 -12.36 5.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.422 -0.798 . . . . 0.0 110.696 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.575 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -90.86 137.0 32.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.917 -1.115 . . . . 0.0 109.523 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.18 132.09 45.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.654 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.92 128.78 54.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 109.297 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.56 136.22 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.563 -0.711 . . . . 0.0 109.85 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 40.9 t80 -132.36 117.02 17.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.233 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.35 36.96 8.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.895 -1.128 . . . . 0.0 109.436 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.8 13.0 68.51 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.295 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -115.45 137.8 51.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.263 . . . . 0.0 109.524 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.56 126.17 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.013 . . . . 0.0 109.435 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.414 HD13 HD12 ' B' ' 223' ' ' ILE . 23.0 mt -70.69 139.78 51.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -92.6 142.2 27.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.192 -0.942 . . . . 0.0 109.486 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.5 m-20 -69.26 3.45 2.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 109.712 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.44 41.68 1.73 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.543 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -144.78 171.25 14.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 109.332 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 25.8 p -111.73 158.32 19.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.962 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.481 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.4 mt -54.88 -40.7 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 89.0 p -64.2 -28.35 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.547 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.61 -17.17 62.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.17 3.16 29.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 109.084 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 37.85 3.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 0.0 109.999 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.48 135.92 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -125.74 177.78 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 109.925 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.489 ' H ' ' HE3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.53 157.13 3.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.021 0.915 . . . . 0.0 111.008 -178.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 57.87 12.43 1.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.671 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 22.0 m -75.9 148.3 38.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.729 ' C ' HD12 ' B' ' 267' ' ' LEU . 30.8 m -115.58 138.97 50.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.772 . . . . 0.0 110.048 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 266' ' ' THR . 11.2 mp -120.72 166.46 13.68 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -112.13 137.47 50.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.795 . . . . 0.0 109.426 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.575 HD11 ' HG3' ' B' ' 241' ' ' GLN . 18.6 tp -108.86 126.05 52.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.478 -0.763 . . . . 0.0 109.285 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.07 130.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.435 -0.791 . . . . 0.0 109.624 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.592 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.4 mt -80.79 143.22 33.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.092 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.545 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.1 ttt180 -93.38 -140.3 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 108.85 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.547 ' CD2' ' OE2' ' A' ' 87' ' ' GLU . 56.3 mt -123.68 -16.95 6.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 109.602 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.122 -0.986 . . . . 0.0 109.455 -179.853 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 mttp . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.174 0.988 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.527 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.5 mt -117.15 138.06 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.112 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 m -114.5 125.26 53.61 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.527 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 78.6 m-85 -113.7 137.28 22.17 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 110.489 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.84 164.79 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.642 2.228 . . . . 0.0 112.962 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.0 p -69.13 -2.47 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.768 -0.582 . . . . 0.0 110.509 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.847 ' O ' HG22 ' B' ' 209' ' ' THR . 32.2 m-20 -121.56 6.62 10.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.017 -1.052 . . . . 0.0 110.204 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -108.78 129.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.905 . . . . 0.0 111.275 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.8 t0 -100.49 138.33 20.13 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.7 -47.12 1.45 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.149 1.899 . . . . 0.0 112.009 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 7.1 tt0 -50.47 -43.04 55.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.889 -0.507 . . . . 0.0 110.1 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.629 HG11 ' O ' ' B' ' 207' ' ' THR . 62.1 t -80.55 -23.97 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.699 -1.251 . . . . 0.0 110.022 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -73.59 -52.79 12.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.093 -1.005 . . . . 0.0 110.655 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' OH ' HD12 ' A' ' 62' ' ' ILE . 56.2 m-85 -62.56 -17.4 59.88 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.916 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -81.07 -6.37 58.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.9 -1.125 . . . . 0.0 109.779 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' B' ' 268' ' ' HIS . 95.6 mt -90.65 151.74 44.24 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.13 155.99 17.61 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.005 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -50.03 71.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.96 -43.28 50.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.92 -1.113 . . . . 0.0 110.352 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' B' ' 270' ' ' VAL . 89.7 t -75.13 -32.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.889 -1.132 . . . . 0.0 108.642 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.1 tt0 -59.26 -51.44 69.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -57.62 -49.06 77.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.562 -0.711 . . . . 0.0 110.352 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.79 -41.28 81.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.045 . . . . 0.0 110.861 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.7 mt -71.22 -36.33 71.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.7 -1.25 . . . . 0.0 109.632 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 mt -71.45 -37.85 71.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.71 -1.244 . . . . 0.0 108.854 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.22 72.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.101 -0.999 . . . . 0.0 109.435 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' O ' HG22 ' A' ' 91' ' ' THR . 24.3 tp10 -74.39 -37.02 63.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 108.888 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -74.57 -12.35 60.44 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.882 -1.136 . . . . 0.0 108.612 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -92.81 -47.45 7.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.427 -0.796 . . . . 0.0 109.574 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -53.53 -39.36 64.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.678 -1.264 . . . . 0.0 107.766 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 87' ' ' GLU . 11.3 t -84.51 -36.63 22.08 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -95.45 165.63 12.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.437 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.0 pp -146.66 141.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' B' ' 266' ' ' THR . 8.6 m-85 -94.52 141.98 27.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.974 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.49 114.37 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.479 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.3 OUTLIER -99.0 138.92 35.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.629 ' O ' HG11 ' A' ' 72' ' ' VAL . 30.1 p -98.65 -175.5 3.09 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -0.936 . . . . 0.0 110.573 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.23 -15.91 62.98 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.188 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.847 HG22 ' O ' ' A' ' 67' ' ' ASP . 7.9 p -100.3 -3.07 32.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.132 -0.98 . . . . 0.0 109.655 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.1 3.61 57.83 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.353 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.8 117.61 9.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.289 . . . . 0.0 108.962 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 4.7 m -99.92 132.97 44.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 20.5 mt -127.95 136.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.46 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 67.6 m -105.95 119.95 40.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.8 mt -123.87 122.53 38.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 132.76 48.12 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.93 -174.04 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.93 -1.106 . . . . 0.0 109.77 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -135.93 154.51 77.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.89 . . . . 0.0 109.206 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.85 -29.03 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.69 2.26 . . . . 0.0 112.105 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 t -98.4 6.06 47.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.694 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.25 142.37 52.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.001 -1.062 . . . . 0.0 109.502 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.6 p -87.99 145.32 26.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.029 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.412 HD12 HD13 ' B' ' 250' ' ' LEU . 36.0 mm -51.5 -37.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.114 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -34.01 58.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -72.58 -50.48 25.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.193 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.9 -51.22 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 108.928 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -50.76 -42.31 57.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.336 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.0 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 0.0 109.735 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.511 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.8 mtpp -57.03 -54.01 51.62 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.008 -1.057 . . . . 0.0 109.19 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.431 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -60.08 -32.36 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -62.1 -47.14 85.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -72.66 -26.51 61.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.806 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -92.48 -48.38 6.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.815 -1.178 . . . . 0.0 110.504 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.22 -6.66 47.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 111.261 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.46 72.54 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 120.571 -1.331 . . . . 0.0 110.328 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.82 126.68 31.95 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.086 -1.243 . . . . 0.0 109.232 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -72.04 156.61 55.77 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.813 1.676 . . . . 0.0 111.58 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.93 -29.9 22.35 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.617 2.211 . . . . 0.0 112.851 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.3 -14.5 60.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.431 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.462 HE21 HD22 ' B' ' 271' ' ' LEU . 0.3 OUTLIER -122.87 -20.97 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.37 -0.831 . . . . 0.0 110.288 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.67 136.27 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.857 -1.152 . . . . 0.0 108.894 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -127.47 132.8 49.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.53 123.53 48.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.099 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 93.9 mt -118.19 135.75 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.7 t80 -131.92 115.89 16.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.852 . . . . 0.0 108.956 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.9 35.87 8.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.97 10.49 68.34 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.173 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -111.28 136.86 49.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.686 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.94 122.21 27.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 109.483 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.576 HD11 HD23 ' B' ' 267' ' ' LEU . 29.5 mt -68.39 146.6 53.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 109.25 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -101.24 143.86 30.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.74 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.589 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.2 OUTLIER -71.26 3.91 3.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.949 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.6 36.31 3.17 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 19.8 mtt85 -142.54 174.34 10.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.903 -1.351 . . . . 0.0 109.692 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 14.1 p -113.09 158.79 19.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 110.104 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.5 mt -56.9 -43.45 81.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.78 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 59.1 p -59.63 -27.17 66.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -19.21 61.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.637 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -103.84 3.89 34.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.329 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.54 38.31 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.0 109.792 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -93.02 135.98 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.003 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.67 176.76 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.111 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.588 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.44 155.4 2.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.885 0.85 . . . . 0.0 111.196 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 59.93 14.21 4.14 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.19 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.437 ' OG ' HG22 ' B' ' 203' ' ' ILE . 88.9 p -76.87 149.91 36.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.801 -1.187 . . . . 0.0 108.551 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.767 ' C ' HD12 ' B' ' 267' ' ' LEU . 3.1 m -114.57 135.68 53.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.737 . . . . 0.0 110.276 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.767 HD12 ' C ' ' B' ' 266' ' ' THR . 9.1 mp -122.98 140.11 53.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.504 -0.747 . . . . 0.0 109.253 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.408 ' HB3' HD21 ' A' ' 76' ' ' LEU . 66.1 m80 -88.5 141.55 28.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.144 -0.973 . . . . 0.0 110.203 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.05 126.96 53.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.452 -0.78 . . . . 0.0 108.951 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 2.5 t -114.75 128.99 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.884 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.462 HD22 HE21 ' B' ' 240' ' ' GLN . 48.9 mt -80.77 143.57 32.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.032 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.666 ' NH1' ' NH2' ' B' ' 274' ' ' ARG . 16.6 ttt180 -96.25 -139.19 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.424 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 61.5 mt -123.72 -27.9 3.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.403 -0.811 . . . . 0.0 109.26 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.666 ' NH2' ' NH1' ' B' ' 272' ' ' ARG . 21.6 mtm105 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 51.4 mt -106.74 132.73 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 0.0 109.97 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 m -115.86 124.43 50.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 81.0 m-85 -110.24 137.13 20.51 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.439 -0.788 . . . . 0.0 109.902 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -48.46 163.96 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.229 1.953 . . . . 0.0 112.749 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.45 -1.78 5.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.862 ' O ' HG22 ' B' ' 209' ' ' THR . 8.5 m-20 -123.46 9.64 9.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.131 -0.981 . . . . 0.0 110.553 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 68' ' ' ILE . 25.7 mm -111.28 129.17 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.218 -0.926 . . . . 0.0 111.327 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.7 t0 -98.44 138.93 20.86 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.81 -44.89 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.286 1.99 . . . . 0.0 112.066 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 14.2 tt0 -47.67 -47.01 29.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.878 -0.514 . . . . 0.0 110.409 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG11 ' O ' ' B' ' 207' ' ' THR . 24.7 t -79.87 -39.88 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -52.57 -54.59 30.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.838 -1.164 . . . . 0.0 111.007 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -61.3 -18.49 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 110.016 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -82.76 -5.36 58.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.822 -1.174 . . . . 0.0 109.638 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD11 ' CD2' ' B' ' 208' ' ' LEU . 95.1 mt -89.38 152.06 47.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.032 -1.043 . . . . 0.0 109.527 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.4 154.19 25.15 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.326 2.018 . . . . 0.0 112.004 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -48.57 77.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.835 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.59 -42.82 62.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.977 -1.077 . . . . 0.0 110.168 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.08 -31.64 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.9 -1.125 . . . . 0.0 108.475 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.446 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.3 tt0 -60.18 -53.17 60.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -54.95 -49.31 71.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -57.38 -39.25 75.64 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.006 -1.059 . . . . 0.0 110.609 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.87 -37.34 64.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.644 -1.285 . . . . 0.0 109.917 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.406 HD23 ' HE3' ' A' ' 88' ' ' TRP . 28.0 mt -71.44 -38.33 71.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.761 -1.212 . . . . 0.0 108.889 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.94 -34.15 75.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 109.442 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -74.31 -33.55 63.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.406 ' HE3' HD23 ' A' ' 85' ' ' LEU . 42.9 m0 -75.92 -15.26 60.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.898 -1.126 . . . . 0.0 107.995 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -92.61 -46.73 7.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.492 -0.755 . . . . 0.0 109.452 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' A' ' 91' ' ' THR . 11.5 ptm180 -54.03 -40.63 67.22 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.452 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 6.2 t -87.13 -36.78 17.89 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -96.73 163.68 12.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.356 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.42 142.56 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.527 -0.733 . . . . 0.0 109.346 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' B' ' 266' ' ' THR . 9.5 m-85 -94.06 142.46 27.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.62 113.91 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.19 -0.944 . . . . 0.0 109.701 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.552 ' NZ ' ' CB ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.5 135.14 43.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.077 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.501 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.0 p -93.38 -175.61 3.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.014 0.912 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.493 HD11 ' H ' ' B' ' 271' ' ' LEU . 43.2 mt -70.32 -19.8 63.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.6 p -96.56 -3.31 43.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.974 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.99 58.06 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.545 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -68.45 118.62 11.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.895 -1.356 . . . . 0.0 108.973 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.0 m -102.43 139.43 38.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.262 -0.899 . . . . 0.0 109.808 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.403 HG21 HD13 ' B' ' 213' ' ' ILE . 54.5 mt -137.94 137.67 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 0.0 109.339 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 36.1 m -105.45 122.55 46.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 108.741 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.545 HD13 ' CB ' ' B' ' 229' ' ' LYS . 19.4 mt -125.29 121.55 34.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 110.567 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -65.79 131.38 46.16 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.95 -173.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.013 -1.054 . . . . 0.0 109.902 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -134.36 156.04 79.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.0 108.923 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.09 -20.42 67.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.433 2.088 . . . . 0.0 111.899 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 4.3 m -103.54 6.94 37.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.837 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 144.78 48.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.996 -1.065 . . . . 0.0 109.544 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 80.4 p -86.43 148.83 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.3 -25.16 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.912 . . . . 0.0 108.92 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -35.43 77.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.801 . . . . 0.0 109.35 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.09 -51.09 34.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.62 -48.18 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 108.385 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -51.05 -44.9 61.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.05 76.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.337 -0.852 . . . . 0.0 109.583 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.545 ' CB ' HD13 ' B' ' 215' ' ' LEU . 4.2 mtpm? -56.96 -54.69 43.83 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.544 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.411 HG13 HD11 ' B' ' 215' ' ' LEU . 2.5 mp -59.95 -31.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.037 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.94 -48.46 78.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.72 -27.9 67.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -94.67 -52.57 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.929 -1.107 . . . . 0.0 110.374 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -87.93 -7.99 56.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.31 24.34 73.52 Favored Glycine 0 N--CA 1.494 2.503 0 O-C-N 120.44 -1.413 . . . . 0.0 110.458 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.5 mt -100.69 130.89 24.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.325 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.53 152.83 43.75 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.077 1.852 . . . . 0.0 111.676 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.07 -32.74 16.74 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.573 2.182 . . . . 0.0 113.107 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.408 ' C ' ' OD1' ' B' ' 239' ' ' ASP . 15.1 p30 -64.06 -8.84 13.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.69 -21.66 3.39 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.451 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.473 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -85.49 136.82 33.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.71 -1.244 . . . . 0.0 108.776 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -128.04 133.2 49.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.32 -0.863 . . . . 0.0 109.685 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.407 ' CB ' HD12 ' B' ' 250' ' ' LEU . 11.5 mt -105.24 125.8 51.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.0 mt -116.93 156.0 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.1 t80 -151.81 116.57 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.271 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 59.96 43.02 15.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.843 -1.161 . . . . 0.0 109.507 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 23.82 67.19 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.2 ptmm? -121.59 136.91 54.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 0.0 109.479 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.85 123.81 31.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.265 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.426 HD11 HD23 ' B' ' 267' ' ' LEU . 25.7 mt -74.51 141.68 44.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.37 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.45 147.53 24.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.95 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -73.02 3.4 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.519 -0.738 . . . . 0.0 109.755 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.49 33.64 4.58 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -143.11 172.21 13.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.95 -1.323 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 82.2 p -111.51 159.61 17.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 110.075 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.498 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.0 mt -55.51 -40.98 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.468 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.7 p -63.28 -28.21 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.102 -0.999 . . . . 0.0 109.535 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -18.75 62.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.982 . . . . 0.0 109.53 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -103.06 4.09 36.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.097 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 69.81 40.91 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.687 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 52.0 mt -98.52 136.81 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 -178.87 4.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 108.96 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.533 ' HD3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.41 163.31 0.63 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.37 1.081 . . . . 0.0 111.525 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 55.71 11.32 0.64 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.145 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 147.12 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.82 -1.175 . . . . 0.0 108.924 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.838 ' C ' HD12 ' B' ' 267' ' ' LEU . 5.7 m -113.89 138.39 50.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.597 -0.689 . . . . 0.0 110.083 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.838 HD12 ' C ' ' B' ' 266' ' ' THR . 10.2 mp -127.17 144.27 51.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.34 -0.85 . . . . 0.0 110.18 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.43 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 62.1 m80 -91.9 142.45 27.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.188 -0.945 . . . . 0.0 110.382 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.473 HD11 ' HG3' ' B' ' 241' ' ' GLN . 14.0 tp -109.35 127.02 54.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.365 -0.835 . . . . 0.0 108.924 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.75 131.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.383 -0.823 . . . . 0.0 109.729 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.493 ' H ' HD11 ' B' ' 208' ' ' LEU . 39.4 mt -81.76 143.87 31.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.558 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.1 ttt180 -94.93 -139.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 108.706 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.558 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 58.6 mt -123.93 -20.51 5.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 109.501 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.392 -0.818 . . . . 0.0 109.472 -179.928 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 122.093 0.949 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.619 HD12 ' OH ' ' A' ' 74' ' ' TYR . 33.8 mt -118.44 137.41 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.485 0.659 . . . . 0.0 110.27 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -115.91 127.44 54.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.501 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 72.4 m-85 -114.32 137.13 22.41 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.594 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.77 165.06 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.641 2.227 . . . . 0.0 113.176 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -2.75 10.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 110.691 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.839 ' O ' HG22 ' B' ' 209' ' ' THR . 45.4 m-20 -120.85 5.61 10.45 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.031 -1.043 . . . . 0.0 109.894 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.7 mm -109.62 130.44 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 111.001 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.85 134.57 20.4 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.01 -45.55 5.82 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.965 1.777 . . . . 0.0 112.024 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -50.23 -44.71 53.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.849 -0.532 . . . . 0.0 110.485 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.62 HG11 ' O ' ' B' ' 207' ' ' THR . 38.8 t -80.2 -26.44 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.834 -1.166 . . . . 0.0 110.147 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.0 t80 -68.99 -51.67 36.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.536 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.619 ' OH ' HD12 ' A' ' 62' ' ' ILE . 51.3 m-85 -62.59 -17.48 60.22 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.803 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.94 -6.74 59.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.865 -1.147 . . . . 0.0 109.641 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 76' ' ' LEU . 97.0 mt -89.15 151.75 47.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.144 -0.972 . . . . 0.0 109.753 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.38 155.64 19.81 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.41 2.074 . . . . 0.0 111.91 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.39 -50.81 68.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 110.679 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.22 -42.99 52.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.297 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.16 -30.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 108.423 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.0 tt0 -60.6 -51.59 68.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -56.9 -47.83 79.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.525 -0.735 . . . . 0.0 110.202 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.24 -40.31 85.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.044 -1.035 . . . . 0.0 110.775 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.0 mt -72.31 -35.7 68.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.796 -1.19 . . . . 0.0 109.561 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.44 -37.49 71.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 108.853 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.77 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.025 -1.047 . . . . 0.0 109.197 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -72.71 -37.89 67.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.401 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 42.5 m0 -75.17 -13.49 60.46 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.95 -1.094 . . . . 0.0 108.77 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -92.49 -46.83 7.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.408 -0.807 . . . . 0.0 109.604 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -39.41 67.82 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.668 -1.27 . . . . 0.0 107.949 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 3.7 t -87.73 -36.98 17.04 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -95.12 165.59 12.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.86 151.97 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.392 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' B' ' 264' ' ' GLU . 8.8 m-85 -104.29 142.61 34.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.878 . . . . 0.0 109.782 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.38 114.02 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.528 ' HE3' HG22 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -101.31 130.46 47.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 108.818 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.62 ' O ' HG11 ' A' ' 72' ' ' VAL . 38.1 p -89.11 -175.53 4.84 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.999 0.904 . . . . 0.0 111.019 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.517 HD11 ' H ' ' B' ' 271' ' ' LEU . 25.1 mt -71.41 -11.33 60.83 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.585 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.9 p -103.48 -2.88 26.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.836 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.35 60.51 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.243 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -67.77 117.84 10.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.265 . . . . 0.0 108.845 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -99.96 139.33 35.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.176 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.549 HD11 ' CD ' ' B' ' 234' ' ' GLU . 29.1 mt -135.54 137.81 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.2 m -105.14 122.59 46.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 108.837 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' B' ' 229' ' ' LYS . 21.5 mt -127.01 119.29 26.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.945 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.71 132.36 49.44 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.3 -175.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.947 -1.095 . . . . 0.0 109.764 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.36 154.43 78.59 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 108.978 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.39 -24.74 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.62 2.214 . . . . 0.0 112.005 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 6.54 42.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.24 142.88 52.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.505 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 11.9 p -85.66 145.7 27.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.34 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 34.8 mm -51.81 -35.76 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.251 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' B' ' 225' ' ' ASN . 5.8 pt-20 -61.38 -36.21 79.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.417 ' N ' ' CG ' ' B' ' 224' ' ' GLU . 7.2 m120 -68.16 -52.45 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.25 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.84 -48.29 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.919 -1.113 . . . . 0.0 108.045 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.99 -43.65 60.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.709 -0.619 . . . . 0.0 109.492 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 109.27 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.511 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.7 mtpp -57.48 -53.98 52.05 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.085 -1.009 . . . . 0.0 109.433 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.22 -33.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.122 -0.986 . . . . 0.0 109.083 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -62.78 -48.46 79.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.212 -0.93 . . . . 0.0 110.031 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.76 -25.43 66.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.635 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -98.95 -57.62 2.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.043 . . . . 0.0 110.522 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.549 ' CD ' HD11 ' B' ' 213' ' ' ILE . 34.9 mm-40 -81.43 -8.48 59.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.25 -0.906 . . . . 0.0 111.187 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.77 22.24 73.55 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 120.502 -1.374 . . . . 0.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.422 HD13 HD21 ' B' ' 271' ' ' LEU . 64.7 mt -101.73 131.13 23.24 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.977 -1.307 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.2 153.65 41.01 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.029 1.819 . . . . 0.0 111.798 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.43 -30.86 43.6 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.558 2.172 . . . . 0.0 112.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.27 -16.62 63.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.638 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.472 HE21 HD22 ' B' ' 271' ' ' LEU . 0.4 OUTLIER -121.78 -18.22 7.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.25 137.57 32.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.75 -1.219 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -129.0 134.12 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.403 ' HB3' HD12 ' B' ' 250' ' ' LEU . 11.9 mt -105.71 124.8 50.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 78.4 mt -118.33 135.46 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.71 -0.619 . . . . 0.0 109.533 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.539 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 41.2 t80 -129.91 113.49 14.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.47 -0.769 . . . . 0.0 109.004 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.34 38.7 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.65 7.78 55.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.441 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.6 OUTLIER -105.75 135.84 46.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.242 . . . . 0.0 109.489 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -83.61 119.76 25.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 0.0 109.338 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' B' ' 243' ' ' LEU . 39.2 mt -67.6 140.47 56.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 2.0 tm-20 -92.5 143.1 26.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -71.54 3.5 3.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 109.636 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 251' ' ' GLU . . . -121.35 39.66 2.32 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -146.21 173.7 11.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.968 -1.313 . . . . 0.0 109.383 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 5.7 p -112.32 161.56 16.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 109.864 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.509 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.1 mt -58.54 -41.16 84.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.787 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 93.7 p -62.24 -29.04 70.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.742 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.57 -19.98 62.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -101.93 3.97 39.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.267 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.6 38.18 3.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 32.7 mt -93.27 136.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -125.19 176.74 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.539 -0.726 . . . . 0.0 109.757 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.78 159.58 1.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.935 0.874 . . . . 0.0 110.719 -179.184 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' CE2' ' B' ' 204' ' ' PHE . 2.7 mm-40 55.76 27.55 10.94 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.162 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.17 149.09 21.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.164 . . . . 0.0 108.525 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 9.5 m -112.65 136.36 52.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 110.268 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.56 139.47 53.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.129 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -87.79 141.51 28.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.9 tp -108.86 126.62 53.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.53 129.21 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.639 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.517 ' H ' HD11 ' B' ' 208' ' ' LEU . 48.5 mt -81.31 143.89 31.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.0 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.427 ' CG ' ' H ' ' B' ' 273' ' ' LEU . 17.6 ttt180 -95.53 -138.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.91 . . . . 0.0 109.061 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.427 ' H ' ' CG ' ' B' ' 272' ' ' ARG . 56.6 mt -123.52 -41.99 2.24 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.495 ' C ' ' CD ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.376 -0.828 . . . . 0.0 109.309 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.534 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 37.0 mt -110.85 132.73 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.392 -0.818 . . . . 0.0 110.374 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.4 m -113.95 124.96 53.43 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 71.1 m-85 -110.18 136.98 20.46 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 110.212 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.37 164.12 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.451 2.1 . . . . 0.0 113.172 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -68.6 -2.09 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.761 -0.587 . . . . 0.0 110.468 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.891 ' O ' HG22 ' B' ' 209' ' ' THR . 0.7 OUTLIER -122.12 8.41 9.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.074 -1.016 . . . . 0.0 110.436 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HA ' HD13 ' A' ' 68' ' ' ILE . 25.6 mm -108.71 126.5 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.924 . . . . 0.0 111.295 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 5.3 t0 -98.25 113.38 63.94 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -46.49 -47.24 15.85 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.161 1.907 . . . . 0.0 112.271 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -48.53 -45.18 37.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.469 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG11 ' O ' ' B' ' 207' ' ' THR . 40.6 t -80.47 -24.25 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.646 -1.284 . . . . 0.0 110.423 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.2 t80 -69.68 -52.6 24.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.77 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -62.52 -17.07 58.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.925 . . . . 0.0 110.021 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -81.66 -6.36 58.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.787 -1.196 . . . . 0.0 109.95 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.61 152.64 43.59 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 109.63 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.09 155.22 19.68 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.534 2.156 . . . . 0.0 112.135 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -50.25 70.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.12 -43.2 51.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.889 -1.132 . . . . 0.0 110.387 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.35 -30.99 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.982 -1.074 . . . . 0.0 108.324 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.2 tt0 -59.96 -51.45 69.64 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -57.56 -48.06 80.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.613 -0.679 . . . . 0.0 110.244 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.15 -39.81 79.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.696 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.75 -36.81 67.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.714 -1.241 . . . . 0.0 109.745 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.93 -37.77 69.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.785 -1.197 . . . . 0.0 108.789 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.76 -34.23 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 109.515 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.92 -33.69 59.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 108.644 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -74.04 -16.68 61.04 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -92.83 -44.8 8.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.592 -0.693 . . . . 0.0 109.81 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -53.98 -40.54 66.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.51 -1.369 . . . . 0.0 107.804 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 12.3 t -86.26 -36.64 19.25 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -94.39 163.9 13.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.917 . . . . 0.0 109.999 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.533 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.87 142.3 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.221 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -94.48 142.82 26.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.092 -1.005 . . . . 0.0 109.691 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.48 114.7 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' B' ' 268' ' ' HIS . 14.0 ptmt -101.42 132.98 46.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.898 . . . . 0.0 109.159 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.67 ' O ' HG11 ' A' ' 72' ' ' VAL . 18.6 p -91.01 -175.62 4.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.32 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.469 HD11 ' H ' ' B' ' 271' ' ' LEU . 74.8 mt -70.69 -15.54 62.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -101.93 -1.68 31.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.688 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.77 4.8 58.91 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.392 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -68.3 117.75 10.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.323 . . . . 0.0 108.807 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.9 m -99.74 140.41 33.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.421 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 22.2 mt -137.56 137.86 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 22.7 m -104.26 124.35 49.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' B' ' 229' ' ' LYS . 23.5 mt -129.2 119.3 23.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.87 . . . . 0.0 110.06 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.88 133.94 51.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.65 -0.656 . . . . 0.0 109.439 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.26 -173.38 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 0.0 109.616 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' B' ' 221' ' ' ASP . 20.1 mt-10 -135.81 153.38 77.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 108.862 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.68 -21.47 25.22 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.569 2.18 . . . . 0.0 112.03 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.0 7.58 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.955 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' B' ' 218' ' ' GLU . 0.9 OUTLIER -70.29 142.34 52.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.901 -1.125 . . . . 0.0 109.507 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.6 p -86.55 145.8 26.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.188 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.432 HD12 HD13 ' B' ' 250' ' ' LEU . 39.2 mm -50.97 -43.17 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.418 ' CD ' ' OD1' ' B' ' 225' ' ' ASN . 0.2 OUTLIER -52.62 -34.76 52.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.475 -0.766 . . . . 0.0 109.699 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.418 ' OD1' ' CD ' ' B' ' 224' ' ' GLU . 63.5 m-20 -71.22 -52.21 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.23 -45.47 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.037 -1.04 . . . . 0.0 108.529 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -43.12 70.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.98 78.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.413 -0.804 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.558 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.1 mtpp -57.78 -53.75 54.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.084 -1.01 . . . . 0.0 109.363 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.564 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.7 mp -57.22 -35.61 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.007 -1.058 . . . . 0.0 109.246 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.895 -1.128 . . . . 0.0 109.967 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.98 -29.2 70.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.843 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -95.51 -52.28 4.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.381 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -87.76 -6.58 58.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.31 24.02 71.93 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.45 -1.406 . . . . 0.0 110.289 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 44.6 mt -103.03 128.79 26.92 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.25 . . . . 0.0 109.774 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.57 155.95 31.85 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.159 1.906 . . . . 0.0 111.828 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.77 -30.62 33.69 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.944 2.429 . . . . 0.0 112.939 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -61.95 -13.3 23.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.465 HE21 HD22 ' B' ' 271' ' ' LEU . 0.7 OUTLIER -128.77 -17.2 4.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -0.77 . . . . 0.0 110.746 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.23 137.04 32.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.701 -1.25 . . . . 0.0 109.417 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -129.54 130.78 46.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 109.567 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.74 125.13 50.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 109.32 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 39.9 mt -118.78 136.22 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.672 -0.642 . . . . 0.0 109.428 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -131.06 119.23 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.758 . . . . 0.0 109.459 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.0 47.29 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.923 -1.111 . . . . 0.0 109.464 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.53 26.28 64.29 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.7 OUTLIER -123.91 135.3 53.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.315 -1.109 . . . . 0.0 109.622 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -84.09 122.11 28.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 109.258 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.432 HD13 HD12 ' B' ' 223' ' ' ILE . 38.1 mt -72.38 144.02 48.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -96.89 143.5 27.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 3.68 3.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.442 -0.786 . . . . 0.0 109.843 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.11 44.74 1.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.49 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -148.26 174.1 12.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.141 -1.211 . . . . 0.0 109.079 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.7 p -111.91 160.15 17.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.354 -0.841 . . . . 0.0 110.185 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.493 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.6 mt -60.21 -40.72 91.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.842 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.4 p -61.68 -28.77 69.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.957 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.58 -15.86 62.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -104.28 2.38 31.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 108.933 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.07 38.54 3.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.89 137.45 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.102 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -126.7 179.49 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 108.987 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 163.73 0.51 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.45 1.119 . . . . 0.0 111.492 -178.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 55.54 12.04 0.72 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.093 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.533 ' OG ' HG22 ' B' ' 203' ' ' ILE . 89.2 p -76.09 148.31 38.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 108.714 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.75 ' C ' HD12 ' B' ' 267' ' ' LEU . 17.7 m -114.19 136.8 52.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.459 -0.776 . . . . 0.0 110.268 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.75 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -123.74 139.43 53.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.533 -0.73 . . . . 0.0 109.361 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 60.9 m80 -88.77 142.13 27.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 110.287 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.58 125.61 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.39 130.05 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.746 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.469 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.7 mt -80.76 143.34 32.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.082 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.546 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 28.5 ttt180 -94.9 -139.26 0.23 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 108.694 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.546 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 50.5 mt -123.77 -47.7 1.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 109.331 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.508 ' C ' ' CD ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.161 -0.962 . . . . 0.0 109.466 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.53 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 40.1 mt -108.79 133.88 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.427 -0.796 . . . . 0.0 110.102 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.6 m -116.08 126.7 54.11 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.53 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 95.5 m-85 -112.68 134.41 21.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.2 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.61 165.2 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.055 1.837 . . . . 0.0 112.22 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 t -66.01 -12.53 55.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.701 -0.624 . . . . 0.0 110.88 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.884 ' O ' HG22 ' B' ' 209' ' ' THR . 1.6 m-20 -112.49 8.65 19.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.479 HG21 ' CH2' ' A' ' 88' ' ' TRP . 30.4 mm -111.41 129.71 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.111 -0.993 . . . . 0.0 110.707 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.4 t70 -97.96 139.13 21.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.27 -36.58 3.99 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.228 1.952 . . . . 0.0 112.537 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 8.5 tp60 -59.13 -44.5 92.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.536 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.704 HG11 ' O ' ' B' ' 207' ' ' THR . 61.6 t -79.02 -23.9 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.809 -1.182 . . . . 0.0 110.047 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 19.8 t80 -66.4 -52.38 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.087 -1.008 . . . . 0.0 110.729 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -63.41 -16.31 60.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.52 -6.87 59.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 109.767 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.473 HD11 ' CD2' ' B' ' 208' ' ' LEU . 91.5 mt -90.18 152.26 45.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.13 154.86 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.409 2.073 . . . . 0.0 112.03 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.1 -50.47 70.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.4 -44.37 34.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.936 -1.103 . . . . 0.0 110.013 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' B' ' 270' ' ' VAL . 57.4 t -74.61 -31.82 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.911 -1.118 . . . . 0.0 108.603 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.3 tt0 -59.57 -50.06 75.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -57.85 -48.56 79.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.804 . . . . 0.0 109.944 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.18 -35.12 71.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.95 . . . . 0.0 110.113 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.66 -41.74 37.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.962 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.78 -38.23 88.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.647 -1.283 . . . . 0.0 108.671 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.74 82.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 108.981 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.485 ' O ' HG22 ' A' ' 91' ' ' THR . 72.2 tt0 -67.13 -33.19 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 108.639 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.479 ' CH2' HG21 ' A' ' 68' ' ' ILE . 48.0 m0 -78.28 -20.78 50.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -86.89 -38.8 16.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.15 -0.969 . . . . 0.0 109.643 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' CG ' ' N ' ' A' ' 91' ' ' THR . 11.9 ptm180 -65.34 -46.73 79.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.73 -1.231 . . . . 0.0 108.304 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.501 HG23 ' N ' ' A' ' 92' ' ' GLY . 11.9 t -71.23 -37.79 72.02 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 217' ' ' VAL . 6.9 ptt? . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.51 166.92 10.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 110.387 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.43 142.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 0.0 109.376 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -95.14 146.96 23.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.571 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.47 110.93 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.202 -0.937 . . . . 0.0 110.161 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.855 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.0 OUTLIER -96.99 138.7 34.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.704 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.8 p -102.7 -173.03 2.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 111.3 -178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.473 ' CD2' HD11 ' A' ' 76' ' ' LEU . 21.4 mt -70.81 -17.86 62.75 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.298 0.57 . . . . 0.0 109.597 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -96.84 -5.15 38.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 109.299 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.64 60.63 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -69.67 119.44 13.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 0.0 108.948 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 47.7 m -101.04 133.15 45.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 109.335 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.0 mt -128.2 136.87 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.416 ' O ' HD23 ' B' ' 215' ' ' LEU . 58.5 m -105.34 124.34 49.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.381 -0.824 . . . . 0.0 109.029 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.7 mt -129.8 120.01 24.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.842 . . . . 0.0 110.234 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.78 132.65 48.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.709 . . . . 0.0 109.17 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 201' ' ' MET . 15.5 m -138.97 -175.7 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.014 -1.054 . . . . 0.0 109.972 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -132.49 154.89 81.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.532 -0.73 . . . . 0.0 109.074 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.02 -19.35 47.94 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.505 2.137 . . . . 0.0 112.123 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.19 8.2 31.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.22 143.17 48.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.939 -1.101 . . . . 0.0 109.784 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 13.6 p -85.7 148.53 25.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.799 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.0 mm -52.2 -39.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.79 67.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.775 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -70.06 -53.3 18.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 0.0 109.302 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.52 -44.15 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.179 -0.951 . . . . 0.0 108.638 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -57.56 -38.71 75.25 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.75 -36.87 84.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.537 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.3 mtpp -57.59 -53.31 59.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.564 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.8 mp -59.24 -34.57 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 109.131 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -61.67 -43.47 98.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -28.78 63.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.977 -1.077 . . . . 0.0 110.721 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -92.99 -49.86 5.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 110.489 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -91.39 -6.86 52.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.195 -0.941 . . . . 0.0 111.357 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.97 74.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.104 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 61.2 mt -102.06 123.19 44.38 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.046 -1.267 . . . . 0.0 109.135 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.71 152.13 41.94 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.83 1.687 . . . . 0.0 111.802 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.99 -29.47 75.63 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.597 2.198 . . . . 0.0 112.802 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 49.9 p-10 -64.15 -13.74 50.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.085 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.2 OUTLIER -126.89 -20.79 4.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.464 -0.772 . . . . 0.0 109.945 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.588 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -85.91 133.39 33.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 109.043 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -126.98 132.42 50.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.88 123.38 47.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.372 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.4 132.82 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.53 123.73 34.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 54.13 41.63 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.786 -1.197 . . . . 0.0 109.312 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 67.68 3.97 30.19 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 135.4 42.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.82 125.63 33.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.154 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.8 mt -74.89 139.67 43.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 109.794 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.07 146.95 23.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.12 3.82 4.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.122 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.62 46.32 1.11 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.685 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -151.38 172.46 15.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -1.23 . . . . 0.0 109.485 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 63.9 p -111.57 160.89 16.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 110.106 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.496 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.0 mt -60.63 -43.68 97.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.232 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 56.9 p -59.35 -28.35 66.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.38 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.23 -13.1 61.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 109.065 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -107.35 5.32 27.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -0.829 . . . . 0.0 109.116 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.03 39.31 10.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 57.9 mt -92.74 136.36 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 108.987 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -125.54 175.71 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.765 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.91 160.65 0.67 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.776 0.798 . . . . 0.0 110.71 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 56.77 13.97 1.63 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.291 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 55.2 m -75.84 146.1 40.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.752 -1.217 . . . . 0.0 108.607 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.855 HG21 ' NZ ' ' B' ' 206' ' ' LYS . 5.5 m -112.31 138.01 49.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 0.0 110.018 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.786 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -124.7 138.79 54.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -86.86 140.73 29.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' B' ' 241' ' ' GLN . 18.9 tp -110.31 127.71 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.452 -0.78 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 14.9 t -114.62 129.39 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.439 HD22 HE21 ' B' ' 240' ' ' GLN . 47.3 mt -82.27 143.97 30.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.168 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.522 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 31.0 ttt180 -93.63 -138.85 0.21 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.522 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 64.4 mt -123.36 -33.33 3.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.143 -0.973 . . . . 0.0 109.374 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.444 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.406 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 31.5 mt -109.03 135.8 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -116.2 125.56 52.43 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.406 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 76.6 m-85 -110.99 135.71 20.82 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 109.758 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.9 164.58 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.224 1.949 . . . . 0.0 113.05 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 -2.07 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.568 . . . . 0.0 110.517 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.872 ' O ' HG22 ' B' ' 209' ' ' THR . 1.8 m-20 -123.05 10.57 9.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.148 -0.97 . . . . 0.0 110.373 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.7 mm -113.21 129.85 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.244 -0.91 . . . . 0.0 111.361 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.6 t70 -99.33 140.24 21.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.07 -37.51 3.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.41 2.073 . . . . 0.0 112.723 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.7 tt0 -61.26 -41.01 96.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.861 . . . . 0.0 110.184 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.69 HG11 ' O ' ' B' ' 207' ' ' THR . 25.4 t -80.98 -24.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.0 110.036 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 27.2 t80 -72.6 -53.58 11.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.993 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -61.29 -15.81 39.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.47 -5.23 59.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.911 -1.118 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.6 151.66 48.29 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 109.819 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.12 152.73 29.28 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.006 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.03 -50.39 70.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.777 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.15 -43.28 51.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.987 -1.071 . . . . 0.0 109.96 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 63.7 t -74.76 -32.12 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.009 -1.057 . . . . 0.0 108.348 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.8 tt0 -60.41 -51.74 68.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -55.15 -49.16 72.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.715 . . . . 0.0 109.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -58.45 -36.85 74.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 0.0 110.49 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.74 -39.9 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.749 -1.22 . . . . 0.0 109.831 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.41 -37.86 74.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 108.986 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.1 79.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 108.973 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 91' ' ' THR . 4.3 tm-20 -69.84 -36.78 75.84 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -77.47 -12.51 59.97 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.758 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -91.68 -44.02 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.33 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 91' ' ' THR . 35.9 ptt180 -60.24 -43.07 96.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.88 -1.138 . . . . 0.0 108.754 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 87' ' ' GLU . 14.8 t -84.71 -37.36 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.092 -1.005 . . . . 0.0 108.697 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.14 165.13 12.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 0.0 110.67 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.95 143.07 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.557 -0.714 . . . . 0.0 109.269 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -95.13 142.48 27.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.56 112.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.548 ' NZ ' ' CB ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.25 131.8 47.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 108.948 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.69 ' O ' HG11 ' A' ' 72' ' ' VAL . 32.8 p -91.55 -173.75 3.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 110.968 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.5 mt -70.58 -16.21 62.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.229 0.538 . . . . 0.0 109.954 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.872 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.7 p -99.39 -2.64 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.957 . . . . 0.0 109.614 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.16 1.38 61.14 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.217 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -64.42 116.9 6.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.332 . . . . 0.0 108.675 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.1 m -99.42 136.63 39.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.98 137.04 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.8 m -105.98 118.91 37.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 108.81 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' B' ' 229' ' ' LYS . 20.7 mt -124.6 122.18 36.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.388 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -68.29 133.56 48.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.429 HG11 HG22 ' B' ' 226' ' ' VAL . 11.0 m -139.73 -174.24 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.822 -1.173 . . . . 0.0 110.004 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.15 154.56 81.7 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 0.0 109.053 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.81 -21.79 58.7 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.573 2.182 . . . . 0.0 112.013 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 28.0 p -103.31 8.17 38.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.653 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -71.73 142.03 49.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.017 . . . . 0.0 109.497 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.9 p -85.93 145.63 27.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.479 HD12 HD13 ' B' ' 250' ' ' LEU . 36.5 mm -51.62 -21.54 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -37.07 70.06 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.998 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.11 -52.52 34.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.429 HG22 HG11 ' B' ' 217' ' ' VAL . 47.9 t -52.24 -46.32 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 108.548 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -43.12 72.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.292 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.13 72.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 109.561 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.525 ' CB ' HD13 ' B' ' 215' ' ' LEU . 22.3 mtpp -60.29 -53.29 59.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.023 -1.048 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.472 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.4 mp -59.71 -32.01 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.106 -0.996 . . . . 0.0 108.928 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -63.51 -44.76 93.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.37 -23.54 61.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.444 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -97.66 -51.39 4.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 110.672 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -89.4 -7.97 54.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.03 24.34 76.56 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.497 -1.377 . . . . 0.0 110.577 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 34.0 mt -106.65 131.76 21.45 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.059 -1.259 . . . . 0.0 109.594 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' PRO . . . . . 0.454 ' HG2' HE21 ' B' ' 240' ' ' GLN . 37.9 Cg_endo -71.15 162.26 43.16 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.204 1.936 . . . . 0.0 112.678 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.94 -34.05 7.0 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.155 2.57 . . . . 0.0 113.131 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.62 -5.98 33.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.28 -0.888 . . . . 0.0 111.152 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.454 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -124.22 -26.18 4.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.252 -0.905 . . . . 0.0 111.356 -179.278 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' B' ' 269' ' ' LEU . 2.0 pt20 -88.61 127.74 35.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.283 -1.511 . . . . 0.0 109.23 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.42 ' HE ' ' HD2' ' B' ' 272' ' ' ARG . 93.6 mtt180 -111.96 134.93 53.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.35 126.02 51.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 108.91 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.28 134.92 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.567 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.551 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 47.5 t80 -128.11 110.52 12.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.181 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 67.34 39.4 2.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.328 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.5 2.94 45.85 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.886 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -100.86 137.34 39.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.299 . . . . 0.0 109.689 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.23 122.33 28.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.963 -1.086 . . . . 0.0 109.292 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.479 HD13 HD12 ' B' ' 223' ' ' ILE . 41.8 mt -71.95 145.74 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 109.315 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -100.59 144.93 28.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.1 3.69 4.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.413 -0.804 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.58 43.79 1.41 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -150.06 172.08 15.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.145 -1.209 . . . . 0.0 109.325 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.4 p -110.9 159.41 17.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.472 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.8 mt -56.61 -42.16 78.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.692 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.1 p -61.21 -27.96 68.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.005 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -20.15 63.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -102.78 3.85 37.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.166 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.44 39.34 2.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.582 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.8 mt -92.94 135.53 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.308 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -124.02 176.56 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.12 159.69 1.19 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.978 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.04 28.49 12.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.097 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 12.5 p -91.28 149.65 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.588 -1.32 . . . . 0.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 4.3 m -111.4 135.39 52.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.533 -0.729 . . . . 0.0 109.966 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 10.7 mp -124.29 140.21 53.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.539 -0.726 . . . . 0.0 109.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -88.77 142.01 28.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' B' ' 241' ' ' GLN . 13.5 tp -110.74 129.59 55.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.433 -0.792 . . . . 0.0 109.249 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.06 133.09 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.408 -0.808 . . . . 0.0 109.891 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' B' ' 271' ' ' LEU . 47.2 mt -80.68 143.19 33.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 27.4 ttt180 -93.77 -140.02 0.22 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 108.733 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.575 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 67.0 mt -124.65 -54.38 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.416 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.405 ' O ' ' NE ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 109.505 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 tttt . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.485 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.4 mt -111.57 131.6 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.138 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.0 m -114.87 127.76 55.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 87.4 m-85 -112.79 135.74 21.61 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.9 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.13 164.65 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.34 2.027 . . . . 0.0 112.956 178.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.8 t -67.13 -2.45 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.908 ' O ' HG22 ' B' ' 209' ' ' THR . 7.6 m-20 -123.18 9.39 9.23 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.72 128.78 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.14 -0.975 . . . . 0.0 110.951 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.37 139.3 21.36 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.21 -36.42 4.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.404 2.069 . . . . 0.0 112.97 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.82 -40.74 97.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.511 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.724 HG11 ' O ' ' B' ' 207' ' ' THR . 21.8 t -80.1 -23.67 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.68 -1.263 . . . . 0.0 109.559 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.2 t80 -71.7 -54.0 11.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.718 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -61.1 -18.19 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.06 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -82.39 -4.88 58.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.142 . . . . 0.0 109.343 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.6 mt -89.99 151.96 45.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.842 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.98 153.34 32.27 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.318 2.012 . . . . 0.0 111.985 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.13 -49.53 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.698 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.64 -44.38 57.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 -178.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.79 -31.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 108.377 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -61.58 -49.1 77.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -58.8 -48.55 80.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.623 -0.673 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.9 -40.27 75.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 110.051 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.58 -38.1 67.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.882 -1.136 . . . . 0.0 109.741 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.61 -39.18 73.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.713 -1.242 . . . . 0.0 108.996 178.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.135 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' OE2' ' CZ ' ' A' ' 90' ' ' ARG . 18.0 tp10 -73.14 -35.52 66.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.835 . . . . 0.0 108.944 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.436 ' O ' ' CA ' ' A' ' 92' ' ' GLY . 44.1 m0 -74.9 -16.53 60.66 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.846 179.102 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -89.16 -45.37 9.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.582 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' CZ ' ' OE2' ' A' ' 87' ' ' GLU . 14.8 ptt180 -58.36 -41.83 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.865 -1.147 . . . . 0.0 108.821 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 5.4 t -92.3 -36.88 12.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.96 . . . . 0.0 108.599 178.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.446 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.4 ptt? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.42 166.37 10.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.748 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.65 142.92 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.589 -0.694 . . . . 0.0 109.33 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -95.74 143.6 26.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 31.8 t -123.85 109.05 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -0.879 . . . . 0.0 109.808 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.1 OUTLIER -93.09 135.45 34.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 108.57 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.724 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.5 p -96.26 -174.9 3.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.243 -0.91 . . . . 0.0 110.867 -178.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.573 HD11 ' H ' ' B' ' 271' ' ' LEU . 27.5 mt -72.17 -13.86 61.66 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.908 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.8 p -99.56 -4.11 31.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.451 -0.781 . . . . 0.0 109.558 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.08 1.12 61.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -67.03 119.05 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -1.148 . . . . 0.0 109.118 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.7 m -100.09 135.78 41.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.043 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 43.7 mt -131.25 135.18 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.571 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 33.4 m -104.55 120.28 40.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.416 -0.802 . . . . 0.0 108.886 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' B' ' 229' ' ' LYS . 26.1 mt -123.85 119.59 30.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.772 . . . . 0.0 110.017 -179.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -66.83 131.16 45.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.43 -175.57 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 110.065 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.48 154.4 81.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.044 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -58.79 -20.16 50.3 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.599 2.199 . . . . 0.0 112.386 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.4 t -105.24 9.3 34.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.9 142.99 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.98 -1.075 . . . . 0.0 109.433 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 69.6 p -86.46 147.62 25.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 110.144 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mm -51.64 -33.8 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -33.95 73.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -71.44 -51.32 24.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 108.954 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.6 -50.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -50.41 -38.12 41.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.484 0.659 . . . . 0.0 109.265 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.72 84.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.585 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.4 mtpp -57.9 -53.15 61.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.2 -0.938 . . . . 0.0 109.223 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.43 -35.23 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.062 -1.024 . . . . 0.0 108.566 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.53 -45.94 90.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 109.743 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -24.12 64.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -100.26 -54.52 2.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.051 -1.031 . . . . 0.0 110.465 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -85.89 -5.83 59.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 111.243 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.28 27.01 70.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.594 -1.317 . . . . 0.0 110.321 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.99 128.56 26.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -1.205 . . . . 0.0 109.283 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.77 157.01 48.37 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.892 1.728 . . . . 0.0 111.932 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.54 -30.84 22.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.683 2.256 . . . . 0.0 112.385 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.4 -9.13 22.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.399 -0.813 . . . . 0.0 110.248 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.408 HE21 HD22 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -128.9 -20.33 3.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 110.431 -179.669 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.39 133.88 34.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.848 -1.158 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.46 134.95 50.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 109.457 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.38 126.95 52.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 109.638 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.03 133.43 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 41.6 t80 -128.49 114.54 16.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.124 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 63.06 46.6 4.62 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.781 -1.199 . . . . 0.0 109.075 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.97 6.4 6.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.46 ' NZ ' ' CB ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -103.22 137.55 41.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -1.143 . . . . 0.0 109.537 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -85.81 128.58 34.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.493 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 28.8 mt -80.25 140.38 36.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 251' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' B' ' 253' ' ' GLY . 11.3 tp10 -90.87 142.62 27.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.588 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.0 OUTLIER -68.75 3.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.474 -0.766 . . . . 0.0 109.791 179.883 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 253' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -127.85 40.94 1.66 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.661 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.51 168.38 19.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.279 . . . . 0.0 108.977 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 21.0 p -106.59 157.45 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.529 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.1 mt -58.46 -42.36 87.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.012 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 40.2 p -61.73 -29.04 69.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.54 -16.93 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.131 -0.981 . . . . 0.0 109.277 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -104.56 2.91 31.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.092 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 67.55 38.93 2.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.408 -0.807 . . . . 0.0 109.773 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 37.7 mt -91.62 136.41 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.308 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 262' ' ' GLN . . . . . 0.469 ' O ' ' OG ' ' B' ' 265' ' ' SER . 57.5 mt-30 -122.9 172.78 8.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.89 162.61 0.42 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.963 0.887 . . . . 0.0 110.844 -178.915 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 54.46 11.08 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.81 177.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 39.0 m -72.08 144.82 48.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.893 -1.129 . . . . 0.0 108.631 178.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.736 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.8 m -111.16 137.08 49.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 110.296 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.736 HD12 ' C ' ' B' ' 266' ' ' THR . 11.3 mp -120.9 162.85 19.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 79.4 m80 -108.22 137.44 46.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.318 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.0 tp -106.87 123.07 47.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.009 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.6 127.11 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.454 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.573 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.5 mt -81.46 142.95 32.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.224 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.522 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 24.5 ttt180 -96.94 -136.65 0.25 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.522 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 51.1 mt -124.24 -49.33 1.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.457 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.918 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.7 tttm . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.482 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 38.2 mt -113.45 130.2 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.401 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.0 m -114.7 127.52 55.8 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 81.4 m-85 -111.1 135.21 20.89 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 110.134 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.02 164.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.257 1.971 . . . . 0.0 112.804 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 t -67.85 -2.68 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.67 -0.644 . . . . 0.0 110.508 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.904 ' O ' HG22 ' B' ' 209' ' ' THR . 9.3 m-20 -121.37 6.58 10.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.001 . . . . 0.0 110.296 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.66 128.21 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.834 -179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.6 t70 -99.56 140.04 21.31 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.73 -48.73 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.425 2.084 . . . . 0.0 112.196 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.1 tt0 -48.2 -44.19 32.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.698 -0.626 . . . . 0.0 110.228 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG11 ' O ' ' B' ' 207' ' ' THR . 58.1 t -80.27 -23.5 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.006 -1.059 . . . . 0.0 110.439 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 25.4 t80 -72.11 -53.01 14.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 110.918 -178.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -62.71 -17.36 60.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.24 -7.32 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.863 -1.148 . . . . 0.0 109.749 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.84 152.39 46.57 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.41 154.58 29.1 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.455 2.103 . . . . 0.0 111.922 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -62.99 -49.03 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -44.75 54.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.951 -1.093 . . . . 0.0 110.24 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -74.73 -29.94 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.023 -1.048 . . . . 0.0 108.426 178.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.5 tt0 -61.53 -51.65 67.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -56.88 -49.29 75.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -56.69 -37.62 71.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.107 -0.995 . . . . 0.0 110.451 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.2 mt -74.8 -36.98 62.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.865 -1.147 . . . . 0.0 109.886 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -71.01 -39.77 72.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.844 -1.16 . . . . 0.0 109.049 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.71 75.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.932 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.624 ' O ' HG22 ' A' ' 91' ' ' THR . 54.0 tt0 -70.42 -38.21 74.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -76.8 -11.7 59.87 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.947 -1.096 . . . . 0.0 108.886 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -90.66 -46.19 8.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.2 -0.938 . . . . 0.0 109.142 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 91' ' ' THR . 2.0 ptt180 -56.68 -39.76 74.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.975 -1.078 . . . . 0.0 108.661 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 87' ' ' GLU . 8.5 t -90.06 -37.62 14.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.142 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.46 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.19 165.83 11.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.094 -1.004 . . . . 0.0 110.572 -178.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 145.33 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.593 -0.692 . . . . 0.0 109.681 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' B' ' 204' ' ' PHE . 2.0 m-30 -94.02 139.97 30.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 109.035 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.91 106.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.5 ptpt -92.63 134.89 34.57 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.322 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.586 ' O ' HG11 ' A' ' 72' ' ' VAL . 44.4 p -94.58 -177.4 4.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 110.541 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' B' ' 270' ' ' VAL . 53.5 mt -72.51 -12.12 60.95 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.7 p -100.95 -3.03 30.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.63 -1.44 63.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -66.07 119.73 11.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.986 -1.302 . . . . 0.0 108.843 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 27.7 m -100.82 137.81 38.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 57.2 mt -133.58 136.82 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 109.329 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 18.2 m -104.86 119.37 38.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 108.681 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.2 mt -123.16 120.08 32.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -66.36 132.87 49.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.513 -0.742 . . . . 0.0 109.065 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.75 -176.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.87 -1.144 . . . . 0.0 110.01 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -134.09 154.06 79.96 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.5 -26.85 65.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.598 2.199 . . . . 0.0 112.328 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 t -97.65 7.18 46.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.3 140.67 48.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.079 -1.013 . . . . 0.0 109.34 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 38.5 p -85.92 146.72 26.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 29.2 mm -51.8 -27.25 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 109.206 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.22 -29.24 67.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.729 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -75.44 -51.15 13.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.72 -47.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -51.99 -46.55 64.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.43 70.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.621 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.569 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.5 mtpp -55.95 -53.65 54.3 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.404 HG13 HD11 ' B' ' 215' ' ' LEU . 2.6 mp -58.2 -34.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.035 . . . . 0.0 109.257 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -62.08 -53.4 55.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.933 -1.104 . . . . 0.0 109.852 179.657 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.25 -29.54 67.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.558 -178.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -95.92 -57.86 2.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.021 -1.049 . . . . 0.0 110.666 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -84.09 -5.36 59.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 111.509 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.14 24.83 70.66 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 120.524 -1.36 . . . . 0.0 110.462 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.7 mt -104.21 128.48 27.0 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.026 -1.279 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 237' ' ' PRO . . . . . 0.45 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.5 Cg_endo -75.71 156.48 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.124 1.883 . . . . 0.0 111.914 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.51 -29.19 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.724 2.283 . . . . 0.0 112.951 -179.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -65.21 -15.51 62.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.45 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.8 -22.47 5.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.481 -179.536 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.585 -1.322 . . . . 0.0 108.964 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -125.51 132.52 52.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -0.842 . . . . 0.0 109.807 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.36 125.45 51.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.303 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 60.5 mt -120.29 136.17 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.3 t80 -131.6 114.3 14.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.4 -0.813 . . . . 0.0 109.327 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 65.21 39.26 5.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.01 -1.057 . . . . 0.0 109.323 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.79 15.97 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -97.65 138.29 35.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.318 . . . . 0.0 109.702 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -83.47 128.3 34.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.985 . . . . 0.0 109.244 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.2 mt -78.32 137.29 37.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.029 -1.045 . . . . 0.0 109.326 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.53 146.46 23.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.027 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.18 3.95 3.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.074 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.19 40.04 2.09 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.624 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -147.41 151.35 36.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.113 -1.228 . . . . 0.0 109.272 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.8 p -91.16 161.61 15.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.461 HD23 ' N ' ' B' ' 256' ' ' LEU . 7.5 mt -57.13 -42.38 80.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.718 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 77.4 p -60.98 -28.35 68.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 109.75 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -70.73 -13.23 61.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.164 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -109.9 2.39 19.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.444 -0.785 . . . . 0.0 109.268 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 65.39 39.61 5.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.471 -0.768 . . . . 0.0 109.253 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.0 mt -92.79 98.45 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -87.37 174.81 8.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.453 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.1 165.39 0.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.0 0.905 . . . . 0.0 111.262 -178.879 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 55.57 11.58 0.65 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.913 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 43.0 m -74.97 148.38 40.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.631 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.764 ' C ' HD12 ' B' ' 267' ' ' LEU . 22.2 m -115.14 138.19 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.502 -0.748 . . . . 0.0 109.8 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.764 HD12 ' C ' ' B' ' 266' ' ' THR . 10.2 mp -121.3 166.41 14.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.2 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 56.5 m80 -113.04 138.96 49.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.637 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 9.4 tp -107.99 124.47 50.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.444 -0.785 . . . . 0.0 109.242 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.459 ' HA ' HD11 ' B' ' 208' ' ' LEU . 2.3 t -115.43 130.26 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.4 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.7 mt -79.0 142.67 36.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.237 -0.914 . . . . 0.0 108.937 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.472 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 17.4 ttt180 -94.44 -141.27 0.24 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.472 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 82.2 mt -124.65 -51.74 1.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.514 -0.741 . . . . 0.0 109.52 179.754 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.483 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 34.5 mt -112.14 129.42 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 110.022 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.8 m -112.84 126.08 55.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 77.4 m-85 -111.54 134.4 21.23 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.387 -0.82 . . . . 0.0 109.504 -179.633 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.95 164.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.404 2.07 . . . . 0.0 112.967 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -2.48 7.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.851 -0.53 . . . . 0.0 110.652 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.891 ' O ' HG22 ' B' ' 209' ' ' THR . 0.0 OUTLIER -121.19 7.12 10.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.0 110.114 -179.486 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 68' ' ' ILE . 28.2 mm -109.97 128.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 111.178 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.69 138.73 20.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 -31.18 14.97 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.303 2.002 . . . . 0.0 113.112 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.72 -38.91 77.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.615 HG11 ' O ' ' B' ' 207' ' ' THR . 98.6 t -79.77 -23.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.3 t80 -73.4 -54.75 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 111.105 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -61.87 -14.93 38.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.989 -1.069 . . . . 0.0 109.842 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -84.35 -7.65 59.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.995 -1.065 . . . . 0.0 109.876 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' B' ' 268' ' ' HIS . 95.4 mt -87.77 151.43 49.99 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 109.532 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' GLU . 10.8 Cg_endo -56.66 128.38 29.77 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.299 1.999 . . . . 0.0 112.172 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' PRO . 28.9 tt0 -40.24 -47.96 2.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.451 -0.78 . . . . 0.0 110.688 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.97 -45.36 51.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.8 -1.187 . . . . 0.0 109.829 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.536 HG11 HG21 ' B' ' 270' ' ' VAL . 86.9 t -74.6 -30.27 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 108.594 178.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 16.5 tt0 -60.76 -50.95 71.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -58.29 -47.82 82.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.574 -0.704 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -57.81 -39.66 78.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 110.044 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.4 -36.18 65.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.95 -1.094 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.61 -38.94 74.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.76 -1.213 . . . . 0.0 108.883 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.95 74.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.06 -36.21 66.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 108.863 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.4 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 45.1 m0 -75.88 -18.63 59.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.117 -0.989 . . . . 0.0 108.702 178.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -92.55 -41.56 10.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -0.797 . . . . 0.0 109.527 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' CG ' ' N ' ' A' ' 91' ' ' THR . 10.5 ptm180 -59.13 -43.41 91.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.885 -1.134 . . . . 0.0 108.343 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.49 ' N ' ' CG ' ' A' ' 90' ' ' ARG . 6.1 t -88.16 -37.5 16.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.238 -0.914 . . . . 0.0 108.625 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 217' ' ' VAL . 3.9 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -98.9 167.01 11.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.02 144.13 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' B' ' 204' ' ' PHE . 2.5 m-30 -94.07 138.99 31.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.98 108.82 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.471 -0.768 . . . . 0.0 109.081 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 13.6 ptpt -95.84 137.77 34.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.615 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.7 p -99.22 -175.1 2.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.997 . . . . 0.0 110.662 -178.837 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.96 -9.47 58.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.608 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 67' ' ' ASP . 16.2 p -102.83 -4.12 25.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.89 . . . . 0.0 109.397 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.0 1.45 63.06 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -66.86 118.88 10.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -1.173 . . . . 0.0 108.831 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.6 m -101.42 139.54 36.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.716 HD11 ' OE2' ' B' ' 234' ' ' GLU . 50.2 mt -135.02 136.85 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.382 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 8.7 m -105.02 118.94 37.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 0.0 108.928 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.4 mt -122.51 120.56 34.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.943 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.99 132.08 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 201' ' ' MET . 12.2 m -139.6 -175.32 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.08 . . . . 0.0 109.864 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -134.27 154.98 80.26 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.451 -0.781 . . . . 0.0 109.046 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.65 -21.38 46.84 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.51 2.14 . . . . 0.0 112.207 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.4 7.51 38.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.238 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.84 142.12 49.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.865 -1.147 . . . . 0.0 109.389 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.3 p -87.12 145.36 26.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 109.814 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.44 HD12 HD13 ' B' ' 250' ' ' LEU . 34.3 mm -51.57 -22.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 109.054 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 224' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -70.06 -35.47 74.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.408 -0.808 . . . . 0.0 109.011 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -72.38 -49.88 30.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 45.5 t -52.21 -51.85 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.043 -1.036 . . . . 0.0 108.775 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -50.68 -41.01 55.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.547 -0.72 . . . . 0.0 109.482 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.07 83.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.222 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.552 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.0 mtpp -55.91 -53.6 54.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.332 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.411 HG13 HD11 ' B' ' 215' ' ' LEU . 2.6 mp -58.03 -35.0 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 0.0 109.2 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -62.18 -39.21 91.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.993 . . . . 0.0 109.773 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.07 -28.25 62.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -98.02 -54.15 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.049 . . . . 0.0 110.668 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 234' ' ' GLU . . . . . 0.716 ' OE2' HD11 ' B' ' 213' ' ' ILE . 75.7 mm-40 -83.84 -8.73 59.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.12 -0.988 . . . . 0.0 111.254 -178.508 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.65 73.64 Favored Glycine 0 N--CA 1.493 2.451 0 O-C-N 120.526 -1.359 . . . . 0.0 110.513 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.9 mt -105.22 132.17 21.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.116 -1.226 . . . . 0.0 109.266 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 237' ' ' PRO . . . . . 0.429 ' HG2' HE21 ' B' ' 240' ' ' GLN . 38.4 Cg_endo -71.25 161.64 45.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.216 1.944 . . . . 0.0 112.617 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.61 -34.66 8.91 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.158 2.572 . . . . 0.0 113.467 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -71.14 -5.92 35.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.998 -1.064 . . . . 0.0 111.534 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.429 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.26 -26.74 4.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.227 -0.921 . . . . 0.0 110.718 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.686 ' HB2' HD11 ' B' ' 269' ' ' LEU . 1.7 pt20 -88.96 132.63 34.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.431 -1.418 . . . . 0.0 109.156 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -117.95 135.31 54.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 109.682 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.06 124.51 49.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.078 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 92.4 mt -118.81 135.14 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.608 -0.682 . . . . 0.0 109.392 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.544 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 44.6 t80 -131.36 114.6 15.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.023 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.26 39.04 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.006 -1.059 . . . . 0.0 109.355 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.23 17.67 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.853 178.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -100.34 138.58 37.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.285 . . . . 0.0 109.68 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -84.04 125.93 32.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 109.527 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.44 HD13 HD12 ' B' ' 223' ' ' ILE . 39.8 mt -73.26 145.09 46.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.21 -0.931 . . . . 0.0 109.094 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -101.09 146.89 26.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.931 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.64 3.78 4.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.335 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -120.18 32.85 4.76 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.648 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -142.42 170.3 15.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.989 -1.301 . . . . 0.0 109.628 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.3 p -110.27 160.97 16.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 0.0 110.135 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.501 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.8 mt -58.15 -44.08 87.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.7 p -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.427 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.31 -12.02 60.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.656 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 28.1 m-85 -108.12 4.81 25.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 260' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' B' ' 259' ' ' TYR . 0.2 OUTLIER 64.21 36.49 9.41 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.092 0.948 . . . . 0.0 109.911 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 90.7 mt -89.73 134.42 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.263 . . . . 0.0 109.075 178.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -123.19 174.33 7.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.433 ' H ' ' HE3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 158.58 1.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.42 -0.8 . . . . 0.0 110.724 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 264' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER 57.21 11.37 1.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.427 179.242 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 4.2 m -72.42 144.88 47.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.947 -1.095 . . . . 0.0 108.352 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.746 ' C ' HD12 ' B' ' 267' ' ' LEU . 26.4 m -111.71 136.9 50.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.746 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -120.66 166.29 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.409 ' HB3' HD21 ' A' ' 76' ' ' LEU . 73.2 m80 -112.78 137.94 50.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.678 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' B' ' 241' ' ' GLN . 16.5 tp -108.1 125.19 51.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.236 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 80' ' ' VAL . 2.3 t -115.22 130.41 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.713 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.39 140.47 37.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.264 -0.897 . . . . 0.0 109.226 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.477 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 21.0 ttt180 -92.09 -141.87 0.19 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.339 -0.851 . . . . 0.0 108.731 -179.261 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.477 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 78.4 mt -124.62 -41.36 2.15 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.51 -0.744 . . . . 0.0 109.13 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.338 0.59 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.413 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 30.8 mt -124.41 133.42 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.613 -0.679 . . . . 0.0 110.525 -179.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.1 m -117.56 128.28 54.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 78.8 m-85 -113.82 134.43 22.09 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 109.977 -179.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.32 165.37 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.268 1.979 . . . . 0.0 113.026 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.7 t -67.98 -2.72 8.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.728 -0.608 . . . . 0.0 110.78 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.941 ' O ' HG22 ' B' ' 209' ' ' THR . 76.3 m-20 -121.54 3.36 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.984 -1.073 . . . . 0.0 110.408 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mm -105.89 129.57 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.157 -0.964 . . . . 0.0 110.432 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.5 t70 -98.18 139.05 20.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 -36.97 7.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.497 2.131 . . . . 0.0 112.693 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 24.1 tt0 -60.75 -42.48 97.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.476 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.733 HG11 ' O ' ' B' ' 207' ' ' THR . 36.7 t -80.9 -24.17 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 110.566 -179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.3 t80 -69.83 -54.1 15.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.992 -1.067 . . . . 0.0 110.706 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -62.36 -16.65 55.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.748 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.47 -7.11 58.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.603 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' B' ' 268' ' ' HIS . 93.3 mt -91.35 152.08 43.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.51 156.45 17.82 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.304 2.003 . . . . 0.0 111.932 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.53 -51.49 67.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 110.648 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -43.79 36.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -178.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -31.77 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 108.807 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.0 tt0 -60.25 -49.35 77.96 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -58.93 -48.43 81.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.52 -0.737 . . . . 0.0 110.158 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -57.7 -41.48 81.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.049 -1.032 . . . . 0.0 110.496 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.27 -38.82 75.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.827 -1.17 . . . . 0.0 109.817 -179.31 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.7 mt -68.79 -37.52 79.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.769 -1.207 . . . . 0.0 108.922 178.49 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.84 76.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 108.954 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 91' ' ' THR . 2.6 tm-20 -68.69 -39.43 80.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 108.9 179.044 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -74.9 -12.71 60.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.062 -1.023 . . . . 0.0 109.099 179.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -92.0 -45.54 8.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.935 . . . . 0.0 109.406 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 91' ' ' THR . 14.8 ptp180 -57.24 -40.89 78.5 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.809 -1.182 . . . . 0.0 108.201 179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 92' ' ' GLY . 13.7 t -89.16 -36.62 15.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 108.801 178.872 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -98.65 165.92 11.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.955 . . . . 0.0 110.588 -178.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.45 144.07 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.464 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.419 ' HB2' HG23 ' B' ' 266' ' ' THR . 3.0 m-30 -94.38 142.44 27.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 109.357 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.29 112.04 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.315 -0.866 . . . . 0.0 109.684 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 131.27 43.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 108.725 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.733 ' O ' HG11 ' A' ' 72' ' ' VAL . 28.0 p -91.29 -175.64 4.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.707 HD11 ' H ' ' B' ' 271' ' ' LEU . 24.7 mt -71.85 -11.47 60.81 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.218 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.941 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.2 p -101.49 -2.55 30.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.802 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.47 0.06 63.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -66.02 118.91 10.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -1.181 . . . . 0.0 109.066 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.96 131.01 47.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.341 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.08 134.24 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.488 -0.757 . . . . 0.0 109.501 -179.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 24.9 m -103.3 122.97 45.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' B' ' 229' ' ' LYS . 24.7 mt -125.95 121.71 33.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.377 -0.827 . . . . 0.0 110.319 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.9 130.15 42.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.49 -174.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.059 -1.025 . . . . 0.0 109.881 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -137.35 154.61 75.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.67 -23.56 41.38 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.491 2.127 . . . . 0.0 112.307 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 95.3 p -101.2 7.26 43.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.015 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.01 141.48 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.954 -1.092 . . . . 0.0 109.354 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 59.8 p -85.43 149.05 25.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.178 -0.951 . . . . 0.0 109.969 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.7 -40.7 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 109.513 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -56.86 -33.85 67.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.584 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.19 -52.92 28.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 108.897 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.6 t -52.6 -49.15 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.82 -42.35 58.3 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.526 0.679 . . . . 0.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.32 83.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.593 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.1 mtpp -56.42 -53.19 60.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.086 -1.008 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.97 -32.92 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 109.22 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -62.71 -44.11 97.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.88 -27.13 61.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.979 -1.075 . . . . 0.0 110.439 -179.151 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -93.52 -50.38 5.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.026 -1.046 . . . . 0.0 110.375 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.33 -7.29 51.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.196 -0.94 . . . . 0.0 111.441 -178.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.47 23.27 76.59 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.382 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 124.07 40.1 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.144 -1.209 . . . . 0.0 109.348 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.4 155.41 41.09 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.027 1.818 . . . . 0.0 112.04 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.79 -30.36 49.86 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.729 2.286 . . . . 0.0 112.961 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.24 -8.92 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.52 -18.15 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.222 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.457 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -92.64 139.31 30.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.97 -1.081 . . . . 0.0 109.57 -179.47 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -130.64 133.45 46.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.785 . . . . 0.0 109.093 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.3 mt -106.01 125.97 51.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 58.9 mt -120.84 135.63 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.61 -0.681 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -129.65 122.81 29.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 108.806 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.93 45.83 23.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.27 0.77 4.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -98.07 134.75 40.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.318 . . . . 0.0 109.44 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -85.02 123.17 30.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.41 144.2 49.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -96.93 144.58 26.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.99 3.42 3.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 109.729 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.44 44.03 1.33 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.481 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -148.08 172.57 14.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -1.218 . . . . 0.0 109.56 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.6 p -110.84 159.52 17.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.195 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.507 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.7 mt -59.23 -43.09 92.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.654 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.0 p -60.57 -29.33 69.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.669 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.03 -14.24 62.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.15 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -107.65 2.25 23.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.0 109.278 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.68 39.5 2.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -0.823 . . . . 0.0 109.877 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.16 135.7 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -124.44 175.98 6.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.481 -0.762 . . . . 0.0 109.569 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.62 162.33 0.4 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.852 0.835 . . . . 0.0 110.908 -178.877 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 55.35 11.23 0.55 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.891 177.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.6 m -72.26 144.13 48.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.862 -1.149 . . . . 0.0 108.538 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.718 ' C ' HD12 ' B' ' 267' ' ' LEU . 1.7 m -110.73 134.92 52.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.019 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.718 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -120.92 158.07 28.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.773 . . . . 0.0 109.182 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.417 ' HB3' HD21 ' A' ' 76' ' ' LEU . 64.6 m80 -105.72 138.22 42.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.457 HD11 ' HG3' ' B' ' 241' ' ' GLN . 11.9 tp -106.88 124.15 49.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 108.941 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.36 127.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.707 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.8 mt -80.99 142.14 33.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.273 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.542 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 19.3 ttt-85 -91.06 -141.38 0.17 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.542 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 57.3 mt -123.66 -27.83 3.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.576 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.742 0.782 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.532 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.2 mt -118.07 134.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.508 0.671 . . . . 0.0 110.364 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.2 m -114.75 127.4 55.72 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 79.1 m-85 -113.58 135.97 21.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 110.423 -178.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -47.57 165.27 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.497 2.131 . . . . 0.0 112.859 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -1.93 7.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.648 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.938 ' O ' HG22 ' B' ' 209' ' ' THR . 39.3 m-20 -122.37 6.9 9.59 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 68' ' ' ILE . 27.2 mm -110.54 130.49 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.381 -0.824 . . . . 0.0 110.756 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.5 139.35 20.56 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.54 -45.83 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.441 2.094 . . . . 0.0 112.295 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -47.35 -48.56 25.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.701 -0.625 . . . . 0.0 110.814 -179.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.575 HG11 ' O ' ' B' ' 207' ' ' THR . 59.5 t -78.27 -26.82 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.856 -1.152 . . . . 0.0 110.71 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.455 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -65.73 -52.85 47.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.031 -1.043 . . . . 0.0 110.912 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.467 ' OH ' HD12 ' A' ' 62' ' ' ILE . 48.4 m-85 -62.33 -18.46 61.48 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 -178.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -81.34 -5.72 58.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.863 -1.148 . . . . 0.0 109.558 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.0 mt -89.96 151.86 45.7 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.24 156.26 21.61 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.342 2.028 . . . . 0.0 111.887 179.44 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.38 -52.45 61.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.48 -43.87 24.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -178.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.487 HG11 HG21 ' B' ' 270' ' ' VAL . 87.1 t -74.82 -31.52 26.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 108.639 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.455 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.8 tt0 -60.2 -50.83 72.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -57.27 -48.71 78.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -58.12 -43.57 87.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.076 -1.015 . . . . 0.0 110.612 -178.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.24 -37.34 77.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.914 -1.116 . . . . 0.0 109.739 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 mt -70.62 -37.21 73.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 108.829 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.21 71.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.01 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -75.97 -38.95 56.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 109.121 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.2 m0 -76.57 -17.86 58.98 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.015 -1.053 . . . . 0.0 108.95 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -92.62 -46.04 7.79 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.324 -0.86 . . . . 0.0 109.094 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' CG ' ' N ' ' A' ' 91' ' ' THR . 7.7 ptm180 -53.78 -40.07 65.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.931 -1.105 . . . . 0.0 108.332 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 92' ' ' GLY . 3.0 t -93.46 -36.37 12.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 108.944 178.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.477 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 201' ' ' MET . . . . . 0.403 ' O ' HG23 ' B' ' 217' ' ' VAL . 10.9 ptt? . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -95.63 164.72 12.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -144.63 142.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.311 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -94.41 143.08 26.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.892 . . . . 0.0 109.731 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.5 t -122.02 109.85 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.46 127.49 42.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.575 ' O ' HG11 ' A' ' 72' ' ' VAL . 23.9 p -87.91 -175.56 5.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 111.065 -178.412 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.468 HD11 ' H ' ' B' ' 271' ' ' LEU . 23.7 mt -71.68 -16.3 62.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.414 0.626 . . . . 0.0 109.347 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.938 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.5 p -98.15 -4.41 35.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.48 2.4 57.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -66.55 117.1 8.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.245 . . . . 0.0 109.106 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.57 132.85 45.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -130.55 136.79 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.427 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 60.8 m -105.5 121.07 43.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' B' ' 229' ' ' LYS . 17.5 mt -125.4 121.88 35.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 110.268 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.15 133.22 48.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.645 . . . . 0.0 109.417 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.475 HG11 HG22 ' B' ' 226' ' ' VAL . 7.6 m -140.19 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.911 -1.118 . . . . 0.0 109.753 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -136.53 152.84 75.47 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.209 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.26 -26.96 54.63 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.565 2.177 . . . . 0.0 112.271 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.5 p -99.38 5.99 46.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.03 143.38 50.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 70.4 p -87.09 147.13 25.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.729 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.422 HD12 HD13 ' B' ' 250' ' ' LEU . 32.8 mm -52.78 -42.47 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -52.09 -32.04 33.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -73.38 -53.11 11.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.011 -1.055 . . . . 0.0 109.223 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.475 HG22 HG11 ' B' ' 217' ' ' VAL . 39.1 t -52.49 -42.18 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.959 . . . . 0.0 108.599 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.511 ' NZ ' ' OD1' ' B' ' 252' ' ' ASP . 6.1 ttmt -58.48 -42.47 87.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.19 -33.47 73.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.721 . . . . 0.0 109.264 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.507 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.1 mtpp -58.63 -53.16 61.5 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 108.94 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.592 HD12 ' H ' ' B' ' 230' ' ' ILE . 3.9 mp -59.99 -32.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -62.41 -45.11 94.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.03 . . . . 0.0 110.025 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -73.32 -23.86 60.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -179.12 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -95.36 -50.59 4.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 110.039 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -91.86 -5.74 52.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 111.44 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.11 22.86 71.04 Favored Glycine 0 N--CA 1.492 2.4 0 O-C-N 120.53 -1.356 . . . . 0.0 110.371 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 62.3 mt -101.66 130.45 24.59 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 0.0 109.403 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -74.04 156.7 47.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.051 1.834 . . . . 0.0 111.949 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.47 -31.94 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.734 2.289 . . . . 0.0 112.785 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -66.95 -7.16 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 110.061 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.461 HE21 HD22 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -128.52 -22.33 3.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 -179.592 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.83 138.15 31.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.687 -1.258 . . . . 0.0 108.93 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -128.54 132.99 48.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.859 . . . . 0.0 109.654 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -105.5 125.85 51.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 109.174 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.17 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.597 -0.69 . . . . 0.0 109.505 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.504 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 49.3 t80 -127.84 112.62 14.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 0.0 109.149 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.56 40.68 5.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.041 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.74 17.06 66.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.475 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.4 ptmm? -112.18 135.52 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -1.153 . . . . 0.0 109.437 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.32 125.75 33.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.037 -1.039 . . . . 0.0 109.53 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.422 HD13 HD12 ' B' ' 223' ' ' ILE . 25.8 mt -80.28 143.99 33.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.624 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.33 147.2 28.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 252' ' ' ASP . . . . . 0.511 ' OD1' ' NZ ' ' B' ' 227' ' ' LYS . 18.0 m-20 -69.72 3.37 2.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.929 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.83 42.2 1.84 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.855 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -150.51 172.89 14.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.078 -1.248 . . . . 0.0 109.475 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.0 p -113.28 157.39 21.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 110.198 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.8 mt -56.12 -43.63 78.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.271 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 67.9 p -60.49 -28.97 68.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -16.75 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 108.819 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -106.52 0.99 25.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.482 -0.761 . . . . 0.0 108.983 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 260' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' B' ' 260' ' ' ASN . 0.9 OUTLIER 66.33 39.42 4.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -0.78 . . . . 0.0 109.879 179.843 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.04 138.34 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.69 175.37 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 263' ' ' LYS . . . . . 0.57 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.63 161.14 1.13 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.862 0.839 . . . . 0.0 110.913 -179.073 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 58.17 10.54 1.27 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.328 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.1 m -75.35 149.69 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.891 -1.131 . . . . 0.0 108.682 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 266' ' ' THR . . . . . 0.781 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.3 m -114.32 137.41 51.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.468 -0.77 . . . . 0.0 110.071 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.781 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -124.44 139.62 53.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -0.81 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.405 ' HB3' HD21 ' A' ' 76' ' ' LEU . 42.5 m80 -88.89 142.6 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.42 126.96 54.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.152 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.487 HG21 HG11 ' A' ' 80' ' ' VAL . 4.4 t -113.96 128.61 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.468 ' H ' HD11 ' B' ' 208' ' ' LEU . 50.1 mt -82.03 143.91 31.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.515 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 27.9 ttt180 -96.05 -135.78 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.515 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 49.2 mt -122.86 -26.98 4.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 108.992 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 274' ' ' ARG . . . . . 0.57 ' NE ' ' C ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.089 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.1 164.84 0.23 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.227 1.951 . . . . 0.0 112.75 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -2.12 6.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.735 -0.603 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.832 ' O ' HG22 ' B' ' 209' ' ' THR . 5.3 m-20 -122.46 11.65 9.97 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.171 -0.956 . . . . 0.0 110.591 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 68' ' ' ILE . 31.6 mm -114.36 130.32 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.232 -0.917 . . . . 0.0 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.26 138.16 20.5 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.75 -33.65 9.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.142 1.895 . . . . 0.0 113.072 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -43.0 99.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.863 . . . . 0.0 110.679 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.63 HG11 ' O ' ' B' ' 207' ' ' THR . 61.8 t -80.32 -23.81 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.704 -1.247 . . . . 0.0 109.878 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -68.29 -54.83 14.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.852 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -60.82 -15.25 28.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.42 -6.47 59.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.68 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' B' ' 268' ' ' HIS . 90.4 mt -90.03 151.98 45.7 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.189 -0.945 . . . . 0.0 109.559 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.74 154.79 24.54 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.267 1.978 . . . . 0.0 111.961 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -62.73 -52.17 64.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 110.584 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.02 -44.09 30.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.968 -1.082 . . . . 0.0 110.036 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.521 HG11 HG21 ' B' ' 270' ' ' VAL . 67.2 t -74.93 -32.19 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.937 -1.102 . . . . 0.0 108.489 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.3 tt0 -60.51 -50.03 75.17 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -57.56 -48.7 78.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.59 -0.694 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -56.68 -41.64 77.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.024 -1.047 . . . . 0.0 110.064 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.93 -38.46 69.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.074 -1.016 . . . . 0.0 109.786 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.53 -39.59 77.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.69 -1.256 . . . . 0.0 109.024 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.119 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -74.61 -38.11 62.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.407 ' CH2' HG21 ' A' ' 68' ' ' ILE . 42.4 m0 . . . . . 0 C--N 1.303 -1.43 0 O-C-N 121.013 -1.054 . . . . 0.0 108.865 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -97.57 163.06 13.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.465 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.523 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.1 pp -144.36 143.53 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.31 141.68 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.54 108.53 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.401 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.4 OUTLIER -93.54 131.04 39.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 108.822 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.63 ' O ' HG11 ' A' ' 72' ' ' VAL . 24.1 p -90.57 -175.82 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.102 -0.999 . . . . 0.0 110.676 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.579 HD11 ' H ' ' B' ' 271' ' ' LEU . 35.4 mt -70.71 -20.71 62.64 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.463 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.1 p -94.25 -4.08 49.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.725 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.28 5.89 56.91 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.367 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -69.8 118.89 13.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.966 -1.314 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 134.39 44.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 35.4 mt -131.07 136.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.866 . . . . 0.0 109.635 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -105.69 114.58 28.83 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.614 HD13 ' CB ' ' B' ' 229' ' ' LYS . 21.2 mt -118.54 123.64 45.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 110.4 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.59 132.17 46.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.7 m -139.79 -170.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.919 -1.113 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.13 152.84 76.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.033 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.74 -20.03 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.381 2.054 . . . . 0.0 111.943 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 17.7 m -105.2 7.57 33.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -70.29 141.86 52.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.045 -1.034 . . . . 0.0 109.408 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.9 p -86.29 148.8 25.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.958 . . . . 0.0 110.099 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.459 HD12 HD13 ' B' ' 250' ' ' LEU . 41.3 mm -54.23 -35.46 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -60.14 -30.22 69.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.723 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -74.29 -51.33 15.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.084 -1.01 . . . . 0.0 109.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.98 -47.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 108.809 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -54.2 -42.22 69.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 0.0 109.442 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.85 76.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.614 ' CB ' HD13 ' B' ' 215' ' ' LEU . 5.2 mtpm? -57.66 -53.92 52.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.074 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.512 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.5 mp -58.52 -32.12 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.911 . . . . 0.0 108.781 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' B' ' 237' ' ' PRO . 39.5 tt0 -63.27 -49.57 73.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.059 -1.025 . . . . 0.0 109.734 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -23.6 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.056 -1.028 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -98.72 -53.15 3.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -88.69 -8.22 54.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 0.0 111.317 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 22.58 76.1 Favored Glycine 0 N--CA 1.493 2.493 0 O-C-N 120.567 -1.333 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 22.5 mt -100.86 131.13 23.85 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.992 -1.299 . . . . 0.0 109.087 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.63 ' C ' HE21 ' B' ' 241' ' ' GLN . 59.0 Cg_endo -75.11 160.27 39.98 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.045 1.83 . . . . 0.0 112.549 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . 0.552 ' N ' HE21 ' B' ' 241' ' ' GLN . 38.2 Cg_endo -69.5 -34.43 15.45 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.288 2.658 . . . . 0.0 113.486 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' B' ' 239' ' ' ASP . 4.0 p30 -69.89 -5.44 25.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.998 . . . . 0.0 111.501 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -25.83 3.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 111.315 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.63 HE21 ' C ' ' B' ' 237' ' ' PRO . 16.9 pt20 -88.55 144.7 26.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.235 -1.541 . . . . 0.0 109.418 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -129.32 134.05 47.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 109.663 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.65 126.14 51.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.508 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.35 135.75 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 50.5 t80 -130.59 114.12 15.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.313 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.25 39.05 7.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.54 12.52 66.96 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.846 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.443 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.5 ptmm? -111.68 136.78 50.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -1.155 . . . . 0.0 109.674 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -83.57 122.74 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 109.218 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.459 HD13 HD12 ' B' ' 223' ' ' ILE . 38.9 mt -69.86 144.31 52.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 37.3 tt0 -100.89 147.0 26.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.997 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -73.4 3.71 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.431 -0.793 . . . . 0.0 109.649 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -121.93 41.68 1.81 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -150.18 172.07 15.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.293 . . . . 0.0 109.539 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 68.2 p -111.9 162.13 15.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -0.79 . . . . 0.0 109.883 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.473 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.8 mt -58.12 -43.91 87.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.811 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 73.1 p -59.9 -27.69 66.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -25.74 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.687 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -96.73 5.55 50.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.217 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.9 38.18 2.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.53 136.7 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.146 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.47 175.28 7.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.916 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.604 ' NZ ' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.81 160.24 1.45 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.739 0.781 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 56.4 9.9 0.59 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.406 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.523 ' OG ' HG22 ' B' ' 203' ' ' ILE . 16.1 p -73.61 146.86 44.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.008 -1.058 . . . . 0.0 108.367 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.742 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.4 m -114.06 139.38 49.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.539 -0.726 . . . . 0.0 109.913 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.742 HD12 ' C ' ' B' ' 266' ' ' THR . 11.2 mp -121.14 165.92 14.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.409 ' HB3' HD21 ' A' ' 76' ' ' LEU . 79.8 m80 -113.1 139.27 48.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.466 -0.771 . . . . 0.0 109.191 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.03 125.15 51.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 109.513 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.521 HG21 HG11 ' A' ' 80' ' ' VAL . 2.5 t -113.52 129.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.579 ' H ' HD11 ' B' ' 208' ' ' LEU . 39.2 mt -83.23 142.44 31.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.167 -0.958 . . . . 0.0 109.992 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.781 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.22 164.3 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.287 1.992 . . . . 0.0 113.0 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.9 m -67.66 -1.91 6.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 110.296 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.924 ' O ' HG22 ' B' ' 209' ' ' THR . 2.3 m-20 -123.01 7.87 9.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.26 -0.9 . . . . 0.0 110.782 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.3 mm -108.65 128.74 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.06 . . . . 0.0 110.81 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.77 109.67 58.44 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -47.32 -45.07 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.252 1.968 . . . . 0.0 112.539 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -49.69 -48.21 49.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 110.313 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.16 -24.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.796 -1.19 . . . . 0.0 108.902 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.1 t80 -67.99 -52.86 30.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 110.922 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -18.85 62.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -83.15 -5.41 59.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.75 151.99 46.26 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.945 . . . . 0.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.51 153.02 24.59 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.536 2.157 . . . . 0.0 112.099 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.98 -50.9 68.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 110.635 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.69 -43.9 37.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.942 -1.099 . . . . 0.0 109.838 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.6 t -75.01 -33.59 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 108.763 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -58.96 -49.97 75.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -58.9 -49.71 76.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 110.237 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -56.18 -42.3 76.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.076 -1.015 . . . . 0.0 110.412 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.41 -36.99 74.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.148 . . . . 0.0 109.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.5 -38.27 74.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.716 -1.24 . . . . 0.0 109.102 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.23 73.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 108.862 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -72.82 -37.74 67.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.4 m0 . . . . . 0 C--N 1.301 -1.517 0 O-C-N 120.999 -1.063 . . . . 0.0 108.933 179.213 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.85 162.73 13.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 110.39 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.2 145.81 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.618 -0.677 . . . . 0.0 109.36 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -99.34 144.07 28.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.51 112.18 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.851 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.1 OUTLIER -96.71 131.64 43.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 108.846 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.8 p -92.0 177.12 6.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 110.65 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.627 HD11 ' H ' ' B' ' 271' ' ' LEU . 29.9 mt -64.03 -11.16 26.65 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.497 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.924 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.1 p -102.53 -3.37 26.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.09 -0.2 64.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -65.74 118.93 10.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.249 . . . . 0.0 108.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.4 m -100.17 137.93 37.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.937 . . . . 0.0 109.159 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' B' ' 234' ' ' GLU . 26.6 mt -134.09 136.26 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.19 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 44.1 m -105.04 119.56 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 108.948 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.1 mt -121.98 121.88 38.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -0.766 . . . . 0.0 110.058 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.82 132.37 47.27 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.8 m -139.8 -172.11 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.907 -1.121 . . . . 0.0 109.979 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -135.99 155.02 77.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.32 -19.08 26.75 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.528 2.152 . . . . 0.0 112.165 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.58 8.99 29.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.158 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.0 141.53 50.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.875 -1.141 . . . . 0.0 109.379 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 22.5 p -85.99 144.55 27.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.56 -33.66 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 108.899 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -62.42 -30.94 71.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.205 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 86.4 m-20 -73.96 -52.4 12.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 108.905 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 31.6 t -52.3 -47.76 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -51.48 -43.05 62.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.477 0.656 . . . . 0.0 109.292 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.54 80.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.556 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.3 mtpp -56.51 -53.85 52.67 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.03 -1.044 . . . . 0.0 109.351 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.7 mp -58.16 -34.43 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 108.908 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -62.75 -49.66 74.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 0.0 109.748 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -22.9 66.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.42 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -100.11 -59.92 1.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.004 -1.06 . . . . 0.0 110.17 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' B' ' 213' ' ' ILE . 77.9 mm-40 -79.78 -6.6 57.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.977 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.82 25.7 71.92 Favored Glycine 0 N--CA 1.492 2.432 0 O-C-N 120.544 -1.348 . . . . 0.0 110.358 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.438 HG23 HE21 ' B' ' 240' ' ' GLN . 68.8 mt -103.61 133.87 20.05 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.155 -1.203 . . . . 0.0 109.553 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.428 ' HD2' HE21 ' B' ' 240' ' ' GLN . 56.6 Cg_endo -73.05 153.14 52.04 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.45 2.1 . . . . 0.0 112.024 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.19 -34.06 10.6 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.676 2.251 . . . . 0.0 113.272 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.1 -7.95 27.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.498 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.438 HE21 HG23 ' B' ' 236' ' ' ILE . 0.0 OUTLIER -127.25 -14.24 5.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.465 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -95.78 136.18 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.755 -1.215 . . . . 0.0 108.362 178.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.426 ' HE ' ' HD2' ' B' ' 272' ' ' ARG . 78.0 mtt180 -125.22 134.97 52.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.172 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.28 124.89 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.88 135.41 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.516 -0.74 . . . . 0.0 109.48 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -130.06 118.72 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 61.06 37.56 17.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.645 -1.284 . . . . 0.0 109.57 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.88 -10.12 9.91 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.124 -0.985 . . . . 0.0 111.486 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.96 136.23 33.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.542 -1.564 . . . . 0.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -82.17 126.42 32.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.8 mt -74.25 146.92 42.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.449 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -103.34 146.12 28.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.887 . . . . 0.0 109.752 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 p30 -71.0 3.86 3.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.8 37.34 3.15 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.725 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -145.87 173.65 11.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.019 -1.283 . . . . 0.0 109.638 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 71.7 p -113.15 161.58 16.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.129 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.541 HD23 ' N ' ' B' ' 256' ' ' LEU . 2.9 mt -59.7 -43.03 94.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.873 . . . . 0.0 110.035 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 97.6 p -60.72 -29.22 69.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 109.796 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.78 -15.23 63.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.033 . . . . 0.0 109.272 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -107.26 3.73 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.17 38.79 3.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.399 -0.813 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.0 135.26 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.892 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -123.58 172.58 8.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.099 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -50.97 157.99 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.568 0.699 . . . . 0.0 110.382 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 59.18 10.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 17.1 m -75.17 150.14 38.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.932 -1.105 . . . . 0.0 108.38 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.851 HG21 ' NZ ' ' B' ' 206' ' ' LYS . 7.7 m -116.23 139.12 50.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.43 140.47 52.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.543 -0.723 . . . . 0.0 109.56 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.46 ' NE2' ' CE ' ' B' ' 206' ' ' LYS . 64.6 m80 -89.36 142.23 27.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.142 -0.974 . . . . 0.0 110.015 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.465 HD11 ' HG3' ' B' ' 241' ' ' GLN . 22.4 tp -110.02 127.93 55.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 0.0 109.097 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.22 130.83 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.396 -0.815 . . . . 0.0 110.154 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.627 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.2 mt -79.64 141.59 36.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.232 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.426 ' HD2' ' HE ' ' B' ' 242' ' ' ARG . 22.4 ttt180 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.348 -0.845 . . . . 0.0 108.778 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 120.421 0.153 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -47.89 165.36 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 112.875 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -2.67 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.729 -0.607 . . . . 0.0 110.738 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.877 ' O ' HG22 ' B' ' 209' ' ' THR . 0.6 OUTLIER -121.88 6.82 9.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.083 -1.011 . . . . 0.0 110.125 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 mm -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 111.223 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.97 138.12 20.26 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.52 -38.76 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.58 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -55.37 -44.72 76.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.569 -0.707 . . . . 0.0 110.516 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.683 HG11 ' O ' ' B' ' 207' ' ' THR . 56.8 t -80.76 -23.66 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.852 -1.155 . . . . 0.0 110.283 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.3 t80 -69.1 -53.5 19.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 110.822 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -62.39 -15.71 50.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.088 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.19 -6.6 59.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.6 mt -90.39 151.85 44.86 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.228 -0.92 . . . . 0.0 109.776 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.71 154.14 27.2 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.453 2.102 . . . . 0.0 112.092 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.92 -50.93 68.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -45.06 38.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.945 -1.097 . . . . 0.0 110.262 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.88 -31.93 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 108.509 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.19 -50.76 72.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -56.68 -47.3 80.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.434 -0.792 . . . . 0.0 110.01 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -58.87 -37.72 77.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 0.0 110.482 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.37 -40.34 62.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.812 -1.18 . . . . 0.0 110.145 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -69.88 -38.8 76.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.763 -1.21 . . . . 0.0 108.874 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.16 77.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 108.906 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 4.8 tm-20 -69.0 -38.55 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 108.877 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.461 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.0 m0 . . . . . 0 C--N 1.303 -1.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.041 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.68 164.99 12.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.231 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.437 HG22 ' OG ' ' B' ' 265' ' ' SER . 1.8 pp -144.26 147.9 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' B' ' 264' ' ' GLU . 9.8 m-85 -102.04 144.17 30.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.222 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.98 112.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.984 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.575 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.2 OUTLIER -97.46 133.98 41.31 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.683 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.5 p -93.98 -174.39 3.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.781 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.522 HD11 ' H ' ' B' ' 271' ' ' LEU . 26.9 mt -72.26 -11.72 60.84 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.877 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.9 p -102.61 -2.44 28.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.36 -0.838 . . . . 0.0 109.574 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 94.99 2.73 62.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -67.22 118.37 10.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -1.225 . . . . 0.0 108.823 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.1 m -99.62 138.12 37.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.033 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.421 HG22 HD21 ' B' ' 215' ' ' LEU . 40.0 mt -135.01 136.21 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.334 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 72.5 m -105.34 120.21 41.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.663 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 13.1 mt -125.68 121.84 34.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.963 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.654 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 4.8 mt-10 -67.18 130.3 42.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.496 -0.753 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.522 HG13 ' NZ ' ' B' ' 229' ' ' LYS . 27.5 m -136.16 -174.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.08 -1.012 . . . . 0.0 110.131 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -133.86 155.3 80.42 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.43 -20.39 56.2 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.402 2.068 . . . . 0.0 112.195 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -105.24 7.95 33.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.24 143.47 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.839 -1.163 . . . . 0.0 109.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 52.3 p -86.37 145.94 26.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -51.68 -26.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -36.22 83.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.205 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.0 -52.75 21.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.109 -0.994 . . . . 0.0 109.021 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.42 ' O ' HD12 ' B' ' 230' ' ' ILE . 35.7 t -52.28 -37.54 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 108.926 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -65.41 -32.48 74.13 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.441 -0.787 . . . . 0.0 108.959 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.89 69.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.663 ' HZ3' ' C ' ' B' ' 215' ' ' LEU . 12.6 mtpt -57.37 -52.65 64.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 108.781 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.569 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.6 mp -59.71 -36.52 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 108.808 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -59.98 -42.81 94.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.063 -1.023 . . . . 0.0 110.07 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.49 -31.31 68.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.116 -0.99 . . . . 0.0 110.831 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -92.76 -50.43 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.43 -6.44 57.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.972 . . . . 0.0 111.331 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.48 26.95 72.05 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.51 -1.369 . . . . 0.0 110.456 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.07 131.6 21.79 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.128 -1.219 . . . . 0.0 109.569 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.438 ' HG2' HE21 ' B' ' 240' ' ' GLN . 57.5 Cg_endo -74.62 156.67 44.69 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.212 1.941 . . . . 0.0 112.261 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.6 -34.67 8.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.922 2.414 . . . . 0.0 113.393 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -65.34 -6.8 10.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.228 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.438 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.89 -21.06 3.4 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.748 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.5 136.52 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.606 -1.309 . . . . 0.0 109.252 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -125.98 135.73 52.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.95 126.61 52.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 79.7 mt -120.21 136.52 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.9 t80 -129.65 112.82 14.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.32 -0.863 . . . . 0.0 109.435 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.95 44.56 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.865 -1.147 . . . . 0.0 109.485 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 -6.07 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -94.19 137.77 32.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.817 -1.402 . . . . 0.0 109.504 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -84.4 132.59 34.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.875 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.56 146.33 28.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 109.09 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 2.6 tt0 -105.49 148.0 27.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.69 3.82 3.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.921 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -120.63 45.54 1.22 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.874 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.54 172.39 18.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.987 -1.302 . . . . 0.0 109.261 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 65.1 p -109.84 161.07 15.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.482 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.4 mt -58.01 -40.44 80.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.815 . . . . 0.0 109.938 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 98.3 p -62.51 -28.04 69.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.08 -15.8 62.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.255 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -105.03 1.72 28.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 109.067 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.8 39.73 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.88 133.99 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.038 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.34 174.59 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.471 ' HE3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.15 158.09 1.64 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.895 0.855 . . . . 0.0 110.698 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' CE2' ' B' ' 204' ' ' PHE . 91.5 mt-10 57.99 14.26 2.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.044 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.437 ' OG ' HG22 ' B' ' 203' ' ' ILE . 70.4 p -78.03 150.44 33.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.955 -1.091 . . . . 0.0 108.79 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.765 ' C ' HD12 ' B' ' 267' ' ' LEU . 6.7 m -115.03 138.58 50.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -0.796 . . . . 0.0 110.233 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.765 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.82 140.97 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.527 -0.733 . . . . 0.0 109.641 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.404 ' HB3' HD21 ' A' ' 76' ' ' LEU . 58.4 m80 -90.19 141.71 28.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 109.783 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 13.5 tp -108.94 126.06 52.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.376 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 42.8 t -112.69 128.09 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.8 . . . . 0.0 109.546 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.522 ' H ' HD11 ' B' ' 208' ' ' LEU . 47.1 mt -82.82 143.9 30.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.018 -1.052 . . . . 0.0 109.552 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.256 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.04 164.75 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.215 1.944 . . . . 0.0 112.762 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -2.75 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.739 -0.6 . . . . 0.0 110.722 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.899 ' O ' HG22 ' B' ' 209' ' ' THR . 4.1 m-20 -122.24 8.34 9.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.046 -1.034 . . . . 0.0 110.348 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 mm -111.05 129.34 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.272 -0.892 . . . . 0.0 111.001 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.7 t70 -99.85 139.56 20.89 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.48 -47.38 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.269 1.979 . . . . 0.0 112.242 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.478 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 6.8 tt0 -47.88 -44.68 29.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.696 -0.627 . . . . 0.0 110.33 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.658 HG11 ' O ' ' B' ' 207' ' ' THR . 41.4 t -80.85 -32.26 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.957 -1.09 . . . . 0.0 110.318 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -61.05 -54.13 48.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 110.742 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -61.25 -15.86 39.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.907 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -83.55 -6.12 59.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.053 . . . . 0.0 109.808 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' B' ' 268' ' ' HIS . 92.6 mt -90.33 151.93 45.08 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.51 154.17 20.74 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.37 2.047 . . . . 0.0 112.098 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.82 -49.26 75.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.18 -44.74 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.064 . . . . 0.0 110.196 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.3 t -74.84 -32.46 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.874 -1.141 . . . . 0.0 108.478 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.2 tt0 -59.22 -51.83 68.29 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -57.25 -48.96 77.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -56.41 -42.76 78.53 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 110.56 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -69.97 -37.87 75.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.863 -1.148 . . . . 0.0 109.776 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.0 mt -70.03 -40.11 75.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.739 -1.226 . . . . 0.0 109.024 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.49 70.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 108.785 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.56 -40.19 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.9 m0 . . . . . 0 C--N 1.302 -1.491 0 O-C-N 121.005 -1.06 . . . . 0.0 109.535 179.687 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.34 164.76 12.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.55 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.555 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.7 142.72 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.462 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.33 141.7 28.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.443 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.6 t -120.82 108.23 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 109.608 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 13.6 ptpt -94.61 135.32 36.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.658 ' O ' HG11 ' A' ' 72' ' ' VAL . 46.4 p -97.14 -173.94 2.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.025 -1.047 . . . . 0.0 110.998 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.681 HD11 ' H ' ' B' ' 271' ' ' LEU . 20.1 mt -71.4 -14.67 62.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.466 0.651 . . . . 0.0 109.284 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.899 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -99.93 -4.6 29.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.6 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.51 3.01 59.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -67.82 118.45 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.081 -1.247 . . . . 0.0 109.199 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 10.2 m -99.8 137.8 37.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 48.3 mt -133.49 135.34 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.8 m -104.22 117.03 33.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.724 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.8 mt -122.18 121.92 37.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.448 -0.783 . . . . 0.0 110.084 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -67.78 132.69 47.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.57 -174.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.797 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.72 152.55 77.79 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.975 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.15 -24.12 48.31 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.587 2.191 . . . . 0.0 112.191 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 49.2 m -100.4 6.1 44.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.879 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -71.44 143.55 50.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.966 -1.084 . . . . 0.0 109.375 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.586 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 45.0 p -86.26 151.49 23.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 0.0 109.932 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 35.2 mm -54.53 -43.32 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -52.61 -35.65 54.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.586 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 84.1 m-20 -67.28 -52.77 36.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.337 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 25.1 t -52.05 -47.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 108.549 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -52.41 -43.49 64.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.507 -0.746 . . . . 0.0 109.182 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.79 -36.11 78.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.814 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.54 ' HB2' HD13 ' B' ' 215' ' ' LEU . 15.3 mtpp -57.78 -53.46 57.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 0.0 109.41 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.529 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.6 mp -58.3 -34.23 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.205 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . 0.463 HE21 ' HD3' ' B' ' 238' ' ' PRO . 15.3 tt0 -60.75 -47.39 86.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.921 -1.112 . . . . 0.0 109.826 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -68.69 -24.33 64.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.249 -0.907 . . . . 0.0 110.634 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -97.53 -53.24 3.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 110.457 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.17 -7.55 53.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.289 -0.882 . . . . 0.0 111.578 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.47 24.67 75.09 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.215 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 36.7 mt -104.41 124.94 35.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.498 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.447 ' HA ' HE21 ' B' ' 231' ' ' GLN . 61.6 Cg_endo -77.56 154.73 31.35 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.164 1.91 . . . . 0.0 111.986 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . 0.463 ' HD3' HE21 ' B' ' 231' ' ' GLN . 29.7 Cg_endo -64.95 -28.57 58.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.733 2.289 . . . . 0.0 112.881 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 44.2 p30 -62.6 -14.73 46.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.952 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.51 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.0 OUTLIER -128.52 -21.41 3.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.508 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -84.57 136.54 33.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.897 -1.127 . . . . 0.0 109.243 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -129.46 132.11 46.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.421 -0.799 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.42 127.42 53.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.38 134.23 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.629 -0.669 . . . . 0.0 109.348 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.6 t80 -127.2 112.84 15.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 65.14 37.53 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.868 -1.145 . . . . 0.0 109.458 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.6 -7.66 18.26 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.144 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -94.06 134.78 36.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.74 -1.447 . . . . 0.0 109.692 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -80.97 125.0 29.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.452 HD11 HD23 ' B' ' 267' ' ' LEU . 29.0 mt -69.91 142.37 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -97.19 144.36 27.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.19 3.69 2.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.92 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.0 47.21 1.03 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.795 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -152.68 172.53 16.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.384 . . . . 0.0 109.078 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 37.9 p -111.5 159.24 18.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.948 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.2 mt -57.3 -41.71 80.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 69.4 p -61.17 -29.12 69.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.845 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.24 -16.5 63.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 109.333 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -105.58 3.31 29.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.48 39.35 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.848 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.6 mt -91.71 135.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.25 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.31 173.11 7.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.04 162.66 0.44 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.548 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.37 10.46 0.47 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.555 ' OG ' HG22 ' B' ' 203' ' ' ILE . 62.7 p -73.67 148.32 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.823 -1.173 . . . . 0.0 108.657 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.721 ' C ' HD12 ' B' ' 267' ' ' LEU . 22.1 m -113.77 137.89 51.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 0.0 110.038 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.721 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -121.03 160.14 24.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.011 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.411 ' HB3' HD21 ' A' ' 76' ' ' LEU . 79.5 m80 -107.58 139.62 41.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.333 -0.854 . . . . 0.0 109.741 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' B' ' 241' ' ' GLN . 24.8 tp -110.21 126.03 53.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.401 ' HA ' HD21 ' B' ' 208' ' ' LEU . 11.6 t -114.62 130.06 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.454 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.681 ' H ' HD11 ' B' ' 208' ' ' LEU . 47.1 mt -82.42 144.4 30.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.652 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -47.66 165.56 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.454 2.102 . . . . 0.0 112.916 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -6.18 21.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.942 ' O ' HG22 ' B' ' 209' ' ' THR . 1.8 m-20 -117.01 2.56 12.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.099 -1.001 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.77 128.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 4.7 t70 -98.91 138.35 20.64 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.62 -40.31 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.355 2.037 . . . . 0.0 112.467 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 37.4 tt0 -56.21 -43.49 78.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.617 -0.677 . . . . 0.0 110.581 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.653 HG11 ' O ' ' B' ' 207' ' ' THR . 61.4 t -80.09 -23.79 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.784 -1.198 . . . . 0.0 110.35 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.9 t80 -70.41 -52.38 22.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 110.832 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -64.32 -18.12 64.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.174 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -79.87 -7.94 59.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.861 -1.149 . . . . 0.0 109.49 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.8 mt -89.92 151.63 45.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 154.96 22.29 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.41 2.074 . . . . 0.0 111.95 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -63.05 -51.84 65.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.72 -44.33 38.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 110.09 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.408 HG11 HG21 ' B' ' 270' ' ' VAL . 60.3 t -74.77 -31.56 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.02 -1.05 . . . . 0.0 108.448 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.8 -50.05 75.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -58.36 -49.68 76.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.665 . . . . 0.0 110.38 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.72 -36.87 67.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.037 -1.039 . . . . 0.0 110.043 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.3 mt -75.44 -36.58 60.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.852 -1.155 . . . . 0.0 109.687 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.12 -40.34 71.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.77 -1.206 . . . . 0.0 109.147 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.73 79.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.965 . . . . 0.0 109.046 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.95 -38.48 82.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.0 m0 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.101 -1.0 . . . . 0.0 109.205 179.338 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.429 ' O ' HG23 ' B' ' 217' ' ' VAL . 5.8 ptt? . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.08 166.51 11.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -145.29 145.11 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.628 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.419 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.4 m-85 -95.75 142.4 28.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.01 108.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -93.33 134.11 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 108.767 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.653 ' O ' HG11 ' A' ' 72' ' ' VAL . 20.8 p -94.33 -174.34 3.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.702 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 35.6 mt -72.36 -10.73 60.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.942 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.2 p -104.33 -3.1 24.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.782 . . . . 0.0 109.655 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.36 2.89 60.2 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -66.65 117.0 8.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -1.199 . . . . 0.0 108.854 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -99.19 136.73 38.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.102 -0.999 . . . . 0.0 109.086 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.568 HD11 ' OE2' ' B' ' 234' ' ' GLU . 23.2 mt -132.79 133.86 58.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.278 -0.889 . . . . 0.0 109.462 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.9 m -103.32 120.13 40.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.9 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' B' ' 229' ' ' LYS . 18.8 mt -123.85 120.5 32.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.846 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.62 133.05 49.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 201' ' ' MET . 11.5 m -140.69 -171.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 109.831 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -138.14 152.36 71.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.16 -28.2 78.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.422 2.081 . . . . 0.0 112.264 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.2 m -96.01 5.0 52.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 110.061 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.58 145.21 49.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.639 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.455 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 36.3 p -87.07 150.57 23.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.095 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 31.8 mm -56.81 -40.54 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.72 -31.38 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.087 -1.008 . . . . 0.0 109.604 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.455 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 64.1 m-20 -73.85 -51.13 17.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.99 -50.35 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 108.509 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -52.05 -39.46 59.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 0.0 109.198 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.16 86.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.43 -0.794 . . . . 0.0 109.591 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' B' ' 215' ' ' LEU . 15.6 mtpp -57.81 -53.73 54.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.51 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.5 mp -57.88 -37.25 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.086 -1.009 . . . . 0.0 109.107 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -58.52 -43.14 89.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.43 -22.41 60.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 110.344 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -98.83 -56.45 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.026 -1.047 . . . . 0.0 110.484 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.568 ' OE2' HD11 ' B' ' 213' ' ' ILE . 58.6 mm-40 -83.35 -7.02 59.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 111.088 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.55 24.62 73.9 Favored Glycine 0 N--CA 1.49 2.274 0 O-C-N 120.575 -1.328 . . . . 0.0 109.974 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.72 125.21 33.86 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 109.467 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.438 ' HG2' HE21 ' B' ' 240' ' ' GLN . 58.5 Cg_endo -75.62 154.67 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.996 1.797 . . . . 0.0 111.658 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.92 -29.82 67.25 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.7 2.267 . . . . 0.0 113.049 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.97 -17.27 36.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 110.475 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.438 HE21 ' HG2' ' B' ' 237' ' ' PRO . 1.4 pt20 -127.99 -15.54 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.78 133.62 33.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 109.488 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -127.97 132.37 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.503 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.9 mt -105.85 127.34 53.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.93 136.03 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.683 -0.636 . . . . 0.0 109.413 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -131.25 119.06 21.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 108.983 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 59.73 42.45 16.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.87 -1.144 . . . . 0.0 109.455 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.26 23.87 70.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.112 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 140.51 52.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.117 -1.225 . . . . 0.0 109.615 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -87.97 125.14 34.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 109.603 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.2 mt -71.42 146.56 48.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -0.82 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -99.68 142.59 30.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -68.6 3.2 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.99 40.41 2.01 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -144.55 168.63 19.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 109.258 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 15.0 p -108.79 155.48 20.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.814 . . . . 0.0 109.98 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.51 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.2 mt -54.16 -42.95 70.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 83.6 p -61.2 -27.14 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -15.85 62.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.515 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -106.54 3.42 27.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 109.242 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.59 40.53 1.86 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.53 -0.731 . . . . 0.0 109.285 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.57 133.43 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.364 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -124.79 176.28 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.54 159.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.277 -0.889 . . . . 0.0 111.07 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 57.85 13.14 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.092 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -75.23 148.19 39.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 108.676 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 8.0 m -114.06 137.05 52.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.405 -0.81 . . . . 0.0 110.647 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.66 144.42 50.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.772 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.42 ' HB3' HD21 ' A' ' 76' ' ' LEU . 32.5 m80 -94.39 143.3 26.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.132 -0.98 . . . . 0.0 110.349 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.2 tp -109.56 125.88 52.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.352 -0.842 . . . . 0.0 109.415 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.408 HG21 HG11 ' A' ' 80' ' ' VAL . 34.8 t -115.25 131.25 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.91 . . . . 0.0 110.135 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' B' ' 271' ' ' LEU . 46.5 mt -82.76 143.95 30.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -0.824 . . . . 0.0 109.626 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.478 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.19 165.18 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.191 1.927 . . . . 0.0 112.74 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -65.8 -14.71 61.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.754 -0.591 . . . . 0.0 110.469 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.876 ' O ' HG22 ' B' ' 209' ' ' THR . 0.5 OUTLIER -108.65 8.45 27.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.08 -1.012 . . . . 0.0 110.45 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.12 129.54 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 111.071 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 5.0 t70 -99.74 138.65 20.43 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.69 -46.66 0.79 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.251 1.967 . . . . 0.0 112.315 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.425 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.7 tt0 -51.07 -44.64 61.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.695 -0.628 . . . . 0.0 110.656 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.739 HG11 ' O ' ' B' ' 207' ' ' THR . 40.0 t -79.06 -24.04 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.812 -1.18 . . . . 0.0 110.203 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.428 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.9 t80 -70.47 -51.44 29.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 110.699 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -63.09 -16.96 61.67 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.142 -0.974 . . . . 0.0 110.055 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -82.97 -7.06 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 76' ' ' LEU . 95.1 mt -89.03 151.31 46.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.842 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.23 154.02 19.91 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.356 2.037 . . . . 0.0 111.913 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.04 -51.45 66.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.671 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.42 -44.81 45.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.982 -1.074 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.04 -30.66 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.992 -1.068 . . . . 0.0 108.716 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.428 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 39.7 tt0 -61.7 -49.36 76.77 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -58.9 -49.7 76.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.552 -0.718 . . . . 0.0 110.359 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.92 -40.66 70.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.004 -1.06 . . . . 0.0 110.121 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.42 -36.2 71.23 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.987 -1.07 . . . . 0.0 109.837 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.92 -39.98 69.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.804 -1.185 . . . . 0.0 109.172 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.59 -32.95 72.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -75.87 -34.35 60.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 108.752 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.4 m0 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 120.962 -1.086 . . . . 0.0 108.491 178.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.92 164.04 12.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 110.585 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.513 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.8 141.95 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.32 141.96 27.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.969 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -121.35 110.03 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -96.41 135.65 37.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 108.735 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.739 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.4 p -96.35 -173.46 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.771 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.442 HD11 ' H ' ' B' ' 271' ' ' LEU . 21.2 mt -72.55 -13.26 61.36 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.348 0.594 . . . . 0.0 109.671 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.876 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.6 p -100.8 -3.26 30.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.62 61.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.39 118.68 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 108.812 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 2.2 m -100.6 138.88 37.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.2 mt -135.22 136.72 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.3 m -104.06 121.43 43.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 108.818 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' B' ' 229' ' ' LYS . 16.1 mt -124.57 120.97 33.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.882 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.1 133.32 48.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.651 -0.656 . . . . 0.0 109.382 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 -173.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.935 -1.103 . . . . 0.0 110.126 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -135.93 153.68 77.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 108.959 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.26 -25.48 65.1 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.528 2.152 . . . . 0.0 112.171 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 m -100.24 5.94 44.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.936 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -71.87 144.93 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.022 -1.049 . . . . 0.0 109.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.3 p -86.71 146.19 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.84 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.411 HD12 HD13 ' B' ' 250' ' ' LEU . 32.2 mm -51.65 -34.3 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.431 ' C ' ' CD ' ' B' ' 224' ' ' GLU . 0.2 OUTLIER -56.8 -38.39 72.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.384 -0.822 . . . . 0.0 109.037 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -66.57 -52.48 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 109.244 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.412 ' H ' HG23 ' B' ' 226' ' ' VAL . 15.6 t -52.6 -48.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.758 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -53.44 -38.7 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.53 83.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.356 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.434 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.8 mtpp -57.16 -52.84 63.68 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 109.111 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.604 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.9 mp -59.04 -36.46 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.178 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . 0.436 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 2.1 tt0 -58.81 -49.56 77.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.943 -1.098 . . . . 0.0 109.741 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.56 -27.6 68.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.422 -0.799 . . . . 0.0 110.649 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -95.4 -57.01 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.895 -1.128 . . . . 0.0 110.55 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -83.04 -6.18 59.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 111.311 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.08 24.76 71.94 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.244 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.495 HD13 HD21 ' B' ' 271' ' ' LEU . 63.1 mt -105.95 128.45 26.38 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.132 -1.217 . . . . 0.0 109.641 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.95 158.69 38.36 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.113 1.875 . . . . 0.0 111.933 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . 0.436 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 37.7 Cg_endo -68.11 -30.18 32.12 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.942 2.428 . . . . 0.0 113.196 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -69.14 -6.14 26.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.1 -20.68 3.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.39 139.03 31.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 109.341 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.94 132.31 47.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.404 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.01 123.42 47.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 109.439 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.51 135.81 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.662 -0.649 . . . . 0.0 109.357 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.486 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.4 t80 -129.84 113.64 14.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.761 . . . . 0.0 109.217 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.34 42.25 5.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.931 -1.106 . . . . 0.0 109.203 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.97 39.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.93 137.9 43.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -1.188 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.41 126.08 33.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.411 HD13 HD12 ' B' ' 223' ' ' ILE . 22.2 mt -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.223 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.4 144.28 31.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.176 -0.953 . . . . 0.0 109.927 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.03 3.35 3.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 109.827 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.39 37.03 3.29 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -145.16 173.35 12.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.284 . . . . 0.0 109.542 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 81.6 p -113.17 161.22 17.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.498 -0.751 . . . . 0.0 109.943 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.494 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.1 mt -60.42 -42.23 95.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.6 p -60.63 -28.26 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.089 -1.007 . . . . 0.0 109.201 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.26 -13.86 61.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 108.959 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.611 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 25.7 m-85 -107.1 0.36 23.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.465 -0.772 . . . . 0.0 109.572 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' B' ' 260' ' ' ASN . 0.0 OUTLIER 68.25 33.42 4.3 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.132 0.968 . . . . 0.0 109.725 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -85.63 133.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.551 -1.343 . . . . 0.0 109.523 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . 0.432 ' O ' ' OG ' ' B' ' 265' ' ' SER . 26.1 mt-30 -120.66 170.51 9.36 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.696 0.76 . . . . 0.0 109.75 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.76 160.42 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.779 0.799 . . . . 0.0 110.698 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 56.58 13.58 1.41 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.513 ' OG ' HG22 ' B' ' 203' ' ' ILE . 3.0 p -76.7 150.02 36.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 108.525 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.745 ' C ' HD12 ' B' ' 267' ' ' LEU . 11.4 m -114.59 137.01 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.383 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.745 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -123.25 140.18 53.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.264 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.412 ' HB3' HD21 ' A' ' 76' ' ' LEU . 60.7 m80 -89.46 141.84 28.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 0.0 109.796 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 17.2 tp -110.55 128.44 55.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 10.7 t -114.19 128.77 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.495 HD21 HD13 ' B' ' 236' ' ' ILE . 43.4 mt -82.4 145.43 29.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.035 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 28.1 ttt-85 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 108.754 -179.115 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.72 164.61 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.485 2.123 . . . . 0.0 113.006 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.47 -1.94 9.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.825 -0.547 . . . . 0.0 110.284 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.878 ' O ' HG22 ' B' ' 209' ' ' THR . 0.2 OUTLIER -120.67 7.23 10.51 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.178 -0.951 . . . . 0.0 110.214 -179.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 68' ' ' ILE . 27.3 mm -109.3 127.67 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.84 . . . . 0.0 111.258 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 9.6 t0 -102.24 110.71 63.27 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.96 -43.83 23.8 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.94 . . . . 0.0 112.625 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -47.86 -47.62 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 110.389 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.707 HG11 ' O ' ' B' ' 207' ' ' THR . 43.8 t -78.32 -23.5 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -70.66 -53.85 14.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.867 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -61.62 -17.49 55.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.876 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -81.98 -6.53 59.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.897 -1.127 . . . . 0.0 109.731 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 76' ' ' LEU . 93.1 mt -90.56 151.48 44.12 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.169 -0.957 . . . . 0.0 109.546 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.66 154.63 19.83 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.301 2.0 . . . . 0.0 111.898 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -49.97 71.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.733 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.65 -44.33 47.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.101 . . . . 0.0 110.087 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.484 HG11 HG21 ' B' ' 270' ' ' VAL . 45.7 t -74.68 -32.07 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.954 -1.091 . . . . 0.0 108.38 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.1 tt0 -59.61 -52.16 66.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.11 -49.05 74.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.196 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.5 -40.79 75.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.021 . . . . 0.0 110.125 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.5 -37.83 68.3 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.49 -39.14 77.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.927 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.86 -32.9 72.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 108.925 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -73.28 -35.61 66.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.42 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 44.9 m0 . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 109.088 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.58 166.15 11.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 pp -145.79 142.11 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -95.18 143.07 26.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 29.2 t -123.43 111.58 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 109.685 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -97.04 140.43 31.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 108.68 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.707 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.9 p -100.56 -173.52 2.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.715 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.449 HD11 ' H ' ' B' ' 271' ' ' LEU . 30.6 mt -70.94 -13.58 62.06 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.527 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.878 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.3 p -102.16 -3.77 26.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.78 2.89 61.08 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -66.65 117.67 9.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.236 . . . . 0.0 108.571 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.0 m -99.91 139.2 35.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.47 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.477 HG22 HD21 ' B' ' 215' ' ' LEU . 23.2 mt -134.94 135.77 52.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.485 -0.759 . . . . 0.0 109.289 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -103.67 122.59 45.35 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.675 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 17.1 mt -126.04 119.66 28.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.44 -0.788 . . . . 0.0 109.935 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . 0.663 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 11.5 mt-10 -66.07 129.92 41.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.626 HG13 ' NZ ' ' B' ' 229' ' ' LYS . 14.1 m -137.38 -172.72 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.0 110.012 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.11 153.77 71.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 108.755 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.55 -25.87 42.94 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.577 2.184 . . . . 0.0 112.489 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -99.6 6.83 45.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.873 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 141.11 52.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.605 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.4 p -86.07 148.69 25.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.998 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -54.93 -42.5 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.311 -0.868 . . . . 0.0 109.257 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -52.44 -37.34 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 109.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -67.92 -49.25 62.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 108.971 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 52.8 t -52.1 -49.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 108.463 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 -37.79 49.21 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.99 87.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.675 ' HZ3' ' C ' ' B' ' 215' ' ' LEU . 15.1 mtpt -55.84 -53.49 56.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 109.056 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.446 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -60.89 -32.81 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' B' ' 237' ' ' PRO . 49.2 tt0 -62.41 -51.0 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.254 -0.904 . . . . 0.0 110.014 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -63.33 -29.33 70.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.522 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -94.22 -58.48 2.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.973 -1.08 . . . . 0.0 110.504 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.08 -6.55 59.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.955 . . . . 0.0 111.596 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.69 25.28 70.28 Favored Glycine 0 N--CA 1.492 2.416 0 O-C-N 120.338 -1.476 . . . . 0.0 110.541 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.63 129.06 26.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.063 -1.257 . . . . 0.0 109.325 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.416 ' HA ' HE21 ' B' ' 231' ' ' GLN . 56.1 Cg_endo -75.02 155.2 42.8 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.985 1.79 . . . . 0.0 111.903 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.1 -29.82 26.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.772 2.314 . . . . 0.0 113.361 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.36 -8.34 45.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.411 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -125.55 -20.7 4.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.39 -0.819 . . . . 0.0 109.608 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 137.63 32.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 108.985 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -127.87 132.37 49.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.872 . . . . 0.0 109.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.19 124.52 49.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.435 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.8 mt -119.68 134.03 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.549 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 45.6 t80 -128.28 111.6 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.46 38.29 4.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.772 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.58 4.62 53.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.464 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -101.48 137.71 39.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 109.765 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -86.2 125.96 33.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.019 . . . . 0.0 109.492 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.464 HD11 HD23 ' B' ' 267' ' ' LEU . 20.1 mt -77.95 142.97 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' B' ' 253' ' ' GLY . 12.7 tt0 -99.8 143.56 29.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.405 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 3.83 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -123.7 49.24 0.91 Allowed Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.786 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -153.44 169.76 22.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -1.228 . . . . 0.0 109.211 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -110.94 158.08 19.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.434 -0.792 . . . . 0.0 110.097 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.429 HD23 ' N ' ' B' ' 256' ' ' LEU . 8.0 mt -55.24 -42.53 73.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.72 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 24.6 p -61.9 -28.1 69.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.92 -13.97 61.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.297 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -105.9 1.94 27.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.7 37.97 3.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.07 135.14 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.35 175.26 6.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.237 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.49 162.09 0.59 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.986 -178.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 56.42 13.38 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.216 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.3 m -75.37 148.17 39.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.794 -1.191 . . . . 0.0 108.585 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.775 ' C ' HD12 ' B' ' 267' ' ' LEU . 4.1 m -114.04 137.43 51.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.458 -0.776 . . . . 0.0 110.177 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.775 HD12 ' C ' ' B' ' 266' ' ' THR . 8.2 mp -124.93 141.97 51.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -90.85 143.06 27.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.874 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 tp -108.44 125.58 51.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.529 -0.732 . . . . 0.0 109.322 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 80' ' ' VAL . 3.0 t -110.52 125.62 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 109.525 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.449 ' H ' HD11 ' B' ' 208' ' ' LEU . 43.0 mt -82.31 144.78 30.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.034 -179.266 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.47 164.72 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.302 2.001 . . . . 0.0 112.881 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p -67.66 -1.81 5.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.757 -0.59 . . . . 0.0 110.789 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.857 ' O ' HG22 ' B' ' 209' ' ' THR . 6.7 m-20 -123.77 9.1 8.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.014 -1.054 . . . . 0.0 110.549 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 68' ' ' ILE . 28.3 mm -110.12 129.07 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.08 -1.013 . . . . 0.0 111.463 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 7.7 t70 -93.34 136.91 23.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' O ' ' CD2' ' A' ' 74' ' ' TYR . 51.8 Cg_endo -72.12 -33.35 9.6 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.457 2.105 . . . . 0.0 113.233 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.43 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 39.3 tt0 -71.65 -37.06 70.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.0 110.577 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.631 HG11 ' O ' ' B' ' 207' ' ' THR . 61.8 t -78.23 -23.66 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.591 -1.318 . . . . 0.0 109.169 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -71.98 -53.33 13.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.409 -0.807 . . . . 0.0 110.698 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 70' ' ' PRO . 46.3 m-85 -61.36 -17.27 53.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.951 . . . . 0.0 109.949 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -83.42 -5.47 59.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.526 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 76' ' ' LEU . 91.3 mt -89.42 152.19 47.16 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.169 -0.957 . . . . 0.0 109.598 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.72 153.92 28.16 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.321 2.014 . . . . 0.0 111.938 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -50.68 69.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.572 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.45 -42.57 43.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.013 -1.054 . . . . 0.0 110.262 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.0 t -74.92 -32.89 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 108.325 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.7 tt0 -59.2 -51.95 67.79 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -56.7 -48.45 77.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.3 -40.71 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.61 -38.54 67.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.842 -1.161 . . . . 0.0 109.63 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.57 -38.78 77.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.736 -1.228 . . . . 0.0 108.948 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.02 73.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.53 -34.43 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 108.748 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 49.4 m0 . . . . . 0 C--N 1.301 -1.536 0 O-C-N 121.016 -1.052 . . . . 0.0 108.729 178.876 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.09 164.84 12.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.128 -0.983 . . . . 0.0 110.362 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.84 143.58 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.197 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.8 142.16 28.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.04 114.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.409 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.1 ptpt -99.84 139.36 35.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 108.993 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.631 ' O ' HG11 ' A' ' 72' ' ' VAL . 30.9 p -98.09 -178.18 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 110.945 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 51.3 mt -71.69 -12.63 61.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.3 p -102.59 -3.99 25.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.05 57.27 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.882 -1.152 . . . . 0.0 110.527 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -69.28 119.07 12.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.002 -1.293 . . . . 0.0 108.999 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 19.3 m -102.83 140.95 36.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.479 HD11 ' CD ' ' B' ' 234' ' ' GLU . 37.6 mt -138.75 137.51 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 37.6 m -104.94 119.34 38.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.6 mt -123.15 121.5 36.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.18 131.49 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.89 -175.07 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.02 -1.05 . . . . 0.0 109.628 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -134.8 152.77 78.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.389 -0.819 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.64 -23.03 46.74 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.555 2.17 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' B' ' 220' ' ' SER . 1.4 t -104.47 5.83 34.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.956 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.89 144.99 52.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.956 -1.09 . . . . 0.0 109.412 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 73.1 p -85.81 150.38 24.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.2 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 36.6 mm -54.51 -45.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.369 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.51 -35.89 54.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -67.77 -52.58 35.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.072 -1.017 . . . . 0.0 109.129 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.7 t -51.9 -48.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.93 -1.106 . . . . 0.0 108.107 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.96 -46.64 61.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.55 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.03 -36.86 70.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.585 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.7 mtpp -56.92 -54.24 48.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.983 -1.073 . . . . 0.0 109.259 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.406 HD13 ' OE1' ' B' ' 241' ' ' GLN . 2.9 mp -57.31 -33.68 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 108.975 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -30.95 71.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.634 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -96.27 -51.97 4.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.026 -1.046 . . . . 0.0 110.683 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.479 ' CD ' HD11 ' B' ' 213' ' ' ILE . 60.4 mm-40 -85.77 -8.0 58.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 111.413 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.69 25.06 72.88 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.501 -1.374 . . . . 0.0 110.524 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.66 130.31 23.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.139 -1.212 . . . . 0.0 109.733 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.445 ' HG2' HE21 ' B' ' 240' ' ' GLN . 57.6 Cg_endo -74.92 155.01 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.214 1.942 . . . . 0.0 111.748 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.48 -30.57 29.05 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.738 2.292 . . . . 0.0 113.219 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.05 -13.04 61.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.445 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.73 -19.86 6.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.418 -0.802 . . . . 0.0 110.13 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.467 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -86.09 139.79 30.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.696 -1.253 . . . . 0.0 108.928 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.425 ' NH1' HE22 ' B' ' 249' ' ' GLN . 66.5 mtt180 -129.76 129.63 44.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.345 -0.847 . . . . 0.0 109.449 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.1 mt -105.04 124.23 49.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.83 . . . . 0.0 109.338 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.99 134.08 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -130.36 121.12 25.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.092 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.46 39.4 28.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.735 -1.228 . . . . 0.0 109.871 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.3 7.31 60.05 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.057 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.66 132.86 52.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.242 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.425 HE22 ' NH1' ' B' ' 242' ' ' ARG . 30.3 tt0 -82.65 125.95 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.614 HD11 HD23 ' B' ' 267' ' ' LEU . 21.3 mt -76.54 141.83 41.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.49 147.16 26.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -68.91 3.91 1.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 110.131 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -121.57 48.29 0.96 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.916 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -156.08 171.7 19.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.989 -1.301 . . . . 0.0 109.245 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' B' ' 258' ' ' ASP . 7.0 p -112.69 161.32 16.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.478 -0.764 . . . . 0.0 110.058 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.519 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.8 mt -60.0 -42.56 94.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.956 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 78.2 p -60.55 -29.05 68.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.081 -1.012 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' B' ' 255' ' ' THR . 1.3 m-20 -70.96 -14.64 62.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.127 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.27 2.81 27.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.05 38.25 4.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.525 -0.734 . . . . 0.0 109.605 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.9 mt -91.19 135.25 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -122.46 172.96 7.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.649 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.606 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.93 160.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.709 0.766 . . . . 0.0 110.506 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 58.08 11.68 1.58 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 2.5 m -73.68 145.35 45.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.776 -1.202 . . . . 0.0 108.875 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.761 ' C ' HD12 ' B' ' 267' ' ' LEU . 17.2 m -113.12 136.97 52.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.584 -0.698 . . . . 0.0 109.953 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.761 HD12 ' C ' ' B' ' 266' ' ' THR . 7.4 mp -124.69 141.7 51.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.409 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 66.5 m80 -88.57 141.06 28.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.092 -1.005 . . . . 0.0 110.059 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' B' ' 241' ' ' GLN . 11.5 tp -108.93 126.38 53.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.289 -0.882 . . . . 0.0 108.985 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 130.03 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.21 144.23 33.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 108.985 -179.13 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.32 164.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.323 2.016 . . . . 0.0 112.742 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.63 -1.88 5.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 110.762 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.864 ' O ' HG22 ' B' ' 209' ' ' THR . 6.9 m-20 -122.9 8.29 9.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.066 -1.021 . . . . 0.0 110.367 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.8 mm -109.37 128.2 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.4 t70 -101.42 139.79 20.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.76 -46.99 1.45 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.502 2.135 . . . . 0.0 112.663 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 tt0 -47.44 -47.0 27.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 110.608 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.5 HG11 ' O ' ' B' ' 207' ' ' THR . 50.3 t -78.99 -42.82 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.4 t80 -51.43 -53.41 37.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.998 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -63.42 -18.82 64.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.0 110.281 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.81 -6.1 56.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.55 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' B' ' 268' ' ' HIS . 92.8 mt -91.07 152.35 44.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.147 -0.97 . . . . 0.0 109.836 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.62 154.51 30.56 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.416 2.077 . . . . 0.0 111.864 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -62.93 -50.16 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.698 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -44.61 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.971 -1.081 . . . . 0.0 110.092 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.3 -31.73 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 108.323 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.7 tt0 -60.02 -51.96 67.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.35 -49.57 74.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.589 -0.694 . . . . 0.0 110.307 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -56.5 -40.06 74.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.096 -1.003 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.96 -36.94 67.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.812 -1.18 . . . . 0.0 109.97 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -70.96 -38.71 72.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.716 -1.24 . . . . 0.0 108.884 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.72 -33.7 73.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.954 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -72.95 -35.06 66.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m0 . . . . . 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 108.749 179.053 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.431 ' HE2' HD12 ' B' ' 256' ' ' LEU . 2.5 ptt? . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.13 165.03 12.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.467 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.484 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -145.42 142.56 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.06 140.84 29.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.2 108.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.513 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -96.54 135.37 38.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.5 ' O ' HG11 ' A' ' 72' ' ' VAL . 70.4 p -96.27 -174.66 3.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 110.557 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 18.0 mt -72.45 -10.54 59.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.32 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -102.48 -3.43 26.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.88 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.65 0.27 62.65 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.102 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -66.93 119.67 12.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 108.887 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.1 m -101.44 140.03 36.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.352 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 41.2 mt -135.4 136.19 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 109.212 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.0 m -105.26 121.05 43.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' B' ' 229' ' ' LYS . 18.8 mt -125.4 120.73 31.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.437 -0.789 . . . . 0.0 109.868 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.39 133.85 51.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.457 HG11 HG22 ' B' ' 226' ' ' VAL . 11.4 m -140.88 -174.31 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 110.08 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -135.32 152.05 76.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.847 . . . . 0.0 109.068 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.04 -26.36 49.52 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.569 2.179 . . . . 0.0 112.516 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -98.1 7.22 46.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.55 142.08 50.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.104 -0.997 . . . . 0.0 110.009 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 62.4 p -86.02 144.59 27.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.409 ' H ' HG12 ' B' ' 223' ' ' ILE . 26.2 mm -51.98 -31.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.129 -0.982 . . . . 0.0 108.699 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.431 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -61.58 -32.95 73.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 109.392 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -72.66 -52.55 14.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.127 -0.983 . . . . 0.0 108.778 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.457 HG22 HG11 ' B' ' 217' ' ' VAL . 66.5 t -52.61 -47.43 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.077 -1.015 . . . . 0.0 108.388 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -52.8 -40.56 63.36 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.77 80.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.522 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.0 mtpp -59.04 -53.81 54.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.819 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.433 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -58.98 -34.24 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.867 -1.145 . . . . 0.0 109.213 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -60.98 -47.0 88.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -21.73 61.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.034 -1.041 . . . . 0.0 110.281 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -97.56 -59.32 1.8 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -82.94 -5.05 58.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.905 . . . . 0.0 111.341 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.61 73.68 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.558 -1.339 . . . . 0.0 110.357 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.33 125.32 35.37 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.102 -1.234 . . . . 0.0 109.439 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.448 ' HG2' HE21 ' B' ' 240' ' ' GLN . 54.4 Cg_endo -73.63 154.12 49.41 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.956 1.77 . . . . 0.0 111.928 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.27 -31.23 53.59 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.673 2.249 . . . . 0.0 112.945 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -63.83 -13.0 40.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.296 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.448 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -126.54 -16.54 5.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.792 . . . . 0.0 110.357 -179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.499 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -88.9 132.05 34.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 109.166 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.72 132.5 53.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.447 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.5 mt -107.16 126.56 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.498 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.44 134.54 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 49.4 t80 -128.71 114.44 16.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.158 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.05 42.47 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.008 -1.057 . . . . 0.0 109.193 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.69 16.81 61.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -114.78 138.94 50.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -1.157 . . . . 0.0 109.479 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -86.65 125.98 34.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.722 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.4 157.78 28.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -117.48 144.48 45.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.483 -0.761 . . . . 0.0 109.842 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.18 3.77 1.98 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.698 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.02 33.71 4.77 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 -145.41 172.02 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.085 -1.244 . . . . 0.0 109.403 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.1 p -112.56 160.63 17.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.405 -0.809 . . . . 0.0 110.071 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.431 HD12 ' HE2' ' B' ' 201' ' ' MET . 3.1 mt -56.94 -42.38 79.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -0.891 . . . . 0.0 109.388 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.4 p -60.26 -29.11 68.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.534 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.95 -18.59 64.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.241 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.69 3.05 31.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.338 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.34 38.97 3.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.4 mt -91.02 135.87 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -121.77 172.91 7.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 109.545 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.837 ' H ' ' HZ3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.86 161.76 0.72 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.346 -0.847 . . . . 0.0 110.466 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 57.31 11.28 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.484 ' OG ' HG22 ' B' ' 203' ' ' ILE . 69.9 p -76.02 151.91 37.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.931 -1.105 . . . . 0.0 108.632 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.749 ' C ' HD12 ' B' ' 267' ' ' LEU . 16.1 m -116.27 136.94 52.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 110.12 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.749 HD12 ' C ' ' B' ' 266' ' ' THR . 10.0 mp -122.06 140.95 51.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.402 ' HB3' HD21 ' A' ' 76' ' ' LEU . 52.7 m80 -89.92 139.8 30.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' B' ' 241' ' ' GLN . 20.8 tp -109.22 126.47 53.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.041 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.83 130.77 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.12 142.08 36.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -0.888 . . . . 0.0 109.136 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.6 ttt180 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.184 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.2 165.25 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.388 2.058 . . . . 0.0 113.03 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -67.47 -2.35 6.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.818 -0.551 . . . . 0.0 110.692 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.905 ' O ' HG22 ' B' ' 209' ' ' THR . 1.6 m-20 -122.95 9.02 9.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.028 -1.045 . . . . 0.0 110.321 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -111.55 129.35 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 0.0 110.956 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -96.08 137.01 21.77 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.86 -38.47 2.99 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.457 2.105 . . . . 0.0 112.643 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.37 -42.84 92.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 110.356 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.56 HG11 ' O ' ' B' ' 207' ' ' THR . 84.1 t -79.21 -23.76 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 0.0 109.783 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.6 t80 -68.04 -53.39 26.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.714 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -62.21 -17.29 57.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.969 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -81.78 -6.07 58.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 76' ' ' LEU . 91.4 mt -90.23 151.44 44.7 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.532 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.79 155.06 18.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.436 2.091 . . . . 0.0 111.914 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.0 -50.52 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 110.769 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.27 54.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.057 . . . . 0.0 110.266 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.89 -31.1 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 108.234 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -60.51 -49.8 76.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -58.34 -48.27 81.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.553 -0.717 . . . . 0.0 110.163 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.1 -40.09 80.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.011 -1.056 . . . . 0.0 110.336 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.56 -39.05 70.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.884 -1.135 . . . . 0.0 109.874 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.22 -36.72 74.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.726 -1.234 . . . . 0.0 109.062 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.51 -34.16 76.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.233 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.521 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 5.3 tm-20 -72.0 -41.18 67.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.848 . . . . 0.0 109.082 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.521 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.1 m0 . . . . . 0 C--N 1.303 -1.416 0 O-C-N 120.95 -1.094 . . . . 0.0 109.045 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.26 163.44 13.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 110.233 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.62 140.97 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.537 -0.727 . . . . 0.0 109.139 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -93.77 142.23 27.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -122.69 110.94 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.412 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -98.46 138.31 35.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.56 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.0 p -97.27 -175.04 3.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 111.08 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.501 HD11 ' H ' ' B' ' 271' ' ' LEU . 31.8 mt -71.54 -14.9 62.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.0 p -99.05 -4.06 33.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.616 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.31 2.42 60.47 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -67.63 119.19 11.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.045 -1.267 . . . . 0.0 109.062 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 135.71 41.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 47.4 mt -134.22 135.42 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.434 -0.791 . . . . 0.0 109.088 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 59.5 m -104.56 124.21 48.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.019 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' B' ' 229' ' ' LYS . 22.0 mt -126.73 120.68 29.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.11 133.67 51.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.574 -0.704 . . . . 0.0 109.295 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.83 -174.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.969 -1.082 . . . . 0.0 109.788 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -133.92 153.36 79.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.115 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.16 -18.37 23.33 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.423 2.082 . . . . 0.0 111.876 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 31.4 t -108.67 7.66 26.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 110.071 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.68 145.86 46.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.39 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.481 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 58.3 p -87.84 145.3 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.433 HD12 HD13 ' B' ' 250' ' ' LEU . 28.3 mm -51.73 -34.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 0.0 109.163 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -62.3 -32.16 72.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.479 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.481 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 46.9 m-20 -70.21 -51.66 29.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.031 -1.043 . . . . 0.0 108.251 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.416 ' H ' HG23 ' B' ' 226' ' ' VAL . 15.9 t -52.21 -44.14 40.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.464 ' HD3' HD12 ' B' ' 243' ' ' LEU . 0.0 OUTLIER -51.63 -48.31 63.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.622 -0.674 . . . . 0.0 109.431 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.46 70.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.729 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.586 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.8 mtpp -58.76 -54.25 49.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.12 -0.988 . . . . 0.0 109.761 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.5 -34.36 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.097 . . . . 0.0 109.033 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . 0.408 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 8.7 tt0 -62.2 -50.38 72.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.955 -1.091 . . . . 0.0 109.821 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.72 -27.5 69.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.684 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -97.41 -54.41 3.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.967 -1.083 . . . . 0.0 110.518 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -86.1 -6.44 59.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 111.329 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.23 24.18 73.37 Favored Glycine 0 N--CA 1.492 2.379 0 O-C-N 120.467 -1.396 . . . . 0.0 110.281 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 59.6 mt -107.34 130.65 22.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -1.159 . . . . 0.0 109.675 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.435 ' HG2' HE21 ' B' ' 240' ' ' GLN . 27.7 Cg_endo -69.66 166.59 26.95 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.029 1.819 . . . . 0.0 111.271 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . 0.408 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 64.8 Cg_endo -83.12 -27.75 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.464 2.109 . . . . 0.0 112.711 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.79 -10.16 58.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.937 . . . . 0.0 110.31 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.435 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -120.52 -25.63 5.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.485 -0.759 . . . . 0.0 109.78 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.02 137.8 31.98 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.621 -1.299 . . . . 0.0 108.55 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -124.07 134.39 53.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 110.156 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.464 HD12 ' HD3' ' B' ' 227' ' ' LYS . 16.9 mt -103.18 120.37 40.59 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 53.9 mt -115.24 133.94 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.598 -0.689 . . . . 0.0 109.399 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -128.23 123.79 35.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.55 41.58 30.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.629 -1.294 . . . . 0.0 108.935 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.29 1.07 6.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -93.02 134.19 35.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.035 -1.273 . . . . 0.0 109.458 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -84.2 120.83 26.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.919 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.535 HD11 HD23 ' B' ' 267' ' ' LEU . 24.2 mt -73.5 142.55 46.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.645 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 144.52 25.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.661 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -72.98 4.2 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.84 42.28 1.6 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -147.37 172.9 13.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.012 -1.287 . . . . 0.0 109.365 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.433 ' OG1' ' OD1' ' B' ' 258' ' ' ASP . 6.5 p -110.03 158.16 18.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.067 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.451 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.7 mt -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 109.849 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.2 p -61.32 -28.99 69.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.807 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . 0.433 ' OD1' ' OG1' ' B' ' 255' ' ' THR . 0.7 OUTLIER -70.12 -15.97 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.129 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.69 3.03 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.82 39.05 3.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.748 . . . . 0.0 109.468 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.7 mt -92.78 136.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.124 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.64 175.11 7.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.386 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.81 162.94 0.53 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.345 -0.847 . . . . 0.0 110.686 -178.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 57.36 13.36 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.098 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -77.01 148.84 36.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.94 -1.1 . . . . 0.0 108.595 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.809 ' C ' HD12 ' B' ' 267' ' ' LEU . 6.7 m -115.09 137.8 51.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.977 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.809 HD12 ' C ' ' B' ' 266' ' ' THR . 9.5 mp -125.54 140.86 52.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.22 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -89.05 143.05 27.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.234 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.95 126.35 52.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.56 131.4 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.353 -0.842 . . . . 0.0 109.749 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.501 ' H ' HD11 ' B' ' 208' ' ' LEU . 45.2 mt -81.58 143.97 31.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.324 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.285 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -47.64 164.75 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.364 2.042 . . . . 0.0 112.874 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.412 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -67.2 -1.72 4.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.757 -0.589 . . . . 0.0 110.682 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.851 ' O ' HG22 ' B' ' 209' ' ' THR . 4.0 m-20 -123.95 9.91 8.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.388 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.2 mm -112.63 129.99 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 0.0 111.268 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t70 -100.19 139.93 21.09 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -71.24 -48.88 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.221 1.947 . . . . 0.0 112.297 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 31.8 tt0 -47.98 -44.02 30.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.691 -0.631 . . . . 0.0 110.271 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.593 HG11 ' O ' ' B' ' 207' ' ' THR . 49.0 t -80.2 -23.63 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.79 -1.194 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 27.7 t80 -70.55 -53.08 17.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.071 . . . . 0.0 111.074 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -61.63 -16.32 47.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.75 -5.32 58.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.731 -1.231 . . . . 0.0 110.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.2 mt -90.72 151.94 44.31 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.04 155.95 17.32 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.476 2.118 . . . . 0.0 112.08 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.29 -50.06 71.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.685 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.87 -43.05 59.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.92 -1.113 . . . . 0.0 110.115 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.418 HG11 HG21 ' B' ' 270' ' ' VAL . 61.7 t -75.85 -31.85 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 108.616 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.5 tt0 -60.84 -50.4 73.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -57.16 -49.04 77.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.661 -0.65 . . . . 0.0 110.277 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -57.7 -40.51 79.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.095 -1.003 . . . . 0.0 110.808 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.3 mt -70.53 -38.63 74.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.851 -1.156 . . . . 0.0 109.943 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.9 mt -71.49 -37.42 71.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.744 -1.222 . . . . 0.0 108.908 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.81 70.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 108.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.19 -37.7 57.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 108.793 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 34.1 m0 . . . . . 0 C--N 1.301 -1.503 0 O-C-N 120.925 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.5 167.62 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.54 143.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.37 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -95.62 144.03 26.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -0.856 . . . . 0.0 110.032 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.28 115.29 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 130.0 46.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.593 ' O ' HG11 ' A' ' 72' ' ' VAL . 32.6 p -87.21 -177.1 5.91 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.011 0.91 . . . . 0.0 110.774 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.603 HD11 ' H ' ' B' ' 271' ' ' LEU . 46.9 mt -72.74 -14.98 61.67 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.424 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.851 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -98.11 -3.88 36.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.529 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.04 5.05 57.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.311 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -71.37 118.08 13.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.364 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 20.0 m -99.59 135.56 40.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.278 -0.888 . . . . 0.0 109.012 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.667 HD11 ' CD ' ' B' ' 234' ' ' GLU . 37.6 mt -134.11 137.35 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.521 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 86.5 m -104.77 125.23 50.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.5 mt -127.47 119.95 27.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.58 131.9 47.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.83 -173.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.573 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.19 153.06 76.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 108.869 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.75 -24.26 45.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.382 2.054 . . . . 0.0 111.906 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.29 5.98 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.921 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -70.45 142.51 51.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.997 -1.064 . . . . 0.0 109.363 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 60.5 p -86.2 146.0 26.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.141 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.7 mm -51.41 -35.31 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.066 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -34.62 72.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.813 . . . . 0.0 109.546 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -70.99 -52.6 18.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.365 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.407 ' O ' HD12 ' B' ' 230' ' ' ILE . 38.0 t -52.32 -43.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 108.824 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.31 -41.29 79.6 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.277 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' B' ' 215' ' ' LEU . 16.7 mtpp -56.94 -53.72 54.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.095 -1.003 . . . . 0.0 108.744 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.604 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.5 mp -56.59 -35.49 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.934 . . . . 0.0 108.925 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.77 -49.58 74.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 0.0 109.921 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -31.45 70.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 110.763 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -98.1 -53.96 3.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.966 -1.083 . . . . 0.0 110.846 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.667 ' CD ' HD11 ' B' ' 213' ' ' ILE . 14.7 mm-40 -81.22 -8.65 59.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.165 -0.959 . . . . 0.0 111.132 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.84 68.97 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 120.625 -1.297 . . . . 0.0 110.396 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 53.5 mt -100.72 129.51 27.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.238 . . . . 0.0 109.345 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.47 ' HG2' HE21 ' B' ' 240' ' ' GLN . 48.4 Cg_endo -73.23 158.67 48.49 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.069 1.846 . . . . 0.0 111.88 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.18 -31.25 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.692 2.261 . . . . 0.0 112.899 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.59 -6.24 29.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 110.443 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.47 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.99 -16.86 4.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 110.26 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.7 140.2 31.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 0.0 109.184 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -129.74 134.49 47.65 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.431 ' CB ' HD12 ' B' ' 250' ' ' LEU . 12.1 mt -106.85 126.67 52.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.269 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.9 mt -119.81 135.18 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.628 -0.67 . . . . 0.0 109.626 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.557 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 50.7 t80 -127.11 109.21 11.63 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 67.41 41.21 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.868 -1.145 . . . . 0.0 109.267 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.18 1.99 23.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -98.57 135.85 39.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.26 . . . . 0.0 109.585 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -82.75 123.62 29.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 109.272 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.524 HD11 HD23 ' B' ' 267' ' ' LEU . 39.7 mt -71.45 142.72 50.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.0 146.51 28.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.5 OUTLIER -72.81 3.43 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.684 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.23 44.09 1.46 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -155.86 172.44 18.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.905 -1.35 . . . . 0.0 109.461 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 76.2 p -113.54 162.5 16.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.624 -0.672 . . . . 0.0 110.149 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.472 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.8 mt -56.34 -44.5 80.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.4 p -60.22 -27.99 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.88 . . . . 0.0 109.737 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -20.85 62.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.9 5.45 43.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 66.91 39.69 3.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.01 137.0 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -126.26 178.39 5.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.05 158.98 1.3 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.971 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 58.11 24.02 10.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.304 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.35 148.72 25.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.479 -1.388 . . . . 0.0 108.675 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.786 ' C ' HD12 ' B' ' 267' ' ' LEU . 1.8 m -110.87 134.48 52.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.649 -0.657 . . . . 0.0 109.685 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.786 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -124.04 139.06 54.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.541 -0.724 . . . . 0.0 109.226 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -89.05 143.56 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.08 -1.012 . . . . 0.0 110.001 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.86 127.41 54.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.023 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 80' ' ' VAL . 42.5 t -112.76 128.17 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.576 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.603 ' H ' HD11 ' B' ' 208' ' ' LEU . 44.9 mt -81.3 143.6 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.242 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 . . . . . 0 C--N 1.301 -1.527 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.312 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -48.12 164.81 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.457 2.104 . . . . 0.0 112.917 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -2.14 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.573 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.877 ' O ' HG22 ' B' ' 209' ' ' THR . 0.5 OUTLIER -123.63 9.17 8.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.141 -0.975 . . . . 0.0 110.423 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.4 mm -110.84 129.37 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.167 -0.958 . . . . 0.0 111.267 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t0 -100.24 140.19 21.28 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.24 -47.04 0.57 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.407 2.071 . . . . 0.0 112.219 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.531 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -47.25 -45.32 23.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.738 -0.601 . . . . 0.0 110.336 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.595 HG11 ' O ' ' B' ' 207' ' ' THR . 21.6 t -80.71 -33.03 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.82 -1.175 . . . . 0.0 110.526 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 18.1 t80 -60.76 -54.39 45.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.909 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.66 -18.13 58.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -81.35 -5.88 58.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.86 -1.15 . . . . 0.0 109.712 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 76' ' ' LEU . 95.2 mt -90.63 151.56 44.09 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.619 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 155.28 16.34 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.342 2.028 . . . . 0.0 111.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -63.53 -49.03 75.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.02 -42.97 60.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.898 -1.126 . . . . 0.0 110.156 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.77 -32.19 27.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.373 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.61 -49.5 77.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -58.09 -49.47 76.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.206 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -58.29 -39.52 79.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.0 110.366 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.922 -1.111 . . . . 0.0 109.817 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.8 mt -71.04 -37.14 72.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 109.089 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -33.23 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.68 -38.22 64.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.267 -0.895 . . . . 0.0 109.0 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 38.0 m0 . . . . . 0 C--N 1.3 -1.582 0 O-C-N 120.949 -1.095 . . . . 0.0 108.485 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.86 163.92 12.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 110.482 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.52 145.93 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.226 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.13 141.98 31.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 113.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.714 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.548 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -100.81 129.31 46.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 108.79 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.595 ' O ' HG11 ' A' ' 72' ' ' VAL . 31.1 p -90.19 -171.79 3.24 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.036 0.922 . . . . 0.0 111.36 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.617 HD11 ' H ' ' B' ' 271' ' ' LEU . 40.8 mt -71.74 -17.79 62.17 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.716 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.877 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.8 p -97.56 -2.64 41.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.675 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.07 2.42 62.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.61 118.63 9.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -1.214 . . . . 0.0 108.856 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 23.0 m -101.35 133.07 46.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.5 mt -128.27 137.88 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.468 -0.77 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 49.6 m -105.96 120.76 42.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 108.768 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' B' ' 229' ' ' LYS . 23.6 mt -125.53 121.02 32.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.393 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.29 132.2 47.25 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.86 -172.56 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.888 -1.132 . . . . 0.0 109.854 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -134.73 153.56 78.93 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -58.15 -24.03 64.54 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.478 2.118 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.76 6.91 41.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.825 . . . . 0.0 109.783 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.63 143.93 49.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.954 -1.091 . . . . 0.0 109.571 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.404 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 16.2 p -87.63 145.92 25.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.0 109.824 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 33.2 mm -51.79 -39.82 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.178 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -34.4 57.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.565 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.404 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 63.4 m-20 -72.24 -50.22 29.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.178 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 51.2 t -51.99 -49.72 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 108.557 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -42.87 62.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.571 -0.705 . . . . 0.0 109.477 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.88 75.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.517 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.5 mtpp -57.41 -53.71 55.08 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.246 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.52 -33.16 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.013 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . 0.42 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 1.3 tt0 -61.04 -47.63 85.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.99 -1.069 . . . . 0.0 110.118 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.56 -26.71 63.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.008 -1.058 . . . . 0.0 110.906 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -94.52 -50.06 5.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.886 -1.134 . . . . 0.0 110.529 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -92.64 -7.69 46.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 0.0 111.396 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.27 21.18 77.19 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 120.44 -1.413 . . . . 0.0 110.726 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 24.9 mt -103.98 128.11 27.88 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.909 -1.347 . . . . 0.0 109.587 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.442 ' HG2' HE21 ' B' ' 240' ' ' GLN . 28.6 Cg_endo -70.87 164.79 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.183 1.922 . . . . 0.0 112.497 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . 0.42 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 57.3 Cg_endo -73.9 -31.95 7.7 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.011 2.474 . . . . 0.0 113.383 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.63 -5.91 43.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.243 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.442 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.9 -25.97 4.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.476 ' HB2' HD11 ' B' ' 269' ' ' LEU . 1.6 pt20 -90.19 147.95 23.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.385 -1.447 . . . . 0.0 108.816 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -131.37 133.37 45.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -0.995 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.5 mt -103.84 123.24 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.439 -0.788 . . . . 0.0 109.016 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 97.8 mt -117.55 133.97 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.65 -0.657 . . . . 0.0 109.378 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 44.5 t80 -129.05 117.24 20.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 60.3 37.23 20.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.654 -1.279 . . . . 0.0 109.21 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.29 28.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -94.96 132.56 39.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.828 -1.395 . . . . 0.0 109.501 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.58 125.07 30.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.11 140.75 41.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' B' ' 253' ' ' GLY . 9.0 tp10 -101.62 148.92 24.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.58 4.16 2.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.337 -0.852 . . . . 0.0 110.832 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . 0.453 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -119.15 46.02 1.18 Allowed Glycine 0 N--CA 1.497 2.721 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.937 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.92 174.41 15.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.905 -1.35 . . . . 0.0 109.515 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 17.0 p -112.65 160.67 17.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 110.257 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.6 mt -58.48 -41.11 84.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 109.749 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 30.0 p -61.72 -28.04 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 0.0 109.418 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -70.55 -19.68 62.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.38 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -103.17 3.58 35.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.062 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 66.54 38.93 3.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.551 -0.718 . . . . 0.0 109.99 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 49.6 mt -92.81 137.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.155 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -126.16 176.23 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.073 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.509 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.69 160.35 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.914 0.864 . . . . 0.0 110.834 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 56.04 12.67 0.97 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.123 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 16.1 m -78.22 152.03 32.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.882 -1.136 . . . . 0.0 108.644 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.781 ' C ' HD12 ' B' ' 267' ' ' LEU . 15.4 m -116.34 137.97 51.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -0.764 . . . . 0.0 110.388 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.781 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -123.97 140.88 52.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.359 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.433 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 68.2 m80 -88.95 141.12 28.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.115 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' B' ' 241' ' ' GLN . 14.3 tp -110.08 127.85 55.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 132.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 109.776 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.617 ' H ' HD11 ' B' ' 208' ' ' LEU . 45.4 mt -80.84 141.39 34.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.115 -0.991 . . . . 0.0 109.289 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.361 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -48.25 164.84 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.309 2.006 . . . . 0.0 113.12 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.88 -2.16 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.754 -0.591 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.952 ' O ' HG22 ' B' ' 209' ' ' THR . 2.2 m-20 -122.66 7.31 9.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.098 -1.001 . . . . 0.0 110.387 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.96 128.66 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -0.993 . . . . 0.0 110.967 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.3 t0 -101.09 140.45 21.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.11 -48.75 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.495 2.13 . . . . 0.0 112.432 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.3 tt0 -47.07 -46.86 22.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.733 -0.604 . . . . 0.0 110.46 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.674 HG11 ' O ' ' B' ' 207' ' ' THR . 57.8 t -80.42 -23.67 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.234 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.9 t80 -72.17 -54.89 8.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 111.03 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.9 -19.13 59.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -80.26 -4.18 52.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.877 -1.14 . . . . 0.0 109.302 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 152.65 43.41 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.257 -0.902 . . . . 0.0 109.847 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.5 154.36 30.62 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.415 2.077 . . . . 0.0 111.852 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -63.31 -48.06 79.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -0.854 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.16 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.92 -1.113 . . . . 0.0 110.44 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.49 HG11 HG21 ' B' ' 270' ' ' VAL . 57.9 t -75.06 -31.97 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 0.0 108.361 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.6 tt0 -59.88 -50.51 73.51 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -58.39 -48.14 81.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.86 -41.98 88.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 110.789 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.4 mt -71.15 -37.31 72.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.689 -1.257 . . . . 0.0 109.723 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.26 -37.54 74.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.855 -1.153 . . . . 0.0 109.036 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.78 73.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.055 -1.028 . . . . 0.0 109.003 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -71.36 -40.31 70.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 108.819 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 23.8 m0 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 121.057 -1.027 . . . . 0.0 109.192 179.225 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 164.28 12.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 110.599 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.0 143.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.83 140.78 29.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.712 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.04 110.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 109.304 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.7 ptpt -97.1 132.4 42.93 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.674 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.8 p -94.45 -174.61 3.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.101 -1.0 . . . . 0.0 111.066 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.17 -14.27 61.77 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.343 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.952 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.1 p -99.71 -4.33 30.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.455 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.63 1.8 60.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -66.8 117.85 9.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -1.21 . . . . 0.0 108.848 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 8.6 m -101.0 133.07 46.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 108.978 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 26.6 mt -127.63 135.6 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 109.503 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 19.0 m -102.63 121.38 42.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.591 HD13 ' CB ' ' B' ' 229' ' ' LYS . 33.2 mt -127.39 119.45 26.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.369 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.5 130.97 45.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.27 -177.01 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -130.18 153.54 81.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 109.034 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.26 -17.95 42.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.401 2.068 . . . . 0.0 111.946 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.33 8.47 29.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.0 144.54 47.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.847 -1.158 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 64.6 p -87.04 145.86 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.129 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.455 HD12 HD13 ' B' ' 250' ' ' LEU . 42.9 mm -50.88 -28.51 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 108.916 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -64.3 -37.39 87.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.388 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -69.06 -50.38 48.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.174 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.91 -48.81 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.096 -1.003 . . . . 0.0 108.685 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -52.5 -40.48 62.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.688 . . . . 0.0 109.359 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.41 -35.61 80.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.639 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.591 ' CB ' HD13 ' B' ' 215' ' ' LEU . 17.2 mtpp -58.21 -53.64 55.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.915 -1.116 . . . . 0.0 109.145 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.8 mp -59.46 -35.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.111 -0.993 . . . . 0.0 109.204 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -59.36 -44.25 92.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.095 -1.003 . . . . 0.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.91 -29.28 63.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 0.0 110.764 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -91.99 -48.87 6.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.928 -1.108 . . . . 0.0 110.605 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -92.26 -6.71 49.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 111.58 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.68 22.98 73.85 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.482 -1.386 . . . . 0.0 110.389 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 56.5 mt -101.31 129.49 26.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.312 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.455 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.6 Cg_endo -75.4 155.46 41.08 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.029 1.819 . . . . 0.0 111.643 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.6 -32.39 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.698 2.265 . . . . 0.0 113.015 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -64.42 -8.97 15.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.455 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.64 -21.58 3.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.753 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.532 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -84.48 135.38 34.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.749 -1.219 . . . . 0.0 109.299 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.95 131.54 51.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.04 126.76 52.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.333 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.93 134.69 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -128.31 121.51 29.4 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.84 42.79 28.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.571 -1.331 . . . . 0.0 109.275 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.72 0.03 7.89 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -95.52 132.37 40.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.872 -1.37 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.7 123.61 29.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.084 -1.01 . . . . 0.0 108.83 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.548 HD11 HD23 ' B' ' 267' ' ' LEU . 19.4 mt -68.81 150.73 47.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 0.0 109.744 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.3 141.57 36.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.51 3.49 3.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.322 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.18 35.77 3.4 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -142.34 170.95 14.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.295 . . . . 0.0 109.813 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.3 p -111.79 159.96 17.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.001 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.505 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.0 mt -56.5 -42.85 79.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 79.5 p -62.74 -29.13 70.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.8 -18.61 63.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.158 -0.964 . . . . 0.0 109.101 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.55 3.45 34.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.151 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.84 39.15 2.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.501 -0.749 . . . . 0.0 109.837 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.7 mt -93.86 136.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . 0.467 ' O ' ' OG ' ' B' ' 265' ' ' SER . 55.6 mt-30 -125.81 177.17 6.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.26 162.24 0.76 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.245 -0.909 . . . . 0.0 110.927 -178.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 56.33 12.42 1.01 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.053 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 72.7 m -76.5 149.05 36.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.891 -1.131 . . . . 0.0 108.75 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.799 ' C ' HD12 ' B' ' 267' ' ' LEU . 20.5 m -115.83 138.95 50.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 110.352 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.799 HD12 ' C ' ' B' ' 266' ' ' THR . 10.3 mp -124.88 142.81 51.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.432 -0.793 . . . . 0.0 109.406 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.407 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 69.2 m80 -90.67 141.75 28.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.034 -1.041 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' B' ' 241' ' ' GLN . 23.0 tp -111.28 128.89 56.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.412 -0.805 . . . . 0.0 109.578 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 80' ' ' VAL . 3.1 t -116.76 130.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' B' ' 271' ' ' LEU . 48.3 mt -82.57 145.66 29.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.566 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -48.09 164.13 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.287 1.991 . . . . 0.0 112.757 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -2.19 5.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.653 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.932 ' O ' HG22 ' B' ' 209' ' ' THR . 2.6 m-20 -123.22 9.66 9.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.081 -1.012 . . . . 0.0 110.698 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.8 mm -110.29 127.61 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.101 -0.999 . . . . 0.0 111.119 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.0 t70 -98.33 138.73 20.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.36 -41.69 4.53 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.338 2.025 . . . . 0.0 112.567 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 61.2 tt0 -56.61 -43.34 80.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 110.466 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.599 HG11 ' O ' ' B' ' 207' ' ' THR . 66.0 t -81.11 -24.24 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.748 -1.22 . . . . 0.0 110.402 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -72.24 -55.07 7.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -59.09 -16.76 20.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -83.93 -5.76 59.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.996 -1.065 . . . . 0.0 109.877 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.4 151.38 48.39 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.006 -1.059 . . . . 0.0 109.786 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 153.81 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.28 1.987 . . . . 0.0 111.792 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -63.03 -51.57 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.583 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.5 39.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.928 -1.108 . . . . 0.0 110.239 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.27 -31.45 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.712 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -60.49 -50.03 75.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -58.1 -49.04 78.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.753 . . . . 0.0 110.145 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -57.11 -41.99 80.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.63 -38.61 73.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.852 -1.155 . . . . 0.0 110.023 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.56 -38.33 74.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.68 -1.262 . . . . 0.0 109.327 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.48 -31.44 70.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.161 -0.962 . . . . 0.0 108.708 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -72.21 -42.64 65.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.0 m0 . . . . . 0 C--N 1.302 -1.476 0 O-C-N 120.983 -1.073 . . . . 0.0 109.391 179.672 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.441 ' O ' HG23 ' B' ' 217' ' ' VAL . 3.2 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' B' ' 202' ' ' GLN . 0.7 OUTLIER -98.19 166.84 11.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 110.334 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.34 146.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.427 -0.796 . . . . 0.0 109.781 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -97.89 141.06 31.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.87 109.12 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.463 ' HE2' HG21 ' B' ' 266' ' ' THR . 0.5 OUTLIER -95.17 133.31 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.599 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.6 p -94.78 -176.38 3.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 110.914 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.592 HD11 ' H ' ' B' ' 271' ' ' LEU . 25.7 mt -71.22 -12.8 61.67 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.489 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.932 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.7 p -101.79 -3.96 27.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.709 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.63 2.94 58.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -68.41 118.41 11.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.272 . . . . 0.0 109.021 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -101.01 135.86 41.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 40.9 mt -133.43 136.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.384 -0.823 . . . . 0.0 109.349 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.1 m -105.91 122.49 46.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.534 HD13 ' CB ' ' B' ' 229' ' ' LYS . 18.4 mt -126.11 121.7 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.391 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.54 132.24 47.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 201' ' ' MET . 8.2 m -140.2 -173.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.968 -1.082 . . . . 0.0 109.58 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -134.95 154.2 79.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.97 -20.62 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.545 2.163 . . . . 0.0 112.223 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 67.4 m -106.3 7.66 31.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 110.219 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 142.2 54.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.77 -1.206 . . . . 0.0 109.404 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.5 p -85.43 146.85 26.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.414 HD12 HD13 ' B' ' 250' ' ' LEU . 40.5 mm -51.7 -40.26 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.389 -0.82 . . . . 0.0 109.384 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.17 -35.67 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.568 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -69.13 -52.3 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.338 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 99.0 t -52.51 -45.58 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.377 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.06 -43.69 70.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.7 73.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.444 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.534 ' CB ' HD13 ' B' ' 215' ' ' LEU . 4.4 mtpm? -58.55 -54.53 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.495 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.3 mp -57.86 -34.18 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.848 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.1 -46.14 88.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.236 -0.915 . . . . 0.0 109.997 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -30.81 71.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.184 -0.947 . . . . 0.0 110.902 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -95.87 -50.67 4.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.008 -1.058 . . . . 0.0 110.556 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -87.39 -7.69 57.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.032 -1.043 . . . . 0.0 111.412 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.75 23.27 70.67 Favored Glycine 0 N--CA 1.493 2.446 0 O-C-N 120.535 -1.353 . . . . 0.0 110.305 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 45.9 mt -100.48 126.7 34.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.086 -1.244 . . . . 0.0 109.271 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.451 ' HG2' HE21 ' B' ' 240' ' ' GLN . 57.7 Cg_endo -75.15 152.78 40.48 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.064 1.843 . . . . 0.0 111.767 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.04 -30.1 47.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.668 2.245 . . . . 0.0 112.694 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.24 -16.1 41.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.521 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.451 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -127.08 -12.36 5.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.422 -0.798 . . . . 0.0 110.696 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.575 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -90.86 137.0 32.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.917 -1.115 . . . . 0.0 109.523 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.18 132.09 45.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.654 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.92 128.78 54.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 109.297 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.56 136.22 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.563 -0.711 . . . . 0.0 109.85 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 40.9 t80 -132.36 117.02 17.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.233 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.35 36.96 8.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.895 -1.128 . . . . 0.0 109.436 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.8 13.0 68.51 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.295 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -115.45 137.8 51.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.263 . . . . 0.0 109.524 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.56 126.17 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.013 . . . . 0.0 109.435 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.414 HD13 HD12 ' B' ' 223' ' ' ILE . 23.0 mt -70.69 139.78 51.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -92.6 142.2 27.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.192 -0.942 . . . . 0.0 109.486 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.5 m-20 -69.26 3.45 2.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 109.712 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.44 41.68 1.73 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.543 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -144.78 171.25 14.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 109.332 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 25.8 p -111.73 158.32 19.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.962 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.481 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.4 mt -54.88 -40.7 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 89.0 p -64.2 -28.35 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.547 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.61 -17.17 62.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.17 3.16 29.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 109.084 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 37.85 3.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 0.0 109.999 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.48 135.92 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -125.74 177.78 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 109.925 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.489 ' HE3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.53 157.13 3.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.021 0.915 . . . . 0.0 111.008 -178.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 57.87 12.43 1.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.671 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 22.0 m -75.9 148.3 38.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.729 ' C ' HD12 ' B' ' 267' ' ' LEU . 30.8 m -115.58 138.97 50.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.772 . . . . 0.0 110.048 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 266' ' ' THR . 11.2 mp -120.72 166.46 13.68 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -112.13 137.47 50.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.795 . . . . 0.0 109.426 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.575 HD11 ' HG3' ' B' ' 241' ' ' GLN . 18.6 tp -108.86 126.05 52.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.478 -0.763 . . . . 0.0 109.285 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.07 130.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.435 -0.791 . . . . 0.0 109.624 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.592 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.4 mt -80.79 143.22 33.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.092 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 108.85 -178.876 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.489 -0.189 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.84 164.79 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.642 2.228 . . . . 0.0 112.962 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.0 p -69.13 -2.47 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.768 -0.582 . . . . 0.0 110.509 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.847 ' O ' HG22 ' B' ' 209' ' ' THR . 32.2 m-20 -121.56 6.62 10.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.017 -1.052 . . . . 0.0 110.204 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -108.78 129.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.905 . . . . 0.0 111.275 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.8 t0 -100.49 138.33 20.13 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.7 -47.12 1.45 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.149 1.899 . . . . 0.0 112.009 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 7.1 tt0 -50.47 -43.04 55.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.889 -0.507 . . . . 0.0 110.1 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.629 HG11 ' O ' ' B' ' 207' ' ' THR . 62.1 t -80.55 -23.97 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.699 -1.251 . . . . 0.0 110.022 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -73.59 -52.79 12.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.093 -1.005 . . . . 0.0 110.655 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -62.56 -17.4 59.88 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.916 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -81.07 -6.37 58.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.9 -1.125 . . . . 0.0 109.779 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' B' ' 268' ' ' HIS . 95.6 mt -90.65 151.74 44.24 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.13 155.99 17.61 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.005 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -50.03 71.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.96 -43.28 50.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.92 -1.113 . . . . 0.0 110.352 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' B' ' 270' ' ' VAL . 89.7 t -75.13 -32.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.889 -1.132 . . . . 0.0 108.642 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.1 tt0 -59.26 -51.44 69.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -57.62 -49.06 77.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.562 -0.711 . . . . 0.0 110.352 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.79 -41.28 81.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.045 . . . . 0.0 110.861 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.7 mt -71.22 -36.33 71.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.7 -1.25 . . . . 0.0 109.632 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 mt -71.45 -37.85 71.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.71 -1.244 . . . . 0.0 108.854 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.22 72.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.101 -0.999 . . . . 0.0 109.435 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.3 tp10 -74.39 -37.02 63.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 108.888 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.1 m0 . . . . . 0 C--N 1.301 -1.536 0 O-C-N 120.882 -1.136 . . . . 0.0 108.612 178.809 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.45 165.63 12.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.437 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.0 pp -146.66 141.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' B' ' 266' ' ' THR . 8.6 m-85 -94.52 141.98 27.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.974 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.49 114.37 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.479 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.3 OUTLIER -99.0 138.92 35.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.629 ' O ' HG11 ' A' ' 72' ' ' VAL . 30.1 p -98.65 -175.5 3.09 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -0.936 . . . . 0.0 110.573 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.23 -15.91 62.98 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.188 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.847 HG22 ' O ' ' A' ' 67' ' ' ASP . 7.9 p -100.3 -3.07 32.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.132 -0.98 . . . . 0.0 109.655 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.1 3.61 57.83 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.353 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.8 117.61 9.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.289 . . . . 0.0 108.962 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 4.7 m -99.92 132.97 44.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 20.5 mt -127.95 136.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.46 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 67.6 m -105.95 119.95 40.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.8 mt -123.87 122.53 38.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 132.76 48.12 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.93 -174.04 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.93 -1.106 . . . . 0.0 109.77 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -135.93 154.51 77.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.89 . . . . 0.0 109.206 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.85 -29.03 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.69 2.26 . . . . 0.0 112.105 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 t -98.4 6.06 47.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.694 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.25 142.37 52.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.001 -1.062 . . . . 0.0 109.502 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.6 p -87.99 145.32 26.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.029 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.412 HD12 HD13 ' B' ' 250' ' ' LEU . 36.0 mm -51.5 -37.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.114 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -34.01 58.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -72.58 -50.48 25.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.193 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.9 -51.22 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 108.928 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -50.76 -42.31 57.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.336 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.0 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 0.0 109.735 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.511 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.8 mtpp -57.03 -54.01 51.62 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.008 -1.057 . . . . 0.0 109.19 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.431 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -60.08 -32.36 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -62.1 -47.14 85.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -72.66 -26.51 61.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.806 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -92.48 -48.38 6.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.815 -1.178 . . . . 0.0 110.504 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.22 -6.66 47.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 111.261 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.46 72.54 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 120.571 -1.331 . . . . 0.0 110.328 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.82 126.68 31.95 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.086 -1.243 . . . . 0.0 109.232 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.462 ' HG2' HE21 ' B' ' 240' ' ' GLN . 38.6 Cg_endo -72.04 156.61 55.77 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.813 1.676 . . . . 0.0 111.58 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.93 -29.9 22.35 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.617 2.211 . . . . 0.0 112.851 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.3 -14.5 60.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.431 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.462 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.87 -20.97 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.37 -0.831 . . . . 0.0 110.288 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.67 136.27 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.857 -1.152 . . . . 0.0 108.894 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -127.47 132.8 49.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.53 123.53 48.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.099 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 93.9 mt -118.19 135.75 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.7 t80 -131.92 115.89 16.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.852 . . . . 0.0 108.956 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.9 35.87 8.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.97 10.49 68.34 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.173 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -111.28 136.86 49.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.686 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.94 122.21 27.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 109.483 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.576 HD11 HD23 ' B' ' 267' ' ' LEU . 29.5 mt -68.39 146.6 53.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 109.25 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -101.24 143.86 30.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.74 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.589 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.2 OUTLIER -71.26 3.91 3.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.949 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.6 36.31 3.17 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 19.8 mtt85 -142.54 174.34 10.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.903 -1.351 . . . . 0.0 109.692 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 14.1 p -113.09 158.79 19.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 110.104 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.5 mt -56.9 -43.45 81.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.78 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 59.1 p -59.63 -27.17 66.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -19.21 61.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.637 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -103.84 3.89 34.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.329 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.54 38.31 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.0 109.792 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -93.02 135.98 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.003 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.67 176.76 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.111 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.588 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.44 155.4 2.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.885 0.85 . . . . 0.0 111.196 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 59.93 14.21 4.14 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.19 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.437 ' OG ' HG22 ' B' ' 203' ' ' ILE . 88.9 p -76.87 149.91 36.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.801 -1.187 . . . . 0.0 108.551 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.767 ' C ' HD12 ' B' ' 267' ' ' LEU . 3.1 m -114.57 135.68 53.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.737 . . . . 0.0 110.276 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.767 HD12 ' C ' ' B' ' 266' ' ' THR . 9.1 mp -122.98 140.11 53.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.504 -0.747 . . . . 0.0 109.253 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.408 ' HB3' HD21 ' A' ' 76' ' ' LEU . 66.1 m80 -88.5 141.55 28.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.144 -0.973 . . . . 0.0 110.203 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.05 126.96 53.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.452 -0.78 . . . . 0.0 108.951 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 2.5 t -114.75 128.99 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.884 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.77 143.57 32.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.032 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -178.761 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -48.46 163.96 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.229 1.953 . . . . 0.0 112.749 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.45 -1.78 5.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.862 ' O ' HG22 ' B' ' 209' ' ' THR . 8.5 m-20 -123.46 9.64 9.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.131 -0.981 . . . . 0.0 110.553 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 68' ' ' ILE . 25.7 mm -111.28 129.17 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.218 -0.926 . . . . 0.0 111.327 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.7 t0 -98.44 138.93 20.86 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.81 -44.89 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.286 1.99 . . . . 0.0 112.066 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 14.2 tt0 -47.67 -47.01 29.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.878 -0.514 . . . . 0.0 110.409 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG11 ' O ' ' B' ' 207' ' ' THR . 24.7 t -79.87 -39.88 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -52.57 -54.59 30.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.838 -1.164 . . . . 0.0 111.007 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -61.3 -18.49 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 110.016 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -82.76 -5.36 58.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.822 -1.174 . . . . 0.0 109.638 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD11 ' CD2' ' B' ' 208' ' ' LEU . 95.1 mt -89.38 152.06 47.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.032 -1.043 . . . . 0.0 109.527 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.4 154.19 25.15 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.326 2.018 . . . . 0.0 112.004 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -48.57 77.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.835 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.59 -42.82 62.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.977 -1.077 . . . . 0.0 110.168 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.08 -31.64 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.9 -1.125 . . . . 0.0 108.475 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.446 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.3 tt0 -60.18 -53.17 60.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -54.95 -49.31 71.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -57.38 -39.25 75.64 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.006 -1.059 . . . . 0.0 110.609 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.87 -37.34 64.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.644 -1.285 . . . . 0.0 109.917 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.406 HD23 ' HE3' ' A' ' 88' ' ' TRP . 28.0 mt -71.44 -38.33 71.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.761 -1.212 . . . . 0.0 108.889 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.94 -34.15 75.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 109.442 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -74.31 -33.55 63.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.406 ' HE3' HD23 ' A' ' 85' ' ' LEU . 42.9 m0 . . . . . 0 C--N 1.3 -1.557 0 O-C-N 120.898 -1.126 . . . . 0.0 107.995 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.73 163.68 12.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.356 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.42 142.56 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.527 -0.733 . . . . 0.0 109.346 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' B' ' 266' ' ' THR . 9.5 m-85 -94.06 142.46 27.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.62 113.91 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.19 -0.944 . . . . 0.0 109.701 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.552 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.5 135.14 43.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.077 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.501 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.0 p -93.38 -175.61 3.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.014 0.912 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.493 HD11 ' H ' ' B' ' 271' ' ' LEU . 43.2 mt -70.32 -19.8 63.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.6 p -96.56 -3.31 43.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.974 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.99 58.06 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.545 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -68.45 118.62 11.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.895 -1.356 . . . . 0.0 108.973 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.0 m -102.43 139.43 38.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.262 -0.899 . . . . 0.0 109.808 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.403 HG21 HD13 ' B' ' 213' ' ' ILE . 54.5 mt -137.94 137.67 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 0.0 109.339 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 36.1 m -105.45 122.55 46.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 108.741 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.545 HD13 ' CB ' ' B' ' 229' ' ' LYS . 19.4 mt -125.29 121.55 34.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 110.567 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -65.79 131.38 46.16 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.95 -173.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.013 -1.054 . . . . 0.0 109.902 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -134.36 156.04 79.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.0 108.923 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.09 -20.42 67.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.433 2.088 . . . . 0.0 111.899 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 4.3 m -103.54 6.94 37.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.837 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 144.78 48.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.996 -1.065 . . . . 0.0 109.544 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 80.4 p -86.43 148.83 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.3 -25.16 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.912 . . . . 0.0 108.92 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -35.43 77.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.801 . . . . 0.0 109.35 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.09 -51.09 34.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.62 -48.18 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 108.385 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -51.05 -44.9 61.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.05 76.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.337 -0.852 . . . . 0.0 109.583 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.545 ' CB ' HD13 ' B' ' 215' ' ' LEU . 4.2 mtpm? -56.96 -54.69 43.83 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.544 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.411 HG13 HD11 ' B' ' 215' ' ' LEU . 2.5 mp -59.95 -31.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.037 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.94 -48.46 78.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.72 -27.9 67.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -94.67 -52.57 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.929 -1.107 . . . . 0.0 110.374 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -87.93 -7.99 56.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.31 24.34 73.52 Favored Glycine 0 N--CA 1.494 2.503 0 O-C-N 120.44 -1.413 . . . . 0.0 110.458 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.5 mt -100.69 130.89 24.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.325 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.408 ' CG ' HE21 ' B' ' 240' ' ' GLN . 56.7 Cg_endo -74.53 152.83 43.75 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.077 1.852 . . . . 0.0 111.676 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.07 -32.74 16.74 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.573 2.182 . . . . 0.0 113.107 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.408 ' C ' ' OD1' ' B' ' 239' ' ' ASP . 15.1 p30 -64.06 -8.84 13.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.408 HE21 ' CG ' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.69 -21.66 3.39 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.451 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.473 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -85.49 136.82 33.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.71 -1.244 . . . . 0.0 108.776 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -128.04 133.2 49.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.32 -0.863 . . . . 0.0 109.685 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.407 ' CB ' HD12 ' B' ' 250' ' ' LEU . 11.5 mt -105.24 125.8 51.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.0 mt -116.93 156.0 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.1 t80 -151.81 116.57 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.271 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 59.96 43.02 15.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.843 -1.161 . . . . 0.0 109.507 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 23.82 67.19 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.2 ptmm? -121.59 136.91 54.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 0.0 109.479 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.85 123.81 31.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.265 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.426 HD11 HD23 ' B' ' 267' ' ' LEU . 25.7 mt -74.51 141.68 44.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.37 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.45 147.53 24.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.95 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -73.02 3.4 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.519 -0.738 . . . . 0.0 109.755 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.49 33.64 4.58 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -143.11 172.21 13.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.95 -1.323 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 82.2 p -111.51 159.61 17.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 110.075 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.498 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.0 mt -55.51 -40.98 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.468 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.7 p -63.28 -28.21 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.102 -0.999 . . . . 0.0 109.535 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -18.75 62.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.982 . . . . 0.0 109.53 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -103.06 4.09 36.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.097 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 69.81 40.91 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.687 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 52.0 mt -98.52 136.81 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 -178.87 4.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 108.96 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.533 ' HD3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.41 163.31 0.63 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.37 1.081 . . . . 0.0 111.525 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 55.71 11.32 0.64 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.145 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 147.12 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.82 -1.175 . . . . 0.0 108.924 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.838 ' C ' HD12 ' B' ' 267' ' ' LEU . 5.7 m -113.89 138.39 50.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.597 -0.689 . . . . 0.0 110.083 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.838 HD12 ' C ' ' B' ' 266' ' ' THR . 10.2 mp -127.17 144.27 51.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.34 -0.85 . . . . 0.0 110.18 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.43 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 62.1 m80 -91.9 142.45 27.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.188 -0.945 . . . . 0.0 110.382 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.473 HD11 ' HG3' ' B' ' 241' ' ' GLN . 14.0 tp -109.35 127.02 54.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.365 -0.835 . . . . 0.0 108.924 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.75 131.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.383 -0.823 . . . . 0.0 109.729 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.493 ' H ' HD11 ' B' ' 208' ' ' LEU . 39.4 mt -81.76 143.87 31.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 108.706 -179.24 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.552 0.215 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.77 165.06 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.641 2.227 . . . . 0.0 113.176 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -2.75 10.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 110.691 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.839 ' O ' HG22 ' B' ' 209' ' ' THR . 45.4 m-20 -120.85 5.61 10.45 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.031 -1.043 . . . . 0.0 109.894 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.7 mm -109.62 130.44 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 111.001 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.85 134.57 20.4 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.01 -45.55 5.82 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.965 1.777 . . . . 0.0 112.024 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -50.23 -44.71 53.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.849 -0.532 . . . . 0.0 110.485 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.62 HG11 ' O ' ' B' ' 207' ' ' THR . 38.8 t -80.2 -26.44 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.834 -1.166 . . . . 0.0 110.147 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.0 t80 -68.99 -51.67 36.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.536 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -62.59 -17.48 60.22 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.803 -179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.94 -6.74 59.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.865 -1.147 . . . . 0.0 109.641 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 76' ' ' LEU . 97.0 mt -89.15 151.75 47.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.144 -0.972 . . . . 0.0 109.753 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.38 155.64 19.81 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.41 2.074 . . . . 0.0 111.91 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.39 -50.81 68.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 110.679 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.22 -42.99 52.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.297 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.16 -30.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 108.423 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.0 tt0 -60.6 -51.59 68.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -56.9 -47.83 79.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.525 -0.735 . . . . 0.0 110.202 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.24 -40.31 85.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.044 -1.035 . . . . 0.0 110.775 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.0 mt -72.31 -35.7 68.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.796 -1.19 . . . . 0.0 109.561 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.44 -37.49 71.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 108.853 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.77 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.025 -1.047 . . . . 0.0 109.197 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -72.71 -37.89 67.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.401 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 42.5 m0 . . . . . 0 C--N 1.302 -1.487 0 O-C-N 120.95 -1.094 . . . . 0.0 108.77 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.12 165.59 12.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.86 151.97 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.392 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' B' ' 264' ' ' GLU . 8.8 m-85 -104.29 142.61 34.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.878 . . . . 0.0 109.782 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.38 114.02 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.528 ' HE3' HG22 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -101.31 130.46 47.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 108.818 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.62 ' O ' HG11 ' A' ' 72' ' ' VAL . 38.1 p -89.11 -175.53 4.84 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.999 0.904 . . . . 0.0 111.019 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.517 HD11 ' H ' ' B' ' 271' ' ' LEU . 25.1 mt -71.41 -11.33 60.83 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.585 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.9 p -103.48 -2.88 26.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.836 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.35 60.51 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.243 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -67.77 117.84 10.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.265 . . . . 0.0 108.845 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -99.96 139.33 35.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.176 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.549 HD11 ' CD ' ' B' ' 234' ' ' GLU . 29.1 mt -135.54 137.81 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.2 m -105.14 122.59 46.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 108.837 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' B' ' 229' ' ' LYS . 21.5 mt -127.01 119.29 26.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.945 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.71 132.36 49.44 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.3 -175.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.947 -1.095 . . . . 0.0 109.764 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.36 154.43 78.59 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 108.978 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.39 -24.74 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.62 2.214 . . . . 0.0 112.005 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 6.54 42.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.24 142.88 52.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.505 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.452 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 11.9 p -85.66 145.7 27.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.34 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 34.8 mm -51.81 -35.76 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.251 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' B' ' 225' ' ' ASN . 5.8 pt-20 -61.38 -36.21 79.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.452 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 63.4 m-20 -68.16 -52.45 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.25 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.84 -48.29 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.919 -1.113 . . . . 0.0 108.045 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.99 -43.65 60.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.709 -0.619 . . . . 0.0 109.492 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 109.27 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.511 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.7 mtpp -57.48 -53.98 52.05 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.085 -1.009 . . . . 0.0 109.433 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.22 -33.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.122 -0.986 . . . . 0.0 109.083 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.78 -48.46 79.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.212 -0.93 . . . . 0.0 110.031 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.76 -25.43 66.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.635 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -98.95 -57.62 2.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.043 . . . . 0.0 110.522 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.549 ' CD ' HD11 ' B' ' 213' ' ' ILE . 34.9 mm-40 -81.43 -8.48 59.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.25 -0.906 . . . . 0.0 111.187 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.77 22.24 73.55 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 120.502 -1.374 . . . . 0.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.422 HD13 HD21 ' B' ' 271' ' ' LEU . 64.7 mt -101.73 131.13 23.24 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.977 -1.307 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.459 ' HG2' HE21 ' B' ' 240' ' ' GLN . 58.6 Cg_endo -75.2 153.65 41.01 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.029 1.819 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.43 -30.86 43.6 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.558 2.172 . . . . 0.0 112.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.27 -16.62 63.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.638 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.459 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.78 -18.22 7.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.25 137.57 32.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.75 -1.219 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -129.0 134.12 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.403 ' HB3' HD12 ' B' ' 250' ' ' LEU . 11.9 mt -105.71 124.8 50.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 78.4 mt -118.33 135.46 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.71 -0.619 . . . . 0.0 109.533 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.539 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 41.2 t80 -129.91 113.49 14.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.47 -0.769 . . . . 0.0 109.004 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.34 38.7 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.65 7.78 55.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.441 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.6 OUTLIER -105.75 135.84 46.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.242 . . . . 0.0 109.489 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -83.61 119.76 25.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 0.0 109.338 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' B' ' 243' ' ' LEU . 39.2 mt -67.6 140.47 56.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 2.0 tm-20 -92.5 143.1 26.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -71.54 3.5 3.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 109.636 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 251' ' ' GLU . . . -121.35 39.66 2.32 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -146.21 173.7 11.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.968 -1.313 . . . . 0.0 109.383 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 5.7 p -112.32 161.56 16.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 109.864 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.509 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.1 mt -58.54 -41.16 84.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.787 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 93.7 p -62.24 -29.04 70.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.742 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.57 -19.98 62.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -101.93 3.97 39.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.267 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.6 38.18 3.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 32.7 mt -93.27 136.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -125.19 176.74 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.539 -0.726 . . . . 0.0 109.757 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.78 159.58 1.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.935 0.874 . . . . 0.0 110.719 -179.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' CE2' ' B' ' 204' ' ' PHE . 2.7 mm-40 55.76 27.55 10.94 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.162 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.17 149.09 21.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.164 . . . . 0.0 108.525 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 9.5 m -112.65 136.36 52.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 110.268 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.56 139.47 53.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.129 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -87.79 141.51 28.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.9 tp -108.86 126.62 53.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.53 129.21 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.639 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.517 ' H ' HD11 ' B' ' 208' ' ' LEU . 48.5 mt -81.31 143.89 31.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.0 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.91 . . . . 0.0 109.061 -179.222 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.37 164.12 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.451 2.1 . . . . 0.0 113.172 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -68.6 -2.09 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.761 -0.587 . . . . 0.0 110.468 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.891 ' O ' HG22 ' B' ' 209' ' ' THR . 0.7 OUTLIER -122.12 8.41 9.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.074 -1.016 . . . . 0.0 110.436 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HA ' HD13 ' A' ' 68' ' ' ILE . 25.6 mm -108.71 126.5 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.924 . . . . 0.0 111.295 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 5.3 t0 -98.25 113.38 63.94 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -46.49 -47.24 15.85 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.161 1.907 . . . . 0.0 112.271 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -48.53 -45.18 37.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.469 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG11 ' O ' ' B' ' 207' ' ' THR . 40.6 t -80.47 -24.25 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.646 -1.284 . . . . 0.0 110.423 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.2 t80 -69.68 -52.6 24.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.77 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -62.52 -17.07 58.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.925 . . . . 0.0 110.021 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -81.66 -6.36 58.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.787 -1.196 . . . . 0.0 109.95 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.61 152.64 43.59 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 109.63 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.09 155.22 19.68 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.534 2.156 . . . . 0.0 112.135 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -50.25 70.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.12 -43.2 51.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.889 -1.132 . . . . 0.0 110.387 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.35 -30.99 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.982 -1.074 . . . . 0.0 108.324 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.2 tt0 -59.96 -51.45 69.64 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -57.56 -48.06 80.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.613 -0.679 . . . . 0.0 110.244 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.15 -39.81 79.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.696 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.75 -36.81 67.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.714 -1.241 . . . . 0.0 109.745 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.93 -37.77 69.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.785 -1.197 . . . . 0.0 108.789 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.76 -34.23 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 109.515 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.92 -33.69 59.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 108.644 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 50.4 m0 . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.261 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.39 163.9 13.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.917 . . . . 0.0 109.999 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.533 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.87 142.3 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.221 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -94.48 142.82 26.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.092 -1.005 . . . . 0.0 109.691 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.48 114.7 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' B' ' 268' ' ' HIS . 14.0 ptmt -101.42 132.98 46.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.898 . . . . 0.0 109.159 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.67 ' O ' HG11 ' A' ' 72' ' ' VAL . 18.6 p -91.01 -175.62 4.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.32 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.469 HD11 ' H ' ' B' ' 271' ' ' LEU . 74.8 mt -70.69 -15.54 62.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -101.93 -1.68 31.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.688 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.77 4.8 58.91 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.392 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -68.3 117.75 10.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.323 . . . . 0.0 108.807 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.9 m -99.74 140.41 33.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.421 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 22.2 mt -137.56 137.86 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 22.7 m -104.26 124.35 49.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' B' ' 229' ' ' LYS . 23.5 mt -129.2 119.3 23.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.87 . . . . 0.0 110.06 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.88 133.94 51.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.65 -0.656 . . . . 0.0 109.439 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.26 -173.38 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 0.0 109.616 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' B' ' 221' ' ' ASP . 20.1 mt-10 -135.81 153.38 77.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 108.862 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.68 -21.47 25.22 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.569 2.18 . . . . 0.0 112.03 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.0 7.58 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.955 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' B' ' 218' ' ' GLU . 0.9 OUTLIER -70.29 142.34 52.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.901 -1.125 . . . . 0.0 109.507 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.6 p -86.55 145.8 26.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.188 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.432 HD12 HD13 ' B' ' 250' ' ' LEU . 39.2 mm -50.97 -43.17 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.418 ' CD ' ' OD1' ' B' ' 225' ' ' ASN . 0.2 OUTLIER -52.62 -34.76 52.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.475 -0.766 . . . . 0.0 109.699 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.418 ' OD1' ' CD ' ' B' ' 224' ' ' GLU . 63.5 m-20 -71.22 -52.21 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.23 -45.47 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.037 -1.04 . . . . 0.0 108.529 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -43.12 70.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.98 78.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.413 -0.804 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.558 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.1 mtpp -57.78 -53.75 54.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.084 -1.01 . . . . 0.0 109.363 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.564 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.7 mp -57.22 -35.61 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.007 -1.058 . . . . 0.0 109.246 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . 0.424 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 2.9 tt0 -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.895 -1.128 . . . . 0.0 109.967 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.98 -29.2 70.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.843 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -95.51 -52.28 4.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.381 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -87.76 -6.58 58.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.31 24.02 71.93 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.45 -1.406 . . . . 0.0 110.289 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 44.6 mt -103.03 128.79 26.92 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.25 . . . . 0.0 109.774 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.436 ' HG2' HE21 ' B' ' 240' ' ' GLN . 68.9 Cg_endo -77.57 155.95 31.85 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.159 1.906 . . . . 0.0 111.828 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . 0.424 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 37.6 Cg_endo -67.77 -30.62 33.69 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.944 2.429 . . . . 0.0 112.939 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -61.95 -13.3 23.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.436 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.77 -17.2 4.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -0.77 . . . . 0.0 110.746 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.23 137.04 32.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.701 -1.25 . . . . 0.0 109.417 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -129.54 130.78 46.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 109.567 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.74 125.13 50.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 109.32 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 39.9 mt -118.78 136.22 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.672 -0.642 . . . . 0.0 109.428 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -131.06 119.23 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.758 . . . . 0.0 109.459 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.0 47.29 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.923 -1.111 . . . . 0.0 109.464 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.53 26.28 64.29 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.7 OUTLIER -123.91 135.3 53.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.315 -1.109 . . . . 0.0 109.622 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -84.09 122.11 28.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 109.258 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.432 HD13 HD12 ' B' ' 223' ' ' ILE . 38.1 mt -72.38 144.02 48.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -96.89 143.5 27.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 3.68 3.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.442 -0.786 . . . . 0.0 109.843 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.11 44.74 1.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.49 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -148.26 174.1 12.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.141 -1.211 . . . . 0.0 109.079 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.7 p -111.91 160.15 17.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.354 -0.841 . . . . 0.0 110.185 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.493 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.6 mt -60.21 -40.72 91.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.842 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.4 p -61.68 -28.77 69.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.957 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.58 -15.86 62.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -104.28 2.38 31.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 108.933 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.07 38.54 3.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.89 137.45 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.102 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -126.7 179.49 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 108.987 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 163.73 0.51 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.45 1.119 . . . . 0.0 111.492 -178.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 55.54 12.04 0.72 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.093 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.533 ' OG ' HG22 ' B' ' 203' ' ' ILE . 89.2 p -76.09 148.31 38.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 108.714 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.75 ' C ' HD12 ' B' ' 267' ' ' LEU . 17.7 m -114.19 136.8 52.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.459 -0.776 . . . . 0.0 110.268 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.75 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -123.74 139.43 53.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.533 -0.73 . . . . 0.0 109.361 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 60.9 m80 -88.77 142.13 27.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 110.287 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.58 125.61 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.39 130.05 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.746 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.469 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.7 mt -80.76 143.34 32.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.082 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 108.694 -179.199 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.61 165.2 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.055 1.837 . . . . 0.0 112.22 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 t -66.01 -12.53 55.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.701 -0.624 . . . . 0.0 110.88 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.884 ' O ' HG22 ' B' ' 209' ' ' THR . 1.6 m-20 -112.49 8.65 19.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.479 HG21 ' CH2' ' A' ' 88' ' ' TRP . 30.4 mm -111.41 129.71 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.111 -0.993 . . . . 0.0 110.707 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.4 t70 -97.96 139.13 21.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.27 -36.58 3.99 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.228 1.952 . . . . 0.0 112.537 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 8.5 tp60 -59.13 -44.5 92.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.536 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.704 HG11 ' O ' ' B' ' 207' ' ' THR . 61.6 t -79.02 -23.9 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.809 -1.182 . . . . 0.0 110.047 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 19.8 t80 -66.4 -52.38 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.087 -1.008 . . . . 0.0 110.729 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -63.41 -16.31 60.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.52 -6.87 59.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 109.767 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.473 HD11 ' CD2' ' B' ' 208' ' ' LEU . 91.5 mt -90.18 152.26 45.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.13 154.86 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.409 2.073 . . . . 0.0 112.03 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.1 -50.47 70.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.4 -44.37 34.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.936 -1.103 . . . . 0.0 110.013 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' B' ' 270' ' ' VAL . 57.4 t -74.61 -31.82 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.911 -1.118 . . . . 0.0 108.603 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.3 tt0 -59.57 -50.06 75.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -57.85 -48.56 79.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.804 . . . . 0.0 109.944 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.18 -35.12 71.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.95 . . . . 0.0 110.113 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.66 -41.74 37.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.962 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.78 -38.23 88.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.647 -1.283 . . . . 0.0 108.671 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.74 82.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 108.981 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -67.13 -33.19 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 108.639 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.479 ' CH2' HG21 ' A' ' 68' ' ' ILE . 48.0 m0 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 217' ' ' VAL . 6.9 ptt? . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.51 166.92 10.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 110.387 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.43 142.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 0.0 109.376 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -95.14 146.96 23.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.571 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.47 110.93 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.202 -0.937 . . . . 0.0 110.161 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.855 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.0 OUTLIER -96.99 138.7 34.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.704 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.8 p -102.7 -173.03 2.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 111.3 -178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.473 ' CD2' HD11 ' A' ' 76' ' ' LEU . 21.4 mt -70.81 -17.86 62.75 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.298 0.57 . . . . 0.0 109.597 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -96.84 -5.15 38.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 109.299 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.64 60.63 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -69.67 119.44 13.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 0.0 108.948 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 47.7 m -101.04 133.15 45.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 109.335 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.0 mt -128.2 136.87 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . 0.416 ' O ' HD23 ' B' ' 215' ' ' LEU . 58.5 m -105.34 124.34 49.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.381 -0.824 . . . . 0.0 109.029 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.7 mt -129.8 120.01 24.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.842 . . . . 0.0 110.234 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.78 132.65 48.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.709 . . . . 0.0 109.17 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 201' ' ' MET . 15.5 m -138.97 -175.7 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.014 -1.054 . . . . 0.0 109.972 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -132.49 154.89 81.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.532 -0.73 . . . . 0.0 109.074 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.02 -19.35 47.94 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.505 2.137 . . . . 0.0 112.123 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.19 8.2 31.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.22 143.17 48.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.939 -1.101 . . . . 0.0 109.784 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 13.6 p -85.7 148.53 25.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.799 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.0 mm -52.2 -39.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.79 67.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.775 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -70.06 -53.3 18.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 0.0 109.302 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.52 -44.15 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.179 -0.951 . . . . 0.0 108.638 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -57.56 -38.71 75.25 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.75 -36.87 84.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.537 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.3 mtpp -57.59 -53.31 59.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.564 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.8 mp -59.24 -34.57 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 109.131 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -61.67 -43.47 98.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -28.78 63.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.977 -1.077 . . . . 0.0 110.721 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -92.99 -49.86 5.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 110.489 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -91.39 -6.86 52.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.195 -0.941 . . . . 0.0 111.357 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.97 74.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.104 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 61.2 mt -102.06 123.19 44.38 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.046 -1.267 . . . . 0.0 109.135 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.43 ' HG2' HE21 ' B' ' 240' ' ' GLN . 55.5 Cg_endo -74.71 152.13 41.94 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.83 1.687 . . . . 0.0 111.802 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.99 -29.47 75.63 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.597 2.198 . . . . 0.0 112.802 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 49.9 p-10 -64.15 -13.74 50.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.085 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.0 OUTLIER -126.89 -20.79 4.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.464 -0.772 . . . . 0.0 109.945 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.588 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -85.91 133.39 33.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 109.043 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -126.98 132.42 50.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.88 123.38 47.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.372 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.4 132.82 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.53 123.73 34.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 54.13 41.63 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.786 -1.197 . . . . 0.0 109.312 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 67.68 3.97 30.19 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 135.4 42.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.82 125.63 33.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.154 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.8 mt -74.89 139.67 43.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 109.794 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.07 146.95 23.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.12 3.82 4.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.122 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.62 46.32 1.11 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.685 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -151.38 172.46 15.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -1.23 . . . . 0.0 109.485 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 63.9 p -111.57 160.89 16.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 110.106 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.496 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.0 mt -60.63 -43.68 97.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.232 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 56.9 p -59.35 -28.35 66.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.38 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.23 -13.1 61.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 109.065 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.613 ' C ' HD22 ' B' ' 260' ' ' ASN . 33.2 m-85 -107.35 5.32 27.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -0.829 . . . . 0.0 109.116 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . 0.613 HD22 ' C ' ' B' ' 259' ' ' TYR . 1.0 OUTLIER 63.03 39.31 10.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 -179.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 57.9 mt -92.74 136.36 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 108.987 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -125.54 175.71 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.765 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.91 160.65 0.67 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.776 0.798 . . . . 0.0 110.71 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 56.77 13.97 1.63 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.291 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 55.2 m -75.84 146.1 40.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.752 -1.217 . . . . 0.0 108.607 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.855 HG21 ' NZ ' ' B' ' 206' ' ' LYS . 5.5 m -112.31 138.01 49.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 0.0 110.018 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.786 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -124.7 138.79 54.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -86.86 140.73 29.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' B' ' 241' ' ' GLN . 18.9 tp -110.31 127.71 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.452 -0.78 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 14.9 t -114.62 129.39 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' B' ' 271' ' ' LEU . 47.3 mt -82.27 143.97 30.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.168 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.3 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.9 164.58 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.224 1.949 . . . . 0.0 113.05 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 -2.07 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.568 . . . . 0.0 110.517 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.872 ' O ' HG22 ' B' ' 209' ' ' THR . 1.8 m-20 -123.05 10.57 9.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.148 -0.97 . . . . 0.0 110.373 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.7 mm -113.21 129.85 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.244 -0.91 . . . . 0.0 111.361 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.6 t70 -99.33 140.24 21.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.07 -37.51 3.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.41 2.073 . . . . 0.0 112.723 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.7 tt0 -61.26 -41.01 96.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.861 . . . . 0.0 110.184 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.69 HG11 ' O ' ' B' ' 207' ' ' THR . 25.4 t -80.98 -24.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.0 110.036 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 27.2 t80 -72.6 -53.58 11.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.993 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -61.29 -15.81 39.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.47 -5.23 59.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.911 -1.118 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.6 151.66 48.29 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 109.819 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.12 152.73 29.28 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.006 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.03 -50.39 70.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.777 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.15 -43.28 51.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.987 -1.071 . . . . 0.0 109.96 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 63.7 t -74.76 -32.12 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.009 -1.057 . . . . 0.0 108.348 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.8 tt0 -60.41 -51.74 68.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -55.15 -49.16 72.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.715 . . . . 0.0 109.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -58.45 -36.85 74.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 0.0 110.49 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.74 -39.9 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.749 -1.22 . . . . 0.0 109.831 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.41 -37.86 74.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 108.986 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.1 79.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 108.973 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.84 -36.78 75.84 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.5 m0 . . . . . 0 C--N 1.301 -1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.758 179.059 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.14 165.13 12.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 0.0 110.67 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.95 143.07 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.557 -0.714 . . . . 0.0 109.269 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -95.13 142.48 27.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.56 112.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.548 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.25 131.8 47.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 108.948 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.69 ' O ' HG11 ' A' ' 72' ' ' VAL . 32.8 p -91.55 -173.75 3.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 110.968 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.5 mt -70.58 -16.21 62.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.229 0.538 . . . . 0.0 109.954 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.872 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.7 p -99.39 -2.64 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.957 . . . . 0.0 109.614 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.16 1.38 61.14 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.217 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -64.42 116.9 6.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.332 . . . . 0.0 108.675 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.1 m -99.42 136.63 39.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.98 137.04 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.8 m -105.98 118.91 37.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 108.81 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' B' ' 229' ' ' LYS . 20.7 mt -124.6 122.18 36.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.388 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -68.29 133.56 48.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.429 HG11 HG22 ' B' ' 226' ' ' VAL . 11.0 m -139.73 -174.24 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.822 -1.173 . . . . 0.0 110.004 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.15 154.56 81.7 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 0.0 109.053 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.81 -21.79 58.7 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.573 2.182 . . . . 0.0 112.013 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 28.0 p -103.31 8.17 38.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.653 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -71.73 142.03 49.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.017 . . . . 0.0 109.497 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.9 p -85.93 145.63 27.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.479 HD12 HD13 ' B' ' 250' ' ' LEU . 36.5 mm -51.62 -21.54 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -37.07 70.06 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.998 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.11 -52.52 34.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.429 HG22 HG11 ' B' ' 217' ' ' VAL . 47.9 t -52.24 -46.32 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 108.548 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -43.12 72.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.292 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.13 72.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 109.561 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.525 ' CB ' HD13 ' B' ' 215' ' ' LEU . 22.3 mtpp -60.29 -53.29 59.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.023 -1.048 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.472 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.4 mp -59.71 -32.01 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.106 -0.996 . . . . 0.0 108.928 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -63.51 -44.76 93.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.37 -23.54 61.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.444 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -97.66 -51.39 4.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 110.672 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -89.4 -7.97 54.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.03 24.34 76.56 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.497 -1.377 . . . . 0.0 110.577 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 34.0 mt -106.65 131.76 21.45 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.059 -1.259 . . . . 0.0 109.594 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.454 ' HG2' HE21 ' B' ' 240' ' ' GLN . 37.9 Cg_endo -71.15 162.26 43.16 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.204 1.936 . . . . 0.0 112.678 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.94 -34.05 7.0 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.155 2.57 . . . . 0.0 113.131 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.62 -5.98 33.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.28 -0.888 . . . . 0.0 111.152 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.454 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -124.22 -26.18 4.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.252 -0.905 . . . . 0.0 111.356 -179.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' B' ' 269' ' ' LEU . 2.0 pt20 -88.61 127.74 35.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.283 -1.511 . . . . 0.0 109.23 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.42 ' HE ' ' HD2' ' B' ' 272' ' ' ARG . 93.6 mtt180 -111.96 134.93 53.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.35 126.02 51.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 108.91 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.28 134.92 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.567 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.551 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 47.5 t80 -128.11 110.52 12.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.181 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 67.34 39.4 2.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.328 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.5 2.94 45.85 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.886 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -100.86 137.34 39.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.299 . . . . 0.0 109.689 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.23 122.33 28.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.963 -1.086 . . . . 0.0 109.292 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.479 HD13 HD12 ' B' ' 223' ' ' ILE . 41.8 mt -71.95 145.74 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 109.315 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -100.59 144.93 28.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.1 3.69 4.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.413 -0.804 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.58 43.79 1.41 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -150.06 172.08 15.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.145 -1.209 . . . . 0.0 109.325 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.4 p -110.9 159.41 17.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.472 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.8 mt -56.61 -42.16 78.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.692 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.1 p -61.21 -27.96 68.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.005 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -20.15 63.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -102.78 3.85 37.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.166 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.44 39.34 2.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.582 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.8 mt -92.94 135.53 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.308 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -124.02 176.56 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.12 159.69 1.19 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.978 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.04 28.49 12.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.097 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 12.5 p -91.28 149.65 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.588 -1.32 . . . . 0.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 4.3 m -111.4 135.39 52.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.533 -0.729 . . . . 0.0 109.966 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 10.7 mp -124.29 140.21 53.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.539 -0.726 . . . . 0.0 109.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -88.77 142.01 28.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' B' ' 241' ' ' GLN . 13.5 tp -110.74 129.59 55.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.433 -0.792 . . . . 0.0 109.249 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.06 133.09 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.408 -0.808 . . . . 0.0 109.891 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' B' ' 271' ' ' LEU . 47.2 mt -80.68 143.19 33.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.42 ' HD2' ' HE ' ' B' ' 242' ' ' ARG . 27.4 ttt180 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 108.733 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.13 164.65 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.34 2.027 . . . . 0.0 112.956 178.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.8 t -67.13 -2.45 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.908 ' O ' HG22 ' B' ' 209' ' ' THR . 7.6 m-20 -123.18 9.39 9.23 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.72 128.78 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.14 -0.975 . . . . 0.0 110.951 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.37 139.3 21.36 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.21 -36.42 4.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.404 2.069 . . . . 0.0 112.97 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.82 -40.74 97.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.511 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.724 HG11 ' O ' ' B' ' 207' ' ' THR . 21.8 t -80.1 -23.67 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.68 -1.263 . . . . 0.0 109.559 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.2 t80 -71.7 -54.0 11.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.718 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -61.1 -18.19 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.06 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -82.39 -4.88 58.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.142 . . . . 0.0 109.343 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.6 mt -89.99 151.96 45.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.842 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.98 153.34 32.27 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.318 2.012 . . . . 0.0 111.985 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.13 -49.53 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.698 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.64 -44.38 57.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 -178.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.79 -31.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 108.377 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -61.58 -49.1 77.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -58.8 -48.55 80.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.623 -0.673 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.9 -40.27 75.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 110.051 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.58 -38.1 67.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.882 -1.136 . . . . 0.0 109.741 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.61 -39.18 73.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.713 -1.242 . . . . 0.0 108.996 178.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.135 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -73.14 -35.52 66.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.835 . . . . 0.0 108.944 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 44.1 m0 . . . . . 0 C--N 1.302 -1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.846 179.102 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.4 ptt? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.42 166.37 10.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.748 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.65 142.92 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.589 -0.694 . . . . 0.0 109.33 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -95.74 143.6 26.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 31.8 t -123.85 109.05 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -0.879 . . . . 0.0 109.808 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.1 OUTLIER -93.09 135.45 34.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 108.57 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.724 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.5 p -96.26 -174.9 3.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.243 -0.91 . . . . 0.0 110.867 -178.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.573 HD11 ' H ' ' B' ' 271' ' ' LEU . 27.5 mt -72.17 -13.86 61.66 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.908 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.8 p -99.56 -4.11 31.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.451 -0.781 . . . . 0.0 109.558 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.08 1.12 61.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -67.03 119.05 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -1.148 . . . . 0.0 109.118 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.7 m -100.09 135.78 41.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.043 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 43.7 mt -131.25 135.18 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.571 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 33.4 m -104.55 120.28 40.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.416 -0.802 . . . . 0.0 108.886 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' B' ' 229' ' ' LYS . 26.1 mt -123.85 119.59 30.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.772 . . . . 0.0 110.017 -179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -66.83 131.16 45.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.43 -175.57 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 110.065 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.48 154.4 81.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.044 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -58.79 -20.16 50.3 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.599 2.199 . . . . 0.0 112.386 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.4 t -105.24 9.3 34.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.9 142.99 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.98 -1.075 . . . . 0.0 109.433 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 69.6 p -86.46 147.62 25.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 110.144 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mm -51.64 -33.8 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -33.95 73.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -71.44 -51.32 24.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 108.954 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.6 -50.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -50.41 -38.12 41.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.484 0.659 . . . . 0.0 109.265 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.72 84.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.585 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.4 mtpp -57.9 -53.15 61.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.2 -0.938 . . . . 0.0 109.223 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.43 -35.23 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.062 -1.024 . . . . 0.0 108.566 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.53 -45.94 90.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 109.743 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -24.12 64.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -100.26 -54.52 2.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.051 -1.031 . . . . 0.0 110.465 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -85.89 -5.83 59.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 111.243 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.28 27.01 70.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.594 -1.317 . . . . 0.0 110.321 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.99 128.56 26.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -1.205 . . . . 0.0 109.283 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.449 ' HG2' HE21 ' B' ' 240' ' ' GLN . 47.6 Cg_endo -73.77 157.01 48.37 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.892 1.728 . . . . 0.0 111.932 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.54 -30.84 22.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.683 2.256 . . . . 0.0 112.385 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.4 -9.13 22.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.399 -0.813 . . . . 0.0 110.248 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.449 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.9 -20.33 3.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 110.431 -179.669 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.39 133.88 34.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.848 -1.158 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.46 134.95 50.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 109.457 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.38 126.95 52.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 109.638 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.03 133.43 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 41.6 t80 -128.49 114.54 16.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.124 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 63.06 46.6 4.62 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.781 -1.199 . . . . 0.0 109.075 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.97 6.4 6.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.46 ' NZ ' ' CB ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -103.22 137.55 41.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -1.143 . . . . 0.0 109.537 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -85.81 128.58 34.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.493 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 28.8 mt -80.25 140.38 36.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' B' ' 253' ' ' GLY . 11.3 tp10 -90.87 142.62 27.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.588 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.0 OUTLIER -68.75 3.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.474 -0.766 . . . . 0.0 109.791 179.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -127.85 40.94 1.66 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.661 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.51 168.38 19.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.279 . . . . 0.0 108.977 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 21.0 p -106.59 157.45 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.529 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.1 mt -58.46 -42.36 87.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.012 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 40.2 p -61.73 -29.04 69.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.54 -16.93 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.131 -0.981 . . . . 0.0 109.277 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -104.56 2.91 31.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.092 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.55 38.93 2.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.408 -0.807 . . . . 0.0 109.773 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 37.7 mt -91.62 136.41 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.308 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . 0.469 ' O ' ' OG ' ' B' ' 265' ' ' SER . 10.4 mt-30 -122.9 172.78 8.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.89 162.61 0.42 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.963 0.887 . . . . 0.0 110.844 -178.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 54.46 11.08 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.81 177.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 39.0 m -72.08 144.82 48.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.893 -1.129 . . . . 0.0 108.631 178.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.736 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.8 m -111.16 137.08 49.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 110.296 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.736 HD12 ' C ' ' B' ' 266' ' ' THR . 11.3 mp -120.9 162.85 19.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 79.4 m80 -108.22 137.44 46.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.318 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.0 tp -106.87 123.07 47.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.009 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.6 127.11 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.454 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.573 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.5 mt -81.46 142.95 32.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.224 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 24.5 ttt180 . . . . . 0 C--N 1.302 -1.496 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.245 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.02 164.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.257 1.971 . . . . 0.0 112.804 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 t -67.85 -2.68 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.67 -0.644 . . . . 0.0 110.508 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.904 ' O ' HG22 ' B' ' 209' ' ' THR . 9.3 m-20 -121.37 6.58 10.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.001 . . . . 0.0 110.296 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.66 128.21 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.834 -179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.6 t70 -99.56 140.04 21.31 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.73 -48.73 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.425 2.084 . . . . 0.0 112.196 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.1 tt0 -48.2 -44.19 32.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.698 -0.626 . . . . 0.0 110.228 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG11 ' O ' ' B' ' 207' ' ' THR . 58.1 t -80.27 -23.5 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.006 -1.059 . . . . 0.0 110.439 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 25.4 t80 -72.11 -53.01 14.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 110.918 -178.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -62.71 -17.36 60.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.24 -7.32 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.863 -1.148 . . . . 0.0 109.749 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.84 152.39 46.57 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.41 154.58 29.1 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.455 2.103 . . . . 0.0 111.922 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -62.99 -49.03 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -44.75 54.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.951 -1.093 . . . . 0.0 110.24 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -74.73 -29.94 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.023 -1.048 . . . . 0.0 108.426 178.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.5 tt0 -61.53 -51.65 67.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -56.88 -49.29 75.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -56.69 -37.62 71.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.107 -0.995 . . . . 0.0 110.451 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.2 mt -74.8 -36.98 62.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.865 -1.147 . . . . 0.0 109.886 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -71.01 -39.77 72.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.844 -1.16 . . . . 0.0 109.049 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.71 75.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.932 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -70.42 -38.21 74.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 30.7 m0 . . . . . 0 C--N 1.301 -1.531 0 O-C-N 120.947 -1.096 . . . . 0.0 108.886 179.113 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.19 165.83 11.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.094 -1.004 . . . . 0.0 110.572 -178.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 145.33 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.593 -0.692 . . . . 0.0 109.681 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.0 m-30 -94.02 139.97 30.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 109.035 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.91 106.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.5 ptpt -92.63 134.89 34.57 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.586 ' O ' HG11 ' A' ' 72' ' ' VAL . 44.4 p -94.58 -177.4 4.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 110.541 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' B' ' 270' ' ' VAL . 53.5 mt -72.51 -12.12 60.95 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.7 p -100.95 -3.03 30.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.63 -1.44 63.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -66.07 119.73 11.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.986 -1.302 . . . . 0.0 108.843 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 27.7 m -100.82 137.81 38.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 57.2 mt -133.58 136.82 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 109.329 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 18.2 m -104.86 119.37 38.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 108.681 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.2 mt -123.16 120.08 32.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -66.36 132.87 49.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.513 -0.742 . . . . 0.0 109.065 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.75 -176.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.87 -1.144 . . . . 0.0 110.01 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -134.09 154.06 79.96 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.5 -26.85 65.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.598 2.199 . . . . 0.0 112.328 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 t -97.65 7.18 46.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.3 140.67 48.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.079 -1.013 . . . . 0.0 109.34 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 38.5 p -85.92 146.72 26.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 29.2 mm -51.8 -27.25 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 109.206 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.22 -29.24 67.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.729 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -75.44 -51.15 13.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.72 -47.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -51.99 -46.55 64.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.43 70.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.621 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.569 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.5 mtpp -55.95 -53.65 54.3 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.404 HG13 HD11 ' B' ' 215' ' ' LEU . 2.6 mp -58.2 -34.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.035 . . . . 0.0 109.257 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . 0.419 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 7.0 tt0 -62.08 -53.4 55.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.933 -1.104 . . . . 0.0 109.852 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.25 -29.54 67.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.558 -178.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -95.92 -57.86 2.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.021 -1.049 . . . . 0.0 110.666 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -84.09 -5.36 59.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 111.509 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.14 24.83 70.66 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 120.524 -1.36 . . . . 0.0 110.462 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.7 mt -104.21 128.48 27.0 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.026 -1.279 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.45 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.5 Cg_endo -75.71 156.48 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.124 1.883 . . . . 0.0 111.914 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . 0.419 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 43.2 Cg_endo -70.51 -29.19 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.724 2.283 . . . . 0.0 112.951 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -65.21 -15.51 62.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.45 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.8 -22.47 5.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.481 -179.536 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.585 -1.322 . . . . 0.0 108.964 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -125.51 132.52 52.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -0.842 . . . . 0.0 109.807 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.36 125.45 51.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.303 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 60.5 mt -120.29 136.17 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.3 t80 -131.6 114.3 14.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.4 -0.813 . . . . 0.0 109.327 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 65.21 39.26 5.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.01 -1.057 . . . . 0.0 109.323 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.79 15.97 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -97.65 138.29 35.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.318 . . . . 0.0 109.702 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -83.47 128.3 34.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.985 . . . . 0.0 109.244 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.2 mt -78.32 137.29 37.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.029 -1.045 . . . . 0.0 109.326 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.53 146.46 23.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.027 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.18 3.95 3.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.074 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.19 40.04 2.09 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.624 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -147.41 151.35 36.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.113 -1.228 . . . . 0.0 109.272 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.8 p -91.16 161.61 15.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.461 HD23 ' N ' ' B' ' 256' ' ' LEU . 7.5 mt -57.13 -42.38 80.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.718 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 77.4 p -60.98 -28.35 68.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 109.75 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -70.73 -13.23 61.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.164 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -109.9 2.39 19.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.444 -0.785 . . . . 0.0 109.268 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.39 39.61 5.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.471 -0.768 . . . . 0.0 109.253 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.0 mt -92.79 98.45 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -87.37 174.81 8.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.453 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.1 165.39 0.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.0 0.905 . . . . 0.0 111.262 -178.879 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 55.57 11.58 0.65 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.913 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 43.0 m -74.97 148.38 40.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.631 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.764 ' C ' HD12 ' B' ' 267' ' ' LEU . 22.2 m -115.14 138.19 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.502 -0.748 . . . . 0.0 109.8 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.764 HD12 ' C ' ' B' ' 266' ' ' THR . 10.2 mp -121.3 166.41 14.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.2 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 56.5 m80 -113.04 138.96 49.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.637 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 9.4 tp -107.99 124.47 50.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.444 -0.785 . . . . 0.0 109.242 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.459 ' HA ' HD11 ' B' ' 208' ' ' LEU . 2.3 t -115.43 130.26 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.4 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.7 mt -79.0 142.67 36.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.237 -0.914 . . . . 0.0 108.937 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 . . . . . 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 -179.115 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.95 164.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.404 2.07 . . . . 0.0 112.967 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -2.48 7.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.851 -0.53 . . . . 0.0 110.652 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.891 ' O ' HG22 ' B' ' 209' ' ' THR . 0.0 OUTLIER -121.19 7.12 10.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.0 110.114 -179.486 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 68' ' ' ILE . 28.2 mm -109.97 128.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 111.178 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.69 138.73 20.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 -31.18 14.97 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.303 2.002 . . . . 0.0 113.112 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.72 -38.91 77.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.615 HG11 ' O ' ' B' ' 207' ' ' THR . 98.6 t -79.77 -23.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.3 t80 -73.4 -54.75 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 111.105 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -61.87 -14.93 38.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.989 -1.069 . . . . 0.0 109.842 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -84.35 -7.65 59.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.995 -1.065 . . . . 0.0 109.876 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' B' ' 268' ' ' HIS . 95.4 mt -87.77 151.43 49.99 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 109.532 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' GLU . 10.8 Cg_endo -56.66 128.38 29.77 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.299 1.999 . . . . 0.0 112.172 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' PRO . 28.9 tt0 -40.24 -47.96 2.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.451 -0.78 . . . . 0.0 110.688 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.97 -45.36 51.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.8 -1.187 . . . . 0.0 109.829 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.536 HG11 HG21 ' B' ' 270' ' ' VAL . 86.9 t -74.6 -30.27 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 108.594 178.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.76 -50.95 71.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -58.29 -47.82 82.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.574 -0.704 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -57.81 -39.66 78.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 110.044 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.4 -36.18 65.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.95 -1.094 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.61 -38.94 74.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.76 -1.213 . . . . 0.0 108.883 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.95 74.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.06 -36.21 66.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 108.863 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.4 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 45.1 m0 . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.117 -0.989 . . . . 0.0 108.702 178.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 217' ' ' VAL . 3.9 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -98.9 167.01 11.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.02 144.13 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.5 m-30 -94.07 138.99 31.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.98 108.82 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.471 -0.768 . . . . 0.0 109.081 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 13.6 ptpt -95.84 137.77 34.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.615 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.7 p -99.22 -175.1 2.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.997 . . . . 0.0 110.662 -178.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.96 -9.47 58.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.608 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 67' ' ' ASP . 16.2 p -102.83 -4.12 25.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.89 . . . . 0.0 109.397 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.0 1.45 63.06 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -66.86 118.88 10.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -1.173 . . . . 0.0 108.831 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.6 m -101.42 139.54 36.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.716 HD11 ' OE2' ' B' ' 234' ' ' GLU . 50.2 mt -135.02 136.85 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.382 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 8.7 m -105.02 118.94 37.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 0.0 108.928 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.4 mt -122.51 120.56 34.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.943 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.99 132.08 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 201' ' ' MET . 12.2 m -139.6 -175.32 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.08 . . . . 0.0 109.864 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -134.27 154.98 80.26 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.451 -0.781 . . . . 0.0 109.046 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.65 -21.38 46.84 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.51 2.14 . . . . 0.0 112.207 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.4 7.51 38.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.238 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.84 142.12 49.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.865 -1.147 . . . . 0.0 109.389 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.483 ' H ' HD22 ' B' ' 225' ' ' ASN . 72.3 p -87.12 145.36 26.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 109.814 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.44 HD12 HD13 ' B' ' 250' ' ' LEU . 34.3 mm -51.57 -22.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 109.054 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -70.06 -35.47 74.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.408 -0.808 . . . . 0.0 109.011 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.483 HD22 ' H ' ' B' ' 222' ' ' THR . 86.0 m-20 -72.38 -49.88 30.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 45.5 t -52.21 -51.85 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.043 -1.036 . . . . 0.0 108.775 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -50.68 -41.01 55.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.547 -0.72 . . . . 0.0 109.482 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.07 83.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.222 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.552 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.0 mtpp -55.91 -53.6 54.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.332 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.411 HG13 HD11 ' B' ' 215' ' ' LEU . 2.6 mp -58.03 -35.0 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 0.0 109.2 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.18 -39.21 91.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.993 . . . . 0.0 109.773 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.07 -28.25 62.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -98.02 -54.15 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.049 . . . . 0.0 110.668 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . 0.716 ' OE2' HD11 ' B' ' 213' ' ' ILE . 75.7 mm-40 -83.84 -8.73 59.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.12 -0.988 . . . . 0.0 111.254 -178.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.65 73.64 Favored Glycine 0 N--CA 1.493 2.451 0 O-C-N 120.526 -1.359 . . . . 0.0 110.513 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.9 mt -105.22 132.17 21.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.116 -1.226 . . . . 0.0 109.266 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.429 ' HG2' HE21 ' B' ' 240' ' ' GLN . 38.4 Cg_endo -71.25 161.64 45.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.216 1.944 . . . . 0.0 112.617 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.61 -34.66 8.91 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.158 2.572 . . . . 0.0 113.467 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -71.14 -5.92 35.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.998 -1.064 . . . . 0.0 111.534 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.429 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.26 -26.74 4.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.227 -0.921 . . . . 0.0 110.718 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.686 ' HB2' HD11 ' B' ' 269' ' ' LEU . 1.7 pt20 -88.96 132.63 34.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.431 -1.418 . . . . 0.0 109.156 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -117.95 135.31 54.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 109.682 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.06 124.51 49.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.078 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 92.4 mt -118.81 135.14 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.608 -0.682 . . . . 0.0 109.392 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.544 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 44.6 t80 -131.36 114.6 15.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.023 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.26 39.04 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.006 -1.059 . . . . 0.0 109.355 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.23 17.67 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.853 178.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -100.34 138.58 37.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.285 . . . . 0.0 109.68 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -84.04 125.93 32.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 109.527 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.44 HD13 HD12 ' B' ' 223' ' ' ILE . 39.8 mt -73.26 145.09 46.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.21 -0.931 . . . . 0.0 109.094 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -101.09 146.89 26.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.931 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.64 3.78 4.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.335 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -120.18 32.85 4.76 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.648 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -142.42 170.3 15.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.989 -1.301 . . . . 0.0 109.628 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.3 p -110.27 160.97 16.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 0.0 110.135 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.501 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.8 mt -58.15 -44.08 87.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.7 p -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.427 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.31 -12.02 60.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.656 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 28.1 m-85 -108.12 4.81 25.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' B' ' 259' ' ' TYR . 0.2 OUTLIER 64.21 36.49 9.41 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.092 0.948 . . . . 0.0 109.911 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 90.7 mt -89.73 134.42 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.263 . . . . 0.0 109.075 178.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -123.19 174.33 7.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.433 ' HE3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 158.58 1.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.42 -0.8 . . . . 0.0 110.724 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER 57.21 11.37 1.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.427 179.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 4.2 m -72.42 144.88 47.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.947 -1.095 . . . . 0.0 108.352 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.746 ' C ' HD12 ' B' ' 267' ' ' LEU . 26.4 m -111.71 136.9 50.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.746 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -120.66 166.29 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.409 ' HB3' HD21 ' A' ' 76' ' ' LEU . 73.2 m80 -112.78 137.94 50.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.678 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' B' ' 241' ' ' GLN . 16.5 tp -108.1 125.19 51.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.236 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 80' ' ' VAL . 2.3 t -115.22 130.41 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.713 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.39 140.47 37.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.264 -0.897 . . . . 0.0 109.226 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 . . . . . 0 C--N 1.302 -1.489 0 O-C-N 121.339 -0.851 . . . . 0.0 108.731 -179.261 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.32 165.37 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.268 1.979 . . . . 0.0 113.026 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.7 t -67.98 -2.72 8.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.728 -0.608 . . . . 0.0 110.78 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.941 ' O ' HG22 ' B' ' 209' ' ' THR . 76.3 m-20 -121.54 3.36 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.984 -1.073 . . . . 0.0 110.408 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mm -105.89 129.57 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.157 -0.964 . . . . 0.0 110.432 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.5 t70 -98.18 139.05 20.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 -36.97 7.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.497 2.131 . . . . 0.0 112.693 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 24.1 tt0 -60.75 -42.48 97.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.476 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.733 HG11 ' O ' ' B' ' 207' ' ' THR . 36.7 t -80.9 -24.17 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 110.566 -179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.3 t80 -69.83 -54.1 15.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.992 -1.067 . . . . 0.0 110.706 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -62.36 -16.65 55.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.748 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.47 -7.11 58.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.603 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' B' ' 268' ' ' HIS . 93.3 mt -91.35 152.08 43.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.51 156.45 17.82 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.304 2.003 . . . . 0.0 111.932 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.53 -51.49 67.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 110.648 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -43.79 36.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -178.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -31.77 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 108.807 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.0 tt0 -60.25 -49.35 77.96 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -58.93 -48.43 81.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.52 -0.737 . . . . 0.0 110.158 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -57.7 -41.48 81.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.049 -1.032 . . . . 0.0 110.496 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.27 -38.82 75.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.827 -1.17 . . . . 0.0 109.817 -179.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.7 mt -68.79 -37.52 79.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.769 -1.207 . . . . 0.0 108.922 178.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.84 76.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 108.954 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -68.69 -39.43 80.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 108.9 179.044 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.8 m0 . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.062 -1.023 . . . . 0.0 109.099 179.211 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.92 11.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.955 . . . . 0.0 110.588 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.45 144.07 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.464 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.419 ' HB2' HG23 ' B' ' 266' ' ' THR . 3.0 m-30 -94.38 142.44 27.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 109.357 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.29 112.04 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.315 -0.866 . . . . 0.0 109.684 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 131.27 43.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 108.725 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.733 ' O ' HG11 ' A' ' 72' ' ' VAL . 28.0 p -91.29 -175.64 4.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.707 HD11 ' H ' ' B' ' 271' ' ' LEU . 24.7 mt -71.85 -11.47 60.81 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.218 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.941 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.2 p -101.49 -2.55 30.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.802 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.47 0.06 63.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -66.02 118.91 10.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -1.181 . . . . 0.0 109.066 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.96 131.01 47.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.341 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.08 134.24 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.488 -0.757 . . . . 0.0 109.501 -179.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 24.9 m -103.3 122.97 45.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' B' ' 229' ' ' LYS . 24.7 mt -125.95 121.71 33.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.377 -0.827 . . . . 0.0 110.319 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.9 130.15 42.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.49 -174.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.059 -1.025 . . . . 0.0 109.881 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -137.35 154.61 75.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.67 -23.56 41.38 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.491 2.127 . . . . 0.0 112.307 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 95.3 p -101.2 7.26 43.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.015 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.01 141.48 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.954 -1.092 . . . . 0.0 109.354 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 59.8 p -85.43 149.05 25.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.178 -0.951 . . . . 0.0 109.969 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.7 -40.7 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 109.513 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -56.86 -33.85 67.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.584 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.19 -52.92 28.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 108.897 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.6 t -52.6 -49.15 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.82 -42.35 58.3 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.526 0.679 . . . . 0.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.32 83.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.593 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.1 mtpp -56.42 -53.19 60.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.086 -1.008 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.97 -32.92 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 109.22 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -62.71 -44.11 97.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.88 -27.13 61.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.979 -1.075 . . . . 0.0 110.439 -179.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -93.52 -50.38 5.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.026 -1.046 . . . . 0.0 110.375 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.33 -7.29 51.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.196 -0.94 . . . . 0.0 111.441 -178.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.47 23.27 76.59 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.382 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 124.07 40.1 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.144 -1.209 . . . . 0.0 109.348 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.4 155.41 41.09 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.027 1.818 . . . . 0.0 112.04 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.79 -30.36 49.86 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.729 2.286 . . . . 0.0 112.961 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.24 -8.92 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -18.15 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.222 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.457 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -92.64 139.31 30.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.97 -1.081 . . . . 0.0 109.57 -179.47 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -130.64 133.45 46.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.785 . . . . 0.0 109.093 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.3 mt -106.01 125.97 51.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 58.9 mt -120.84 135.63 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.61 -0.681 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -129.65 122.81 29.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 108.806 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.93 45.83 23.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.27 0.77 4.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -98.07 134.75 40.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.318 . . . . 0.0 109.44 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -85.02 123.17 30.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.41 144.2 49.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -96.93 144.58 26.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.99 3.42 3.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 109.729 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.44 44.03 1.33 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.481 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -148.08 172.57 14.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -1.218 . . . . 0.0 109.56 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.6 p -110.84 159.52 17.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.195 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.507 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.7 mt -59.23 -43.09 92.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.654 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.0 p -60.57 -29.33 69.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.669 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.03 -14.24 62.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.15 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -107.65 2.25 23.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.0 109.278 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.68 39.5 2.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -0.823 . . . . 0.0 109.877 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.16 135.7 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -124.44 175.98 6.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.481 -0.762 . . . . 0.0 109.569 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.62 162.33 0.4 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.852 0.835 . . . . 0.0 110.908 -178.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 55.35 11.23 0.55 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.891 177.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.6 m -72.26 144.13 48.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.862 -1.149 . . . . 0.0 108.538 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.718 ' C ' HD12 ' B' ' 267' ' ' LEU . 1.7 m -110.73 134.92 52.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.019 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.718 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -120.92 158.07 28.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.773 . . . . 0.0 109.182 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.417 ' HB3' HD21 ' A' ' 76' ' ' LEU . 64.6 m80 -105.72 138.22 42.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.457 HD11 ' HG3' ' B' ' 241' ' ' GLN . 11.9 tp -106.88 124.15 49.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 108.941 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.36 127.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.707 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.8 mt -80.99 142.14 33.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.273 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' B' ' 272' ' ' ARG . 19.3 ttt-85 . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -47.57 165.27 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.497 2.131 . . . . 0.0 112.859 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -1.93 7.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.648 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.938 ' O ' HG22 ' B' ' 209' ' ' THR . 39.3 m-20 -122.37 6.9 9.59 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 68' ' ' ILE . 27.2 mm -110.54 130.49 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.381 -0.824 . . . . 0.0 110.756 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.5 139.35 20.56 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.54 -45.83 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.441 2.094 . . . . 0.0 112.295 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -47.35 -48.56 25.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.701 -0.625 . . . . 0.0 110.814 -179.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.575 HG11 ' O ' ' B' ' 207' ' ' THR . 59.5 t -78.27 -26.82 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.856 -1.152 . . . . 0.0 110.71 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.455 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -65.73 -52.85 47.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.031 -1.043 . . . . 0.0 110.912 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -62.33 -18.46 61.48 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -81.34 -5.72 58.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.863 -1.148 . . . . 0.0 109.558 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.0 mt -89.96 151.86 45.7 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.24 156.26 21.61 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.342 2.028 . . . . 0.0 111.887 179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.38 -52.45 61.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.48 -43.87 24.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -178.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.487 HG11 HG21 ' B' ' 270' ' ' VAL . 87.1 t -74.82 -31.52 26.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 108.639 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.455 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.8 tt0 -60.2 -50.83 72.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -57.27 -48.71 78.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -58.12 -43.57 87.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.076 -1.015 . . . . 0.0 110.612 -178.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.24 -37.34 77.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.914 -1.116 . . . . 0.0 109.739 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 mt -70.62 -37.21 73.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 108.829 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.21 71.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.01 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -75.97 -38.95 56.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 109.121 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.2 m0 . . . . . 0 N--CA 1.488 1.448 0 O-C-N 121.015 -1.053 . . . . 0.0 108.95 179.286 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . 0.403 ' O ' HG23 ' B' ' 217' ' ' VAL . 10.9 ptt? . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.63 164.72 12.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 -179.276 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -144.63 142.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.311 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -94.41 143.08 26.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.892 . . . . 0.0 109.731 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.5 t -122.02 109.85 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.46 127.49 42.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.575 ' O ' HG11 ' A' ' 72' ' ' VAL . 23.9 p -87.91 -175.56 5.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 111.065 -178.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.468 HD11 ' H ' ' B' ' 271' ' ' LEU . 23.7 mt -71.68 -16.3 62.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.414 0.626 . . . . 0.0 109.347 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.938 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.5 p -98.15 -4.41 35.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.48 2.4 57.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -66.55 117.1 8.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.245 . . . . 0.0 109.106 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.57 132.85 45.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -130.55 136.79 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.427 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 60.8 m -105.5 121.07 43.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' B' ' 229' ' ' LYS . 17.5 mt -125.4 121.88 35.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 110.268 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.15 133.22 48.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.645 . . . . 0.0 109.417 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.475 HG11 HG22 ' B' ' 226' ' ' VAL . 7.6 m -140.19 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.911 -1.118 . . . . 0.0 109.753 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -136.53 152.84 75.47 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.209 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.26 -26.96 54.63 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.565 2.177 . . . . 0.0 112.271 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.5 p -99.38 5.99 46.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.03 143.38 50.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 70.4 p -87.09 147.13 25.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.729 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.422 HD12 HD13 ' B' ' 250' ' ' LEU . 32.8 mm -52.78 -42.47 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -52.09 -32.04 33.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -73.38 -53.11 11.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.011 -1.055 . . . . 0.0 109.223 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.475 HG22 HG11 ' B' ' 217' ' ' VAL . 39.1 t -52.49 -42.18 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.959 . . . . 0.0 108.599 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.511 ' NZ ' ' OD1' ' B' ' 252' ' ' ASP . 6.1 ttmt -58.48 -42.47 87.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.19 -33.47 73.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.721 . . . . 0.0 109.264 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.507 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.1 mtpp -58.63 -53.16 61.5 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 108.94 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.592 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.9 mp -59.99 -32.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.41 -45.11 94.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.03 . . . . 0.0 110.025 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -73.32 -23.86 60.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -179.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -95.36 -50.59 4.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 110.039 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -91.86 -5.74 52.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 111.44 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.11 22.86 71.04 Favored Glycine 0 N--CA 1.492 2.4 0 O-C-N 120.53 -1.356 . . . . 0.0 110.371 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 62.3 mt -101.66 130.45 24.59 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 0.0 109.403 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.439 ' HG2' HE21 ' B' ' 240' ' ' GLN . 54.7 Cg_endo -74.04 156.7 47.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.051 1.834 . . . . 0.0 111.949 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.47 -31.94 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.734 2.289 . . . . 0.0 112.785 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -66.95 -7.16 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 110.061 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.439 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.52 -22.33 3.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 -179.592 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.83 138.15 31.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.687 -1.258 . . . . 0.0 108.93 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -128.54 132.99 48.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.859 . . . . 0.0 109.654 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -105.5 125.85 51.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 109.174 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.17 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.597 -0.69 . . . . 0.0 109.505 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.504 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 49.3 t80 -127.84 112.62 14.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 0.0 109.149 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.56 40.68 5.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.041 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.74 17.06 66.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.475 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.4 ptmm? -112.18 135.52 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -1.153 . . . . 0.0 109.437 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.32 125.75 33.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.037 -1.039 . . . . 0.0 109.53 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.422 HD13 HD12 ' B' ' 223' ' ' ILE . 25.8 mt -80.28 143.99 33.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.624 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.33 147.2 28.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . 0.511 ' OD1' ' NZ ' ' B' ' 227' ' ' LYS . 18.0 m-20 -69.72 3.37 2.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.929 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.83 42.2 1.84 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.855 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -150.51 172.89 14.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.078 -1.248 . . . . 0.0 109.475 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.0 p -113.28 157.39 21.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 110.198 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.8 mt -56.12 -43.63 78.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.271 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 67.9 p -60.49 -28.97 68.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -16.75 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 108.819 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -106.52 0.99 25.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.482 -0.761 . . . . 0.0 108.983 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' B' ' 260' ' ' ASN . 0.9 OUTLIER 66.33 39.42 4.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -0.78 . . . . 0.0 109.879 179.843 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.04 138.34 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.69 175.37 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . 0.57 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.63 161.14 1.13 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.862 0.839 . . . . 0.0 110.913 -179.073 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 58.17 10.54 1.27 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.328 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.1 m -75.35 149.69 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.891 -1.131 . . . . 0.0 108.682 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . 0.781 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.3 m -114.32 137.41 51.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.468 -0.77 . . . . 0.0 110.071 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.781 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -124.44 139.62 53.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -0.81 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.405 ' HB3' HD21 ' A' ' 76' ' ' LEU . 42.5 m80 -88.89 142.6 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.42 126.96 54.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.152 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.487 HG21 HG11 ' A' ' 80' ' ' VAL . 4.4 t -113.96 128.61 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.468 ' H ' HD11 ' B' ' 208' ' ' LEU . 50.1 mt -82.03 143.91 31.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 27.9 ttt180 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.649 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.4 tttt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.471 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.6 mt -113.7 132.06 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.413 -0.805 . . . . 0.0 110.452 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.4 m -113.83 127.91 56.19 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 89.7 m-85 -112.9 135.9 21.66 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.236 -0.915 . . . . 0.0 109.983 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -49.1 164.84 0.23 Allowed 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.227 1.951 . . . . 0.0 112.75 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.63 -2.12 6.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.735 -0.603 . . . . 0.0 110.611 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.832 ' O ' HG22 ' B' ' 209' ' ' THR . 5.3 m-20 -122.46 11.65 9.97 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.171 -0.956 . . . . 0.0 110.591 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 68' ' ' ILE . 31.6 mm -114.36 130.32 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.232 -0.917 . . . . 0.0 110.774 -179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -99.26 138.16 20.5 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -71.75 -33.65 9.99 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.142 1.895 . . . . 0.0 113.072 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -43.0 99.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.318 -0.863 . . . . 0.0 110.679 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.63 HG11 ' O ' ' B' ' 207' ' ' THR . 61.8 t -80.32 -23.81 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.704 -1.247 . . . . 0.0 109.878 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.441 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -68.29 -54.83 14.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.147 -0.971 . . . . 0.0 110.852 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -60.82 -15.25 28.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.225 -0.922 . . . . 0.0 109.822 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -83.42 -6.47 59.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.014 -1.054 . . . . 0.0 109.68 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' B' ' 268' ' ' HIS . 90.4 mt -90.03 151.98 45.7 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.189 -0.945 . . . . 0.0 109.559 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.74 154.79 24.54 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 122.267 1.978 . . . . 0.0 111.961 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -62.73 -52.17 64.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 110.584 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.02 -44.09 30.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.968 -1.082 . . . . 0.0 110.036 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG11 HG21 ' B' ' 270' ' ' VAL . 67.2 t -74.93 -32.19 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.937 -1.102 . . . . 0.0 108.489 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.441 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.3 tt0 -60.51 -50.03 75.17 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 47.0 mmtt -57.56 -48.7 78.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.59 -0.694 . . . . 0.0 109.968 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -56.68 -41.64 77.67 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.024 -1.047 . . . . 0.0 110.064 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -71.93 -38.46 69.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.074 -1.016 . . . . 0.0 109.786 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.53 -39.59 77.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.69 -1.256 . . . . 0.0 109.024 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.1 -30.94 71.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.119 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -74.61 -38.11 62.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.303 -0.873 . . . . 0.0 109.071 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.407 ' CH2' HG21 ' A' ' 68' ' ' ILE . 42.4 m0 -73.37 -21.17 60.58 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.013 -1.054 . . . . 0.0 108.865 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -87.06 -45.5 10.67 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.294 -0.879 . . . . 0.0 109.808 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -40.96 74.58 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.715 -1.241 . . . . 0.0 108.732 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 92' ' ' GLY . 11.0 t -89.75 -37.28 14.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.137 -0.977 . . . . 0.0 109.055 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.1 ptt? . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -97.57 163.06 13.0 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.201 -0.937 . . . . 0.0 110.465 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.523 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.1 pp -144.36 143.53 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.526 -0.734 . . . . 0.0 109.563 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -96.31 141.68 29.36 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.54 108.53 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 109.661 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.401 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.4 OUTLIER -93.54 131.04 39.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.0 108.822 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.63 ' O ' HG11 ' A' ' 72' ' ' VAL . 24.1 p -90.57 -175.82 4.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.102 -0.999 . . . . 0.0 110.676 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.579 HD11 ' H ' ' B' ' 271' ' ' LEU . 35.4 mt -70.71 -20.71 62.64 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.463 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.1 p -94.25 -4.08 49.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.263 -0.898 . . . . 0.0 109.725 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.28 5.89 56.91 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.367 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -69.8 118.89 13.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.966 -1.314 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 134.39 44.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 0.0 109.376 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 35.4 mt -131.07 136.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.866 . . . . 0.0 109.635 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -105.69 114.58 28.83 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.614 HD13 ' CB ' ' B' ' 229' ' ' LYS . 21.2 mt -118.54 123.64 45.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.398 -0.814 . . . . 0.0 110.4 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.59 132.17 46.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 7.7 m -139.79 -170.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.919 -1.113 . . . . 0.0 109.768 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -136.13 152.84 76.13 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.033 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.74 -20.03 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.381 2.054 . . . . 0.0 111.943 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 17.7 m -105.2 7.57 33.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.756 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -70.29 141.86 52.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.045 -1.034 . . . . 0.0 109.408 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 72.9 p -86.29 148.8 25.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.958 . . . . 0.0 110.099 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.459 HD12 HD13 ' B' ' 250' ' ' LEU . 41.3 mm -54.23 -35.46 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.445 -0.784 . . . . 0.0 109.404 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -60.14 -30.22 69.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.723 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -74.29 -51.33 15.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.084 -1.01 . . . . 0.0 109.381 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -51.98 -47.11 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 108.809 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -54.2 -42.22 69.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.393 -0.817 . . . . 0.0 109.442 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.85 76.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.614 ' CB ' HD13 ' B' ' 215' ' ' LEU . 5.2 mtpm? -57.66 -53.92 52.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.108 -0.995 . . . . 0.0 109.074 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.512 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.5 mp -58.52 -32.12 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.242 -0.911 . . . . 0.0 108.781 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' B' ' 237' ' ' PRO . 39.5 tt0 -63.27 -49.57 73.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.059 -1.025 . . . . 0.0 109.734 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.47 -23.6 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.056 -1.028 . . . . 0.0 110.653 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -98.72 -53.15 3.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.99 -1.069 . . . . 0.0 110.404 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -88.69 -8.22 54.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.113 -0.992 . . . . 0.0 111.317 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.14 22.58 76.1 Favored Glycine 0 N--CA 1.493 2.493 0 O-C-N 120.567 -1.333 . . . . 0.0 110.414 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 22.5 mt -100.86 131.13 23.85 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 120.992 -1.299 . . . . 0.0 109.087 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.63 ' C ' HE21 ' B' ' 241' ' ' GLN . 59.0 Cg_endo -75.11 160.27 39.98 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 122.045 1.83 . . . . 0.0 112.549 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . 0.552 ' N ' HE21 ' B' ' 241' ' ' GLN . 38.2 Cg_endo -69.5 -34.43 15.45 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.288 2.658 . . . . 0.0 113.486 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.428 ' C ' ' OD1' ' B' ' 239' ' ' ASP . 4.0 p30 -69.89 -5.44 25.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.998 . . . . 0.0 111.501 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.23 -25.83 3.74 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.223 -0.923 . . . . 0.0 111.315 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.63 HE21 ' C ' ' B' ' 237' ' ' PRO . 16.9 pt20 -88.55 144.7 26.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.235 -1.541 . . . . 0.0 109.418 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -129.32 134.05 47.73 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.293 -0.88 . . . . 0.0 109.663 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.2 mt -105.65 126.14 51.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.508 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 67.2 mt -120.35 135.75 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.594 -0.691 . . . . 0.0 109.518 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 50.5 t80 -130.59 114.12 15.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.313 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.25 39.05 7.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.976 -1.077 . . . . 0.0 109.434 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.54 12.52 66.96 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 120.324 -0.941 . . . . 0.0 110.846 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.443 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.5 ptmm? -111.68 136.78 50.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -1.155 . . . . 0.0 109.674 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -83.57 122.74 28.97 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.034 -1.041 . . . . 0.0 109.218 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.459 HD13 HD12 ' B' ' 223' ' ' ILE . 38.9 mt -69.86 144.31 52.58 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.161 -0.962 . . . . 0.0 109.367 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 37.3 tt0 -100.89 147.0 26.63 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 109.997 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -73.4 3.71 5.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.431 -0.793 . . . . 0.0 109.649 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.41 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -121.93 41.68 1.81 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.8 mtt-85 -150.18 172.07 15.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.002 -1.293 . . . . 0.0 109.539 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 68.2 p -111.9 162.13 15.64 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.435 -0.79 . . . . 0.0 109.883 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.473 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.8 mt -58.12 -43.91 87.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 109.811 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 73.1 p -59.9 -27.69 66.94 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.251 -0.906 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.59 -25.74 63.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.687 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -96.73 5.55 50.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.137 -0.977 . . . . 0.0 109.217 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.9 38.18 2.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.524 -0.735 . . . . 0.0 110.037 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 91.3 mt -93.53 136.7 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -0.939 . . . . 0.0 109.146 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.47 175.28 7.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.916 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.604 ' NZ ' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.81 160.24 1.45 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.739 0.781 . . . . 0.0 110.822 -179.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 56.4 9.9 0.59 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.406 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.523 ' OG ' HG22 ' B' ' 203' ' ' ILE . 16.1 p -73.61 146.86 44.32 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.008 -1.058 . . . . 0.0 108.367 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.742 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.4 m -114.06 139.38 49.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.539 -0.726 . . . . 0.0 109.913 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.742 HD12 ' C ' ' B' ' 266' ' ' THR . 11.2 mp -121.14 165.92 14.68 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.409 ' HB3' HD21 ' A' ' 76' ' ' LEU . 79.8 m80 -113.1 139.27 48.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.466 -0.771 . . . . 0.0 109.191 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.0 tp -109.03 125.15 51.78 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.473 -0.767 . . . . 0.0 109.513 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.521 HG21 HG11 ' A' ' 80' ' ' VAL . 2.5 t -113.52 129.63 68.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.579 ' H ' HD11 ' B' ' 208' ' ' LEU . 39.2 mt -83.23 142.44 31.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.167 -0.958 . . . . 0.0 109.992 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.0 ttt180 -91.06 -139.05 0.16 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.538 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 52.6 mt -123.42 -45.56 2.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.046 -1.033 . . . . 0.0 109.187 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 41.6 ttt180 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.343 -0.848 . . . . 0.0 109.508 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.0 mttp . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.555 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 40.0 mt -108.13 132.38 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.308 -0.87 . . . . 0.0 109.779 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 85.9 m -113.22 124.3 52.2 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.555 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 98.1 m-85 -111.35 136.73 20.94 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.394 -0.816 . . . . 0.0 109.584 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.22 164.3 0.2 Allowed 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.287 1.992 . . . . 0.0 113.0 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.9 m -67.66 -1.91 6.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.79 -0.569 . . . . 0.0 110.296 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.924 ' O ' HG22 ' B' ' 209' ' ' THR . 2.3 m-20 -123.01 7.87 9.27 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.26 -0.9 . . . . 0.0 110.782 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.3 mm -108.65 128.74 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.005 -1.06 . . . . 0.0 110.81 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.77 109.67 58.44 Favored Pre-proline 0 N--CA 1.492 1.656 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -47.32 -45.07 23.26 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.252 1.968 . . . . 0.0 112.539 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -49.69 -48.21 49.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.527 -0.733 . . . . 0.0 110.313 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.16 -24.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.796 -1.19 . . . . 0.0 108.902 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.438 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.1 t80 -67.99 -52.86 30.94 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 110.922 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -62.38 -18.85 62.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 0.0 110.363 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -83.15 -5.41 59.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.794 -1.191 . . . . 0.0 109.738 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.75 151.99 46.26 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.187 -0.945 . . . . 0.0 109.696 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.51 153.02 24.59 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.536 2.157 . . . . 0.0 112.099 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -62.98 -50.9 68.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.256 -0.902 . . . . 0.0 110.635 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.69 -43.9 37.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.942 -1.099 . . . . 0.0 109.838 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.6 t -75.01 -33.59 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.922 -1.111 . . . . 0.0 108.763 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -58.96 -49.97 75.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt -58.9 -49.71 76.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.62 -0.675 . . . . 0.0 110.237 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -56.18 -42.3 76.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.076 -1.015 . . . . 0.0 110.412 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.41 -36.99 74.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.148 . . . . 0.0 109.936 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -70.5 -38.27 74.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.716 -1.24 . . . . 0.0 109.102 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.07 -33.23 73.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.118 -0.989 . . . . 0.0 108.862 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' OE1' HD21 ' B' ' 273' ' ' LEU . 37.0 tt0 -72.82 -37.74 67.4 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 37.4 m0 -78.06 -13.63 59.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.999 -1.063 . . . . 0.0 108.933 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -92.63 -47.24 7.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -0.839 . . . . 0.0 109.029 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.41 ' CG ' ' N ' ' A' ' 91' ' ' THR . 17.2 ptp180 -55.12 -40.64 70.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.008 -1.057 . . . . 0.0 108.582 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.444 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 2.1 t -88.76 -36.71 15.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 108.861 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.444 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.468 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.85 162.73 13.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -0.926 . . . . 0.0 110.39 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.2 145.81 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.618 -0.677 . . . . 0.0 109.36 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -99.34 144.07 28.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.196 -0.94 . . . . 0.0 109.73 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 45.5 t -124.51 112.18 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.242 -0.911 . . . . 0.0 109.476 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.851 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.1 OUTLIER -96.71 131.64 43.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 108.846 179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 30.8 p -92.0 177.12 6.27 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.121 -0.987 . . . . 0.0 110.65 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.627 HD11 ' H ' ' B' ' 271' ' ' LEU . 29.9 mt -64.03 -11.16 26.65 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.497 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.924 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.1 p -102.53 -3.37 26.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.09 -0.2 64.01 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.3 tptm -65.74 118.93 10.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.077 -1.249 . . . . 0.0 108.695 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.4 m -100.17 137.93 37.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.937 . . . . 0.0 109.159 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.668 HD11 ' OE2' ' B' ' 234' ' ' GLU . 26.6 mt -134.09 136.26 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.19 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 44.1 m -105.04 119.56 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 0.0 108.948 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.556 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.1 mt -121.98 121.88 38.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.474 -0.766 . . . . 0.0 110.058 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -67.82 132.37 47.27 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.8 m -139.8 -172.11 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.907 -1.121 . . . . 0.0 109.979 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -135.99 155.02 77.99 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.344 -0.847 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.32 -19.08 26.75 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.528 2.152 . . . . 0.0 112.165 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.58 8.99 29.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.283 -0.886 . . . . 0.0 110.158 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.0 141.53 50.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.875 -1.141 . . . . 0.0 109.379 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.431 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 22.5 p -85.99 144.55 27.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 41.0 mm -51.56 -33.66 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 108.899 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -62.42 -30.94 71.58 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.327 -0.858 . . . . 0.0 109.205 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.431 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 86.4 m-20 -73.96 -52.4 12.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.112 -0.993 . . . . 0.0 108.905 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 31.6 t -52.3 -47.76 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -51.48 -43.05 62.06 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.477 0.656 . . . . 0.0 109.292 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.5 -36.54 80.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.498 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.556 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.3 mtpp -56.51 -53.85 52.67 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.03 -1.044 . . . . 0.0 109.351 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.7 mp -58.16 -34.43 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 108.908 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -62.75 -49.66 74.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.067 -1.021 . . . . 0.0 109.748 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -22.9 66.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.087 -1.008 . . . . 0.0 110.42 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -100.11 -59.92 1.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.004 -1.06 . . . . 0.0 110.17 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.668 ' OE2' HD11 ' B' ' 213' ' ' ILE . 77.9 mm-40 -79.78 -6.6 57.61 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.312 -0.868 . . . . 0.0 110.977 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.82 25.7 71.92 Favored Glycine 0 N--CA 1.492 2.432 0 O-C-N 120.544 -1.348 . . . . 0.0 110.358 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.438 HG23 HE21 ' B' ' 240' ' ' GLN . 68.8 mt -103.61 133.87 20.05 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.155 -1.203 . . . . 0.0 109.553 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.428 ' HD2' HE21 ' B' ' 240' ' ' GLN . 56.6 Cg_endo -73.05 153.14 52.04 Favored 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.45 2.1 . . . . 0.0 112.024 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.19 -34.06 10.6 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.676 2.251 . . . . 0.0 113.272 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.1 -7.95 27.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.135 -0.978 . . . . 0.0 110.498 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.438 HE21 HG23 ' B' ' 236' ' ' ILE . 0.0 OUTLIER -127.25 -14.24 5.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.465 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -95.78 136.18 36.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.755 -1.215 . . . . 0.0 108.362 178.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.426 ' HE ' ' HD2' ' B' ' 272' ' ' ARG . 78.0 mtt180 -125.22 134.97 52.14 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.111 -0.993 . . . . 0.0 110.172 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.1 mt -105.28 124.89 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 72.4 mt -118.88 135.41 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.516 -0.74 . . . . 0.0 109.48 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -130.06 118.72 21.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 108.889 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 61.06 37.56 17.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.645 -1.284 . . . . 0.0 109.57 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.88 -10.12 9.91 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.124 -0.985 . . . . 0.0 111.486 177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.96 136.23 33.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.542 -1.564 . . . . 0.0 109.751 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -82.17 126.42 32.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.245 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.8 mt -74.25 146.92 42.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.449 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -103.34 146.12 28.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.282 -0.887 . . . . 0.0 109.752 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 32.5 p30 -71.0 3.86 3.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 109.984 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.8 37.34 3.15 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.725 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.5 mtt180 -145.87 173.65 11.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.019 -1.283 . . . . 0.0 109.638 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 71.7 p -113.15 161.58 16.96 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.448 -0.783 . . . . 0.0 110.129 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.541 HD23 ' N ' ' B' ' 256' ' ' LEU . 2.9 mt -59.7 -43.03 94.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.304 -0.873 . . . . 0.0 110.035 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 97.6 p -60.72 -29.22 69.22 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.076 -1.015 . . . . 0.0 109.796 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.78 -15.23 63.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.048 -1.033 . . . . 0.0 109.272 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -107.26 3.73 25.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.391 -0.818 . . . . 0.0 109.403 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.17 38.79 3.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.399 -0.813 . . . . 0.0 109.885 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.0 135.26 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.892 . . . . 0.0 108.947 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 -123.58 172.58 8.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.099 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.586 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -50.97 157.99 0.76 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.568 0.699 . . . . 0.0 110.382 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 59.18 10.48 1.7 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 120.943 0.402 . . . . 0.0 110.886 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 17.1 m -75.17 150.14 38.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.932 -1.105 . . . . 0.0 108.38 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.851 HG21 ' NZ ' ' B' ' 206' ' ' LYS . 7.7 m -116.23 139.12 50.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.39 -0.819 . . . . 0.0 110.309 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.43 140.47 52.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.543 -0.723 . . . . 0.0 109.56 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.46 ' NE2' ' CE ' ' B' ' 206' ' ' LYS . 64.6 m80 -89.36 142.23 27.85 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.142 -0.974 . . . . 0.0 110.015 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.465 HD11 ' HG3' ' B' ' 241' ' ' GLN . 22.4 tp -110.02 127.93 55.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 0.0 109.097 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.22 130.83 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.396 -0.815 . . . . 0.0 110.154 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.627 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.2 mt -79.64 141.59 36.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.232 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 22.4 ttt180 -95.04 -140.0 0.24 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.348 -0.845 . . . . 0.0 108.778 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.575 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 63.5 mt -124.84 -52.03 1.68 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.326 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.409 -0.807 . . . . 0.0 109.63 -179.81 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.8 tttp . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.6 mt -115.58 133.76 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.429 -0.794 . . . . 0.0 111.229 -178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 88.8 m -116.95 129.16 55.87 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 74.8 m-85 -113.72 135.65 21.99 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.355 -0.841 . . . . 0.0 110.692 -178.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -47.89 165.36 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.413 2.075 . . . . 0.0 112.875 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -2.67 7.88 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.729 -0.607 . . . . 0.0 110.738 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.877 ' O ' HG22 ' B' ' 209' ' ' THR . 0.6 OUTLIER -121.88 6.82 9.86 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.083 -1.011 . . . . 0.0 110.125 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.7 mm -110.71 129.93 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.287 -0.883 . . . . 0.0 111.223 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -99.97 138.12 20.26 Favored Pre-proline 0 N--CA 1.492 1.628 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.52 -38.76 4.19 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.271 1.981 . . . . 0.0 112.58 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -55.37 -44.72 76.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.569 -0.707 . . . . 0.0 110.516 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.683 HG11 ' O ' ' B' ' 207' ' ' THR . 56.8 t -80.76 -23.66 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.852 -1.155 . . . . 0.0 110.283 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.422 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.3 t80 -69.1 -53.5 19.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.98 . . . . 0.0 110.822 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.419 ' OH ' HD12 ' A' ' 62' ' ' ILE . 56.1 m-85 -62.39 -15.71 50.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 0.0 110.088 -179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -83.19 -6.6 59.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.93 -1.106 . . . . 0.0 109.585 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.404 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.6 mt -90.39 151.85 44.86 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.228 -0.92 . . . . 0.0 109.776 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.71 154.14 27.2 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.453 2.102 . . . . 0.0 112.092 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.92 -50.93 68.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.272 -0.892 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.71 -45.06 38.71 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.945 -1.097 . . . . 0.0 110.262 -178.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.88 -31.93 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 108.509 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.422 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.19 -50.76 72.41 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 34.4 mmtt -56.68 -47.3 80.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.434 -0.792 . . . . 0.0 110.01 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -58.87 -37.72 77.16 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.111 -0.993 . . . . 0.0 110.482 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.6 mt -74.37 -40.34 62.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.812 -1.18 . . . . 0.0 110.145 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.0 mt -69.88 -38.8 76.5 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.763 -1.21 . . . . 0.0 108.874 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.16 77.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 0.0 108.906 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 4.8 tm-20 -69.0 -38.55 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 108.877 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.461 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.0 m0 -76.16 -11.68 59.97 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.063 -1.023 . . . . 0.0 109.041 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -91.44 -46.67 7.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.298 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -57.48 -42.43 82.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.971 -1.081 . . . . 0.0 108.429 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.46 HG23 ' N ' ' A' ' 92' ' ' GLY . 14.5 t -84.12 -37.68 21.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 0.0 108.482 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.68 164.99 12.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.039 -1.038 . . . . 0.0 110.231 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.437 HG22 ' OG ' ' B' ' 265' ' ' SER . 1.8 pp -144.26 147.9 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.571 -0.706 . . . . 0.0 109.53 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' B' ' 264' ' ' GLU . 9.8 m-85 -102.04 144.17 30.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -0.904 . . . . 0.0 109.222 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.98 112.62 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.984 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.575 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.2 OUTLIER -97.46 133.98 41.31 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.683 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.5 p -93.98 -174.39 3.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.022 -1.049 . . . . 0.0 110.781 -178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.522 HD11 ' H ' ' B' ' 271' ' ' LEU . 26.9 mt -72.26 -11.72 60.84 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.877 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.9 p -102.61 -2.44 28.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.36 -0.838 . . . . 0.0 109.574 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 94.99 2.73 62.36 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -67.22 118.37 10.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.118 -1.225 . . . . 0.0 108.823 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.1 m -99.62 138.12 37.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 109.033 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.421 HG22 HD21 ' B' ' 215' ' ' LEU . 40.0 mt -135.01 136.21 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.345 -0.847 . . . . 0.0 109.334 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 72.5 m -105.34 120.21 41.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.663 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 13.1 mt -125.68 121.84 34.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.497 -0.752 . . . . 0.0 109.963 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.654 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 4.8 mt-10 -67.18 130.3 42.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.496 -0.753 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.522 HG13 ' NZ ' ' B' ' 229' ' ' LYS . 27.5 m -136.16 -174.2 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.08 -1.012 . . . . 0.0 110.131 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -133.86 155.3 80.42 Favored Pre-proline 0 N--CA 1.488 1.471 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -59.43 -20.39 56.2 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.402 2.068 . . . . 0.0 112.195 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -105.24 7.95 33.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 110.014 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.24 143.47 48.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.839 -1.163 . . . . 0.0 109.599 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 52.3 p -86.37 145.94 26.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.353 -0.842 . . . . 0.0 110.155 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -51.68 -26.5 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.432 -0.792 . . . . 0.0 108.955 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.42 -36.22 83.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.205 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -70.0 -52.75 21.61 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.109 -0.994 . . . . 0.0 109.021 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.42 ' O ' HD12 ' B' ' 230' ' ' ILE . 35.7 t -52.28 -37.54 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.222 -0.924 . . . . 0.0 108.926 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -65.41 -32.48 74.13 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.441 -0.787 . . . . 0.0 108.959 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.89 69.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.0 109.226 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.663 ' HZ3' ' C ' ' B' ' 215' ' ' LEU . 12.6 mtpt -57.37 -52.65 64.5 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.013 -1.055 . . . . 0.0 108.781 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.569 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.6 mp -59.71 -36.52 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 0.0 108.808 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -59.98 -42.81 94.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.063 -1.023 . . . . 0.0 110.07 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -70.49 -31.31 68.37 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.116 -0.99 . . . . 0.0 110.831 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -92.76 -50.43 5.58 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.123 . . . . 0.0 110.606 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -88.43 -6.44 57.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.972 . . . . 0.0 111.331 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.48 26.95 72.05 Favored Glycine 0 N--CA 1.493 2.458 0 O-C-N 120.51 -1.369 . . . . 0.0 110.456 179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 54.1 mt -104.07 131.6 21.79 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.128 -1.219 . . . . 0.0 109.569 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.438 ' HG2' HE21 ' B' ' 240' ' ' GLN . 57.5 Cg_endo -74.62 156.67 44.69 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.212 1.941 . . . . 0.0 112.261 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -71.6 -34.67 8.92 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 122.922 2.414 . . . . 0.0 113.393 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -65.34 -6.8 10.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 110.228 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.438 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.89 -21.06 3.4 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.748 -179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -90.5 136.52 33.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.606 -1.309 . . . . 0.0 109.252 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -125.98 135.73 52.17 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.95 126.61 52.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.366 -0.834 . . . . 0.0 109.17 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 79.7 mt -120.21 136.52 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.545 -0.722 . . . . 0.0 109.503 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.507 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.9 t80 -129.65 112.82 14.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.32 -0.863 . . . . 0.0 109.435 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.95 44.56 3.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.865 -1.147 . . . . 0.0 109.485 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.57 -6.07 2.02 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -94.19 137.77 32.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.817 -1.402 . . . . 0.0 109.504 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -84.4 132.59 34.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.089 -1.007 . . . . 0.0 109.875 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.56 146.33 28.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 0.0 109.09 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.503 ' HG2' ' H ' ' B' ' 253' ' ' GLY . 2.6 tt0 -105.49 148.0 27.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 0.0 110.058 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.69 3.82 3.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.921 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.503 ' H ' ' HG2' ' B' ' 251' ' ' GLU . . . -120.63 45.54 1.22 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.148 -1.025 . . . . 0.0 110.874 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.54 172.39 18.64 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.987 -1.302 . . . . 0.0 109.261 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 65.1 p -109.84 161.07 15.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.995 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.482 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.4 mt -58.01 -40.44 80.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.395 -0.815 . . . . 0.0 109.938 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 98.3 p -62.51 -28.04 69.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -0.975 . . . . 0.0 109.913 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -71.08 -15.8 62.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.109 -0.994 . . . . 0.0 109.255 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -105.03 1.72 28.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.35 -0.844 . . . . 0.0 109.067 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.8 39.73 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.481 -0.762 . . . . 0.0 109.812 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 59.3 mt -92.88 133.99 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.295 -0.878 . . . . 0.0 109.038 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.34 174.59 7.23 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.402 -0.811 . . . . 0.0 109.838 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.471 ' HE3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.15 158.09 1.64 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.895 0.855 . . . . 0.0 110.698 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' CE2' ' B' ' 204' ' ' PHE . 91.5 mt-10 57.99 14.26 2.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.044 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.437 ' OG ' HG22 ' B' ' 203' ' ' ILE . 70.4 p -78.03 150.44 33.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.955 -1.091 . . . . 0.0 108.79 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.765 ' C ' HD12 ' B' ' 267' ' ' LEU . 6.7 m -115.03 138.58 50.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -0.796 . . . . 0.0 110.233 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.765 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.82 140.97 52.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.527 -0.733 . . . . 0.0 109.641 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.404 ' HB3' HD21 ' A' ' 76' ' ' LEU . 58.4 m80 -90.19 141.71 28.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.271 -0.893 . . . . 0.0 109.783 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 13.5 tp -108.94 126.06 52.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.518 -0.738 . . . . 0.0 109.376 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 42.8 t -112.69 128.09 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.421 -0.8 . . . . 0.0 109.546 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.522 ' H ' HD11 ' B' ' 208' ' ' LEU . 47.1 mt -82.82 143.9 30.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.018 -1.052 . . . . 0.0 109.552 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.546 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.1 ttt180 -95.25 -137.57 0.23 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.546 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 56.4 mt -124.02 -29.19 3.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.291 -0.88 . . . . 0.0 109.275 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.35 -0.843 . . . . 0.0 109.492 -179.873 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.3 pttt . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.509 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 42.0 mt -112.74 132.22 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.034 -1.041 . . . . 0.0 110.834 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 21.9 m -116.48 126.64 53.67 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.509 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 77.0 m-85 -111.54 135.14 21.08 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.34 -0.85 . . . . 0.0 110.233 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.04 164.75 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.215 1.944 . . . . 0.0 112.762 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -2.75 6.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.739 -0.6 . . . . 0.0 110.722 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.899 ' O ' HG22 ' B' ' 209' ' ' THR . 4.1 m-20 -122.24 8.34 9.72 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.046 -1.034 . . . . 0.0 110.348 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.1 mm -111.05 129.34 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.272 -0.892 . . . . 0.0 111.001 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.7 t70 -99.85 139.56 20.89 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -71.48 -47.38 0.51 Allowed 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.269 1.979 . . . . 0.0 112.242 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.478 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 6.8 tt0 -47.88 -44.68 29.63 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.696 -0.627 . . . . 0.0 110.33 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.658 HG11 ' O ' ' B' ' 207' ' ' THR . 41.4 t -80.85 -32.26 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.957 -1.09 . . . . 0.0 110.318 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -61.05 -54.13 48.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 110.742 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -61.25 -15.86 39.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.174 -0.954 . . . . 0.0 109.907 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -83.55 -6.12 59.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.016 -1.053 . . . . 0.0 109.808 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' B' ' 268' ' ' HIS . 92.6 mt -90.33 151.93 45.08 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.098 -1.001 . . . . 0.0 109.726 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -54.51 154.17 20.74 Favored 'Trans proline' 0 N--CA 1.492 1.389 0 C-N-CA 122.37 2.047 . . . . 0.0 112.098 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -62.82 -49.26 75.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.885 . . . . 0.0 110.52 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.18 -44.74 53.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.997 -1.064 . . . . 0.0 110.196 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.3 t -74.84 -32.46 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.874 -1.141 . . . . 0.0 108.478 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.2 tt0 -59.22 -51.83 68.29 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt -57.25 -48.96 77.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 110.203 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -56.41 -42.76 78.53 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.038 -1.039 . . . . 0.0 110.56 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.5 mt -69.97 -37.87 75.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.863 -1.148 . . . . 0.0 109.776 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.0 mt -70.03 -40.11 75.38 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.739 -1.226 . . . . 0.0 109.024 178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.69 -32.49 70.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.184 -0.947 . . . . 0.0 108.785 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.661 ' O ' HG22 ' A' ' 91' ' ' THR . 6.9 tt0 -70.56 -40.19 73.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 0.0 109.038 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.9 m0 -75.63 -12.36 60.19 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.005 -1.06 . . . . 0.0 109.535 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -93.04 -46.75 7.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.047 -1.033 . . . . 0.0 109.188 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -55.67 -40.46 72.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.818 -1.176 . . . . 0.0 108.421 179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 87' ' ' GLU . 8.9 t -88.98 -36.88 15.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.267 -0.896 . . . . 0.0 108.662 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.9 ptt? . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.34 164.76 12.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.55 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.555 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.7 142.72 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.511 -0.743 . . . . 0.0 109.462 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.33 141.7 28.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.043 -1.036 . . . . 0.0 109.443 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.6 t -120.82 108.23 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.381 -0.825 . . . . 0.0 109.608 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 13.6 ptpt -94.61 135.32 36.2 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.658 ' O ' HG11 ' A' ' 72' ' ' VAL . 46.4 p -97.14 -173.94 2.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.025 -1.047 . . . . 0.0 110.998 -178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.681 HD11 ' H ' ' B' ' 271' ' ' LEU . 20.1 mt -71.4 -14.67 62.24 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.466 0.651 . . . . 0.0 109.284 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.899 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -99.93 -4.6 29.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.39 -0.819 . . . . 0.0 109.6 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.51 3.01 59.94 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -67.82 118.45 11.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.081 -1.247 . . . . 0.0 109.199 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 10.2 m -99.8 137.8 37.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.337 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 48.3 mt -133.49 135.34 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 109.553 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.8 m -104.22 117.03 33.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.724 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.54 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.8 mt -122.18 121.92 37.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.448 -0.783 . . . . 0.0 110.084 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -67.78 132.69 47.9 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.57 -174.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.985 -1.072 . . . . 0.0 109.797 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -134.72 152.55 77.79 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.975 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.15 -24.12 48.31 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.587 2.191 . . . . 0.0 112.191 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 49.2 m -100.4 6.1 44.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.253 -0.904 . . . . 0.0 109.879 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -71.44 143.55 50.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.966 -1.084 . . . . 0.0 109.375 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.586 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 45.0 p -86.26 151.49 23.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.86 . . . . 0.0 109.932 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 35.2 mm -54.53 -43.32 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -0.837 . . . . 0.0 109.625 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -52.61 -35.65 54.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 0.0 109.703 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.586 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 84.1 m-20 -67.28 -52.77 36.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 0.0 109.337 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 25.1 t -52.05 -47.6 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.047 -1.033 . . . . 0.0 108.549 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -52.41 -43.49 64.83 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.507 -0.746 . . . . 0.0 109.182 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.79 -36.11 78.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.331 -0.856 . . . . 0.0 109.814 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.54 ' HB2' HD13 ' B' ' 215' ' ' LEU . 15.3 mtpp -57.78 -53.46 57.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.034 -1.041 . . . . 0.0 109.41 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.529 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.6 mp -58.3 -34.23 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.014 -1.054 . . . . 0.0 109.205 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.463 HE21 ' HD3' ' B' ' 238' ' ' PRO . 15.3 tt0 -60.75 -47.39 86.51 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.921 -1.112 . . . . 0.0 109.826 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -68.69 -24.33 64.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.249 -0.907 . . . . 0.0 110.634 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -97.53 -53.24 3.5 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.972 -1.08 . . . . 0.0 110.457 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -90.17 -7.55 53.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.289 -0.882 . . . . 0.0 111.578 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.47 24.67 75.09 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.215 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 36.7 mt -104.41 124.94 35.55 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.173 -1.192 . . . . 0.0 109.498 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.447 ' HA ' HE21 ' B' ' 231' ' ' GLN . 61.6 Cg_endo -77.56 154.73 31.35 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.164 1.91 . . . . 0.0 111.986 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . 0.463 ' HD3' HE21 ' B' ' 231' ' ' GLN . 29.7 Cg_endo -64.95 -28.57 58.07 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.733 2.289 . . . . 0.0 112.881 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 44.2 p30 -62.6 -14.73 46.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.952 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.51 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.0 OUTLIER -128.52 -21.41 3.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.455 -0.778 . . . . 0.0 110.348 -179.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.508 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -84.57 136.54 33.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.897 -1.127 . . . . 0.0 109.243 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -129.46 132.11 46.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.421 -0.799 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.1 mt -106.42 127.42 53.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.352 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 71.5 mt -120.38 134.23 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.629 -0.669 . . . . 0.0 109.348 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.513 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.6 t80 -127.2 112.84 15.59 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 65.14 37.53 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.868 -1.145 . . . . 0.0 109.458 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 74.6 -7.66 18.26 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.313 -0.946 . . . . 0.0 111.144 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.2 ptpt -94.06 134.78 36.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.74 -1.447 . . . . 0.0 109.692 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -80.97 125.0 29.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.266 -0.896 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.452 HD11 HD23 ' B' ' 267' ' ' LEU . 29.0 mt -69.91 142.37 52.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.173 -0.955 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -97.19 144.36 27.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.19 3.69 2.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.92 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.0 47.21 1.03 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.96 -1.114 . . . . 0.0 110.795 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -152.68 172.53 16.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.847 -1.384 . . . . 0.0 109.078 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 37.9 p -111.5 159.24 18.28 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.459 -0.776 . . . . 0.0 109.948 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.2 mt -57.3 -41.71 80.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.481 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 69.4 p -61.17 -29.12 69.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.231 -0.918 . . . . 0.0 109.845 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.24 -16.5 63.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.06 -1.025 . . . . 0.0 109.333 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -105.58 3.31 29.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.357 -0.839 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.48 39.35 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.848 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.6 mt -91.71 135.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.25 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.31 173.11 7.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.486 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.468 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.04 162.66 0.44 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.492 -0.755 . . . . 0.0 110.548 -179.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 55.37 10.46 0.47 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.944 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.555 ' OG ' HG22 ' B' ' 203' ' ' ILE . 62.7 p -73.67 148.32 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.823 -1.173 . . . . 0.0 108.657 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.721 ' C ' HD12 ' B' ' 267' ' ' LEU . 22.1 m -113.77 137.89 51.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 0.0 110.038 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.721 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -121.03 160.14 24.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.517 -0.739 . . . . 0.0 109.011 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.411 ' HB3' HD21 ' A' ' 76' ' ' LEU . 79.5 m80 -107.58 139.62 41.84 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.333 -0.854 . . . . 0.0 109.741 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' B' ' 241' ' ' GLN . 24.8 tp -110.21 126.03 53.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.475 -0.765 . . . . 0.0 109.451 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.401 ' HA ' HD21 ' B' ' 208' ' ' LEU . 11.6 t -114.62 130.06 69.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.782 . . . . 0.0 109.454 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.681 ' H ' HD11 ' B' ' 208' ' ' LEU . 47.1 mt -82.42 144.4 30.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.249 -0.907 . . . . 0.0 109.425 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.524 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 27.2 ttt180 -93.21 -138.62 0.2 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.524 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.2 mt -122.36 -26.56 4.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 109.548 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 63.3 mtt-85 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 109.422 179.898 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.476 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.4 mt -112.53 131.73 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.471 -0.768 . . . . 0.0 110.293 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.9 m -115.53 128.96 56.36 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.476 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 77.3 m-85 -114.13 135.61 22.15 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.345 -0.847 . . . . 0.0 110.156 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -47.66 165.56 0.12 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.454 2.102 . . . . 0.0 112.916 177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.09 -6.18 21.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.735 -0.603 . . . . 0.0 110.697 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.942 ' O ' HG22 ' B' ' 209' ' ' THR . 1.8 m-20 -117.01 2.56 12.71 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.099 -1.001 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.6 mm -104.77 128.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 110.827 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 4.7 t70 -98.91 138.35 20.64 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -70.62 -40.31 4.09 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 122.355 2.037 . . . . 0.0 112.467 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 37.4 tt0 -56.21 -43.49 78.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.617 -0.677 . . . . 0.0 110.581 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG11 ' O ' ' B' ' 207' ' ' THR . 61.4 t -80.09 -23.79 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.784 -1.198 . . . . 0.0 110.35 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.9 t80 -70.41 -52.38 22.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 110.832 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -64.32 -18.12 64.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.202 -0.936 . . . . 0.0 110.174 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -79.87 -7.94 59.01 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.861 -1.149 . . . . 0.0 109.49 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.8 mt -89.92 151.63 45.51 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.187 -0.945 . . . . 0.0 109.745 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.44 154.96 22.29 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 122.41 2.074 . . . . 0.0 111.95 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -63.05 -51.84 65.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 110.721 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.72 -44.33 38.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.048 -1.032 . . . . 0.0 110.09 -178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.408 HG11 HG21 ' B' ' 270' ' ' VAL . 60.3 t -74.77 -31.56 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.02 -1.05 . . . . 0.0 108.448 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.8 -50.05 75.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.4 mmtp -58.36 -49.68 76.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.637 -0.665 . . . . 0.0 110.38 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -55.72 -36.87 67.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.037 -1.039 . . . . 0.0 110.043 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.3 mt -75.44 -36.58 60.72 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.852 -1.155 . . . . 0.0 109.687 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.9 mt -71.12 -40.34 71.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.77 -1.206 . . . . 0.0 109.147 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.73 79.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.157 -0.965 . . . . 0.0 109.046 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -67.95 -38.48 82.85 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -76.85 -12.76 60.01 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.101 -1.0 . . . . 0.0 109.205 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.97 -45.75 9.41 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.187 -0.945 . . . . 0.0 109.055 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -58.54 -39.62 80.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.137 -0.977 . . . . 0.0 109.234 179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.465 ' O ' ' C ' ' A' ' 92' ' ' GLY . 11.8 t -94.77 -37.01 11.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.044 -1.035 . . . . 0.0 109.695 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.495 2.606 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.429 ' O ' HG23 ' B' ' 217' ' ' VAL . 5.8 ptt? . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.08 166.51 11.39 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.17 -0.956 . . . . 0.0 110.079 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -145.29 145.11 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.628 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.419 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.4 m-85 -95.75 142.4 28.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 109.56 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.01 108.05 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.176 -0.952 . . . . 0.0 109.486 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -93.33 134.11 35.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 108.767 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.653 ' O ' HG11 ' A' ' 72' ' ' VAL . 20.8 p -94.33 -174.34 3.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.978 . . . . 0.0 110.702 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 35.6 mt -72.36 -10.73 60.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.942 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.2 p -104.33 -3.1 24.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.782 . . . . 0.0 109.655 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.36 2.89 60.2 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -66.65 117.0 8.19 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.163 -1.199 . . . . 0.0 108.854 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -99.19 136.73 38.72 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.102 -0.999 . . . . 0.0 109.086 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.568 HD11 ' OE2' ' B' ' 234' ' ' GLU . 23.2 mt -132.79 133.86 58.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.278 -0.889 . . . . 0.0 109.462 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 28.9 m -103.32 120.13 40.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.235 -0.916 . . . . 0.0 108.9 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' B' ' 229' ' ' LYS . 18.8 mt -123.85 120.5 32.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.439 -0.788 . . . . 0.0 109.846 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -66.62 133.05 49.48 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 201' ' ' MET . 11.5 m -140.69 -171.4 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 109.831 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -138.14 152.36 71.62 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 108.798 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.16 -28.2 78.05 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.422 2.081 . . . . 0.0 112.264 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.2 m -96.01 5.0 52.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 110.061 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.58 145.21 49.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.989 -1.069 . . . . 0.0 109.639 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.455 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 36.3 p -87.07 150.57 23.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.095 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 31.8 mm -56.81 -40.54 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.0 109.497 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -52.72 -31.38 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.087 -1.008 . . . . 0.0 109.604 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.455 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 64.1 m-20 -73.85 -51.13 17.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.181 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.8 t -51.99 -50.35 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.134 -0.979 . . . . 0.0 108.509 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -52.05 -39.46 59.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 0.0 109.198 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.75 -37.16 86.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.43 -0.794 . . . . 0.0 109.591 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' B' ' 215' ' ' LEU . 15.6 mtpp -57.81 -53.73 54.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -0.925 . . . . 0.0 109.406 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.51 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.5 mp -57.88 -37.25 59.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.086 -1.009 . . . . 0.0 109.107 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -58.52 -43.14 89.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 109.87 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.43 -22.41 60.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 0.0 110.344 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -98.83 -56.45 2.43 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.026 -1.047 . . . . 0.0 110.484 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.568 ' OE2' HD11 ' B' ' 213' ' ' ILE . 58.6 mm-40 -83.35 -7.02 59.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 111.088 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.55 24.62 73.9 Favored Glycine 0 N--CA 1.49 2.274 0 O-C-N 120.575 -1.328 . . . . 0.0 109.974 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 69.5 mt -105.72 125.21 33.86 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -1.131 . . . . 0.0 109.467 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.438 ' HG2' HE21 ' B' ' 240' ' ' GLN . 58.5 Cg_endo -75.62 154.67 39.79 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.996 1.797 . . . . 0.0 111.658 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.92 -29.82 67.25 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.7 2.267 . . . . 0.0 113.049 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.97 -17.27 36.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 0.0 110.475 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.438 HE21 ' HG2' ' B' ' 237' ' ' PRO . 1.4 pt20 -127.99 -15.54 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.51 -0.744 . . . . 0.0 110.774 -179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.78 133.62 33.64 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.037 -1.04 . . . . 0.0 109.488 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -127.97 132.37 49.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.411 -0.806 . . . . 0.0 109.503 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.9 mt -105.85 127.34 53.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.372 -0.83 . . . . 0.0 109.123 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 74.1 mt -119.93 136.03 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.683 -0.636 . . . . 0.0 109.413 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -131.25 119.06 21.25 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.449 -0.782 . . . . 0.0 108.983 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 59.73 42.45 16.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.87 -1.144 . . . . 0.0 109.455 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.26 23.87 70.21 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.112 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.18 140.51 52.5 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.117 -1.225 . . . . 0.0 109.615 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -87.97 125.14 34.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.047 -1.033 . . . . 0.0 109.603 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 20.2 mt -71.42 146.56 48.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -0.82 . . . . 0.0 109.507 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -99.68 142.59 30.96 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -68.6 3.2 1.95 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.256 -0.902 . . . . 0.0 109.599 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.99 40.41 2.01 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.6 mtt85 -144.55 168.63 19.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.06 -1.259 . . . . 0.0 109.258 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 15.0 p -108.79 155.48 20.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.397 -0.814 . . . . 0.0 109.98 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.51 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.2 mt -54.16 -42.95 70.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.888 . . . . 0.0 109.637 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 83.6 p -61.2 -27.14 68.21 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.122 -0.986 . . . . 0.0 109.511 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -15.85 62.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.965 . . . . 0.0 109.515 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -106.54 3.42 27.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.29 -0.881 . . . . 0.0 109.242 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.59 40.53 1.86 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.53 -0.731 . . . . 0.0 109.285 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.57 133.43 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.426 -0.796 . . . . 0.0 109.364 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -124.79 176.28 6.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.495 -0.753 . . . . 0.0 109.415 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.54 159.94 1.38 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.277 -0.889 . . . . 0.0 111.07 -178.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 57.85 13.14 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.092 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -75.23 148.19 39.69 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.903 -1.123 . . . . 0.0 108.676 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 8.0 m -114.06 137.05 52.24 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.405 -0.81 . . . . 0.0 110.647 -178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.66 144.42 50.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.466 -0.772 . . . . 0.0 109.328 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.42 ' HB3' HD21 ' A' ' 76' ' ' LEU . 32.5 m80 -94.39 143.3 26.52 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.132 -0.98 . . . . 0.0 110.349 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.2 tp -109.56 125.88 52.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.352 -0.842 . . . . 0.0 109.415 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.408 HG21 HG11 ' A' ' 80' ' ' VAL . 34.8 t -115.25 131.25 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.243 -0.91 . . . . 0.0 110.135 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' B' ' 271' ' ' LEU . 46.5 mt -82.76 143.95 30.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.382 -0.824 . . . . 0.0 109.626 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.528 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 23.2 ttt180 -98.46 -137.15 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.528 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 67.4 mt -124.23 -34.75 2.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.124 -0.985 . . . . 0.0 109.098 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' B' ' 273' ' ' LEU . 11.5 ttt85 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.338 -0.852 . . . . 0.0 109.545 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.1 mmtt . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.459 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 39.2 mt -107.68 134.61 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 109.942 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 70.7 m -117.17 126.34 52.63 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 75.8 m-85 -113.35 135.1 21.82 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.388 -0.82 . . . . 0.0 109.544 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.19 165.18 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.191 1.927 . . . . 0.0 112.74 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 t -65.8 -14.71 61.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.754 -0.591 . . . . 0.0 110.469 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.876 ' O ' HG22 ' B' ' 209' ' ' THR . 0.5 OUTLIER -108.65 8.45 27.0 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.08 -1.012 . . . . 0.0 110.45 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -112.12 129.54 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.261 -0.899 . . . . 0.0 111.071 -179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 5.0 t70 -99.74 138.65 20.43 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -70.69 -46.66 0.79 Allowed 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.251 1.967 . . . . 0.0 112.315 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.425 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.7 tt0 -51.07 -44.64 61.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.695 -0.628 . . . . 0.0 110.656 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.739 HG11 ' O ' ' B' ' 207' ' ' THR . 40.0 t -79.06 -24.04 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.812 -1.18 . . . . 0.0 110.203 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.428 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.9 t80 -70.47 -51.44 29.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.107 -0.996 . . . . 0.0 110.699 -179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -63.09 -16.96 61.67 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.142 -0.974 . . . . 0.0 110.055 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -82.97 -7.06 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.946 -1.096 . . . . 0.0 109.869 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 76' ' ' LEU . 95.1 mt -89.03 151.31 46.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.142 -0.974 . . . . 0.0 109.842 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -54.23 154.02 19.91 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.356 2.037 . . . . 0.0 111.913 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -63.04 -51.45 66.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 110.671 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.42 -44.81 45.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.982 -1.074 . . . . 0.0 110.085 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.5 t -75.04 -30.66 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.992 -1.068 . . . . 0.0 108.716 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.428 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 39.7 tt0 -61.7 -49.36 76.77 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.5 mmtp -58.9 -49.7 76.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.552 -0.718 . . . . 0.0 110.359 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -54.92 -40.66 70.09 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.004 -1.06 . . . . 0.0 110.121 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.42 -36.2 71.23 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.987 -1.07 . . . . 0.0 109.837 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.92 -39.98 69.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.804 -1.185 . . . . 0.0 109.172 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.59 -32.95 72.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.527 ' O ' HG22 ' A' ' 91' ' ' THR . 5.1 tp10 -75.87 -34.35 60.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.238 -0.914 . . . . 0.0 108.752 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -76.88 -17.45 58.95 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.962 -1.086 . . . . 0.0 108.491 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -89.19 -47.23 8.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.374 -0.828 . . . . 0.0 109.279 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -54.62 -39.34 67.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.797 -1.19 . . . . 0.0 108.731 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 87' ' ' GLU . 14.6 t -93.52 -36.53 12.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.148 -0.97 . . . . 0.0 109.178 179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.494 2.555 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.8 ptt? . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -95.92 164.04 12.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 110.585 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.513 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.8 141.95 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.32 141.96 27.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.298 -0.876 . . . . 0.0 109.969 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 25.0 t -121.35 110.03 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.268 -0.895 . . . . 0.0 109.388 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -96.41 135.65 37.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.885 . . . . 0.0 108.735 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.739 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.4 p -96.35 -173.46 2.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.151 -0.968 . . . . 0.0 110.771 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.442 HD11 ' H ' ' B' ' 271' ' ' LEU . 21.2 mt -72.55 -13.26 61.36 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.348 0.594 . . . . 0.0 109.671 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.876 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.6 p -100.8 -3.26 30.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.377 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.35 2.62 61.85 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.39 118.68 11.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.124 -1.221 . . . . 0.0 108.812 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 2.2 m -100.6 138.88 37.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.231 -0.918 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.2 mt -135.22 136.72 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 0.0 109.612 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.3 m -104.06 121.43 43.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.274 -0.891 . . . . 0.0 108.818 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' B' ' 229' ' ' LYS . 16.1 mt -124.57 120.97 33.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.44 -0.788 . . . . 0.0 109.882 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -68.1 133.32 48.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.651 -0.656 . . . . 0.0 109.382 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.8 m -140.82 -173.39 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.935 -1.103 . . . . 0.0 110.126 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -135.93 153.68 77.2 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.325 -0.859 . . . . 0.0 108.959 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -57.26 -25.48 65.1 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.528 2.152 . . . . 0.0 112.171 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 m -100.24 5.94 44.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 109.936 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -71.87 144.93 48.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.022 -1.049 . . . . 0.0 109.504 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.3 p -86.71 146.19 26.38 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.84 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.411 HD12 HD13 ' B' ' 250' ' ' LEU . 32.2 mm -51.65 -34.3 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.431 ' C ' ' CD ' ' B' ' 224' ' ' GLU . 0.2 OUTLIER -56.8 -38.39 72.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.384 -0.822 . . . . 0.0 109.037 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -66.57 -52.48 45.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.082 -1.011 . . . . 0.0 109.244 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.412 ' H ' HG23 ' B' ' 226' ' ' VAL . 15.6 t -52.6 -48.03 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -0.978 . . . . 0.0 108.758 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -53.44 -38.7 63.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.42 -0.8 . . . . 0.0 109.15 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -66.12 -36.53 83.38 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 109.356 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.434 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.8 mtpp -57.16 -52.84 63.68 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 109.111 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.604 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.9 mp -59.04 -36.46 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.153 -0.967 . . . . 0.0 109.178 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.436 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 2.1 tt0 -58.81 -49.56 77.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.943 -1.098 . . . . 0.0 109.741 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.56 -27.6 68.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.422 -0.799 . . . . 0.0 110.649 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 10.6 mttt -95.4 -57.01 2.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.895 -1.128 . . . . 0.0 110.55 -179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -83.04 -6.18 59.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 111.311 -178.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.08 24.76 71.94 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.244 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.495 HD13 HD21 ' B' ' 271' ' ' LEU . 63.1 mt -105.95 128.45 26.38 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.132 -1.217 . . . . 0.0 109.641 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.95 158.69 38.36 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.113 1.875 . . . . 0.0 111.933 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . 0.436 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 37.7 Cg_endo -68.11 -30.18 32.12 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.942 2.428 . . . . 0.0 113.196 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 60.0 p30 -69.14 -6.14 26.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 110.064 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.1 -20.68 3.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.769 . . . . 0.0 110.116 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.39 139.03 31.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.953 -1.092 . . . . 0.0 109.341 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -128.94 132.31 47.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.315 -0.866 . . . . 0.0 109.404 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.0 mt -105.01 123.42 47.76 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.311 -0.868 . . . . 0.0 109.439 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 56.0 mt -119.51 135.81 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.662 -0.649 . . . . 0.0 109.357 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.486 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 46.4 t80 -129.84 113.64 14.92 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.761 . . . . 0.0 109.217 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.34 42.25 5.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.931 -1.106 . . . . 0.0 109.203 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.97 39.91 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.589 -1.005 . . . . 0.0 110.589 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -105.93 137.9 43.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.181 -1.188 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -85.41 126.08 33.5 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.031 -1.043 . . . . 0.0 109.653 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.411 HD13 HD12 ' B' ' 223' ' ' ILE . 22.2 mt -77.08 145.36 37.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.199 -0.938 . . . . 0.0 109.223 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.4 144.28 31.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.176 -0.953 . . . . 0.0 109.927 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.03 3.35 3.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 109.827 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.39 37.03 3.29 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.1 mtt85 -145.16 173.35 12.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.284 . . . . 0.0 109.542 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 81.6 p -113.17 161.22 17.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.498 -0.751 . . . . 0.0 109.943 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.494 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.1 mt -60.42 -42.23 95.58 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.319 -0.863 . . . . 0.0 109.913 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.6 p -60.63 -28.26 68.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.089 -1.007 . . . . 0.0 109.201 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.26 -13.86 61.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.396 -0.815 . . . . 0.0 108.959 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.611 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 25.7 m-85 -107.1 0.36 23.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.465 -0.772 . . . . 0.0 109.572 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' B' ' 260' ' ' ASN . 0.0 OUTLIER 68.25 33.42 4.3 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 122.132 0.968 . . . . 0.0 109.725 179.637 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -85.63 133.76 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.551 -1.343 . . . . 0.0 109.523 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . 0.432 ' O ' ' OG ' ' B' ' 265' ' ' SER . 26.1 mt-30 -120.66 170.51 9.36 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.696 0.76 . . . . 0.0 109.75 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.587 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.76 160.42 0.3 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.779 0.799 . . . . 0.0 110.698 -179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 56.58 13.58 1.41 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.12 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.513 ' OG ' HG22 ' B' ' 203' ' ' ILE . 3.0 p -76.7 150.02 36.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.897 -1.127 . . . . 0.0 108.525 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.745 ' C ' HD12 ' B' ' 267' ' ' LEU . 11.4 m -114.59 137.01 52.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.482 -0.761 . . . . 0.0 110.383 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.745 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -123.25 140.18 53.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.551 -0.718 . . . . 0.0 109.264 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.412 ' HB3' HD21 ' A' ' 76' ' ' LEU . 60.7 m80 -89.46 141.84 28.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 0.0 109.796 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 17.2 tp -110.55 128.44 55.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.468 -0.77 . . . . 0.0 109.49 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 10.7 t -114.19 128.77 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 0.0 109.859 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.495 HD21 HD13 ' B' ' 236' ' ' ILE . 43.4 mt -82.4 145.43 29.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.809 . . . . 0.0 109.035 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.528 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 28.1 ttt-85 -96.33 -137.12 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 108.754 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.528 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 59.3 mt -123.1 -12.72 7.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.268 -0.895 . . . . 0.0 109.228 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.554 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 39.2 mt -109.98 133.72 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.287 -0.883 . . . . 0.0 110.149 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.9 m -115.03 126.51 54.81 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.554 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 89.0 m-85 -113.04 137.18 21.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.025 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -48.72 164.61 0.21 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.485 2.123 . . . . 0.0 113.006 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.47 -1.94 9.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.825 -0.547 . . . . 0.0 110.284 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.878 ' O ' HG22 ' B' ' 209' ' ' THR . 0.2 OUTLIER -120.67 7.23 10.51 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.178 -0.951 . . . . 0.0 110.214 -179.46 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 68' ' ' ILE . 27.3 mm -109.3 127.67 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.357 -0.84 . . . . 0.0 111.258 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.434 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 9.6 t0 -102.24 110.71 63.27 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.96 -43.83 23.8 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.211 1.94 . . . . 0.0 112.625 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -47.86 -47.62 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 110.389 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.707 HG11 ' O ' ' B' ' 207' ' ' THR . 43.8 t -78.32 -23.5 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.693 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -70.66 -53.85 14.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.974 . . . . 0.0 110.867 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -61.62 -17.49 55.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.192 -0.943 . . . . 0.0 109.876 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -81.98 -6.53 59.2 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.897 -1.127 . . . . 0.0 109.731 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 76' ' ' LEU . 93.1 mt -90.56 151.48 44.12 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.169 -0.957 . . . . 0.0 109.546 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.66 154.63 19.83 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.301 2.0 . . . . 0.0 111.898 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -49.97 71.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.324 -0.86 . . . . 0.0 110.733 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.65 -44.33 47.52 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.101 . . . . 0.0 110.087 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.484 HG11 HG21 ' B' ' 270' ' ' VAL . 45.7 t -74.68 -32.07 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.954 -1.091 . . . . 0.0 108.38 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.1 tt0 -59.61 -52.16 66.72 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.362 -0.836 . . . . 0.0 108.975 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -56.11 -49.05 74.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.524 -0.735 . . . . 0.0 110.196 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -56.5 -40.79 75.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.066 -1.021 . . . . 0.0 110.125 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.5 -37.83 68.3 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.881 -1.137 . . . . 0.0 110.039 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.7 mt -69.49 -39.14 77.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.795 -1.191 . . . . 0.0 108.927 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.86 -32.9 72.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.162 -0.961 . . . . 0.0 108.925 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.764 ' O ' HG22 ' A' ' 91' ' ' THR . 44.3 tt0 -73.28 -35.61 66.19 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.42 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 44.9 m0 -78.56 -19.24 53.26 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.184 -0.948 . . . . 0.0 109.088 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -88.71 -46.91 8.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.307 -0.87 . . . . 0.0 109.143 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.421 ' CG ' ' N ' ' A' ' 91' ' ' THR . 9.7 ptm180 -54.05 -41.49 68.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.849 -1.157 . . . . 0.0 108.367 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.764 HG22 ' O ' ' A' ' 87' ' ' GLU . 8.9 t -86.69 -35.52 19.24 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.41 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.487 2.073 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -97.58 166.15 11.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 0.0 110.708 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 pp -145.79 142.11 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -95.18 143.07 26.9 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.208 -0.933 . . . . 0.0 109.697 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 29.2 t -123.43 111.58 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.352 -0.843 . . . . 0.0 109.685 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt -97.04 140.43 31.57 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.317 -0.864 . . . . 0.0 108.68 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.707 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.9 p -100.56 -173.52 2.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.172 -0.955 . . . . 0.0 110.715 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.449 HD11 ' H ' ' B' ' 271' ' ' LEU . 30.6 mt -70.94 -13.58 62.06 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.291 -0.563 . . . . 0.0 109.527 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.878 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.3 p -102.16 -3.77 26.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.324 -0.86 . . . . 0.0 109.817 -179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.78 2.89 61.08 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -66.65 117.67 9.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.236 . . . . 0.0 108.571 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.0 m -99.91 139.2 35.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.924 . . . . 0.0 109.47 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.477 HG22 HD21 ' B' ' 215' ' ' LEU . 23.2 mt -134.94 135.77 52.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.485 -0.759 . . . . 0.0 109.289 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.0 m -103.67 122.59 45.35 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.675 ' C ' ' HZ3' ' B' ' 229' ' ' LYS . 17.1 mt -126.04 119.66 28.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.44 -0.788 . . . . 0.0 109.935 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . 0.663 ' O ' ' NZ ' ' B' ' 229' ' ' LYS . 11.5 mt-10 -66.07 129.92 41.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.484 -0.76 . . . . 0.0 109.619 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.626 HG13 ' NZ ' ' B' ' 229' ' ' LYS . 14.1 m -137.38 -172.72 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.029 -1.044 . . . . 0.0 110.012 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.11 153.77 71.74 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.847 . . . . 0.0 108.755 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -54.55 -25.87 42.94 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.577 2.184 . . . . 0.0 112.489 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 38.0 m -99.6 6.83 45.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.959 . . . . 0.0 109.873 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -70.06 141.11 52.87 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 109.605 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 24.4 p -86.07 148.69 25.6 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.312 -0.867 . . . . 0.0 109.998 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 37.9 mm -54.93 -42.5 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.311 -0.868 . . . . 0.0 109.257 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -52.44 -37.34 56.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.192 -0.942 . . . . 0.0 109.42 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -67.92 -49.25 62.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.0 108.971 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 52.8 t -52.1 -49.98 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.163 -0.961 . . . . 0.0 108.463 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.28 -37.79 49.21 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.99 -37.99 87.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.239 -0.913 . . . . 0.0 109.679 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.675 ' HZ3' ' C ' ' B' ' 215' ' ' LEU . 15.1 mtpt -55.84 -53.49 56.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.133 -0.979 . . . . 0.0 109.056 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.446 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -60.89 -32.81 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.057 -1.027 . . . . 0.0 109.149 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.416 HE21 ' HA ' ' B' ' 237' ' ' PRO . 49.2 tt0 -62.41 -51.0 69.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.254 -0.904 . . . . 0.0 110.014 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -63.33 -29.33 70.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.522 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -94.22 -58.48 2.21 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.973 -1.08 . . . . 0.0 110.504 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -82.08 -6.55 59.25 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.173 -0.955 . . . . 0.0 111.596 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.69 25.28 70.28 Favored Glycine 0 N--CA 1.492 2.416 0 O-C-N 120.338 -1.476 . . . . 0.0 110.541 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 40.9 mt -102.63 129.06 26.67 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.063 -1.257 . . . . 0.0 109.325 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.416 ' HA ' HE21 ' B' ' 231' ' ' GLN . 56.1 Cg_endo -75.02 155.2 42.8 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 121.985 1.79 . . . . 0.0 111.903 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -69.1 -29.82 26.38 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.772 2.314 . . . . 0.0 113.361 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -69.36 -8.34 45.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 110.353 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.411 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -125.55 -20.7 4.66 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.39 -0.819 . . . . 0.0 109.608 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 137.63 32.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.874 -1.141 . . . . 0.0 108.985 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -127.87 132.37 49.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.872 . . . . 0.0 109.038 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 27.2 mt -105.19 124.52 49.67 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.419 -0.801 . . . . 0.0 109.435 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.8 mt -119.68 134.03 64.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.549 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 45.6 t80 -128.28 111.6 13.56 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.46 38.29 4.32 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.97 -1.081 . . . . 0.0 108.772 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.58 4.62 53.29 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.464 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -101.48 137.71 39.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 109.765 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -86.2 125.96 33.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.069 -1.019 . . . . 0.0 109.492 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.464 HD11 HD23 ' B' ' 267' ' ' LEU . 20.1 mt -77.95 142.97 38.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.181 -0.949 . . . . 0.0 109.525 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.409 ' C ' ' H ' ' B' ' 253' ' ' GLY . 12.7 tt0 -99.8 143.56 29.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.405 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.95 3.83 1.0 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.912 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 251' ' ' GLU . . . -123.7 49.24 0.91 Allowed Glycine 0 N--CA 1.495 2.596 0 C-N-CA 120.017 -1.087 . . . . 0.0 110.786 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -153.44 169.76 22.37 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.113 -1.228 . . . . 0.0 109.211 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 3.2 p -110.94 158.08 19.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.434 -0.792 . . . . 0.0 110.097 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.429 HD23 ' N ' ' B' ' 256' ' ' LEU . 8.0 mt -55.24 -42.53 73.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.291 -0.88 . . . . 0.0 109.72 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 24.6 p -61.9 -28.1 69.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.181 -0.949 . . . . 0.0 109.741 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -72.92 -13.97 61.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.297 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -105.9 1.94 27.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 108.931 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.7 37.97 3.12 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.484 -0.76 . . . . 0.0 109.409 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.07 135.14 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.35 175.26 6.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.515 -0.741 . . . . 0.0 109.237 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.49 162.09 0.59 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.252 -0.905 . . . . 0.0 110.986 -178.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 56.42 13.38 1.28 Allowed 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.216 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.3 m -75.37 148.17 39.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.794 -1.191 . . . . 0.0 108.585 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.775 ' C ' HD12 ' B' ' 267' ' ' LEU . 4.1 m -114.04 137.43 51.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.458 -0.776 . . . . 0.0 110.177 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.775 HD12 ' C ' ' B' ' 266' ' ' THR . 8.2 mp -124.93 141.97 51.77 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.76 . . . . 0.0 109.286 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -90.85 143.06 27.11 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.089 -1.007 . . . . 0.0 109.874 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 tp -108.44 125.58 51.93 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.529 -0.732 . . . . 0.0 109.322 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.484 HG21 HG11 ' A' ' 80' ' ' VAL . 3.0 t -110.52 125.62 67.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.343 -0.848 . . . . 0.0 109.525 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.449 ' H ' HD11 ' B' ' 208' ' ' LEU . 43.0 mt -82.31 144.78 30.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.295 -0.878 . . . . 0.0 109.366 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -95.76 -137.8 0.24 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.034 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 62.9 mt -123.06 -8.78 8.25 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.239 -0.913 . . . . 0.0 109.677 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.2 tttp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.425 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 37.4 mt -113.24 132.99 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 110.657 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 86.7 m -116.9 129.77 56.27 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 90.2 m-85 -114.1 135.92 22.16 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.469 -0.77 . . . . 0.0 110.251 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -48.47 164.72 0.19 Allowed 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.302 2.001 . . . . 0.0 112.881 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 2.0 p -67.66 -1.81 5.82 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.757 -0.59 . . . . 0.0 110.789 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.857 ' O ' HG22 ' B' ' 209' ' ' THR . 6.7 m-20 -123.77 9.1 8.84 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.014 -1.054 . . . . 0.0 110.549 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.424 HD13 ' HA ' ' A' ' 68' ' ' ILE . 28.3 mm -110.12 129.07 65.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.08 -1.013 . . . . 0.0 111.463 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 7.7 t70 -93.34 136.91 23.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' O ' ' CD2' ' A' ' 74' ' ' TYR . 51.8 Cg_endo -72.12 -33.35 9.6 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.457 2.105 . . . . 0.0 113.233 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.43 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 39.3 tt0 -71.65 -37.06 70.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.187 -0.945 . . . . 0.0 110.577 -179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.631 HG11 ' O ' ' B' ' 207' ' ' THR . 61.8 t -78.23 -23.66 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 120.591 -1.318 . . . . 0.0 109.169 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -71.98 -53.33 13.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.409 -0.807 . . . . 0.0 110.698 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' ' 70' ' ' PRO . 46.3 m-85 -61.36 -17.27 53.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.179 -0.951 . . . . 0.0 109.949 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -83.42 -5.47 59.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.869 -1.144 . . . . 0.0 109.526 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 76' ' ' LEU . 91.3 mt -89.42 152.19 47.16 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.169 -0.957 . . . . 0.0 109.598 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.72 153.92 28.16 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.321 2.014 . . . . 0.0 111.938 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -50.68 69.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.281 -0.887 . . . . 0.0 110.572 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.45 -42.57 43.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.013 -1.054 . . . . 0.0 110.262 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 98.0 t -74.92 -32.89 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 108.325 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.7 tt0 -59.2 -51.95 67.79 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -56.7 -48.45 77.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.527 -0.733 . . . . 0.0 109.992 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -58.3 -40.71 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.116 -0.99 . . . . 0.0 110.217 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.61 -38.54 67.78 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.842 -1.161 . . . . 0.0 109.63 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.3 mt -69.57 -38.78 77.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.736 -1.228 . . . . 0.0 108.948 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.07 -33.02 73.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.53 -34.43 65.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 108.748 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 49.4 m0 -74.34 -17.98 60.76 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.016 -1.052 . . . . 0.0 108.729 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.9 mttp -90.71 -44.31 9.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.525 -0.734 . . . . 0.0 110.017 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.401 ' CG ' ' N ' ' A' ' 91' ' ' THR . 9.9 ptm180 -56.32 -41.24 75.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.632 -1.292 . . . . 0.0 108.004 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 92' ' ' GLY . 7.1 t -89.41 -36.26 15.57 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.494 2.549 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -95.09 164.84 12.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.128 -0.983 . . . . 0.0 110.362 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.84 143.58 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.197 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -95.8 142.16 28.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.851 . . . . 0.0 109.933 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.04 114.26 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.197 -0.939 . . . . 0.0 109.535 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.409 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.1 ptpt -99.84 139.36 35.62 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 108.993 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.631 ' O ' HG11 ' A' ' 72' ' ' VAL . 30.9 p -98.09 -178.18 3.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.933 . . . . 0.0 110.945 -178.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 51.3 mt -71.69 -12.63 61.42 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.3 p -102.59 -3.99 25.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.443 -0.786 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.05 57.27 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 119.882 -1.152 . . . . 0.0 110.527 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.9 tptm -69.28 119.07 12.97 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.002 -1.293 . . . . 0.0 108.999 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 19.3 m -102.83 140.95 36.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.479 HD11 ' CD ' ' B' ' 234' ' ' GLU . 37.6 mt -138.75 137.51 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 37.6 m -104.94 119.34 38.78 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.532 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.6 mt -123.15 121.5 36.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.438 -0.789 . . . . 0.0 109.992 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -65.18 131.49 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.0 m -137.89 -175.07 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.02 -1.05 . . . . 0.0 109.628 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -134.8 152.77 78.1 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.389 -0.819 . . . . 0.0 108.94 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.64 -23.03 46.74 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.555 2.17 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' B' ' 220' ' ' SER . 1.4 t -104.47 5.83 34.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 109.956 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.89 144.99 52.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.956 -1.09 . . . . 0.0 109.412 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 73.1 p -85.81 150.38 24.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.2 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 36.6 mm -54.51 -45.12 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.36 -0.837 . . . . 0.0 109.369 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.51 -35.89 54.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 0.0 109.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 57.2 m-20 -67.77 -52.58 35.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.072 -1.017 . . . . 0.0 109.129 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.7 t -51.9 -48.24 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.93 -1.106 . . . . 0.0 108.107 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.96 -46.64 61.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.55 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.03 -36.86 70.96 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.585 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.7 mtpp -56.92 -54.24 48.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.983 -1.073 . . . . 0.0 109.259 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.406 HD13 ' OE1' ' B' ' 241' ' ' GLN . 2.9 mp -57.31 -33.68 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.108 -0.995 . . . . 0.0 108.975 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -63.85 -44.65 92.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 109.964 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.86 -30.95 71.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 0.0 110.634 -179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -96.27 -51.97 4.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.026 -1.046 . . . . 0.0 110.683 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.479 ' CD ' HD11 ' B' ' 213' ' ' ILE . 60.4 mm-40 -85.77 -8.0 58.41 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 111.413 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.69 25.06 72.88 Favored Glycine 0 N--CA 1.492 2.426 0 O-C-N 120.501 -1.374 . . . . 0.0 110.524 179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.9 mt -104.66 130.31 23.45 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.139 -1.212 . . . . 0.0 109.733 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.445 ' HG2' HE21 ' B' ' 240' ' ' GLN . 57.6 Cg_endo -74.92 155.01 43.32 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.214 1.942 . . . . 0.0 111.748 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.48 -30.57 29.05 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.738 2.292 . . . . 0.0 113.219 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -67.05 -13.04 61.54 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 110.715 -178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.445 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.73 -19.86 6.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.418 -0.802 . . . . 0.0 110.13 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.467 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -86.09 139.79 30.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.696 -1.253 . . . . 0.0 108.928 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.425 ' NH1' HE22 ' B' ' 249' ' ' GLN . 66.5 mtt180 -129.76 129.63 44.37 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.345 -0.847 . . . . 0.0 109.449 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 17.1 mt -105.04 124.23 49.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.373 -0.83 . . . . 0.0 109.338 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 68.3 mt -117.99 134.08 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -130.36 121.12 25.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 0.0 109.092 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.46 39.4 28.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.735 -1.228 . . . . 0.0 109.871 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.3 7.31 60.05 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.057 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.66 132.86 52.16 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.089 -1.242 . . . . 0.0 109.544 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.425 HE22 ' NH1' ' B' ' 242' ' ' ARG . 30.3 tt0 -82.65 125.95 31.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.198 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.614 HD11 HD23 ' B' ' 267' ' ' LEU . 21.3 mt -76.54 141.83 41.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.574 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -101.49 147.16 26.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.26 -0.9 . . . . 0.0 109.34 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -68.91 3.91 1.76 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.872 . . . . 0.0 110.131 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -121.57 48.29 0.96 Allowed Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.916 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -156.08 171.7 19.69 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.989 -1.301 . . . . 0.0 109.245 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.469 ' OG1' ' OD2' ' B' ' 258' ' ' ASP . 7.0 p -112.69 161.32 16.99 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.478 -0.764 . . . . 0.0 110.058 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.519 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.8 mt -60.0 -42.56 94.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.956 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 78.2 p -60.55 -29.05 68.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.081 -1.012 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.469 ' OD2' ' OG1' ' B' ' 255' ' ' THR . 1.3 m-20 -70.96 -14.64 62.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.334 -0.854 . . . . 0.0 109.127 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -106.27 2.81 27.05 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 66.05 38.25 4.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.525 -0.734 . . . . 0.0 109.605 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 78.9 mt -91.19 135.25 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.339 -0.851 . . . . 0.0 109.215 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -122.46 172.96 7.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 0.0 109.649 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.606 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -49.93 160.53 0.32 Allowed 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.709 0.766 . . . . 0.0 110.506 -179.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 58.08 11.68 1.58 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.821 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 2.5 m -73.68 145.35 45.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.776 -1.202 . . . . 0.0 108.875 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.761 ' C ' HD12 ' B' ' 267' ' ' LEU . 17.2 m -113.12 136.97 52.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.584 -0.698 . . . . 0.0 109.953 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.761 HD12 ' C ' ' B' ' 266' ' ' THR . 7.4 mp -124.69 141.7 51.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.619 -0.675 . . . . 0.0 109.198 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.409 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 66.5 m80 -88.57 141.06 28.84 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.092 -1.005 . . . . 0.0 110.059 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.467 HD11 ' HG3' ' B' ' 241' ' ' GLN . 11.5 tp -108.93 126.38 53.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.289 -0.882 . . . . 0.0 108.985 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.78 130.03 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.396 -0.815 . . . . 0.0 109.836 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.5 mt -80.21 144.23 33.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.175 -0.953 . . . . 0.0 108.847 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 17.5 ttt180 -92.13 -140.76 0.19 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 108.985 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.435 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.8 mt -123.17 -21.85 5.31 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.185 -0.947 . . . . 0.0 109.496 -179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.3 mmt85 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.153 -0.967 . . . . 0.0 109.38 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 122.044 0.926 . . . . 0.0 111.203 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.445 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 30.0 mt -111.38 141.38 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 121.477 0.655 . . . . 0.0 109.694 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 80.3 m -115.94 122.13 44.36 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 71.5 m-85 -111.54 135.57 21.07 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 110.122 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.32 164.34 0.2 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.323 2.016 . . . . 0.0 112.742 178.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.63 -1.88 5.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.638 -0.664 . . . . 0.0 110.762 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.864 ' O ' HG22 ' B' ' 209' ' ' THR . 6.9 m-20 -122.9 8.29 9.34 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.066 -1.021 . . . . 0.0 110.367 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.8 mm -109.37 128.2 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.281 -0.887 . . . . 0.0 110.981 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.4 t70 -101.42 139.79 20.71 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.76 -46.99 1.45 Allowed 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.502 2.135 . . . . 0.0 112.663 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.4 tt0 -47.44 -47.0 27.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.627 -0.671 . . . . 0.0 110.608 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.5 HG11 ' O ' ' B' ' 207' ' ' THR . 50.3 t -78.99 -42.82 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 0.0 110.505 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 20.4 t80 -51.43 -53.41 37.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.028 -1.045 . . . . 0.0 110.998 -178.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -63.42 -18.82 64.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.0 110.281 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.81 -6.1 56.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.79 -1.194 . . . . 0.0 109.55 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' B' ' 268' ' ' HIS . 92.8 mt -91.07 152.35 44.09 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.147 -0.97 . . . . 0.0 109.836 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.62 154.51 30.56 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.416 2.077 . . . . 0.0 111.864 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -62.93 -50.16 71.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.27 -0.894 . . . . 0.0 110.698 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -44.61 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.971 -1.081 . . . . 0.0 110.092 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.3 -31.73 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 108.323 178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.7 tt0 -60.02 -51.96 67.42 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -56.35 -49.57 74.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.589 -0.694 . . . . 0.0 110.307 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -56.5 -40.06 74.32 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.096 -1.003 . . . . 0.0 110.495 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.96 -36.94 67.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.812 -1.18 . . . . 0.0 109.97 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.6 mt -70.96 -38.71 72.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.716 -1.24 . . . . 0.0 108.884 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.72 -33.7 73.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.145 -0.972 . . . . 0.0 108.954 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.759 ' O ' HG22 ' A' ' 91' ' ' THR . 1.7 tt0 -72.95 -35.06 66.88 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.9 m0 -79.0 -11.29 60.0 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 108.749 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -92.88 -47.7 6.9 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.328 -0.858 . . . . 0.0 108.893 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -54.4 -39.7 67.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.857 -1.152 . . . . 0.0 108.241 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 87' ' ' GLU . 7.0 t -89.21 -36.89 15.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 108.966 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.431 ' HE2' HD12 ' B' ' 256' ' ' LEU . 2.5 ptt? . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -97.13 165.03 12.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.111 -0.993 . . . . 0.0 110.467 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.484 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -145.42 142.56 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 109.581 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -94.06 140.84 29.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.2 108.99 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.304 -0.873 . . . . 0.0 109.24 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.513 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -96.54 135.37 38.52 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.5 ' O ' HG11 ' A' ' 72' ' ' VAL . 70.4 p -96.27 -174.66 3.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.077 -1.015 . . . . 0.0 110.557 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 18.0 mt -72.45 -10.54 59.92 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.32 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.864 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -102.48 -3.43 26.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.88 . . . . 0.0 109.615 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.65 0.27 62.65 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.102 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -66.93 119.67 12.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.057 -1.261 . . . . 0.0 108.887 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 14.1 m -101.44 140.03 36.29 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 109.352 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 41.2 mt -135.4 136.19 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 109.212 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.0 m -105.26 121.05 43.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 109.01 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' B' ' 229' ' ' LYS . 18.8 mt -125.4 120.73 31.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.437 -0.789 . . . . 0.0 109.868 -179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.39 133.85 51.33 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.457 HG11 HG22 ' B' ' 226' ' ' VAL . 11.4 m -140.88 -174.31 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.917 -1.114 . . . . 0.0 110.08 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -135.32 152.05 76.02 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.346 -0.847 . . . . 0.0 109.068 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.04 -26.36 49.52 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.569 2.179 . . . . 0.0 112.516 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -98.1 7.22 46.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 0.0 109.792 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -71.55 142.08 50.08 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.104 -0.997 . . . . 0.0 110.009 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 62.4 p -86.02 144.59 27.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.358 -0.839 . . . . 0.0 109.565 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.409 ' H ' HG12 ' B' ' 223' ' ' ILE . 26.2 mm -51.98 -31.79 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.129 -0.982 . . . . 0.0 108.699 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.431 ' CD ' ' C ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -61.58 -32.95 73.06 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 109.392 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 31.7 m-20 -72.66 -52.55 14.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.127 -0.983 . . . . 0.0 108.778 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.457 HG22 HG11 ' B' ' 217' ' ' VAL . 66.5 t -52.61 -47.43 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.077 -1.015 . . . . 0.0 108.388 178.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -52.8 -40.56 63.36 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.77 80.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.522 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.546 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.0 mtpp -59.04 -53.81 54.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.303 -0.873 . . . . 0.0 109.819 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.433 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -58.98 -34.24 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.867 -1.145 . . . . 0.0 109.213 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -60.98 -47.0 88.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 110.191 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -21.73 61.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.034 -1.041 . . . . 0.0 110.281 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -97.56 -59.32 1.8 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -82.94 -5.05 58.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.905 . . . . 0.0 111.341 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.52 23.61 73.68 Favored Glycine 0 N--CA 1.491 2.355 0 O-C-N 120.558 -1.339 . . . . 0.0 110.357 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 70.9 mt -103.33 125.32 35.37 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.102 -1.234 . . . . 0.0 109.439 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.448 ' HG2' HE21 ' B' ' 240' ' ' GLN . 54.4 Cg_endo -73.63 154.12 49.41 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.956 1.77 . . . . 0.0 111.928 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -65.27 -31.23 53.59 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.673 2.249 . . . . 0.0 112.945 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -63.83 -13.0 40.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.151 -0.968 . . . . 0.0 110.296 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.448 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -126.54 -16.54 5.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.792 . . . . 0.0 110.357 -179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.499 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -88.9 132.05 34.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.932 -1.105 . . . . 0.0 109.166 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.72 132.5 53.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.364 -0.835 . . . . 0.0 109.447 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.5 mt -107.16 126.56 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.498 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 83.1 mt -119.44 134.54 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 49.4 t80 -128.71 114.44 16.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 109.158 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.05 42.47 5.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.008 -1.057 . . . . 0.0 109.193 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.69 16.81 61.75 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.524 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -114.78 138.94 50.15 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.234 -1.157 . . . . 0.0 109.479 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -86.65 125.98 34.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 0.0 109.722 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 18.8 mt -78.4 157.78 28.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -117.48 144.48 45.01 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.483 -0.761 . . . . 0.0 109.842 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.18 3.77 1.98 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.453 -0.779 . . . . 0.0 109.698 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.02 33.71 4.77 Favored Glycine 0 N--CA 1.495 2.623 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 14.7 mtt85 -145.41 172.02 13.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.085 -1.244 . . . . 0.0 109.403 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.1 p -112.56 160.63 17.64 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.405 -0.809 . . . . 0.0 110.071 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.431 HD12 ' HE2' ' B' ' 201' ' ' MET . 3.1 mt -56.94 -42.38 79.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.275 -0.891 . . . . 0.0 109.388 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.4 p -60.26 -29.11 68.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 0.0 109.534 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.95 -18.59 64.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 0.0 109.241 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -104.69 3.05 31.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.383 -0.823 . . . . 0.0 109.338 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 67.34 38.97 3.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.428 -0.795 . . . . 0.0 109.89 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 47.4 mt -91.02 135.87 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -121.77 172.91 7.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.433 -0.792 . . . . 0.0 109.545 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.837 ' H ' ' HZ3' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.86 161.76 0.72 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.346 -0.847 . . . . 0.0 110.466 -179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 57.31 11.28 1.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.484 ' OG ' HG22 ' B' ' 203' ' ' ILE . 69.9 p -76.02 151.91 37.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.931 -1.105 . . . . 0.0 108.632 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.749 ' C ' HD12 ' B' ' 267' ' ' LEU . 16.1 m -116.27 136.94 52.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 110.12 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.749 HD12 ' C ' ' B' ' 266' ' ' THR . 10.0 mp -122.06 140.95 51.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.402 ' HB3' HD21 ' A' ' 76' ' ' LEU . 52.7 m80 -89.92 139.8 30.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 110.119 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.499 HD11 ' HG3' ' B' ' 241' ' ' GLN . 20.8 tp -109.22 126.47 53.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.501 -0.749 . . . . 0.0 109.041 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.0 t -115.83 130.77 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.747 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 44.0 mt -79.12 142.08 36.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -0.888 . . . . 0.0 109.136 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.6 ttt180 -92.38 -141.73 0.2 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.571 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 69.9 mt -124.62 -54.36 1.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.458 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.442 -0.786 . . . . 0.0 109.343 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.3 mttm . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.516 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 36.2 mt -111.8 131.37 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.216 -0.927 . . . . 0.0 110.314 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 59.1 m -114.36 128.21 56.23 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.516 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 75.7 m-85 -113.51 135.08 21.87 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.379 -0.826 . . . . 0.0 109.927 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -48.2 165.25 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 122.388 2.058 . . . . 0.0 113.03 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -67.47 -2.35 6.28 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.818 -0.551 . . . . 0.0 110.692 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.905 ' O ' HG22 ' B' ' 209' ' ' THR . 1.6 m-20 -122.95 9.02 9.33 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.028 -1.045 . . . . 0.0 110.321 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -111.55 129.35 67.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.369 -0.832 . . . . 0.0 110.956 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -96.08 137.01 21.77 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -72.86 -38.47 2.99 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.457 2.105 . . . . 0.0 112.643 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.37 -42.84 92.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.475 -0.766 . . . . 0.0 110.356 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.56 HG11 ' O ' ' B' ' 207' ' ' THR . 84.1 t -79.21 -23.76 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.905 -1.122 . . . . 0.0 109.783 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.6 t80 -68.04 -53.39 26.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.957 . . . . 0.0 110.714 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -62.21 -17.29 57.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 109.969 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -81.78 -6.07 58.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.958 -1.089 . . . . 0.0 109.696 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 76' ' ' LEU . 91.4 mt -90.23 151.44 44.7 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 109.532 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.79 155.06 18.87 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 122.436 2.091 . . . . 0.0 111.914 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -63.0 -50.52 70.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 110.769 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.41 -43.27 54.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.008 -1.057 . . . . 0.0 110.266 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 64.8 t -74.89 -31.1 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.929 -1.107 . . . . 0.0 108.234 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.43 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 35.0 tt0 -60.51 -49.8 76.12 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -58.34 -48.27 81.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.553 -0.717 . . . . 0.0 110.163 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.1 -40.09 80.27 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.011 -1.056 . . . . 0.0 110.336 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -71.56 -39.05 70.87 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.884 -1.135 . . . . 0.0 109.874 -179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -70.22 -36.72 74.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.726 -1.234 . . . . 0.0 109.062 178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.51 -34.16 76.32 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.233 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.521 ' OE1' ' CD1' ' A' ' 88' ' ' TRP . 5.3 tm-20 -72.0 -41.18 67.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.344 -0.848 . . . . 0.0 109.082 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.521 ' CD1' ' OE1' ' A' ' 87' ' ' GLU . 31.1 m0 -74.8 -13.13 60.54 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.95 -1.094 . . . . 0.0 109.045 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -92.79 -47.35 7.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.245 -0.909 . . . . 0.0 109.779 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 91' ' ' THR . 4.4 ptp180 -53.85 -38.83 65.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.745 -1.222 . . . . 0.0 108.508 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.423 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 5.8 t -93.25 -36.86 12.36 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.268 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.423 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.26 163.44 13.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.082 -1.011 . . . . 0.0 110.233 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.62 140.97 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.537 -0.727 . . . . 0.0 109.139 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -93.77 142.23 27.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.506 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 34.1 t -122.69 110.94 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.442 -0.786 . . . . 0.0 109.412 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -98.46 138.31 35.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.56 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.0 p -97.27 -175.04 3.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.079 -1.013 . . . . 0.0 111.08 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.501 HD11 ' H ' ' B' ' 271' ' ' LEU . 31.8 mt -71.54 -14.9 62.24 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.0 p -99.05 -4.06 33.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.616 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.31 2.42 60.47 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.9 tptm -67.63 119.19 11.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.045 -1.267 . . . . 0.0 109.062 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.98 135.71 41.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 109.588 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 47.4 mt -134.22 135.42 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.434 -0.791 . . . . 0.0 109.088 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 59.5 m -104.56 124.21 48.91 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.019 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.586 HD13 ' HB2' ' B' ' 229' ' ' LYS . 22.0 mt -126.73 120.68 29.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.45 -0.781 . . . . 0.0 109.817 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -66.11 133.67 51.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.574 -0.704 . . . . 0.0 109.295 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.5 m -139.83 -174.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.969 -1.082 . . . . 0.0 109.788 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -133.92 153.36 79.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.115 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -56.16 -18.37 23.33 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.423 2.082 . . . . 0.0 111.876 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 31.4 t -108.67 7.66 26.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.311 -0.868 . . . . 0.0 110.071 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.68 145.86 46.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.814 -1.179 . . . . 0.0 109.39 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.481 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 58.3 p -87.84 145.3 26.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.433 HD12 HD13 ' B' ' 250' ' ' LEU . 28.3 mm -51.73 -34.47 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.294 -0.879 . . . . 0.0 109.163 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.438 ' OE1' ' O ' ' B' ' 224' ' ' GLU . 0.0 OUTLIER -62.3 -32.16 72.87 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.479 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.481 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 46.9 m-20 -70.21 -51.66 29.25 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.031 -1.043 . . . . 0.0 108.251 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.416 ' H ' HG23 ' B' ' 226' ' ' VAL . 15.9 t -52.21 -44.14 40.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.464 ' HD3' HD12 ' B' ' 243' ' ' LEU . 0.0 OUTLIER -51.63 -48.31 63.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.622 -0.674 . . . . 0.0 109.431 179.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.58 -35.46 70.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.729 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.586 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.8 mtpp -58.76 -54.25 49.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.12 -0.988 . . . . 0.0 109.761 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.5 -34.36 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.097 . . . . 0.0 109.033 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.408 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 8.7 tt0 -62.2 -50.38 72.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.955 -1.091 . . . . 0.0 109.821 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.72 -27.5 69.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.684 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -97.41 -54.41 3.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.967 -1.083 . . . . 0.0 110.518 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -86.1 -6.44 59.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.0 111.329 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.23 24.18 73.37 Favored Glycine 0 N--CA 1.492 2.379 0 O-C-N 120.467 -1.396 . . . . 0.0 110.281 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 59.6 mt -107.34 130.65 22.54 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.229 -1.159 . . . . 0.0 109.675 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.435 ' HG2' HE21 ' B' ' 240' ' ' GLN . 27.7 Cg_endo -69.66 166.59 26.95 Favored 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 122.029 1.819 . . . . 0.0 111.271 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . 0.408 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 64.8 Cg_endo -83.12 -27.75 1.79 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.464 2.109 . . . . 0.0 112.711 -179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.79 -10.16 58.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.2 -0.937 . . . . 0.0 110.31 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.435 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -120.52 -25.63 5.53 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.485 -0.759 . . . . 0.0 109.78 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.02 137.8 31.98 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.621 -1.299 . . . . 0.0 108.55 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -124.07 134.39 53.41 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 110.156 -179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.464 HD12 ' HD3' ' B' ' 227' ' ' LYS . 16.9 mt -103.18 120.37 40.59 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 53.9 mt -115.24 133.94 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.598 -0.689 . . . . 0.0 109.399 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -128.23 123.79 35.09 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.55 41.58 30.58 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.629 -1.294 . . . . 0.0 108.935 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 65.29 1.07 6.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.1 ptpt -93.02 134.19 35.41 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.035 -1.273 . . . . 0.0 109.458 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -84.2 120.83 26.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 108.919 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.535 HD11 HD23 ' B' ' 267' ' ' LEU . 24.2 mt -73.5 142.55 46.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.092 -1.005 . . . . 0.0 109.645 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.1 144.52 25.42 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.892 . . . . 0.0 109.661 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -72.98 4.2 4.5 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 0.0 109.623 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.84 42.28 1.6 Allowed Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -147.37 172.9 13.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.012 -1.287 . . . . 0.0 109.365 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.433 ' OG1' ' OD1' ' B' ' 258' ' ' ASP . 6.5 p -110.03 158.16 18.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.407 -0.808 . . . . 0.0 110.067 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.451 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.7 mt -57.51 -42.23 82.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 109.849 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.2 p -61.32 -28.99 69.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.171 -0.955 . . . . 0.0 109.807 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . 0.433 ' OD1' ' OG1' ' B' ' 255' ' ' THR . 0.7 OUTLIER -70.12 -15.97 63.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.129 179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -104.69 3.03 31.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.032 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.82 39.05 3.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.504 -0.748 . . . . 0.0 109.468 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.7 mt -92.78 136.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.338 -0.851 . . . . 0.0 109.124 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -123.64 175.11 7.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.493 -0.754 . . . . 0.0 109.386 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.81 162.94 0.53 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.345 -0.847 . . . . 0.0 110.686 -178.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 57.36 13.36 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.098 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -77.01 148.84 36.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.94 -1.1 . . . . 0.0 108.595 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.809 ' C ' HD12 ' B' ' 267' ' ' LEU . 6.7 m -115.09 137.8 51.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.407 -0.808 . . . . 0.0 109.977 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.809 HD12 ' C ' ' B' ' 266' ' ' THR . 9.5 mp -125.54 140.86 52.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 0.0 109.22 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -89.05 143.05 27.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.146 -0.971 . . . . 0.0 110.234 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.95 126.35 52.99 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 5.9 t -116.56 131.4 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.353 -0.842 . . . . 0.0 109.749 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.501 ' H ' HD11 ' B' ' 208' ' ' LEU . 45.2 mt -81.58 143.97 31.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.324 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.549 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.9 ttt180 -98.69 -136.16 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.549 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.4 mt -124.09 -35.04 2.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 108.694 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.46 -0.775 . . . . 0.0 109.252 179.884 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.434 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 37.1 mt -109.36 131.81 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 110.14 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.9 m -115.61 126.11 53.77 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 76.1 m-85 -110.33 135.44 20.61 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.464 -0.772 . . . . 0.0 109.83 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -47.64 164.75 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.364 2.042 . . . . 0.0 112.874 178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.412 ' C ' ' OD1' ' A' ' 67' ' ' ASP . 0.3 OUTLIER -67.2 -1.72 4.81 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.757 -0.589 . . . . 0.0 110.682 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.851 ' O ' HG22 ' B' ' 209' ' ' THR . 4.0 m-20 -123.95 9.91 8.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.069 -1.019 . . . . 0.0 110.388 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.2 mm -112.63 129.99 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.307 -0.871 . . . . 0.0 111.268 -179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t70 -100.19 139.93 21.09 Favored Pre-proline 0 N--CA 1.492 1.651 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -71.24 -48.88 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.221 1.947 . . . . 0.0 112.297 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 31.8 tt0 -47.98 -44.02 30.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.691 -0.631 . . . . 0.0 110.271 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.593 HG11 ' O ' ' B' ' 207' ' ' THR . 49.0 t -80.2 -23.63 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.79 -1.194 . . . . 0.0 110.035 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 27.7 t80 -70.55 -53.08 17.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.987 -1.071 . . . . 0.0 111.074 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.0 m-85 -61.63 -16.32 47.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.0 110.272 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -82.75 -5.32 58.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.731 -1.231 . . . . 0.0 110.032 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 67.2 mt -90.72 151.94 44.31 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.049 -1.032 . . . . 0.0 109.857 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -55.04 155.95 17.32 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.476 2.118 . . . . 0.0 112.08 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -63.29 -50.06 71.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.263 -0.898 . . . . 0.0 110.685 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.87 -43.05 59.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.92 -1.113 . . . . 0.0 110.115 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.418 HG11 HG21 ' B' ' 270' ' ' VAL . 61.7 t -75.85 -31.85 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 108.616 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.5 tt0 -60.84 -50.4 73.6 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.8 mmtt -57.16 -49.04 77.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.661 -0.65 . . . . 0.0 110.277 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -57.7 -40.51 79.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.095 -1.003 . . . . 0.0 110.808 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.3 mt -70.53 -38.63 74.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.851 -1.156 . . . . 0.0 109.943 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.9 mt -71.49 -37.42 71.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.744 -1.222 . . . . 0.0 108.908 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.81 70.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.955 . . . . 0.0 108.916 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -76.19 -37.7 57.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.345 -0.847 . . . . 0.0 108.793 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.419 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 34.1 m0 -77.52 -18.21 57.22 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.925 -1.11 . . . . 0.0 108.77 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -92.25 -45.3 8.3 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' CG ' ' N ' ' A' ' 91' ' ' THR . 1.1 ptm85 -53.27 -39.0 63.56 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.864 -1.147 . . . . 0.0 107.992 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.424 ' N ' ' CG ' ' A' ' 90' ' ' ARG . 6.5 t -94.26 -36.2 12.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 0.0 109.152 178.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.727 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.5 167.62 10.87 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.231 -0.918 . . . . 0.0 110.429 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.54 143.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.37 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -95.62 144.03 26.4 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.331 -0.856 . . . . 0.0 110.032 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.0 t -125.28 115.29 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.61 130.0 46.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.287 -0.883 . . . . 0.0 108.944 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.593 ' O ' HG11 ' A' ' 72' ' ' VAL . 32.6 p -87.21 -177.1 5.91 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.011 0.91 . . . . 0.0 110.774 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.603 HD11 ' H ' ' B' ' 271' ' ' LEU . 46.9 mt -72.74 -14.98 61.67 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.424 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.851 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -98.11 -3.88 36.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.388 -0.82 . . . . 0.0 109.529 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.04 5.05 57.48 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.311 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -71.37 118.08 13.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.881 -1.364 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 20.0 m -99.59 135.56 40.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.278 -0.888 . . . . 0.0 109.012 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.667 HD11 ' CD ' ' B' ' 234' ' ' GLU . 37.6 mt -134.11 137.35 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.449 -0.782 . . . . 0.0 109.521 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 86.5 m -104.77 125.23 50.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.74 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.5 mt -127.47 119.95 27.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 110.049 -179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -65.58 131.9 47.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.83 -173.92 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.964 -1.085 . . . . 0.0 109.573 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -136.19 153.06 76.36 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 108.869 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.75 -24.26 45.5 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.382 2.054 . . . . 0.0 111.906 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.29 5.98 44.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.921 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -70.45 142.51 51.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.997 -1.064 . . . . 0.0 109.363 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 60.5 p -86.2 146.0 26.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.219 -0.926 . . . . 0.0 110.141 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.7 mm -51.41 -35.31 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.408 -0.807 . . . . 0.0 109.066 179.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.13 -34.62 72.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.4 -0.813 . . . . 0.0 109.546 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -70.99 -52.6 18.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 0.0 109.365 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.407 ' O ' HD12 ' B' ' 230' ' ' ILE . 38.0 t -52.32 -43.13 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.135 -0.978 . . . . 0.0 108.824 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.31 -41.29 79.6 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.8 -36.14 82.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.418 -0.801 . . . . 0.0 109.277 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' B' ' 215' ' ' LEU . 16.7 mtpp -56.94 -53.72 54.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.095 -1.003 . . . . 0.0 108.744 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.604 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.5 mp -56.59 -35.49 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.205 -0.934 . . . . 0.0 108.925 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -62.77 -49.58 74.43 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.237 -0.914 . . . . 0.0 109.921 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.41 -31.45 70.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.251 -0.906 . . . . 0.0 110.763 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -98.1 -53.96 3.22 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.966 -1.083 . . . . 0.0 110.846 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.667 ' CD ' HD11 ' B' ' 213' ' ' ILE . 14.7 mm-40 -81.22 -8.65 59.79 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.165 -0.959 . . . . 0.0 111.132 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.88 20.84 68.97 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 120.625 -1.297 . . . . 0.0 110.396 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 53.5 mt -100.72 129.51 27.4 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.096 -1.238 . . . . 0.0 109.345 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.47 ' HG2' HE21 ' B' ' 240' ' ' GLN . 48.4 Cg_endo -73.23 158.67 48.49 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.069 1.846 . . . . 0.0 111.88 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.18 -31.25 14.84 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.692 2.261 . . . . 0.0 112.899 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -69.59 -6.24 29.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.142 -0.974 . . . . 0.0 110.443 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.47 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.99 -16.86 4.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.364 -0.835 . . . . 0.0 110.26 -179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.7 140.2 31.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 0.0 109.184 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 -129.74 134.49 47.65 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.431 ' CB ' HD12 ' B' ' 250' ' ' LEU . 12.1 mt -106.85 126.67 52.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.347 -0.845 . . . . 0.0 109.269 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.9 mt -119.81 135.18 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.628 -0.67 . . . . 0.0 109.626 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.557 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 50.7 t80 -127.11 109.21 11.63 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 67.41 41.21 2.48 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.868 -1.145 . . . . 0.0 109.267 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.18 1.99 23.2 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -98.57 135.85 39.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.059 -1.26 . . . . 0.0 109.585 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -82.75 123.62 29.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 109.272 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.524 HD11 HD23 ' B' ' 267' ' ' LEU . 39.7 mt -71.45 142.72 50.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.11 -0.994 . . . . 0.0 109.156 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.0 146.51 28.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.954 . . . . 0.0 109.916 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.5 OUTLIER -72.81 3.43 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 0.0 109.684 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.23 44.09 1.46 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -155.86 172.44 18.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.905 -1.35 . . . . 0.0 109.461 179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 76.2 p -113.54 162.5 16.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.624 -0.672 . . . . 0.0 110.149 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.472 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.8 mt -56.34 -44.5 80.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.4 p -60.22 -27.99 67.63 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.291 -0.88 . . . . 0.0 109.737 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.75 -20.85 62.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.015 . . . . 0.0 109.469 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -100.9 5.45 43.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 66.91 39.69 3.26 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.663 -0.648 . . . . 0.0 109.591 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 95.6 mt -96.01 137.0 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.305 -0.872 . . . . 0.0 109.345 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -126.26 178.39 5.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 109.334 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.548 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.05 158.98 1.3 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.971 -178.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 58.11 24.02 10.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.304 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.35 148.72 25.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.479 -1.388 . . . . 0.0 108.675 178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.786 ' C ' HD12 ' B' ' 267' ' ' LEU . 1.8 m -110.87 134.48 52.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.649 -0.657 . . . . 0.0 109.685 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.786 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -124.04 139.06 54.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.541 -0.724 . . . . 0.0 109.226 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -89.05 143.56 26.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.08 -1.012 . . . . 0.0 110.001 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.2 tp -109.86 127.41 54.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.493 -0.754 . . . . 0.0 109.023 179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.418 HG21 HG11 ' A' ' 80' ' ' VAL . 42.5 t -112.76 128.17 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.391 -0.818 . . . . 0.0 109.576 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.603 ' H ' HD11 ' B' ' 208' ' ' LEU . 44.9 mt -81.3 143.6 32.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.242 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.521 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 31.9 ttt180 -96.94 -136.26 0.25 Allowed 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.521 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 46.5 mt -123.75 -24.63 4.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.171 -0.955 . . . . 0.0 109.073 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.825 . . . . 0.0 109.389 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.9 mttm . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.587 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 49.2 mt -109.44 131.99 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -0.882 . . . . 0.0 110.391 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 97.2 m -113.76 125.41 54.08 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.587 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 80.0 m-85 -111.58 136.37 21.06 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.351 -0.843 . . . . 0.0 110.079 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_exo -48.12 164.81 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.457 2.104 . . . . 0.0 112.917 177.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.35 -2.14 5.72 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.782 -0.573 . . . . 0.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.877 ' O ' HG22 ' B' ' 209' ' ' THR . 0.5 OUTLIER -123.63 9.17 8.93 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.141 -0.975 . . . . 0.0 110.423 -179.401 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.4 mm -110.84 129.37 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.167 -0.958 . . . . 0.0 111.267 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.5 t0 -100.24 140.19 21.28 Favored Pre-proline 0 N--CA 1.493 1.702 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.24 -47.04 0.57 Allowed 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.407 2.071 . . . . 0.0 112.219 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.531 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 0.2 OUTLIER -47.25 -45.32 23.59 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.738 -0.601 . . . . 0.0 110.336 -179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.595 HG11 ' O ' ' B' ' 207' ' ' THR . 21.6 t -80.71 -33.03 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.82 -1.175 . . . . 0.0 110.526 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 18.1 t80 -60.76 -54.39 45.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 0.0 110.909 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -61.66 -18.13 58.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.85 . . . . 0.0 109.936 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -81.35 -5.88 58.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.86 -1.15 . . . . 0.0 109.712 179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 76' ' ' LEU . 95.2 mt -90.63 151.56 44.09 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.619 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.28 155.28 16.34 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.342 2.028 . . . . 0.0 111.99 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.3 tt0 -63.53 -49.03 75.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 110.744 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.02 -42.97 60.78 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.898 -1.126 . . . . 0.0 110.156 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.7 t -74.77 -32.19 27.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.973 -1.08 . . . . 0.0 108.373 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.425 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.0 tt0 -59.61 -49.5 77.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -58.09 -49.47 76.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.54 -0.725 . . . . 0.0 110.206 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -58.29 -39.52 79.51 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.0 110.366 -179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 94.9 mt -72.28 -38.23 68.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.922 -1.111 . . . . 0.0 109.817 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.8 mt -71.04 -37.14 72.55 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.716 -1.24 . . . . 0.0 109.089 178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.45 -33.23 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.222 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 91' ' ' THR . 2.9 tm-20 -73.68 -38.22 64.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.267 -0.895 . . . . 0.0 109.0 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 38.0 m0 -75.97 -14.71 60.24 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.949 -1.095 . . . . 0.0 108.485 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -92.96 -46.28 7.56 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.388 -0.82 . . . . 0.0 109.439 179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -53.97 -40.5 66.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.73 -1.231 . . . . 0.0 108.028 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 87' ' ' GLU . 14.7 t -87.05 -36.89 17.93 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.9 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.86 163.92 12.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.12 -0.988 . . . . 0.0 110.482 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.52 145.93 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.226 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -99.13 141.98 31.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.717 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -121.38 113.37 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.266 -0.896 . . . . 0.0 109.714 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.548 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -100.81 129.31 46.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.179 -0.951 . . . . 0.0 108.79 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.595 ' O ' HG11 ' A' ' 72' ' ' VAL . 31.1 p -90.19 -171.79 3.24 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.036 0.922 . . . . 0.0 111.36 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.617 HD11 ' H ' ' B' ' 271' ' ' LEU . 40.8 mt -71.74 -17.79 62.17 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.716 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.877 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.8 p -97.56 -2.64 41.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.675 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.07 2.42 62.41 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -65.61 118.63 9.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.136 -1.214 . . . . 0.0 108.856 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 23.0 m -101.35 133.07 46.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.108 -0.995 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.5 mt -128.27 137.88 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.468 -0.77 . . . . 0.0 109.626 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 49.6 m -105.96 120.76 42.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 108.768 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.557 HD13 ' HB2' ' B' ' 229' ' ' LYS . 23.6 mt -125.53 121.02 32.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 110.393 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -67.29 132.2 47.25 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.5 m -138.86 -172.56 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.888 -1.132 . . . . 0.0 109.854 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 57.6 mt-10 -134.73 153.56 78.93 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.083 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -58.15 -24.03 64.54 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.478 2.118 . . . . 0.0 111.815 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.76 6.91 41.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.381 -0.825 . . . . 0.0 109.783 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -71.63 143.93 49.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.954 -1.091 . . . . 0.0 109.571 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.404 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 16.2 p -87.63 145.92 25.96 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.0 109.824 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 33.2 mm -51.79 -39.82 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.891 . . . . 0.0 109.178 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.26 -34.4 57.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.565 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.404 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 63.4 m-20 -72.24 -50.22 29.01 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.178 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 51.2 t -51.99 -49.72 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.031 -1.043 . . . . 0.0 108.557 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.54 -42.87 62.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.571 -0.705 . . . . 0.0 109.477 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.0 -35.88 75.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.321 -0.862 . . . . 0.0 109.517 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.557 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.5 mtpp -57.41 -53.71 55.08 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.246 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -59.52 -33.16 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.078 -1.013 . . . . 0.0 109.425 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.42 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 1.3 tt0 -61.04 -47.63 85.5 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.99 -1.069 . . . . 0.0 110.118 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.56 -26.71 63.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.008 -1.058 . . . . 0.0 110.906 -178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -94.52 -50.06 5.38 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.886 -1.134 . . . . 0.0 110.529 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -92.64 -7.69 46.23 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.175 -0.953 . . . . 0.0 111.396 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.27 21.18 77.19 Favored Glycine 0 N--CA 1.493 2.441 0 O-C-N 120.44 -1.413 . . . . 0.0 110.726 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 24.9 mt -103.98 128.11 27.88 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.909 -1.347 . . . . 0.0 109.587 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.442 ' HG2' HE21 ' B' ' 240' ' ' GLN . 28.6 Cg_endo -70.87 164.79 34.38 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.183 1.922 . . . . 0.0 112.497 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . 0.42 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 57.3 Cg_endo -73.9 -31.95 7.7 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.011 2.474 . . . . 0.0 113.383 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -73.63 -5.91 43.41 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.111 -0.993 . . . . 0.0 111.243 -178.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.442 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.9 -25.97 4.9 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.283 -0.886 . . . . 0.0 110.663 -179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.476 ' HB2' HD11 ' B' ' 269' ' ' LEU . 1.6 pt20 -90.19 147.95 23.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.385 -1.447 . . . . 0.0 108.816 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -131.37 133.37 45.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -0.995 . . . . 0.0 109.622 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.5 mt -103.84 123.24 46.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.439 -0.788 . . . . 0.0 109.016 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 97.8 mt -117.55 133.97 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.65 -0.657 . . . . 0.0 109.378 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.427 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 44.5 t80 -129.05 117.24 20.55 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 60.3 37.23 20.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.654 -1.279 . . . . 0.0 109.21 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.79 -3.29 28.03 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -94.96 132.56 39.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.828 -1.395 . . . . 0.0 109.501 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -82.58 125.07 30.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.111 -0.993 . . . . 0.0 109.481 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 15.5 mt -76.11 140.75 41.96 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.275 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.453 ' HG3' ' H ' ' B' ' 253' ' ' GLY . 9.0 tp10 -101.62 148.92 24.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.58 4.16 2.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.337 -0.852 . . . . 0.0 110.832 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.453 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -119.15 46.02 1.18 Allowed Glycine 0 N--CA 1.497 2.721 0 C-N-CA 119.914 -1.136 . . . . 0.0 110.937 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.92 174.41 15.38 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.905 -1.35 . . . . 0.0 109.515 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 17.0 p -112.65 160.67 17.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.45 -0.781 . . . . 0.0 110.257 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.6 mt -58.48 -41.11 84.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.42 -0.8 . . . . 0.0 109.749 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 30.0 p -61.72 -28.04 69.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.19 -0.944 . . . . 0.0 109.418 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -70.55 -19.68 62.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.334 -0.854 . . . . 0.0 109.38 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -103.17 3.58 35.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.95 . . . . 0.0 109.062 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 66.54 38.93 3.97 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.551 -0.718 . . . . 0.0 109.99 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 49.6 mt -92.81 137.69 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.155 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -126.16 176.23 7.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 0.0 110.073 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.509 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.69 160.35 0.91 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.914 0.864 . . . . 0.0 110.834 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 56.04 12.67 0.97 Allowed 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.123 177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 16.1 m -78.22 152.03 32.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.882 -1.136 . . . . 0.0 108.644 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.781 ' C ' HD12 ' B' ' 267' ' ' LEU . 15.4 m -116.34 137.97 51.71 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.478 -0.764 . . . . 0.0 110.388 -178.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.781 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -123.97 140.88 52.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.607 -0.683 . . . . 0.0 109.359 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.433 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 68.2 m80 -88.95 141.12 28.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.115 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.476 HD11 ' HB2' ' B' ' 241' ' ' GLN . 14.3 tp -110.08 127.85 55.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 39.0 t -116.97 132.21 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.347 -0.846 . . . . 0.0 109.776 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.617 ' H ' HD11 ' B' ' 208' ' ' LEU . 45.4 mt -80.84 141.39 34.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.115 -0.991 . . . . 0.0 109.289 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.572 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 24.9 ttt180 -96.46 -137.31 0.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.572 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 82.3 mt -124.73 -45.47 1.9 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 0.0 109.522 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.466 -0.771 . . . . 0.0 109.511 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.524 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 37.3 mt -110.43 131.61 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 110.266 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.1 m -113.58 127.93 56.25 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.524 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 77.4 m-85 -113.98 136.13 22.12 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.837 . . . . 0.0 110.285 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -48.25 164.84 0.17 Allowed 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.309 2.006 . . . . 0.0 113.12 177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.88 -2.16 6.88 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.754 -0.591 . . . . 0.0 110.534 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.952 ' O ' HG22 ' B' ' 209' ' ' THR . 2.2 m-20 -122.66 7.31 9.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.098 -1.001 . . . . 0.0 110.387 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 25.5 mm -108.96 128.66 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.111 -0.993 . . . . 0.0 110.967 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.3 t0 -101.09 140.45 21.31 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.11 -48.75 0.42 Allowed 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.495 2.13 . . . . 0.0 112.432 179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.504 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.3 tt0 -47.07 -46.86 22.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.733 -0.604 . . . . 0.0 110.46 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.674 HG11 ' O ' ' B' ' 207' ' ' THR . 57.8 t -80.42 -23.67 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.966 -1.084 . . . . 0.0 110.234 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 22.9 t80 -72.17 -54.89 8.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.9 -1.125 . . . . 0.0 111.03 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -60.9 -19.13 59.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 109.926 -178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -80.26 -4.18 52.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.877 -1.14 . . . . 0.0 109.302 179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 83.8 mt -91.74 152.65 43.41 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.257 -0.902 . . . . 0.0 109.847 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.5 154.36 30.62 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.415 2.077 . . . . 0.0 111.852 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -63.31 -48.06 79.66 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.333 -0.854 . . . . 0.0 110.933 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.25 -43.16 61.46 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.92 -1.113 . . . . 0.0 110.44 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.49 HG11 HG21 ' B' ' 270' ' ' VAL . 57.9 t -75.06 -31.97 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 0.0 108.361 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.435 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.6 tt0 -59.88 -50.51 73.51 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.2 mmtt -58.39 -48.14 81.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.747 . . . . 0.0 110.201 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -58.86 -41.98 88.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -0.938 . . . . 0.0 110.789 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.4 mt -71.15 -37.31 72.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.689 -1.257 . . . . 0.0 109.723 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.6 mt -70.26 -37.54 74.93 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.855 -1.153 . . . . 0.0 109.036 178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.78 73.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.055 -1.028 . . . . 0.0 109.003 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' O ' HG22 ' A' ' 91' ' ' THR . 20.8 tt0 -71.36 -40.31 70.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.0 108.819 178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 23.8 m0 -74.86 -12.15 60.31 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.057 -1.027 . . . . 0.0 109.192 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -92.36 -47.87 6.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.288 -0.882 . . . . 0.0 109.506 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -53.63 -38.86 64.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.752 -1.217 . . . . 0.0 108.136 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 87' ' ' GLU . 12.5 t -91.96 -36.76 13.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.27 -0.894 . . . . 0.0 108.97 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.444 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 2.8 ptt? . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 164.28 12.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.119 -0.988 . . . . 0.0 110.599 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.0 143.02 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -94.83 140.78 29.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.712 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.6 t -120.04 110.43 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.241 -0.912 . . . . 0.0 109.304 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.7 ptpt -97.1 132.4 42.93 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.674 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.8 p -94.45 -174.61 3.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.101 -1.0 . . . . 0.0 111.066 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 33.3 mt -72.17 -14.27 61.77 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.343 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.952 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.1 p -99.71 -4.33 30.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.455 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.63 1.8 60.2 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -66.8 117.85 9.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.143 -1.21 . . . . 0.0 108.848 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 8.6 m -101.0 133.07 46.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 108.978 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 26.6 mt -127.63 135.6 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.48 -0.762 . . . . 0.0 109.503 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 19.0 m -102.63 121.38 42.29 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.591 HD13 ' CB ' ' B' ' 229' ' ' LYS . 33.2 mt -127.39 119.45 26.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 110.369 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -65.5 130.97 45.19 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 10.7 m -137.27 -177.01 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.985 -1.072 . . . . 0.0 110.066 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -130.18 153.54 81.18 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.394 -0.816 . . . . 0.0 109.034 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -59.26 -17.95 42.27 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.401 2.068 . . . . 0.0 111.946 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.33 8.47 29.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 110.024 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.0 144.54 47.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.847 -1.158 . . . . 0.0 109.803 -179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 64.6 p -87.04 145.86 26.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.376 -0.827 . . . . 0.0 110.129 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.455 HD12 HD13 ' B' ' 250' ' ' LEU . 42.9 mm -50.88 -28.51 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.366 -0.834 . . . . 0.0 108.916 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.425 ' C ' ' CD ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -64.3 -37.39 87.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.837 . . . . 0.0 109.388 179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -69.06 -50.38 48.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.0 109.174 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 91.6 t -51.91 -48.81 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.096 -1.003 . . . . 0.0 108.685 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -52.5 -40.48 62.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.6 -0.688 . . . . 0.0 109.359 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -63.41 -35.61 80.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.345 -0.847 . . . . 0.0 109.639 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.591 ' CB ' HD13 ' B' ' 215' ' ' LEU . 17.2 mtpp -58.21 -53.64 55.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.915 -1.116 . . . . 0.0 109.145 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.8 mp -59.46 -35.11 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.111 -0.993 . . . . 0.0 109.204 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -59.36 -44.25 92.72 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.095 -1.003 . . . . 0.0 109.966 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.91 -29.28 63.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.13 -0.981 . . . . 0.0 110.764 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -91.99 -48.87 6.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.928 -1.108 . . . . 0.0 110.605 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -92.26 -6.71 49.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.164 -0.96 . . . . 0.0 111.58 -178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.68 22.98 73.85 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.482 -1.386 . . . . 0.0 110.389 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 56.5 mt -101.31 129.49 26.85 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 120.97 -1.312 . . . . 0.0 109.47 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.455 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.6 Cg_endo -75.4 155.46 41.08 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 122.029 1.819 . . . . 0.0 111.643 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.6 -32.39 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.698 2.265 . . . . 0.0 113.015 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -64.42 -8.97 15.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.455 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.64 -21.58 3.41 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.834 -0.746 . . . . 0.0 110.753 -179.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.532 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -84.48 135.38 34.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.749 -1.219 . . . . 0.0 109.299 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -126.95 131.54 51.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 10.2 mt -106.04 126.76 52.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.35 -0.844 . . . . 0.0 109.333 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 54.2 mt -120.93 134.69 63.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -128.31 121.51 29.4 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.84 42.79 28.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.571 -1.331 . . . . 0.0 109.275 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.72 0.03 7.89 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -95.52 132.37 40.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.872 -1.37 . . . . 0.0 109.291 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.7 123.61 29.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.084 -1.01 . . . . 0.0 108.83 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.548 HD11 HD23 ' B' ' 267' ' ' LEU . 19.4 mt -68.81 150.73 47.5 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.186 -0.946 . . . . 0.0 109.744 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -104.3 141.57 36.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.375 -0.828 . . . . 0.0 109.42 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.51 3.49 3.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.336 -0.853 . . . . 0.0 109.322 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.18 35.77 3.4 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -142.34 170.95 14.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.295 . . . . 0.0 109.813 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 36.3 p -111.79 159.96 17.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.515 -0.741 . . . . 0.0 110.001 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.505 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.0 mt -56.5 -42.85 79.02 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.244 -0.91 . . . . 0.0 109.806 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 79.5 p -62.74 -29.13 70.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.199 -0.938 . . . . 0.0 109.649 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.8 -18.61 63.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.158 -0.964 . . . . 0.0 109.101 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -103.55 3.45 34.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 109.151 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.84 39.15 2.68 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.501 -0.749 . . . . 0.0 109.837 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 56.7 mt -93.86 136.97 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.228 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . 0.467 ' O ' ' OG ' ' B' ' 265' ' ' SER . 55.6 mt-30 -125.81 177.17 6.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.48 -0.763 . . . . 0.0 109.593 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.447 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.26 162.24 0.76 Allowed 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.245 -0.909 . . . . 0.0 110.927 -178.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 56.33 12.42 1.01 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.053 177.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 72.7 m -76.5 149.05 36.79 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.891 -1.131 . . . . 0.0 108.75 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.799 ' C ' HD12 ' B' ' 267' ' ' LEU . 20.5 m -115.83 138.95 50.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 110.352 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.799 HD12 ' C ' ' B' ' 266' ' ' THR . 10.3 mp -124.88 142.81 51.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.432 -0.793 . . . . 0.0 109.406 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.407 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 69.2 m80 -90.67 141.75 28.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.034 -1.041 . . . . 0.0 109.858 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' B' ' 241' ' ' GLN . 23.0 tp -111.28 128.89 56.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.412 -0.805 . . . . 0.0 109.578 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.49 HG21 HG11 ' A' ' 80' ' ' VAL . 3.1 t -116.76 130.74 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.401 -0.812 . . . . 0.0 109.576 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' B' ' 271' ' ' LEU . 48.3 mt -82.57 145.66 29.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.187 -0.946 . . . . 0.0 109.369 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.526 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 32.0 ttt180 -97.69 -136.31 0.26 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.526 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 53.9 mt -124.25 -33.07 3.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.241 -0.912 . . . . 0.0 109.429 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.536 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.7 tptp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 122.052 0.929 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.407 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 30.1 mt -114.45 136.86 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.419 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.9 m -113.94 122.96 48.55 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.407 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 83.5 m-85 -109.21 135.92 20.19 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.793 . . . . 0.0 109.94 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_exo -48.09 164.13 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.287 1.991 . . . . 0.0 112.757 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.18 -2.19 5.44 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.709 -0.619 . . . . 0.0 110.653 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.932 ' O ' HG22 ' B' ' 209' ' ' THR . 2.6 m-20 -123.22 9.66 9.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.081 -1.012 . . . . 0.0 110.698 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.8 mm -110.29 127.61 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.101 -0.999 . . . . 0.0 111.119 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.0 t70 -98.33 138.73 20.87 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -69.36 -41.69 4.53 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.338 2.025 . . . . 0.0 112.567 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 61.2 tt0 -56.61 -43.34 80.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.513 -0.742 . . . . 0.0 110.466 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.599 HG11 ' O ' ' B' ' 207' ' ' THR . 66.0 t -81.11 -24.24 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.748 -1.22 . . . . 0.0 110.402 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.5 t80 -72.24 -55.07 7.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -59.09 -16.76 20.94 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -83.93 -5.76 59.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.996 -1.065 . . . . 0.0 109.877 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 97.5 mt -88.4 151.38 48.39 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.006 -1.059 . . . . 0.0 109.786 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -54.6 153.81 22.37 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.28 1.987 . . . . 0.0 111.792 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -63.03 -51.57 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 110.583 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.94 -43.5 39.66 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.928 -1.108 . . . . 0.0 110.239 -178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 69.5 t -75.27 -31.45 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.928 -1.107 . . . . 0.0 108.712 178.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -60.49 -50.03 75.19 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -58.1 -49.04 78.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.753 . . . . 0.0 110.145 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -57.11 -41.99 80.01 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.134 -0.979 . . . . 0.0 110.325 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.6 mt -70.63 -38.61 73.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.852 -1.155 . . . . 0.0 110.023 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 mt -70.56 -38.33 74.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.68 -1.262 . . . . 0.0 109.327 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.48 -31.44 70.47 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.161 -0.962 . . . . 0.0 108.708 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.547 ' OE2' ' CD2' ' B' ' 273' ' ' LEU . 5.9 tt0 -72.21 -42.64 65.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.553 -0.717 . . . . 0.0 109.302 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -73.02 -13.95 61.32 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.983 -1.073 . . . . 0.0 109.391 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -92.73 -46.28 7.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.191 -0.943 . . . . 0.0 109.504 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.454 ' HE ' ' HA ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -53.35 -38.75 63.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.765 -1.209 . . . . 0.0 108.15 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 6.3 t -91.32 -36.56 13.79 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.0 108.923 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.427 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.419 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.441 ' O ' HG23 ' B' ' 217' ' ' VAL . 3.2 ptt? . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' B' ' 202' ' ' GLN . 0.7 OUTLIER -98.19 166.84 11.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 110.334 -178.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -146.34 146.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.427 -0.796 . . . . 0.0 109.781 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -97.89 141.06 31.34 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.192 -0.943 . . . . 0.0 109.333 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.87 109.12 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.58 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.463 ' HE2' HG21 ' B' ' 266' ' ' THR . 0.5 OUTLIER -95.17 133.31 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.599 ' O ' HG11 ' A' ' 72' ' ' VAL . 34.6 p -94.78 -176.38 3.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.028 -1.045 . . . . 0.0 110.914 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.592 HD11 ' H ' ' B' ' 271' ' ' LEU . 25.7 mt -71.22 -12.8 61.67 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.489 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.932 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.7 p -101.79 -3.96 27.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 0.0 109.709 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.63 2.94 58.53 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.7 tptm -68.41 118.41 11.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.272 . . . . 0.0 109.021 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -101.01 135.86 41.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 40.9 mt -133.43 136.77 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.384 -0.823 . . . . 0.0 109.349 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 31.1 m -105.91 122.49 46.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.534 HD13 ' CB ' ' B' ' 229' ' ' LYS . 18.4 mt -126.11 121.7 33.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.463 -0.773 . . . . 0.0 110.391 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.54 132.24 47.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 201' ' ' MET . 8.2 m -140.2 -173.65 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.968 -1.082 . . . . 0.0 109.58 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -134.95 154.2 79.06 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.904 . . . . 0.0 109.034 179.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -55.97 -20.62 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.545 2.163 . . . . 0.0 112.223 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 67.4 m -106.3 7.66 31.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 110.219 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.33 142.2 54.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.77 -1.206 . . . . 0.0 109.404 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 14.5 p -85.43 146.85 26.77 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.414 HD12 HD13 ' B' ' 250' ' ' LEU . 40.5 mm -51.7 -40.26 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.389 -0.82 . . . . 0.0 109.384 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -56.17 -35.67 67.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.335 -0.853 . . . . 0.0 109.568 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -69.13 -52.3 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -0.883 . . . . 0.0 109.338 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 99.0 t -52.51 -45.58 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.984 -1.073 . . . . 0.0 108.377 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -54.06 -43.69 70.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.567 -0.708 . . . . 0.0 109.335 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.97 -34.7 73.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.37 -0.831 . . . . 0.0 109.444 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.534 ' CB ' HD13 ' B' ' 215' ' ' LEU . 4.4 mtpm? -58.55 -54.53 46.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.409 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.495 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.3 mp -57.86 -34.18 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 108.848 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -63.1 -46.14 88.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.236 -0.915 . . . . 0.0 109.997 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -30.81 71.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.184 -0.947 . . . . 0.0 110.902 -178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -95.87 -50.67 4.79 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.008 -1.058 . . . . 0.0 110.556 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -87.39 -7.69 57.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.032 -1.043 . . . . 0.0 111.412 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.75 23.27 70.67 Favored Glycine 0 N--CA 1.493 2.446 0 O-C-N 120.535 -1.353 . . . . 0.0 110.305 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 45.9 mt -100.48 126.7 34.95 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.086 -1.244 . . . . 0.0 109.271 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.451 ' HG2' HE21 ' B' ' 240' ' ' GLN . 57.7 Cg_endo -75.15 152.78 40.48 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.064 1.843 . . . . 0.0 111.767 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.04 -30.1 47.95 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.668 2.245 . . . . 0.0 112.694 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -61.24 -16.1 41.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.364 -0.835 . . . . 0.0 110.521 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.451 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -127.08 -12.36 5.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.422 -0.798 . . . . 0.0 110.696 -179.371 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.575 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -90.86 137.0 32.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.917 -1.115 . . . . 0.0 109.523 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -130.18 132.09 45.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 109.654 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.2 mt -106.92 128.78 54.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.27 -0.894 . . . . 0.0 109.297 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 61.8 mt -121.56 136.22 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.563 -0.711 . . . . 0.0 109.85 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.501 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 40.9 t80 -132.36 117.02 17.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.414 -0.804 . . . . 0.0 109.233 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.35 36.96 8.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.895 -1.128 . . . . 0.0 109.436 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.8 13.0 68.51 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 120.494 -0.86 . . . . 0.0 111.295 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -115.45 137.8 51.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.052 -1.263 . . . . 0.0 109.524 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -81.56 126.17 31.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.08 -1.013 . . . . 0.0 109.435 -179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.414 HD13 HD12 ' B' ' 223' ' ' ILE . 23.0 mt -70.69 139.78 51.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -92.6 142.2 27.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.192 -0.942 . . . . 0.0 109.486 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.471 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.5 m-20 -69.26 3.45 2.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.304 -0.872 . . . . 0.0 109.712 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.44 41.68 1.73 Allowed Glycine 0 N--CA 1.494 2.513 0 C-N-CA 120.116 -1.04 . . . . 0.0 110.543 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.8 mtt85 -144.78 171.25 14.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.253 . . . . 0.0 109.332 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 25.8 p -111.73 158.32 19.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.454 -0.779 . . . . 0.0 109.962 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.481 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.4 mt -54.88 -40.7 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 89.0 p -64.2 -28.35 69.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.91 . . . . 0.0 109.547 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.61 -17.17 62.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 109.395 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -105.17 3.16 29.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 109.084 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.69 37.85 3.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.49 -0.756 . . . . 0.0 109.999 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 70.8 mt -93.48 135.92 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -125.74 177.78 6.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 0.0 109.925 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.489 ' HE3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.53 157.13 3.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 122.021 0.915 . . . . 0.0 111.008 -178.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 57.87 12.43 1.72 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.671 178.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 22.0 m -75.9 148.3 38.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.028 -1.045 . . . . 0.0 108.624 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.729 ' C ' HD12 ' B' ' 267' ' ' LEU . 30.8 m -115.58 138.97 50.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.772 . . . . 0.0 110.048 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 266' ' ' THR . 11.2 mp -120.72 166.46 13.68 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -112.13 137.47 50.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.427 -0.795 . . . . 0.0 109.426 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.575 HD11 ' HG3' ' B' ' 241' ' ' GLN . 18.6 tp -108.86 126.05 52.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.478 -0.763 . . . . 0.0 109.285 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 52.1 t -115.07 130.33 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.435 -0.791 . . . . 0.0 109.624 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.592 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.4 mt -80.79 143.22 33.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.367 -0.833 . . . . 0.0 109.092 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.545 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.1 ttt180 -93.38 -140.3 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 108.85 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.547 ' CD2' ' OE2' ' A' ' 87' ' ' GLU . 56.3 mt -123.68 -16.95 6.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 109.602 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.122 -0.986 . . . . 0.0 109.455 -179.853 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 mttp . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.174 0.988 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.527 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.5 mt -117.15 138.06 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.112 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.7 m -114.5 125.26 53.61 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.527 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 78.6 m-85 -113.7 137.28 22.17 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 110.489 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -47.84 164.79 0.15 Allowed 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.642 2.228 . . . . 0.0 112.962 177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.0 p -69.13 -2.47 10.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.768 -0.582 . . . . 0.0 110.509 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.847 ' O ' HG22 ' B' ' 209' ' ' THR . 32.2 m-20 -121.56 6.62 10.03 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.017 -1.052 . . . . 0.0 110.204 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.8 mm -108.78 129.07 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.251 -0.905 . . . . 0.0 111.275 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.8 t0 -100.49 138.33 20.13 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -68.7 -47.12 1.45 Allowed 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.149 1.899 . . . . 0.0 112.009 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.418 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 7.1 tt0 -50.47 -43.04 55.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.889 -0.507 . . . . 0.0 110.1 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.629 HG11 ' O ' ' B' ' 207' ' ' THR . 62.1 t -80.55 -23.97 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.699 -1.251 . . . . 0.0 110.022 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 21.0 t80 -73.59 -52.79 12.26 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.093 -1.005 . . . . 0.0 110.655 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.5 ' OH ' HD12 ' A' ' 62' ' ' ILE . 56.2 m-85 -62.56 -17.4 59.88 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.228 -0.92 . . . . 0.0 109.916 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -81.07 -6.37 58.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.9 -1.125 . . . . 0.0 109.779 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.408 HD21 ' HB3' ' B' ' 268' ' ' HIS . 95.6 mt -90.65 151.74 44.24 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.13 155.99 17.61 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.31 2.007 . . . . 0.0 112.005 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.23 -50.03 71.85 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 110.811 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.96 -43.28 50.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.92 -1.113 . . . . 0.0 110.352 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' B' ' 270' ' ' VAL . 89.7 t -75.13 -32.01 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 120.889 -1.132 . . . . 0.0 108.642 178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.1 tt0 -59.26 -51.44 69.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.8 mmtt -57.62 -49.06 77.69 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.562 -0.711 . . . . 0.0 110.352 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.79 -41.28 81.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.027 -1.045 . . . . 0.0 110.861 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.7 mt -71.22 -36.33 71.83 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.7 -1.25 . . . . 0.0 109.632 -179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.1 mt -71.45 -37.85 71.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.71 -1.244 . . . . 0.0 108.854 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.74 -33.22 72.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.101 -0.999 . . . . 0.0 109.435 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.476 ' O ' HG22 ' A' ' 91' ' ' THR . 24.3 tp10 -74.39 -37.02 63.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 108.888 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.1 m0 -74.57 -12.35 60.44 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.882 -1.136 . . . . 0.0 108.612 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -92.81 -47.45 7.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.427 -0.796 . . . . 0.0 109.574 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -53.53 -39.36 64.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.678 -1.264 . . . . 0.0 107.766 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 87' ' ' GLU . 11.3 t -84.51 -36.63 22.08 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -95.45 165.63 12.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.437 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.0 pp -146.66 141.97 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 0.0 109.235 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.405 ' HB2' HG23 ' B' ' 266' ' ' THR . 8.6 m-85 -94.52 141.98 27.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.141 -0.974 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 24.4 t -122.49 114.37 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.366 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.479 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.3 OUTLIER -99.0 138.92 35.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.629 ' O ' HG11 ' A' ' 72' ' ' VAL . 30.1 p -98.65 -175.5 3.09 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -0.936 . . . . 0.0 110.573 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.7 mt -70.23 -15.91 62.98 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.188 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.847 HG22 ' O ' ' A' ' 67' ' ' ASP . 7.9 p -100.3 -3.07 32.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.132 -0.98 . . . . 0.0 109.655 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.1 3.61 57.83 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.743 -1.218 . . . . 0.0 110.353 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.2 tptm -67.8 117.61 9.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.009 -1.289 . . . . 0.0 108.962 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 4.7 m -99.92 132.97 44.95 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.182 -0.949 . . . . 0.0 109.422 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 20.5 mt -127.95 136.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.398 -0.814 . . . . 0.0 109.46 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 67.6 m -105.95 119.95 40.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.8 mt -123.87 122.53 38.24 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.302 -0.874 . . . . 0.0 110.493 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.65 132.76 48.12 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 6.8 m -138.93 -174.04 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.93 -1.106 . . . . 0.0 109.77 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -135.93 154.51 77.76 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.275 -0.89 . . . . 0.0 109.206 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -56.85 -29.03 79.87 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.69 2.26 . . . . 0.0 112.105 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 2.2 t -98.4 6.06 47.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -0.882 . . . . 0.0 109.694 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -70.25 142.37 52.35 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.001 -1.062 . . . . 0.0 109.502 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 8.6 p -87.99 145.32 26.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.415 -0.803 . . . . 0.0 110.029 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.412 HD12 HD13 ' B' ' 250' ' ' LEU . 36.0 mm -51.5 -37.97 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.114 179.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -34.01 58.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.443 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 -72.58 -50.48 25.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.199 -0.938 . . . . 0.0 109.193 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 40.2 t -51.9 -51.22 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.122 -0.986 . . . . 0.0 108.928 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -50.76 -42.31 57.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.336 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.54 -36.0 79.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.323 -0.86 . . . . 0.0 109.735 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.511 ' HB2' HD13 ' B' ' 215' ' ' LEU . 19.8 mtpp -57.03 -54.01 51.62 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.008 -1.057 . . . . 0.0 109.19 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.431 HG13 HD11 ' B' ' 215' ' ' LEU . 2.9 mp -60.08 -32.36 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.103 -0.998 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -62.1 -47.14 85.93 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.096 -1.003 . . . . 0.0 110.24 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -72.66 -26.51 61.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.118 -0.989 . . . . 0.0 110.806 -178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -92.48 -48.38 6.67 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.815 -1.178 . . . . 0.0 110.504 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -93.22 -6.66 47.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 0.0 111.261 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.13 22.46 72.54 Favored Glycine 0 N--CA 1.492 2.368 0 O-C-N 120.571 -1.331 . . . . 0.0 110.328 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.6 mt -102.82 126.68 31.95 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.086 -1.243 . . . . 0.0 109.232 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.462 ' HG2' HE21 ' B' ' 240' ' ' GLN . 38.6 Cg_endo -72.04 156.61 55.77 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.813 1.676 . . . . 0.0 111.58 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.93 -29.9 22.35 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.617 2.211 . . . . 0.0 112.851 -179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.3 -14.5 60.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.313 -0.867 . . . . 0.0 110.431 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.462 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.87 -20.97 5.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.37 -0.831 . . . . 0.0 110.288 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.67 136.27 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.857 -1.152 . . . . 0.0 108.894 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.0 mtt180 -127.47 132.8 49.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 0.0 109.642 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.3 mt -105.53 123.53 48.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.348 -0.845 . . . . 0.0 109.099 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 93.9 mt -118.19 135.75 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.7 t80 -131.92 115.89 16.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.336 -0.852 . . . . 0.0 108.956 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.9 35.87 8.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.911 -1.118 . . . . 0.0 109.257 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.97 10.49 68.34 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.173 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -111.28 136.86 49.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.132 -1.216 . . . . 0.0 109.686 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -82.94 122.21 27.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.967 -1.083 . . . . 0.0 109.483 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.576 HD11 HD23 ' B' ' 267' ' ' LEU . 29.5 mt -68.39 146.6 53.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 0.0 109.25 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.589 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 0.9 OUTLIER -101.24 143.86 30.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -0.957 . . . . 0.0 109.74 -179.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.589 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.2 OUTLIER -71.26 3.91 3.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.949 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.6 36.31 3.17 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.447 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 19.8 mtt85 -142.54 174.34 10.72 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.903 -1.351 . . . . 0.0 109.692 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 14.1 p -113.09 158.79 19.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.571 -0.706 . . . . 0.0 110.104 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.502 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.5 mt -56.9 -43.45 81.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.78 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 59.1 p -59.63 -27.17 66.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -19.21 61.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.637 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -103.84 3.89 34.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.9 . . . . 0.0 109.329 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 66.54 38.31 4.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.488 -0.758 . . . . 0.0 109.792 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 75.9 mt -93.02 135.98 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 0.0 109.003 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -126.67 176.76 6.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.111 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.588 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.44 155.4 2.13 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.885 0.85 . . . . 0.0 111.196 -178.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 59.93 14.21 4.14 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.19 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.437 ' OG ' HG22 ' B' ' 203' ' ' ILE . 88.9 p -76.87 149.91 36.08 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.801 -1.187 . . . . 0.0 108.551 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.767 ' C ' HD12 ' B' ' 267' ' ' LEU . 3.1 m -114.57 135.68 53.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.52 -0.737 . . . . 0.0 110.276 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.767 HD12 ' C ' ' B' ' 266' ' ' THR . 9.1 mp -122.98 140.11 53.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.504 -0.747 . . . . 0.0 109.253 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.408 ' HB3' HD21 ' A' ' 76' ' ' LEU . 66.1 m80 -88.5 141.55 28.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.144 -0.973 . . . . 0.0 110.203 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 20.7 tp -109.05 126.96 53.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.452 -0.78 . . . . 0.0 108.951 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 2.5 t -114.75 128.99 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.0 109.884 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.77 143.57 32.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.378 -0.826 . . . . 0.0 109.032 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.666 ' NH1' ' NH2' ' B' ' 274' ' ' ARG . 16.6 ttt180 -96.25 -139.19 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.389 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.424 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 61.5 mt -123.72 -27.9 3.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.403 -0.811 . . . . 0.0 109.26 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.666 ' NH2' ' NH1' ' B' ' 272' ' ' ARG . 21.6 mtm105 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.452 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.8 mtpp . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 51.4 mt -106.74 132.73 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.163 -0.961 . . . . 0.0 109.97 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.7 m -115.86 124.43 50.63 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.497 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 81.0 m-85 -110.24 137.13 20.51 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.439 -0.788 . . . . 0.0 109.902 -179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -48.46 163.96 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.229 1.953 . . . . 0.0 112.749 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.45 -1.78 5.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.704 -0.623 . . . . 0.0 110.599 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.862 ' O ' HG22 ' B' ' 209' ' ' THR . 8.5 m-20 -123.46 9.64 9.09 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.131 -0.981 . . . . 0.0 110.553 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 68' ' ' ILE . 25.7 mm -111.28 129.17 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.218 -0.926 . . . . 0.0 111.327 -179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.7 t0 -98.44 138.93 20.86 Favored Pre-proline 0 N--CA 1.489 1.518 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -70.81 -44.89 1.17 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.286 1.99 . . . . 0.0 112.066 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 14.2 tt0 -47.67 -47.01 29.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.878 -0.514 . . . . 0.0 110.409 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG11 ' O ' ' B' ' 207' ' ' THR . 24.7 t -79.87 -39.88 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.433 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.5 t80 -52.57 -54.59 30.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.838 -1.164 . . . . 0.0 111.007 -178.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -61.3 -18.49 58.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.316 -0.865 . . . . 0.0 110.016 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -82.76 -5.36 58.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.822 -1.174 . . . . 0.0 109.638 179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD11 ' CD2' ' B' ' 208' ' ' LEU . 95.1 mt -89.38 152.06 47.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.032 -1.043 . . . . 0.0 109.527 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -55.4 154.19 25.15 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.326 2.018 . . . . 0.0 112.004 179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -48.57 77.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.263 -0.898 . . . . 0.0 110.835 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.59 -42.82 62.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.977 -1.077 . . . . 0.0 110.168 -178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -75.08 -31.64 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.9 -1.125 . . . . 0.0 108.475 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.446 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.3 tt0 -60.18 -53.17 60.85 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -54.95 -49.31 71.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.515 -0.741 . . . . 0.0 110.239 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -57.38 -39.25 75.64 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.006 -1.059 . . . . 0.0 110.609 -178.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.87 -37.34 64.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.644 -1.285 . . . . 0.0 109.917 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.406 HD23 ' HE3' ' A' ' 88' ' ' TRP . 28.0 mt -71.44 -38.33 71.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.761 -1.212 . . . . 0.0 108.889 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.94 -34.15 75.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 0.0 109.442 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -74.31 -33.55 63.22 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.406 ' HE3' HD23 ' A' ' 85' ' ' LEU . 42.9 m0 -75.92 -15.26 60.22 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.898 -1.126 . . . . 0.0 107.995 178.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -92.61 -46.73 7.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.492 -0.755 . . . . 0.0 109.452 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' A' ' 91' ' ' THR . 11.5 ptm180 -54.03 -40.63 67.22 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.452 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 6.2 t -87.13 -36.78 17.89 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.73 163.68 12.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.356 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -144.42 142.56 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.527 -0.733 . . . . 0.0 109.346 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.421 ' HB2' HG23 ' B' ' 266' ' ' THR . 9.5 m-85 -94.06 142.46 27.36 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.544 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -123.62 113.91 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.19 -0.944 . . . . 0.0 109.701 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.552 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.5 135.14 43.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.077 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.501 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.0 p -93.38 -175.61 3.86 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.014 0.912 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.493 HD11 ' H ' ' B' ' 271' ' ' LEU . 43.2 mt -70.32 -19.8 63.05 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.862 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.6 p -96.56 -3.31 43.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.832 . . . . 0.0 109.974 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 97.78 3.99 58.06 Favored Glycine 0 N--CA 1.493 2.44 0 C-N-CA 119.757 -1.211 . . . . 0.0 110.545 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -68.45 118.62 11.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.895 -1.356 . . . . 0.0 108.973 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 7.0 m -102.43 139.43 38.04 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.262 -0.899 . . . . 0.0 109.808 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.403 HG21 HD13 ' B' ' 213' ' ' ILE . 54.5 mt -137.94 137.67 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.353 -0.842 . . . . 0.0 109.339 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 36.1 m -105.45 122.55 46.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 108.741 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.545 HD13 ' CB ' ' B' ' 229' ' ' LYS . 19.4 mt -125.29 121.55 34.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.419 -0.801 . . . . 0.0 110.567 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -65.79 131.38 46.16 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.6 m -139.95 -173.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.013 -1.054 . . . . 0.0 109.902 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -134.36 156.04 79.27 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.371 -0.831 . . . . 0.0 108.923 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.09 -20.42 67.68 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.433 2.088 . . . . 0.0 111.899 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 4.3 m -103.54 6.94 37.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 109.837 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.22 144.78 48.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.996 -1.065 . . . . 0.0 109.544 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 80.4 p -86.43 148.83 25.38 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 110.027 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 32.4 mm -55.3 -25.16 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.912 . . . . 0.0 108.92 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -35.43 77.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.418 -0.801 . . . . 0.0 109.35 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.09 -51.09 34.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 57.6 t -51.62 -48.18 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.099 -1.001 . . . . 0.0 108.385 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -51.05 -44.9 61.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.615 -0.678 . . . . 0.0 109.465 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.05 76.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.337 -0.852 . . . . 0.0 109.583 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.545 ' CB ' HD13 ' B' ' 215' ' ' LEU . 4.2 mtpm? -56.96 -54.69 43.83 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.544 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.411 HG13 HD11 ' B' ' 215' ' ' LEU . 2.5 mp -59.95 -31.68 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -0.938 . . . . 0.0 109.037 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -62.94 -48.46 78.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.092 -1.005 . . . . 0.0 109.979 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.72 -27.9 67.2 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.062 -1.024 . . . . 0.0 110.681 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -94.67 -52.57 4.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.929 -1.107 . . . . 0.0 110.374 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -87.93 -7.99 56.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 111.561 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.31 24.34 73.52 Favored Glycine 0 N--CA 1.494 2.503 0 O-C-N 120.44 -1.413 . . . . 0.0 110.458 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 68.5 mt -100.69 130.89 24.46 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.947 -1.325 . . . . 0.0 109.426 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.408 ' CG ' HE21 ' B' ' 240' ' ' GLN . 56.7 Cg_endo -74.53 152.83 43.75 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 122.077 1.852 . . . . 0.0 111.676 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.07 -32.74 16.74 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.573 2.182 . . . . 0.0 113.107 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.408 ' C ' ' OD1' ' B' ' 239' ' ' ASP . 15.1 p30 -64.06 -8.84 13.12 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.24 -0.913 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.408 HE21 ' CG ' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.69 -21.66 3.39 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.451 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.473 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -85.49 136.82 33.26 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.71 -1.244 . . . . 0.0 108.776 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -128.04 133.2 49.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.32 -0.863 . . . . 0.0 109.685 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.407 ' CB ' HD12 ' B' ' 250' ' ' LEU . 11.5 mt -105.24 125.8 51.39 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.323 -0.861 . . . . 0.0 109.335 179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 81.0 mt -116.93 156.0 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.408 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.1 t80 -151.81 116.57 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.271 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 59.96 43.02 15.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.843 -1.161 . . . . 0.0 109.507 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 63.53 23.82 67.19 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 178.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.2 ptmm? -121.59 136.91 54.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -1.127 . . . . 0.0 109.479 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.85 123.81 31.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.265 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.426 HD11 HD23 ' B' ' 267' ' ' LEU . 25.7 mt -74.51 141.68 44.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.37 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.45 147.53 24.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.95 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 0.0 OUTLIER -73.02 3.4 5.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.519 -0.738 . . . . 0.0 109.755 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -119.49 33.64 4.58 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.6 mtt-85 -143.11 172.21 13.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.95 -1.323 . . . . 0.0 109.624 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 82.2 p -111.51 159.61 17.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 110.075 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.498 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.0 mt -55.51 -40.98 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.468 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 85.7 p -63.28 -28.21 69.86 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.102 -0.999 . . . . 0.0 109.535 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -18.75 62.81 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.128 -0.982 . . . . 0.0 109.53 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -103.06 4.09 36.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.186 -0.946 . . . . 0.0 109.097 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 69.81 40.91 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.505 -0.747 . . . . 0.0 109.687 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 52.0 mt -98.52 136.81 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.296 -0.877 . . . . 0.0 109.443 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.69 -178.87 4.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.432 -0.793 . . . . 0.0 108.96 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.533 ' HD3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.41 163.31 0.63 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 122.37 1.081 . . . . 0.0 111.525 -178.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 55.71 11.32 0.64 Allowed 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.145 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 36.7 m -75.09 147.12 40.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.82 -1.175 . . . . 0.0 108.924 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.838 ' C ' HD12 ' B' ' 267' ' ' LEU . 5.7 m -113.89 138.39 50.37 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.597 -0.689 . . . . 0.0 110.083 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.838 HD12 ' C ' ' B' ' 266' ' ' THR . 10.2 mp -127.17 144.27 51.07 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.34 -0.85 . . . . 0.0 110.18 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.43 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 62.1 m80 -91.9 142.45 27.55 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.188 -0.945 . . . . 0.0 110.382 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.473 HD11 ' HG3' ' B' ' 241' ' ' GLN . 14.0 tp -109.35 127.02 54.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.365 -0.835 . . . . 0.0 108.924 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 41.6 t -116.75 131.95 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.383 -0.823 . . . . 0.0 109.729 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.493 ' H ' HD11 ' B' ' 208' ' ' LEU . 39.4 mt -81.76 143.87 31.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.558 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 25.1 ttt180 -94.93 -139.26 0.23 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 108.706 -179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.558 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 58.6 mt -123.93 -20.51 5.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.183 -0.948 . . . . 0.0 109.501 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.392 -0.818 . . . . 0.0 109.472 -179.928 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 122.093 0.949 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.619 HD12 ' OH ' ' A' ' 74' ' ' TYR . 33.8 mt -118.44 137.41 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.485 0.659 . . . . 0.0 110.27 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.5 m -115.91 127.44 54.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.501 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 72.4 m-85 -114.32 137.13 22.41 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.875 . . . . 0.0 110.594 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -47.77 165.06 0.14 Allowed 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.641 2.227 . . . . 0.0 113.176 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -2.75 10.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.729 -0.607 . . . . 0.0 110.691 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.839 ' O ' HG22 ' B' ' 209' ' ' THR . 45.4 m-20 -120.85 5.61 10.45 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.031 -1.043 . . . . 0.0 109.894 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.444 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.7 mm -109.62 130.44 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 0.0 111.001 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -100.85 134.57 20.4 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.01 -45.55 5.82 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.965 1.777 . . . . 0.0 112.024 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -50.23 -44.71 53.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.849 -0.532 . . . . 0.0 110.485 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.62 HG11 ' O ' ' B' ' 207' ' ' THR . 38.8 t -80.2 -26.44 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.834 -1.166 . . . . 0.0 110.147 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.0 t80 -68.99 -51.67 36.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.536 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.619 ' OH ' HD12 ' A' ' 62' ' ' ILE . 51.3 m-85 -62.59 -17.48 60.22 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.803 -179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -80.94 -6.74 59.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.865 -1.147 . . . . 0.0 109.641 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 76' ' ' LEU . 97.0 mt -89.15 151.75 47.13 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.144 -0.972 . . . . 0.0 109.753 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.38 155.64 19.81 Favored 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 122.41 2.074 . . . . 0.0 111.91 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -63.39 -50.81 68.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.202 -0.936 . . . . 0.0 110.679 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.22 -42.99 52.54 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.03 -1.044 . . . . 0.0 110.297 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 94.9 t -75.16 -30.71 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 108.423 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.445 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.0 tt0 -60.6 -51.59 68.77 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -56.9 -47.83 79.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.525 -0.735 . . . . 0.0 110.202 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -59.24 -40.31 85.51 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.044 -1.035 . . . . 0.0 110.775 -178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.0 mt -72.31 -35.7 68.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.796 -1.19 . . . . 0.0 109.561 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.44 -37.49 71.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.822 -1.174 . . . . 0.0 108.853 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.82 -33.77 75.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.025 -1.047 . . . . 0.0 109.197 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -72.71 -37.89 67.67 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.401 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 42.5 m0 -75.17 -13.49 60.46 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.95 -1.094 . . . . 0.0 108.77 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -92.49 -46.83 7.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.408 -0.807 . . . . 0.0 109.604 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.59 -39.41 67.82 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.668 -1.27 . . . . 0.0 107.949 179.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 3.7 t -87.73 -36.98 17.04 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.463 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.6 ptt? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.12 165.59 12.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.237 -0.914 . . . . 0.0 110.041 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -144.86 151.97 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.445 -0.784 . . . . 0.0 109.392 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' B' ' 264' ' ' GLU . 8.8 m-85 -104.29 142.61 34.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.296 -0.878 . . . . 0.0 109.782 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 39.9 t -122.38 114.02 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.528 ' HE3' HG22 ' A' ' 72' ' ' VAL . 0.4 OUTLIER -101.31 130.46 47.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.284 -0.885 . . . . 0.0 108.818 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.62 ' O ' HG11 ' A' ' 72' ' ' VAL . 38.1 p -89.11 -175.53 4.84 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.999 0.904 . . . . 0.0 111.019 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.517 HD11 ' H ' ' B' ' 271' ' ' LEU . 25.1 mt -71.41 -11.33 60.83 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.585 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.839 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.9 p -103.48 -2.88 26.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 0.0 109.836 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.3 2.35 60.51 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.243 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -67.77 117.84 10.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.049 -1.265 . . . . 0.0 108.845 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.1 m -99.96 139.33 35.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.165 -0.959 . . . . 0.0 109.176 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.549 HD11 ' CD ' ' B' ' 234' ' ' GLU . 29.1 mt -135.54 137.81 49.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 121.39 -0.819 . . . . 0.0 109.253 -179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 27.2 m -105.14 122.59 46.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.383 -0.823 . . . . 0.0 108.837 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' B' ' 229' ' ' LYS . 21.5 mt -127.01 119.29 26.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.945 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -64.71 132.36 49.44 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 19.0 m -139.3 -175.22 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.947 -1.095 . . . . 0.0 109.764 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.36 154.43 78.59 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.251 -0.906 . . . . 0.0 108.978 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -56.39 -24.74 53.67 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.62 2.214 . . . . 0.0 112.005 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.65 6.54 42.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.257 -0.902 . . . . 0.0 109.867 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -70.24 142.88 52.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.035 -1.041 . . . . 0.0 109.505 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.452 ' OG1' ' ND2' ' B' ' 225' ' ' ASN . 11.9 p -85.66 145.7 27.19 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.292 -0.88 . . . . 0.0 110.34 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 34.8 mm -51.81 -35.76 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.472 -0.768 . . . . 0.0 109.251 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.417 ' CG ' ' N ' ' B' ' 225' ' ' ASN . 5.8 pt-20 -61.38 -36.21 79.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.615 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.452 ' ND2' ' OG1' ' B' ' 222' ' ' THR . 63.4 m-20 -68.16 -52.45 34.37 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.121 -0.987 . . . . 0.0 109.25 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 47.5 t -51.84 -48.29 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.919 -1.113 . . . . 0.0 108.045 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt -50.99 -43.65 60.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.709 -0.619 . . . . 0.0 109.492 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -0.904 . . . . 0.0 109.27 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.511 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.7 mtpp -57.48 -53.98 52.05 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.085 -1.009 . . . . 0.0 109.433 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.412 ' O ' ' N ' ' B' ' 234' ' ' GLU . 2.6 mp -58.22 -33.34 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.122 -0.986 . . . . 0.0 109.083 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.78 -48.46 79.04 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.212 -0.93 . . . . 0.0 110.031 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.76 -25.43 66.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.2 -0.937 . . . . 0.0 110.635 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 19.2 mttm -98.95 -57.62 2.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.043 . . . . 0.0 110.522 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.549 ' CD ' HD11 ' B' ' 213' ' ' ILE . 34.9 mm-40 -81.43 -8.48 59.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.25 -0.906 . . . . 0.0 111.187 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.77 22.24 73.55 Favored Glycine 0 N--CA 1.492 2.397 0 O-C-N 120.502 -1.374 . . . . 0.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.422 HD13 HD21 ' B' ' 271' ' ' LEU . 64.7 mt -101.73 131.13 23.24 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.977 -1.307 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.459 ' HG2' HE21 ' B' ' 240' ' ' GLN . 58.6 Cg_endo -75.2 153.65 41.01 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.029 1.819 . . . . 0.0 111.798 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -66.43 -30.86 43.6 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.558 2.172 . . . . 0.0 112.554 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.27 -16.62 63.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.638 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.459 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.78 -18.22 7.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.473 -0.767 . . . . 0.0 110.336 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.25 137.57 32.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.75 -1.219 . . . . 0.0 109.173 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 -129.0 134.12 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 0.0 109.603 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.403 ' HB3' HD12 ' B' ' 250' ' ' LEU . 11.9 mt -105.71 124.8 50.16 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 108.845 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 78.4 mt -118.33 135.46 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.71 -0.619 . . . . 0.0 109.533 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.539 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 41.2 t80 -129.91 113.49 14.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.47 -0.769 . . . . 0.0 109.004 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.34 38.7 4.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.004 -1.06 . . . . 0.0 109.219 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 68.65 7.78 55.03 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.441 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.6 OUTLIER -105.75 135.84 46.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.089 -1.242 . . . . 0.0 109.489 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -83.61 119.76 25.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.043 -1.036 . . . . 0.0 109.338 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.403 HD12 ' HB3' ' B' ' 243' ' ' LEU . 39.2 mt -67.6 140.47 56.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.568 ' OE1' ' N ' ' B' ' 252' ' ' ASP . 2.0 tm-20 -92.5 143.1 26.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.534 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OE1' ' B' ' 251' ' ' GLU . 0.0 OUTLIER -71.54 3.5 3.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.383 -0.823 . . . . 0.0 109.636 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.535 ' N ' ' OE1' ' B' ' 251' ' ' GLU . . . -121.35 39.66 2.32 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.1 mtt180 -146.21 173.7 11.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.968 -1.313 . . . . 0.0 109.383 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 5.7 p -112.32 161.56 16.51 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.4 -0.812 . . . . 0.0 109.864 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.509 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.1 mt -58.54 -41.16 84.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.225 -0.922 . . . . 0.0 109.787 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 93.7 p -62.24 -29.04 70.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.742 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -70.57 -19.98 62.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -101.93 3.97 39.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.267 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 67.6 38.18 3.14 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.497 -0.752 . . . . 0.0 109.926 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 32.7 mt -93.27 136.78 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 108.954 179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -125.19 176.74 6.52 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.539 -0.726 . . . . 0.0 109.757 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.485 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -52.78 159.58 1.08 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.935 0.874 . . . . 0.0 110.719 -179.184 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.4 ' HA ' ' CE2' ' B' ' 204' ' ' PHE . 2.7 mm-40 55.76 27.55 10.94 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.162 177.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.17 149.09 21.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.837 -1.164 . . . . 0.0 108.525 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 9.5 m -112.65 136.36 52.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.455 -0.778 . . . . 0.0 110.268 -179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -124.56 139.47 53.85 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.586 -0.696 . . . . 0.0 109.129 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -87.79 141.51 28.54 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.103 -0.998 . . . . 0.0 110.136 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.9 tp -108.86 126.62 53.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 2.3 t -114.53 129.21 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.38 -0.825 . . . . 0.0 109.639 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.517 ' H ' HD11 ' B' ' 208' ' ' LEU . 48.5 mt -81.31 143.89 31.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.0 179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.427 ' CG ' ' H ' ' B' ' 273' ' ' LEU . 17.6 ttt180 -95.53 -138.48 0.24 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.245 -0.91 . . . . 0.0 109.061 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.427 ' H ' ' CG ' ' B' ' 272' ' ' ARG . 56.6 mt -123.52 -41.99 2.24 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.495 ' CD ' ' C ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.376 -0.828 . . . . 0.0 109.309 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.534 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 37.0 mt -110.85 132.73 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.392 -0.818 . . . . 0.0 110.374 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 96.4 m -113.95 124.96 53.43 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 71.1 m-85 -110.18 136.98 20.46 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 110.212 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.37 164.12 0.22 Allowed 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.451 2.1 . . . . 0.0 113.172 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 m -68.6 -2.09 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.761 -0.587 . . . . 0.0 110.468 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.891 ' O ' HG22 ' B' ' 209' ' ' THR . 0.7 OUTLIER -122.12 8.41 9.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.074 -1.016 . . . . 0.0 110.436 -179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.406 ' HA ' HD13 ' A' ' 68' ' ' ILE . 25.6 mm -108.71 126.5 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.924 . . . . 0.0 111.295 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 69' ' ' ASP . 5.3 t0 -98.25 113.38 63.94 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -46.49 -47.24 15.85 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.161 1.907 . . . . 0.0 112.271 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -48.53 -45.18 37.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.85 -0.531 . . . . 0.0 110.469 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG11 ' O ' ' B' ' 207' ' ' THR . 40.6 t -80.47 -24.25 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.646 -1.284 . . . . 0.0 110.423 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 23.2 t80 -69.68 -52.6 24.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.028 -1.045 . . . . 0.0 110.77 -179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -62.52 -17.07 58.99 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.925 . . . . 0.0 110.021 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -81.66 -6.36 58.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.787 -1.196 . . . . 0.0 109.95 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.8 mt -91.61 152.64 43.59 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.087 -1.008 . . . . 0.0 109.63 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.09 155.22 19.68 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 C-N-CA 122.534 2.156 . . . . 0.0 112.135 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.55 -50.25 70.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.37 -0.831 . . . . 0.0 110.959 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.12 -43.2 51.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.889 -1.132 . . . . 0.0 110.387 -178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 43.3 t -75.35 -30.99 23.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.982 -1.074 . . . . 0.0 108.324 178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.444 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.2 tt0 -59.96 -51.45 69.64 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -57.56 -48.06 80.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.613 -0.679 . . . . 0.0 110.244 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -58.15 -39.81 79.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.696 -178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.3 mt -72.75 -36.81 67.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.714 -1.241 . . . . 0.0 109.745 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.0 mt -71.93 -37.77 69.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.785 -1.197 . . . . 0.0 108.789 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.76 -34.23 75.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.179 -0.951 . . . . 0.0 109.515 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -75.92 -33.69 59.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.239 -0.913 . . . . 0.0 108.644 178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -74.04 -16.68 61.04 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -92.83 -44.8 8.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.592 -0.693 . . . . 0.0 109.81 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -53.98 -40.54 66.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.51 -1.369 . . . . 0.0 107.804 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 12.3 t -86.26 -36.64 19.25 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.432 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -94.39 163.9 13.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.917 . . . . 0.0 109.999 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.533 HG22 ' OG ' ' B' ' 265' ' ' SER . 2.2 pp -144.87 142.3 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.449 -0.782 . . . . 0.0 109.221 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -94.48 142.82 26.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.092 -1.005 . . . . 0.0 109.691 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.48 114.7 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.152 -0.967 . . . . 0.0 109.396 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' B' ' 268' ' ' HIS . 14.0 ptmt -101.42 132.98 46.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.264 -0.898 . . . . 0.0 109.159 179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.67 ' O ' HG11 ' A' ' 72' ' ' VAL . 18.6 p -91.01 -175.62 4.38 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.063 0.935 . . . . 0.0 111.32 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.469 HD11 ' H ' ' B' ' 271' ' ' LEU . 74.8 mt -70.69 -15.54 62.72 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.789 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -101.93 -1.68 31.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.688 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.77 4.8 58.91 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.761 -1.209 . . . . 0.0 110.392 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -68.3 117.75 10.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.951 -1.323 . . . . 0.0 108.807 179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.9 m -99.74 140.41 33.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.421 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 22.2 mt -137.56 137.86 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.249 -0.907 . . . . 0.0 109.382 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 22.7 m -104.26 124.35 49.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 108.752 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.558 HD13 ' HB2' ' B' ' 229' ' ' LYS . 23.5 mt -129.2 119.3 23.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.307 -0.87 . . . . 0.0 110.06 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -66.88 133.94 51.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.65 -0.656 . . . . 0.0 109.439 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.26 -173.38 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.066 -1.021 . . . . 0.0 109.616 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' B' ' 221' ' ' ASP . 20.1 mt-10 -135.81 153.38 77.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.125 -0.984 . . . . 0.0 108.862 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -54.68 -21.47 25.22 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.569 2.18 . . . . 0.0 112.03 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.0 7.58 34.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.955 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.41 ' HB2' ' H ' ' B' ' 218' ' ' GLU . 0.9 OUTLIER -70.29 142.34 52.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.901 -1.125 . . . . 0.0 109.507 -179.284 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 16.6 p -86.55 145.8 26.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 0.0 110.188 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.432 HD12 HD13 ' B' ' 250' ' ' LEU . 39.2 mm -50.97 -43.17 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.418 ' CD ' ' OD1' ' B' ' 225' ' ' ASN . 0.2 OUTLIER -52.62 -34.76 52.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.475 -0.766 . . . . 0.0 109.699 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.418 ' OD1' ' CD ' ' B' ' 224' ' ' GLU . 63.5 m-20 -71.22 -52.21 20.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.23 -45.47 43.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.037 -1.04 . . . . 0.0 108.529 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.27 -43.12 70.73 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.96 -36.98 78.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.413 -0.804 . . . . 0.0 109.611 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.558 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.1 mtpp -57.78 -53.75 54.65 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.084 -1.01 . . . . 0.0 109.363 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.564 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.7 mp -57.22 -35.61 49.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.007 -1.058 . . . . 0.0 109.246 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.424 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 2.9 tt0 -60.7 -49.77 76.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.895 -1.128 . . . . 0.0 109.967 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.98 -29.2 70.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.26 -0.9 . . . . 0.0 110.843 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -95.51 -52.28 4.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.381 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -87.76 -6.58 58.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 111.548 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.31 24.02 71.93 Favored Glycine 0 N--CA 1.493 2.44 0 O-C-N 120.45 -1.406 . . . . 0.0 110.289 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 44.6 mt -103.03 128.79 26.92 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.076 -1.25 . . . . 0.0 109.774 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.436 ' HG2' HE21 ' B' ' 240' ' ' GLN . 68.9 Cg_endo -77.57 155.95 31.85 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.159 1.906 . . . . 0.0 111.828 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . 0.424 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 37.6 Cg_endo -67.77 -30.62 33.69 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.944 2.429 . . . . 0.0 112.939 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 16.1 p30 -61.95 -13.3 23.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.152 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.436 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.77 -17.2 4.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.467 -0.77 . . . . 0.0 110.746 -179.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.23 137.04 32.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.701 -1.25 . . . . 0.0 109.417 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -129.54 130.78 46.19 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.377 -0.827 . . . . 0.0 109.567 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.3 mt -105.74 125.13 50.62 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 0.0 109.32 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 39.9 mt -118.78 136.22 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.672 -0.642 . . . . 0.0 109.428 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -131.06 119.23 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.488 -0.758 . . . . 0.0 109.459 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 57.0 47.29 17.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.923 -1.111 . . . . 0.0 109.464 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.53 26.28 64.29 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 0.7 OUTLIER -123.91 135.3 53.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.315 -1.109 . . . . 0.0 109.622 179.784 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -84.09 122.11 28.35 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 109.258 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.432 HD13 HD12 ' B' ' 223' ' ' ILE . 38.1 mt -72.38 144.02 48.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.155 -0.965 . . . . 0.0 109.571 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -96.89 143.5 27.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.22 3.68 3.41 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.442 -0.786 . . . . 0.0 109.843 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -126.11 44.74 1.22 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.49 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -148.26 174.1 12.34 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.141 -1.211 . . . . 0.0 109.079 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.7 p -111.91 160.15 17.69 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.354 -0.841 . . . . 0.0 110.185 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.493 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.6 mt -60.21 -40.72 91.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.224 -0.923 . . . . 0.0 109.842 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.4 p -61.68 -28.77 69.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.957 . . . . 0.0 109.576 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -70.58 -15.86 62.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -104.28 2.38 31.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.467 -0.771 . . . . 0.0 108.933 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 67.07 38.54 3.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.546 -0.721 . . . . 0.0 109.392 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 50.8 mt -93.89 137.45 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.102 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -126.7 179.49 5.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.429 -0.794 . . . . 0.0 108.987 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 163.73 0.51 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.45 1.119 . . . . 0.0 111.492 -178.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 55.54 12.04 0.72 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.093 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.533 ' OG ' HG22 ' B' ' 203' ' ' ILE . 89.2 p -76.09 148.31 38.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.857 -1.152 . . . . 0.0 108.714 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.75 ' C ' HD12 ' B' ' 267' ' ' LEU . 17.7 m -114.19 136.8 52.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.459 -0.776 . . . . 0.0 110.268 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.75 HD12 ' C ' ' B' ' 266' ' ' THR . 11.0 mp -123.74 139.43 53.99 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.533 -0.73 . . . . 0.0 109.361 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.415 ' CD2' ' HD3' ' B' ' 206' ' ' LYS . 60.9 m80 -88.77 142.13 27.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 110.287 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.6 tp -108.58 125.61 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.0 t -114.39 130.05 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.361 -0.837 . . . . 0.0 109.746 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.469 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.7 mt -80.76 143.34 32.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.347 -0.846 . . . . 0.0 109.082 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.546 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 28.5 ttt180 -94.9 -139.26 0.23 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 108.694 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.546 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 50.5 mt -123.77 -47.7 1.93 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.0 109.331 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.508 ' CD ' ' C ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.161 -0.962 . . . . 0.0 109.466 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.53 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 40.1 mt -108.79 133.88 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.427 -0.796 . . . . 0.0 110.102 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.6 m -116.08 126.7 54.11 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.53 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 95.5 m-85 -112.68 134.41 21.68 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.2 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.61 165.2 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.285 0 C-N-CA 122.055 1.837 . . . . 0.0 112.22 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 t -66.01 -12.53 55.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.701 -0.624 . . . . 0.0 110.88 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.884 ' O ' HG22 ' B' ' 209' ' ' THR . 1.6 m-20 -112.49 8.65 19.41 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.102 -0.999 . . . . 0.0 110.79 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.479 HG21 ' CH2' ' A' ' 88' ' ' TRP . 30.4 mm -111.41 129.71 66.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.111 -0.993 . . . . 0.0 110.707 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 6.4 t70 -97.96 139.13 21.09 Favored Pre-proline 0 N--CA 1.49 1.568 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.27 -36.58 3.99 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.228 1.952 . . . . 0.0 112.537 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.446 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 8.5 tp60 -59.13 -44.5 92.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.42 -0.8 . . . . 0.0 110.536 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.704 HG11 ' O ' ' B' ' 207' ' ' THR . 61.6 t -79.02 -23.9 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.809 -1.182 . . . . 0.0 110.047 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.43 ' CE1' ' CH2' ' A' ' 88' ' ' TRP . 19.8 t80 -66.4 -52.38 47.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.087 -1.008 . . . . 0.0 110.729 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -63.41 -16.31 60.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.094 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -82.52 -6.87 59.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 109.767 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.473 HD11 ' CD2' ' B' ' 208' ' ' LEU . 91.5 mt -90.18 152.26 45.73 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.206 -0.934 . . . . 0.0 109.956 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -56.13 154.86 26.26 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.409 2.073 . . . . 0.0 112.03 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -63.1 -50.47 70.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.295 -0.878 . . . . 0.0 110.712 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.4 -44.37 34.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.936 -1.103 . . . . 0.0 110.013 -178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.409 HG11 HG21 ' B' ' 270' ' ' VAL . 57.4 t -74.61 -31.82 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.911 -1.118 . . . . 0.0 108.603 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.417 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.3 tt0 -59.57 -50.06 75.37 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -57.85 -48.56 79.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.413 -0.804 . . . . 0.0 109.944 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.18 -35.12 71.12 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.179 -0.95 . . . . 0.0 110.113 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.6 mt -77.66 -41.74 37.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.043 -1.036 . . . . 0.0 109.962 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.4 mt -65.78 -38.23 88.48 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.647 -1.283 . . . . 0.0 108.671 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.74 82.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 108.981 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.485 ' O ' HG22 ' A' ' 91' ' ' THR . 72.2 tt0 -67.13 -33.19 74.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 0.0 108.639 179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.479 ' CH2' HG21 ' A' ' 68' ' ' ILE . 48.0 m0 -78.28 -20.78 50.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.9 mttt -86.89 -38.8 16.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.15 -0.969 . . . . 0.0 109.643 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' CG ' ' N ' ' A' ' 91' ' ' THR . 11.9 ptm180 -65.34 -46.73 79.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.73 -1.231 . . . . 0.0 108.304 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.501 HG23 ' N ' ' A' ' 92' ' ' GLY . 11.9 t -71.23 -37.79 72.02 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.501 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.492 2.382 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 217' ' ' VAL . 6.9 ptt? . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.51 166.92 10.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.151 -0.968 . . . . 0.0 110.387 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.43 142.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.49 -0.756 . . . . 0.0 109.376 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -95.14 146.96 23.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.292 -0.88 . . . . 0.0 109.571 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.5 t -125.47 110.93 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.202 -0.937 . . . . 0.0 110.161 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.855 ' NZ ' HG21 ' B' ' 266' ' ' THR . 0.0 OUTLIER -96.99 138.7 34.11 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.704 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.8 p -102.7 -173.03 2.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.0 111.3 -178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.473 ' CD2' HD11 ' A' ' 76' ' ' LEU . 21.4 mt -70.81 -17.86 62.75 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.298 0.57 . . . . 0.0 109.597 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.884 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.5 p -96.84 -5.15 38.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 109.299 -179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.14 5.64 60.63 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.9 tptm -69.67 119.44 13.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.163 -1.198 . . . . 0.0 108.948 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 47.7 m -101.04 133.15 45.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.209 -0.932 . . . . 0.0 109.335 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.0 mt -128.2 136.87 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.416 ' O ' HD23 ' B' ' 215' ' ' LEU . 58.5 m -105.34 124.34 49.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.381 -0.824 . . . . 0.0 109.029 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.537 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.7 mt -129.8 120.01 24.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.842 . . . . 0.0 110.234 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -66.78 132.65 48.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.565 -0.709 . . . . 0.0 109.17 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 201' ' ' MET . 15.5 m -138.97 -175.7 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.014 -1.054 . . . . 0.0 109.972 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -132.49 154.89 81.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.532 -0.73 . . . . 0.0 109.074 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -59.02 -19.35 47.94 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.505 2.137 . . . . 0.0 112.123 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.19 8.2 31.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.987 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -72.22 143.17 48.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.939 -1.101 . . . . 0.0 109.784 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 13.6 p -85.7 148.53 25.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.799 . . . . 0.0 109.849 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.0 mm -52.2 -39.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.387 -0.82 . . . . 0.0 109.432 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -33.79 67.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.775 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -70.06 -53.3 18.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.032 -1.043 . . . . 0.0 109.302 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 58.7 t -53.52 -44.15 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.179 -0.951 . . . . 0.0 108.638 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -57.56 -38.71 75.25 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.75 -36.87 84.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.537 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.3 mtpp -57.59 -53.31 59.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.702 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.564 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.8 mp -59.24 -34.57 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 0.0 109.131 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -61.67 -43.47 98.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.174 -0.954 . . . . 0.0 110.395 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -28.78 63.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.977 -1.077 . . . . 0.0 110.721 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 12.3 mttm -92.99 -49.86 5.82 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.012 -1.055 . . . . 0.0 110.489 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -91.39 -6.86 52.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.195 -0.941 . . . . 0.0 111.357 -178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.97 74.69 Favored Glycine 0 N--CA 1.491 2.337 0 C-N-CA 119.347 -1.406 . . . . 0.0 110.104 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 61.2 mt -102.06 123.19 44.38 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.046 -1.267 . . . . 0.0 109.135 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.43 ' HG2' HE21 ' B' ' 240' ' ' GLN . 55.5 Cg_endo -74.71 152.13 41.94 Favored 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.83 1.687 . . . . 0.0 111.802 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.99 -29.47 75.63 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.597 2.198 . . . . 0.0 112.802 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' B' ' 240' ' ' GLN . 49.9 p-10 -64.15 -13.74 50.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.261 -0.9 . . . . 0.0 110.085 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.501 ' N ' ' OD1' ' B' ' 239' ' ' ASP . 0.0 OUTLIER -126.89 -20.79 4.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.464 -0.772 . . . . 0.0 109.945 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.588 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -85.91 133.39 33.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 0.0 109.043 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -126.98 132.42 50.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.8 mt -104.88 123.38 47.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.363 -0.835 . . . . 0.0 109.372 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.4 132.82 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -128.53 123.73 34.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -0.839 . . . . 0.0 109.059 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 54.13 41.63 31.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.786 -1.197 . . . . 0.0 109.312 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 67.68 3.97 30.19 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.73 135.4 42.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.147 -1.208 . . . . 0.0 109.362 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.82 125.63 33.42 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.154 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.8 mt -74.89 139.67 43.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.977 . . . . 0.0 109.794 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -95.07 146.95 23.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 109.398 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.12 3.82 4.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.122 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.62 46.32 1.11 Allowed Glycine 0 N--CA 1.496 2.661 0 C-N-CA 119.968 -1.111 . . . . 0.0 110.685 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 11.9 mtt85 -151.38 172.46 15.89 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.109 -1.23 . . . . 0.0 109.485 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 63.9 p -111.57 160.89 16.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.378 -0.826 . . . . 0.0 110.106 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.496 HD23 ' N ' ' B' ' 256' ' ' LEU . 4.0 mt -60.63 -43.68 97.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.232 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 56.9 p -59.35 -28.35 66.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.044 -1.035 . . . . 0.0 109.38 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -72.23 -13.1 61.44 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 0.0 109.065 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.613 ' C ' HD22 ' B' ' 260' ' ' ASN . 33.2 m-85 -107.35 5.32 27.33 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.373 -0.829 . . . . 0.0 109.116 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . 0.613 HD22 ' C ' ' B' ' 259' ' ' TYR . 1.0 OUTLIER 63.03 39.31 10.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.699 -0.625 . . . . 0.0 109.532 -179.481 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 57.9 mt -92.74 136.36 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.391 -0.818 . . . . 0.0 108.987 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -125.54 175.71 7.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.381 -0.824 . . . . 0.0 109.765 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.452 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.91 160.65 0.67 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 121.776 0.798 . . . . 0.0 110.71 -179.119 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 56.77 13.97 1.63 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.291 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 55.2 m -75.84 146.1 40.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.752 -1.217 . . . . 0.0 108.607 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.855 HG21 ' NZ ' ' B' ' 206' ' ' LYS . 5.5 m -112.31 138.01 49.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.518 -0.739 . . . . 0.0 110.018 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.786 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -124.7 138.79 54.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -86.86 140.73 29.38 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.588 HD11 ' HG3' ' B' ' 241' ' ' GLN . 18.9 tp -110.31 127.71 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.452 -0.78 . . . . 0.0 109.693 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.409 HG21 HG11 ' A' ' 80' ' ' VAL . 14.9 t -114.62 129.39 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' B' ' 271' ' ' LEU . 47.3 mt -82.27 143.97 30.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.337 -0.852 . . . . 0.0 109.168 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.522 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 31.0 ttt180 -93.63 -138.85 0.21 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.522 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 64.4 mt -123.36 -33.33 3.27 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.143 -0.973 . . . . 0.0 109.374 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.444 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.406 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 31.5 mt -109.03 135.8 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 0.0 110.172 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.8 m -116.2 125.56 52.43 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.406 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 76.6 m-85 -110.99 135.71 20.82 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.38 -0.825 . . . . 0.0 109.758 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -47.9 164.58 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.224 1.949 . . . . 0.0 113.05 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.4 t -67.71 -2.07 6.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.568 . . . . 0.0 110.517 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.872 ' O ' HG22 ' B' ' 209' ' ' THR . 1.8 m-20 -123.05 10.57 9.44 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.148 -0.97 . . . . 0.0 110.373 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 68' ' ' ILE . 26.7 mm -113.21 129.85 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.244 -0.91 . . . . 0.0 111.361 -179.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.6 t70 -99.33 140.24 21.52 Favored Pre-proline 0 N--CA 1.489 1.519 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.07 -37.51 3.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.41 2.073 . . . . 0.0 112.723 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.455 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 52.7 tt0 -61.26 -41.01 96.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.323 -0.861 . . . . 0.0 110.184 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.69 HG11 ' O ' ' B' ' 207' ' ' THR . 25.4 t -80.98 -24.07 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.877 -1.139 . . . . 0.0 110.036 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 27.2 t80 -72.6 -53.58 11.5 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.074 -1.016 . . . . 0.0 110.993 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -61.29 -15.81 39.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.12 -0.987 . . . . 0.0 110.052 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -85.47 -5.23 59.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.911 -1.118 . . . . 0.0 109.777 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 93.8 mt -88.6 151.66 48.29 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 121.069 -1.019 . . . . 0.0 109.819 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -55.12 152.73 29.28 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 122.457 2.105 . . . . 0.0 112.006 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.03 -50.39 70.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.777 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.15 -43.28 51.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.987 -1.071 . . . . 0.0 109.96 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 63.7 t -74.76 -32.12 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.009 -1.057 . . . . 0.0 108.348 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.411 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 33.8 tt0 -60.41 -51.74 68.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.3 mmtp -55.15 -49.16 72.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.555 -0.715 . . . . 0.0 109.826 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -58.45 -36.85 74.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.17 -0.956 . . . . 0.0 110.49 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.74 -39.9 61.57 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.749 -1.22 . . . . 0.0 109.831 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.4 mt -70.41 -37.86 74.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.751 -1.218 . . . . 0.0 108.986 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.48 -35.1 79.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.086 -1.009 . . . . 0.0 108.973 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.473 ' O ' HG22 ' A' ' 91' ' ' THR . 4.3 tm-20 -69.84 -36.78 75.84 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -77.47 -12.51 59.97 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.758 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.2 mttm -91.68 -44.02 9.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.33 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 91' ' ' THR . 35.9 ptt180 -60.24 -43.07 96.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.88 -1.138 . . . . 0.0 108.754 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 87' ' ' GLU . 14.8 t -84.71 -37.36 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.092 -1.005 . . . . 0.0 108.697 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.14 165.13 12.38 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.149 -0.969 . . . . 0.0 110.67 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -145.95 143.07 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.557 -0.714 . . . . 0.0 109.269 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -95.13 142.48 27.53 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.116 -0.99 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.56 112.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.548 ' CB ' ' NZ ' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -101.25 131.8 47.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 108.948 179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.69 ' O ' HG11 ' A' ' 72' ' ' VAL . 32.8 p -91.55 -173.75 3.66 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 110.968 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 48.5 mt -70.58 -16.21 62.84 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.229 0.538 . . . . 0.0 109.954 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.872 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.7 p -99.39 -2.64 35.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.17 -0.957 . . . . 0.0 109.614 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.16 1.38 61.14 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.217 179.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.5 tptm -64.42 116.9 6.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.936 -1.332 . . . . 0.0 108.675 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.1 m -99.42 136.63 39.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 32.6 mt -132.98 137.04 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.439 -0.788 . . . . 0.0 109.381 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 32.8 m -105.98 118.91 37.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.213 -0.929 . . . . 0.0 108.81 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.525 HD13 ' CB ' ' B' ' 229' ' ' LYS . 20.7 mt -124.6 122.18 36.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.382 -0.824 . . . . 0.0 110.388 -179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -68.29 133.56 48.96 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.429 HG11 HG22 ' B' ' 226' ' ' VAL . 11.0 m -139.73 -174.24 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.822 -1.173 . . . . 0.0 110.004 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -132.15 154.56 81.7 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.414 -0.804 . . . . 0.0 109.053 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.81 -21.79 58.7 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.573 2.182 . . . . 0.0 112.013 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 28.0 p -103.31 8.17 38.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.653 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -71.73 142.03 49.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.017 . . . . 0.0 109.497 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 33.9 p -85.93 145.63 27.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.909 . . . . 0.0 110.024 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.479 HD12 HD13 ' B' ' 250' ' ' LEU . 36.5 mm -51.62 -21.54 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -37.07 70.06 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.381 -0.825 . . . . 0.0 108.998 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -68.11 -52.52 34.06 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.278 -0.889 . . . . 0.0 109.162 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.429 HG22 HG11 ' B' ' 217' ' ' VAL . 47.9 t -52.24 -46.32 44.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.119 -0.988 . . . . 0.0 108.548 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -43.12 72.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.521 -0.737 . . . . 0.0 109.292 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.61 -33.13 72.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.32 -0.863 . . . . 0.0 109.561 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.525 ' CB ' HD13 ' B' ' 215' ' ' LEU . 22.3 mtpp -60.29 -53.29 59.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.023 -1.048 . . . . 0.0 109.122 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.472 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.4 mp -59.71 -32.01 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.106 -0.996 . . . . 0.0 108.928 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -63.51 -44.76 93.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.097 -1.002 . . . . 0.0 110.073 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -72.37 -23.54 61.14 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 0.0 110.444 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -97.66 -51.39 4.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.953 -1.092 . . . . 0.0 110.672 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -89.4 -7.97 54.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 0.0 111.243 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 70.03 24.34 76.56 Favored Glycine 0 N--CA 1.493 2.439 0 O-C-N 120.497 -1.377 . . . . 0.0 110.577 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 34.0 mt -106.65 131.76 21.45 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.059 -1.259 . . . . 0.0 109.594 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.454 ' HG2' HE21 ' B' ' 240' ' ' GLN . 37.9 Cg_endo -71.15 162.26 43.16 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.204 1.936 . . . . 0.0 112.678 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.94 -34.05 7.0 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.155 2.57 . . . . 0.0 113.131 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -70.62 -5.98 33.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.28 -0.888 . . . . 0.0 111.152 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.454 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -124.22 -26.18 4.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.252 -0.905 . . . . 0.0 111.356 -179.278 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' B' ' 269' ' ' LEU . 2.0 pt20 -88.61 127.74 35.57 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.283 -1.511 . . . . 0.0 109.23 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.42 ' HE ' ' HD2' ' B' ' 272' ' ' ARG . 93.6 mtt180 -111.96 134.93 53.21 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 12.9 mt -105.35 126.02 51.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.437 -0.789 . . . . 0.0 108.91 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.28 134.92 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.567 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.551 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 47.5 t80 -128.11 110.52 12.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.181 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 67.34 39.4 2.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 0.0 109.328 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.5 2.94 45.85 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 120.395 -0.907 . . . . 0.0 110.886 178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.8 ptmt -100.86 137.34 39.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.991 -1.299 . . . . 0.0 109.689 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -84.23 122.33 28.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.963 -1.086 . . . . 0.0 109.292 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.479 HD13 HD12 ' B' ' 223' ' ' ILE . 41.8 mt -71.95 145.74 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.13 -0.981 . . . . 0.0 109.315 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -100.59 144.93 28.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.204 -0.935 . . . . 0.0 109.75 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.1 3.69 4.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.413 -0.804 . . . . 0.0 109.746 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -122.58 43.79 1.41 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -150.06 172.08 15.83 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.145 -1.209 . . . . 0.0 109.325 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.4 p -110.9 159.41 17.72 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.454 -0.779 . . . . 0.0 109.918 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.472 HD23 ' N ' ' B' ' 256' ' ' LEU . 5.8 mt -56.61 -42.16 78.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.692 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 25.1 p -61.21 -27.96 68.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.091 -1.005 . . . . 0.0 109.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.47 -20.15 63.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.46 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -102.78 3.85 37.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.166 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.44 39.34 2.93 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.403 -0.811 . . . . 0.0 109.582 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 65.8 mt -92.94 135.53 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.308 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -124.02 176.56 6.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.409 -0.807 . . . . 0.0 109.418 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.12 159.69 1.19 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 110.978 -179.039 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 56.04 28.49 12.9 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.097 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 12.5 p -91.28 149.65 21.66 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.588 -1.32 . . . . 0.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.778 ' C ' HD12 ' B' ' 267' ' ' LEU . 4.3 m -111.4 135.39 52.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.533 -0.729 . . . . 0.0 109.966 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.778 HD12 ' C ' ' B' ' 266' ' ' THR . 10.7 mp -124.29 140.21 53.17 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.539 -0.726 . . . . 0.0 109.315 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -88.77 142.01 28.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 0.0 109.696 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' B' ' 241' ' ' GLN . 13.5 tp -110.74 129.59 55.8 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.433 -0.792 . . . . 0.0 109.249 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.7 t -120.06 133.09 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.408 -0.808 . . . . 0.0 109.891 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' B' ' 271' ' ' LEU . 47.2 mt -80.68 143.19 33.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.575 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 27.4 ttt180 -93.77 -140.02 0.22 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.34 -0.85 . . . . 0.0 108.733 -179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.575 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 67.0 mt -124.65 -54.38 1.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.416 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.405 ' O ' ' NE ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 109.505 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.6 tttt . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.485 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.4 mt -111.57 131.6 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 110.138 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.0 m -114.87 127.76 55.9 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 87.4 m-85 -112.79 135.74 21.61 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.374 -0.829 . . . . 0.0 109.9 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -48.13 164.65 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.34 2.027 . . . . 0.0 112.956 178.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.8 t -67.13 -2.45 5.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.786 -0.571 . . . . 0.0 110.476 179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.908 ' O ' HG22 ' B' ' 209' ' ' THR . 7.6 m-20 -123.18 9.39 9.23 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.135 -0.978 . . . . 0.0 110.687 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.8 mm -110.72 128.78 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.14 -0.975 . . . . 0.0 110.951 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -97.37 139.3 21.36 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.21 -36.42 4.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.404 2.069 . . . . 0.0 112.97 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -63.82 -40.74 97.34 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.348 -0.845 . . . . 0.0 110.511 -179.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.724 HG11 ' O ' ' B' ' 207' ' ' THR . 21.8 t -80.1 -23.67 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.68 -1.263 . . . . 0.0 109.559 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 24.2 t80 -71.7 -54.0 11.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.245 -0.909 . . . . 0.0 110.718 -179.308 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -61.1 -18.19 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.168 -0.958 . . . . 0.0 110.06 -178.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -82.39 -4.88 58.15 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.142 . . . . 0.0 109.343 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 86.6 mt -89.99 151.96 45.77 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.238 -0.914 . . . . 0.0 109.842 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -55.98 153.34 32.27 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.318 2.012 . . . . 0.0 111.985 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -63.13 -49.53 74.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 110.698 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.64 -44.38 57.35 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.899 -1.126 . . . . 0.0 110.269 -178.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 48.1 t -74.79 -31.07 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 108.377 178.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.9 tt0 -61.58 -49.1 77.99 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.1 mmtp -58.8 -48.55 80.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.623 -0.673 . . . . 0.0 110.148 -179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -56.9 -40.27 75.95 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.057 . . . . 0.0 110.051 -179.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.58 -38.1 67.97 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.882 -1.136 . . . . 0.0 109.741 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.4 mt -70.61 -39.18 73.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.713 -1.242 . . . . 0.0 108.996 178.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.209 -0.932 . . . . 0.0 109.135 179.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.53 ' OE2' ' CZ ' ' A' ' 90' ' ' ARG . 18.0 tp10 -73.14 -35.52 66.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.363 -0.835 . . . . 0.0 108.944 179.06 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.436 ' O ' ' CA ' ' A' ' 92' ' ' GLY . 44.1 m0 -74.9 -16.53 60.66 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.846 179.102 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -89.16 -45.37 9.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.582 -179.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' CZ ' ' OE2' ' A' ' 87' ' ' GLU . 14.8 ptt180 -58.36 -41.83 85.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.865 -1.147 . . . . 0.0 108.821 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.446 ' CG2' ' N ' ' A' ' 92' ' ' GLY . 5.4 t -92.3 -36.88 12.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.96 . . . . 0.0 108.599 178.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.446 ' N ' ' CG2' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.4 ptt? . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.42 166.37 10.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.748 -178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.65 142.92 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.589 -0.694 . . . . 0.0 109.33 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -95.74 143.6 26.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.3 -0.875 . . . . 0.0 109.429 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 31.8 t -123.85 109.05 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.293 -0.879 . . . . 0.0 109.808 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 0.1 OUTLIER -93.09 135.45 34.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.09 -1.006 . . . . 0.0 108.57 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.724 ' O ' HG11 ' A' ' 72' ' ' VAL . 29.5 p -96.26 -174.9 3.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.243 -0.91 . . . . 0.0 110.867 -178.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.573 HD11 ' H ' ' B' ' 271' ' ' LEU . 27.5 mt -72.17 -13.86 61.66 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.908 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.8 p -99.56 -4.11 31.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.451 -0.781 . . . . 0.0 109.558 -179.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 96.08 1.12 61.39 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.4 tptm -67.03 119.05 11.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -1.148 . . . . 0.0 109.118 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 1.7 m -100.09 135.78 41.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.043 179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 43.7 mt -131.25 135.18 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.45 -0.781 . . . . 0.0 109.571 -179.082 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 33.4 m -104.55 120.28 40.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.416 -0.802 . . . . 0.0 108.886 179.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' B' ' 229' ' ' LYS . 26.1 mt -123.85 119.59 30.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.464 -0.772 . . . . 0.0 110.017 -179.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -66.83 131.16 45.33 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.3 m -138.43 -175.57 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.021 -1.05 . . . . 0.0 110.065 -179.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -131.48 154.4 81.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.524 -0.735 . . . . 0.0 109.044 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -58.79 -20.16 50.3 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.599 2.199 . . . . 0.0 112.386 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.4 t -105.24 9.3 34.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.133 -0.98 . . . . 0.0 109.953 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -73.9 142.99 45.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.98 -1.075 . . . . 0.0 109.433 -179.42 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 69.6 p -86.46 147.62 25.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 110.144 -179.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.4 mm -51.64 -33.8 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 108.729 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -33.95 73.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.457 -0.777 . . . . 0.0 109.382 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -71.44 -51.32 24.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 108.954 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 61.7 t -52.6 -50.58 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -50.41 -38.12 41.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.484 0.659 . . . . 0.0 109.265 179.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -65.41 -36.72 84.78 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.585 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.4 mtpp -57.9 -53.15 61.48 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.2 -0.938 . . . . 0.0 109.223 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.43 -35.23 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.062 -1.024 . . . . 0.0 108.566 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -62.53 -45.94 90.66 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.1 -1.0 . . . . 0.0 109.743 179.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.87 -24.12 64.3 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mttm -100.26 -54.52 2.85 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.051 -1.031 . . . . 0.0 110.465 -179.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -85.89 -5.83 59.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.901 . . . . 0.0 111.243 -178.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 64.28 27.01 70.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.594 -1.317 . . . . 0.0 110.321 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.99 128.56 26.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.151 -1.205 . . . . 0.0 109.283 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.449 ' HG2' HE21 ' B' ' 240' ' ' GLN . 47.6 Cg_endo -73.77 157.01 48.37 Favored 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.892 1.728 . . . . 0.0 111.932 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -69.54 -30.84 22.64 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.683 2.256 . . . . 0.0 112.385 -179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -65.4 -9.13 22.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.399 -0.813 . . . . 0.0 110.248 -179.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.449 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.9 -20.33 3.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.382 -0.824 . . . . 0.0 110.431 -179.669 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.39 133.88 34.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.848 -1.158 . . . . 0.0 109.255 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -126.46 134.95 50.83 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 109.457 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 14.8 mt -106.38 126.95 52.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.317 -0.865 . . . . 0.0 109.638 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.03 133.43 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 41.6 t80 -128.49 114.54 16.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.299 -0.876 . . . . 0.0 109.124 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 63.06 46.6 4.62 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.781 -1.199 . . . . 0.0 109.075 -179.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 60.97 6.4 6.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.46 ' CB ' ' NZ ' ' B' ' 248' ' ' LYS . 0.0 OUTLIER -103.22 137.55 41.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -1.143 . . . . 0.0 109.537 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -85.81 128.58 34.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.493 -179.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 28.8 mt -80.25 140.38 36.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -0.948 . . . . 0.0 109.322 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' B' ' 253' ' ' GLY . 11.3 tp10 -90.87 142.62 27.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.588 -179.682 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.568 ' N ' ' OD1' ' B' ' 252' ' ' ASP . 1.0 OUTLIER -68.75 3.69 1.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.474 -0.766 . . . . 0.0 109.791 179.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . 0.421 ' H ' ' HG3' ' B' ' 251' ' ' GLU . . . -127.85 40.94 1.66 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.661 -179.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.51 168.38 19.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.026 -1.279 . . . . 0.0 108.977 179.233 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 21.0 p -106.59 157.45 17.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.288 -0.882 . . . . 0.0 109.522 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.529 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.1 mt -58.46 -42.36 87.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.197 -0.94 . . . . 0.0 110.012 -179.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 40.2 p -61.73 -29.04 69.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.03 . . . . 0.0 109.573 -179.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -70.54 -16.93 62.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.131 -0.981 . . . . 0.0 109.277 179.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -104.56 2.91 31.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.092 179.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.55 38.93 2.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.408 -0.807 . . . . 0.0 109.773 179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 37.7 mt -91.62 136.41 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.185 -0.947 . . . . 0.0 109.308 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . 0.469 ' O ' ' OG ' ' B' ' 265' ' ' SER . 10.4 mt-30 -122.9 172.78 8.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.385 -0.822 . . . . 0.0 109.519 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.439 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.89 162.61 0.42 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.963 0.887 . . . . 0.0 110.844 -178.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 54.46 11.08 0.38 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.81 177.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' B' ' 262' ' ' GLN . 39.0 m -72.08 144.82 48.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.893 -1.129 . . . . 0.0 108.631 178.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.736 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.8 m -111.16 137.08 49.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.441 -0.787 . . . . 0.0 110.296 -179.38 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.736 HD12 ' C ' ' B' ' 266' ' ' THR . 11.3 mp -120.9 162.85 19.15 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 79.4 m80 -108.22 137.44 46.19 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.455 -0.778 . . . . 0.0 109.318 179.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 14.0 tp -106.87 123.07 47.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.364 -0.835 . . . . 0.0 109.009 179.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 73.7 t -110.6 127.11 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.46 -0.775 . . . . 0.0 109.454 -179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.573 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.5 mt -81.46 142.95 32.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.224 179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.522 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 24.5 ttt180 -96.94 -136.65 0.25 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.522 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 51.1 mt -124.24 -49.33 1.82 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.457 -179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 109.577 -179.918 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.7 tttm . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.482 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 38.2 mt -113.45 130.2 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.401 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 99.0 m -114.7 127.52 55.8 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 81.4 m-85 -111.1 135.21 20.89 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 110.134 -179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.02 164.84 0.16 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.257 1.971 . . . . 0.0 112.804 178.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 t -67.85 -2.68 7.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.67 -0.644 . . . . 0.0 110.508 179.84 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.904 ' O ' HG22 ' B' ' 209' ' ' THR . 9.3 m-20 -121.37 6.58 10.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.099 -1.001 . . . . 0.0 110.296 -179.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.7 mm -108.66 128.21 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.834 -179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 2.6 t70 -99.56 140.04 21.31 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.507 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.73 -48.73 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.425 2.084 . . . . 0.0 112.196 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 12.1 tt0 -48.2 -44.19 32.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.698 -0.626 . . . . 0.0 110.228 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG11 ' O ' ' B' ' 207' ' ' THR . 58.1 t -80.27 -23.5 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.006 -1.059 . . . . 0.0 110.439 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 25.4 t80 -72.11 -53.01 14.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.061 -1.024 . . . . 0.0 110.918 -178.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -62.71 -17.36 60.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.178 -0.951 . . . . 0.0 110.093 -178.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.24 -7.32 59.55 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.863 -1.148 . . . . 0.0 109.749 179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.1 mt -89.84 152.39 46.57 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.731 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -56.41 154.58 29.1 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.455 2.103 . . . . 0.0 111.922 179.622 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -62.99 -49.03 76.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 110.833 -179.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.3 -44.75 54.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.951 -1.093 . . . . 0.0 110.24 -178.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 54.5 t -74.73 -29.94 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.023 -1.048 . . . . 0.0 108.426 178.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 32.5 tt0 -61.53 -51.65 67.73 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.7 mmtt -56.88 -49.29 75.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.641 -0.662 . . . . 0.0 110.177 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -56.69 -37.62 71.13 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.107 -0.995 . . . . 0.0 110.451 -178.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.2 mt -74.8 -36.98 62.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.865 -1.147 . . . . 0.0 109.886 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.2 mt -71.01 -39.77 72.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.844 -1.16 . . . . 0.0 109.049 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -62.47 -33.71 75.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.932 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.624 ' O ' HG22 ' A' ' 91' ' ' THR . 54.0 tt0 -70.42 -38.21 74.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 178.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -76.8 -11.7 59.87 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.947 -1.096 . . . . 0.0 108.886 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -90.66 -46.19 8.42 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.2 -0.938 . . . . 0.0 109.142 179.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 91' ' ' THR . 2.0 ptt180 -56.68 -39.76 74.36 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.975 -1.078 . . . . 0.0 108.661 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.624 HG22 ' O ' ' A' ' 87' ' ' GLU . 8.5 t -90.06 -37.62 14.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.095 -1.003 . . . . 0.0 109.142 179.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.46 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.3 ptt? . . . . . 0 N--CA 1.493 1.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -100.19 165.83 11.3 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.094 -1.004 . . . . 0.0 110.572 -178.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.09 145.33 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.593 -0.692 . . . . 0.0 109.681 179.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.0 m-30 -94.02 139.97 30.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.217 -0.927 . . . . 0.0 109.035 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.91 106.88 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.46 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.405 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 12.5 ptpt -92.63 134.89 34.57 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.586 ' O ' HG11 ' A' ' 72' ' ' VAL . 44.4 p -94.58 -177.4 4.21 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 110.541 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.459 HD11 ' HA ' ' B' ' 270' ' ' VAL . 53.5 mt -72.51 -12.12 60.95 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 67' ' ' ASP . 10.7 p -100.95 -3.03 30.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.383 -0.823 . . . . 0.0 109.405 -179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.63 -1.44 63.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.8 tptm -66.07 119.73 11.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.986 -1.302 . . . . 0.0 108.843 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 27.7 m -100.82 137.81 38.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -0.967 . . . . 0.0 109.435 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 57.2 mt -133.58 136.82 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 109.329 -179.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 18.2 m -104.86 119.37 38.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.292 -0.88 . . . . 0.0 108.681 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.569 HD13 ' HB2' ' B' ' 229' ' ' LYS . 19.2 mt -123.16 120.08 32.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.346 -0.846 . . . . 0.0 109.773 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -66.36 132.87 49.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.513 -0.742 . . . . 0.0 109.065 179.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 15.5 m -138.75 -176.85 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.87 -1.144 . . . . 0.0 110.01 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -134.09 154.06 79.96 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.5 -26.85 65.8 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.598 2.199 . . . . 0.0 112.328 -179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 t -97.65 7.18 46.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.218 -0.926 . . . . 0.0 109.922 -179.757 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -72.3 140.67 48.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.079 -1.013 . . . . 0.0 109.34 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 38.5 p -85.92 146.72 26.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.145 -0.972 . . . . 0.0 110.404 -179.446 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 29.2 mm -51.8 -27.25 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.43 -0.794 . . . . 0.0 109.206 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -69.22 -29.24 67.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 109.729 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 43.1 m-20 -75.44 -51.15 13.72 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.039 -1.038 . . . . 0.0 109.279 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 59.2 t -51.72 -47.47 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -51.99 -46.55 64.94 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.43 70.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.374 -0.829 . . . . 0.0 109.621 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.569 ' HB2' HD13 ' B' ' 215' ' ' LEU . 21.5 mtpp -55.95 -53.65 54.3 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.125 -0.984 . . . . 0.0 109.548 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.404 HG13 HD11 ' B' ' 215' ' ' LEU . 2.6 mp -58.2 -34.48 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.043 -1.035 . . . . 0.0 109.257 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . 0.419 ' NE2' ' HD3' ' B' ' 238' ' ' PRO . 7.0 tt0 -62.08 -53.4 55.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.933 -1.104 . . . . 0.0 109.852 179.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -59.25 -29.54 67.63 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 110.558 -178.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -95.92 -57.86 2.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.021 -1.049 . . . . 0.0 110.666 -179.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -84.09 -5.36 59.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.934 . . . . 0.0 111.509 -178.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 65.14 24.83 70.66 Favored Glycine 0 N--CA 1.493 2.482 0 O-C-N 120.524 -1.36 . . . . 0.0 110.462 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.7 mt -104.21 128.48 27.0 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.026 -1.279 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.45 ' HG2' HE21 ' B' ' 240' ' ' GLN . 59.5 Cg_endo -75.71 156.48 39.86 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.124 1.883 . . . . 0.0 111.914 179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . 0.419 ' HD3' ' NE2' ' B' ' 231' ' ' GLN . 43.2 Cg_endo -70.51 -29.19 20.65 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.724 2.283 . . . . 0.0 112.951 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -65.21 -15.51 62.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.146 -0.971 . . . . 0.0 110.304 -179.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.45 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -121.8 -22.47 5.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.483 -0.761 . . . . 0.0 110.481 -179.536 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.97 137.06 32.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.585 -1.322 . . . . 0.0 108.964 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -125.51 132.52 52.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.352 -0.842 . . . . 0.0 109.807 -179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.9 mt -105.36 125.45 51.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.267 -0.896 . . . . 0.0 109.303 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 60.5 mt -120.29 136.17 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.512 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 43.3 t80 -131.6 114.3 14.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.4 -0.813 . . . . 0.0 109.327 -179.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 65.21 39.26 5.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.01 -1.057 . . . . 0.0 109.323 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.0 -1.79 15.97 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -97.65 138.29 35.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.96 -1.318 . . . . 0.0 109.702 -179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -83.47 128.3 34.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.125 -0.985 . . . . 0.0 109.244 -179.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 23.2 mt -78.32 137.29 37.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.029 -1.045 . . . . 0.0 109.326 179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -93.53 146.46 23.77 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.027 -179.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.18 3.95 3.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.383 -0.823 . . . . 0.0 110.074 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -123.19 40.04 2.09 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.624 -179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -147.41 151.35 36.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.113 -1.228 . . . . 0.0 109.272 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 59.8 p -91.16 161.61 15.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -0.958 . . . . 0.0 110.204 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.461 HD23 ' N ' ' B' ' 256' ' ' LEU . 7.5 mt -57.13 -42.38 80.8 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.718 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 77.4 p -60.98 -28.35 68.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 109.75 -179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -70.73 -13.23 61.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.164 179.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -109.9 2.39 19.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.444 -0.785 . . . . 0.0 109.268 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.39 39.61 5.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.471 -0.768 . . . . 0.0 109.253 -179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 41.0 mt -92.79 98.45 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.371 -0.83 . . . . 0.0 109.649 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 17.3 mt-30 -87.37 174.81 8.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 110.052 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.453 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -54.1 165.39 0.5 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.0 0.905 . . . . 0.0 111.262 -178.879 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 55.57 11.58 0.65 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.913 177.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 43.0 m -74.97 148.38 40.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.631 179.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.764 ' C ' HD12 ' B' ' 267' ' ' LEU . 22.2 m -115.14 138.19 51.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.502 -0.748 . . . . 0.0 109.8 -179.471 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.764 HD12 ' C ' ' B' ' 266' ' ' THR . 10.2 mp -121.3 166.41 14.07 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.59 -0.694 . . . . 0.0 109.2 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.405 ' CD2' ' HD2' ' B' ' 206' ' ' LYS . 56.5 m80 -113.04 138.96 49.1 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.493 -0.754 . . . . 0.0 109.637 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 9.4 tp -107.99 124.47 50.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.444 -0.785 . . . . 0.0 109.242 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.459 ' HA ' HD11 ' B' ' 208' ' ' LEU . 2.3 t -115.43 130.26 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.4 ' H ' HD11 ' B' ' 208' ' ' LEU . 41.7 mt -79.0 142.67 36.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.237 -0.914 . . . . 0.0 108.937 179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.472 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 17.4 ttt180 -94.44 -141.27 0.24 Allowed 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.472 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 82.2 mt -124.65 -51.74 1.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 11.5 ttt85 . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.514 -0.741 . . . . 0.0 109.52 179.754 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.483 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 34.5 mt -112.14 129.42 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.101 -0.999 . . . . 0.0 110.022 -179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 66.8 m -112.84 126.08 55.06 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 77.4 m-85 -111.54 134.4 21.23 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.387 -0.82 . . . . 0.0 109.504 -179.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -47.95 164.96 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.404 2.07 . . . . 0.0 112.967 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.84 -2.48 7.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.851 -0.53 . . . . 0.0 110.652 179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.891 ' O ' HG22 ' B' ' 209' ' ' THR . 0.0 OUTLIER -121.19 7.12 10.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.0 110.114 -179.486 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' A' ' 68' ' ' ILE . 28.2 mm -109.97 128.27 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.901 . . . . 0.0 111.178 -178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -98.69 138.73 20.76 Favored Pre-proline 0 N--CA 1.491 1.612 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.17 -31.18 14.97 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.303 2.002 . . . . 0.0 113.112 -179.372 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -69.72 -38.91 77.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.183 -0.948 . . . . 0.0 110.685 -179.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.615 HG11 ' O ' ' B' ' 207' ' ' THR . 98.6 t -79.77 -23.61 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.698 -1.251 . . . . 0.0 109.415 179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.44 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 16.3 t80 -73.4 -54.75 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 111.105 -178.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -61.87 -14.93 38.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.989 -1.069 . . . . 0.0 109.842 -179.123 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -84.35 -7.65 59.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.995 -1.065 . . . . 0.0 109.876 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' B' ' 268' ' ' HIS . 95.4 mt -87.77 151.43 49.99 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 109.532 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' O ' ' C ' ' A' ' 78' ' ' GLU . 10.8 Cg_endo -56.66 128.38 29.77 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.299 1.999 . . . . 0.0 112.172 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 77' ' ' PRO . 28.9 tt0 -40.24 -47.96 2.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.451 -0.78 . . . . 0.0 110.688 -179.174 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.97 -45.36 51.47 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.8 -1.187 . . . . 0.0 109.829 -179.097 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.536 HG11 HG21 ' B' ' 270' ' ' VAL . 86.9 t -74.6 -30.27 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.948 -1.095 . . . . 0.0 108.594 178.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.44 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 34.8 tt0 -60.76 -50.95 71.41 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.183 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -58.29 -47.82 82.46 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.574 -0.704 . . . . 0.0 110.086 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 89.7 mt-10 -57.81 -39.66 78.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.04 -1.038 . . . . 0.0 110.044 -179.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.5 mt -73.4 -36.18 65.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.95 -1.094 . . . . 0.0 109.691 -179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.7 mt -70.61 -38.94 74.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.76 -1.213 . . . . 0.0 108.883 178.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.95 74.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.126 179.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -73.06 -36.21 66.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.293 -0.879 . . . . 0.0 108.863 179.133 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.4 ' CH2' ' CE1' ' A' ' 73' ' ' PHE . 45.1 m0 -75.88 -18.63 59.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.117 -0.989 . . . . 0.0 108.702 178.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.4 mttm -92.55 -41.56 10.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.425 -0.797 . . . . 0.0 109.527 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' CG ' ' N ' ' A' ' 91' ' ' THR . 10.5 ptm180 -59.13 -43.41 91.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.885 -1.134 . . . . 0.0 108.343 179.328 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.49 ' N ' ' CG ' ' A' ' 90' ' ' ARG . 6.1 t -88.16 -37.5 16.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.238 -0.914 . . . . 0.0 108.625 178.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.456 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.4 ' O ' HG23 ' B' ' 217' ' ' VAL . 3.9 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -98.9 167.01 11.02 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -0.995 . . . . 0.0 110.15 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.1 pp -145.02 144.13 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.427 -0.796 . . . . 0.0 109.639 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' B' ' 204' ' ' PHE . 2.5 m-30 -94.07 138.99 31.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.159 -0.963 . . . . 0.0 109.075 179.416 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.98 108.82 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.471 -0.768 . . . . 0.0 109.081 179.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' B' ' 268' ' ' HIS . 13.6 ptpt -95.84 137.77 34.44 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.615 ' O ' HG11 ' A' ' 72' ' ' VAL . 43.7 p -99.22 -175.1 2.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.997 . . . . 0.0 110.662 -178.837 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 23.8 mt -71.96 -9.47 58.41 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.608 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 67' ' ' ASP . 16.2 p -102.83 -4.12 25.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.89 . . . . 0.0 109.397 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.0 1.45 63.06 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -66.86 118.88 10.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.207 -1.173 . . . . 0.0 108.831 179.592 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 5.6 m -101.42 139.54 36.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.288 -0.883 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.716 HD11 ' OE2' ' B' ' 234' ' ' GLU . 50.2 mt -135.02 136.85 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 109.382 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 8.7 m -105.02 118.94 37.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.377 -0.827 . . . . 0.0 108.928 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.552 HD13 ' HB2' ' B' ' 229' ' ' LYS . 20.4 mt -122.51 120.56 34.23 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.943 -179.517 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.99 132.08 47.73 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 201' ' ' MET . 12.2 m -139.6 -175.32 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.08 . . . . 0.0 109.864 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -134.27 154.98 80.26 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.451 -0.781 . . . . 0.0 109.046 179.825 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.65 -21.38 46.84 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.51 2.14 . . . . 0.0 112.207 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.4 7.51 38.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.238 -179.513 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.84 142.12 49.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.865 -1.147 . . . . 0.0 109.389 -179.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.483 ' H ' HD22 ' B' ' 225' ' ' ASN . 72.3 p -87.12 145.36 26.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.334 -0.854 . . . . 0.0 109.814 -179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.44 HD12 HD13 ' B' ' 250' ' ' LEU . 34.3 mm -51.57 -22.86 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.251 -0.906 . . . . 0.0 109.054 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . 0.434 ' CD ' ' O ' ' B' ' 224' ' ' GLU . 0.1 OUTLIER -70.06 -35.47 74.27 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.408 -0.808 . . . . 0.0 109.011 179.773 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.483 HD22 ' H ' ' B' ' 222' ' ' THR . 86.0 m-20 -72.38 -49.88 30.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.262 -0.899 . . . . 0.0 109.358 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 45.5 t -52.21 -51.85 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.043 -1.036 . . . . 0.0 108.775 179.282 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -50.68 -41.01 55.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.547 -0.72 . . . . 0.0 109.482 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.07 83.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.312 -0.868 . . . . 0.0 109.222 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.552 ' HB2' HD13 ' B' ' 215' ' ' LEU . 18.0 mtpp -55.91 -53.6 54.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.13 -0.981 . . . . 0.0 109.332 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.411 HG13 HD11 ' B' ' 215' ' ' LEU . 2.6 mp -58.03 -35.0 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 0.0 109.2 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.18 -39.21 91.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.993 . . . . 0.0 109.773 179.739 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.07 -28.25 62.2 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 110.398 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 24.1 mttm -98.02 -54.15 3.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.021 -1.049 . . . . 0.0 110.668 -179.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . 0.716 ' OE2' HD11 ' B' ' 213' ' ' ILE . 75.7 mm-40 -83.84 -8.73 59.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.12 -0.988 . . . . 0.0 111.254 -178.508 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 67.35 24.65 73.64 Favored Glycine 0 N--CA 1.493 2.451 0 O-C-N 120.526 -1.359 . . . . 0.0 110.513 179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 46.9 mt -105.22 132.17 21.11 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.116 -1.226 . . . . 0.0 109.266 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.429 ' HG2' HE21 ' B' ' 240' ' ' GLN . 38.4 Cg_endo -71.25 161.64 45.09 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.216 1.944 . . . . 0.0 112.617 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -71.61 -34.66 8.91 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 123.158 2.572 . . . . 0.0 113.467 -179.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -71.14 -5.92 35.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.998 -1.064 . . . . 0.0 111.534 -178.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.429 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -122.26 -26.74 4.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.227 -0.921 . . . . 0.0 110.718 -179.366 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.686 ' HB2' HD11 ' B' ' 269' ' ' LEU . 1.7 pt20 -88.96 132.63 34.63 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.431 -1.418 . . . . 0.0 109.156 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -117.95 135.31 54.21 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.362 -0.837 . . . . 0.0 109.682 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 18.3 mt -104.06 124.51 49.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.388 -0.82 . . . . 0.0 109.078 179.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 92.4 mt -118.81 135.14 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.608 -0.682 . . . . 0.0 109.392 -179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.544 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 44.6 t80 -131.36 114.6 15.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 109.023 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 66.26 39.04 4.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.006 -1.059 . . . . 0.0 109.355 -179.613 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.2 -0.23 17.67 Favored Glycine 0 N--CA 1.491 2.359 0 C-N-CA 120.408 -0.901 . . . . 0.0 110.853 178.807 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? -100.34 138.58 37.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.285 . . . . 0.0 109.68 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -84.04 125.93 32.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.138 -0.976 . . . . 0.0 109.527 -179.317 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.44 HD13 HD12 ' B' ' 223' ' ' ILE . 39.8 mt -73.26 145.09 46.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.21 -0.931 . . . . 0.0 109.094 179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -101.09 146.89 26.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.198 -0.939 . . . . 0.0 109.931 -179.561 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.64 3.78 4.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.462 -0.774 . . . . 0.0 109.335 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -120.18 32.85 4.76 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 0.0 110.648 -179.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 22.5 mtt180 -142.42 170.3 15.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.989 -1.301 . . . . 0.0 109.628 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.3 p -110.27 160.97 16.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 0.0 110.135 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.501 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.8 mt -58.15 -44.08 87.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 87.7 p -59.91 -29.06 68.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.145 -0.972 . . . . 0.0 109.427 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.31 -12.02 60.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.254 -0.904 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.656 ' O ' ' ND2' ' B' ' 260' ' ' ASN . 28.1 m-85 -108.12 4.81 25.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.476 -0.765 . . . . 0.0 109.374 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . 0.656 ' ND2' ' O ' ' B' ' 259' ' ' TYR . 0.2 OUTLIER 64.21 36.49 9.41 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.092 0.948 . . . . 0.0 109.911 179.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 90.7 mt -89.73 134.42 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.679 -1.263 . . . . 0.0 109.075 178.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -123.19 174.33 7.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.347 -0.846 . . . . 0.0 109.809 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.433 ' HE3' ' H ' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.17 158.58 1.51 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.42 -0.8 . . . . 0.0 110.724 -178.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' B' ' 264' ' ' GLU . 0.0 OUTLIER 57.21 11.37 1.06 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.427 179.242 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 4.2 m -72.42 144.88 47.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.947 -1.095 . . . . 0.0 108.352 178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.746 ' C ' HD12 ' B' ' 267' ' ' LEU . 26.4 m -111.71 136.9 50.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 -179.23 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.746 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -120.66 166.29 13.89 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.409 ' HB3' HD21 ' A' ' 76' ' ' LEU . 73.2 m80 -112.78 137.94 50.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.402 -0.811 . . . . 0.0 109.678 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' B' ' 241' ' ' GLN . 16.5 tp -108.1 125.19 51.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.379 -0.825 . . . . 0.0 109.236 179.671 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 80' ' ' VAL . 2.3 t -115.22 130.41 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.501 -0.75 . . . . 0.0 109.713 -179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.39 140.47 37.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.264 -0.897 . . . . 0.0 109.226 179.412 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.477 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 21.0 ttt180 -92.09 -141.87 0.19 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.339 -0.851 . . . . 0.0 108.731 -179.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.477 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 78.4 mt -124.62 -41.36 2.15 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.7 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.51 -0.744 . . . . 0.0 109.13 179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.338 0.59 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.413 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 30.8 mt -124.41 133.42 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.613 -0.679 . . . . 0.0 110.525 -179.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.1 m -117.56 128.28 54.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 78.8 m-85 -113.82 134.43 22.09 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.398 -0.814 . . . . 0.0 109.977 -179.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.32 165.37 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.268 1.979 . . . . 0.0 113.026 178.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.7 t -67.98 -2.72 8.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.728 -0.608 . . . . 0.0 110.78 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.941 ' O ' HG22 ' B' ' 209' ' ' THR . 76.3 m-20 -121.54 3.36 10.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.984 -1.073 . . . . 0.0 110.408 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 32.5 mm -105.89 129.57 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.157 -0.964 . . . . 0.0 110.432 -179.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 71' ' ' GLN . 3.5 t70 -98.18 139.05 20.97 Favored Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 -36.97 7.03 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 122.497 2.131 . . . . 0.0 112.693 -179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.569 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 24.1 tt0 -60.75 -42.48 97.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.476 -179.5 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.733 HG11 ' O ' ' B' ' 207' ' ' THR . 36.7 t -80.9 -24.17 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 110.566 -179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.442 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 26.3 t80 -69.83 -54.1 15.13 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.992 -1.067 . . . . 0.0 110.706 -178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -62.36 -16.65 55.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.105 -0.997 . . . . 0.0 109.748 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.47 -7.11 58.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.002 -1.061 . . . . 0.0 109.603 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' B' ' 268' ' ' HIS . 93.3 mt -91.35 152.08 43.42 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 109.693 -179.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -55.51 156.45 17.82 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.304 2.003 . . . . 0.0 111.932 179.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -62.53 -51.49 67.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 110.648 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.64 -43.79 36.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.006 -1.059 . . . . 0.0 110.311 -178.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.2 t -74.55 -31.77 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.0 108.807 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.442 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.0 tt0 -60.25 -49.35 77.96 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -58.93 -48.43 81.51 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.52 -0.737 . . . . 0.0 110.158 179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -57.7 -41.48 81.78 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.049 -1.032 . . . . 0.0 110.496 -179.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.0 mt -70.27 -38.82 75.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.827 -1.17 . . . . 0.0 109.817 -179.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.7 mt -68.79 -37.52 79.34 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.769 -1.207 . . . . 0.0 108.922 178.49 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -61.48 -34.84 76.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 108.954 179.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.446 ' O ' HG22 ' A' ' 91' ' ' THR . 2.6 tm-20 -68.69 -39.43 80.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.417 -0.802 . . . . 0.0 108.9 179.044 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.8 m0 -74.9 -12.71 60.43 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.062 -1.023 . . . . 0.0 109.099 179.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -92.0 -45.54 8.27 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.205 -0.935 . . . . 0.0 109.406 -179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.409 ' HG3' ' N ' ' A' ' 91' ' ' THR . 14.8 ptp180 -57.24 -40.89 78.5 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.809 -1.182 . . . . 0.0 108.201 179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 92' ' ' GLY . 13.7 t -89.16 -36.62 15.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.176 -0.953 . . . . 0.0 108.801 178.872 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.494 2.536 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 9.5 ptt? . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.65 165.92 11.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.173 -0.955 . . . . 0.0 110.588 -178.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.2 pp -143.45 144.07 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.771 . . . . 0.0 109.464 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.419 ' HB2' HG23 ' B' ' 266' ' ' THR . 3.0 m-30 -94.38 142.44 27.41 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 109.357 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.29 112.04 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.315 -0.866 . . . . 0.0 109.684 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 131.27 43.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.17 -0.956 . . . . 0.0 108.725 179.225 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.733 ' O ' HG11 ' A' ' 72' ' ' VAL . 28.0 p -91.29 -175.64 4.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.195 -0.941 . . . . 0.0 110.409 -178.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.707 HD11 ' H ' ' B' ' 271' ' ' LEU . 24.7 mt -71.85 -11.47 60.81 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.218 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.941 HG22 ' O ' ' A' ' 67' ' ' ASP . 11.2 p -101.49 -2.55 30.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.802 -179.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 95.47 0.06 63.13 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -66.02 118.91 10.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.192 -1.181 . . . . 0.0 109.066 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.96 131.01 47.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.201 -0.937 . . . . 0.0 109.341 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 28.3 mt -127.08 134.24 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.488 -0.757 . . . . 0.0 109.501 -179.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 24.9 m -103.3 122.97 45.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.476 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' B' ' 229' ' ' LYS . 24.7 mt -125.95 121.71 33.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.377 -0.827 . . . . 0.0 110.319 -179.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -65.9 130.15 42.26 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.49 -174.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.059 -1.025 . . . . 0.0 109.881 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -137.35 154.61 75.57 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.67 -23.56 41.38 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.491 2.127 . . . . 0.0 112.307 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 95.3 p -101.2 7.26 43.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.158 -0.964 . . . . 0.0 110.015 -179.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.01 141.48 50.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.954 -1.092 . . . . 0.0 109.354 -179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 59.8 p -85.43 149.05 25.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.178 -0.951 . . . . 0.0 109.969 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.7 -40.7 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.425 -0.797 . . . . 0.0 109.513 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -56.86 -33.85 67.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.235 -0.916 . . . . 0.0 109.584 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 14.1 m-20 -68.19 -52.92 28.93 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.001 -1.062 . . . . 0.0 108.897 179.814 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 22.6 t -52.6 -49.15 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.161 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -50.82 -42.35 58.3 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.526 0.679 . . . . 0.0 109.404 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.32 83.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.658 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.593 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.1 mtpp -56.42 -53.19 60.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.086 -1.008 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 3.0 mp -60.97 -32.92 53.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.062 -1.024 . . . . 0.0 109.22 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -62.71 -44.11 97.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.165 -0.959 . . . . 0.0 110.133 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.88 -27.13 61.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.979 -1.075 . . . . 0.0 110.439 -179.151 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 36.3 mttm -93.52 -50.38 5.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.026 -1.046 . . . . 0.0 110.375 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -91.33 -7.29 51.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.196 -0.94 . . . . 0.0 111.441 -178.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 69.47 23.27 76.59 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.382 179.574 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.83 124.07 40.1 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.144 -1.209 . . . . 0.0 109.348 179.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -75.4 155.41 41.09 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 122.027 1.818 . . . . 0.0 112.04 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.79 -30.36 49.86 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.729 2.286 . . . . 0.0 112.961 -179.423 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -66.24 -8.92 27.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 -179.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 -18.15 4.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.449 -0.782 . . . . 0.0 110.222 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.457 ' HG3' HD11 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -92.64 139.31 30.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.97 -1.081 . . . . 0.0 109.57 -179.47 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -130.64 133.45 46.14 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.445 -0.785 . . . . 0.0 109.093 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 11.3 mt -106.01 125.97 51.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.221 -0.925 . . . . 0.0 109.543 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 58.9 mt -120.84 135.63 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.61 -0.681 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -129.65 122.81 29.77 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 0.0 108.806 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 55.93 45.83 23.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 64.27 0.77 4.83 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.634 -0.987 . . . . 0.0 110.634 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -98.07 134.75 40.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.959 -1.318 . . . . 0.0 109.44 -179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -85.02 123.17 30.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.175 -0.953 . . . . 0.0 109.202 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.41 144.2 49.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.269 -0.894 . . . . 0.0 109.71 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -96.93 144.58 26.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.501 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -70.99 3.42 3.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.317 -0.865 . . . . 0.0 109.729 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -124.44 44.03 1.33 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.481 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -148.08 172.57 14.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.13 -1.218 . . . . 0.0 109.56 179.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 66.6 p -110.84 159.52 17.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.417 -0.802 . . . . 0.0 110.195 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.507 HD23 ' N ' ' B' ' 256' ' ' LEU . 3.7 mt -59.23 -43.09 92.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.654 -179.915 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 95.0 p -60.57 -29.33 69.1 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.105 -0.997 . . . . 0.0 109.669 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.03 -14.24 62.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.15 179.667 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -107.65 2.25 23.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 0.0 109.278 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 68.68 39.5 2.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.383 -0.823 . . . . 0.0 109.877 179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 55.3 mt -93.16 135.7 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.177 -0.952 . . . . 0.0 109.525 179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -124.44 175.98 6.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.481 -0.762 . . . . 0.0 109.569 179.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -51.62 162.33 0.4 Allowed 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.852 0.835 . . . . 0.0 110.908 -178.877 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 55.35 11.23 0.55 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.891 177.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.6 m -72.26 144.13 48.52 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.862 -1.149 . . . . 0.0 108.538 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.718 ' C ' HD12 ' B' ' 267' ' ' LEU . 1.7 m -110.73 134.92 52.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.42 -0.8 . . . . 0.0 110.019 -179.136 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.718 HD12 ' C ' ' B' ' 266' ' ' THR . 11.1 mp -120.92 158.07 28.49 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.462 -0.773 . . . . 0.0 109.182 179.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.417 ' HB3' HD21 ' A' ' 76' ' ' LEU . 64.6 m80 -105.72 138.22 42.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.457 HD11 ' HG3' ' B' ' 241' ' ' GLN . 11.9 tp -106.88 124.15 49.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.438 -0.789 . . . . 0.0 108.941 179.333 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 25.1 t -111.36 127.68 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.413 -0.805 . . . . 0.0 109.586 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.707 ' H ' HD11 ' B' ' 208' ' ' LEU . 36.8 mt -80.99 142.14 33.72 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 0.0 109.273 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.542 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 19.3 ttt-85 -91.06 -141.38 0.17 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.542 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 57.3 mt -123.66 -27.83 3.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.576 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.23 -0.919 . . . . 0.0 109.477 -179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.742 0.782 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.532 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 35.2 mt -118.07 134.29 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 121.508 0.671 . . . . 0.0 110.364 -179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.2 m -114.75 127.4 55.72 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CZ ' HG21 ' A' ' 62' ' ' ILE . 79.1 m-85 -113.58 135.97 21.95 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.34 -0.85 . . . . 0.0 110.423 -178.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -47.57 165.27 0.12 Allowed 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.497 2.131 . . . . 0.0 112.859 177.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -1.93 7.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.663 -0.648 . . . . 0.0 110.719 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.938 ' O ' HG22 ' B' ' 209' ' ' THR . 39.3 m-20 -122.37 6.9 9.59 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.057 -1.027 . . . . 0.0 109.97 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 68' ' ' ILE . 27.2 mm -110.54 130.49 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.381 -0.824 . . . . 0.0 110.756 -179.513 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -100.5 139.35 20.56 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -70.54 -45.83 1.07 Allowed 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.441 2.094 . . . . 0.0 112.295 179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -47.35 -48.56 25.55 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.701 -0.625 . . . . 0.0 110.814 -179.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.575 HG11 ' O ' ' B' ' 207' ' ' THR . 59.5 t -78.27 -26.82 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.856 -1.152 . . . . 0.0 110.71 -179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.455 ' CE2' ' HG3' ' A' ' 81' ' ' GLN . 17.4 t80 -65.73 -52.85 47.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.031 -1.043 . . . . 0.0 110.912 -178.733 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.467 ' OH ' HD12 ' A' ' 62' ' ' ILE . 48.4 m-85 -62.33 -18.46 61.48 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.032 -178.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -81.34 -5.72 58.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.863 -1.148 . . . . 0.0 109.558 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' B' ' 268' ' ' HIS . 94.0 mt -89.96 151.86 45.7 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.089 -1.007 . . . . 0.0 109.796 -179.778 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -56.24 156.26 21.61 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.342 2.028 . . . . 0.0 111.887 179.44 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -63.38 -52.45 61.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.48 -43.87 24.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.062 -1.024 . . . . 0.0 110.361 -178.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.487 HG11 HG21 ' B' ' 270' ' ' VAL . 87.1 t -74.82 -31.52 26.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.015 -1.053 . . . . 0.0 108.639 178.84 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.455 ' HG3' ' CE2' ' A' ' 73' ' ' PHE . 31.8 tt0 -60.2 -50.83 72.11 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.037 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -57.27 -48.71 78.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.428 -0.795 . . . . 0.0 110.222 179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -58.12 -43.57 87.27 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.076 -1.015 . . . . 0.0 110.612 -178.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.24 -37.34 77.92 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.914 -1.116 . . . . 0.0 109.739 -179.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 28.8 mt -70.62 -37.21 73.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 108.829 178.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.21 71.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.192 -0.942 . . . . 0.0 109.01 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -75.97 -38.95 56.94 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.345 -0.847 . . . . 0.0 109.121 179.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 32.2 m0 -76.57 -17.86 58.98 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.015 -1.053 . . . . 0.0 108.95 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.0 mttm -92.62 -46.04 7.79 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.324 -0.86 . . . . 0.0 109.094 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.437 ' CG ' ' N ' ' A' ' 91' ' ' THR . 7.7 ptm180 -53.78 -40.07 65.95 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.931 -1.105 . . . . 0.0 108.332 179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 92' ' ' GLY . 3.0 t -93.46 -36.37 12.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.35 -0.844 . . . . 0.0 108.944 178.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 91' ' ' THR . . . . . . . . 0 N--CA 1.493 2.477 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . 0.403 ' O ' HG23 ' B' ' 217' ' ' VAL . 10.9 ptt? . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.63 164.72 12.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.192 -0.942 . . . . 0.0 110.254 -179.276 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 2.0 pp -144.63 142.19 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.559 -0.713 . . . . 0.0 109.311 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -94.41 143.08 26.71 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.274 -0.892 . . . . 0.0 109.731 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.5 t -122.02 109.85 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.186 -0.946 . . . . 0.0 109.659 -179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.46 127.49 42.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.575 ' O ' HG11 ' A' ' 72' ' ' VAL . 23.9 p -87.91 -175.56 5.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 111.065 -178.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.468 HD11 ' H ' ' B' ' 271' ' ' LEU . 23.7 mt -71.68 -16.3 62.24 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.414 0.626 . . . . 0.0 109.347 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.938 HG22 ' O ' ' A' ' 67' ' ' ASP . 9.5 p -98.15 -4.41 35.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 109.443 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 98.48 2.4 57.67 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -66.55 117.1 8.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.084 -1.245 . . . . 0.0 109.106 179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 3.9 m -100.57 132.85 45.74 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.081 -1.012 . . . . 0.0 109.316 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 27.6 mt -130.55 136.79 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.433 -0.792 . . . . 0.0 109.427 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 60.8 m -105.5 121.07 43.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.507 HD13 ' HB2' ' B' ' 229' ' ' LYS . 17.5 mt -125.4 121.88 35.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.351 -0.843 . . . . 0.0 110.268 -179.072 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -68.15 133.22 48.55 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.667 -0.645 . . . . 0.0 109.417 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.475 HG11 HG22 ' B' ' 226' ' ' VAL . 7.6 m -140.19 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.911 -1.118 . . . . 0.0 109.753 179.65 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -136.53 152.84 75.47 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.209 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.26 -26.96 54.63 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.565 2.177 . . . . 0.0 112.271 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.5 p -99.38 5.99 46.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.216 -0.927 . . . . 0.0 109.785 -179.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -71.03 143.38 50.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.098 -1.001 . . . . 0.0 109.716 -179.33 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 70.4 p -87.09 147.13 25.8 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.729 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.422 HD12 HD13 ' B' ' 250' ' ' LEU . 32.8 mm -52.78 -42.47 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.892 . . . . 0.0 109.614 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -52.09 -32.04 33.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.201 -0.937 . . . . 0.0 109.671 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -73.38 -53.11 11.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.011 -1.055 . . . . 0.0 109.223 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.475 HG22 HG11 ' B' ' 217' ' ' VAL . 39.1 t -52.49 -42.18 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.166 -0.959 . . . . 0.0 108.599 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.511 ' NZ ' ' OD1' ' B' ' 252' ' ' ASP . 6.1 ttmt -58.48 -42.47 87.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -61.19 -33.47 73.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.721 . . . . 0.0 109.264 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.507 ' HB2' HD13 ' B' ' 215' ' ' LEU . 20.1 mtpp -58.63 -53.16 61.5 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 108.94 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.592 ' H ' HD12 ' B' ' 230' ' ' ILE . 3.9 mp -59.99 -32.98 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 109.13 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -62.41 -45.11 94.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.051 -1.03 . . . . 0.0 110.025 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -73.32 -23.86 60.31 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.09 -1.006 . . . . 0.0 110.49 -179.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -95.36 -50.59 4.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.941 -1.099 . . . . 0.0 110.039 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -91.86 -5.74 52.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.385 -0.822 . . . . 0.0 111.44 -178.678 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 66.11 22.86 71.04 Favored Glycine 0 N--CA 1.492 2.4 0 O-C-N 120.53 -1.356 . . . . 0.0 110.371 179.586 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 62.3 mt -101.66 130.45 24.59 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.087 -1.243 . . . . 0.0 109.403 179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.439 ' HG2' HE21 ' B' ' 240' ' ' GLN . 54.7 Cg_endo -74.04 156.7 47.31 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.051 1.834 . . . . 0.0 111.949 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -70.47 -31.94 16.49 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.734 2.289 . . . . 0.0 112.785 -179.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 52.1 p30 -66.95 -7.16 20.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.188 -0.945 . . . . 0.0 110.061 -179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.439 HE21 ' HG2' ' B' ' 237' ' ' PRO . 0.0 OUTLIER -128.52 -22.33 3.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.503 -0.748 . . . . 0.0 110.307 -179.592 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.83 138.15 31.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.687 -1.258 . . . . 0.0 108.93 179.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -128.54 132.99 48.28 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.325 -0.859 . . . . 0.0 109.654 -179.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 13.4 mt -105.5 125.85 51.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.433 -0.792 . . . . 0.0 109.174 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.17 134.23 63.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.597 -0.69 . . . . 0.0 109.505 -179.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.504 ' O ' ' HB3' ' B' ' 246' ' ' ALA . 49.3 t80 -127.84 112.62 14.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 0.0 109.149 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' B' ' 245' ' ' PHE . . . 64.56 40.68 5.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.94 -1.1 . . . . 0.0 109.041 -179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 66.74 17.06 66.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.475 ' HZ3' ' HB2' ' B' ' 248' ' ' LYS . 1.4 ptmm? -112.18 135.52 52.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -1.153 . . . . 0.0 109.437 179.88 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -85.32 125.75 33.18 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.037 -1.039 . . . . 0.0 109.53 -179.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.422 HD13 HD12 ' B' ' 223' ' ' ILE . 25.8 mt -80.28 143.99 33.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.624 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -105.33 147.2 28.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.772 -179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . 0.511 ' OD1' ' NZ ' ' B' ' 227' ' ' LYS . 18.0 m-20 -69.72 3.37 2.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.814 . . . . 0.0 109.929 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -118.83 42.2 1.84 Allowed Glycine 0 N--CA 1.495 2.567 0 C-N-CA 120.082 -1.056 . . . . 0.0 110.855 -179.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.4 mtt85 -150.51 172.89 14.76 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.078 -1.248 . . . . 0.0 109.475 179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 73.0 p -113.28 157.39 21.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.456 -0.777 . . . . 0.0 110.198 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.475 HD23 ' N ' ' B' ' 256' ' ' LEU . 6.8 mt -56.12 -43.63 78.33 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.318 -0.864 . . . . 0.0 109.271 179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 67.9 p -60.49 -28.97 68.78 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.82 -16.75 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.285 -0.884 . . . . 0.0 108.819 179.21 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -106.52 0.99 25.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.482 -0.761 . . . . 0.0 108.983 179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' B' ' 260' ' ' ASN . 0.9 OUTLIER 66.33 39.42 4.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.452 -0.78 . . . . 0.0 109.879 179.843 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 42.2 mt -91.04 138.34 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -124.69 175.37 7.26 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.309 -0.869 . . . . 0.0 109.715 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . 0.57 ' H ' ' HD2' ' B' ' 263' ' ' LYS . 0.0 OUTLIER -53.63 161.14 1.13 Allowed 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.862 0.839 . . . . 0.0 110.913 -179.073 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 58.17 10.54 1.27 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.328 177.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.1 m -75.35 149.69 38.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.891 -1.131 . . . . 0.0 108.682 179.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . 0.781 ' C ' HD12 ' B' ' 267' ' ' LEU . 10.3 m -114.32 137.41 51.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.468 -0.77 . . . . 0.0 110.071 -179.374 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.781 HD12 ' C ' ' B' ' 266' ' ' THR . 10.8 mp -124.44 139.62 53.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -0.81 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.405 ' HB3' HD21 ' A' ' 76' ' ' LEU . 42.5 m80 -88.89 142.6 27.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.91 -179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 11.6 tp -109.42 126.96 54.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.152 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.487 HG21 HG11 ' A' ' 80' ' ' VAL . 4.4 t -113.96 128.61 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.468 ' H ' HD11 ' B' ' 208' ' ' LEU . 50.1 mt -82.03 143.91 31.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.31 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.515 ' HG2' ' H ' ' B' ' 273' ' ' LEU . 27.9 ttt180 -96.05 -135.78 0.23 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.515 ' H ' ' HG2' ' B' ' 272' ' ' ARG . 49.2 mt -122.86 -26.98 4.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.238 -0.914 . . . . 0.0 108.992 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.57 ' C ' ' NE ' ' B' ' 274' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.35 -0.844 . . . . 0.0 109.089 179.778 . . . . . . . . 2 2 . 1 stop_ save_